Citrus Sinensis ID: 011627
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 481 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFT8 | 505 | Cyclin-dependent kinase C | yes | no | 0.956 | 0.910 | 0.790 | 0.0 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.962 | 0.902 | 0.775 | 0.0 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | yes | no | 0.975 | 0.914 | 0.781 | 0.0 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.852 | 0.789 | 0.806 | 0.0 | |
| Q6ZAG3 | 324 | Cyclin-dependent kinase C | no | no | 0.586 | 0.870 | 0.613 | 3e-96 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | yes | no | 0.733 | 0.233 | 0.463 | 4e-93 | |
| D2H526 | 1491 | Cyclin-dependent kinase 1 | yes | no | 0.648 | 0.209 | 0.517 | 9e-93 | |
| Q14AX6 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.648 | 0.210 | 0.514 | 4e-92 | |
| Q3MJK5 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.648 | 0.210 | 0.514 | 5e-92 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.648 | 0.251 | 0.514 | 5e-92 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 743 bits (1919), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/482 (79%), Positives = 414/482 (85%), Gaps = 22/482 (4%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI+LKEIVTSPG +
Sbjct: 39 QVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIQLKEIVTSPGRD 98
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
RD+QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN
Sbjct: 99 RDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 158
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKY
Sbjct: 159 QVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKY 218
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPA+DMWSVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE +WPGVSKMP +N+FK
Sbjct: 219 GPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDEKLWPGVSKMPWFNNFK 278
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
P+R +KRRVRE FRHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP
Sbjct: 279 PARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLP 338
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQHAGQSH---HW-SGPNH 361
YESSHE+QTKK+RQQQRQ+EEA KRQKL H P H RLPP+QH GQSH HW +GPNH
Sbjct: 339 TYESSHEFQTKKKRQQQRQNEEAAKRQKLQHPPLQHSRLPPLQHGGQSHAAPHWPAGPNH 398
Query: 362 PMNNAPPPVPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPP 420
P NNAPP VP GP H+ YGKPRGPP G NRY PSGNQSGGYN GGYS+ YPP
Sbjct: 399 PTNNAPPQVPAGPSHNFYGKPRGPP-GPNRYPPSGNQSGGYNQSR-----GGYSSGSYPP 452
Query: 421 QGRGPPYAGAGMPANGPRGPASG-YGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGW 479
QGRG PY GPRGP+ G YGVGP +Y+Q GQYG S + + RNQQYGW
Sbjct: 453 QGRGAPYVA------GPRGPSGGPYGVGPPNYTQGGQYGGSGSS---GRGQNQRNQQYGW 503
Query: 480 QQ 481
QQ
Sbjct: 504 QQ 505
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 720 bits (1858), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/485 (77%), Positives = 409/485 (84%), Gaps = 22/485 (4%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPG +
Sbjct: 39 QVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIHLKEIVTSPGRD 98
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
RD+QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN
Sbjct: 99 RDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 158
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKY
Sbjct: 159 QVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKY 218
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPA+DMWSVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K
Sbjct: 219 GPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMK 278
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
SR +KRRVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP
Sbjct: 279 SSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLP 338
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHHP-QPHGRLPPIQH-AGQSHH---W-SGPN 360
YESSHE+QTKK+RQQ R +EEA K+QKL HP Q H RLPP QH GQSH W +GPN
Sbjct: 339 TYESSHEFQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSHAAPLWPAGPN 398
Query: 361 HPM-NNAPPP-VPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAP 417
HPM NNAPPP +P G GH++ GKPRG NRY PSGNQ+GGYNN +R GGYS+
Sbjct: 399 HPMNNNAPPPQIPAG-GHYYGGKPRGGAPVPNRYPPSGNQTGGYNNQSR----GGYSSGA 453
Query: 418 YPPQGRGPPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRNQ 475
YPPQGRG PY GPRGP+ GYGVGP S G+ +GRG N MGG+RNQ
Sbjct: 454 YPPQGRGAPYGA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARNQ 507
Query: 476 QYGWQ 480
QYGWQ
Sbjct: 508 QYGWQ 512
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 693 bits (1788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/481 (78%), Positives = 404/481 (83%), Gaps = 12/481 (2%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MA+E +T EIVALKKIRMDNE+EGFPITAIREIKILKKL H+NVI+LKEIVTSPGPE
Sbjct: 38 QVYMAKETETNEIVALKKIRMDNEREGFPITAIREIKILKKLHHQNVIQLKEIVTSPGPE 97
Query: 67 RDEQGRP-DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
RDEQG+P +GNKY+GS YMVFEYMDHDLTGLADRPG+RFTVPQIKCYM+QLLTGLHYCHV
Sbjct: 98 RDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHV 157
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLG+T+
Sbjct: 158 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNGNLTNRVITLWYRPPELLLGSTR 217
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
YGPAVDMWSVGCIFAELLNGKPIL GKNE EQLSKIFELCG+PDE IWPGV+KMP YN+F
Sbjct: 218 YGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFELCGTPDELIWPGVTKMPWYNNF 277
Query: 246 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 305
KP R MKRRV+E F+HFD+HAL+LLEKML LDPSQRISAKDALD+EYFWTDPLPCDPKSL
Sbjct: 278 KPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSL 337
Query: 306 PKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNN 365
PKYE+SHE+QTKK+RQQQRQ EEA KRQKL HP PH RLPPIQ+ GQ H P PM+N
Sbjct: 338 PKYEASHEFQTKKKRQQQRQAEEAAKRQKLQHPPPHSRLPPIQNPGQPHQIR-PGQPMHN 396
Query: 366 APPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQ---G 422
A PPV GP HHY KPRG PGG NRYP G GGY NPNRGGQGGGY + PYP Q
Sbjct: 397 A-PPVAAGPS-HHYAKPRG-PGGPNRYPQGGNQGGY-NPNRGGQGGGYGSGPYPQQGRGP 452
Query: 423 RGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPN-QMGGSRN-QQYG-W 479
P G G G SGYGVG +Y Q G YG S GRGPN GGSRN QQYG W
Sbjct: 453 PPYPGGGMGGAGGPRGGGGSGYGVGGPNYQQGGPYGASGPGRGPNYNQGGSRNQQQYGNW 512
Query: 480 Q 480
Q
Sbjct: 513 Q 513
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 675 bits (1741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/414 (80%), Positives = 364/414 (87%), Gaps = 4/414 (0%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MARE +T EIVALKKIRMDNE+EGFPITAIREIKILKKL H+NVI+LKEIVTSPGPE
Sbjct: 38 QVYMARETETQEIVALKKIRMDNEREGFPITAIREIKILKKLHHQNVIQLKEIVTSPGPE 97
Query: 67 RDEQGRP-DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
RDEQG+P GNKY+GS YMVFEYMDHDLTGLADRPG+RFTVPQIKCYMKQLLTGLHYCH+
Sbjct: 98 RDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMKQLLTGLHYCHI 157
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLG+TK
Sbjct: 158 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNGNLTNRVITLWYRPPELLLGSTK 217
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
YGPAVDMWSVGCIFAELLNGKPILPGKNE EQLSKIF++CG+PDE+ WPGV+KMP YN+F
Sbjct: 218 YGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFDVCGTPDESNWPGVTKMPWYNNF 277
Query: 246 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 305
KP R +KRRV+E F+HFDR AL+LLEKML LDP+QRISA+DALD+EYFW+DPLPCDPKSL
Sbjct: 278 KPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRISAQDALDAEYFWSDPLPCDPKSL 337
Query: 306 PKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNN 365
PKYESSHE+QTKK+RQQ RQ +EA KRQK HPQPHGRLPPIQ GQ H P PMNN
Sbjct: 338 PKYESSHEFQTKKKRQQMRQADEAAKRQKTQHPQPHGRLPPIQQTGQPHPQIRPGQPMNN 397
Query: 366 APPPVPGGPGHHHYGKPRGPPGGANRYPS-GNQSGGYNNPNRGGQGGGYSNAPY 418
P+ GPG HHY KPRG PGG++RYP GNQ GGY N G GG Y NAPY
Sbjct: 398 PHAPMAAGPG-HHYAKPRG-PGGSSRYPQGGNQGGGYPNRGGQGGGGSYGNAPY 449
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6ZAG3|CDKC3_ORYSJ Cyclin-dependent kinase C-3 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 352 bits (903), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 178/290 (61%), Positives = 214/290 (73%), Gaps = 8/290 (2%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+VF A +I TGE ALKKI++D+ KEGFP +REIK+LKKL HEN+I+LKEIV SPG
Sbjct: 40 EVFEAMDIITGERAALKKIKLDDGKEGFPRQILREIKLLKKLDHENIIRLKEIVVSPGTA 99
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
G D YRG YMVFEYMDHDL + T Q+K YM+QLL GLHYCHVN
Sbjct: 100 HGAGG-SDDYMYRGDIYMVFEYMDHDLKKVLHHS----TPSQVKYYMEQLLKGLHYCHVN 154
Query: 127 QVLHRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
VLHRDIKG+NLLI G L KLADFGLAR F+ D + TN VITLWYRPPELLLGAT
Sbjct: 155 NVLHRDIKGANLLISGGGKLLKLADFGLARPFTRD--GSFTNHVITLWYRPPELLLGATN 212
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y AVD+WSVGCIFAE L KP+ PG+ E EQLSKIFELCG P+E WPGVSK+P Y
Sbjct: 213 YAEAVDIWSVGCIFAEFLLRKPLFPGRTEQEQLSKIFELCGFPNEENWPGVSKLPLYKTI 272
Query: 246 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295
+P+ KRR+R++F +FD HA++L+++ML+L+P++RISA DAL + YF T
Sbjct: 273 RPTTPTKRRLRDIFHNFDSHAVDLIDRMLILNPTERISAHDALCAAYFIT 322
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 4e-93, Method: Compositional matrix adjust.
Identities = 176/380 (46%), Positives = 235/380 (61%), Gaps = 27/380 (7%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+ AR+ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H+++I +KEIVT
Sbjct: 718 QVYKARDKDTGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVT----- 772
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D++ D K +G+ Y+VFEYMDHDL GL + + F IK +M+QL+ GL YCH
Sbjct: 773 -DKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYCHKK 831
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
LHRDIK SN+L++N G +KLADFGLAR +S + + TN+VITLWYRPPELLLG +Y
Sbjct: 832 NFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYRPPELLLGEERY 891
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
PA+D+WS GCI EL KPI E QL I +CGSP +WP V K+P +N K
Sbjct: 892 TPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDVIKLPYFNTMK 951
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW-TDPLPCDPKSL 305
P + +R++RE F AL+L + ML LDPS+R +A+ AL E+ +P P L
Sbjct: 952 PKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEFLRDVEPSKMPPPDL 1011
Query: 306 PKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQ--------------PHGRLPPIQHAG 351
P ++ HE +KKRR +Q+Q + P+ P G LPP Q
Sbjct: 1012 PLWQDCHELWSKKRR-RQKQMGMTDDLSTIKAPRKDLSLGLDDSRTNTPQGVLPPAQLKS 1070
Query: 352 QSHH-----WSGPNHPMNNA 366
QS+ +GP P+N++
Sbjct: 1071 QSNSNVAPVITGPGQPLNHS 1090
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 341 bits (874), Expect = 9e-93, Method: Compositional matrix adjust.
Identities = 165/319 (51%), Positives = 216/319 (67%), Gaps = 7/319 (2%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+ A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H +V+ +KEIVT
Sbjct: 741 QVYKAKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLIHRSVVNMKEIVT----- 795
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D+Q D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQL+ GL YCH
Sbjct: 796 -DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKK 854
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
LHRDIK SN+L++N G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y
Sbjct: 855 NFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 914
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
PA+D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N K
Sbjct: 915 TPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK 974
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP-CDPKSL 305
P + +RR+RE F AL+LL+ ML LDPS+R +A+ L S++ L DP L
Sbjct: 975 PKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMDPPDL 1034
Query: 306 PKYESSHEYQTKKRRQQQR 324
P ++ HE +KKRR+Q++
Sbjct: 1035 PHWQDCHELWSKKRRRQRQ 1053
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14AX6|CDK12_MOUSE Cyclin-dependent kinase 12 OS=Mus musculus GN=Cdk12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 338 bits (868), Expect = 4e-92, Method: Compositional matrix adjust.
Identities = 164/319 (51%), Positives = 216/319 (67%), Gaps = 7/319 (2%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+ A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H++V+ +KEIVT
Sbjct: 736 QVYKAKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLVHQSVVNMKEIVT----- 790
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D+Q D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQL+ GL YCH
Sbjct: 791 -DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKK 849
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
LHRDIK SN+L++N G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y
Sbjct: 850 NFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 909
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
PA+D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N K
Sbjct: 910 TPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK 969
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP-CDPKSL 305
P + +RR+RE F AL+LL+ ML LDPS+R +A+ L S++ L P L
Sbjct: 970 PKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMAPPDL 1029
Query: 306 PKYESSHEYQTKKRRQQQR 324
P ++ HE +KKRR+Q++
Sbjct: 1030 PHWQDCHELWSKKRRRQRQ 1048
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (867), Expect = 5e-92, Method: Compositional matrix adjust.
Identities = 164/319 (51%), Positives = 216/319 (67%), Gaps = 7/319 (2%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+ A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H++V+ +KEIVT
Sbjct: 736 QVYKAKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLVHQSVVNMKEIVT----- 790
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D+Q D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQL+ GL YCH
Sbjct: 791 -DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKK 849
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
LHRDIK SN+L++N G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y
Sbjct: 850 NFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 909
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
PA+D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N K
Sbjct: 910 TPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK 969
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP-CDPKSL 305
P + +RR+RE F AL+LL+ ML LDPS+R +A+ L S++ L P L
Sbjct: 970 PKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMAPPDL 1029
Query: 306 PKYESSHEYQTKKRRQQQR 324
P ++ HE +KKRR+Q++
Sbjct: 1030 PHWQDCHELWSKKRRRQRQ 1048
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (867), Expect = 5e-92, Method: Compositional matrix adjust.
Identities = 164/319 (51%), Positives = 216/319 (67%), Gaps = 7/319 (2%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+ A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H++V+ +KEIVT
Sbjct: 723 QVYKAKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLIHKSVVNMKEIVT----- 777
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D+Q D K +G+ Y+VFEYMDHDL GL + ++F+ IK +MKQL+ GL YCH
Sbjct: 778 -DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDHIKSFMKQLMEGLEYCHKK 836
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
LHRDIK SN+L++N G +KLADFGLAR +S + + TN+VITLWYRPPELLLG +Y
Sbjct: 837 NFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVITLWYRPPELLLGEERY 896
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
PA+D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N K
Sbjct: 897 TPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK 956
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW-TDPLPCDPKSL 305
P + +RR+RE F AL+LL+ ML LDPS+R +A+ L S++ D L
Sbjct: 957 PKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVDVCKMATPDL 1016
Query: 306 PKYESSHEYQTKKRRQQQR 324
P ++ HE +KKRR+Q++
Sbjct: 1017 PHWQDCHELWSKKRRRQRQ 1035
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 481 | ||||||
| 225435987 | 517 | PREDICTED: cyclin-dependent kinase C-1-l | 0.985 | 0.916 | 0.808 | 0.0 | |
| 255553496 | 516 | ATP binding protein, putative [Ricinus c | 0.985 | 0.918 | 0.791 | 0.0 | |
| 15238114 | 505 | cyclin-dependent kinase C-1 [Arabidopsis | 0.956 | 0.910 | 0.790 | 0.0 | |
| 350537283 | 512 | cyclin dependent kinase C [Solanum lycop | 0.983 | 0.923 | 0.777 | 0.0 | |
| 356501366 | 516 | PREDICTED: cyclin-dependent kinase C-2-l | 0.985 | 0.918 | 0.785 | 0.0 | |
| 297794099 | 514 | cyclin-dependent kinase C_2 [Arabidopsis | 0.964 | 0.902 | 0.788 | 0.0 | |
| 297811129 | 505 | cyclin-dependent kinase C_1 [Arabidopsis | 0.958 | 0.912 | 0.777 | 0.0 | |
| 15238314 | 513 | cyclin-dependent kinase C-2 [Arabidopsis | 0.962 | 0.902 | 0.775 | 0.0 | |
| 17064746 | 513 | cdc2-like protein kinase [Arabidopsis th | 0.962 | 0.902 | 0.773 | 0.0 | |
| 356574675 | 520 | PREDICTED: cyclin-dependent kinase C-1-l | 0.985 | 0.911 | 0.778 | 0.0 |
| >gi|225435987|ref|XP_002272429.1| PREDICTED: cyclin-dependent kinase C-1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1922), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/481 (80%), Positives = 422/481 (87%), Gaps = 7/481 (1%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MAREIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVIKLKEIVTSPGPE
Sbjct: 38 QVYMAREIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIKLKEIVTSPGPE 97
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+D+QGRPDGNKY+G YMVFEYMDHDLTGLADRPG+RF+VPQIKCYM+QLLTGLHYCHVN
Sbjct: 98 KDDQGRPDGNKYKGGIYMVFEYMDHDLTGLADRPGMRFSVPQIKCYMRQLLTGLHYCHVN 157
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLG T+Y
Sbjct: 158 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNGNLTNRVITLWYRPPELLLGTTRY 217
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPAVDMWSVGCIFAELL+GKPI PGK+E EQL+KIFELCG+PDE WPGVSK+P Y++FK
Sbjct: 218 GPAVDMWSVGCIFAELLHGKPIFPGKDEPEQLNKIFELCGAPDEVNWPGVSKIPWYSNFK 277
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
P+R MKRR+REVFRHFDRHALELLE+ML LDPSQRISAKDALD+EYFWTDPLPCDPKSLP
Sbjct: 278 PTRPMKRRLREVFRHFDRHALELLERMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLP 337
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHW--SGPNHPMN 364
KYESSHE+QTKK+RQQQRQH+E KRQKL HPQ H RLPPIQ +GQ H +GPN PM+
Sbjct: 338 KYESSHEFQTKKKRQQQRQHDETAKRQKLQHPQQHARLPPIQQSGQVHAQMRAGPNQPMH 397
Query: 365 -NAPPPVPGGPGHHHYGKPRGPPGGANRYP-SGNQSGGYNNPNR--GGQGGGYSNAPYPP 420
+ PPV GP HHYGKPRGP GG +RYP SGN SGGYN+PNR G GGGY N P+PP
Sbjct: 398 GGSQPPVAAGPS-HHYGKPRGPSGGPSRYPQSGNPSGGYNHPNRGGQGGGGGYGNGPFPP 456
Query: 421 QGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQ 480
QGRGPPYA +GMP GPRG SGYGVG +Y Q G Y S AGRG N MGG+RNQ YGWQ
Sbjct: 457 QGRGPPYASSGMPGAGPRGGGSGYGVGAPNYPQGGPYSGSGAGRGSNMMGGNRNQNYGWQ 516
Query: 481 Q 481
Q
Sbjct: 517 Q 517
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255553496|ref|XP_002517789.1| ATP binding protein, putative [Ricinus communis] gi|223543061|gb|EEF44596.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1920), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/480 (79%), Positives = 414/480 (86%), Gaps = 6/480 (1%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MAREIKT EIVALKKIRMDNE+EGFPITAIREIKILKKL HENVIKLKEIVTSPG E
Sbjct: 38 QVYMAREIKTNEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIKLKEIVTSPGSE 97
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+DEQG+PDGNKY+G YMVFEYMDHDLTGLADRPG++F+VPQIKCYM+QLLTGLHYCHVN
Sbjct: 98 KDEQGKPDGNKYKGGIYMVFEYMDHDLTGLADRPGMKFSVPQIKCYMRQLLTGLHYCHVN 157
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARSFS +HN LTNRVITLWYRPPELLLG TKY
Sbjct: 158 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNEHNANLTNRVITLWYRPPELLLGTTKY 217
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPAVDMWSVGCIFAELL GKPI PGK+E EQ++KIFELCG+PDE WPGVSKMP YN+FK
Sbjct: 218 GPAVDMWSVGCIFAELLYGKPIFPGKDEPEQINKIFELCGAPDEVNWPGVSKMPWYNNFK 277
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
P+R MKRR+R++FR FDRHALELLEKML LDPSQRISAKDALD+EYFWTDPLPCDPKSLP
Sbjct: 278 PNRPMKRRLRDLFRGFDRHALELLEKMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLP 337
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSH--HWSGPNHPMN 364
KYESSHE+QTKK+RQQQRQHEE KRQKL HPQ HGRLPPIQ +GQ+H SGPN M+
Sbjct: 338 KYESSHEFQTKKKRQQQRQHEENAKRQKLQHPQQHGRLPPIQQSGQAHVQMRSGPNQQMH 397
Query: 365 NAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNR---GGQGGGYSNAPYPPQ 421
++ PV GP HHYGKPRGP GG RYP SGGYN+PNR GG GGGY + PYPPQ
Sbjct: 398 SSQAPVAAGPS-HHYGKPRGPAGGPGRYPPSGTSGGYNHPNRGGGGGGGGGYGSGPYPPQ 456
Query: 422 GRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 481
GR PPY +GMP G +SGYGVG +Y Q YG+S AGRG N MGG+RNQQYGWQQ
Sbjct: 457 GRAPPYGSSGMPGAPRGGGSSGYGVGAPNYPQGAPYGSSGAGRGSNMMGGNRNQQYGWQQ 516
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15238114|ref|NP_196589.1| cyclin-dependent kinase C-1 [Arabidopsis thaliana] gi|75334961|sp|Q9LFT8.1|CDKC1_ARATH RecName: Full=Cyclin-dependent kinase C-1; Short=CDKC;1 gi|14030693|gb|AAK53021.1|AF375437_1 AT5g10270/F18D22_40 [Arabidopsis thaliana] gi|8953408|emb|CAB96683.1| cdc2-like protein kinase [Arabidopsis thaliana] gi|21464557|gb|AAM52233.1| AT5g10270/F18D22_40 [Arabidopsis thaliana] gi|332004132|gb|AED91515.1| cyclin-dependent kinase C-1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1919), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/482 (79%), Positives = 414/482 (85%), Gaps = 22/482 (4%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI+LKEIVTSPG +
Sbjct: 39 QVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIQLKEIVTSPGRD 98
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
RD+QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN
Sbjct: 99 RDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 158
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKY
Sbjct: 159 QVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKY 218
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPA+DMWSVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE +WPGVSKMP +N+FK
Sbjct: 219 GPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDEKLWPGVSKMPWFNNFK 278
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
P+R +KRRVRE FRHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP
Sbjct: 279 PARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLP 338
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQHAGQSH---HW-SGPNH 361
YESSHE+QTKK+RQQQRQ+EEA KRQKL H P H RLPP+QH GQSH HW +GPNH
Sbjct: 339 TYESSHEFQTKKKRQQQRQNEEAAKRQKLQHPPLQHSRLPPLQHGGQSHAAPHWPAGPNH 398
Query: 362 PMNNAPPPVPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPP 420
P NNAPP VP GP H+ YGKPRGPP G NRY PSGNQSGGYN GGYS+ YPP
Sbjct: 399 PTNNAPPQVPAGPSHNFYGKPRGPP-GPNRYPPSGNQSGGYNQSR-----GGYSSGSYPP 452
Query: 421 QGRGPPYAGAGMPANGPRGPASG-YGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGW 479
QGRG PY GPRGP+ G YGVGP +Y+Q GQYG S + + RNQQYGW
Sbjct: 453 QGRGAPYVA------GPRGPSGGPYGVGPPNYTQGGQYGGSGSS---GRGQNQRNQQYGW 503
Query: 480 QQ 481
QQ
Sbjct: 504 QQ 505
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350537283|ref|NP_001234799.1| cyclin dependent kinase C [Solanum lycopersicum] gi|15215944|emb|CAC51391.1| cyclin dependent kinase C [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/477 (77%), Positives = 402/477 (84%), Gaps = 4/477 (0%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MAR+ +TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKL EIVTS GPE
Sbjct: 38 QVYMARDKQTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLLEIVTSQGPE 97
Query: 67 RDEQGR--PDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
DE + D NKY+G+ YMVFEYMDHDLTGLADRPGLRFT+PQIKCYMKQLLTGLHYCH
Sbjct: 98 EDEPEKLGIDSNKYKGNIYMVFEYMDHDLTGLADRPGLRFTIPQIKCYMKQLLTGLHYCH 157
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
+NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLGAT
Sbjct: 158 INQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSGDHNANLTNRVITLWYRPPELLLGAT 217
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
KYGPAVDMWSVGCIFAELL GKPILPGKNE EQL+KIFELCG+PDE WPGVSK+P Y+
Sbjct: 218 KYGPAVDMWSVGCIFAELLFGKPILPGKNEPEQLNKIFELCGTPDEINWPGVSKIPWYSK 277
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 304
FKP+R MKRRVREVFRHFDRHAL+LL+KML LDPSQRI AKDALD EYFWTDPLPCDP+S
Sbjct: 278 FKPARPMKRRVREVFRHFDRHALDLLDKMLNLDPSQRICAKDALDGEYFWTDPLPCDPRS 337
Query: 305 LPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMN 364
LPKYESSHE+QTKK+RQQQRQ+EE KR KL HPQ H RLPPIQ G S HW G H M+
Sbjct: 338 LPKYESSHEFQTKKKRQQQRQNEEMAKRHKLQHPQQHSRLPPIQQPGHSQHWGGSTHQMS 397
Query: 365 NAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRG 424
N+ P + G GHH +GKPRG GG+NRYP G GG +RG QGGGYS+ YPPQGR
Sbjct: 398 NSQPAISAGAGHHQFGKPRG-TGGSNRYPPGGNPGGGYYQDRGAQGGGYSSGAYPPQGRA 456
Query: 425 PPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 481
PP+ G+G+ A SG GP +YSQSGQYG S AGRG NQM G+RNQQYGWQQ
Sbjct: 457 PPFPGSGL-APSGPRGPSGGYGGPPNYSQSGQYGGSGAGRGSNQMSGNRNQQYGWQQ 512
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501366|ref|XP_003519496.1| PREDICTED: cyclin-dependent kinase C-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/480 (78%), Positives = 409/480 (85%), Gaps = 6/480 (1%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVIKLKEIVTS GPE
Sbjct: 38 QVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIKLKEIVTSQGPE 97
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+DEQG+PDGNKY+G YMVFEYMDHDLTGLADRPG+RFTVPQIKCYM+QLLTGLHYCHVN
Sbjct: 98 KDEQGKPDGNKYKGGIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHVN 157
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARSFS D N LTNRVITLWYRPPELLLG TKY
Sbjct: 158 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDQNANLTNRVITLWYRPPELLLGTTKY 217
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPAVDMWSVGCIFAELL GKPI PGK+E EQL+KI+ELCG+P+E WPGVSK+P YN F
Sbjct: 218 GPAVDMWSVGCIFAELLQGKPIFPGKDEPEQLNKIYELCGAPNEVNWPGVSKIPYYNKFM 277
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
P+R MKRR+R+VFRHFD HALELLEKML LDPSQRI+AKDALD+EYFWTDPLPCDPKSLP
Sbjct: 278 PTRPMKRRLRDVFRHFDHHALELLEKMLTLDPSQRITAKDALDAEYFWTDPLPCDPKSLP 337
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQ-SHHWSGPNHPMNN 365
KYESSHE+QTKK+RQQQRQ+EE KRQK+ HPQPH RLPPIQ GQ + SGPN P++
Sbjct: 338 KYESSHEFQTKKKRQQQRQNEEMAKRQKMQHPQPHTRLPPIQQPGQHAQMRSGPNQPIHG 397
Query: 366 APPPVPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQ-GGGYSNAPYPPQGR 423
+ P V GP HHYGKPRGP GG RY P+GN GGY++PNR GQ G GY + PYPPQGR
Sbjct: 398 SQPQVSAGP-THHYGKPRGPSGGPGRYPPNGNPGGGYSHPNRAGQGGSGYGSGPYPPQGR 456
Query: 424 GPPYAGAGMPANGPRGP-ASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRN-QQYGWQQ 481
G PY MP GPRG ASGY P Q G YG SAAGRG N MGG+RN QQYGWQQ
Sbjct: 457 GAPYGSNSMPGGGPRGSGASGYVGAPNYPQQGGPYGGSAAGRGSNMMGGNRNQQQYGWQQ 516
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297794099|ref|XP_002864934.1| cyclin-dependent kinase C_2 [Arabidopsis lyrata subsp. lyrata] gi|297310769|gb|EFH41193.1| cyclin-dependent kinase C_2 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/486 (78%), Positives = 414/486 (85%), Gaps = 22/486 (4%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPG +
Sbjct: 39 QVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIHLKEIVTSPGRD 98
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
RD+QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN
Sbjct: 99 RDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 158
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARSFS+DH+ LTNRVITLWYRPPELLLGATKY
Sbjct: 159 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSHDHSGNLTNRVITLWYRPPELLLGATKY 218
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPA+DMWSVGCIFAELLNGKPILPGK E+EQL+KI+ELCGSPDE WPGVSKMP Y K
Sbjct: 219 GPAIDMWSVGCIFAELLNGKPILPGKTESEQLNKIYELCGSPDENNWPGVSKMPWYGQMK 278
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
SR +KRRVRE++RHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP
Sbjct: 279 SSRPLKRRVREIYRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLP 338
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQH-AGQSH---HW-SGPN 360
YESSHE+QTKK+RQQ R +EEA K+QKL H PQ H RLPP QH GQSH HW +GPN
Sbjct: 339 TYESSHEFQTKKKRQQMRHNEEAAKKQKLQHPPQQHSRLPPQQHGVGQSHAAPHWPAGPN 398
Query: 361 HPM-NNAPPP-VP-GGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNA 416
HPM NNAPPP +P GGPG H+YGKPRG G NRY PSGNQ GGYNN +R GGYSN
Sbjct: 399 HPMNNNAPPPQIPAGGPGGHYYGKPRGGAPGQNRYPPSGNQPGGYNNQSR----GGYSNG 454
Query: 417 PYPPQGRGPPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRN 474
YPPQGRG PYA GPRGP+ GYGVGP S G+ +GRG N MGG+RN
Sbjct: 455 AYPPQGRGAPYAA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARN 508
Query: 475 QQYGWQ 480
QQYGWQ
Sbjct: 509 QQYGWQ 514
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297811129|ref|XP_002873448.1| cyclin-dependent kinase C_1 [Arabidopsis lyrata subsp. lyrata] gi|297319285|gb|EFH49707.1| cyclin-dependent kinase C_1 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1890), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/481 (77%), Positives = 400/481 (83%), Gaps = 20/481 (4%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI+LKEIVTSPG +
Sbjct: 39 QVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIQLKEIVTSPGRD 98
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
RD+QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN
Sbjct: 99 RDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 158
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARSFS+DH+ LTNRVITLWYRPPELLLGATKY
Sbjct: 159 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSHDHSGNLTNRVITLWYRPPELLLGATKY 218
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPA+DMWSVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE IWPGVSKMP YN+FK
Sbjct: 219 GPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDENIWPGVSKMPWYNNFK 278
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
P+R +KRRVRE FRHFDRHALELLEKML+LDPSQRISAKDALD+EYFWTDPLPCDPKSLP
Sbjct: 279 PARPLKRRVREFFRHFDRHALELLEKMLVLDPSQRISAKDALDAEYFWTDPLPCDPKSLP 338
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQHAGQSH---HW-SGPNH 361
YESSHE+QTKK+RQQQRQ+EEA KRQK+ H PQ H RLPP+QH GQSH HW +GPNH
Sbjct: 339 TYESSHEFQTKKKRQQQRQNEEAAKRQKVQHPPQQHSRLPPLQHGGQSHAAPHWPAGPNH 398
Query: 362 PMNNAPPPVPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPP 420
P NNAPP VP GP HH YGKPRGPP G NRY PSGNQSGGYN GGYS+ YPP
Sbjct: 399 PTNNAPPQVPAGPSHHFYGKPRGPP-GPNRYPPSGNQSGGYNQSR-----GGYSSGSYPP 452
Query: 421 QGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQ 480
QGRG PY GPR G Q G + RNQQYGWQ
Sbjct: 453 QGRGAPYVA------GPR--GPSGGGYGVGPPNYTQGGQYGGSGSSGRGQNPRNQQYGWQ 504
Query: 481 Q 481
Q
Sbjct: 505 Q 505
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15238314|ref|NP_201301.1| cyclin-dependent kinase C-2 [Arabidopsis thaliana] gi|152013386|sp|Q8W4P1.2|CDKC2_ARATH RecName: Full=Cyclin-dependent kinase C-2; Short=CDKC;2 gi|13430444|gb|AAK25844.1|AF360134_1 putative cdc2 protein kinase [Arabidopsis thaliana] gi|8843760|dbj|BAA97308.1| cdc2-like protein kinase [Arabidopsis thaliana] gi|14532732|gb|AAK64067.1| putative cdc2 protein kinase [Arabidopsis thaliana] gi|332010592|gb|AED97975.1| cyclin-dependent kinase C-2 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 720 bits (1858), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/485 (77%), Positives = 409/485 (84%), Gaps = 22/485 (4%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPG +
Sbjct: 39 QVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIHLKEIVTSPGRD 98
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
RD+QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN
Sbjct: 99 RDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 158
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKY
Sbjct: 159 QVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKY 218
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPA+DMWSVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K
Sbjct: 219 GPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMK 278
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
SR +KRRVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP
Sbjct: 279 SSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLP 338
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHHP-QPHGRLPPIQH-AGQSHH---W-SGPN 360
YESSHE+QTKK+RQQ R +EEA K+QKL HP Q H RLPP QH GQSH W +GPN
Sbjct: 339 TYESSHEFQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSHAAPLWPAGPN 398
Query: 361 HPM-NNAPPP-VPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAP 417
HPM NNAPPP +P G GH++ GKPRG NRY PSGNQ+GGYNN +R GGYS+
Sbjct: 399 HPMNNNAPPPQIPAG-GHYYGGKPRGGAPVPNRYPPSGNQTGGYNNQSR----GGYSSGA 453
Query: 418 YPPQGRGPPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRNQ 475
YPPQGRG PY GPRGP+ GYGVGP S G+ +GRG N MGG+RNQ
Sbjct: 454 YPPQGRGAPYGA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARNQ 507
Query: 476 QYGWQ 480
QYGWQ
Sbjct: 508 QYGWQ 512
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|17064746|gb|AAL32527.1| cdc2-like protein kinase [Arabidopsis thaliana] gi|27311919|gb|AAO00925.1| cdc2-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1850), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/485 (77%), Positives = 408/485 (84%), Gaps = 22/485 (4%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPG +
Sbjct: 39 QVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIHLKEIVTSPGRD 98
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
RD+QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN
Sbjct: 99 RDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 158
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLAR +S+DH LTNRVITLWYRPPELLLGATKY
Sbjct: 159 QVLHRDIKGSNLLIDNEGNLKLADFGLARPYSHDHTGNLTNRVITLWYRPPELLLGATKY 218
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPA+DMWSVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K
Sbjct: 219 GPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMK 278
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
SR +KRRVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP
Sbjct: 279 SSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLP 338
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHHP-QPHGRLPPIQH-AGQSHH---W-SGPN 360
YESSHE+QTKK+RQQ R +EEA K+QKL HP Q H RLPP QH GQSH W +GPN
Sbjct: 339 TYESSHEFQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSHAAPLWPAGPN 398
Query: 361 HPM-NNAPPP-VPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAP 417
HPM NNAPPP +P G GH++ GKPRG NRY PSGNQ+GGYNN +R GGYS+
Sbjct: 399 HPMNNNAPPPQIPAG-GHYYGGKPRGGAPVPNRYPPSGNQTGGYNNQSR----GGYSSGA 453
Query: 418 YPPQGRGPPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRNQ 475
YPPQGRG PY GPRGP+ GYGVGP S G+ +GRG N MGG+RNQ
Sbjct: 454 YPPQGRGAPYGA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARNQ 507
Query: 476 QYGWQ 480
QYGWQ
Sbjct: 508 QYGWQ 512
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574675|ref|XP_003555471.1| PREDICTED: cyclin-dependent kinase C-1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 703 bits (1815), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/484 (77%), Positives = 406/484 (83%), Gaps = 10/484 (2%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MAREIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPGPE
Sbjct: 38 QVYMAREIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVINLKEIVTSPGPE 97
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+DEQGRPDGNKY+G YMVFEYMDHDLTGLADRPG+RFTVPQIKCYM+QLLTGLHYCHVN
Sbjct: 98 KDEQGRPDGNKYKGGIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHVN 157
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARSFS +HN LTNRVITLWYRPPELLLG T+Y
Sbjct: 158 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNEHNANLTNRVITLWYRPPELLLGTTRY 217
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPAVDMWSVGCIFAELL+GKPI PGK+E EQL+KIFELCG+PDE WPGVSK P YN FK
Sbjct: 218 GPAVDMWSVGCIFAELLHGKPIFPGKDEPEQLNKIFELCGAPDEVNWPGVSKTPWYNQFK 277
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
P+R MKRR+REVFRHFDRHALELLEKML LD +QRI+AKDALD+EYFWTDPLPCDPKSLP
Sbjct: 278 PTRPMKRRLREVFRHFDRHALELLEKMLTLDLAQRITAKDALDAEYFWTDPLPCDPKSLP 337
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSH--HWSGPNHPMN 364
KYESSHE+QTKK+RQQQRQ+EE KR K+ HPQ H RLPPIQ AGQ H GPNHP++
Sbjct: 338 KYESSHEFQTKKKRQQQRQNEENAKRLKMQHPQQHTRLPPIQQAGQQHPQMRQGPNHPIH 397
Query: 365 NAPPPVPGGPGHHHYGKPRGPPGGANR-YPSGNQSGGYNNPNRGGQ--GGGYSNAPYPPQ 421
+ P V GP HHYGKPRGP GG R GN GGYN+PNR GQ G GY + PYPPQ
Sbjct: 398 GSQPAVAAGPS-HHYGKPRGPSGGPGRYPSGGNSGGGYNHPNRAGQGGGSGYGSGPYPPQ 456
Query: 422 GRGPPYAGAGMPANGPRGPASGYGVGPQ----SYSQSGQYGNSAAGRGPNQMGGSRNQQY 477
GRG PY +GMP GP G G G +Y Q YG SAAGRG N MGG+RNQQY
Sbjct: 457 GRGAPYGSSGMPGGPSGGPRGGGGSGYGVGAPNYPQGAPYGGSAAGRGSNMMGGNRNQQY 516
Query: 478 GWQQ 481
GWQQ
Sbjct: 517 GWQQ 520
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 481 | ||||||
| TAIR|locus:2177744 | 513 | CDKC2 "cyclin dependent kinase | 0.723 | 0.678 | 0.842 | 4.8e-183 | |
| TAIR|locus:2145397 | 505 | CDKC;1 "cyclin-dependent kinas | 0.727 | 0.693 | 0.841 | 9.9e-183 | |
| DICTYBASE|DDB_G0273721 | 694 | cdk9-2 "CDK family protein kin | 0.708 | 0.491 | 0.534 | 4.6e-103 | |
| DICTYBASE|DDB_G0273207 | 694 | cdk9-1 "CDK family protein kin | 0.708 | 0.491 | 0.534 | 4.6e-103 | |
| ZFIN|ZDB-GENE-030131-4975 | 1289 | cdk13 "cyclin-dependent kinase | 0.661 | 0.246 | 0.495 | 9.8e-85 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.615 | 0.510 | 0.536 | 1.7e-84 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.679 | 0.507 | 0.494 | 2.8e-84 | |
| RGD|621111 | 1484 | Cdk12 "cyclin-dependent kinase | 0.636 | 0.206 | 0.514 | 3.5e-84 | |
| UNIPROTKB|Q3MJK5 | 1484 | Cdk12 "Cyclin-dependent kinase | 0.636 | 0.206 | 0.514 | 3.5e-84 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.615 | 0.482 | 0.530 | 1.9e-83 |
| TAIR|locus:2177744 CDKC2 "cyclin dependent kinase group C2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1582 (562.0 bits), Expect = 4.8e-183, Sum P(2) = 4.8e-183
Identities = 295/350 (84%), Positives = 316/350 (90%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPG +
Sbjct: 39 QVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIHLKEIVTSPGRD 98
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
RD+QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN
Sbjct: 99 RDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 158
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKY
Sbjct: 159 QVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKY 218
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPA+DMWSVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K
Sbjct: 219 GPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMK 278
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
SR +KRRVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP
Sbjct: 279 SSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLP 338
Query: 307 KYESSHEYQTKKXXXXXXXHEEATKRQKLHHPQP-HGRLPPIQHA-GQSH 354
YESSHE+QTKK +EEA K+QKL HPQ H RLPP QH GQSH
Sbjct: 339 TYESSHEFQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSH 388
|
|
| TAIR|locus:2145397 CDKC;1 "cyclin-dependent kinase C;1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1612 (572.5 bits), Expect = 9.9e-183, Sum P(2) = 9.9e-183
Identities = 298/354 (84%), Positives = 322/354 (90%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI+LKEIVTSPG +
Sbjct: 39 QVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIQLKEIVTSPGRD 98
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
RD+QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN
Sbjct: 99 RDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 158
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QVLHRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKY
Sbjct: 159 QVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKY 218
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPA+DMWSVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE +WPGVSKMP +N+FK
Sbjct: 219 GPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDEKLWPGVSKMPWFNNFK 278
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
P+R +KRRVRE FRHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP
Sbjct: 279 PARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLP 338
Query: 307 KYESSHEYQTKKXXXXXXXHEEATKRQKLHHPQ-PHGRLPPIQHAGQSH---HW 356
YESSHE+QTKK +EEA KRQKL HP H RLPP+QH GQSH HW
Sbjct: 339 TYESSHEFQTKKKRQQQRQNEEAAKRQKLQHPPLQHSRLPPLQHGGQSHAAPHW 392
|
|
| DICTYBASE|DDB_G0273721 cdk9-2 "CDK family protein kinase 9" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 4.6e-103, Sum P(2) = 4.6e-103
Identities = 192/359 (53%), Positives = 243/359 (67%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+ A+ G+IVALKK+ MDNE EGFPITAIREIKILK+L H NV+ LKE+VTS
Sbjct: 222 QVYKAKNKSNGDIVALKKVIMDNEVEGFPITAIREIKILKELNHANVVNLKEVVTSKASA 281
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP-QIKCYMKQLLTGLHYCHV 125
N ++GS YMVFEYMDHDL GL D P ++ P QIKCY+KQLL GL YCH
Sbjct: 282 --------SNNHKGSVYMVFEYMDHDLNGLMDSPAFKYFAPGQIKCYLKQLLEGLDYCHR 333
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGAT 184
N VLHRDIKGSNLL+DN G LKLADFGLAR F S + LTNRVITLWYRPPELLLG
Sbjct: 334 NNVLHRDIKGSNLLLDNNGILKLADFGLARPFNSSEKKQILTNRVITLWYRPPELLLGTF 393
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
YGP +DMWSVGCI AELL+ K + PG+N +QL KI+++CGSP+ WP +P ++
Sbjct: 394 HYGPEIDMWSVGCIMAELLSKKTLFPGRNSIDQLDKIYQVCGSPNANNWPEAMDLPFWDA 453
Query: 245 FKPSRTMKR-RVREVFRH-----FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298
KP R +++ ++H F + A +LL+K+L +DP +RI+A +ALD +YFWTDP+
Sbjct: 454 LKPKREYNSLSLKDFYQHENPSFFTKEAFDLLDKLLCMDPKKRITASEALDHQYFWTDPM 513
Query: 299 PCDPKSLPKYESSHEYQTKKXXXXXXXHEEATKRQKLHHPQPHGRLPPIQHAGQS--HH 355
P +PK LP+Y S HEY+TKK ++ + Q+ QP + Q+ G + HH
Sbjct: 514 PVNPKDLPQYPSCHEYRTKKRLRQQNQNQNQQQNQQQQQQQPQNQHQQSQYQGANVNHH 572
|
|
| DICTYBASE|DDB_G0273207 cdk9-1 "CDK family protein kinase 9" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 4.6e-103, Sum P(2) = 4.6e-103
Identities = 192/359 (53%), Positives = 243/359 (67%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+ A+ G+IVALKK+ MDNE EGFPITAIREIKILK+L H NV+ LKE+VTS
Sbjct: 222 QVYKAKNKSNGDIVALKKVIMDNEVEGFPITAIREIKILKELNHANVVNLKEVVTSKASA 281
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP-QIKCYMKQLLTGLHYCHV 125
N ++GS YMVFEYMDHDL GL D P ++ P QIKCY+KQLL GL YCH
Sbjct: 282 --------SNNHKGSVYMVFEYMDHDLNGLMDSPAFKYFAPGQIKCYLKQLLEGLDYCHR 333
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGAT 184
N VLHRDIKGSNLL+DN G LKLADFGLAR F S + LTNRVITLWYRPPELLLG
Sbjct: 334 NNVLHRDIKGSNLLLDNNGILKLADFGLARPFNSSEKKQILTNRVITLWYRPPELLLGTF 393
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
YGP +DMWSVGCI AELL+ K + PG+N +QL KI+++CGSP+ WP +P ++
Sbjct: 394 HYGPEIDMWSVGCIMAELLSKKTLFPGRNSIDQLDKIYQVCGSPNANNWPEAMDLPFWDA 453
Query: 245 FKPSRTMKR-RVREVFRH-----FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298
KP R +++ ++H F + A +LL+K+L +DP +RI+A +ALD +YFWTDP+
Sbjct: 454 LKPKREYNSLSLKDFYQHENPSFFTKEAFDLLDKLLCMDPKKRITASEALDHQYFWTDPM 513
Query: 299 PCDPKSLPKYESSHEYQTKKXXXXXXXHEEATKRQKLHHPQPHGRLPPIQHAGQS--HH 355
P +PK LP+Y S HEY+TKK ++ + Q+ QP + Q+ G + HH
Sbjct: 514 PVNPKDLPQYPSCHEYRTKKRLRQQNQNQNQQQNQQQQQQQPQNQHQQSQYQGANVNHH 572
|
|
| ZFIN|ZDB-GENE-030131-4975 cdk13 "cyclin-dependent kinase 13" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 819 (293.4 bits), Expect = 9.8e-85, Sum P(2) = 9.8e-85
Identities = 161/325 (49%), Positives = 213/325 (65%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+ A++ T E+VALKK+R+DNEKEGFPITAIREIKIL++L H+++I +KEIVT
Sbjct: 607 QVYKAKDKDTAELVALKKVRLDNEKEGFPITAIREIKILRQLNHKSIINMKEIVT----- 661
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D++ D +G+ Y+VFEYMDHDL GL + + F IK +M+QLL GL YCH
Sbjct: 662 -DKEDALDFKNDKGAFYLVFEYMDHDLMGLLESGLVHFNESHIKSFMRQLLEGLDYCHKK 720
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
LHRDIK SN+L++N+G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y
Sbjct: 721 NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 780
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
PA+D+WS GCI EL KPI E QL I +CGSP +WP V K+P +N K
Sbjct: 781 TPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDVIKLPYFNTMK 840
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW-TDPLPCDPKSL 305
P + +RR+RE F AL+L + ML LDPS+R +A+ AL+S++ DP P L
Sbjct: 841 PKKQYRRRLREEFAFIPLMALDLFDHMLALDPSKRCTAEQALNSDFLRDVDPAKMPPPDL 900
Query: 306 PKYESSHEYQTKKXXXXXXXHEEAT 330
P ++ HE +KK EE T
Sbjct: 901 PLWQDCHELWSKKRRRQKQMPEELT 925
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 168/313 (53%), Positives = 216/313 (69%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
S V+ A+++ +G+IVALKK+R DN E E A REI +L++L H NVIKL+ +VTS
Sbjct: 126 SNVYKAKDLLSGKIVALKKVRFDNLEAESVKFMA-REILVLRRLNHPNVIKLQGLVTS-- 182
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+ S Y+VFEYM+HDL+GLA GL+F +PQ+KC+MKQLL+GL +CH
Sbjct: 183 ------------RVSCSLYLVFEYMEHDLSGLAATQGLKFDLPQVKCFMKQLLSGLEHCH 230
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
VLHRDIKGSNLLIDN+G LK+ADFGLA + T+T+RV+TLWYRPPELLLGAT
Sbjct: 231 SRGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPKQKQTMTSRVVTLWYRPPELLLGAT 290
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
YG VD+WS GCI AELL GKP++PG+ E EQL KIF+LCGSP ++ W ++P
Sbjct: 291 SYGTGVDLWSAGCIMAELLAGKPVMPGRTEVEQLHKIFKLCGSPSDSYWKKY-RLPNATL 349
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 304
FKP KR V E F F ++ L+E +L +DP+ R ++ AL+SE+F T+PLPCDP S
Sbjct: 350 FKPQHPYKRCVAEAFNGFTPSSVHLVETLLTIDPADRGTSTSALNSEFFTTEPLPCDPSS 409
Query: 305 LPKYESSHEYQTK 317
LPKY S E K
Sbjct: 410 LPKYPPSKELNVK 422
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 822 (294.4 bits), Expect = 2.8e-84, Sum P(2) = 2.8e-84
Identities = 172/348 (49%), Positives = 223/348 (64%)
Query: 6 SQVFMAREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
S V+ AR++ +IVALK++R D ++ E A REI ++++L H NV+KL+ ++T+
Sbjct: 149 SSVYKARDLTNNKIVALKRVRFDLSDLESVKFMA-REIIVMRRLDHPNVLKLEGLITA-- 205
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
S Y+VFEYMDHDL GLA PG++F+ PQ+KCYM+QLL+GLH+CH
Sbjct: 206 ------------SVSSSLYLVFEYMDHDLVGLASIPGIKFSEPQVKCYMQQLLSGLHHCH 253
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
VLHRDIKGSNLLID+ G LK+ADFGLA F + LT+RV+TLWYRPPELLLGA
Sbjct: 254 SRGVLHRDIKGSNLLIDSNGVLKIADFGLATFFDPQNCVPLTSRVVTLWYRPPELLLGAC 313
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
YG VD+WS GCI EL +GKPIL GK E EQL KIF+LCGSP E W + K+P
Sbjct: 314 HYGVGVDLWSTGCILGELYSGKPILAGKTEVEQLHKIFKLCGSPTEDYWRKL-KLPPSAA 372
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 304
F+P+ RRV E+F+ + L LLE +L +DP +R SA AL+SEYF T+P CDP S
Sbjct: 373 FRPALPYGRRVAEMFKDLPTNVLSLLEALLSIDPDRRGSAARALESEYFRTEPFACDPSS 432
Query: 305 LPKYESSHEYQTKKXXXXXXXH--EEATKRQKLHHPQPHGR--LPPIQ 348
LPKY S E K +E +RQ + H R +PP++
Sbjct: 433 LPKYPPSKEIDAKIRDDAKRQRPTQEKHERQDSQTRRSHERKLIPPVK 480
|
|
| RGD|621111 Cdk12 "cyclin-dependent kinase 12" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 814 (291.6 bits), Expect = 3.5e-84, Sum P(3) = 3.5e-84
Identities = 161/313 (51%), Positives = 210/313 (67%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+ A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H++V+ +KEIVT
Sbjct: 736 QVYKAKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLVHQSVVNMKEIVT----- 790
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D+Q D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQL+ GL YCH
Sbjct: 791 -DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKK 849
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
LHRDIK SN+L++N G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y
Sbjct: 850 NFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 909
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
PA+D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N K
Sbjct: 910 TPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK 969
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP-CDPKSL 305
P + +RR+RE F AL+LL+ ML LDPS+R +A+ L S++ L P L
Sbjct: 970 PKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMAPPDL 1029
Query: 306 PKYESSHEYQTKK 318
P ++ HE +KK
Sbjct: 1030 PHWQDCHELWSKK 1042
|
|
| UNIPROTKB|Q3MJK5 Cdk12 "Cyclin-dependent kinase 12" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 814 (291.6 bits), Expect = 3.5e-84, Sum P(3) = 3.5e-84
Identities = 161/313 (51%), Positives = 210/313 (67%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+ A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H++V+ +KEIVT
Sbjct: 736 QVYKAKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLVHQSVVNMKEIVT----- 790
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D+Q D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQL+ GL YCH
Sbjct: 791 -DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKK 849
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
LHRDIK SN+L++N G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y
Sbjct: 850 NFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 909
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
PA+D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N K
Sbjct: 910 TPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK 969
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP-CDPKSL 305
P + +RR+RE F AL+LL+ ML LDPS+R +A+ L S++ L P L
Sbjct: 970 PKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMAPPDL 1029
Query: 306 PKYESSHEYQTKK 318
P ++ HE +KK
Sbjct: 1030 PHWQDCHELWSKK 1042
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 836 (299.3 bits), Expect = 1.9e-83, P = 1.9e-83
Identities = 166/313 (53%), Positives = 217/313 (69%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
S V+ AR+++TG+IVA+KK+R N + E A REI IL+KL H NV+KL+ +VTS
Sbjct: 153 SIVYKARDLETGKIVAMKKVRFANMDPESVRFMA-REINILRKLDHPNVMKLQCLVTS-- 209
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
K GS ++VFEYM+HDL+GLA RPG++FT PQIKC+MKQLL GL +CH
Sbjct: 210 ------------KLSGSLHLVFEYMEHDLSGLALRPGVKFTEPQIKCFMKQLLCGLEHCH 257
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
+LHRDIKGSNLL++N+G LK+ DFGLA + D + LT+RV+TLWYR PELLLG+T
Sbjct: 258 SRGILHRDIKGSNLLVNNDGVLKIGDFGLASFYKPDQDQPLTSRVVTLWYRAPELLLGST 317
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
+YGPA+D+WSVGCI AEL KPI+PG+ E EQ+ KIF+LCGSP E W +K P
Sbjct: 318 EYGPAIDLWSVGCILAELFVCKPIMPGRTEVEQMHKIFKLCGSPSEEFW-NTTKFPQATS 376
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 304
+KP KR + E F++ +L+LL+K+L ++P +R SA L SE+F T+PLPC S
Sbjct: 377 YKPQHPYKRVLLETFKNLSSSSLDLLDKLLSVEPEKRCSASSTLLSEFFTTEPLPCHISS 436
Query: 305 LPKYESSHEYQTK 317
LPKY S E K
Sbjct: 437 LPKYPPSKELDAK 449
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8W4P1 | CDKC2_ARATH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7752 | 0.9625 | 0.9025 | no | no |
| Q9LFT8 | CDKC1_ARATH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7904 | 0.9563 | 0.9108 | yes | no |
| Q5JK68 | CDKC2_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7817 | 0.9750 | 0.9142 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.22 | 0.979 |
| 3rd Layer | 2.7.11.23 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 481 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 0.0 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-145 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-132 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-129 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-129 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-129 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-129 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-114 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-112 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-106 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-103 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-100 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-96 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-94 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-93 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-92 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-92 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-89 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-89 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-87 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-84 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-83 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-82 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-79 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-74 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-74 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-73 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-73 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-73 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-71 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-70 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-69 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-68 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-68 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-67 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-65 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-65 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-62 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-61 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-61 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-60 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-59 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-59 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-57 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-56 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-56 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-56 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-54 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-54 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-50 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-49 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-48 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-48 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-45 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-41 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-38 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-35 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-34 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-34 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-34 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-33 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-23 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-22 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-18 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 9e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-05 | |
| pfam06682 | 317 | pfam06682, DUF1183, Protein of unknown function (D | 2e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.001 | |
| pfam02084 | 239 | pfam02084, Bindin, Bindin | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.001 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.003 | |
| pfam07415 | 489 | pfam07415, Herpes_LMP2, Gammaherpesvirus latent me | 0.004 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 534 bits (1377), Expect = 0.0
Identities = 189/289 (65%), Positives = 221/289 (76%), Gaps = 15/289 (5%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
QV+ AR KTGE+VALKKIRM+NEKEGFPITAIREIK+L+KL+H N+++LKEIVTS G
Sbjct: 13 GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG- 71
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+GS YMVFEYMDHDLTGL D P ++FT QIKCYMKQLL GL Y H
Sbjct: 72 -------------KGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
N +LHRDIKGSN+LI+N+G LKLADFGLAR ++ ++ TNRVITLWYRPPELLLGAT+
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
YGP VDMWSVGCI AEL GKPI G E EQL KIFELCGSP + WPGVSK+P + +
Sbjct: 179 YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238
Query: 246 KPSRTMKRRVREVFRHF-DRHALELLEKMLMLDPSQRISAKDALDSEYF 293
KP + KRR+RE F+H D AL+LL+K+L LDP +RISA AL EYF
Sbjct: 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 416 bits (1073), Expect = e-145
Identities = 138/286 (48%), Positives = 187/286 (65%), Gaps = 18/286 (6%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ AR+ KTGEIVALKKIR+DNE+EG P TA+REI +LK+L+H N++KL +++ +
Sbjct: 15 VYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER--- 71
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
Y+VFEY D DL D+ + IK M QLL GL YCH ++
Sbjct: 72 -------------KLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 187
+LHRD+K N+LI+ +G LKLADFGLAR+F T T+ V+TLWYR PE+LLG+ Y
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGSKHYS 177
Query: 188 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 247
AVD+WSVGCIFAE++ GKP+ PG +E +QL KIF++ G+P E WPGV+K+P Y P
Sbjct: 178 TAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237
Query: 248 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ + +V D ++LL KML +P++RISAK+AL YF
Sbjct: 238 KFP-PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 384 bits (988), Expect = e-132
Identities = 141/292 (48%), Positives = 189/292 (64%), Gaps = 25/292 (8%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ AR+ KTGEIVALKK++M+ EKEGFPIT++REI IL KLQH N++ +KE+V
Sbjct: 21 VYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV------ 74
Query: 68 DEQGRPDGNKYRGST----YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
GS YMV EY++HDL L + F ++KC M QLL+G+ +
Sbjct: 75 ------------GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
H N +LHRD+K SNLL++N G LK+ DFGLAR + T V+TLWYR PELLLGA
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAPELLLGA 181
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
+Y A+DMWSVGCIFAELL KP+ PGK+E +QL+KIF+L G+P E IWPG S++P
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241
Query: 244 HFKPSRTMKRRVREVFRHF--DRHALELLEKMLMLDPSQRISAKDALDSEYF 293
++ ++R+ F + +LL ++L DP++RISA+DAL YF
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 378 bits (972), Expect = e-129
Identities = 148/299 (49%), Positives = 191/299 (63%), Gaps = 22/299 (7%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V+ AR+IKTG +VALKKI M NEK+GFPITA+REIKILKKL+H NV+ L ++ +
Sbjct: 23 EVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK 82
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+ RGS YMV YMDHDL+GL + P ++ T QIKCYM QLL G++Y H N
Sbjct: 83 SKRK--------RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN 134
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT------------LTNRVITLWY 174
+LHRDIK +N+LIDN+G LK+ADFGLAR YD TN V+T WY
Sbjct: 135 HILHRDIKAANILIDNQGILKIADFGLARP--YDGPPPNPKGGGGGGTRKYTNLVVTRWY 192
Query: 175 RPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234
RPPELLLG +Y AVD+W +GC+FAE+ +PIL GK++ +QL IF+LCG+P E WP
Sbjct: 193 RPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWP 252
Query: 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
G +P R + E F L+LL K+L LDP +R++A DAL+ YF
Sbjct: 253 GWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 377 bits (970), Expect = e-129
Identities = 149/292 (51%), Positives = 200/292 (68%), Gaps = 13/292 (4%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+VF AR KT +IVALKK+ M+NEKEGFPITA+REIKIL+ L+HENV+ L EI +
Sbjct: 27 EVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
N+Y+GS Y+VFE+ +HDL GL ++FT+ +IK MK LL GL+Y H N
Sbjct: 87 --------YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN 138
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGA 183
++LHRD+K +N+LI +G LKLADFGLAR+FS N N TNRV+TLWYRPPELLLG
Sbjct: 139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE 198
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
YGP +DMW GCI AE+ PI+ G E QL+ I +LCGS +WPGV K+ +
Sbjct: 199 RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFK 258
Query: 244 HFKPSRTMKRRVREVFRHF--DRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ + KR+V+E + + D HAL+L++K+L+LDP++RI A AL+ ++F
Sbjct: 259 KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 376 bits (968), Expect = e-129
Identities = 136/303 (44%), Positives = 187/303 (61%), Gaps = 22/303 (7%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKE---GFPITAIREIKILKKLQHENVIKLKEIVTSP 63
V+ AR+ +TG IVA+KKI++ KE G TA+REIK+L++L+H N+I L ++
Sbjct: 15 VVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH- 73
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+ + +VFE+M+ DL + + T IK YM L GL Y
Sbjct: 74 ---------------KSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
H N +LHRD+K +NLLI ++G LKLADFGLARSF + +T++V+T WYR PELL GA
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVVTRWYRAPELLFGA 177
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
YG VDMWSVGCIFAELL P LPG ++ +QL KIFE G+P E WPGV+ +P Y
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 303
FKP ++++F AL+LL+++L L+P++RI+A+ AL+ YF DP P P
Sbjct: 238 EFKPFP--PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS 295
Query: 304 SLP 306
LP
Sbjct: 296 QLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 376 bits (966), Expect = e-129
Identities = 158/286 (55%), Positives = 203/286 (70%), Gaps = 6/286 (2%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV+ AR+ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H N++ LKEIVT
Sbjct: 22 QVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVT----- 76
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D+Q D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQLL GL+YCH
Sbjct: 77 -DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK 135
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
LHRDIK SN+L++N+G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y
Sbjct: 136 NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 195
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GPA+D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N K
Sbjct: 196 GPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK 255
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292
P + +RR+RE F AL+LL+ ML LDPS+R +A++AL+S +
Sbjct: 256 PKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 337 bits (866), Expect = e-114
Identities = 143/305 (46%), Positives = 196/305 (64%), Gaps = 23/305 (7%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ AR+ +GEIVALKK+RMDNE++G PI+++REI +L L+H N+++LKE+V G
Sbjct: 23 VYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV--GKHL 80
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
D S ++V EY + DL L D F+ Q+KC M QLL GL Y H N
Sbjct: 81 D------------SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 187
++HRD+K SNLL+ ++G LK+ADFGLAR++ +T +V+TLWYR PELLLG T Y
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKVVTLWYRAPELLLGCTTYT 187
Query: 188 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK- 246
A+DMW+VGCI AELL KP+LPGK+E EQL I +L G+P+E+IWPG S +P F
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTL 247
Query: 247 ---PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 303
P +K + F L LL +LM DP +R +A++AL+S YF PLPC+P+
Sbjct: 248 PKQPYNNLKHK----FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPE 303
Query: 304 SLPKY 308
+P +
Sbjct: 304 MMPTF 308
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 333 bits (857), Expect = e-112
Identities = 142/289 (49%), Positives = 191/289 (66%), Gaps = 23/289 (7%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ AR+ TGEIVALKKIR++ E EG P TAIREI +LK+L H N+++L ++V S
Sbjct: 15 VYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS----- 69
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVN 126
NK Y+VFE++D DL D P P IK Y+ QLL G+ YCH +
Sbjct: 70 -------ENKL----YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
+VLHRD+K NLLID EG LKLADFGLAR+F T T+ V+TLWYR PE+LLG+ +Y
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQY 177
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
VD+WS+GCIFAE++N +P+ PG +E +QL +IF G+PDE +WPGV+ +P Y K
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY---K 234
Query: 247 PS--RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P+ + ++ + +V + D L+LL KML+ DP++RISAK AL YF
Sbjct: 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 316 bits (812), Expect = e-106
Identities = 128/291 (43%), Positives = 179/291 (61%), Gaps = 26/291 (8%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
VF A++ +TGE VALKK+ + + G P A+REIK L+ QH V+KL ++
Sbjct: 16 VFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF------- 68
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGL---ADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
P G +V EYM DL+ + +RP Q+K YM+ LL G+ Y H
Sbjct: 69 -----PHG----SGFVLVMEYMPSDLSEVLRDEERP---LPEAQVKSYMRMLLKGVAYMH 116
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
N ++HRD+K +NLLI +G LK+ADFGLAR FS + +++V T WYR PELL GA
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN- 243
KY P VD+W+VGCIFAELLNG P+ PG+N+ EQL+ +F G+P+E WPG++ +P YN
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236
Query: 244 -HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
F S+ + + E+F AL+LL+ +L+ DPS+R+SA +AL YF
Sbjct: 237 ITFPESKPI--PLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 312 bits (800), Expect = e-103
Identities = 129/325 (39%), Positives = 188/325 (57%), Gaps = 44/325 (13%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKE------------GFPITAIREIKILKKLQHENVI 54
+V A + TG+IVA+KK+++ G T +RE+KI+ +++HEN++
Sbjct: 24 KVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83
Query: 55 KLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMK 114
L ++ +V + M DL + DR +R T Q+KC +
Sbjct: 84 GLVDVYVE----------------GDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILL 126
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-------------H 161
Q+L GL+ H +HRD+ +N+ I+++G K+ADFGLAR + Y
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
+T++V+TLWYR PELL+GA KY AVDMWSVGCIFAELL GKP+ PG+NE +QL +I
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
Query: 222 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
FEL G+P+E WP K+P Y F P + ++ +F + A++LL+ +L L+P +R
Sbjct: 247 FELLGTPNEDNWPQAKKLPLYTEFTPR--KPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304
Query: 282 ISAKDALDSEYFWTDPLPCDPKSLP 306
ISAK+AL EYF +DPLPCDP LP
Sbjct: 305 ISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 302 bits (776), Expect = e-100
Identities = 131/286 (45%), Positives = 173/286 (60%), Gaps = 17/286 (5%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ AR+ TGEIVA+KKI++ E EG P TA+REIK+LK+L H N+IKL ++
Sbjct: 15 VYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH----- 69
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+G Y+VFE+MD DL L IK Y+ QLL GL +CH +
Sbjct: 70 -----------KGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 187
+LHRD+K NLLI+ EG LKLADFGLARSF T+ V+T WYR PELLLG Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGYS 177
Query: 188 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 247
VD+WSVGCIFAELL+ +P+ PGK+E +QL KIF G+PD +WP + + F
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 248 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ + ++F + AL+LL +ML DP +RI+A+ AL YF
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 292 bits (749), Expect = 2e-96
Identities = 133/289 (46%), Positives = 181/289 (62%), Gaps = 23/289 (7%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ AR TGE+VALKKIR+D E EG P TAIREI +LK+L H N++KL +++ +
Sbjct: 16 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----- 70
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
Y+VFE++ DL D P +P IK Y+ QLL GL +CH +
Sbjct: 71 -----------ENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
+VLHRD+K NLLI+ EG +KLADFGLAR+F T T+ V+TLWYR PE+LLG Y
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYY 178
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
AVD+WS+GCIFAE++ + + PG +E +QL +IF G+PDE +WPGV+ +P Y K
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY---K 235
Query: 247 PS--RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
PS + ++ +V D +LL +ML DP++RISAK AL +F
Sbjct: 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 287 bits (738), Expect = 1e-94
Identities = 117/292 (40%), Positives = 172/292 (58%), Gaps = 25/292 (8%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPG 64
V+ AR++ TG VALKK+R+ +EG P++ +REI +LK+L+ H N+++L ++ G
Sbjct: 15 VYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH--G 72
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLH 121
P D + +VFE++D DL + PGL IK M+QLL G+
Sbjct: 73 PRTDREL---------KLTLVFEHVDQDLATYLSKCPKPGL--PPETIKDLMRQLLRGVD 121
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
+ H ++++HRD+K N+L+ ++G +K+ADFGLAR Y LT+ V+TLWYR PE+LL
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVVTLWYRAPEVLL 179
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
++ Y VDMWSVGCIFAEL +P+ G +EA+QL KIF++ G P E WP +P
Sbjct: 180 QSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP- 237
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ F R + L+LL+KML +P +RISA +AL YF
Sbjct: 238 RSSFPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 282 bits (724), Expect = 9e-93
Identities = 128/293 (43%), Positives = 184/293 (62%), Gaps = 30/293 (10%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ R KTG+IVA+KKIR+++E+EG P TAIREI +LK+LQH N++ L++++
Sbjct: 16 VYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE---- 71
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD--RPGLRFTVPQIKCYMKQLLTGLHYCHV 125
++ Y++FE++ DL D G +K Y+ Q+L G+ +CH
Sbjct: 72 --------SR----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS-----YDHNNTLTNRVITLWYRPPELL 180
+VLHRD+K NLLIDN+G +KLADFGLAR+F Y H V+TLWYR PE+L
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH------EVVTLWYRAPEVL 173
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
LG+ +Y VD+WS+G IFAE+ KP+ G +E +QL +IF + G+P E +WPGV+ +P
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233
Query: 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
Y + P K +R ++ D L+LLEKML+ DP++RISAK AL+ YF
Sbjct: 234 DYKNTFPKWK-KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 282 bits (723), Expect = 1e-92
Identities = 131/288 (45%), Positives = 186/288 (64%), Gaps = 21/288 (7%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ R TGEIVALK+I +D E EG P TAIREI ++K+L+HEN+++L +++ +
Sbjct: 16 VYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTE---- 70
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP--QIKCYMKQLLTGLHYCHV 125
NK +VFEYMD DL D G+R + +K + QLL G+ +CH
Sbjct: 71 --------NKL----MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
N+VLHRD+K NLLI+ G LKLADFGLAR+F NT +N V+TLWYR P++LLG+
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-VNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y ++D+WSVGCI AE++ G+P+ PG N +QL KIF + G+P E+ WPG+S++P Y
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237
Query: 246 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P R + ++++F H D ++LL ++L L+P RISA DAL +F
Sbjct: 238 FP-RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 3e-92
Identities = 135/288 (46%), Positives = 185/288 (64%), Gaps = 20/288 (6%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ AR+ T E +ALKKIR++ E EG P TAIREI +LK++QH N+++L+++V S E+
Sbjct: 18 VYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS---EK 74
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVN 126
Y+VFEY+D DL D P IK Y+ Q+L G+ YCH +
Sbjct: 75 -------------RLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 127 QVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
+VLHRD+K NLLID N LKLADFGLAR+F T T+ V+TLWYR PE+LLG+
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VRTFTHEVVTLWYRAPEILLGSRH 180
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y VD+WSVGCIFAE++N KP+ PG +E ++L KIF + G+P+E WPGV+ +P Y
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240
Query: 246 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P + + + V + ++LL KML LDPS+RI+A+ AL+ EYF
Sbjct: 241 FP-KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 273 bits (699), Expect = 6e-89
Identities = 125/292 (42%), Positives = 173/292 (59%), Gaps = 29/292 (9%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
VF A+ +T EIVALK++R+D++ EG P +A+REI +LK+L+H+N+++L +++ S
Sbjct: 16 VFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS----- 70
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+VFEY D DL D +K +M QLL GL +CH +
Sbjct: 71 -----------DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSF-----SYDHNNTLTNRVITLWYRPPELLLG 182
VLHRD+K NLLI+ G LKLADFGLAR+F Y V+TLWYRPP++L G
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA------EVVTLWYRPPDVLFG 173
Query: 183 ATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
A Y ++DMWS GCIFAEL N G+P+ PG + +QL +IF L G+P E WPGVSK+P
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
Y + V V + +LL+ +L+ +P QRISA++AL YF
Sbjct: 234 YKPYPMYPATTSLVNVVPKLNST-GRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 273 bits (699), Expect = 6e-89
Identities = 122/289 (42%), Positives = 171/289 (59%), Gaps = 21/289 (7%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ R TG++VALK+IR+ +EG P TAIRE +LK L+H N++ L +I+ +
Sbjct: 21 VYKGRSKLTGQLVALKEIRL-EHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT----- 74
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+ + +VFEY+D DL D G ++ ++ ++ QLL GL YCH +
Sbjct: 75 -----------KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR 123
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 187
VLHRD+K NLLI G LKLADFGLAR+ S + T +N V+TLWYRPP++LLG+T+Y
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVP-SKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 188 PAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
++DMW VGCIF E+ G+P+ PG + +QL KIF + G+P E WPGVS P + +
Sbjct: 183 TSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242
Query: 247 PSRTMKRRVREVFRHFDR--HALELLEKMLMLDPSQRISAKDALDSEYF 293
R + DR H EL K L +P +RISA +A+ YF
Sbjct: 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 267 bits (685), Expect = 3e-87
Identities = 100/289 (34%), Positives = 151/289 (52%), Gaps = 48/289 (16%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V++AR+ KTG++VA+K I+ K+ +REIKILKKL+H N+++L ++
Sbjct: 13 GKVYLARDKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKLKHPNIVRLYDVFEDED- 70
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
Y+V EY + DL L + G R + + + Y++Q+L+ L Y H
Sbjct: 71 ---------------KLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLH 114
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
++HRD+K N+L+D +G++KLADFGLAR D LT V T Y PE+LLG
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLLG-K 171
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
YG AVD+WS+G I ELL GKP PG + QL ++F+ G P P
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPPPEWD------ 222
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
A +L+ K+L+ DP +R++A++AL +F
Sbjct: 223 -----------------ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 2e-84
Identities = 124/295 (42%), Positives = 180/295 (61%), Gaps = 24/295 (8%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN-VIKLKEIVTSPGP 65
+V+ AR+ TG++VALKK R++ ++EG P TA+REI +L+ L +++L ++
Sbjct: 16 KVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHV--- 72
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLH 121
++ G+P S Y+VFEY+D DL D PG IK +M QLL G+
Sbjct: 73 -EEKNGKP-------SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 180
+CH + V+HRD+K NLL+D + LK+AD GL R+FS + T+ ++TLWYR PE+L
Sbjct: 125 HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVL 183
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
LG+T Y VD+WSVGCIFAE+ +P+ PG +E +QL IF+L G+P E +WPGVSK+
Sbjct: 184 LGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLR 243
Query: 241 AYNHFK--PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
++ F + + R L+LL+KML DP++RISAK AL YF
Sbjct: 244 DWHEFPQWKPQDLSR----AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 260 bits (666), Expect = 2e-83
Identities = 114/296 (38%), Positives = 168/296 (56%), Gaps = 29/296 (9%)
Query: 8 VFMAREIKTGEIVALKKIRM--DNEKEGFPITA---IREIKILKKLQHENVIKLKEIVTS 62
V A + +TG VA+KKI D+ I A +REIK+L+ L+HEN+I L +I+
Sbjct: 16 VCSAVDKRTGRKVAIKKISNVFDD-----LIDAKRILREIKLLRHLRHENIIGLLDILRP 70
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
P PE Y+V E M+ DL + + T I+ ++ Q+L GL Y
Sbjct: 71 PSPEDFN-----------DVYIVTELMETDLHKVI-KSPQPLTDDHIQYFLYQILRGLKY 118
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELL 180
H V+HRD+K SN+L+++ +LK+ DFGLAR D + LT V+T WYR PELL
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL 178
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP-DETI-WPGVSK 238
L +++Y A+D+WSVGCIFAELL KP+ PG++ +QL+ I E+ G+P +E + + K
Sbjct: 179 LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238
Query: 239 MPAY-NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
Y K+ + ++F A++LLEKML+ DP +RI+A +AL Y
Sbjct: 239 ARNYLKSLPKKP--KKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 254 bits (652), Expect = 3e-82
Identities = 95/290 (32%), Positives = 139/290 (47%), Gaps = 44/290 (15%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V+ A+ TG+IVA+K ++ +EK TA REI+IL++L H N+++L +
Sbjct: 13 GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKD- 71
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
Y+V EY + DL G + + K Q+L GL Y H
Sbjct: 72 ---------------HLYLVMEYCEGGDLFDY-LSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
N ++HRD+K N+L+D G +K+ADFGLA+ +++LT V T WY PE+LLG
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE-LCGSPDETIWPGVSKMPAYN 243
YGP VD+WS+G I ELL GKP G+N +QL I L + S
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE-- 232
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
A +L++K L DPS+R +A++ L +F
Sbjct: 233 ----------------------AKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 247 bits (634), Expect = 9e-79
Identities = 116/328 (35%), Positives = 173/328 (52%), Gaps = 56/328 (17%)
Query: 4 CISQ-----VFMAR--EIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIK 55
CI + V+ A+ K G+ A+KK + D E+ G +A REI +L++L+HENV+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 56 LKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD--RPGLRFTVPQ--IKC 111
L E+ S Y++F+Y +HDL + R R ++P +K
Sbjct: 67 LVEVFL--------------EHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS 112
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN----LKLADFGLARSF------SYDH 161
+ Q+L G+HY H N VLHRD+K +N+L+ EG +K+ D GLAR F D
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE------- 214
+ V+T+WYR PELLLGA Y A+D+W++GCIFAELL +PI G+
Sbjct: 173 DPV----VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228
Query: 215 --AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-----VREVFRHFDR--H 265
+QL +IFE+ G+P E WP + KMP Y+ K + + +H
Sbjct: 229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQ 288
Query: 266 ALELLEKMLMLDPSQRISAKDALDSEYF 293
+LL K+L DP++RI+A++AL+ YF
Sbjct: 289 GFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 236 bits (602), Expect = 2e-74
Identities = 121/291 (41%), Positives = 172/291 (59%), Gaps = 24/291 (8%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+ VF R T +VALK+IR+++E EG P TAIRE+ +LK L+H N++ L +I+ +
Sbjct: 19 ATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--- 74
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
ER +VFEY+D DL D G ++ +K +M QLL GL YCH
Sbjct: 75 ER-------------CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
++LHRD+K NLLI+ +G LKLADFGLAR+ S T +N V+TLWYRPP++LLG+T+
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y +DMW VGCI E+ G+P+ PG E+L IF L G+P E WPG++ + F
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT---SNEEF 237
Query: 246 KPSRTMKRRVREVFRH---FDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ + R + + H D ++LL +L+ + RISA+ AL YF
Sbjct: 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 2e-74
Identities = 102/291 (35%), Positives = 154/291 (52%), Gaps = 24/291 (8%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V R TGEIVA+KK + + E TA+RE+K+L++L+HEN++ LKE
Sbjct: 17 VLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF------- 69
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+ +G Y+VFEY++ L L + ++ Y+ QLL + YCH +
Sbjct: 70 ---------RRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 187
++HRDIK N+L+ G LKL DFG AR+ + LT+ V T WYR PELL+G T YG
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 188 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK- 246
VD+W++GCI AELL+G+P+ PG ++ +QL I + G + S P +
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240
Query: 247 ----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+++RR AL+ L+ L +DP +R++ + L YF
Sbjct: 241 PEPSQPESLERRYPGK---VSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 1e-73
Identities = 112/306 (36%), Positives = 167/306 (54%), Gaps = 50/306 (16%)
Query: 8 VFMAREIKTGEIVALKKI------RMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIV 60
V+ A + +T E+VALKKI D ++ REI L++L H N++KL ++
Sbjct: 23 VWKAIDRRTKEVVALKKIFDAFRNATDAQR------TFREIMFLQELGDHPNIVKLLNVI 76
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGL 120
+ + +K Y+VFEYM+ DL + R + V + M QLL L
Sbjct: 77 -----------KAENDK---DIYLVFEYMETDLHAVI-RANILEDV-HKRYIMYQLLKAL 120
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS----YDHNNTLTNRVITLWYRP 176
Y H V+HRD+K SN+L++++ +KLADFGLARS S N LT+ V T WYR
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP-DETI--- 232
PE+LLG+T+Y VDMWSVGCI E+L GKP+ PG + QL KI E+ G P E I
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240
Query: 233 -----WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 287
+ +P+ +P + + E+ AL+LL+K+L+ +P++R++A++A
Sbjct: 241 KSPFAATMLDSLPS----RPRKPLD----ELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292
Query: 288 LDSEYF 293
L+ Y
Sbjct: 293 LEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 4e-73
Identities = 123/291 (42%), Positives = 169/291 (58%), Gaps = 24/291 (8%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+ V+ R T +VALK+IR+++E EG P TAIRE+ +LK L+H N++ L +I+ +
Sbjct: 20 ATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT--- 75
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
S +VFEY+D DL D G + +K ++ QLL GL+YCH
Sbjct: 76 -------------EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
+VLHRD+K NLLI+ G LKLADFGLAR+ S T +N V+TLWYRPP++LLG+T
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYSNEVVTLWYRPPDILLGSTD 181
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y +DMW VGCIF E+ G+P+ PG EQL IF + G+P E WPG+ + F
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL---SNEEF 238
Query: 246 KPSRTMKRRVREVFRH---FDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
K K R + H D ELL K+L + +RISA++A+ YF
Sbjct: 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 8e-73
Identities = 108/293 (36%), Positives = 159/293 (54%), Gaps = 29/293 (9%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFP----ITAIREIKILKKLQ-HENVIKLKEIVT 61
V++AR +TGE+VA+KK M K+ F +RE+K L+KL H N++KLKE+
Sbjct: 14 SVYLARNKETGELVAIKK--M---KKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR 68
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGL-ADRPGLRFTVPQIKCYMKQLLTGL 120
E DE Y VFEYM+ +L L DR G F+ I+ + Q+L GL
Sbjct: 69 ----ENDE------------LYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 180
+ H + HRD+K NLL+ +K+ADFGLAR T+ V T WYR PE+L
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYVSTRWYRAPEIL 170
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
L +T Y VD+W++GCI AEL +P+ PG +E +QL KI + G+P + WP K+
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230
Query: 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ F+ + + ++ + A++L++ ML DP +R +A AL YF
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 228 bits (582), Expect = 3e-71
Identities = 122/291 (41%), Positives = 174/291 (59%), Gaps = 24/291 (8%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+ VF R T +VALK+IR+++E EG P TAIRE+ +LK L+H N++ L +IV +
Sbjct: 20 ATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK- 77
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
S +VFEY+D DL D G ++ +K ++ Q+L GL YCH
Sbjct: 78 ---------------SLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
+VLHRD+K NLLI+ G LKLADFGLAR+ S T +N V+TLWYRPP++LLG+++
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSSE 181
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y +DMW VGCIF E+ +G+P+ PG ++L IF L G+P E WPG+S + + F
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS---SNDEF 238
Query: 246 KPSRTMKRRVREVFRH---FDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
K K + + + H D +ELL K L + +RISA++A+ YF
Sbjct: 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 225 bits (574), Expect = 2e-70
Identities = 116/292 (39%), Positives = 169/292 (57%), Gaps = 25/292 (8%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPG 64
V+ AR+ +G VALK +R+ ++G P++ +RE+ +LK+L+ H N+++L ++ +
Sbjct: 16 VYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR 75
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLH 121
+R+ + +VFE++D DL D+ PGL IK M+Q L GL
Sbjct: 76 TDRETK-----------VTLVFEHVDQDLRTYLDKVPPPGL--PAETIKDLMRQFLRGLD 122
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
+ H N ++HRD+K N+L+ + G +KLADFGLAR +S LT V+TLWYR PE+LL
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAPEVLL 180
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
+T Y VDMWSVGCIFAE+ KP+ G +EA+QL KIF+L G P E WP +P
Sbjct: 181 QST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
F P R V+ V + +LL +ML +P +RISA AL +F
Sbjct: 240 GA-FSPRG--PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 1e-69
Identities = 125/283 (44%), Positives = 168/283 (59%), Gaps = 27/283 (9%)
Query: 17 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
G++VALK I M E EG P TAIRE +LK L+H N++ L +I+ +
Sbjct: 30 GQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT-------------- 74
Query: 77 KYRGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 135
+ + VFEYM DL + PG ++ +M QLL GL Y H +LHRD+K
Sbjct: 75 --KETLTFVFEYMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKP 131
Query: 136 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 195
NLLI G LKLADFGLAR+ S + T ++ V+TLWYRPP++LLGAT Y A+D+W
Sbjct: 132 QNLLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGA 190
Query: 196 GCIFAELLNGKPILPGKNEA-EQLSKIFELCGSPDETIWPGVSKMPAYNH--FKPSRTMK 252
GCIF E+L G+P PG ++ EQL KI+ + G P E WPGVSK+P Y F P +
Sbjct: 191 GCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKP-- 248
Query: 253 RRVREVFRHFDR--HALELLEKMLMLDPSQRISAKDALDSEYF 293
+++R V++ R A +L +MLM+ P RISA+DAL YF
Sbjct: 249 QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 2e-68
Identities = 117/286 (40%), Positives = 163/286 (56%), Gaps = 18/286 (6%)
Query: 11 AREIKTGEIVALKKIR--MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 68
A+ +T E VA+KKI DN + +REIK+L+ L HENVI +K+I+ P E
Sbjct: 24 AKNSETNEKVAIKKIANAFDNRIDA--KRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81
Query: 69 EQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 128
Y+V+E MD DL + R + + ++ QLL GL Y H V
Sbjct: 82 N-----------DVYIVYELMDTDLHQII-RSSQTLSDDHCQYFLYQLLRGLKYIHSANV 129
Query: 129 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 188
LHRD+K SNLL++ +LK+ DFGLAR+ S + +T V+T WYR PELLL ++Y
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTT 188
Query: 189 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP- 247
A+D+WSVGCIFAELL KP+ PGK+ QL I EL GSP E + A + +
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248
Query: 248 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
T ++ +F H + A++LLEKML+ DPS+RI+ ++AL Y
Sbjct: 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 2e-68
Identities = 112/308 (36%), Positives = 162/308 (52%), Gaps = 17/308 (5%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
QV A + KTG VA+KK+ + RE+++LK + HENVI L ++ T
Sbjct: 30 QVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D Q Y+V M DL + + + I+ + Q+L GL Y H
Sbjct: 90 EDFQ----------DVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSA 137
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
++HRD+K SN+ ++ + LK+ DFGLAR + +T V T WYR PE++L Y
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 193
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
VD+WSVGCI AELL GK + PG + +QL +I L G+PDE + +S A N+ +
Sbjct: 194 NQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQ 253
Query: 247 PSRTMKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 305
M ++ +EVF + A++LLEKML+LDP +RI+A +AL Y P D
Sbjct: 254 SLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVA 313
Query: 306 PKYESSHE 313
P Y+ S E
Sbjct: 314 PPYDQSFE 321
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 1e-67
Identities = 104/295 (35%), Positives = 158/295 (53%), Gaps = 33/295 (11%)
Query: 11 AREIKTGEIVALKKIRMDNEKEGF--PITA---IREIKILKKLQHENVIKLKEIVTSPGP 65
A + ++G+ VA+KKI F P A +RE+KIL+ +H+N+I +++I+ PG
Sbjct: 24 AIDTRSGKKVAIKKI-----PHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGL--ADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+ Y+V + M+ DL + +D+P T I+ ++ QLL GL Y
Sbjct: 79 DFK------------DVYVVMDLMESDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYI 123
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR---SFSYDHNNTLTNRVITLWYRPPELL 180
H V+HRD+K SNLL++ + L++ DFG+AR S +H +T V T WYR PELL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
L +Y A+DMWSVGCIFAE+L + + PGKN QL I + GSP E + +
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 241 AYNHFK--PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ + P + ++F AL+LL +ML DP +RI+ + AL +
Sbjct: 244 VRKYIQNLPRKQ-PVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 2e-65
Identities = 111/289 (38%), Positives = 165/289 (57%), Gaps = 19/289 (6%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V A TG VA+KKI E + F +REIKIL++ +HEN+I + +I+
Sbjct: 21 VCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILDII------- 72
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
RP + Y+V E M+ DL L L + I+ ++ Q+L GL Y H
Sbjct: 73 ----RPPSFESFNDVYIVQELMETDLYKLIKTQHL--SNDHIQYFLYQILRGLKYIHSAN 126
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATK 185
VLHRD+K SNLL++ +LK+ DFGLAR +H++T LT V T WYR PE++L +
Sbjct: 127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG 186
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y A+D+WSVGCI AE+L+ +P+ PGK+ QL+ I + G+P + + + A N+
Sbjct: 187 YTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYI 246
Query: 246 KPSRTMKRRV--REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292
K S K +V ++F + D AL+LL+KML +P +RI+ ++AL Y
Sbjct: 247 K-SLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 213 bits (542), Expect = 2e-65
Identities = 120/294 (40%), Positives = 172/294 (58%), Gaps = 27/294 (9%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+ V+ + G++VALK IR+ E+EG P TAIRE +LK L+H N++ L +I+ +
Sbjct: 19 ATVYKGKSKVNGKLVALKVIRL-QEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT--- 74
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+ + +VFEY+ DL D+ +K ++ QLL GL Y H
Sbjct: 75 -------------KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
+LHRD+K NLLI + G LKLADFGLAR+ S ++T +N V+TLWYRPP++LLG+T+
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
Y +DMW VGCIF E++ G PG K+ +QL +IF + G+P+E WPGV +P H
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP---H 237
Query: 245 FKPSRTM---KRRVREVFRHFD--RHALELLEKMLMLDPSQRISAKDALDSEYF 293
FKP R + +R+ + HA +L K+L P R+SA+ AL EYF
Sbjct: 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 205 bits (522), Expect = 7e-62
Identities = 104/302 (34%), Positives = 159/302 (52%), Gaps = 10/302 (3%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
VF A + + VA+KKI + + + A+REIKI+++L H+N++K+ E++ P
Sbjct: 21 VFSAVDSDCDKRVAVKKIVLTDPQS--VKHALREIKIIRRLDHDNIVKVYEVL-GPSGSD 77
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+ + S Y+V EYM+ DL + ++ + + +M QLL GL Y H
Sbjct: 78 LTEDVGSLTELN-SVYIVQEYMETDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSAN 134
Query: 128 VLHRDIKGSNLLIDNEG-NLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELLLGAT 184
VLHRD+K +N+ I+ E LK+ DFGLAR Y H L+ ++T WYR P LLL
Sbjct: 135 VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN 194
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
Y A+DMW+ GCIFAE+L GKP+ G +E EQ+ I E E + +
Sbjct: 195 NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFV 254
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD-PK 303
+R +R++ + AL+ LE++L +P R++A++AL Y P D P
Sbjct: 255 RNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPV 314
Query: 304 SL 305
SL
Sbjct: 315 SL 316
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 5e-61
Identities = 116/309 (37%), Positives = 167/309 (54%), Gaps = 49/309 (15%)
Query: 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-----REIKILKKLQHENVIKL 56
LVC AR+ TG+ VA+KKI + F + RE+K+LK L+HEN+I L
Sbjct: 25 LVC-----SARDQLTGQNVAIKKIM-----KPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 57 KEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL-TGLADRPGLRFTVPQ-IKCYMK 114
+I SP Y V E + DL L RP Q I+ ++
Sbjct: 75 SDIFISP---------------LEDIYFVTELLGTDLHRLLTSRP----LEKQFIQYFLY 115
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 174
Q+L GL Y H V+HRD+K SN+LI+ +LK+ DFGLAR + +T V T +Y
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYY 171
Query: 175 RPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234
R PE++L KY VD+WS GCIFAE+L GKP+ PGK+ Q S I +L G+P + +
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV-- 229
Query: 235 GVSKMPAYNHFKPSRTMKRRVR----EVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290
++ + + N + +++ +R E F++ D A++LLEKML+ DP +RISA +AL
Sbjct: 230 -INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288
Query: 291 EYF--WTDP 297
Y + DP
Sbjct: 289 PYLAPYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 8e-61
Identities = 108/305 (35%), Positives = 163/305 (53%), Gaps = 27/305 (8%)
Query: 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKL--KE 58
+VC ++ E E VA+KKI K+ A+RE+K+L+ + H+N+ L +
Sbjct: 15 IVCSAR---NAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMD 71
Query: 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLT 118
IV + Y+ E M+ DL + R G T + ++ Q+L
Sbjct: 72 IVFP-------------GNFNE-LYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILC 116
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYR 175
GL Y H VLHRD+K NLL++ + LK+ DFGLAR FS + +T V T WYR
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235
PE++L Y A+D+WSVGCI AELL KP+ GK+ +QL++I ++ G+PDE
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236
Query: 236 VSKMPAYNHFKPSRTM-KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF- 293
+ A N+ + + K+ +F + + AL+LLEK+L DP++RIS ++AL+ Y
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 294 -WTDP 297
W DP
Sbjct: 297 IWHDP 301
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 6e-60
Identities = 105/299 (35%), Positives = 160/299 (53%), Gaps = 40/299 (13%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPG 64
S+V A+ KTG+ A+K ++ + K + +REI+ L++L H N+++L E++
Sbjct: 13 SEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHY 122
G +VFE MD +L L G + +P+ +K YM QLL L +
Sbjct: 72 T--------------GRLALVFELMDMNLYELIK--GRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
H N + HRDIK N+LI ++ LKLADFG R Y T + T WYR PE LL
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGI-YSKP-PYTEYISTRWYRAPECLLT 172
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
YGP +D+W+VGC+F E+L+ P+ PG NE +Q++KI ++ G+PD +
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV---------L 223
Query: 243 NHFKPSRTM-----KRR---VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
F+ SR M ++ +R++ + L+LL+K+L DP +RI+AK AL YF
Sbjct: 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 1e-59
Identities = 106/297 (35%), Positives = 162/297 (54%), Gaps = 38/297 (12%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPIT---AIREIKILKKLQHENVIKLKEIVTSPG 64
VF R +TG+IVA+KK E E P+ A+REI++LK+L+H N++ L E+
Sbjct: 17 VFKCRNRETGQIVAIKKFV---ESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF---- 69
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVP--QIKCYMKQLLTGLH 121
+ + ++VFEY DH L L P VP IK + Q L ++
Sbjct: 70 ------------RRKRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVN 114
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
+CH + +HRD+K N+LI +G +KL DFG AR + + T+ V T WYR PELL+
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVATRWYRAPELLV 173
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
G T+YGP VD+W++GC+FAELL G+P+ PGK++ +QL I + G + P ++ +
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD----LIPRHQQIFS 229
Query: 242 YNHF-----KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
N F P + + F + AL L+ L +DP++R+S ++ L+ YF
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 197 bits (501), Expect = 1e-59
Identities = 118/298 (39%), Positives = 178/298 (59%), Gaps = 34/298 (11%)
Query: 7 QVFMAREIKTG-EIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTS 62
+VF AR++K G VALK++R+ +EG P++ IRE+ +L+ L+ H NV++L ++ T
Sbjct: 16 KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 75
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR---PGLRFTVP--QIKCYMKQLL 117
+R+ + +VFE++D DLT D+ PG VP IK M QLL
Sbjct: 76 SRTDRETK-----------LTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMFQLL 120
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
GL + H ++V+HRD+K N+L+ + G +KLADFGLAR +S+ LT+ V+TLWYR P
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAP 178
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237
E+LL ++ Y VD+WSVGCIFAE+ KP+ G ++ +QL KI ++ G P E WP
Sbjct: 179 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237
Query: 238 KMPAYNHF--KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+P F K ++ +++ V ++ D +LL K L +P++RISA AL YF
Sbjct: 238 ALPR-QAFHSKSAQPIEKFVTDI----DELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-57
Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 20/199 (10%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V++AR+ KTG+ VA+K I+ ++ +REI+ILKKL H N++KL +
Sbjct: 7 GTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENH 65
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
Y+V EY + L L + + +I + Q+L GL Y H
Sbjct: 66 ----------------LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH 109
Query: 125 VNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
N ++HRD+K N+L+D+ G +KLADFGL++ + + L V T Y PE+LLG
Sbjct: 110 SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 184 TKYGPAVDMWSVGCIFAEL 202
Y D+WS+G I EL
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-56
Identities = 120/345 (34%), Positives = 174/345 (50%), Gaps = 36/345 (10%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V A + TGE VA+KKI E +REIK+L+ L+H +++++K I+ P
Sbjct: 16 VCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-- 73
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+++ Y+VFE M+ DL + + T + ++ QLL L Y H
Sbjct: 74 --------REFK-DIYVVFELMESDLHQVI-KANDDLTPEHHQFFLYQLLRALKYIHTAN 123
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGA-- 183
V HRD+K N+L + + LK+ DFGLAR D + T+ V T WYR PEL G+
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-GSFF 182
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
+KY PA+D+WS+GCIFAE+L GKP+ PGKN QL I +L G+P V A
Sbjct: 183 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARR 242
Query: 244 HFKPSRTMK-RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 302
+ R + + F + D AL LLE++L DP R +A++AL YF
Sbjct: 243 YLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF--------- 293
Query: 303 KSLPKYE---SSH-----EYQTKKRRQQQRQHEEATKRQKLH-HP 338
K L K E S+ E++ ++RR + E R+ L HP
Sbjct: 294 KGLAKVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 190 bits (483), Expect = 4e-56
Identities = 105/312 (33%), Positives = 162/312 (51%), Gaps = 22/312 (7%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V A + +TGE VA+KK+ + E F A RE+ +LK +QHENVI L ++ TS
Sbjct: 31 VCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+ Q Y+V YM DL + G + +++ + Q+L GL Y H
Sbjct: 91 EFQ----------DFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG 137
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 187
++HRD+K NL ++ + LK+ DFGLAR + +T V+T WYR PE++L Y
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYN 193
Query: 188 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 247
VD+WSVGCI AE+L GK + GK+ +QL++I ++ G P + A ++ K
Sbjct: 194 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS 253
Query: 248 -SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL--PCDPKS 304
+ ++ +F A++LLEKML LD +R++A +AL+ YF D +
Sbjct: 254 LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF--DSFRDADEETE 311
Query: 305 LPKYESSHEYQT 316
Y+ S E +
Sbjct: 312 QQPYDDSLENEK 323
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 4e-56
Identities = 100/301 (33%), Positives = 162/301 (53%), Gaps = 44/301 (14%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V + +TG+IVA+KK + + A+REI++LK+L+HEN++ L E+
Sbjct: 16 MVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF------ 69
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCH 124
+ + Y+VFE++DH L L P GL + ++ Y+ Q+L G+ +CH
Sbjct: 70 ----------RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESR--VRKYLFQILRGIEFCH 117
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
+ ++HRDIK N+L+ G +KL DFG AR+ + T+ V T WYR PELL+G T
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDT 176
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG------------SPDETI 232
KYG AVD+W+VGC+ E+L G+P+ PG ++ +QL I + G +P +
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP---L 233
Query: 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292
+ G+ ++P +P +++R F L+L ++ L +DP R S+ L E+
Sbjct: 234 FAGM-RLPEVKEIEP---LEKR----FPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
Query: 293 F 293
F
Sbjct: 286 F 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 1e-54
Identities = 109/295 (36%), Positives = 163/295 (55%), Gaps = 33/295 (11%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V R +T EIVA+KK + E E T +RE+K+L+ L+ EN+++LKE
Sbjct: 17 VLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF------- 69
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+ RG Y+VFEY++ ++ L + +++ Y+ QL+ +H+CH N
Sbjct: 70 ---------RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 187
++HRDIK NLLI + LKL DFG AR+ S N T V T WYR PELLLGA YG
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYG 179
Query: 188 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS-PDETI--------WPGVSK 238
AVDMWSVGCI EL +G+P+ PG++E +QL I ++ G P E + + G+ +
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL-R 238
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
PA NH ++++RR + L+L++ +L L+P+ R + L+ F
Sbjct: 239 FPAVNH---PQSLERRYLGILSGV---LLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 5e-54
Identities = 111/329 (33%), Positives = 171/329 (51%), Gaps = 20/329 (6%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V A + +TG VA+KK+ + E F A RE+++LK ++HENVI L ++ T
Sbjct: 31 VCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT------ 84
Query: 68 DEQGRPDGNKYR-GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
PD + R Y+V +M DL L + + +I+ + Q+L GL Y H
Sbjct: 85 -----PDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAA 137
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
++HRD+K NL ++ + LK+ DFGLAR ++ +T V+T WYR PE++L Y
Sbjct: 138 GIIHRDLKPGNLAVNEDCELKILDFGLARQ----TDSEMTGYVVTRWYRAPEVILNWMHY 193
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
VD+WSVGCI AE+L GKP+ G + +QL +I ++ G+P + + A N+ K
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253
Query: 247 P-SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 305
R K+ R + + + A+ +LEKML+LD RI+A +AL YF P D
Sbjct: 254 KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEA 313
Query: 306 PKYESSHEYQTKKRRQQQR-QHEEATKRQ 333
P Y+ S + + + +R E Q
Sbjct: 314 PPYDDSFDEVDQSLEEWKRLTFTEILSFQ 342
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 4e-50
Identities = 99/292 (33%), Positives = 145/292 (49%), Gaps = 38/292 (13%)
Query: 15 KTGEIVALKKIRMDNEKEGFPIT--AIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 72
+ G+ VALKK M N + RE+K+L +H+NV+ +I+ P + E+
Sbjct: 23 RDGKRVALKK--MPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE-- 78
Query: 73 PDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
Y+V E M DL + P + +K ++ Q+L GL Y H +LHRD
Sbjct: 79 ---------IYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILHRD 128
Query: 133 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDM 192
IK NLL+++ LK+ DFGLAR D + +T V+T +YR PE+L+G+ Y AVD+
Sbjct: 129 IKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDI 188
Query: 193 WSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET------------IWPGVSKMP 240
WSVGCIFAELL + + ++ +QL I +L G+P I G K P
Sbjct: 189 WSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPP 248
Query: 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292
+ + + A+ LL +ML+ DP +RISA DAL Y
Sbjct: 249 SLP----------VLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 3e-49
Identities = 102/307 (33%), Positives = 161/307 (52%), Gaps = 17/307 (5%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V A + + + VA+KK+ + RE+++LK ++HENVI L ++ T P
Sbjct: 31 VCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFT-PATSI 89
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+ Y+V M DL + + + ++ + QLL GL Y H
Sbjct: 90 EN---------FNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSAG 138
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 187
++HRD+K SN+ ++ + L++ DFGLAR ++ +T V T WYR PE++L Y
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQ----ADDEMTGYVATRWYRAPEIMLNWMHYN 194
Query: 188 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 247
VD+WSVGCI AELL GK + PG + +QL +I E+ G+P + +S A + +
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQS 254
Query: 248 SRTMKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
M ++ ++++FR + A++LLEKML+LD +RISA +AL YF P D
Sbjct: 255 LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAE 314
Query: 307 KYESSHE 313
Y+ S E
Sbjct: 315 PYDESPE 321
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 3e-48
Identities = 111/325 (34%), Positives = 163/325 (50%), Gaps = 18/325 (5%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V A + KTG VA+KK+ + RE+++LK ++HENVI L ++ T P R
Sbjct: 33 VCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT---PAR 89
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+ D Y+V M DL + L T ++ + Q+L GL Y H
Sbjct: 90 SLEEFND-------VYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHSAD 140
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 187
++HRD+K SNL ++ + LK+ DFGLAR ++ +T V T WYR PE++L Y
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWMHYN 196
Query: 188 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 247
VD+WSVGCI AELL G+ + PG + +QL I L G+P + +S A N+ +
Sbjct: 197 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 256
Query: 248 SRTM-KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
M K VF + A++LLEKML+LD +RI+A AL YF P D
Sbjct: 257 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 316
Query: 307 KYESSHEYQTKKRRQQQRQ-HEEAT 330
Y+ S E + + + ++E
Sbjct: 317 PYDQSFESRDLLIDEWKSLTYDEVI 341
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 6e-48
Identities = 103/304 (33%), Positives = 161/304 (52%), Gaps = 49/304 (16%)
Query: 21 ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80
ALK+I E G ++A REI +L++L+H NVI L+++ S +
Sbjct: 32 ALKQI----EGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRK------------- 74
Query: 81 STYMVFEYMDHDL--------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
+++F+Y +HDL A++ ++ +K + Q+L G+HY H N VLHRD
Sbjct: 75 -VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRD 133
Query: 133 IKGSNLLIDNEG----NLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKY 186
+K +N+L+ EG +K+AD G AR F+ L V+T WYR PELLLGA Y
Sbjct: 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY 193
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGSPDETIWPGVS 237
A+D+W++GCIFAELL +PI + E +QL +IF + G P + W +
Sbjct: 194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIR 253
Query: 238 KMPAYNHF-KPSRTMKRRVREVFRHFDRHALE-------LLEKMLMLDPSQRISAKDALD 289
KMP Y K R + ++ ++H ++ LL+K+L +DP++RI+++ AL
Sbjct: 254 KMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313
Query: 290 SEYF 293
YF
Sbjct: 314 DPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 1e-46
Identities = 102/304 (33%), Positives = 160/304 (52%), Gaps = 49/304 (16%)
Query: 21 ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80
ALK+I E G ++A REI +L++L+H NVI L+++ S +
Sbjct: 32 ALKQI----EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRK------------- 74
Query: 81 STYMVFEYMDHDL--------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
+++F+Y +HDL A++ ++ +K + Q+L G+HY H N VLHRD
Sbjct: 75 -VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 133
Query: 133 IKGSNLLIDNEG----NLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKY 186
+K +N+L+ EG +K+AD G AR F+ L V+T WYR PELLLGA Y
Sbjct: 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY 193
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGSPDETIWPGVS 237
A+D+W++GCIFAELL +PI + E +QL +IF + G P + W +
Sbjct: 194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIK 253
Query: 238 KMPAYNHF-KPSRTMKRRVREVFRHFDRH-------ALELLEKMLMLDPSQRISAKDALD 289
KMP ++ K R + ++ ++H A LL+K+L +DP +RI+++ A+
Sbjct: 254 KMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313
Query: 290 SEYF 293
YF
Sbjct: 314 DPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 88/283 (31%), Positives = 136/283 (48%), Gaps = 49/283 (17%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPG 64
V++A + TGE++A+K + + + E + A+ REI+IL LQH N+++ G
Sbjct: 14 GSVYLALDKDTGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHPNIVRYY------G 66
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
ERDE + N ++ EY+ L+ L + G + P I+ Y +Q+L GL Y
Sbjct: 67 SERDE----EKNTLN--IFL--EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYL 117
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG 182
H N ++HRDIKG+N+L+D++G +KLADFG A+ T V T ++ PE++ G
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIFELCGSPDETIWPGVSKMPA 241
+YG A D+WS+GC E+ GKP L KI P+ +P
Sbjct: 178 -EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE---------IPE 227
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 284
+ E + F L K L DP +R +A
Sbjct: 228 HLS------------EEAKDF-------LRKCLRRDPKKRPTA 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 5e-45
Identities = 83/378 (21%), Positives = 134/378 (35%), Gaps = 51/378 (13%)
Query: 6 SQVFMAREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHE-NVIKLKEIVTSP 63
+V++AR+ K +VALK + K +REI+IL L H N++KL +
Sbjct: 14 GEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE 70
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPG--LRFTVPQIKCYMKQLLTGL 120
G Y+V EY+D L L + G + + + Q+L+ L
Sbjct: 71 GSL----------------YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYD-----HNNTLTNRVITLWY 174
Y H ++HRDIK N+L+D +G +KL DFGLA+ + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 175 RPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 232
PE+LLG + + D+WS+G ELL G P G+ + S+ +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--------- 225
Query: 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHAL-ELLEKMLMLDPSQRISAKDALDSE 291
P+ ++ + A +LL+K+L DP R+S+ L +
Sbjct: 226 ---------IILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 292 YFWTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAG 351
L S + +
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336
Query: 352 QSHHWSGPNHPMNNAPPP 369
+ S H ++
Sbjct: 337 APNGVSSSPHNSSSLLLS 354
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 85/294 (28%), Positives = 124/294 (42%), Gaps = 57/294 (19%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE-IVTSPGP 65
+V++ R G++ LK+I + N E A+ E+KILKKL H N+IK E
Sbjct: 15 KVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE---- 70
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL---ADRPGLRFTVPQIKCYMKQLLTGLH 121
+G +V EY D DL+ + G F QI + QL L
Sbjct: 71 -------------KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPEL 179
Y H ++LHRDIK N+ + + G +KL DFG+++ S D T+ V T +Y PEL
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV---VGTPYYLSPEL 174
Query: 180 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
Y D+WS+GC+ EL K G+N E KI L G +
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI--LKGQYP--------PI 223
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P + + S ++ L+ +L DP +R S L S +
Sbjct: 224 P--SQY--SSELR---------------NLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 96/313 (30%), Positives = 153/313 (48%), Gaps = 47/313 (15%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V A + TG+ VA+KK+ + A RE+ ++K + H+N+I L + T P++
Sbjct: 32 VCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT---PQK 88
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLA----DRPGLRFTVPQIKCYMKQLLTGLHYC 123
+ D Y+V E MD +L + D + + + Q+ C +K L
Sbjct: 89 SLEEFQD-------VYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL------- 134
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
H ++HRD+K SN+++ ++ LK+ DFGLAR+ +T V+T +YR PE++LG
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG- 191
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE--------TIWPG 235
Y VD+WSVGCI E++ G + PG + +Q +KI E G+P + T+
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNY 251
Query: 236 VSKMPAYNHFKPSRTMKRRVREVF-----RHFDR----HALELLEKMLMLDPSQRISAKD 286
V P Y + + +V ++ A +LL KML++DP +RIS D
Sbjct: 252 VENRPKY----AGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307
Query: 287 ALDSEYF--WTDP 297
AL Y W DP
Sbjct: 308 ALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 8e-40
Identities = 81/304 (26%), Positives = 134/304 (44%), Gaps = 56/304 (18%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V+ A + TG+ VA+KK+R+ + + I EI I+K +H N++ +
Sbjct: 34 EVYKATDRATGKEVAIKKMRLRKQNKE---LIINEILIMKDCKHPNIVDYYDSY------ 84
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
++V EYMD LT + + +R PQI +++L GL Y H
Sbjct: 85 ----------LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGA 183
V+HRDIK N+L+ +G++KLADFG A + + + N++ V T ++ PE++
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV---VGTPYWMAPEVIKR- 190
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
YGP VD+WS+G + E+ G+P P E P ++ +K
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEP--PYLRE------------PPLRALFLITTKGI--- 233
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 303
P + F+ F L K L+ DP +R SA++ L + C +
Sbjct: 234 ---PPLKNPEKWSPEFKDF-------LNKCLVKDPEKRPSAEELLQHPFL---KKACPKE 280
Query: 304 SLPK 307
Sbjct: 281 EFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 81/284 (28%), Positives = 128/284 (45%), Gaps = 51/284 (17%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V+ AR +TG+ VA+K I+++++++ I I EI+ILKK +H N++K
Sbjct: 15 EVYKARHKRTGKEVAIKVIKLESKEKKEKI--INEIQILKKCKHPNIVKY---------- 62
Query: 67 RDEQGRPDGNKYRGST-YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
G+ + ++V E+ L L T QI K+LL GL Y H
Sbjct: 63 -------YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
N ++HRDIK +N+L+ ++G +KL DFGL+ S V T ++ PE++ G
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVING-K 172
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
Y D+WS+G EL GKP EL P + + A N
Sbjct: 173 PYDYKADIWSLGITAIELAEGKP------------PYSEL--PPMKAL-----FKIATNG 213
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
R + + F+ F L+K L +P +R +A+ L
Sbjct: 214 PPGLRN-PEKWSDEFKDF-------LKKCLQKNPEKRPTAEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 5e-38
Identities = 92/302 (30%), Positives = 149/302 (49%), Gaps = 42/302 (13%)
Query: 20 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79
VA+KK+ + + A RE+ +LK + H+N+I L + T P++ + D
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT---PQKSLEEFQD----- 100
Query: 80 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 139
Y+V E MD +L + + ++ + Q+L G+ + H ++HRD+K SN++
Sbjct: 101 --VYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 155
Query: 140 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 199
+ ++ LK+ DFGLAR+ N +T V+T +YR PE++LG Y VD+WSVGCI
Sbjct: 156 VKSDCTLKILDFGLARTACT--NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 212
Query: 200 AELLNGKPILPGKNEAEQLSKIFELCGSPD--------ETIWPGVSKMPAYNHFK----- 246
EL+ G I G + +Q +K+ E G+P T+ V P Y
Sbjct: 213 GELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELF 272
Query: 247 -----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLP 299
PS + + +++ A +LL KML++DP +RIS +AL Y W DP
Sbjct: 273 PDWIFPSESERDKLKT------SQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE 326
Query: 300 CD 301
+
Sbjct: 327 AE 328
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 8e-37
Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 24/204 (11%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ ++TG+ VA+K+I ++ KE + ++EI +LK L+H N++K + +
Sbjct: 15 VVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET---- 70
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
S Y++ EY ++ L + + G F + Y+ Q+L GL Y H
Sbjct: 71 ------------SDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHE 117
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL--GA 183
V+HRDIK +N+L +G +KLADFG+A + + + V T ++ PE++ GA
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMSGA 176
Query: 184 TKYGPAVDMWSVGCIFAELLNGKP 207
+ A D+WS+GC ELL G P
Sbjct: 177 ST---ASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 8e-35
Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 56/292 (19%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIK-LKEIVTSPGP 65
V R G+I+ K+I N E + E+ IL++L+H N+++ I+
Sbjct: 15 TVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRII----- 69
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL---ADRPGLRFTVPQIKCYMKQLLTGLH 121
++ + Y+V EY + DL L + I + QLL L+
Sbjct: 70 ----------DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 122 YCHV-----NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
CH N VLHRD+K +N+ +D N+KL DFGLA+ +D + T V T +Y
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYYMS 178
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
PE L Y D+WS+GC+ EL P +N+ + SKI E G
Sbjct: 179 PEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-----------G- 225
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
+ R + + E+++ ML +DP +R S ++ L
Sbjct: 226 -----------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 9e-35
Identities = 90/309 (29%), Positives = 152/309 (49%), Gaps = 44/309 (14%)
Query: 20 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79
VA+KK+ + + A RE+ ++K + H+N+I L + T P++ + D
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT---PQKSLEEFQD----- 103
Query: 80 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 139
Y+V E MD +L + + ++ + Q+L G+ + H ++HRD+K SN++
Sbjct: 104 --VYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 140 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 199
+ ++ LK+ DFGLAR+ +T V+T +YR PE++LG Y VD+WSVGCI
Sbjct: 159 VKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 215
Query: 200 AELLNGKPILPGKNEAEQLSKIFELCGSP--------DETIWPGVSKMPAYNHFK----- 246
E++ G + PG + +Q +K+ E G+P T+ V P Y +
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLF 275
Query: 247 -----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLP 299
P+ + +++ A +LL KML++D S+RIS +AL Y W DP
Sbjct: 276 PDVLFPADSEHNKLKA------SQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE 329
Query: 300 CD--PKSLP 306
+ P +P
Sbjct: 330 AEAPPPKIP 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 78/294 (26%), Positives = 125/294 (42%), Gaps = 67/294 (22%)
Query: 4 CISQVFMAREIKTGEIVALK-----KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE 58
+V + R+ TG++ A+K KI E E + E IL ++ H ++KL
Sbjct: 5 SFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVE----HTLTERNILSRINHPFIVKLH- 59
Query: 59 IVTSPGPERDEQGRPDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYM 113
Y Y+V EY +L + G RF+ + + Y
Sbjct: 60 -------------------YAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYA 99
Query: 114 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 173
+++ L Y H +++RD+K N+L+D +G++KL DFGLA+ S + + T T T
Sbjct: 100 AEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPE 158
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233
Y PE+LLG YG AVD WS+G + E+L GKP ++ E KI L
Sbjct: 159 YLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPL----- 210
Query: 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 287
+ P + A +L+ +L DP++R+ + A
Sbjct: 211 ----RFPEF-------------------LSPEARDLISGLLQKDPTKRLGSGGA 241
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 88/298 (29%), Positives = 150/298 (50%), Gaps = 42/298 (14%)
Query: 20 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79
VA+KK+ + + A RE+ ++K + H+N+I L + T P++ + D
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT---PQKSLEEFQD----- 96
Query: 80 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 139
Y+V E MD +L + + ++ + Q+L G+ + H ++HRD+K SN++
Sbjct: 97 --VYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 140 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 199
+ ++ LK+ DFGLAR+ +T V+T +YR PE++LG Y VD+WSVGCI
Sbjct: 152 VKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 208
Query: 200 AELLNGKPILPGKNEAEQLSKIFELCGSP--------DETIWPGVSKMPAY--------- 242
E++ K + PG++ +Q +K+ E G+P T+ V P Y
Sbjct: 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLF 268
Query: 243 -NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 297
+ P+ + +++ A +LL KML++DP++RIS +AL Y W DP
Sbjct: 269 PDSLFPADSEHNKLKA------SQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 77/313 (24%), Positives = 122/313 (38%), Gaps = 80/313 (25%)
Query: 5 ISQVFMAREIKTGEIVALK---K---IRMDNEKEGFPITAIREIKILKKL-QHENVIKLK 57
S V +A+E +T + A+K K I+ K E ++L +L H +IKL
Sbjct: 14 FSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY-----VKIEKEVLTRLNGHPGIIKL- 67
Query: 58 EIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQL 116
T +DE+ + Y V EY + +L + G + Y ++
Sbjct: 68 -YYTF----QDEE----------NLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEI 111
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW--- 173
L L Y H ++HRD+K N+L+D + ++K+ DFG A+ + + T
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 174 ----------------YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 217
Y PELL G + D+W++GCI ++L GKP G NE
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 218 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 277
KI +L P +F A +L+EK+L+LD
Sbjct: 231 FQKILKLE-----------YSFP-------------------PNFPPDAKDLIEKLLVLD 260
Query: 278 PSQRISAKDALDS 290
P R+ + D
Sbjct: 261 PQDRLGVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 101/310 (32%), Positives = 150/310 (48%), Gaps = 33/310 (10%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ A I T E VA+KK+ D P RE+ I+K L H N+I LK+ + ++
Sbjct: 82 VYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+E+ V +YM H R + +K Y QL L Y H
Sbjct: 136 NEKNIFLNVVMEFIPQTVHKYMKH-----YARNNHALPLFLVKLYSYQLCRALAYIHSKF 190
Query: 128 VLHRDIKGSNLLID-NEGNLKLADFGLA-------RSFSYDHNNTLTNRVITLWYRPPEL 179
+ HRD+K NLLID N LKL DFG A RS SY + + +YR PEL
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---------ICSRFYRAPEL 241
Query: 180 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
+LGAT Y +D+WS+GCI AE++ G PI G++ +QL +I ++ G+P E ++
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN-- 299
Query: 240 PAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298
P Y K + +++VF + A+ + + L +P +R++ +AL +F
Sbjct: 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359
Query: 299 PCDPKSLPKY 308
PC LPKY
Sbjct: 360 PC--IKLPKY 367
|
Length = 440 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 80/289 (27%), Positives = 130/289 (44%), Gaps = 55/289 (19%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
+VF+A++ TG+I A+K I+ + ++ + E IL + Q V+KL
Sbjct: 7 GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-- 64
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+ + Y+V EY+ DL L + G + Y+ +++ L Y
Sbjct: 65 --------------KKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYL 109
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLA------RSFSYDHNNTLTNRVI-TLWYRP 176
H N ++HRD+K N+LID+ G+LKL DFGL+ R + + + R++ T Y
Sbjct: 110 HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
PE++LG + VD WS+GCI E L G P G+ E I L G + WP
Sbjct: 170 PEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LNGKIE---WP-- 221
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 285
+ + A++L+ K+L+ DP +R+ AK
Sbjct: 222 EDVEVSD---------------------EAIDLISKLLVPDPEKRLGAK 249
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 79/287 (27%), Positives = 130/287 (45%), Gaps = 53/287 (18%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAI----REIKILKKLQHENVIKLKEIVTS 62
V+ + G+ A+K++ + ++ A+ +EI +L KLQH N IV
Sbjct: 15 SVYEGLNLDDGDFFAVKEVSLADD-GQTGQEAVKQLEQEIALLSKLQHPN------IVQY 67
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
G ER+E + Y+ E + L L + G F P I+ Y +Q+L GL
Sbjct: 68 LGTEREE----------DNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLE 116
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
Y H +HRDIKG+N+L+D G +KLADFG+A+ + + + ++ PE++
Sbjct: 117 YLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKSFKGSPYWMAPEVIA 174
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
YG A D+WS+GC E+ GKP ++ E ++ +F++ S + +P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKE---------LP- 221
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
+ H A + + K L DPS R +A + L
Sbjct: 222 ---------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 90/292 (30%), Positives = 123/292 (42%), Gaps = 55/292 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V+ R TG+I ALKKI +D ++E F +RE+K L+ + V+K G
Sbjct: 15 GVVYKVRHKPTGKIYALKKIHVDGDEE-FRKQLLRELKTLRSCESPYVVKCYGAFYKEG- 72
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+V EYMD L L + G P + +Q+L GL Y H
Sbjct: 73 ---------------EISIVLEYMDGGSLADLLKKVGK-IPEPVLAYIARQILKGLDYLH 116
Query: 125 -VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELL 180
++HRDIK SNLLI+++G +K+ADFG+++ NTL V T+ Y PE +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE----NTLDQCNTFVGTVTYMSPERI 172
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
G + Y A D+WS+G E GK P LP Q S FEL M
Sbjct: 173 QGES-YSYAADIWSLGLTLLECALGKFPFLP----PGQPS-FFEL--------------M 212
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291
A P FR F + L DP +R SA + L
Sbjct: 213 QAICDGPPPSLPAEEFSPEFRDF-------ISACLQKDPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 82/277 (29%), Positives = 127/277 (45%), Gaps = 51/277 (18%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNE-----KEGFPITAIR-EIKILKKLQHENVIKLKEIV 60
+V++ ++ TG +A+K++ D + KE + A+ EI++LK LQHE IV
Sbjct: 17 RVYLCYDVDTGRELAVKQVPFDPDSPETKKE---VNALECEIQLLKNLQHE------RIV 67
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYM------DHDLTGLADRPGLRFTVPQIKCYMK 114
G RD + + EYM D L L TV + Y +
Sbjct: 68 QYYGCLRD----------DETLSIFMEYMPGGSVKDQ----LKAYGALTETV--TRKYTR 111
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TL 172
Q+L G+ Y H N ++HRDIKG+N+L D+ GN+KL DFG ++ ++ + + T
Sbjct: 112 QILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 173 WYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 232
++ PE++ G YG D+WSVGC E+L KP E E ++ IF++ P
Sbjct: 172 YWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQ 227
Query: 233 WPGVSKMPAYNHFKPSRTMKRRVR------EVFRHFD 263
P S + RT + E+ RHF
Sbjct: 228 LP--SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 72/299 (24%), Positives = 120/299 (40%), Gaps = 72/299 (24%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ A +TG++VA+K + ++ + + I+EI ILK+ ++K
Sbjct: 18 SVYKAIHKETGQVVAIKVVPVEEDLQEI----IKEISILKQCDSPYIVKYY--------- 64
Query: 67 RDEQGRPDGNKYRGSTYM-VFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
G+ ++ + V EY D+ + ++ T +I + Q L GL
Sbjct: 65 --------GSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLE 113
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELL 180
Y H N+ +HRDIK N+L++ EG KLADFG+ S N VI T ++ PE++
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
Y D+WS+G E+ GKP P
Sbjct: 172 QE-IGYNNKADIWSLGITAIEMAEGKP--P------------------------------ 198
Query: 241 AYNHFKPSRTM---KRRVREVFRHFDRHALEL---LEKMLMLDPSQRISAKDALDSEYF 293
Y+ P R + + ++ + E ++K L+ DP +R SA L +
Sbjct: 199 -YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 76/299 (25%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPE 66
V+ A + +T ++VA+K I ++ ++ I I +EI+ L + + + K
Sbjct: 17 VYKAIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRSPYITK----------- 63
Query: 67 RDEQGRPDGNKYRGS------TYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQL 116
Y GS +++ EY DL +PG + I ++++
Sbjct: 64 -----------YYGSFLKGSKLWIIMEYCGGGSCLDLL----KPG-KLDETYIAFILREV 107
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLW 173
L GL Y H +HRDIK +N+L+ EG++KLADFG++ + +T++ R V T +
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT----STMSKRNTFVGTPF 163
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233
+ PE++ + Y D+WS+G EL G+P L + L I P
Sbjct: 164 WMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI------PKN--- 213
Query: 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292
P + + F+ F + L DP +R SAK+ L ++
Sbjct: 214 ------------NPPSLEGNKFSKPFKDF-------VSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 68/244 (27%), Positives = 127/244 (52%), Gaps = 48/244 (19%)
Query: 7 QVFMAREIKTGEIVALKKIRMD------NEKEGFPITAI-REIKILKKLQHENVIKLKEI 59
V++ +GE++A+K++ + +++ + A+ REI +LK+LQHEN+++
Sbjct: 15 SVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ---- 70
Query: 60 VTSPGPERDEQGRPDGNKYRGS----TYMVF--EYM-DHDLTGLADRPGLRFTVPQIKCY 112
Y GS ++ EY+ + L + G F ++ +
Sbjct: 71 ------------------YLGSSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNF 111
Query: 113 MKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-- 170
++Q+L GL+Y H ++HRDIKG+N+L+DN+G +K++DFG+++ + +T TN
Sbjct: 112 VRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 171 ---TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG- 226
++++ PE ++ T Y D+WS+GC+ E+L GK P + QL IF++
Sbjct: 172 LQGSVFWMAPE-VVKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGEN 227
Query: 227 -SPD 229
SP+
Sbjct: 228 ASPE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-26
Identities = 66/229 (28%), Positives = 116/229 (50%), Gaps = 31/229 (13%)
Query: 7 QVFMAREIKTGEIVALKKIRM-------DNEKEGFPITAIR-EIKILKKLQHENVIKLKE 58
+V++A + TGE++A+K++ + + ++ + A+R EI+ LK L H N
Sbjct: 16 RVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLN------ 69
Query: 59 IVTSPGPERDEQGRPDGNKYRGSTYMVF-EYMDHDLTGLADRPGLRFTVPQIKCYMKQLL 117
IV G E E+ +F EY+ G R RF ++ + +Q+L
Sbjct: 70 IVQYLGFETTEE-----------YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL 118
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLTNRVITLWYR 175
GL Y H +LHRD+K NLL+D +G K++DFG+++ YD++ ++ + W
Sbjct: 119 EGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 224
P + + Y VD+WS+GC+ E+ G+ P +E E ++ +F+L
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR--PWSDE-EAIAAMFKL 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 34/209 (16%)
Query: 7 QVFMAR----EIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEI 59
+V+ VA+K ++ + + E F +RE +I++KL H N++KL +
Sbjct: 14 EVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF----LREARIMRKLDHPNIVKLLGV 69
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLL 117
T P +V EYM DL L ++ + + Q+
Sbjct: 70 CTEEEP----------------LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRP 176
G+ Y +HRD+ N L+ +K++DFGL+R + D+ ++ W
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-A 172
Query: 177 PE-LLLGATKYGPAVDMWSVGCIFAELLN 204
PE L G K+ D+WS G + E+
Sbjct: 173 PESLKEG--KFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 29/196 (14%)
Query: 15 KTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 71
K VA+K ++ + + E F +RE +I++KL H NV+KL + T P
Sbjct: 26 KKKVEVAVKTLKEDASEQQIEEF----LREARIMRKLDHPNVVKLLGVCTEEEP------ 75
Query: 72 RPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 130
Y+V EYM+ DL + + ++ + + Q+ G+ Y +H
Sbjct: 76 ----------LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIH 125
Query: 131 RDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPE-LLLGATKYGP 188
RD+ N L+ +K++DFGL+R + D+ ++ W PE L G K+
Sbjct: 126 RDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKEG--KFTS 182
Query: 189 AVDMWSVGCIFAELLN 204
D+WS G + E+
Sbjct: 183 KSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 74/246 (30%), Positives = 127/246 (51%), Gaps = 34/246 (13%)
Query: 6 SQVFMAREIKTGEIVALKKIRM----DNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
S + AR++KTG ++A+K++ +E+E +EI+++ +L H ++I++
Sbjct: 14 SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRML---- 69
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVF-EYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTG 119
G S + +F E+M ++ L + G F I Y +QLL G
Sbjct: 70 -------------GATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRG 115
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNT--LTNRVI-TLWYR 175
L Y H NQ++HRD+KG+NLLID+ G L++ADFG A + +++ T+ +
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC---GSPD--E 230
PE+L G +YG + D+WSVGC+ E+ KP + + L+ IF++ +P E
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234
Query: 231 TIWPGV 236
+ PG+
Sbjct: 235 HLSPGL 240
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 33/227 (14%)
Query: 8 VFMAR----EIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIV 60
V+ T VA+K ++ + E+E F + E I+KKL H N+++L +
Sbjct: 15 VYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMKKLSHPNIVRLLGVC 70
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTG 119
T P Y+V EYM DL + G + T+ + Q+ G
Sbjct: 71 TQGEP----------------LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPP 177
+ Y +HRD+ N L+ +K++DFGL+R + D+ + + W P
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-AP 173
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFE 223
E L K+ D+WS G + E+ G+ PG + E L + +
Sbjct: 174 ESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 69/301 (22%), Positives = 119/301 (39%), Gaps = 69/301 (22%)
Query: 6 SQVFMAREIKTGEIVALKKI-RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
+V + ++ T ++ A+K + + ++G + E +IL++L H ++ L
Sbjct: 14 GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW------- 66
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR--------FTVPQIKCYMKQL 116
++ M Y+ DL D LR F+ Q+K ++ ++
Sbjct: 67 -----------YSFQDEENM---YLVVDLLLGGD---LRYHLSQKVKFSEEQVKFWICEI 109
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
+ L Y H ++HRDIK N+L+D +G++ + DF +A + D T+ T Y
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT--TSTSGTPGYMA 167
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK--NEAEQLSKIFELCGSPDETIWP 234
PE+L Y AVD WS+G E L GK G +Q+ E + D
Sbjct: 168 PEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---TADVLYPA 223
Query: 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS--AKDALDSEY 292
S A++ + K+L DP +R+ KD + Y
Sbjct: 224 TWST--------------------------EAIDAINKLLERDPQKRLGDNLKDLKNHPY 257
Query: 293 F 293
F
Sbjct: 258 F 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 4e-23
Identities = 56/248 (22%), Positives = 102/248 (41%), Gaps = 62/248 (25%)
Query: 7 QVFMAR---EIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIV 60
+V+ + + VA+K ++ + E++ F ++E +++KKL H NV++L +
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF----LKEARVMKKLGHPNVVRLLGVC 65
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL-------TGLADRPGL-RFTVPQIKC 111
T P Y+V EYM+ DL + P ++ +
Sbjct: 66 TEEEP----------------LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVI 170
+ Q+ G+ Y + +HRD+ N L+ + +K++DFGL+R + D+ T +
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL 169
Query: 171 TL-WYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 229
+ W PE L + D+WS G + E IF L +P
Sbjct: 170 PIRWM-APESLKDG-IFTSKSDVWSFGVLLWE-------------------IFTLGATP- 207
Query: 230 ETIWPGVS 237
+PG+S
Sbjct: 208 ---YPGLS 212
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 7e-23
Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 35/219 (15%)
Query: 6 SQVFMAREIKTGEIVALK--KIRMDNEKEGFPITAIR-EIKILKKL-QHENVIKLKEIVT 61
+V+ AR KTG++VA+K I D E+E I+ E IL+K H N+
Sbjct: 20 GKVYKARHKKTGQLVAIKIMDIIEDEEEE------IKEEYNILRKYSNHPNIATFYGAFI 73
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH----DLTGLADRPGLRFTVPQIKCYMKQLL 117
P G D ++V E DL + G R I +++ L
Sbjct: 74 KKNP----PGNDD------QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRP 176
GL Y H N+V+HRDIKG N+L+ +KL DFG++ D N I T ++
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMA 181
Query: 177 PELLLGATKYGPAV------DMWSVGCIFAELLNGKPIL 209
PE++ A P D+WS+G EL +GKP L
Sbjct: 182 PEVI--ACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 31/210 (14%)
Query: 8 VFMAREIKTGEIVALKKIRM-DNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ A + TGE++A+K+IR+ DN+ + A E+K+L+ L+H N++K +
Sbjct: 16 VYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA-DEMKVLELLKHPNLVKYYGVEV----H 70
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
R++ Y+ EY L L G I+ Y QLL GL Y H
Sbjct: 71 REK------------VYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT------NRVITLWYRPPEL 179
+ ++HRDIK +N+ +D+ G +KL DFG A NNT T + T Y PE+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK---NNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 180 LLGATK--YGPAVDMWSVGCIFAELLNGKP 207
+ G +G A D+WS+GC+ E+ GK
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 72/285 (25%)
Query: 8 VFMAREIKTGEIVALKK------IRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
V + R +G+ ALK +++ + + E +IL+ ++H ++ L
Sbjct: 17 VMLVRHKGSGKYYALKILSKAKIVKLKQVEH-----VLNEKRILQSIRHPFLVNLY---- 67
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGL 120
G +D+ + Y+V EY+ +L + G RF P + Y Q++ L
Sbjct: 68 --GSFQDDS----------NLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLAL 114
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW----YRP 176
Y H +++RD+K NLL+D++G +K+ DFG A+ + R TL Y
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VKGRTYTLCGTPEYLA 166
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
PE++L YG AVD W++G + E+L G P P + +I+E I G
Sbjct: 167 PEIILS-KGYGKAVDWWALGILIYEMLAGYP--PFF--DDNPIQIYEK-------ILEGK 214
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
+ P F A +L+ +L +D ++R
Sbjct: 215 VRFP-------------------SFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 46/216 (21%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ AR+I TGE+VA+K I+++ + F I +EI +LK+ +H N++
Sbjct: 18 DVYKARDIATGELVAIKVIKLE-PGDDFEIIQ-QEISMLKECRHPNIVA----------- 64
Query: 67 RDEQGRPDGNKYRGS------TYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQL 116
Y GS ++V EY D+ + P + QI ++
Sbjct: 65 -----------YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRET 110
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLW 173
L GL Y H +HRDIKG+N+L+ +G++KLADFG++ + T+ R + T +
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIAKRKSFIGTPY 166
Query: 174 YRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKP 207
+ PE+ K Y D+W++G EL +P
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 9e-22
Identities = 75/305 (24%), Positives = 131/305 (42%), Gaps = 79/305 (25%)
Query: 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKL--KEI 59
+VCI A + TG VA+KK MD K+ E+ I++ QH N++++ +
Sbjct: 34 IVCI-----ATDKSTGRQVAVKK--MDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLT 118
V DE ++V E+++ LT + R QI +L
Sbjct: 87 VG------DE------------LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLK 126
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYR 175
L + H V+HRDIK ++L+ ++G +KL+DFG S + + R V T ++
Sbjct: 127 ALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWM 182
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235
PE ++ YG VD+WS+G + E+++G+P
Sbjct: 183 APE-VISRLPYGTEVDIWSLGIMVIEMVDGEP---------------------------- 213
Query: 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHA-------LELLEKMLMLDPSQRISAKDAL 288
P +N P + M +R+R+ ++ L++ML+ DP+QR +A + L
Sbjct: 214 ----PYFNE-PPLQAM-KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELL 267
Query: 289 DSEYF 293
+ +
Sbjct: 268 NHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 77/291 (26%), Positives = 125/291 (42%), Gaps = 72/291 (24%)
Query: 8 VFMAREIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHE--NVIKLKEIVTS 62
V++A++ TG+ A+K ++ M + + +T ++ + + +Q E V KL S
Sbjct: 12 VYLAKKRSTGDYFAIKVLKKSDMIAKNQ---VTNVKAERAIMMIQGESPYVAKLYYSFQS 68
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQ--IKCYMKQLLTG 119
+ Y+V EY++ D L G +P+ K Y+ +++ G
Sbjct: 69 ----------------KDYLYLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLG 109
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPP 177
+ H ++HRDIK NLLID G+LKL DFGL+R N L N+ T Y P
Sbjct: 110 VEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSR-------NGLENKKFVGTPDYLAP 162
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237
E +LG D WS+GC+ E L G P AE +F+
Sbjct: 163 ETILGVGD-DKMSDWWSLGCVIFEFLFGYPPF----HAETPDAVFD-------------- 203
Query: 238 KMPAYNHFKPSRTMKRRV---REVFRHFDRHALELLEKMLMLDPSQRISAK 285
+ RR+ EV A++L+ ++L +DP++R+ A
Sbjct: 204 -----------NILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 25/234 (10%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNE--KEGFPITAIR-EIKILKKLQHENVIKLKEIVTSP 63
+V++ + TG +A+K+++ D E + + A+ EI++LK L HE +++ + P
Sbjct: 17 RVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP 76
Query: 64 GPERDEQGRPDGNKYRGSTYMVF-EYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
ER T +F E+M + T + Y +Q+L G+ Y
Sbjct: 77 -MER--------------TLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD--HNNTLTNRVITLWYRPPELL 180
H N ++HRDIKG+N+L D+ GN+KL DFG ++ + + T ++ PE++
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234
G YG D+WSVGC E+L KP E E ++ IF++ P + P
Sbjct: 182 SG-EGYGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 51/220 (23%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ A + E VA+K+I ++ + +E++ + + H NV+K
Sbjct: 17 VYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVK------------ 63
Query: 68 DEQGRPDGNKYRGS------TYMVFEYMD----HDLTGLADRPGLRFTVPQ-------IK 110
Y S ++V Y+ D+ ++ + P+ I
Sbjct: 64 ----------YYTSFVVGDELWLVMPYLSGGSLLDI--------MKSSYPRGGLDEAIIA 105
Query: 111 CYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR-- 168
+K++L GL Y H N +HRDIK N+L+ +G++K+ADFG++ S + + T R
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 169 -VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 207
V T + PE++ Y D+WS G EL G
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V+ + + + ALK++ + + + A+ EI+IL + H N+I KE
Sbjct: 14 GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL---- 69
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMD-HDLT-GLADRPGLRFTVPQ--IKCYMKQLLTGLH 121
DGNK +V EY DL+ ++ R R +P+ I QLL GL
Sbjct: 70 --------DGNKL----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELL 180
H ++LHRD+K +N+L+ +K+ D G+++ + I T Y PE+
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPEVW 173
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
G Y D+WS+GC+ E+ P ++ + K+
Sbjct: 174 KG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 70/234 (29%), Positives = 116/234 (49%), Gaps = 25/234 (10%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNE--KEGFPITAIR-EIKILKKLQHENVIKLKEIVTSP 63
+V++ ++ TG +A K+++ D E + ++A+ EI++LK LQHE +++
Sbjct: 17 RVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYY------ 70
Query: 64 GPERDEQGRPDGNKYRGSTYMVF-EYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
G RD + T +F EYM + T + Y +Q+L G+ Y
Sbjct: 71 GCLRDRAEK---------TLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELL 180
H N ++HRDIKG+N+L D+ GN+KL DFG ++ + R + T ++ PE++
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234
G YG D+WS+GC E+L KP E E ++ IF++ P P
Sbjct: 182 SG-EGYGRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAIFKIATQPTNPQLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 6e-20
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 30/208 (14%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ AR++ T +A+K+I + + P+ EI + L+H N+++
Sbjct: 24 VYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIVQYL---------- 71
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTG-----LADRPG-LRFTVPQIKCYMKQLLTGLH 121
G+ + +F M+ G L + G L+ I Y KQ+L GL
Sbjct: 72 -------GSDSENGFFKIF--MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 122 YCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 180
Y H NQ++HRDIKG N+L++ G +K++DFG ++ + + T T TL Y PE++
Sbjct: 123 YLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG-TLQYMAPEVI 181
Query: 181 -LGATKYGPAVDMWSVGCIFAELLNGKP 207
G YG D+WS+GC E+ GKP
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-20
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
VF + A+K+I + AI E ++L KL +I+ E
Sbjct: 15 VVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD---- 70
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
+G +V EY + H L L + G Q+ + Q+L GL +
Sbjct: 71 ------------KGKLNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
H ++LHRDIK NL +D N+K+ D G+A+ S D+ N V T +Y PE L
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPE-LCE 174
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
Y D+W++G + E GK N+ + KI
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 71/307 (23%)
Query: 5 ISQVFMAREIKTGEIVALKK------IRMDNEKEGFPITAIREIKILKKLQHENVIKLKE 58
+V + R+ + ALK IR+ E+ E ++LK++ H +I+L
Sbjct: 14 FGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH-----VHNEKRVLKEVSHPFIIRLF- 67
Query: 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLT 118
E D++ YM+ EY+ R RF+ Y +++
Sbjct: 68 -----WTEHDQR----------FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC 112
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
L Y H ++++RD+K N+L+D EG++KL DFG A+ D TL T Y PE
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTWTLCG---TPEYLAPE 168
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
++ + + AVD W++G + E+L G P N KI L G + +P
Sbjct: 169 -VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLE---FP---- 218
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYF 293
RH D +A +L++K+L++D ++R+ A D + +F
Sbjct: 219 ---------------------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257
Query: 294 ----WTD 296
W D
Sbjct: 258 KSVDWDD 264
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 72/262 (27%), Positives = 107/262 (40%), Gaps = 51/262 (19%)
Query: 6 SQVFMAREIKTGEIVALKKIR----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
S V+ A + G +VALKK++ MD + ++EI +LK+L H NVIK
Sbjct: 16 SVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLKQLDHPNVIKYL---- 68
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL---ADRPGLRFTVPQIKCYMKQLL 117
+V E D DL+ + + I Y QL
Sbjct: 69 ------------ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
+ L + H +++HRDIK +N+ I G +KL D GL R FS + V T +Y P
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSP 175
Query: 178 ELLLGATKYGPAVDMWSVGCIFAEL----------------LNGK------PILPGKNEA 215
E + Y D+WS+GC+ E+ L K P LP + +
Sbjct: 176 ERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234
Query: 216 EQLSKIFELCGSPDETIWPGVS 237
E+L + C +PD P +S
Sbjct: 235 EELRDLVSRCINPDPEKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 68/289 (23%), Positives = 113/289 (39%), Gaps = 67/289 (23%)
Query: 12 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIK-----LKEIVTSPGPE 66
R + +V K++ + E A+ EI IL LQH N+I + +
Sbjct: 20 RRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-------- 71
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
+ + EY + +D + + G F + Y+ Q+++ + Y
Sbjct: 72 -------------NTLLIEMEYANGGTLYDK--IVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELL 180
H +LHRDIK N+ + G +KL DFG+++ Y T+ V T +Y PEL
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV---VGTPYYMSPELC 173
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
G KY D+W++GC+ ELL K N + KI + +P +++
Sbjct: 174 QGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY------- 225
Query: 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
S + V +L DP +R +A + LD
Sbjct: 226 -------SSELISLVHS---------------LLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 35/200 (17%)
Query: 15 KTGEIVALKKIRMDNEKE---GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 71
TGE VA+K + E++ F REI+IL+ L HEN++K K + PG
Sbjct: 31 NTGEQVAVKSLNHSGEEQHRSDFE----REIEILRTLDHENIVKYKGVCEKPG------- 79
Query: 72 RPDGNKYRGSTYMVFEY-----MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
S ++ EY + L D+ L ++ + Q+ G+ Y
Sbjct: 80 -------GRSLRLIMEYLPSGSLRDYLQRHRDQINL----KRLLLFSSQICKGMDYLGSQ 128
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGA 183
+ +HRD+ N+L+++E +K++DFGLA+ D + WY P L
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT-- 186
Query: 184 TKYGPAVDMWSVGCIFAELL 203
+K+ A D+WS G EL
Sbjct: 187 SKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 68/254 (26%), Positives = 103/254 (40%), Gaps = 64/254 (25%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V++ R+ TG++ A+K +R K ++K+ Q +V ++I+
Sbjct: 15 GEVWLVRDKDTGQVYAMKVLR----KS----------DMIKRNQIAHVRAERDILADADS 60
Query: 66 E---------RDEQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQ 115
+DE+ Y+V EYM DL L R F + Y+ +
Sbjct: 61 PWIVKLYYSFQDEE----------HLYLVMEYMPGGDLMNLLIRKD-VFPEETARFYIAE 109
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF----------SYDHNNTL 165
L+ L H +HRDIK N+LID +G++KLADFGL + + HN
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 166 TNRVITLW------------------YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 207
+ V+ Y PE+L G T YG D WS+G I E+L G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFP 228
Query: 208 ILPGKNEAEQLSKI 221
E +KI
Sbjct: 229 PFYSDTLQETYNKI 242
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 34/189 (17%)
Query: 103 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162
F+ P+ Y ++ GL Y H N++++RD+K NLL+D EG +K+ADFGL +
Sbjct: 97 VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFG 155
Query: 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 222
+ + T + PE+L T Y AVD W +G + E+L G+ PG +E E I
Sbjct: 156 DRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214
Query: 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 282
DE +P R R A+ ++ ++L +P +R+
Sbjct: 215 N-----DEVRYP-------------------------RFLSREAISIMRRLLRRNPERRL 244
Query: 283 SA--KDALD 289
+ KDA D
Sbjct: 245 GSGEKDAED 253
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 71/241 (29%), Positives = 120/241 (49%), Gaps = 32/241 (13%)
Query: 7 QVFMAREIKTGEIVALKKIRMD--NEKEGFPITAIR-EIKILKKLQHENVIKLKEIVTSP 63
+V++ + TG +A+K++ D +++ + A+ EI++LK L+H+ IV
Sbjct: 17 EVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD------RIVQYY 70
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR----FTVPQIKCYMKQLLTG 119
G RD + + + EYM G + + L+ T + Y +Q+L G
Sbjct: 71 GCLRDPEEK--------KLSIFVEYM----PGGSIKDQLKAYGALTENVTRRYTRQILQG 118
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLTNRVITLWYRPP 177
+ Y H N ++HRDIKG+N+L D+ GN+KL DFG ++ + + T ++ P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP-GV 236
E++ G YG D+WSV C E+L KP E E ++ IF++ P + + P GV
Sbjct: 179 EVISG-EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPDGV 234
Query: 237 S 237
S
Sbjct: 235 S 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 70/284 (24%), Positives = 114/284 (40%), Gaps = 62/284 (21%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V + + ALK ++ + E G E +IL++ H ++KL
Sbjct: 9 VELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF------ 62
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMD--------HDLTGLADRPGLRFTVPQIKCYMKQLLT 118
+D++ YM+ EY D GL D RF Y+ ++
Sbjct: 63 KDKK----------YIYMLMEYCLGGELWTILRDR-GLFDEYTARF-------YIACVVL 104
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
Y H +++RD+K NLL+D+ G +KL DFG A+ T T T Y PE
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL-KSGQKTWT-FCGTPEYVAPE 162
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
++L Y +VD WS+G + ELL G+P P + E +I+ I G
Sbjct: 163 IILN-KGYDFSVDYWSLGILLYELLTGRP--PFGEDDEDPMEIYND-------ILKGN-- 210
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 282
P + D+ A +L++++L +P +R+
Sbjct: 211 ---GKLEFP------------NYIDKAAKDLIKQLLRRNPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 74/282 (26%), Positives = 129/282 (45%), Gaps = 50/282 (17%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ A ++ TG+ VA+K++ + + + I I EI ++++ +H N++
Sbjct: 35 VYTAIDVATGQEVAIKQMNLQQQPKKELI--INEILVMRENKHPNIVNYL---------- 82
Query: 68 DEQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D ++V EY+ LT + + QI ++ L L + H N
Sbjct: 83 ------DSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSN 134
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QV+HRDIK N+L+ +G++KL DFG + + + T V T ++ PE++ Y
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT-RKAY 192
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GP VD+WS+G + E++ G+P P NE +P ++ + A N
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEP--PYLNE------------NPLRALY-----LIATNG-T 232
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
P ++ +FR F L + L +D +R SAK+ L
Sbjct: 233 PELQNPEKLSAIFRDF-------LNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 88/324 (27%), Positives = 131/324 (40%), Gaps = 78/324 (24%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIK----ILKKLQHENVIKLKEIVTS 62
QVF+A++ TGEIVALK RM + F + +R + IL + E ++KL
Sbjct: 16 QVFLAKKKDTGEIVALK--RM-KKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD 72
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYM-DHDL------TGLADRPGLRFTVPQIKCYMKQ 115
Y+ EY+ D G+ RF YM +
Sbjct: 73 DE----------------YLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-------YMAE 109
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWY 174
+ + H +HRD+K N LID G++KL DFGL++ T N V+ + Y
Sbjct: 110 MFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-----TYANSVVGSPDY 164
Query: 175 RPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234
PE+L G Y VD WS+GC+ E L G P G P+ET
Sbjct: 165 MAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGST--------------PNET--- 206
Query: 235 GVSKMPAYNHFKPSRTMKRRVREVFRHF---DRHALELLEKMLMLDPSQRI-SAKDALDS 290
+ + K + +R F D A +L+ K++ DPS+R S +D +
Sbjct: 207 -------WENLKYWKETLQRPVYDDPRFNLSDE-AWDLITKLIN-DPSRRFGSLEDIKNH 257
Query: 291 EYF----WTDPLPCDPKSLPKYES 310
+F W + P +P+ ES
Sbjct: 258 PFFKEVDWNELRELKPPFVPELES 281
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 55/299 (18%)
Query: 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+VCI ARE +G VA+K MD K+ E+ I++ QH+NV+++ +
Sbjct: 36 IVCI-----AREKHSGRQVAVKM--MDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGL 120
G E +++ E++ LT + + R QI + +L L
Sbjct: 89 V-GEE---------------LWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQAL 130
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 180
Y H V+HRDIK ++L+ +G +KL+DFG S D + V T ++ PE +
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPE-V 188
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
+ T YG VD+WS+G + E+++G+P + + + ++ + SP
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SP------------ 233
Query: 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299
P ++ V R F LE+ML +P +R +A++ LD + LP
Sbjct: 234 -----PPKLKNAHKISPVLRDF-------LERMLTREPQERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 46/215 (21%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQH---ENVIKLKEIVTSP 63
V+ + + TG +VALK I +D ++ I RE+ +L +L+ N+ K
Sbjct: 17 VYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITK-------- 66
Query: 64 GPERDEQGRPDGNKYRGSTYM----VFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQL 116
Y GS Y+ ++ M++ G + G I ++++
Sbjct: 67 --------------YYGS-YLKGPRLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREV 110
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---- 172
L L Y H V+HRDIK +N+L+ N GN+KL DFG+A N +++ T
Sbjct: 111 LVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-----NQNSSKRSTFVGTP 165
Query: 173 WYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 207
++ PE++ Y D+WS+G E+ G P
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 3e-18
Identities = 77/262 (29%), Positives = 110/262 (41%), Gaps = 36/262 (13%)
Query: 41 EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGL---- 96
EI L +L HEN++K++EI+ S +TYM+ + D DL
Sbjct: 213 EILALGRLNHENILKIEEILRSEA----------------NTYMITQKYDFDLYSFMYDE 256
Query: 97 ----ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 152
DRP L+ Q + MKQLL + Y H +++HRDIK N+ ++ +G + L DFG
Sbjct: 257 AFDWKDRPLLK----QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG 312
Query: 153 LARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP-- 210
A F + V T+ PE+L G Y D+WS G I ++L+ P
Sbjct: 313 TAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLS-HDFCPIG 370
Query: 211 --GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHA-L 267
G +QL KI + DE K+ Y V + R+ A
Sbjct: 371 DGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADF 430
Query: 268 EL-LEKMLMLDPSQRISAKDAL 288
E L KML D R A + L
Sbjct: 431 EYPLVKMLTFDWHLRPGAAELL 452
|
Length = 501 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 3e-18
Identities = 76/287 (26%), Positives = 127/287 (44%), Gaps = 50/287 (17%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
VF A ++ TG+ VA+K+I + + + I I EI ++K+L++ N++
Sbjct: 35 VFTAIDVATGQEVAIKQINLQKQPKKELI--INEILVMKELKNPNIVNFL---------- 82
Query: 68 DEQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D ++V EY+ LT + + QI ++ L L + H N
Sbjct: 83 ------DSFLVGDELFVVMEYLAGGSLTDVVTETCM--DEAQIAAVCRECLQALEFLHAN 134
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QV+HRDIK N+L+ +G++KL DFG + + + T V T ++ PE++ Y
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT-RKAY 192
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GP VD+WS+G + E++ G+P +N L I A N
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNG-T 232
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P ++ +FR F L + L +D +R SAK+ L +
Sbjct: 233 PELQNPEKLSPIFRDF-------LNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-18
Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 57/290 (19%)
Query: 14 IKTGEIVALKKIRMDN------EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
G+++A+K++ +D EKE + E+ +LK L+H N IV G
Sbjct: 21 TNQGQLIAVKQVELDTSNVLAAEKEYEKLQ--EEVDLLKSLKHVN------IVQYLGTCL 72
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
D+ S +M F ++ + +R G P Y KQ+L G+ Y H N
Sbjct: 73 DDNTI--------SIFMEF-VPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLAR-----SFSYDHNNTLTNRVITLWYRPPELLLG 182
V+HRDIKG+N+++ G +KL DFG AR H+N L + T ++ PE ++
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VIN 181
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
+ YG D+WS+GC E+ GKP L ++L+ +F I MP
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF--------YIGAHRGLMPRL 230
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292
F A++ + L D +R SA L ++
Sbjct: 231 PD----------------SFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 34/211 (16%)
Query: 7 QVFMAREIKTGEIVALKKIRM--DNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
+V+ A+ +TG A K I++ + E E F + EI IL + +H N++ L
Sbjct: 20 KVYKAQHKETGLFAAAKIIQIESEEELEDF----MVEIDILSECKHPNIVGLY------- 68
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+ Y +++ E+ D L + T PQI+ +Q+L L++
Sbjct: 69 ---------EAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELL 180
H ++V+HRD+K N+L+ +G++KLADFG+ S + +TL R + T ++ PE++
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGV----SAKNKSTLQKRDTFIGTPYWMAPEVV 175
Query: 181 LGAT----KYGPAVDMWSVGCIFAELLNGKP 207
T Y D+WS+G EL +P
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 26/193 (13%)
Query: 16 TGEIVALKKIRMDNEK--EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
TGE+VA+KK++ + F REI+ILK LQH+N++K K + S G
Sbjct: 32 TGEVVAVKKLQHSTAEHLRDFE----REIEILKSLQHDNIVKYKGVCYSAG--------- 78
Query: 74 DGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
R + +V EY+ L + R ++ Y Q+ G+ Y + +HRD
Sbjct: 79 -----RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRD 133
Query: 133 IKGSNLLIDNEGNLKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLGATKYGPA 189
+ N+L+++E +K+ DFGL + D WY P L +K+ A
Sbjct: 134 LATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES--LTESKFSVA 191
Query: 190 VDMWSVGCIFAEL 202
D+WS G + EL
Sbjct: 192 SDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 65/221 (29%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 7 QVFMAREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V TG+I+A+K IR++ NE I +RE+ IL K IV G
Sbjct: 16 VVSKVLHRPTGKIMAVKTIRLEINEAIQKQI--LRELDILHKCNSPY------IVGFYGA 67
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+ G + EYMD L + R + +L GL Y H
Sbjct: 68 FYNN----------GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 125 -VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
++++HRD+K SN+L+++ G +KL DFG++ T V T Y PE + G
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---VGTSSYMAPERIQG- 173
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 224
Y D+WS+G EL G+ P E + IFEL
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR--FPYPPENDPPDGIFEL 212
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 55/184 (29%), Positives = 83/184 (45%), Gaps = 21/184 (11%)
Query: 21 ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80
A+K+IR+ + +E +L K++H N++ KE + G
Sbjct: 29 AMKEIRLPKSSSAVE-DSRKEAVLLAKMKHPNIVAFKESFEA----------------DG 71
Query: 81 STYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138
Y+V EY D + + + G F I + Q+ G+ + H +VLHRDIK N+
Sbjct: 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131
Query: 139 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 198
+ G +KL DFG AR + T V T +Y PPE+ Y D+WS+GCI
Sbjct: 132 FLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWEN-MPYNNKSDIWSLGCI 189
Query: 199 FAEL 202
EL
Sbjct: 190 LYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 103 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162
+F +P+ Y +++ GL + H +++RD+K N+L+D +G++K+ADFG+ +
Sbjct: 92 KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151
Query: 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 222
T T T Y PE+LLG KY +VD WS G + E+L G+ G +E E I
Sbjct: 152 KTCT-FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI- 208
Query: 223 ELCGSPDETIWPGVSKMPAYNHF------KPSRTM--KRRVRE--VFRHFDRHALELLEK 272
D +P A + +P R + K +R+ FR D ALE E
Sbjct: 209 ----RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEERE- 263
Query: 273 MLMLDPSQRISAKDALDSEYF 293
++P + K A D F
Sbjct: 264 ---IEPPFKPKVKSANDCSNF 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 35/198 (17%)
Query: 16 TGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 72
TGE+VA+K ++ + G+ +EI ILK L HEN++K K + G +
Sbjct: 32 TGEMVAVKTLKRECGQQNTSGW----KKEINILKTLYHENIVKYKGCCSEQGGK------ 81
Query: 73 PDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 131
++ EY+ L L D P + + Q+ + +Q+ G+ Y H +HR
Sbjct: 82 --------GLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHR 131
Query: 132 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI------TLWYRPPELLLGATK 185
D+ N+L+DN+ +K+ DFGLA++ H RV WY L K
Sbjct: 132 DLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAVE--CLKENK 186
Query: 186 YGPAVDMWSVGCIFAELL 203
+ A D+WS G ELL
Sbjct: 187 FSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 71/289 (24%), Positives = 115/289 (39%), Gaps = 68/289 (23%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V +A T E+ A +K+LKK +VI + V E
Sbjct: 10 KVLLAELKGTDELYA--------------------VKVLKK----DVILQDDDVECTMTE 45
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH-----------DLTGLADRPGLRFTVPQIKCYMKQ 115
+ + + + F+ D DL R G RF P+ + Y +
Sbjct: 46 KRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAE 104
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 175
++ GL + H +++RD+K N+L+D+EG++K+ADFG+ + T T T Y
Sbjct: 105 IVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYI 163
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235
PE+L YGPAVD W++G + E+L G+ G +E E I E DE +P
Sbjct: 164 APEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-----DEVRYP- 216
Query: 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 284
R + A +L+ L +P +R+
Sbjct: 217 ------------------------RWLSKEAKSILKSFLTKNPEKRLGC 241
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 47/304 (15%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+VF+A + + V LK G T + E +L+ + H +VI++K+ +
Sbjct: 81 RVFVATKPGQPDPVVLKI--------GQKGTTLIEAMLLQNVNHPSVIRMKDTLV----- 127
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
T MV + DL + + Q KQ+L GL Y H
Sbjct: 128 -----------SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ 176
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATK 185
+++HRD+K N+ I++ + + D G A+ L V T PE+L K
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET---NAPEVLARD-K 232
Query: 186 YGPAVDMWSVGCIFAELL----------NGKPILPGKNEAEQLSKIFELCG-SPDETIWP 234
Y D+WS G + E+L P K+ L KI P+E +P
Sbjct: 233 YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE--FP 290
Query: 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALE-----LLEKMLMLDPSQRISAKDALD 289
F +++R+ + F R L L+ KML D + R SA++ L+
Sbjct: 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350
Query: 290 SEYF 293
F
Sbjct: 351 YPMF 354
|
Length = 357 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 36/223 (16%)
Query: 8 VFMAREIKTGEIVALKKI----RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
V+ AR+++T E+VA+KK+ + NEK I+E++ L++L+H N I+ K
Sbjct: 31 VYFARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQQLRHPNTIEYK------ 81
Query: 64 GPERDEQGRPDGNKYRGST-YMVFEYMDHDLTGLAD--RPGLRFTVPQIKCYMKQLLTGL 120
G R T ++V EY + + + + L+ +I L GL
Sbjct: 82 -----------GCYLREHTAWLVMEYCLGSASDILEVHKKPLQEV--EIAAICHGALQGL 128
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 180
Y H ++ +HRDIK N+L+ G +KLADFG A S N+ V T ++ PE++
Sbjct: 129 AYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS--PANSF---VGTPYWMAPEVI 183
Query: 181 LGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
L +Y VD+WS+G EL KP L N L I
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 8 VFMAREIKTGEIVALKKI----RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
V+ AR+++T E+VA+KK+ + NEK I+E+K L++++H N I+ K
Sbjct: 41 VYFARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVKFLQRIKHPNSIEYK------ 91
Query: 64 GPERDEQGRPDGNKYRGST-YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
G R T ++V EY + L + +I L GL Y
Sbjct: 92 -----------GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
H + ++HRDIK N+L+ G +KLADFG A S + V T ++ PE++L
Sbjct: 141 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMAPEVILA 195
Query: 183 AT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
+Y VD+WS+G EL KP L N L I
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 47/189 (24%), Positives = 86/189 (45%), Gaps = 33/189 (17%)
Query: 103 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162
FT +++ Y+ +++ L + H +++RDIK N+L+D+EG++ L DFGL++ F +
Sbjct: 101 HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 163 NTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKP---ILPGKNEAEQL 218
+ T+ Y PE++ G + + AVD WS+G + ELL G + +N ++
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
Query: 219 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 278
S+ P P + A + ++K+L DP
Sbjct: 221 SRRILKSKPP----------FP-------------------KTMSAEARDFIQKLLEKDP 251
Query: 279 SQRISAKDA 287
+R+ A A
Sbjct: 252 KKRLGANGA 260
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 29/204 (14%)
Query: 25 IRMDNE----KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80
I+M E ++ F I E K++ KL H N+++L + T P
Sbjct: 33 IKMIREGAMSEDDF----IEEAKVMMKLSHPNLVQLYGVCTKQRP--------------- 73
Query: 81 STYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138
++V EYM + L L +R G + + + + Y N +HRD+ N
Sbjct: 74 -IFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNC 131
Query: 139 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 198
L+ + +K++DFGLAR D + + + PPE+ +++ D+WS G +
Sbjct: 132 LVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVL 190
Query: 199 FAELLN-GKPILPGKNEAEQLSKI 221
E+ + GK + +E + +
Sbjct: 191 MWEVFSEGKMPYERFSNSEVVESV 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141
Y V EY++ DL + G +F PQ Y ++ GL + H +++RD+K N+++D
Sbjct: 77 YFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD 135
Query: 142 NEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIF 199
+EG++K+ADFG+ + D +T R T Y PE ++ YG +VD W+ G +
Sbjct: 136 SEGHIKIADFGMCKEHMVD---GVTTRTFCGTPDYIAPE-IIAYQPYGKSVDWWAYGVLL 191
Query: 200 AELLNGKPILPGKNEAEQLSKIFELCGS-PDETIWPGVSKMPAYNHFKPSRTM------K 252
E+L G+P G++E E I E S P VS PS+ + +
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGE 251
Query: 253 RRVRE--VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299
R +RE FR D LE E P ++ K A + + F+T P
Sbjct: 252 RDIREHAFFRRIDWDKLENREIQPPFKP--KVCGKGAENFDKFFTRGQP 298
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 3e-16
Identities = 75/287 (26%), Positives = 126/287 (43%), Gaps = 50/287 (17%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ A +I TG+ VA+K++ + + + I I EI ++++ ++ N++
Sbjct: 35 VYTAIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNPNIVNYL---------- 82
Query: 68 DEQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D ++V EY+ LT + + QI ++ L L + H N
Sbjct: 83 ------DSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALDFLHSN 134
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QV+HRDIK N+L+ +G++KL DFG + + + T V T ++ PE++ Y
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT-RKAY 192
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GP VD+WS+G + E++ G+P +N L I A N
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNG-T 232
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P R+ VFR F L + L +D +R SAK+ L +
Sbjct: 233 PELQNPERLSAVFRDF-------LNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 69/248 (27%), Positives = 103/248 (41%), Gaps = 39/248 (15%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE------I 59
+V + RE TG+I A+K ++ K L E V +E I
Sbjct: 15 GEVQVVREKATGDIYAMKVMK----KSVL-------------LAQETVSFFEEERDILSI 57
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLT 118
SP + + D + + Y+V EY DL L +R +F + Y+ +L+
Sbjct: 58 SNSPWIPQLQYAFQDKD----NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVL 113
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
+H H +HRDIK N+LID G++KLADFG A + + V T Y PE
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 179 LLL-----GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF---ELCGSPDE 230
+L G YG D WS+G I E++ G+ A+ + I P++
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233
Query: 231 TIWPGVSK 238
P VS
Sbjct: 234 ---PKVSS 238
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 51/262 (19%)
Query: 6 SQVFMAREIKTGEIVALKKIR----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
S+V+ A + G VALKK++ MD + I+EI +LK+L H NVIK
Sbjct: 16 SEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQLNHPNVIKYYASFI 72
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQ--IKCYMKQLL 117
E +E +V E D DL+ + + +P+ + Y QL
Sbjct: 73 ----EDNELN------------IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
+ L + H +V+HRDIK +N+ I G +KL D GL R FS + V T +Y P
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSP 175
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGK----------------------PILPGKNEA 215
E + Y D+WS+GC+ E+ + P LP + +
Sbjct: 176 E-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234
Query: 216 EQLSKIFELCGSPDETIWPGVS 237
E+L ++ +C +PD P ++
Sbjct: 235 EELRQLVNMCINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 25/195 (12%)
Query: 15 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 74
TGE VA+K ++ ++ +EI+IL+ L HEN++K K I T ++ G
Sbjct: 31 NTGEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICT------EDGGN-- 81
Query: 75 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 133
++ E++ L R + + Q Y Q+ G+ Y Q +HRD+
Sbjct: 82 ------GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDL 135
Query: 134 KGSNLLIDNEGNLKLADFGLARSFSYDH-----NNTLTNRVITLWYRPPELLLGATKYGP 188
N+L+++E +K+ DFGL ++ D + L + V WY P L+ +K+
Sbjct: 136 AARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FWYAPECLI--QSKFYI 191
Query: 189 AVDMWSVGCIFAELL 203
A D+WS G ELL
Sbjct: 192 ASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 84/307 (27%), Positives = 127/307 (41%), Gaps = 44/307 (14%)
Query: 9 FMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 68
F + KT E V +K ++ G E IL+ + H ++I+LK T
Sbjct: 109 FACIDNKTCEHVVIKA----GQRGG----TATEAHILRAINHPSIIQLKGTFT------- 153
Query: 69 EQGRPDGNKYRGSTYMVFEYMDHDL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
Y T ++ DL LA + + I + +L + Y H N+
Sbjct: 154 ---------YNKFTCLILPRYKTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR 202
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKY 186
++HRDIK N+ I++ G++ L DFG A F D N N T+ PE LL Y
Sbjct: 203 IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIATNAPE-LLARDPY 260
Query: 187 GPAVDMWSVGCIFAELLNG------KPILPGKNEAE-QLSKIFELCGS-PDE-TIWPGVS 237
GPAVD+WS G + E+ K L G +++ Q+ I G+ P+E I +
Sbjct: 261 GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320
Query: 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALE---LLEKMLMLDPSQRISAKDALDSEYFW 294
Y + K R ++ + ++ L+ KML D R SA+ LD F
Sbjct: 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380
Query: 295 T--DPLP 299
DP P
Sbjct: 381 DIPDPYP 387
|
Length = 391 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 61/296 (20%)
Query: 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+VCI+ V +G++VA+KK MD K+ E+ I++ QHENV+++
Sbjct: 35 IVCIATV-----KSSGKLVAVKK--MDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 83
Query: 62 SPGPERDEQGRPDGNKYR--GSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLT 118
N Y ++V E+++ LT + R QI +L
Sbjct: 84 --------------NSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLK 127
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
L H V+HRDIK ++L+ ++G +KL+DFG S + + V T ++ PE
Sbjct: 128 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR-KSLVGTPYWMAPE 186
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
L+ YGP VD+WS+G + E+++G+P P NE P +
Sbjct: 187 -LISRLPYGPEVDIWSLGIMVIEMVDGEP--PYFNE-------------------PPLKA 224
Query: 239 MPAY-NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
M ++ P +V + F L+++L+ DP+QR +A + L +
Sbjct: 225 MKMIRDNLPPKLKNLHKVSPSLKGF-------LDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 6e-16
Identities = 68/239 (28%), Positives = 108/239 (45%), Gaps = 32/239 (13%)
Query: 7 QVFMAREIKTGEIVALKKIRMDN----EKEGFPITAIREIKILKKLQHENVIKLKEIVTS 62
++++A+ E +K+I + EKE + +E+ +L K++H N++
Sbjct: 15 KIYLAKAKSDSEHCVIKEIDLTKMPVKEKEA----SKKEVILLAKMKHPNIVTFFASF-- 68
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGL 120
E GR ++V EY D DL +R G+ F+ QI + Q+ GL
Sbjct: 69 -----QENGR---------LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 179
+ H ++LHRDIK N+ + G + KL DFG+AR + D V T +Y PE+
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEI 173
Query: 180 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
Y D+WS+GC+ EL K G N QL + ++C I P S+
Sbjct: 174 CQN-RPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQL--VLKICQGYFAPISPNFSR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 8e-16
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 34/209 (16%)
Query: 7 QVFMAREIKTGEIVALKKI---RMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTS 62
+ + + + G+ +K+I +M E+E + +E+ +L ++H N+++ +E
Sbjct: 15 KAILVKSKEDGKQYVIKEINISKMSPKERE----ESRKEVAVLSNMKHPNIVQYQESFEE 70
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLAD-RPGLRFTVPQIKCYMKQLLTGL 120
G+ Y+V +Y + DL + + G+ F QI + Q+ L
Sbjct: 71 ----------------NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVI-TLWYRPP 177
+ H ++LHRDIK N+ + +G +KL DFG+AR N+T L I T +Y P
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPYYLSP 170
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGK 206
E+ Y D+W++GC+ E+ K
Sbjct: 171 EICEN-RPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 8 VFMAREIKTGEIVALKKI----RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
V+ AR+++ E+VA+KK+ + NEK I+E++ L+KL+H N I+
Sbjct: 31 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQKLRHPNTIQ-------- 79
Query: 64 GPERDEQGRPDGNKYRG------STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLL 117
YRG + ++V EY + L + +I L
Sbjct: 80 --------------YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL 125
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
GL Y H + ++HRD+K N+L+ G +KL DFG A + V T ++ P
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAP 180
Query: 178 ELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
E++L +Y VD+WS+G EL KP L N L I
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 1e-15
Identities = 70/287 (24%), Positives = 127/287 (44%), Gaps = 50/287 (17%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ A ++ TG+ VA++++ + + + I I EI ++++ ++ N++
Sbjct: 36 VYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYL---------- 83
Query: 68 DEQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
D ++V EY+ LT + + QI ++ L L + H N
Sbjct: 84 ------DSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSN 135
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
QV+HRDIK N+L+ +G++KL DFG + + + + V T ++ PE++ Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVT-RKAY 193
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GP VD+WS+G + E++ G+P +N L I A N
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------------ATNG-T 233
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P ++ +FR F L + L +D +R SAK+ L ++
Sbjct: 234 PELQNPEKLSAIFRDF-------LNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 42/215 (19%)
Query: 7 QVFMAREIKTGEIVALKKI--RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
+V+ A+ +TG + A K I + + E E + + EI IL H N++KL
Sbjct: 20 KVYKAQNKETGVLAAAKVIDTKSEEELEDYMV----EIDILASCDHPNIVKLL------- 68
Query: 65 PERDEQGRPDGNKYRGSTYMVFEY-----MDHDLTGLADRPGLRFTVPQIKCYMKQLLTG 119
D Y + +++ E+ +D + L +RP T PQI+ KQ L
Sbjct: 69 ---------DAFYYENNLWILIEFCAGGAVDAVMLEL-ERP---LTEPQIRVVCKQTLEA 115
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRP 176
L+Y H N+++HRD+K N+L +G++KLADFG+ S + T+ R + T ++
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMA 171
Query: 177 PELLLGATK----YGPAVDMWSVGCIFAELLNGKP 207
PE+++ T Y D+WS+G E+ +P
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 103 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162
+F P+ + Y ++ L + H + V++RD+K N+L+D EG+ KLADFG+ + +
Sbjct: 92 KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNG 150
Query: 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 222
T T T Y PE +L +YGP+VD W++G + E++ G+P NE + I
Sbjct: 151 VTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
Query: 223 ELCGSPDETIWP------GVSKMPAY---NHFK-----PSRTMKRRVRE--VFRHFDRHA 266
D+ ++P VS + A+ N K S+ + +++ F+ D
Sbjct: 210 H-----DDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL 264
Query: 267 LELLEKMLMLDPSQRISAKDA--LDSEYFWTDPL--PCDP 302
LE + P + + +D D ++ +P+ P DP
Sbjct: 265 LEQRKIKPPFKPKIK-TKRDVNNFDQDFTKEEPVLTPVDP 303
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 38/209 (18%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ TG + ALK I N ++ REI+IL+ + H NV+K ++
Sbjct: 90 VYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF------- 141
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDH---DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+ G ++ E+MD + T +AD + +Q+L+G+ Y H
Sbjct: 142 -DHN--------GEIQVLLEFMDGGSLEGTHIADEQ-------FLADVARQILSGIAYLH 185
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL---TNRVITLWYRPPELL- 180
++HRDIK SNLLI++ N+K+ADFG++R T+ + V T+ Y PE +
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL----AQTMDPCNSSVGTIAYMSPERIN 241
Query: 181 --LGATKY-GPAVDMWSVGCIFAELLNGK 206
L Y G A D+WS+G E G+
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 103 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162
RF + + Y ++ + L + H +++RD+K N+L+D+EG+ KLADFG+ + ++
Sbjct: 92 RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151
Query: 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 222
T T T Y PE +L YGP+VD W++G + E+L G +NE + I
Sbjct: 152 TTST-FCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209
Query: 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR----------EVFRH--FDRHALELL 270
DE ++P A + K T +R + RH F E L
Sbjct: 210 N-----DEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264
Query: 271 EKMLMLDP-SQRISAKDAL---DSEYFWTDPL--PCDPKSLP 306
+ + P RI +++ + D ++ DP+ P + LP
Sbjct: 265 NRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPIEESLLP 306
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 81/296 (27%), Positives = 127/296 (42%), Gaps = 61/296 (20%)
Query: 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+VCI A E TG+ VA+KK MD K+ E+ I++ HENV+ +
Sbjct: 37 IVCI-----ATEKHTGKQVAVKK--MDLRKQQRRELLFNEVVIMRDYHHENVVDMY---- 85
Query: 62 SPGPERDEQGRPDGNKYR--GSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLT 118
N Y ++V E+++ LT + R QI +L
Sbjct: 86 --------------NSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLR 129
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
L Y H V+HRDIK ++L+ ++G +KL+DFG S + + V T ++ PE
Sbjct: 130 ALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR-KSLVGTPYWMAPE 188
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
++ YG VD+WS+G + E+++G+P P NE P +
Sbjct: 189 -VISRLPYGTEVDIWSLGIMVIEMIDGEP--PYFNE-------------------PPLQA 226
Query: 239 MPAYNHFKPSRTMK-RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
M P R +V V R F L+ ML+ +PSQR +A++ L +
Sbjct: 227 MRRIRDNLPPRVKDSHKVSSVLRGF-------LDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V+ A+ +TG + A K I +E+E + EI+IL H ++KL
Sbjct: 27 KVYKAKNKETGALAAAKVIETKSEEE--LEDYMVEIEILATCNHPYIVKLL--------- 75
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH---DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+ G +++ E+ D L GL T PQI+ +Q+L L Y
Sbjct: 76 -------GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGL--TEPQIQVICRQMLEALQYL 126
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELL 180
H +++HRD+K N+L+ +G++KLADFG+ S + TL R + T ++ PE++
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 181 LGAT----KYGPAVDMWSVGCIFAELLNGKP 207
+ T Y D+WS+G E+ +P
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 71/281 (25%), Positives = 114/281 (40%), Gaps = 56/281 (19%)
Query: 18 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77
+ LK+I + + A +E ++L KL H ++K + ERD
Sbjct: 29 RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFH----ASFLERD--------- 75
Query: 78 YRGSTYMVFEYM-DHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 133
+ ++ EY DL + G + Q+ + QLL G+HY H ++LHRD+
Sbjct: 76 ---AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDL 132
Query: 134 KGSNLLIDNEGNLKLADFGLARSF--SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 191
K N+ + N LK+ DFG++R S D T T T +Y PE L Y D
Sbjct: 133 KAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTG---TPYYMSPE-ALKHQGYDSKSD 187
Query: 192 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 251
+WS+GCI E+ G+N + +I E P+ ++
Sbjct: 188 IWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE----------------------GPTPSL 225
Query: 252 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292
+ R +++ ML DPS R SA + L + +
Sbjct: 226 PET-------YSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 46/142 (32%), Positives = 75/142 (52%), Gaps = 4/142 (2%)
Query: 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141
Y V EY++ DL + G +F P Y ++ GL + H +++RD+K N+++D
Sbjct: 77 YFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135
Query: 142 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 201
EG++K+ADFG+ + + T T T Y PE++ YG +VD W+ G + E
Sbjct: 136 AEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYE 193
Query: 202 LLNGKPILPGKNEAEQLSKIFE 223
+L G+P G++E E I E
Sbjct: 194 MLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 39/224 (17%)
Query: 103 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162
RF + + Y +++ GL + H +++RD+K N+++D +G++K+ADFG+ + + N
Sbjct: 92 RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151
Query: 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 222
T T Y PE+L G KY +VD WS G + E+L G+ G +E E I
Sbjct: 152 RAST-FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI- 208
Query: 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 282
D +P R + + ++LEK+ DP++R+
Sbjct: 209 ----RVDTPHYP-------------------------RWITKESKDILEKLFERDPTRRL 239
Query: 283 SAKDALDSEYF-----WT--DPLPCDPKSLPKYESSHEYQTKKR 319
+ F WT + DP PK +S +Y R
Sbjct: 240 GVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDR 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 102 LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161
RF + + Y +++ GL + H +++RD+K N+L+D +G++K+ADFG+ +
Sbjct: 91 GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE 150
Query: 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
T T Y PE+L G KY +VD WS G + E+L G+ G++E
Sbjct: 151 GKAST-FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------- 201
Query: 222 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
DE ++ P + P R + A + L K+ DP++R
Sbjct: 202 -------DELFDSILNDRPHF----P------------RWISKEAKDCLSKLFERDPTKR 238
Query: 282 ISAK-DALDSEYF----WT--DPLPCDPKSLPKYESSHEYQ 315
+ D +F W + P PK +S +
Sbjct: 239 LGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDAS 279
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 4 CISQVFMAREIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIV 60
+V+M T + VA+K ++ M E F ++E +I+KKL+H+ +++L +
Sbjct: 18 QFGEVWMGTWNGTTK-VAVKTLKPGTMS--PEAF----LQEAQIMKKLRHDKLVQLYAVC 70
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLT 118
+ + P Y+V EYM L L G + +PQ+ Q+
Sbjct: 71 S--------EEEP--------IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
G+ Y +HRD+ N+L+ K+ADFGLAR D + + PE
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 179 LLLGATKYGP---AVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 221
A YG D+WS G + E++ G+ PG E L ++
Sbjct: 175 ----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 78/287 (27%), Positives = 120/287 (41%), Gaps = 55/287 (19%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPIT-AIREIKILKKLQHENVIKLKEIVTSPGP 65
+V R+ T I ALK IR + +T + E +L ++ ++ LK SP
Sbjct: 8 KVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE- 66
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
Y+V +++ +L R G RF + + + Y +LL L H
Sbjct: 67 ---------------KLYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLH 110
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLAR--SFSYDHNNTLTNRVITLWYRPPELLLG 182
V++RD+K N+L+D +G++ L DFGL + D NT T Y PELLLG
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG---TPEYLAPELLLG 167
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
Y AVD W++G + E+L G P +N E KI + + +P
Sbjct: 168 -HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ-----EPLRFPD------- 214
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
FDR A +LL +L DP++R+ A +
Sbjct: 215 ------------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 67/261 (25%), Positives = 110/261 (42%), Gaps = 48/261 (18%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
F+ + + Y ++++ L Y H V++RD+K NL++D +G++K+ DFGL +
Sbjct: 92 FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGA 150
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 223
T+ T Y PE +L YG AVD W +G + E++ G+ LP N+ + K+FE
Sbjct: 151 TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--KLFE 205
Query: 224 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI- 282
L I + P R A LL +L DP QR+
Sbjct: 206 L-------ILMEEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQRLG 239
Query: 283 ----SAKDALDSEYF----WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQ- 333
AK+ ++ +F W D + K P ++ +T R EE T +
Sbjct: 240 GGPEDAKEIMEHRFFASINWQDVV--QKKLEPPFKPQVTSETDTRYFD----EEFTAQSI 293
Query: 334 KLHHPQPHGRLPPIQHAGQSH 354
+ P + L +Q + H
Sbjct: 294 TITPPDRYDSLGLLQLEERPH 314
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 69/223 (30%), Positives = 100/223 (44%), Gaps = 36/223 (16%)
Query: 8 VFMAREIKTGEIVALKKI----RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
V+ A T E+VA+KK+ + NEK I+E+K L++L+H N I+ K
Sbjct: 37 VYFATNSHTNEVVAVKKMSYSGKQTNEKWQ---DIIKEVKFLQQLKHPNTIEYK------ 87
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYM---DHDLTGLADRPGLRFTVPQIKCYMKQLLTGL 120
G E + ++V EY DL + +P +I L GL
Sbjct: 88 GCYLKEH----------TAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGL 134
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 180
Y H + ++HRDIK N+L+ G +KLADFG A S + V T ++ PE++
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMAPEVI 189
Query: 181 LGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
L +Y VD+WS+G EL KP L N L I
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 74/261 (28%), Positives = 100/261 (38%), Gaps = 34/261 (13%)
Query: 40 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR 99
REI ILK + H +I L +++ + MV DL DR
Sbjct: 135 REIDILKTISHRAIINLI----------------HAYRWKSTVCMVMPKYKCDLFTYVDR 178
Query: 100 PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159
G + Q ++LL L Y H ++HRD+K N+ +D N L DFG A
Sbjct: 179 SG-PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD- 236
Query: 160 DHNNTLTNR--VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK---NE 214
H +T TL PE LL Y D+WS G + E+ L GK +
Sbjct: 237 AHPDTPQCYGWSGTLETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295
Query: 215 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-------PSRTMKRRVREVFRHFDRHAL 267
+ QL I C +P HFK P T+ +R+ H D
Sbjct: 296 SSQLRSIIR-CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMD--VE 352
Query: 268 ELLEKMLMLDPSQRISAKDAL 288
L+ KML D R SA+D L
Sbjct: 353 YLIAKMLTFDQEFRPSAQDIL 373
|
Length = 392 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 72/284 (25%), Positives = 109/284 (38%), Gaps = 65/284 (22%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE--------- 58
V + R ++V +K+I ++ + + A E ++LK L H N+I+ E
Sbjct: 16 VHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALM 75
Query: 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLT 118
IV P G T + EY+ L D I + Q+L
Sbjct: 76 IVMEYAP--------------GGT--LAEYIQKRCNSLLDED-------TILHFFVQILL 112
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
LH+ H +LHRD+K N+L+D +K+ DFG+++ S + V T Y P
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS--SKSKAYTVVGTPCYISP 170
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237
EL G Y D+W++GC+ EL + K N + KI
Sbjct: 171 ELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------- 215
Query: 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
F P + R R L+ ML LDPS+R
Sbjct: 216 -----GTFAP---ISDRYSPDLRQ-------LILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 47/142 (33%), Positives = 76/142 (53%), Gaps = 4/142 (2%)
Query: 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141
Y V EY++ DL + G RF P Y ++ GL + H +++RD+K N+++D
Sbjct: 77 YFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135
Query: 142 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 201
+EG++K+ADFG+ + +D T T T Y PE ++ YG +VD W+ G + E
Sbjct: 136 SEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYE 193
Query: 202 LLNGKPILPGKNEAEQLSKIFE 223
+L G+ G++E E I E
Sbjct: 194 MLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 60/211 (28%), Positives = 84/211 (39%), Gaps = 30/211 (14%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V R TG I ALK I D + +RE++I K + IV G
Sbjct: 17 VTKCRLKNTGMIFALKTITTDPNPD-LQKQILRELEINKSCKSPY------IVKYYGAFL 69
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQL-------LTGL 120
DE S + EY + G D + + K L L GL
Sbjct: 70 DES--------SSSIGIAMEYCE---GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 180
Y H +++HRDIK SN+L+ +G +KL DFG++ T T T +Y PE +
Sbjct: 119 SYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERI 175
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGK-PILP 210
G Y D+WS+G E+ + P P
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
FT + + Y ++++ L Y H V++RDIK NL++D +G++K+ DFGL + D
Sbjct: 92 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 150
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 223
T+ T Y PE+L YG AVD W +G + E++ G+ LP N+ + ++FE
Sbjct: 151 TMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--RLFE 205
Query: 224 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI- 282
L +E +P R A LL +L DP QR+
Sbjct: 206 LI-LMEEIRFP-------------------------RTLSPEAKSLLAGLLKKDPKQRLG 239
Query: 283 ----SAKDALDSEYF----WTDPLPCDPKSLPKYESSHEYQTKKR 319
AK+ ++ +F W D + K LP ++ + R
Sbjct: 240 GGPSDAKEVMEHRFFLSINWQDVV--QKKLLPPFKPQVTSEVDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 29/194 (14%)
Query: 35 PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-- 92
P + + E +I+KKL+H+ +++L +V+ Y+V EYM
Sbjct: 45 PESFLEEAQIMKKLRHDKLVQLYAVVS-----------------EEPIYIVTEYMSKGSL 87
Query: 93 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 152
L L D G +P + Q+ G+ Y +HRD++ +N+L+ + K+ADFG
Sbjct: 88 LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFG 147
Query: 153 LARSFSYDHNNTLTNR----VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKP 207
LAR +N T R W P L G ++ D+WS G + EL+ G+
Sbjct: 148 LARLI---EDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRV 202
Query: 208 ILPGKNEAEQLSKI 221
PG N E L ++
Sbjct: 203 PYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP--- 63
QV+ R+ T I A+K + ++KE + + ++ + N++ + SP
Sbjct: 8 QVYQVRKKDTRRIYAMKVL---SKKE-----IVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
G + Q D Y+V +YM +L + G RF+ + K Y+ +L+ L +
Sbjct: 60 GLKFSFQTDSD-------LYLVTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEH 111
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLL 181
H +++RD+K N+L+D G++ L DFGL+++ D N TN T Y PE+LL
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGTTEYLAPEVLL 169
Query: 182 GATKYGPAVDMWSVGCIFAELLNG 205
Y VD WS+G + E+ G
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 32/184 (17%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
F+ +++ Y +++ L + H +++RDIK N+L+D+EG++ L DFGL++ F +
Sbjct: 102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP--ILPG-KNEAEQLSK 220
+ T+ Y PE++ G +G AVD WS+G + ELL G L G +N ++S+
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 221 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 280
C P P++ + A +LL K+L DP +
Sbjct: 222 RILKCDPP----------FPSFIGPE-------------------AQDLLHKLLRKDPKK 252
Query: 281 RISA 284
R+ A
Sbjct: 253 RLGA 256
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 38/126 (30%), Positives = 70/126 (55%), Gaps = 5/126 (3%)
Query: 83 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 140
+++ +Y++ T L+ R RF +++ Y +++ L + H +++RDIK N+L+
Sbjct: 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL 138
Query: 141 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIF 199
D+ G++ L DFGL++ F D + T+ Y P+++ G + AVD WS+G +
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198
Query: 200 AELLNG 205
ELL G
Sbjct: 199 YELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 71/262 (27%), Positives = 115/262 (43%), Gaps = 51/262 (19%)
Query: 6 SQVFMAREIKTGEIVALKKIR----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
S+V+ A + + VALKK++ MD + ++EI +LK+L H NVIK +
Sbjct: 16 SEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQLNHPNVIKYLDSFI 72
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQ--IKCYMKQLL 117
E +E +V E D DL+ + + +P+ + Y QL
Sbjct: 73 ----EDNELN------------IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
+ + + H +V+HRDIK +N+ I G +KL D GL R FS + V T +Y P
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSP 175
Query: 178 ELLLGATKYGPAVDMWSVGCIFAEL-----------LN-----------GKPILPGKNEA 215
E + Y D+WS+GC+ E+ +N P LP ++ +
Sbjct: 176 ERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 216 EQLSKIFELCGSPDETIWPGVS 237
E+L ++ +C PD P +
Sbjct: 235 EKLRELVSMCIYPDPDQRPDIG 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 75/309 (24%), Positives = 121/309 (39%), Gaps = 49/309 (15%)
Query: 8 VFMAREIKTGEIVALKKIRMDN-EKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGP 65
V +A+ T +VA+KKI +D+ KE + +EI ++LQH N++ VTS
Sbjct: 16 VHLAKHKPTNTLVAVKKINLDSCSKEDL--KLLQQEIITSRQLQHPNILP---YVTS--- 67
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH----DLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
Y+V M + DL GL I +K +L L
Sbjct: 68 ----------FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA--IAFILKDVLNALD 115
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-------NRVITLWY 174
Y H +HR +K S++L+ +G + L+ + S H + V L +
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPW 174
Query: 175 RPPELL----LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP-- 228
PE+L G Y D++SVG EL NG +P K+ + ++ G+
Sbjct: 175 LSPEVLQQNLQG---YNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEKVRGTVPC 229
Query: 229 --DETIWPGVSKMPAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISA 284
D++ +P + + R + R F H + +E L DP R SA
Sbjct: 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA 289
Query: 285 KDALDSEYF 293
L+ +F
Sbjct: 290 SQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 53/184 (28%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 20 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79
VA+K I+ + E I E K++ KL HE +++L + T P
Sbjct: 31 VAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVCTKQRP-------------- 73
Query: 80 GSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138
Y+V EYM + L G RF Q+ K + G+ Y Q +HRD+ N
Sbjct: 74 --IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNC 131
Query: 139 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 198
L+D++G +K++DFGL+R D + + + PPE+LL +K+ D+W+ G +
Sbjct: 132 LVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLL-YSKFSSKSDVWAFGVL 190
Query: 199 FAEL 202
E+
Sbjct: 191 MWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 26/189 (13%)
Query: 39 IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD--LTGL 96
+ E ++K LQH+ +++L +VT P Y++ EYM L L
Sbjct: 49 LEEANLMKTLQHDKLVRLYAVVTKEEP----------------IYIITEYMAKGSLLDFL 92
Query: 97 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156
G + +P++ + Q+ G+ Y +HRD++ +N+L+ K+ADFGLAR
Sbjct: 93 KSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV 152
Query: 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV---DMWSVGCIFAELLN-GKPILPGK 212
+ + + PE A +G D+WS G + E++ GK PG
Sbjct: 153 IEDNEYTAREGAKFPIKWTAPE----AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208
Query: 213 NEAEQLSKI 221
+ ++ +S +
Sbjct: 209 SNSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIR-EIKILKKLQHENVIKLKEIVTSPGP 65
+VF + +T ++VA+K I ++ ++ I I+ EI +L + V K
Sbjct: 19 EVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYY-------- 68
Query: 66 ERDEQGRPDGNKYRGST-YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
G+ +G+ +++ EY+ R G F QI +K++L GL Y H
Sbjct: 69 ---------GSYLKGTKLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLH 118
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
+ +HRDIK +N+L+ +G++KLADFG+A + D V T ++ PE ++ +
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPE-VIQQS 176
Query: 185 KYGPAVDMWSVGCIFAELLNGKP 207
Y D+WS+G EL G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 20 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
VA+K ++ MD P + E +I+KKL+H +I+L + T P
Sbjct: 33 VAVKTLKPGTMD------PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP----------- 75
Query: 77 KYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 134
Y+V E M + L L G +PQ+ Q+ +G+ Y +HRD+
Sbjct: 76 -----IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130
Query: 135 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 194
N+L+ K+ADFGLAR D + + PE L ++ D+WS
Sbjct: 131 ARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL-YNRFSIKSDVWS 189
Query: 195 VGCIFAELLN-GKPILPGKNEAEQLSKI 221
G + E++ G+ PG AE L ++
Sbjct: 190 FGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
F+ + + Y ++++ L Y H ++++RD+K NL++D +G++K+ DFGL + D
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AA 150
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 223
T+ T Y PE +L YG AVD W +G + E++ G+ LP N+ + K+FE
Sbjct: 151 TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--KLFE 205
Query: 224 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI- 282
L D K P R A LL +L+ DP++R+
Sbjct: 206 LILMED-------IKFP-------------------RTLSADAKSLLSGLLIKDPNKRLG 239
Query: 283 ----SAKDALDSEYF----WTDPLPCDPKSLPKYESSHEYQTKKR 319
AK+ + +F W D D K +P ++ +T R
Sbjct: 240 GGPDDAKEIMRHSFFTGVNWQDVY--DKKLVPPFKPQVTSETDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 37/187 (19%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
F + Y Q++ GL + H ++++RD+K N+L+D+ GN++++D GLA
Sbjct: 92 FPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK--GGK 149
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 223
+ R T Y PE+L G Y +VD +++GC E++ G+ P + E++ K
Sbjct: 150 KIKGRAGTPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRS--PFRQRKEKVEK--- 203
Query: 224 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV---FRH-FDRHALELLEKMLMLDPS 279
+KRR E+ + F A +L E +L DP
Sbjct: 204 -------------------------EELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238
Query: 280 QRISAKD 286
+R+ +
Sbjct: 239 KRLGCRG 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
F P+ + Y ++ + L Y H +++RD+K N+L+D++G++ L DFGL + + +HN
Sbjct: 93 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNG 151
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 223
T + T Y PE +L Y VD W +G + E+L G P +N AE I
Sbjct: 152 TTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
Query: 224 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 283
KP + +K + RH LLE +L D ++R+
Sbjct: 211 ----------------------KPLQ-LKPNITNSARH-------LLEGLLQKDRTKRLG 240
Query: 284 AKD 286
AKD
Sbjct: 241 AKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 45/131 (34%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 83 YMVFEYM-DHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 139
YMV EYM DL L + +P+ + Y +++ L H +HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 140 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVG 196
+D G+LKLADFG + V T Y PE+L G YG D WSVG
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 197 CIFAELLNGKP 207
E+L G
Sbjct: 235 VFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 8e-13
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 25/220 (11%)
Query: 7 QVFMAREIK---TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
+VF+ R+I G++ A+K ++ K + E IL ++ H ++KL +
Sbjct: 11 KVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE 70
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYM-DHDL-TGLADRPGLRFTVPQIKCYMKQLLTGLH 121
G Y++ +++ DL T L+ + FT +K Y+ +L L
Sbjct: 71 G----------------KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALD 112
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
+ H +++RD+K N+L+D EG++KL DFGL++ S DH + T+ Y PE ++
Sbjct: 113 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPE-VV 170
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
+ + D WS G + E+L G GK+ E ++ I
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 54/232 (23%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 17 GEIVALKKIRMDNEKEGFPITA--------IREIKILKK-LQHENVIKLKEIVTSPGPER 67
++ALK+I + N G + E+ I+K+ L+H N+++ + E
Sbjct: 26 QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL----EN 81
Query: 68 DEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
D Y+V + ++ + RFT +I Q++ L Y
Sbjct: 82 DR------------LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL 129
Query: 124 HV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
H +++HRD+ +N+++ + + + DFGLA+ + LT+ V T+ Y PE++
Sbjct: 130 HKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ--PESKLTSVVGTILYSCPEIVKN 187
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP-DETIW 233
YG D+W+ GCI ++ +P N +KI E P E ++
Sbjct: 188 -EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 5/144 (3%)
Query: 83 YMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141
Y+V +Y + DL L + R + Y+ +++ +H H +HRDIK N+L+D
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136
Query: 142 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGC 197
G+++LADFG + D + V T Y PE+L G KYGP D WS+G
Sbjct: 137 MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV 196
Query: 198 IFAELLNGKPILPGKNEAEQLSKI 221
E+L G+ ++ E KI
Sbjct: 197 CMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 36/207 (17%)
Query: 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138
G Y++ EY+ +L +R G+ F Y+ ++ L + H +++RD+K N+
Sbjct: 73 GKLYLILEYLSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131
Query: 139 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGC 197
L+D +G++KL DFGL + H T+T+ T+ Y PE+L+ + +G AVD WS+G
Sbjct: 132 LLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILM-RSGHGKAVDWWSLGA 188
Query: 198 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 257
+ ++L G P +N + + KI + G +P Y
Sbjct: 189 LMYDMLTGAPPFTAENRKKTIDKILK-----------GKLNLPPY--------------- 222
Query: 258 VFRHFDRHALELLEKMLMLDPSQRISA 284
A +LL+K+L +PS R+ A
Sbjct: 223 ----LTPEARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 29/194 (14%)
Query: 35 PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-- 92
P ++E +++KKL+HE +++L +V+ Y+V EYM
Sbjct: 45 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-----------------PIYIVTEYMSKGSL 87
Query: 93 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 152
L L G +PQ+ Q+ +G+ Y +HRD++ +N+L+ K+ADFG
Sbjct: 88 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 147
Query: 153 LARSFSYDHNNTLTNR----VITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL-LNGKP 207
LAR +N T R W P L G ++ D+WS G + EL G+
Sbjct: 148 LARLI---EDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 202
Query: 208 ILPGKNEAEQLSKI 221
PG E L ++
Sbjct: 203 PYPGMVNREVLDQV 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 20 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79
VA+K ++ D+ + +E++ LK+L+H+++I L + + G P
Sbjct: 33 VAIKILKSDDLLKQQDFQ--KEVQALKRLRHKHLISLFAVCSV--------GEP------ 76
Query: 80 GSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 137
Y++ E M+ L L G V + Q+ G+ Y +HRD+ N
Sbjct: 77 --VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARN 134
Query: 138 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 197
+L+ + K+ADFGLAR D + ++ W P G + D+WS G
Sbjct: 135 ILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGI 192
Query: 198 IFAELLN-GKPILPGKNEAEQLSKI 221
+ E+ G+ PG N E +I
Sbjct: 193 LLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 43/125 (34%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 101 GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160
G R P I + + L GL + HVN+ +HRD+KG+N+L+ EG +KL DFG++ +
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177
Query: 161 HNNTLTNRVITLWYRPP----ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 216
T+ W P E L +T Y D+WS+G EL +G P L +
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGDPPLADLHPMR 236
Query: 217 QLSKI 221
L KI
Sbjct: 237 ALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 7 QVFMAREIKTGEIVALKKIRM-DNEKEGFPITAIREIKILKKLQHENVIK--LKEIVTSP 63
QV+ R +KTG++ A+K + + ++E+E + EI +LKK H I +
Sbjct: 31 QVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL----EINMLKKYSHHRNIATYYGAFIKKS 86
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLH 121
P D+Q ++V E+ +T L G I +++L GL
Sbjct: 87 PPGHDDQ-----------LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELL 180
+ H ++V+HRDIKG N+L+ +KL DFG+ S D N I T ++ PE++
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 193
Query: 181 L----GATKYGPAVDMWSVGCIFAELLNGKPIL 209
Y D+WS+G E+ G P L
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 2/119 (1%)
Query: 103 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162
F P+ + Y ++ + L Y H +++RD+K N+L+D++G++ L DFGL + +H+
Sbjct: 92 SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHS 150
Query: 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
T + T Y PE+L Y VD W +G + E+L G P ++ AE I
Sbjct: 151 KTTSTFCGTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 3/103 (2%)
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 171
Y ++ GL H ++++RD+K N+L+D+ G+++++D GLA T+ RV T
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIRGRVGT 164
Query: 172 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 214
+ Y PE ++ +Y + D W +GC+ E++ GK + E
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 38/141 (26%), Positives = 54/141 (38%), Gaps = 38/141 (26%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
FT + + Y+ + + + H +HRDIK NLL+D +G++KL+DFGL H
Sbjct: 98 FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
Query: 164 TL---------------------TNRVITLW----------------YRPPELLLGATKY 186
+ R W Y PE+ L T Y
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGY 216
Query: 187 GPAVDMWSVGCIFAELLNGKP 207
D WS+G I E+L G P
Sbjct: 217 NKECDWWSLGVIMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 99 RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158
G R I + L GL + H N+++HRD+KG+N+L+ EG +KL DFG++ +
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPA----VDMWSVGCIFAELLNGKPILPGKNE 214
T+ V T ++ PE++ +Y + D+WS+G EL +G P L +
Sbjct: 180 STRLRRNTS-VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF---D 235
Query: 215 AEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
+ +F++ +P T+ ++NHF
Sbjct: 236 MHPVKTLFKIPRNPPPTLLHPEKWCRSFNHF 266
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 39/203 (19%)
Query: 18 EIVA---LKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 74
E+VA LK+ ++ ++ F RE ++L QHEN++K + T P
Sbjct: 36 ELVAVKTLKETASNDARKDFE----REAELLTNFQHENIVKFYGVCTEGDP--------- 82
Query: 75 GNKYRGSTYMVFEYMDH-DLTGL-------------ADRPGLRFTVPQIKCYMKQLLTGL 120
MVFEYM+H DL D P T+ Q+ Q+ +G+
Sbjct: 83 -------PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM 135
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPEL 179
Y +HRD+ N L+ + +K+ DFG++R ++ D+ + ++ + + PPE
Sbjct: 136 VYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPES 195
Query: 180 LLGATKYGPAVDMWSVGCIFAEL 202
++ K+ D+WS G + E+
Sbjct: 196 IM-YRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 33/240 (13%)
Query: 16 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 75
TG+ VA+K I+ D + F + E ++ KL H+N+++L ++ G
Sbjct: 28 TGQKVAVKNIKCDVTAQAF----LEETAVMTKLHHKNLVRLLGVILHNG----------- 72
Query: 76 NKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 133
Y+V E M + L R +V Q+ + + G+ Y +++HRD+
Sbjct: 73 ------LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 134 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 193
N+L+ +G K++DFGLAR S +N+ ++ W P L K+ D+W
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNS---KLPVKWTAPEALKHK--KFSSKSDVW 181
Query: 194 SVGCIFAELLN-GK---PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 249
S G + E+ + G+ P + K E + K + + P+ M + +P +
Sbjct: 182 SYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM-EPPEGCPADVYVLMTSCWETEPKK 240
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 29/201 (14%)
Query: 24 KIRMDNEKEGF--PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81
K+ + + K+G P + E ++K+LQH +++L +VT +
Sbjct: 32 KVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----------------QEP 74
Query: 82 TYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 139
Y++ EYM++ + L G++ T+ ++ Q+ G+ + +HRD++ +N+L
Sbjct: 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL 134
Query: 140 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP---AVDMWSVG 196
+ K+ADFGLAR + + + PE A YG D+WS G
Sbjct: 135 VSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE----AINYGTFTIKSDVWSFG 190
Query: 197 CIFAELLN-GKPILPGKNEAE 216
+ E++ G+ PG E
Sbjct: 191 ILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 8e-12
Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 2/100 (2%)
Query: 108 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 167
QI ++++L GL Y H + +HRDIK +N+L+ G +KLADFG+A + D
Sbjct: 102 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNT 160
Query: 168 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 207
V T ++ PE ++ + Y D+WS+G EL G+P
Sbjct: 161 FVGTPFWMAPE-VIKQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 64/250 (25%), Positives = 100/250 (40%), Gaps = 53/250 (21%)
Query: 84 MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 142
MV EY++ D L G V + Y + + L Y H ++HRD+K NLLI +
Sbjct: 78 MVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136
Query: 143 EGNLKLADFGLAR-------SFSYDHNNTLTNRVI-------TLWYRPPELLLGATKYGP 188
G++KL DFGL++ + Y+ + R T Y PE++L YG
Sbjct: 137 MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGK 195
Query: 189 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP-GVSKMPAYNHFKP 247
VD W++G I E L G G E ++ D+ WP G +PA
Sbjct: 196 PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-----DDIEWPEGDEALPA------ 244
Query: 248 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD---SEYF----WTDPLPC 300
A +L+ ++L +P +R+ A + +F W L
Sbjct: 245 -----------------DAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQ 287
Query: 301 DPKSLPKYES 310
+ +P+ ES
Sbjct: 288 KAEFIPQLES 297
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 40/204 (19%)
Query: 22 LKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81
LK ++ + + F ++E I+ L HEN+I+L +V +
Sbjct: 31 LKSDKLSDIMDDF----LKEAAIMHSLDHENLIRLYGVVLTH-----------------P 69
Query: 82 TYMVFEYMDHDLTGLADR---PGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 137
MV E L L DR L F + + Y Q+ G+ Y + +HRD+ N
Sbjct: 70 LMMVTELAP--LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARN 127
Query: 138 LLIDNEGNLKLADFGLARSF--SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 195
+L+ ++ +K+ DFGL R+ + DH + + + PE L + A D+W
Sbjct: 128 ILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-SLRTRTFSHASDVWMF 186
Query: 196 GCIFAEL----------LNGKPIL 209
G E+ L+G IL
Sbjct: 187 GVTLWEMFTYGEEPWAGLSGSQIL 210
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 59/247 (23%), Positives = 95/247 (38%), Gaps = 52/247 (21%)
Query: 8 VFMAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
VF+ R TG++ ALK K M + + E +IL L H + L
Sbjct: 17 VFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT--EQEILATLDHPFLPTL-------- 66
Query: 65 PERDEQGRPDGNKYRGSTYMVFEY-MDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHY 122
Y +V +Y +L L R PG + + Y ++L L Y
Sbjct: 67 -----YASFQTETY---LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA---------------RSFSYDHNNTLTN 167
H+ +++RD+K N+L+ G++ L+DF L+ + N++ +
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 168 RVI-------------TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 214
T Y PE++ G +G AVD W++G + E+L G G N
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNR 237
Query: 215 AEQLSKI 221
E S I
Sbjct: 238 DETFSNI 244
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 27/184 (14%)
Query: 39 IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD--LTGL 96
+ E ++K LQH+ ++KL +VT + Y++ E+M L L
Sbjct: 49 LAEANVMKTLQHDKLVKLHAVVT-----------------KEPIYIITEFMAKGSLLDFL 91
Query: 97 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156
G + +P++ + Q+ G+ + +HRD++ +N+L+ K+ADFGLAR
Sbjct: 92 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 151
Query: 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV---DMWSVGCIFAELLN-GKPILPGK 212
+ + + PE A +G D+WS G + E++ G+ PG
Sbjct: 152 IEDNEYTAREGAKFPIKWTAPE----AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207
Query: 213 NEAE 216
+ E
Sbjct: 208 SNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 46/129 (35%), Positives = 61/129 (47%), Gaps = 10/129 (7%)
Query: 83 YMVFEYM-DHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 139
YMV EYM DL L + VP+ + Y +++ L H +HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 140 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVG 196
+D G+LKLADFG + + V T Y PE+L G YG D WSVG
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 197 CIFAELLNG 205
E+L G
Sbjct: 235 VFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 28/178 (15%)
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 171
Y Q+ G+ + H +++RD+K N+L+D++GN +L+D GLA T+T R T
Sbjct: 100 YSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGT 157
Query: 172 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 231
Y PE+L Y VD +++GC E++ G+ P K+ E+++K +E
Sbjct: 158 NGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGR--TPFKDHKEKVAK--------EEL 206
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
RT++ V+ ++F + ++ L P R+ +++ D
Sbjct: 207 K---------------RRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKND 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 32/103 (31%), Positives = 57/103 (55%), Gaps = 3/103 (2%)
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 171
Y ++L GL H ++RD+K N+L+D+ G+++++D GLA ++ RV T
Sbjct: 107 YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGT 164
Query: 172 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 214
+ Y PE +L +Y + D W +GC+ E++ G+ G+ E
Sbjct: 165 VGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ AR + TGE+ A+K I+++ E F + +EI ++K +H N++
Sbjct: 25 VYKARNVNTGELAAIKVIKLE-PGEDFAVVQ-QEIIMMKDCKHSNIVAYFGSYLR----- 77
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP----QIKCYMKQLLTGLHYC 123
R ++ E+ G + + T P QI ++ L GL+Y
Sbjct: 78 -----------RDKLWICMEFCG----GGSLQDIYHVTGPLSESQIAYVSRETLQGLYYL 122
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELL 180
H +HRDIKG+N+L+ + G++KLADFG++ + T+ R + T ++ PE+
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT----ATIAKRKSFIGTPYWMAPEVA 178
Query: 181 LGATK--YGPAVDMWSVGCIFAELLNGKP 207
K Y D+W+VG EL +P
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 5/145 (3%)
Query: 83 YMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141
Y+V +Y + DL L + R + Y+ +++ + H +HRDIK N+L+D
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
Query: 142 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGC 197
G+++LADFG D + V T Y PE+L G KYGP D WS+G
Sbjct: 137 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGV 196
Query: 198 IFAELLNGKPILPGKNEAEQLSKIF 222
E+L G+ ++ E KI
Sbjct: 197 CMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 47/129 (36%), Positives = 60/129 (46%), Gaps = 10/129 (7%)
Query: 83 YMVFEYM-DHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 139
YMV EYM DL L + VP+ K Y +++ L H ++HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNML 174
Query: 140 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVG 196
+D G+LKLADFG V T Y PE+L G YG D WSVG
Sbjct: 175 LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 197 CIFAELLNG 205
E+L G
Sbjct: 235 VFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 34/102 (33%), Positives = 60/102 (58%), Gaps = 3/102 (2%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
F+ +++ Y +++ GL + H V++RD+K +N+L+D G+++++D GLA FS +
Sbjct: 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 205
V T Y PE+L T Y + D +S+GC+ +LL G
Sbjct: 154 A---SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ AR + TGE+ A+K I+++ + F + +EI ++K+ +H N++ S
Sbjct: 25 VYKARNLHTGELAAVKIIKLE-PGDDFSLIQ-QEIFMVKECKHCNIVAYFGSYLS----- 77
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP----QIKCYMKQLLTGLHYC 123
R ++ EY G + + T P QI ++ L GL Y
Sbjct: 78 -----------REKLWICMEYCG----GGSLQDIYHVTGPLSELQIAYVCRETLQGLAYL 122
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELL 180
H +HRDIKG+N+L+ + G++KLADFG+A + T+ R + T ++ PE+
Sbjct: 123 HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT----ATIAKRKSFIGTPYWMAPEVA 178
Query: 181 LGATK--YGPAVDMWSVGCIFAELLNGKP 207
Y D+W+VG EL +P
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 2/99 (2%)
Query: 109 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 168
I ++++L GL Y H + +HRDIK +N+L+ +G++KLADFG+A + D
Sbjct: 103 IATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTF 161
Query: 169 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 207
V T ++ PE ++ + Y D+WS+G EL G+P
Sbjct: 162 VGTPFWMAPE-VIKQSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 39/202 (19%)
Query: 19 IVALKKIRMD---NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 75
+VA+K +R D + F ++EIKI+ +L++ N+I+L + S P
Sbjct: 46 LVAVKMLRADVTKTARNDF----LKEIKIMSRLKNPNIIRLLGVCVSDDP---------- 91
Query: 76 NKYRGSTYMVFEYMDH-DLTGLADRPGLRFT------VPQIK----CYMK-QLLTGLHYC 123
M+ EYM++ DL + + T +P + YM Q+ +G+ Y
Sbjct: 92 ------LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL 145
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLL 181
+HRD+ N L+ N +K+ADFG++R+ +S D+ V+ + W +LL
Sbjct: 146 ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL 205
Query: 182 GATKYGPAVDMWSVGCIFAELL 203
G K+ A D+W+ G E+
Sbjct: 206 G--KFTTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 20 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
VA+K ++ + ++ F + E I+ + H N+I L+ +VT P
Sbjct: 35 VAIKTLKAGYTEKQRRDF----LSEASIMGQFDHPNIIHLEGVVTKSKP----------- 79
Query: 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 135
+V EYM++ L + +FTV Q+ ++ + +G+ Y +HRD+
Sbjct: 80 -----VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 134
Query: 136 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR--VITLWYRPPELLLGATKYGPAVDMW 193
N+L+++ K++DFGL+R D T R I + + PE + K+ A D+W
Sbjct: 135 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVW 193
Query: 194 SVGCIFAELLN 204
S G + E+++
Sbjct: 194 SYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 3/102 (2%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
F+ +++ Y +++ GL + H V++RD+K +N+L+D G+++++D GLA FS +
Sbjct: 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 205
V T Y PE+L Y + D +S+GC+ +LL G
Sbjct: 154 A---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 4/109 (3%)
Query: 98 DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157
+ PG F P+ Y Q+++GL + H ++++RD+K N+L+DN+GN++++D GLA
Sbjct: 90 ENPG--FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147
Query: 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 206
+ T T + PELL G +Y +VD +++G E++ +
Sbjct: 148 KDGQSKT-KGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 37/201 (18%)
Query: 19 IVALKKIR--MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
+VA+K ++ DN ++ F RE ++L LQHE+++K + P
Sbjct: 37 LVAVKTLKDASDNARKDFH----REAELLTNLQHEHIVKFYGVCVEGDP----------- 81
Query: 77 KYRGSTYMVFEYMDH------------DLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYC 123
MVFEYM H D +A+ T Q+ +Q+ G+ Y
Sbjct: 82 -----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL 136
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLG 182
+HRD+ N L+ +K+ DFG++R +S D+ + ++ + + PPE ++
Sbjct: 137 ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM- 195
Query: 183 ATKYGPAVDMWSVGCIFAELL 203
K+ D+WS+G + E+
Sbjct: 196 YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 175
++ GL Y ++LHRD+K SN+L++ G +KL DFG++ N+ V T Y
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYM 160
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGK 206
PE + G +YG D+WS+G F EL G+
Sbjct: 161 APERISG-EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 44/219 (20%)
Query: 19 IVALKKIRMDNE--KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
+VA+K ++ +E ++ F RE ++L LQH+++++ + T +GRP
Sbjct: 37 LVAVKALKEASESARQDFQ----REAELLTVLQHQHIVRFYGVCT--------EGRP--- 81
Query: 77 KYRGSTYMVFEYMDHD---------------LTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
MVFEYM H L G D + T+ Q+ Q+ +G+
Sbjct: 82 -----LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMV 136
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELL 180
Y +HRD+ N L+ +K+ DFG++R +S D+ ++ + + PPE +
Sbjct: 137 YLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI 196
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 219
L K+ D+WS G + E+ GK QLS
Sbjct: 197 L-YRKFTTESDIWSFGVVLWEIFT-----YGKQPWYQLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 66/284 (23%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIK--LKEIVTSPG 64
+V +A+ TGE A+K ++ REI +K++QH K L E+ + P
Sbjct: 33 RVRIAKHKGTGEYYAIKCLKK------------REILKMKQVQHVAQEKSILMEL-SHPF 79
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYM--DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
D N+ Y + E++ T L R RF K Y +L+ Y
Sbjct: 80 IVNMMCSFQDENR----VYFLLEFVVGGELFTHL--RKAGRFPNDVAKFYHAELVLAFEY 133
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW----YRPPE 178
H +++RD+K NLL+DN+G++K+ DFG A+ + +R TL Y PE
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK--------VPDRTFTLCGTPEYLAPE 185
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
++ + +G AVD W++G + E + G P P ++ +I+ E I G K
Sbjct: 186 -VIQSKGHGKAVDWWTMGVLLYEFIAGYP--PFFDDTP--FRIY-------EKILAGRLK 233
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 282
P FD A +L++ +L D ++R+
Sbjct: 234 FP-------------------NWFDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 65/245 (26%), Positives = 105/245 (42%), Gaps = 43/245 (17%)
Query: 4 CISQVFMAREI-------KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIK 55
C QV MA + K VA+K ++ D+ E + E++++K + +H+N+I
Sbjct: 27 CFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIIN 85
Query: 56 LKEIVTSPGP-----ERDEQG---------RPDGNKYRGSTYMVFEYMDHDLTGLADRPG 101
L T GP E +G RP G +Y +D+ + D
Sbjct: 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY-----------SYDIARVPDEQ- 133
Query: 102 LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYD 160
T + Q+ G+ Y + +HRD+ N+L+ +K+ADFGLAR + D
Sbjct: 134 --MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL--LNGKPILPGKNEAEQL 218
+ TN + + + PE L Y D+WS G + E+ L G P PG E+L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP-YPGI-PVEEL 248
Query: 219 SKIFE 223
K+ +
Sbjct: 249 FKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 46/223 (20%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
F P+ + Y ++ + L Y H +++RD+K N+L+D++G++ L DFGL + ++
Sbjct: 93 FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSD 151
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 223
T T T Y PE++ Y VD W +G + E+L G P ++ AE I
Sbjct: 152 TTTTFCGTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH 210
Query: 224 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 283
+ PG S A +LE++L D +R+
Sbjct: 211 ----KPLVLRPGASLT--------------------------AWSILEELLEKDRQRRLG 240
Query: 284 AKDAL----DSEYF----WTD------PLPCDPKSLPKYESSH 312
AK+ + +F WTD P P +P + S+
Sbjct: 241 AKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISN 283
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 7e-11
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 25/212 (11%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIK--LKEIVTSPG 64
QV+ R +KTG++ A+K + + ++E +EI +LKK H I +
Sbjct: 21 QVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHHRNIATYYGAFIKKNP 77
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL-ADRPGLRFTVPQIKCYMKQLLTGLHY 122
P D+Q ++V E+ +T L + G I +++L GL +
Sbjct: 78 PGMDDQ-----------LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLL 181
H ++V+HRDIKG N+L+ +KL DFG+ S D N I T ++ PE++
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 182 ----GATKYGPAVDMWSVGCIFAELLNGKPIL 209
Y D+WS+G E+ G P L
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 83 YMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141
Y+V +Y + DL L + R + Y+ +++ + H +HRDIK N+L+D
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD 136
Query: 142 NEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLL----GATKYGPAVDMWSV 195
G+++LADFG + T+ + V T Y PE+L G +YGP D WS+
Sbjct: 137 KNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL 194
Query: 196 GCIFAELLNGKPILPGKNEAEQLSKI 221
G E+L G+ ++ E KI
Sbjct: 195 GVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 25/186 (13%)
Query: 20 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78
VA+K I +E F I E K++ KL H +++L + T Q +P
Sbjct: 31 VAIKAINEGAMSEEDF----IEEAKVMMKLSHPKLVQLYGVCT--------QQKP----- 73
Query: 79 RGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 136
Y+V E+M++ L L R G + + + + + G+ Y N +HRD+
Sbjct: 74 ---LYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAAR 129
Query: 137 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 196
N L+ + G +K++DFG+ R D + + + + PPE+ +KY D+WS G
Sbjct: 130 NCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN-FSKYSSKSDVWSFG 188
Query: 197 CIFAEL 202
+ E+
Sbjct: 189 VLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 41/122 (33%), Positives = 69/122 (56%), Gaps = 7/122 (5%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQ-VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162
F+ + + Y ++++ L Y H + V++RD+K NL++D +G++K+ DFGL + D
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G 150
Query: 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 222
T+ T Y PE +L YG AVD W +G + E++ G+ LP N+ + K+F
Sbjct: 151 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--KLF 205
Query: 223 EL 224
EL
Sbjct: 206 EL 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 49/196 (25%), Positives = 90/196 (45%), Gaps = 30/196 (15%)
Query: 15 KTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 71
K VA+K ++ D ++ F + E I+ + H N+I+L+ +VT
Sbjct: 30 KKEIDVAIKTLKAGSSDKQRLDF----LTEASIMGQFDHPNIIRLEGVVT---------- 75
Query: 72 RPDGNKYRGSTYM-VFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 129
+ M + EYM++ L +FTV Q+ ++ + +G+ Y +
Sbjct: 76 -------KSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 130 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR--VITLWYRPPELLLGATKYG 187
HRD+ N+L+++ K++DFGL+R D T T + I + + PE + K+
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRWTAPE-AIAYRKFT 186
Query: 188 PAVDMWSVGCIFAELL 203
A D+WS G + E++
Sbjct: 187 SASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 34/231 (14%)
Query: 16 TGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 74
TG VA+K +R D +E RE + +L H N++ L D P
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----------LDSGEAPP 51
Query: 75 GNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKC--YMKQLLTGLHYCHVNQVLHRD 132
G + VFEY+ T L + +P + M Q+L L H ++HRD
Sbjct: 52 G-----LLFAVFEYVP-GRT-LREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRD 104
Query: 133 IKGSNLLI---DNEGNLKLADFGLARSFSYDHNN-----TLTNRVI-TLWYRPPELLLGA 183
+K N+++ + K+ DFG+ + T T V+ T Y PE L G
Sbjct: 105 LKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGE 164
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234
P D+++ G IF E L G+ ++ G + AE L + SP + P
Sbjct: 165 PV-TPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQL----SPVDVSLP 210
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 45/189 (23%), Positives = 80/189 (42%), Gaps = 28/189 (14%)
Query: 17 GEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 75
G+ VA+K ++ D + F + E ++ L+H N+++L +V P
Sbjct: 29 GQKVAVKCLKDDSTAAQAF----LAEASVMTTLRHPNLVQLLGVVLQGNP---------- 74
Query: 76 NKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 133
Y+V EYM + L R T+ Q + + G+ Y +HRD+
Sbjct: 75 ------LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDL 128
Query: 134 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 193
N+L+ + K++DFGLA+ S + + ++ W P L K+ D+W
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREK--KFSTKSDVW 183
Query: 194 SVGCIFAEL 202
S G + E+
Sbjct: 184 SFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 38/202 (18%)
Query: 19 IVALKKIRMD---NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 75
+VA+K +R D N + F ++EIKI+ +L+ N+I+L + + P
Sbjct: 48 LVAVKMLREDANKNARNDF----LKEIKIMSRLKDPNIIRLLAVCITSDP---------- 93
Query: 76 NKYRGSTYMVFEYMD----------HDLTGLADRPGLRFTVPQIKCYMK-QLLTGLHYCH 124
M+ EYM+ H+ A++ + +M Q+ +G+ Y
Sbjct: 94 ------LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS 147
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLLG 182
+HRD+ N L+ +K+ADFG++R+ +S D+ V+ + W +LLG
Sbjct: 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG 207
Query: 183 ATKYGPAVDMWSVGCIFAELLN 204
K+ A D+W+ G E+L
Sbjct: 208 --KFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 72/255 (28%), Positives = 110/255 (43%), Gaps = 47/255 (18%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+VF+ + +T E K I KE + E+ ++++L+H+N+++ +
Sbjct: 28 EVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL----- 82
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQ---IKCYMKQLLTGLHY 122
NK Y++ E+ D DL+ + F + I +QLL L Y
Sbjct: 83 ---------NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133
Query: 123 CHV-------NQVLHRDIKGSNLLID-----------NEGNL------KLADFGLARSFS 158
CH +VLHRD+K N+ + NL K+ DFGL+++
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193
Query: 159 YDHNNTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 217
+ + + V T +Y PELLL TK Y DMW++GCI EL +GK N Q
Sbjct: 194 IE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251
Query: 218 LSKIFELCGSPDETI 232
L I EL PD I
Sbjct: 252 L--ISELKRGPDLPI 264
|
Length = 1021 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 4 CISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
C +V+M T + VA+K ++ P ++E +I+KKL+H+ ++ L +V+
Sbjct: 18 CFGEVWMGTWNGTTK-VAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
Y+V E+M L L + G +PQ+ Q+ G+
Sbjct: 74 -----------------PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR----VITLWYRPP 177
Y +HRD++ +N+L+ + K+ADFGLAR +N T R W P
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPE 173
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 221
L G ++ D+WS G + EL+ G+ PG E L ++
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 64/288 (22%), Positives = 112/288 (38%), Gaps = 48/288 (16%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V + R G+ +KK+ + N A +E ++L +L+H N++ +E
Sbjct: 15 EVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE-------- 66
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+G G Y+V + + DL L ++ G Q+ + Q+ L Y H
Sbjct: 67 -SWEGED------GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
+LHRD+K N+ + +K+ D G+AR + + + + T +Y PE L
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPE-LFSNK 177
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
Y D+W++GC E+ K K+ + +I E K+P
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-------------GKLP---- 220
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292
+ + + EL+ ML P +R S K L Y
Sbjct: 221 ------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 30/103 (29%), Positives = 58/103 (56%), Gaps = 3/103 (2%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
F + Y ++ GL H ++++RD+K N+L+D+ G+++++D GLA
Sbjct: 99 FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 206
T+ RV T+ Y PE++ +Y + D W++GC+ E++ G+
Sbjct: 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 50/168 (29%), Positives = 69/168 (41%), Gaps = 45/168 (26%)
Query: 83 YMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141
Y V +Y+ D+ L R G+ F + Y+ +L + H +HRDIK N+LID
Sbjct: 77 YFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID 135
Query: 142 NEGNLKLADFGLARSFSYDHNN-----------------------------TLTNR---- 168
+G++KL DFGL F + H++ L R
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQ 195
Query: 169 ---------VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 207
V T Y PE+LL T Y D WSVG I E+L G+P
Sbjct: 196 HQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 76/321 (23%), Positives = 122/321 (38%), Gaps = 90/321 (28%)
Query: 4 CISQVFMAREIKTGE-----IVALKKIRMD-NEKEGFPITAIREIKILKKL-QHENVIKL 56
QV A + VA+K ++ D EK+ + E++++K + +H+N+I L
Sbjct: 24 AFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINL 81
Query: 57 KEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL--ADRP--------GLRFT 105
+ T GP Y+V EY H +L A RP R
Sbjct: 82 LGVCTQEGP----------------LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 106 VPQIKCY-----MKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY- 159
+ Q+ G+ + + +HRD+ N+L+ + +K+ADFGLAR +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185
Query: 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 219
D+ TN + + + PE L Y D+WS G + E
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWE------------------ 226
Query: 220 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV---REVFRHFDRHALELLEKMLML 276
IF L GSP +PG+ + K M++ +E++ LM
Sbjct: 227 -IFTLGGSP----YPGIPVEELFKLLKEGYRMEKPQNCTQELY-------------HLMR 268
Query: 277 D-----PSQRISAK---DALD 289
D PSQR + K + LD
Sbjct: 269 DCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 34/180 (18%)
Query: 40 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL-- 96
+E +++ LQH N++ L + T P T M+FEY+ H DL
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQP----------------TCMLFEYLAHGDLHEFLV 100
Query: 97 ----ADRPGLRFTVPQIKCYMK---------QLLTGLHYCHVNQVLHRDIKGSNLLIDNE 143
G +K + Q+ G+ Y + +HRD+ N L+
Sbjct: 101 RNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160
Query: 144 GNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 202
+K++DFGL+R +S D+ + ++ + + PPE +L K+ D+WS G + E+
Sbjct: 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 63/249 (25%), Positives = 97/249 (38%), Gaps = 66/249 (26%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIR-EIKILKKLQHENVIKLKEIVTSPGP 65
+V +A ++ T + A+K +R + + ++ E IL + +E V+KL
Sbjct: 16 EVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--- 72
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+ + Y V +Y+ D+ L R + F + Y+ +L + H
Sbjct: 73 -------------KDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVH 118
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--------------------- 163
+HRDIK N+LID +G++KL DFGL F + HN+
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 164 ------------TLTNR-------------VITLWYRPPELLLGATKYGPAVDMWSVGCI 198
TL R V T Y PE+LL Y D WSVG I
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVI 237
Query: 199 FAELLNGKP 207
E+L G+P
Sbjct: 238 LFEMLVGQP 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 41/125 (32%), Positives = 60/125 (48%), Gaps = 22/125 (17%)
Query: 116 LLTGLHYCH-VNQVLHRDIKGSNLLIDNEGNLKLADFG--------LARSFSYDHNNTLT 166
+L GL Y ++++HRD+K SN+L+++ G +KL DFG +A SF
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--------- 158
Query: 167 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 226
V T Y PE L G T Y D+WS+G E+ G+ +P + E L +F
Sbjct: 159 --VGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPV 214
Query: 227 SPDET 231
S E
Sbjct: 215 SEGEA 219
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 2/95 (2%)
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 171
Y ++ L++ H +++RD+K N+L+D EG++KL D+G+ + + T T T
Sbjct: 101 YSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGT 159
Query: 172 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 206
Y PE+L G YG +VD W++G + E++ G+
Sbjct: 160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 25/186 (13%)
Query: 20 VALKKIRMDNEKEGFPITA--IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77
VA+K IR EG I E +++ KL H +++L + T P
Sbjct: 31 VAIKTIR-----EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP------------ 73
Query: 78 YRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 136
+VFE+M+H L+ +F+ + + G+ Y + V+HRD+
Sbjct: 74 ----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAAR 129
Query: 137 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 196
N L+ +K++DFG+ R D + T + + PE + +KY D+WS G
Sbjct: 130 NCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE-VFSFSKYSSKSDVWSFG 188
Query: 197 CIFAEL 202
+ E+
Sbjct: 189 VLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 30/95 (31%), Positives = 54/95 (56%), Gaps = 3/95 (3%)
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 171
Y +L GL ++++RD+K N+L+D+ G+++++D GLA T+ RV T
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGRVGT 164
Query: 172 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 206
+ Y PE ++ KY + D W +GC+ E++ G+
Sbjct: 165 VGYMAPE-VINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 38/111 (34%), Positives = 59/111 (53%), Gaps = 10/111 (9%)
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV----- 169
Q+L +H+ H ++HRDIK +N+L+ + G +KL DFG FS + T+++ V
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG----FSKMYAATVSDDVGRTFC 206
Query: 170 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 220
T +Y PE+ Y DM+S+G + ELL K G+N E + K
Sbjct: 207 GTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 43/174 (24%), Positives = 81/174 (46%), Gaps = 29/174 (16%)
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 171
Y ++ L+Y H +++RD+K N+L+D+EG++KL D+G+ + +T + T
Sbjct: 101 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGT 159
Query: 172 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS---P 228
Y PE+L G YG +VD W++G + E++ G+ F++ GS P
Sbjct: 160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGR-------------SPFDIVGSSDNP 205
Query: 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 282
D+ + ++ + R++ + V + F L DP +R+
Sbjct: 206 DQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF-----------LNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 35/207 (16%)
Query: 8 VFMAREIKTGEIVALKKIRMD---NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
V+ +K VA+K R + K F ++E +ILK+ H N++KL +
Sbjct: 11 VYKGV-LKGNTEVAVKTCRSTLPPDLKRKF----LQEAEILKQYDHPNIVKLIGVCVQKQ 65
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
P Y+V E + L + R TV ++ G+ Y
Sbjct: 66 P----------------IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-----NRVITLWYRPPE 178
+HRD+ N L+ LK++DFG++R + T ++ W P
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSRE---EEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNG 205
L G +Y D+WS G + E +
Sbjct: 167 LNYG--RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 43/156 (27%), Positives = 61/156 (39%), Gaps = 47/156 (30%)
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-------- 163
YM + + + H +HRDIK N+LID G++KL+DFGL+ F H++
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 164 ---------------------TLTNR-VITLW----------------YRPPELLLGATK 185
T++++ I W Y PE+ L
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QG 224
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
YG D WS+G I E L G P +N E KI
Sbjct: 225 YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 7 QVFMAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
+V +A+ G A+K K + +KE I A R + +LK L+H ++ L +
Sbjct: 10 KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGLHYSFQTA 68
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
Y V +Y++ + F P+ + Y ++ + + Y
Sbjct: 69 E----------------KLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYL 112
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
H +++RD+K N+L+D++G++ L DFGL + + T + T Y PE +L
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPE-VLRK 170
Query: 184 TKYGPAVDMWSVGCIFAELLNGKP 207
Y VD W +G + E+L G P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 41/186 (22%)
Query: 103 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSF---- 157
+ + ++K ++QL+ L+ H + ++H DIK N+L D + + L D+GL +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164
Query: 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 217
YD TL Y PE + G Y + D W+VG + ELL GK P K
Sbjct: 165 CYDG---------TLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGK--HPFKE---- 208
Query: 218 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 277
DE + + + K ++ ++A + ++ ML +
Sbjct: 209 ---------DEDEEL--DLESLLKRQQKKLPFI---------KNVSKNANDFVQSMLKYN 248
Query: 278 PSQRIS 283
+ R++
Sbjct: 249 INYRLT 254
|
Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 42/260 (16%)
Query: 17 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
G VA+K I+ D + F + E ++ +L+H N+++L ++
Sbjct: 29 GNKVAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVEE------------- 71
Query: 77 KYRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMK---QLLTGLHYCHVNQVLHRD 132
+G Y+V EYM L D R +V C +K + + Y N +HRD
Sbjct: 72 --KGGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127
Query: 133 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDM 192
+ N+L+ + K++DFGL + S + T ++ W P L K+ D+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALR--EKKFSTKSDV 182
Query: 193 WSVGCIFAELLN-GK---PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 248
WS G + E+ + G+ P +P K+ ++ K +++ +PD P V Y+ K
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-DAPDGC--PPV----VYDVMKQC 235
Query: 249 RTMKRRVREVFRHFDRHALE 268
+ R F R LE
Sbjct: 236 WHLDAATRPSFLQL-REQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 34/181 (18%)
Query: 40 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-------- 91
RE ++L LQHE+++K + P MVFEYM H
Sbjct: 56 REAELLTNLQHEHIVKFYGVCGDGDP----------------LIMVFEYMKHGDLNKFLR 99
Query: 92 ----DLTGLADRPGLR----FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 143
D L D + + Q+ Q+ +G+ Y +HRD+ N L+
Sbjct: 100 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159
Query: 144 GNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 202
+K+ DFG++R +S D+ + ++ + + PPE ++ K+ D+WS G I E+
Sbjct: 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEI 218
Query: 203 L 203
Sbjct: 219 F 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 65/263 (24%), Positives = 103/263 (39%), Gaps = 66/263 (25%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIR-EIKILKKLQHENVIKLKEIVTSPGP 65
+V +AR++ T + A+K +R + + ++ E IL + +E V++L
Sbjct: 16 EVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--- 72
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+ + Y V +Y+ D+ L R G+ F + Y+ +L + H
Sbjct: 73 -------------KDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVH 118
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT-------------------- 164
+HRDIK N+LID +G++KL DFGL F + H++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 165 -------------LTNR-------------VITLWYRPPELLLGATKYGPAVDMWSVGCI 198
L R V T Y PE+LL T Y D WSVG I
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVI 237
Query: 199 FAELLNGKPILPGKNEAEQLSKI 221
E+L G+P + E K+
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 18/195 (9%)
Query: 19 IVALKKIRMD---NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP-----ERDEQ 70
+VA+K +R D N + F ++E+KIL +L+ N+I+L + P E E
Sbjct: 48 LVAVKILRPDANKNARNDF----LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 71 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 130
G D N++ S ++ + + + + + Q+ +G+ Y +H
Sbjct: 104 G--DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161
Query: 131 RDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLLGATKYGP 188
RD+ N L+ +K+ADFG++R+ ++ D+ V+ + W +L+G K+
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTT 219
Query: 189 AVDMWSVGCIFAELL 203
A D+W+ G E+L
Sbjct: 220 ASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 66/275 (24%)
Query: 4 CISQVFMAREI-----KTGEI--VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIK 55
C QV MA I K + VA+K ++ D ++ I E++++K + +H+N+I
Sbjct: 30 CFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIIN 88
Query: 56 LKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFT-----V 106
L T GP Y++ EY + PG+ + V
Sbjct: 89 LLGACTQDGP----------------LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 107 PQIKCYMKQLLT-------GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159
P+ + K L++ G+ Y + +HRD+ N+L+ + +K+ADFGLAR +
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192
Query: 160 -DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 218
D+ TN + + + PE L Y D+WS G + E
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWE----------------- 234
Query: 219 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 253
IF L GSP +PGV + K M +
Sbjct: 235 --IFTLGGSP----YPGVPVEELFKLLKEGHRMDK 263
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 28/201 (13%)
Query: 7 QVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V+ K VA+K ++ D E E F ++E ++K+++H N+++L + T P
Sbjct: 21 EVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPP 76
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD--RPGLRFTVPQIK-CYM-KQLLTGLH 121
Y++ E+M + L D R R V + YM Q+ + +
Sbjct: 77 ----------------FYIITEFMTYG--NLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
Y +HRD+ N L+ +K+ADFGL+R + D + + PE L
Sbjct: 119 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SL 177
Query: 182 GATKYGPAVDMWSVGCIFAEL 202
K+ D+W+ G + E+
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 22/167 (13%)
Query: 41 EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LAD 98
E I+ + H N+I+L+ +VT K++ ++ EYM++ L D
Sbjct: 56 EASIMGQFSHHNIIRLEGVVT---------------KFK-PAMIITEYMENGALDKYLRD 99
Query: 99 RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158
G F+ Q+ ++ + G+ Y +HRD+ N+L+++ K++DFGL+R
Sbjct: 100 HDG-EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158
Query: 159 YDHNNTLTNR--VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 203
D T T I + + PE + K+ A D+WS G + E++
Sbjct: 159 DDPEGTYTTSGGKIPIRWTAPE-AIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 22/174 (12%)
Query: 31 KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 90
K G+ +++ E ++L++L H V+ L ++ R G G T +V
Sbjct: 200 KAGWYASSVHEARLLRRLSHPAVLALLDV------------RVVG----GLTCLVLPKYR 243
Query: 91 HDL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLA 149
DL T L R + Q+ +QLL+ + Y H ++HRDIK N+L++ ++ L
Sbjct: 244 SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLG 302
Query: 150 DFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAE 201
DFG A F+ +T + I T+ PE+L G Y P+VD+WS G + E
Sbjct: 303 DFG-AACFARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 58/245 (23%), Positives = 94/245 (38%), Gaps = 41/245 (16%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ TG +A+K+IR++ ++ F I E+ IL H+ V IV G
Sbjct: 17 VYKVLHRPTGVTMAMKEIRLELDESKFN-QIIMELDIL----HKAVSP--YIVDFYGAFF 69
Query: 68 DEQGRPDGNKYRGSTYMVFEYMD----------HDLTGLADRPGLRFTVPQIKCYMKQLL 117
E G+ YM EYMD T LR + +K L
Sbjct: 70 IE----------GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
++HRD+K +N+L++ G +KL DFG++ + T + Y P
Sbjct: 120 EEH------NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT---NIGCQSYMAP 170
Query: 178 ELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 232
E + Y D+WS+G E+ G+ P + A +++ + T+
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230
Query: 233 WPGVS 237
G S
Sbjct: 231 PSGYS 235
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 42/109 (38%), Positives = 61/109 (55%), Gaps = 8/109 (7%)
Query: 116 LLTGLHYC-HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 174
+L GL Y +Q++HRD+K SN+L+++ G +KL DFG++ N+ V T Y
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 168
Query: 175 RPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIF 222
PE L G T Y D+WS+G EL G+ PI P +A++L IF
Sbjct: 169 MSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 51/287 (17%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
I TG ++A K + + K +RE++I+ + + IV+ G
Sbjct: 27 IPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPY------IVSFYG--------- 70
Query: 74 DGNKYRGSTYMVFEYMDHD-LTGLADRPG-LRFTV-PQIKCYMKQLLTGLHYCHVNQVLH 130
+ M E+MD L + + G + + +I + + LT L+ H +++H
Sbjct: 71 -AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMH 127
Query: 131 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 190
RDIK SN+L+++ G +KL DFG++ +T V T Y PE + G KY
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF---VGTSTYMSPERIQGG-KYTVKS 183
Query: 191 DMWSVGCIFAELLNGKPILPGKNEAEQLS----KIFELCGSPDETIWPGVSKMPAYNHFK 246
D+WS+G EL GK N + I +L +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL--------------LQQIVQEP 229
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P R F + ++ L+ DP++R + + F
Sbjct: 230 PPRLPSSD-------FPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 29/95 (30%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 171
Y ++ L++ H +++RD+K N+L+D +G++KL D+G+ + +T + T
Sbjct: 101 YAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGT 159
Query: 172 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 206
Y PE+L G +YG +VD W++G + E++ G+
Sbjct: 160 PNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 30/197 (15%)
Query: 22 LKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80
LK +E+E + E+KI+ L HEN++ L T GP
Sbjct: 73 LKPTAHSSEREAL----MSELKIMSHLGNHENIVNLLGACTIGGP--------------- 113
Query: 81 STYMVFEYMDH-DLTGLADRPGLRF-TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138
++ EY + DL R F T+ + + Q+ G+ + +HRD+ N+
Sbjct: 114 -ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172
Query: 139 LIDNEGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGATKYGPAVDMWSVG 196
L+ + +K+ DFGLAR D N + R+ W P + Y D+WS G
Sbjct: 173 LLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYG 230
Query: 197 CIFAEL--LNGKPILPG 211
+ E+ L P PG
Sbjct: 231 ILLWEIFSLGSNP-YPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 42/233 (18%)
Query: 4 CISQVFMAREIKTGE-------IVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIK 55
C QV MA I + VA+K ++ D + + E++++K + +H+N+I
Sbjct: 24 CFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS-DLVSEMEMMKMIGKHKNIIN 82
Query: 56 LKEIVTSPGP-----ERDEQG---------RPDGNKYRGSTYMVFEYMDHDLTGLADRPG 101
L T GP E +G RP G Y T + P
Sbjct: 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL--------------PE 128
Query: 102 LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYD 160
+ T + Q+ G+ Y + +HRD+ N+L+ + +K+ADFGLAR + D
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188
Query: 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL--LNGKPILPG 211
+ TN + + + PE L Y D+WS G + E+ L G P PG
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 38/110 (34%), Positives = 52/110 (47%), Gaps = 7/110 (6%)
Query: 120 LHYCHVNQ-VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
LHY V+HRD+K SN+L+D GN+KL DFG++ T + Y PE
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA--YMAPE 184
Query: 179 LLLGAT---KYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFEL 224
+ KY D+WS+G EL G+ K E E L+KI +
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE 234
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 40/186 (21%)
Query: 40 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT---- 94
RE ++ + H N++KL + G+P ++FEYM + DL
Sbjct: 57 REAALMAEFDHPNIVKLLGVCA--------VGKP--------MCLLFEYMAYGDLNEFLR 100
Query: 95 -----------------GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 137
L + + C KQ+ G+ Y + +HRD+ N
Sbjct: 101 HRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160
Query: 138 LLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 196
L+ +K+ADFGL+R+ +S D+ N I + + PPE + +Y D+W+ G
Sbjct: 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYG 219
Query: 197 CIFAEL 202
+ E+
Sbjct: 220 VVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 42/169 (24%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 41 EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADR 99
E I+ + H N+I L+ +VT P ++ E+M++ L +
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSRP----------------VMIITEFMENGALDSFLRQ 98
Query: 100 PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159
+FTV Q+ ++ + G+ Y +HRD+ N+L+++ K++DFGL+R
Sbjct: 99 NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158
Query: 160 DHNN-TLTNRV---ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 204
D ++ T T+ + I + + PE + K+ A D+WS G + E+++
Sbjct: 159 DTSDPTYTSSLGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 116 LLTGLHYC-HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 174
++ GL Y ++++HRD+K SN+L+++ G +KL DFG++ N+ V T Y
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 168
Query: 175 RPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIF--ELCGSPDET 231
PE L G T Y D+WS+G E+ G+ PI P +A++L +F + G P E+
Sbjct: 169 MSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAES 225
Query: 232 IWPGVSKMPA 241
+ P
Sbjct: 226 ETSPRPRPPG 235
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 36/199 (18%)
Query: 20 VALKKIRMD---NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
VA+K +R D N +E F ++E+KIL +L N+ +L + T P
Sbjct: 49 VAVKVLRPDASDNAREDF----LKEVKILSRLSDPNIARLLGVCTVDPP----------- 93
Query: 77 KYRGSTYMVFEYMDH-DL-----TGLADRPGLRFTVPQIK----CYM-KQLLTGLHYCHV 125
M+ EYM++ DL +A+ GL + YM Q+ +G+ Y
Sbjct: 94 -----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES 148
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGAT 184
+HRD+ N L+ +K+ADFG++R+ +S D+ + + + E +L
Sbjct: 149 LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-G 207
Query: 185 KYGPAVDMWSVGCIFAELL 203
K+ D+W+ G E+L
Sbjct: 208 KFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 13/100 (13%)
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 171
Y Q++ Y +++RD+K NLL+D +G +K+ DFG A+ + R T
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTRTYT 187
Query: 172 LWYRP----PELLLGATKYGPAVDMWSVGCIFAELLNGKP 207
L P PE+LL +G A D W++G E+L G P
Sbjct: 188 LCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 36/116 (31%), Positives = 51/116 (43%), Gaps = 19/116 (16%)
Query: 119 GLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW---- 173
L Y H V+HRD+K SN+LI+ G +KL DFG++ L + V
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS--------GYLVDSVAKTIDAGC 166
Query: 174 --YRPPELLLGATK---YGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFE 223
Y PE + Y D+WS+G EL G+ P K +QL ++ E
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 42/182 (23%), Positives = 69/182 (37%), Gaps = 34/182 (18%)
Query: 22 LKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG----PERDEQGRPDGNK 77
LK+ + K+ F +RE ++ +L H +++L + E G K
Sbjct: 31 LKQEHIAAGKKEF----LREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPL--LK 84
Query: 78 YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 137
Y L R V +K Q+ G+ Y +HRD+ N
Sbjct: 85 Y-----------------LKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARN 125
Query: 138 LLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWS 194
+L+ N K++DFG++R+ + T R WY P + G K+ D+WS
Sbjct: 126 VLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG--KFSSKSDVWS 183
Query: 195 VG 196
G
Sbjct: 184 YG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 28/74 (37%), Positives = 43/74 (58%), Gaps = 2/74 (2%)
Query: 83 YMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141
Y+V EY+ D+ L G F Y+ ++ L Y H + ++HRD+K N+LI
Sbjct: 80 YLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138
Query: 142 NEGNLKLADFGLAR 155
NEG++KL DFGL++
Sbjct: 139 NEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 34/206 (16%)
Query: 20 VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGP-----ERDEQG-- 71
VA+K ++ DN + I E++++K + +H+N+I L + T GP E +G
Sbjct: 47 VAVKMLK-DNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 72 -------RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
RP G Y D+T + + + + Q+ G+ Y
Sbjct: 106 REFLRARRPPGPDY-----------TFDITKVPEEQ---LSFKDLVSCAYQVARGMEYLE 151
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY-DHNNTLTNRVITLWYRPPELLLGA 183
+ +HRD+ N+L+ + +K+ADFGLAR D+ +N + + + PE L
Sbjct: 152 SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR 211
Query: 184 TKYGPAVDMWSVGCIFAEL--LNGKP 207
Y D+WS G + E+ L G P
Sbjct: 212 V-YTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 41/190 (21%), Positives = 80/190 (42%), Gaps = 29/190 (15%)
Query: 20 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
VA+ +R D ++ GF + E L + H N+++L+ ++T
Sbjct: 36 VAIHTLRAGCSDKQRRGF----LAEALTLGQFDHSNIVRLEGVIT--------------- 76
Query: 77 KYRGSTYM-VFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 134
RG+T M V EYM + L + + Q+ + L +G+ Y +H+ +
Sbjct: 77 --RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLA 134
Query: 135 GSNLLIDNEGNLKLADFG-LARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 193
+L++++ K++ F L S T++ + LW P + + A D+W
Sbjct: 135 AHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVW 192
Query: 194 SVGCIFAELL 203
S G + E++
Sbjct: 193 SFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 13/102 (12%)
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFG----LARSFSYDHNNTLTNRVITLWYRPPELLL- 181
+++HRD+K SN+L+D GN+KL DFG L S + + Y PE +
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP------YMAPERIDP 181
Query: 182 -GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA-EQLSKI 221
Y D+WS+G E+ GK P N +QL+++
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV 223
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 24/199 (12%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+VF R VA+K R + ++E +ILK+ H N+++L + T P
Sbjct: 10 EVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP- 67
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
Y+V E + D G R V ++ ++ G+ Y
Sbjct: 68 ---------------IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS---YDHNNTLTNRVITLWYRPPELLLG 182
+HRD+ N L+ + LK++DFG++R Y + ++ W P L G
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM-KQIPVKWTAPEALNYG 171
Query: 183 ATKYGPAVDMWSVGCIFAE 201
+Y D+WS G + E
Sbjct: 172 --RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 37/183 (20%)
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR----SFSYDHNNTLTNRVI 170
Q++ L H +++HRD+K +N+ + G +KL DFG ++ S S D ++
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG--- 233
Query: 171 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 230
T +Y PE L +Y DMWS+G I ELL G ++ E + ++ L G D
Sbjct: 234 TPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV--LYGKYDP 290
Query: 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290
P S M A LL+ +L +P+ R + + L +
Sbjct: 291 FPCPVSSGMKA---------------------------LLDPLLSKNPALRPTTQQLLHT 323
Query: 291 EYF 293
E+
Sbjct: 324 EFL 326
|
Length = 478 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 56/200 (28%), Positives = 82/200 (41%), Gaps = 31/200 (15%)
Query: 19 IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78
+ +L +I E E F ++E I+K H NV+ L I
Sbjct: 28 VKSLNRITDLEEVEQF----LKEGIIMKDFSHPNVLSLLGICLPS--------------- 68
Query: 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 137
GS +V YM H DL TV + + Q+ G+ Y + +HRD+ N
Sbjct: 69 EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN 128
Query: 138 LLIDNEGNLKLADFGLARSFSYD------HNNTLTNRVITLWYRPPELLLGATKYGPAVD 191
++D +K+ADFGLAR YD HN+T ++ W L K+ D
Sbjct: 129 CMLDESFTVKVADFGLARDI-YDKEYYSVHNHT-GAKLPVKWMALES--LQTQKFTTKSD 184
Query: 192 MWSVGCIFAELLN-GKPILP 210
+WS G + EL+ G P P
Sbjct: 185 VWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 56/246 (22%), Positives = 96/246 (39%), Gaps = 55/246 (22%)
Query: 21 ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN---- 76
A ++R+ +K+ I A++ ++ L+ E V ++ ERD DG
Sbjct: 13 AFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIR-------AERDILVEADGAWVVK 65
Query: 77 -----KYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 129
+ + + Y++ E++ +T L + L + + Y+ + + + H +
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTL--SEEATQFYIAETVLAIDAIHQLGFI 123
Query: 130 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDH------------------NNTLTNRVIT 171
HRDIK NLL+D +G++KL+DFGL H N + R
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 172 LW----------------YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 215
W Y PE+ + T Y D WS+G I E+L G P +
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 216 EQLSKI 221
E K+
Sbjct: 243 ETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 35/174 (20%), Positives = 68/174 (39%), Gaps = 28/174 (16%)
Query: 41 EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL--A 97
E ++K+ +V++L +V+ G+P T +V E M DL +
Sbjct: 59 EASVMKEFNCHHVVRLLGVVS--------TGQP--------TLVVMELMAKGDLKSYLRS 102
Query: 98 DRPGLRFTVP-------QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 150
RP + ++ G+ Y + +HRD+ N ++ + +K+ D
Sbjct: 103 RRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162
Query: 151 FGLARSFSY-DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 203
FG+ R D+ ++ + + PE L + D+WS G + E+
Sbjct: 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 108 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 167
+K + +++ L H ++ RD+ +N+L+D+ G+++L F + ++
Sbjct: 86 CVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWS----EVEDSCDG 141
Query: 168 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL 209
+ Y PE + G ++ A D WS+G I ELL GK ++
Sbjct: 142 EAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 31/193 (16%)
Query: 39 IREIKILKKLQHENVIKLKEIVTSPGP-----ERDEQG---------RPDGNKYRGSTYM 84
+ E +LK++ H +VIKL + GP E + G R G Y GS
Sbjct: 51 LSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110
Query: 85 VFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 143
D P R T+ + + Q+ G+ Y +++HRD+ N+L+
Sbjct: 111 RNSSYL-------DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG 163
Query: 144 GNLKLADFGLARSFSYDHNNTLT---NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 200
+K++DFGL+R Y+ ++ + R+ W L Y D+WS G +
Sbjct: 164 RKMKISDFGLSRDV-YEEDSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLW 220
Query: 201 EL--LNGKPILPG 211
E+ L G P PG
Sbjct: 221 EIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 39/152 (25%), Positives = 59/152 (38%), Gaps = 35/152 (23%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-- 161
T + + Y+ + + + H +HRDIK NLL+D++G++KL+DFGL H
Sbjct: 98 LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157
Query: 162 ----------------NNTLTNRVITLWYR----------------PPELLLGATKYGPA 189
N + R W R PE+ + T Y
Sbjct: 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKL 216
Query: 190 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
D WS+G I E+L G P + E K+
Sbjct: 217 CDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 40/183 (21%), Positives = 79/183 (43%), Gaps = 36/183 (19%)
Query: 40 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-------- 91
E + +LQH N++ L +VT P M+F Y H
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQP----------------LSMIFSYCSHSDLHEFLV 100
Query: 92 ------DLTGLADRPGLRFTV--PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 143
D+ D ++ T+ + Q+ G+ + + V+H+D+ N+L+ ++
Sbjct: 101 MRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160
Query: 144 GNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAVDMWSVGCIFAE 201
N+K++D GL R ++ D+ + N ++ + W P ++ G K+ D+WS G + E
Sbjct: 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWE 218
Query: 202 LLN 204
+ +
Sbjct: 219 VFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 24/91 (26%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLW 173
Q+ G+ Y + +H+D+ N+LI + ++K++D GL+R +S D+ ++ +
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLN 204
+ PPE ++ K+ D+WS G + E+ +
Sbjct: 192 WMPPEAIMYG-KFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 44/196 (22%), Positives = 80/196 (40%), Gaps = 35/196 (17%)
Query: 40 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTG--L 96
RE+ + +KL H+NV++L + P YM+ EY D DL
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPH----------------YMILEYTDLGDLKQFLR 100
Query: 97 ADRPGLR------FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 150
A + + Q Q+ G+ + + +HRD+ N L+ ++ +K++
Sbjct: 101 ATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160
Query: 151 FGLAR----SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-G 205
L++ S Y N L I L + PE + + D+WS G + E+ G
Sbjct: 161 LSLSKDVYNSEYYKLRNAL----IPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQG 215
Query: 206 KPILPGKNEAEQLSKI 221
+ G ++ E L+++
Sbjct: 216 ELPFYGLSDEEVLNRL 231
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 47/211 (22%), Positives = 82/211 (38%), Gaps = 31/211 (14%)
Query: 20 VALKKIRMDN----EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 75
VA+K +++D E E F + E +K H NV+KL + Q P
Sbjct: 30 VAVKTMKLDIHTYSEIEEF----LSEAACMKDFDHPNVMKLIGVCFE---ASSLQKIP-- 80
Query: 76 NKYRGSTYMVFEYMDH-DL------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 128
++ +M H DL + L P + + + +M + G+ Y
Sbjct: 81 -----KPMVILPFMKHGDLHSFLLYSRLGGLP-EKLPLQTLLKFMVDIALGMEYLSNRNF 134
Query: 129 LHRDIKGSNLLIDNEGNLKLADFGLARS-FSYD-HNNTLTNRVITLWYRPPELLLGATKY 186
+HRD+ N ++ + + +ADFGL++ +S D + ++ W L Y
Sbjct: 135 IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES--LADRVY 192
Query: 187 GPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216
D+W+ G E+ G+ PG E
Sbjct: 193 TSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 44/184 (23%), Positives = 75/184 (40%), Gaps = 21/184 (11%)
Query: 20 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79
VA+K + D +E I + E +ILK+ H N++KL + T P
Sbjct: 22 VAVKTCKEDLPQE-LKIKFLSEARILKQYDHPNIVKLIGVCTQRQP-------------- 66
Query: 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138
Y+V E + D + Q+ + G+ Y +HRD+ N
Sbjct: 67 --IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNC 124
Query: 139 LIDNEGNLKLADFGLARSFSYD-HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 197
L+ LK++DFG++R ++++ ++ W P L G +Y D+WS G
Sbjct: 125 LVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG--RYSSESDVWSYGI 182
Query: 198 IFAE 201
+ E
Sbjct: 183 LLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 43/223 (19%)
Query: 16 TGEI-VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 71
+G I VA+K +R D EK+ F ++E ++ H N++KL + P+
Sbjct: 24 SGPIRVAVKTLRKGATDQEKKEF----LKEAHLMSNFNHPNIVKLLGVCLLNEPQ----- 74
Query: 72 RPDGNKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLL-------TGLHY 122
Y++ E M+ L+ L D RF P + +K+LL G Y
Sbjct: 75 -----------YIIMELMEGGDLLSYLRDARVERFGPPLLT--LKELLDICLDVAKGCVY 121
Query: 123 CHVNQVLHRDIKGSNLLIDNEGN-----LKLADFGLARS-FSYDHNNTLTNRVITLWYRP 176
+HRD+ N L+ +G +K+ DFGLAR + D+ ++ + +
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQL 218
PE LL K+ D+WS G + E+L G+ P N E L
Sbjct: 182 PESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 38/103 (36%), Positives = 52/103 (50%), Gaps = 3/103 (2%)
Query: 109 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 168
IK M+Q+LTGL H ++HRDIK NLL+ +G +K+ DFG A N
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 169 VITLWYRPPELLLGATKY--GPAVDMWSVGCIFAELLNGKPIL 209
++ Y PPE L+ PA M ++ FA L G+P L
Sbjct: 371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFA-WLYGRPDL 412
|
Length = 507 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 33/145 (22%), Positives = 59/145 (40%), Gaps = 25/145 (17%)
Query: 20 VALKKIRMDNE---KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
VA+K + +E F ++E I+++ H +++KL ++T
Sbjct: 37 VAVKTCKNCTSPSVREKF----LQEAYIMRQFDHPHIVKLIGVITEN------------- 79
Query: 77 KYRGSTYMVFE-YMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 135
++V E +L + + Y QL T L Y + +HRDI
Sbjct: 80 ----PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAA 135
Query: 136 SNLLIDNEGNLKLADFGLARSFSYD 160
N+L+ + +KL DFGL+R +
Sbjct: 136 RNVLVSSPDCVKLGDFGLSRYLEDE 160
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 7e-06
Identities = 65/289 (22%), Positives = 120/289 (41%), Gaps = 31/289 (10%)
Query: 14 IKTGEIVALK-KIRMDNEKEG--FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 70
+ GE V + I++ NE G + + E I+ + H ++++L + SP + Q
Sbjct: 29 VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQ 88
Query: 71 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 130
P G + +Y+ + + L + V Q+ G+ Y +++H
Sbjct: 89 LMPHG--------CLLDYVHEHKDNIGSQLLLNWCV--------QIAKGMMYLEERRLVH 132
Query: 131 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGP 188
RD+ N+L+ + ++K+ DFGLAR D N ++ W + K+
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIHYRKFTH 190
Query: 189 AVDMWSVGCIFAELLN--GKPI--LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
D+WS G EL+ GKP +P + + L K L P TI + + +
Sbjct: 191 QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMI 250
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
SR + +E+ F R A + ++ L++ R+ DS++F
Sbjct: 251 DADSRP---KFKELAAEFSRMARD-PQRYLVIQGDDRMKLPSPNDSKFF 295
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 12/94 (12%)
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLW 173
Q+ G+ Y H V+H+DI N +ID E +K+ D L+R F D++ N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE----- 179
Query: 174 YRP-----PELLLGATKYGPAVDMWSVGCIFAEL 202
RP E L+ +Y A D+WS G + EL
Sbjct: 180 NRPVKWMALESLVN-KEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 48/184 (26%), Positives = 72/184 (39%), Gaps = 39/184 (21%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
T+ + CY Q+ G+ + + +HRD+ N+L+ +K+ DFGLAR D +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 164 TLTNRV-ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 222
+ L + PE + Y D+WS G + E IF
Sbjct: 236 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWE-------------------IF 275
Query: 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE--VFRHFDRHALELLEKMLML---D 277
L SP +PGV K RR++E R D E+ + ML +
Sbjct: 276 SLGASP----YPGV---------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322
Query: 278 PSQR 281
PSQR
Sbjct: 323 PSQR 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 59/246 (23%), Positives = 84/246 (34%), Gaps = 60/246 (24%)
Query: 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 142
Y V Y+ + L GL I+ M+Q+L L H ++HRD+K N++
Sbjct: 233 YNVEPYLLGKVQDLP--KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 143 E-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG------------------- 182
G+ K+ D G A N Y P E LL
Sbjct: 291 GSGSFKIIDLGAAADLRVGIN-----------YIPKEFLLDPRYAAPEQYIMSTQTPSAP 339
Query: 183 ----ATKYGPAV---------DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 229
AT P + D++S G IF ++ P L + Q ++ +
Sbjct: 340 SAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM--AFPNLRSDSNLIQFNRQLKRND--- 394
Query: 230 ETIWPGVSKMPAYNHFKPSRTMK--RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 287
+ A+ R RR EV ELL+ M+ QRISAK A
Sbjct: 395 -------YDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAA 447
Query: 288 LDSEYF 293
L YF
Sbjct: 448 LAHPYF 453
|
Length = 566 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 72/324 (22%), Positives = 122/324 (37%), Gaps = 60/324 (18%)
Query: 5 ISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
++ V++AR TG +V ++ ++N E E+ + +H N++ + T+
Sbjct: 13 LTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-- 70
Query: 65 PERDEQGRPDGNKYRGS-TYMVFEYMDHDLTGLADRPGLRFTVPQ------IKCYMKQLL 117
GS +++ +M + + L+ P+ I + L
Sbjct: 71 ---------------GSWLWVISPFMAYG----SANSLLKTYFPEGMSEALIGNILFGAL 111
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS-----------YDHNNTLT 166
GL+Y H N +HR+IK S++LI +G + L+ GL+ +S YD T
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 167 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELC 225
+ + W P L Y D++SVG EL G+ P L K+
Sbjct: 170 S--VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPP 227
Query: 226 GSP-DETIWP---------------GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALEL 269
SP D T +P G+ + + T +R + F L
Sbjct: 228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNL 287
Query: 270 LEKMLMLDPSQRISAKDALDSEYF 293
+E L DP +R SA L +F
Sbjct: 288 VELCLQQDPEKRPSASSLLSHAFF 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 3/122 (2%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
T+ + CY Q+ G+ + + +HRD+ N+L+ +K+ DFGLAR D +
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 164 TLT-NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 221
+ + L + PE + Y D+WS G + E+ + G PG E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR 289
Query: 222 FE 223
+
Sbjct: 290 LK 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 52/220 (23%), Positives = 81/220 (36%), Gaps = 37/220 (16%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGP 65
QV AR K G +RMD AI+ +K K H + E++ G
Sbjct: 22 QVLKARIKKDG-------LRMD--------AAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHD----------------LTGLADRPGLRFTVPQI 109
+ ++RG Y+ EY H +A+ + Q+
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 110 KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 169
+ + G+ Y Q +HRD+ N+L+ K+ADFGL+R T+ R+
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRL 185
Query: 170 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL--LNGKP 207
W L + Y D+WS G + E+ L G P
Sbjct: 186 PVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 5 ISQVFMAREIKTGEIVALKKIRMD----NEKEGFPITAIREIKILKKLQHENVIKLKEIV 60
+ + + E + + VA+K ++ D ++ E F +RE +K+ H NVIKL +
Sbjct: 15 VREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEF----LREAACMKEFDHPNVIKLIGVS 70
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMV-FEYMDH-DLTG--LADRPGLR-FTVPQ--IKCYM 113
+ R G R MV +M H DL L R G FT+P + +M
Sbjct: 71 L--------RSRAKG---RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 114 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
+ +G+ Y +HRD+ N +++ + +ADFGL++
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 35/213 (16%)
Query: 20 VALKKIRM----DNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 75
VA+K +++ +E E F + E +K+ H NV++L + E +G P
Sbjct: 29 VAVKTMKIAICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQ-TVES--EGYP-- 79
Query: 76 NKYRGSTYMVFEYMDH-DL------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 128
S ++ +M H DL + L D P T +K +M + +G+ Y
Sbjct: 80 -----SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGMEYLSSKSF 133
Query: 129 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL----LGAT 184
+HRD+ N +++ N+ +ADFGL++ Y+ + R+ + P + + L
Sbjct: 134 IHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKM---PVKWIAIESLADR 189
Query: 185 KYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216
Y D+WS G E+ G+ PG +E
Sbjct: 190 VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 30/108 (27%), Positives = 50/108 (46%), Gaps = 7/108 (6%)
Query: 105 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 164
TV + M Q+ G+ Y +HRD+ N+L+ N+ K++DFGL+++ D ++
Sbjct: 93 TVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSY 151
Query: 165 LTNRVITLW---YRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKP 207
R W + PE + K+ D+WS G E + KP
Sbjct: 152 YKARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 5/106 (4%)
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
T Q+ + + TG+ Y Q +HRD+ N+L+ K+ADFGL+R
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL--LNGKP 207
T+ R+ W L + Y D+WS G + E+ L G P
Sbjct: 176 TM-GRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 77/346 (22%), Positives = 128/346 (36%), Gaps = 87/346 (25%)
Query: 7 QVFMAREIKTGEIVALKKIRMD---NE--KEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+V++A + VALKKIR D N K+ F +RE KI L H ++ + I +
Sbjct: 17 EVYLAYDPVCSRRVALKKIREDLSENPLLKKRF----LREAKIAADLIHPGIVPVYSICS 72
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGL------RFTVPQIKCYMKQ 115
G P Y Y+ + L + + L + +V +
Sbjct: 73 --------DGDP---VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS----------FSYD----- 160
+ + Y H VLHRD+K N+L+ G + + D+G A D
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 161 -HNNTLTNRVI-TLWYRPPELLLGATKYGPA---VDMWSVGCIFAELLNGKPILPGKNEA 215
+ T+ +++ T Y PE LLG PA D++++G I ++L P + +
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGV----PASESTDIYALGVILYQMLTLS--FPYRRKK 235
Query: 216 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLM 275
+ KI S + I ++ Y RE+ + A+ K L
Sbjct: 236 GR--KI-----SYRDVI-LSPIEVAPY-------------REIPPFLSQIAM----KALA 270
Query: 276 LDPSQRISAKDAL----------DSEYFWTDPLPCDPKSLPKYESS 311
+DP++R S+ L E+ L KS K+
Sbjct: 271 VDPAERYSSVQELKQDLEPHLQGSPEWTVKATLMTKKKSCWKFYEP 316
|
Length = 932 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 42/194 (21%), Positives = 80/194 (41%), Gaps = 30/194 (15%)
Query: 15 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG----PERDEQ 70
K+ + VA+K ++ DN +RE ++++L + ++++ I + E E
Sbjct: 20 KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAEL 79
Query: 71 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 130
G NK+ V + ++T L + Q+ G+ Y +H
Sbjct: 80 GPL--NKFLQKNKHV---TEKNITEL----------------VHQVSMGMKYLEETNFVH 118
Query: 131 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYG 187
RD+ N+L+ + K++DFGL+++ D N + WY P + K+
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--CMNYYKFS 176
Query: 188 PAVDMWSVGCIFAE 201
D+WS G + E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 8/124 (6%)
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITL 172
Q+ G+ Y +++HRD+ N+L+ + ++K+ DFGLAR D + +V
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 173 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPI--LPGKNEAEQLSKIFELCGSP 228
W +L ++ D+WS G EL+ KP +P + + L K L P
Sbjct: 177 WMALESIL--HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP 234
Query: 229 DETI 232
TI
Sbjct: 235 ICTI 238
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|219133 pfam06682, DUF1183, Protein of unknown function (DUF1183) | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 31/106 (29%), Positives = 34/106 (32%), Gaps = 16/106 (15%)
Query: 380 GKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRG 439
G GP Y G GG GG GGG P PP + P G
Sbjct: 182 GVRGGPRPERAGYGGGGGGGGG-----GGGGGGSGPGPPPPGFKSSFPP----PYGPGAG 232
Query: 440 PASGYGVGPQSYSQSGQYGNSAAGRGPNQMGG-------SRNQQYG 478
P+SGYG G Q G G G G + N YG
Sbjct: 233 PSSGYGSGGTRSGQGGWGPGFWTGLGAGGALGYLFGSRRNNNSSYG 278
|
This family consists of several eukaryotic proteins of around 360 residues in length. The function of this family is unknown. Length = 317 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 42/187 (22%), Positives = 76/187 (40%), Gaps = 23/187 (12%)
Query: 20 VALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78
VA+K +R + + I E ++ + H +V++L I S + Q P G
Sbjct: 39 VAIKVLREETSPKAN--KEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGC-- 94
Query: 79 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138
+ +Y+ + + + L + V Q+ G+ Y +++HRD+ N+
Sbjct: 95 ------LLDYVRNHKDNIGSQYLLNWCV--------QIAKGMSYLEEKRLVHRDLAARNV 140
Query: 139 LIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAVDMWSVG 196
L+ ++K+ DFGLA+ D +V W +L Y D+WS G
Sbjct: 141 LVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYG 198
Query: 197 CIFAELL 203
EL+
Sbjct: 199 VTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 27/134 (20%)
Query: 105 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 164
T+ + Y Q+ G+ + + +HRD+ N+L+ +K+ DFGLAR D +
Sbjct: 171 TLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 230
Query: 165 LTN--RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 222
R+ W P + Y D+WS G + E IF
Sbjct: 231 RKGDARLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWE-------------------IF 269
Query: 223 ELCGSPDETIWPGV 236
L SP +PGV
Sbjct: 270 SLGASP----YPGV 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 6/128 (4%)
Query: 88 YMDHDLT-GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 146
Y+D D+T + + L + + Q+ G+ + +HRD+ N+L+ +
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
Query: 147 KLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 204
K+ DFGLAR D N + R+ W P + Y D+WS G + E+ +
Sbjct: 254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFS 311
Query: 205 -GKPILPG 211
G PG
Sbjct: 312 LGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 5/100 (5%)
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITL 172
Q+ G+ + +HRD+ N+L+ + K+ DFGLAR D N + R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 173 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 211
W P + Y D+WS G + E+ + GK PG
Sbjct: 280 WMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 56/211 (26%), Positives = 84/211 (39%), Gaps = 42/211 (19%)
Query: 115 QLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGN----------------LKLADFGLARSF 157
Q L Y H ++H D+K N+L++ +++ D G
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG----G 294
Query: 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 217
D ++ T V T YR PE++LG + + DMWS+GCI EL GK + + E
Sbjct: 295 CCDERHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 218 LSKIFE-LCGSPDETIWPGVSKMPA----YN---HFKPSRTMK--------RRVREVFRH 261
L + + L P E W G YN +P K R VREV R
Sbjct: 354 LHLMEKTLGRLPSE--WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR- 410
Query: 262 FDRHALELLEKMLMLDPSQRISAKDALDSEY 292
D +L+ +L D +R++A+ Y
Sbjct: 411 -DDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 38/144 (26%), Positives = 60/144 (41%), Gaps = 9/144 (6%)
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
D + + Y E D + + P L + + + Q+ G+ +
Sbjct: 203 DIESSNYESPYDQYLPSAPERTRRDTL-INESPALSYM--DLVGFSYQVANGMEFLASKN 259
Query: 128 VLHRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATK 185
+HRD+ N+LI EG L K+ DFGLAR D N + + + L + PE +
Sbjct: 260 CVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL- 317
Query: 186 YGPAVDMWSVGCIFAEL--LNGKP 207
Y D+WS G + E+ L G P
Sbjct: 318 YTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 30/119 (25%), Positives = 48/119 (40%), Gaps = 5/119 (4%)
Query: 96 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
L+D T + + Q+ G+ + +HRD+ N+L+ +K+ DFGLAR
Sbjct: 226 LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285
Query: 156 SFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 211
+D N W P + Y D+WS G + E+ + G PG
Sbjct: 286 DIMHDSNYVSKGSTFLPVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 5/91 (5%)
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
G+ Y Q +HRD+ N+L+ K+ADFGL+R T+ R+ W
Sbjct: 124 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWMAIES 182
Query: 179 LLLGATKYGPAVDMWSVGCIFAEL--LNGKP 207
L + Y D+WS G + E+ L G P
Sbjct: 183 --LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|216868 pfam02084, Bindin, Bindin | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 24/84 (28%), Positives = 30/84 (35%), Gaps = 2/84 (2%)
Query: 379 YGKPRGPPGGANRYPSGNQ--SGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANG 436
Y + P G YP+ Q GY N GG GG G P G G + G
Sbjct: 7 YPQAMNPQMGGGNYPAPGQPAQQGYANQGMGGPVGGGGGPGAGGGAPGGPVGGGGGGSGG 66
Query: 437 PRGPASGYGVGPQSYSQSGQYGNS 460
P G G + S+ Y +S
Sbjct: 67 PPGGGEVAGEAEDAMSEFDDYSSS 90
|
Length = 239 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 19/51 (37%), Positives = 28/51 (54%)
Query: 107 PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157
IK MK +LT L Y H + + H DIK N+++D + D+G+A F
Sbjct: 126 KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 31/111 (27%), Positives = 35/111 (31%), Gaps = 5/111 (4%)
Query: 368 PPVPGGPGHHHYGKPRGPPGGANRYPSGNQ--SGGYNNPNRGGQGGGYSNAPYPPQGRGP 425
P + + P NR NQ S G N RG G Y PQ G
Sbjct: 462 PQNQRRQQNRGRQSSQPPRQQQNRSNQNNQRQSQGPNQGPRGQGGYNLRPRTYQPQRYG- 520
Query: 426 PYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQ 476
G G N SG G Q Q GN + GP + G R Q
Sbjct: 521 --GGQGRRWNPNPYRQSGQGRSQQQQPQPEARGNQSRTPGPGRGQGGRGNQ 569
|
Length = 582 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 34/124 (27%), Positives = 53/124 (42%), Gaps = 8/124 (6%)
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITL 172
Q+ G++Y +++HRD+ N+L+ ++K+ DFGLA+ D +V
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 173 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPI--LPGKNEAEQLSKIFELCGSP 228
W +L Y D+WS G EL+ KP +P + L K L P
Sbjct: 177 WMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234
Query: 229 DETI 232
TI
Sbjct: 235 ICTI 238
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 23/92 (25%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT--L 172
Q+ G++Y ++++HR++ N+L+ ++ +++ADFG+A D + T
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 173 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN 204
W +L G +Y D+WS G E+++
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/117 (27%), Positives = 53/117 (45%), Gaps = 14/117 (11%)
Query: 113 MKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGN---LKLADFGLARSFSYDHNNTL 165
KQL + LHY +++H ++ G N+L+ NEG +KL+D G+ + +
Sbjct: 107 AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL-----SR 161
Query: 166 TNRVITLWYRPPELL-LGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSK 220
RV + + PE + G A D WS G E+ NG+ L + +E+
Sbjct: 162 EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 39/178 (21%), Positives = 78/178 (43%), Gaps = 28/178 (15%)
Query: 36 ITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 94
I + E ++K+ +V++L +V+ QG+P T ++ E M DL
Sbjct: 54 IEFLNEASVMKEFNCHHVVRLLGVVS--------QGQP--------TLVIMELMTRGDLK 97
Query: 95 GL--ADRPGLRFTVPQIKCYMKQLLT-------GLHYCHVNQVLHRDIKGSNLLIDNEGN 145
+ RP + Q +K+++ G+ Y + N+ +HRD+ N ++ +
Sbjct: 98 SYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157
Query: 146 LKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 202
+K+ DFG+ R + D+ ++ + + PE L + D+WS G + E+
Sbjct: 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 33/134 (24%), Positives = 57/134 (42%), Gaps = 18/134 (13%)
Query: 84 MVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMK---QLLTGLHYCHVNQVLHRDIKGSNL 138
+V E+ DL L G+ + Q + ++ +GL + H +H D+ N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 139 LIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPEL-------LLGA--TKYGP 188
+ + ++K+ D+GLA + D+ T + L + PEL LL TK
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKS- 190
Query: 189 AVDMWSVGCIFAEL 202
++WS+G EL
Sbjct: 191 --NIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 26/152 (17%), Positives = 55/152 (36%), Gaps = 26/152 (17%)
Query: 5 ISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
++V++ LK RE+ IL+ L + + K + +
Sbjct: 11 TNRVYLLGTKDED--YVLKINP----SREKGADREREVAILQLLARKGLPVPKVLASGES 64
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
G +Y++ E+++ L +++ I + +LL LH
Sbjct: 65 --------------DGWSYLLMEWIEGETLDEVSE-----EEKEDIAEQLAELLAKLHQL 105
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
+ + H D+ N+L+D+ L + D+ A
Sbjct: 106 PLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 30/206 (14%)
Query: 10 MAREIKTGEIVALKKIRMDNEKEGFP--ITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
AR+I GE ++ NE I + E ++K +V++L +V+
Sbjct: 26 NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS------ 79
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDH-DLTGL-------ADRPGLRF--TVPQIKCYMKQLL 117
+G+P T +V E M H DL A+ R T+ ++ ++
Sbjct: 80 --KGQP--------TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRP 176
G+ Y + + +HRD+ N ++ ++ +K+ DFG+ R + D+ ++ + +
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 177 PELLLGATKYGPAVDMWSVGCIFAEL 202
PE L + + DMWS G + E+
Sbjct: 190 PESLKDGV-FTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|219404 pfam07415, Herpes_LMP2, Gammaherpesvirus latent membrane protein (LMP2) protein | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 26/92 (28%), Positives = 33/92 (35%), Gaps = 9/92 (9%)
Query: 368 PPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPY 427
P GGP H G P G G +N Y + ++ P G P R PPY
Sbjct: 8 PLGAGGPRSH--GGPDGDEGDSNPYYPSSFGSSWDRP-----GPPVPEDYDAPSHRPPPY 60
Query: 428 AGAGMPANGPRGPASGYGVGPQSYSQSGQYGN 459
G+ +G P P Y+ GQ G
Sbjct: 61 GGSNGDRHGGYQPLGQQ--DPSLYAGLGQNGG 90
|
This family consists of several Gammaherpesvirus latent membrane protein (LMP2) proteins. Epstein-Barr virus is a human Gammaherpesvirus that infects and establishes latency in B lymphocytes in vivo. The latent membrane protein 2 (LMP2) gene is expressed in latently infected B cells and encodes two protein isoforms, LMP2A and LMP2B, that are identical except for an additional N-terminal 119 aa cytoplasmic domain which is present in the LMP2A isoform. LMP2A is thought to play a key role in either the establishment or the maintenance of latency and/or the reactivation of productive infection from the latent state. The significance of LMP2B and its role in pathogenesis remain unclear. Length = 489 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 481 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.46 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.21 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.9 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.86 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.62 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.25 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.99 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.95 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.92 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.82 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.76 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.74 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.69 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 97.66 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.6 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.5 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.49 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.44 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.42 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 97.42 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.33 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.27 | |
| PLN02236 | 344 | choline kinase | 97.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.22 | |
| KOG0921 | 1282 | consensus Dosage compensation complex, subunit MLE | 97.1 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.03 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.93 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.93 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.77 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.35 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.28 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.26 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.26 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.2 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.99 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.99 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.86 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.7 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-69 Score=532.93 Aligned_cols=311 Identities=66% Similarity=1.111 Sum_probs=299.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..||+.||||+++.+..++.+.....|||.||++|+|||||++.+++.+.. .+.+
T Consensus 128 GTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~--------------~~si 193 (560)
T KOG0600|consen 128 GTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL--------------SGSI 193 (560)
T ss_pred cchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC--------------CceE
Confidence 89999999999999999999999999999999999999999999999999999999998832 5789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|||||||++||..++......|++.+|++||+||+.||+|||++||+|||||.+|||||++|++||+|||+|+.+.....
T Consensus 194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999888777
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
..+++++.|+||+|||+|++...|+.++|+||+||||.||++|++.|.+.++.+++.+|+++|+.+.+..|+ ..++|.+
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~ 352 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHA 352 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcc
Confidence 889999999999999999999999999999999999999999999999999999999999999999999999 9999999
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCchHHHHHHHHHH
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKKRRQQ 322 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (481)
..+++....++.+.+.++.++..+++||..||.+||++|.||.++|.|+||+..+++|++..++.+..++++..|+++++
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~ 432 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQ 432 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCCCCcchhHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988887
Q ss_pred HHHHHH
Q 011627 323 QRQHEE 328 (481)
Q Consensus 323 ~~~~~~ 328 (481)
.++...
T Consensus 433 ~r~~~~ 438 (560)
T KOG0600|consen 433 KRRNKG 438 (560)
T ss_pred hhcccc
Confidence 765553
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-63 Score=463.57 Aligned_cols=296 Identities=48% Similarity=0.839 Sum_probs=273.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|+|+.|++.||+|+++++.+++.+....+|||.+|.+++|+|||.+.+++.-.. -+.+
T Consensus 87 GtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~--------------~d~i 152 (419)
T KOG0663|consen 87 GTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN--------------MDKI 152 (419)
T ss_pred CcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc--------------ccee
Confidence 89999999999999999999999999999999999999999999999999999999987532 5579
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|||||||+.||.+++.+-..+|+..++++++.|+|.||+|||.+.|+|||||++|+|+++.|.+||+|||+|+.+... .
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~ 231 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-L 231 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-c
Confidence 999999999999999988889999999999999999999999999999999999999999999999999999988743 4
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
..++..+.|+||+|||++++...|+.++||||+|||+.||+++++.|+++.+.+++.+|+.+++.+.+.+|++++.++..
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 56777888999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCchhhhhhHHHHHhh--hcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCchH
Q 011627 243 NHFKPSRTMKRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 313 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~--~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~~~~~~~~~~~~~~~ 313 (481)
..+.......+.++..|.. +++...+||+.+|.+||.+|+||+|+|+|.||...++++.+..++.+...++
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 7666655555666666654 4599999999999999999999999999999999999999999998876444
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-61 Score=439.20 Aligned_cols=289 Identities=43% Similarity=0.774 Sum_probs=266.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|+|.+||+.||||+|+..+.++.....++|||+.|+.++|+|||.++++|.. .+.+
T Consensus 13 G~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~----------------~~~l 76 (318)
T KOG0659|consen 13 GTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH----------------KSNL 76 (318)
T ss_pred cceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC----------------CCce
Confidence 899999999999999999999999998888888999999999999999999999999987 7789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
.||+||++.||...+......|+...++.|+.+++.||+|||++.|+||||||+|+||+.+|.+||+|||+|+.+....
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 9999999999999999998899999999999999999999999999999999999999999999999999999987543
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
...+..+.|.+|+|||++.+...|+..+||||+|||+.||+.+.+.|++.++.+++..|++.++.|.+..|++++.+++|
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 33444578999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYES 310 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~~~~~~~~~~~~ 310 (481)
..++..... ....+|...++++.|||.+||..||.+|+|+.|+|+|+||+..+.++.+..++.-..
T Consensus 236 ~~~~~~P~~--~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 236 VKIQQFPKP--PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred HHHhcCCCC--ccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence 887732221 222377888999999999999999999999999999999999999988888776544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-59 Score=434.27 Aligned_cols=274 Identities=37% Similarity=0.648 Sum_probs=241.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|+++.||+.||||++....+.+...+.++|||++|++|+|+|+|.++++|.. +..+
T Consensus 13 GSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr----------------krkl 76 (396)
T KOG0593|consen 13 GSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR----------------KRKL 76 (396)
T ss_pred CcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh----------------ccee
Confidence 899999999999999999999998776666677788999999999999999999999987 7899
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
+||||||+.+.+..+.+....++...++.|+.|++.|+.|||++++||||||||||||+.++.+||||||+|+.+.. ..
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 99999999999988888777799999999999999999999999999999999999999999999999999998764 55
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
...+.++.|.||+|||++.++..|+.++||||+||++.||++|.+.|++.++.+++..|...++........-+++.+.+
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 67788999999999999999999999999999999999999999999999999999999999888754433333333333
Q ss_pred ccCC-CchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 243 NHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.-.. +.......+...+.+++..++||+++||.+||++|++.+++|.|+||
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 2222 22223344556667888899999999999999999999999999999
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-58 Score=448.09 Aligned_cols=276 Identities=36% Similarity=0.629 Sum_probs=246.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||+|+.+.+++.||||.++.....- ....-+||++.|++|+ |||||++++++.+. +.+
T Consensus 21 GTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~---------------~~~ 84 (538)
T KOG0661|consen 21 GTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDN---------------DRI 84 (538)
T ss_pred CcceeEEEeeecCCCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhcc---------------Cce
Confidence 899999999999999999999998664332 2234469999999998 99999999999883 338
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+|+|||||+++|..++..++..|++..|+.||.||++||+|+|.+|+.|||||||||||.....|||+|||+|+.+. .
T Consensus 85 L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--S 162 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR--S 162 (538)
T ss_pred EeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--c
Confidence 99999999999999999998889999999999999999999999999999999999999988899999999999875 4
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
....+.++.|.||+|||+|+....|+.++||||+|||++|+.+-+++|++.++.+++.+|+++++.+....|+.-..+..
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 45678889999999999999989999999999999999999999999999999999999999999999999987544444
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
..+++........+..+....+.++.+||.+||..||++||||+++|+||||...
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 4444444444556677777899999999999999999999999999999999653
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-55 Score=418.28 Aligned_cols=283 Identities=46% Similarity=0.813 Sum_probs=254.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCC-ccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN-VIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpn-Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.||+.||||+++.+.+.+......++|+.+|++|+|+| ||++++++..... ..-...
T Consensus 22 Gtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~----------~~~~~~ 91 (323)
T KOG0594|consen 22 GTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN----------HRGIGK 91 (323)
T ss_pred CCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc----------ccccce
Confidence 89999999999999999999999999877888889999999999999999 9999999987321 112458
Q ss_pred EEEEEecCCCChhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 82 TYMVFEYMDHDLTGLADRPG---LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~---~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
++|||||++-||..++.... ..++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+|+.+.
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 99999999999999888765 458888999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. ....+..+.|.+|+|||++.+...|+..+||||+|||++||+++++.|++.++.+++.+|++..+.+.+..|+++..
T Consensus 172 ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 172 IP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred CC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 33 34467778899999999999988899999999999999999999999999999999999999999999999999999
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
++.+...-......+.+....+..+....||+.+||..||.+|.|++.+|.|+||...
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 9988764444444566777777888899999999999999999999999999999653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-55 Score=439.99 Aligned_cols=248 Identities=29% Similarity=0.459 Sum_probs=219.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+|++||.+++..+|+.||+|+|.+.. .+.....++.+||+|++.|+|||||+|+++|++ .++
T Consensus 29 GgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED----------------s~n 92 (592)
T KOG0575|consen 29 GGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED----------------SNN 92 (592)
T ss_pred CcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec----------------CCc
Confidence 899999999999999999999998753 344556788899999999999999999999998 779
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+|||+|+|....+..+.+....++|.+++.|++||+.||.|||+++|||||||..||||+++.+|||+|||+|+.+..+.
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999965555555566789999999999999999999999999999999999999999999999999999886443
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
+...+.|||+.|+||||+.. ..++..+||||+|||+|.||+|++||..++-.+++.+|.......+
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P------------ 238 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP------------ 238 (592)
T ss_pred -cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc------------
Confidence 44556899999999999985 6789999999999999999999999999999999999965332221
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~ 298 (481)
..++.+++|||++||+.||.+|||+++||+|+||+..-.
T Consensus 239 ------------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 239 ------------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFT 277 (592)
T ss_pred ------------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCc
Confidence 257889999999999999999999999999999965543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-56 Score=426.87 Aligned_cols=251 Identities=32% Similarity=0.465 Sum_probs=211.3
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCC-----CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKE-----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~-----~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
-|+||.|-+|.++.|++.||||++++..... .....+.+|++||++|+|||||+++++|..
T Consensus 182 sGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-------------- 247 (475)
T KOG0615|consen 182 SGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-------------- 247 (475)
T ss_pred CCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--------------
Confidence 3899999999999999999999998764222 123345699999999999999999999998
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC---CCeEEeccc
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE---GNLKLADFG 152 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~---~~vkL~DFG 152 (481)
.+..||||||++| +|.+.+..+ ..+.++..+.+++|||.||.|||++||+||||||+||||..+ -.+||+|||
T Consensus 248 --~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 248 --PDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred --CCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 5578999999996 676666654 468999999999999999999999999999999999999876 459999999
Q ss_pred ccccccCCCCCccccccccccCCCchhhcCC--CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCC
Q 011627 153 LARSFSYDHNNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSKIFELCGSPD 229 (481)
Q Consensus 153 ~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~~~ 229 (481)
+|+... ....+.+.|||+.|.||||+.+. ..+..++||||||||||.+|+|.+||....... +.++|........
T Consensus 325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 998875 34567778999999999999763 235568999999999999999999998876555 6666755433322
Q ss_pred CCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 230 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
. ..|..++.++++||.+||..||++|+|+.|+|+||||+..+
T Consensus 403 p--------------------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 403 P--------------------------LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred C--------------------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 2 34567899999999999999999999999999999997643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=413.97 Aligned_cols=282 Identities=39% Similarity=0.650 Sum_probs=241.6
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|+||.|+.|.++.||+.||||++.......-..++.+||+++|+.++|+|||.+++++..+.. ..-+.
T Consensus 32 ~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~-----------~~f~D 100 (359)
T KOG0660|consen 32 RGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR-----------DKFND 100 (359)
T ss_pred CcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc-----------cccce
Confidence 3899999999999999999999998665566667788999999999999999999999987322 22457
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC-
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD- 160 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~- 160 (481)
+|+|+|+|+.||...+.... .|+++.++.++.|||.||+|+|+.+|+||||||+|+|++.+..+||||||+|+.....
T Consensus 101 vYiV~elMetDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHHhhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999999999998887653 4999999999999999999999999999999999999999999999999999987432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
....++.++.|.+|+|||+++....|+.++||||+||||+||++|++.|++++..+++..|.+..+.+.+..+..+....
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 23456788889999999999988899999999999999999999999999999999999999999999776655444211
Q ss_pred c--cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 241 A--YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 241 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
. |....+ .........++++.++.++|||++||.+||.+|+|++|+|+||||..-
T Consensus 260 ar~yi~slp-~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 260 ARPYIKSLP-QIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHhCC-CCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 1 111111 122345677888999999999999999999999999999999999643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-53 Score=405.52 Aligned_cols=244 Identities=29% Similarity=0.420 Sum_probs=209.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC-e
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG-S 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~-~ 81 (481)
|..|+||+|+|+.|++.+|+|+|.... .+...+++.+|++|+++++||+||++|+.|.+ ++ .
T Consensus 90 G~gG~V~kv~Hk~t~~i~AlK~I~~~~-~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~----------------~~~~ 152 (364)
T KOG0581|consen 90 GNGGTVYKVRHKPTGKIYALKVILLNI-DPALQKQILRELEILRSCQSPYIVGFYGAFYS----------------NGEE 152 (364)
T ss_pred CCCcEEEEEEEcCCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe----------------CCce
Confidence 778999999999999999999995543 34467789999999999999999999999998 44 5
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
++|+||||+++.++.+...-++++|..+..|++++|+||.|||+ ++||||||||+||||+..|+|||||||.+..+...
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999975555555544679999999999999999999995 89999999999999999999999999999887533
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHhcCCCCCCCCcc
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-----NEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
...+++||..|||||.+.+ ..|+.++||||||++++||++|+.||... +..+++..|+. .+++..
T Consensus 233 ---~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP~l--- 302 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPPRL--- 302 (364)
T ss_pred ---hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCCCC---
Confidence 5567899999999999998 68999999999999999999999999875 44455555543 222111
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
|. ..|++++++||.+||++||.+|+|+.|+|+|||++.
T Consensus 303 ----P~------------------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 303 ----PE------------------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred ----Cc------------------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 10 138899999999999999999999999999999965
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-54 Score=390.30 Aligned_cols=289 Identities=51% Similarity=0.911 Sum_probs=256.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||+||+|+++.+++.||+|++-++++++.+.+..++|+++|..|+|+||+.+++++.....- .+.....+
T Consensus 28 GtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp--------~~r~r~t~ 99 (376)
T KOG0669|consen 28 GTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP--------TNRDRATF 99 (376)
T ss_pred chHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC--------ccccccee
Confidence 8899999999999999999999999999999999999999999999999999999998774322 12346789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||++|+.||..++.+...+|+..+|+.+++++++||.|+|.+.|+|||+|++|+||+.++.+||+|||+++.+....+
T Consensus 100 ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n 179 (376)
T KOG0669|consen 100 YLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKN 179 (376)
T ss_pred eeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccc
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999987764332
Q ss_pred ---CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 163 ---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 163 ---~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
...++++.|++|++||.+++...|+.+.|||..|||+.||+++.+.|.++++..++..|..+|++.....||++.++
T Consensus 180 ~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~l 259 (376)
T KOG0669|consen 180 VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNL 259 (376)
T ss_pred cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccc
Confidence 34677888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCchhhh---hhHHHHHh--hhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 011627 240 PAYNHFKPSRTMK---RRVREVFR--HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299 (481)
Q Consensus 240 ~~~~~~~~~~~~~---~~~~~~~~--~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~ 299 (481)
+.+.....+..-+ +.+....+ .-++++.|||.+||..||.+|+++.++|+|.|||.++.+
T Consensus 260 pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 260 PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 9887764332111 22222222 125689999999999999999999999999999998776
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=361.92 Aligned_cols=275 Identities=43% Similarity=0.812 Sum_probs=251.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++.+|++.||+|.++.+...+.....+++||.+|+.|+|.|||+++++..+ ++.+
T Consensus 13 gtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs----------------dkkl 76 (292)
T KOG0662|consen 13 GTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----------------DKKL 76 (292)
T ss_pred CcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc----------------Ccee
Confidence 899999999999999999999999999999999999999999999999999999999887 7789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
.+|+|||+.+|..++...++.++.+.++.++.|++.||.|||+++++||||||.|+||+.+|++||+|||+|+.+....
T Consensus 77 tlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999886432
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
......+.|.+|++|.++.+.+-|+.+.|+||.|||+.|+.. |++.|++++.++++.+|+...+.+.+..|+++.+++.
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 233344669999999999998889999999999999999986 8999999999999999999999999999999999998
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
|..... ......+..+.++++..-+||+.++|..+|.+|++++++|+|+||..
T Consensus 236 yk~yp~-ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 236 YKPYPI-YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CcccCC-ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 765432 22334556667788889999999999999999999999999999953
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=410.14 Aligned_cols=245 Identities=32% Similarity=0.488 Sum_probs=218.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+|++|++++|++.||||++.+.. .++....-+.+|-.+|.+| .||.||+||-.|++ +.
T Consensus 84 GSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD----------------~~ 147 (604)
T KOG0592|consen 84 GSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD----------------EE 147 (604)
T ss_pred ccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec----------------cc
Confidence 899999999999999999999998663 3344456677899999999 89999999999998 77
Q ss_pred eEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|+|+||+. |+|++++.+- +.|++..++.|+.+|+.||+|||++|||||||||||||||.++++||.|||.|+.+..
T Consensus 148 sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 8999999998 5888888765 4799999999999999999999999999999999999999999999999999998753
Q ss_pred CCCC------------ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 011627 160 DHNN------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 227 (481)
Q Consensus 160 ~~~~------------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 227 (481)
.... ...+++||..|++||+|.. ...+..+|||+||||||.|+.|.+||.+.++..++++|+++...
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 2211 1256899999999999986 78899999999999999999999999999999999999987544
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 228 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+ +.|++.++|||+++|..||++|+|+.+|.+||||..
T Consensus 306 fp------------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 306 FP------------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CC------------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 33 257789999999999999999999999999999954
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=392.74 Aligned_cols=246 Identities=29% Similarity=0.438 Sum_probs=214.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC-CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+++.+.|++.||+|++++....+ ......+.|..||.+++||+||+++..|++ .+.
T Consensus 36 G~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt----------------~~k 99 (357)
T KOG0598|consen 36 GSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT----------------EEK 99 (357)
T ss_pred cCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc----------------CCe
Confidence 899999999999999999999998774332 346678899999999999999999999998 779
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+|||+||+.|+.+....++.+.|+|+.++.|+..|+.||.|||++|||||||||||||||.+|+|+|+|||+|+.....
T Consensus 100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~- 178 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD- 178 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence 9999999997555555555568999999999999999999999999999999999999999999999999999865433
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.....+.|||+.|||||++.+ ..|+.++|.|||||++|||++|.+||.+.+...+.++|.......
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~------------- 244 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL------------- 244 (357)
T ss_pred CCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC-------------
Confidence 334445799999999999997 689999999999999999999999999999999999997542111
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI----SAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~----sa~eiL~h~~f~~ 295 (481)
....++.+++|||+++|+.||++|. .+.+|-+|+||..
T Consensus 245 ----------------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 245 ----------------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred ----------------CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 1123778999999999999999996 7999999999954
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=396.42 Aligned_cols=248 Identities=30% Similarity=0.483 Sum_probs=214.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+|++||+|++++++..||||.|.+........+.+.+||+||+.|+|||||.++++++. .+.+
T Consensus 21 GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~----------------~~~i 84 (429)
T KOG0595|consen 21 GSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED----------------DDFI 84 (429)
T ss_pred cceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec----------------CCeE
Confidence 899999999999999999999999886555567778899999999999999999999998 6799
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC------CCeEEecccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE------GNLKLADFGLAR 155 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~------~~vkL~DFG~a~ 155 (481)
|||||||+| ||..++.+. +.+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+
T Consensus 85 ~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999995 666666554 479999999999999999999999999999999999999875 358999999999
Q ss_pred cccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.+. ......+.||++.|||||++.. ..|+.|+|+||+|+|||+|++|++||...+..+.+..+......
T Consensus 164 ~L~--~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~-------- 232 (429)
T KOG0595|consen 164 FLQ--PGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI-------- 232 (429)
T ss_pred hCC--chhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc--------
Confidence 876 3445566799999999999975 68999999999999999999999999999999988866432111
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
+..+...++..+.+|+..+|..|+.+|.+..+-+.|++++.++
T Consensus 233 -------------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 233 -------------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred -------------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 1112234566788999999999999999999999999998765
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-51 Score=380.60 Aligned_cols=282 Identities=39% Similarity=0.717 Sum_probs=239.4
Q ss_pred cceeEEEEEEEccCCc----EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||.||+|..+.++. .+|||+++-+.+...+...+.||+.+++.|+|+|||.+..+|.+ +
T Consensus 35 GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~---------------~ 99 (438)
T KOG0666|consen 35 GTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS---------------H 99 (438)
T ss_pred cccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc---------------c
Confidence 8999999998776654 78999999887777788889999999999999999999999976 3
Q ss_pred CCeEEEEEecCCCChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC----CCeEEec
Q 011627 79 RGSTYMVFEYMDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE----GNLKLAD 150 (481)
Q Consensus 79 ~~~~~iV~Ey~~g~L~~~~~~----~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~----~~vkL~D 150 (481)
+..++|++||.+.||+..+.- ....++...++.|++||+.|++|||++=|+||||||+||||..+ |.|||+|
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 678999999999999987763 22358889999999999999999999999999999999999887 8899999
Q ss_pred ccccccccCCCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 011627 151 FGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLS 219 (481)
Q Consensus 151 FG~a~~~~~~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---------~~~~~ 219 (481)
||+|+.+..... ......+.|.+|+|||++++...|+.++||||+|||+.|||+-++.|.+..+ .+++.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999998875432 2334456699999999999999999999999999999999999999987543 47899
Q ss_pred HHHHhcCCCCCCCCccCCCCCccccCCCc----hhhhhhHHH---HHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 011627 220 KIFELCGSPDETIWPGVSKMPAYNHFKPS----RTMKRRVRE---VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292 (481)
Q Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~---~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~ 292 (481)
+|+++++.+.+..|+...++|++...... ......+.. ..+.-++.+.+||.+||..||.+|+|++++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 99999999999999999999988432211 111111222 22345667999999999999999999999999999
Q ss_pred CCCCCCC
Q 011627 293 FWTDPLP 299 (481)
Q Consensus 293 f~~~~~~ 299 (481)
|++++++
T Consensus 340 F~~d~lp 346 (438)
T KOG0666|consen 340 FTEDPLP 346 (438)
T ss_pred cccCCCC
Confidence 9999776
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-50 Score=403.37 Aligned_cols=246 Identities=33% Similarity=0.488 Sum_probs=216.0
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcC---CCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEK---EGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
-|+||+|++|++..+++.||||+++..... ......+.+|+.++++++ ||||+++++++..
T Consensus 27 ~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--------------- 91 (370)
T KOG0583|consen 27 SGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--------------- 91 (370)
T ss_pred CCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec---------------
Confidence 388999999999999999999988765222 133556678999999999 9999999999998
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCeEEecccccc
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLAR 155 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~ 155 (481)
...+|||||||.+ +|++.+.+ ..++.|.+++.+|+||+.||+|||++||+|||||||||||+.+ +++||+|||++.
T Consensus 92 -~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 92 -PTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred -CCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 5579999999996 89998888 6789999999999999999999999999999999999999999 999999999998
Q ss_pred cccCCCCCccccccccccCCCchhhcCCC-CCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
... .....+.+.|||+.|+|||++.+.. +.+.++||||||||||.|++|+.||...+...++.+|.......+
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p----- 243 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP----- 243 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC-----
Confidence 764 3456778899999999999999865 446899999999999999999999999998888888754322111
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhh-cHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHF-DRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..+ +.++++||++||..||.+|+|+.+|++|+||+.
T Consensus 244 -------------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 -------------------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 124 789999999999999999999999999999987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=408.71 Aligned_cols=246 Identities=30% Similarity=0.451 Sum_probs=218.2
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecC-CcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~-~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
.|+-|.|-+|+|.+||+.+|||+|.+. .........+.+||-||+.|.||||+++|++|++ +.
T Consensus 22 ~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~----------------~~ 85 (786)
T KOG0588|consen 22 KGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN----------------KQ 85 (786)
T ss_pred CCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc----------------Cc
Confidence 477889999999999999999999877 4444556678899999999999999999999998 78
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
++|+|+||+.+ .|++++.+. +.|++.++.++++||+.||.|||..+|+||||||+|+|||.+++|||+|||+|..-
T Consensus 86 ~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-- 162 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE-- 162 (786)
T ss_pred eEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc--
Confidence 99999999986 566665554 57999999999999999999999999999999999999999999999999999753
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.....+.+.||++.|.|||++.+..+.+.++||||||||||.||+|+.||++.|-..++.++.......+
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP---------- 232 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP---------- 232 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----------
Confidence 3456677889999999999999977788999999999999999999999999999998888865433322
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
..++.++.+||++||..||++|+|.+||++|||+..-
T Consensus 233 --------------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 233 --------------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred --------------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 2588899999999999999999999999999999643
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=411.04 Aligned_cols=272 Identities=32% Similarity=0.541 Sum_probs=222.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-C-----CCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-H-----ENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-h-----pnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+|.+|.|..|++.||||+|+. ...+..+...|+.||..|+ | -|||+++++|..
T Consensus 197 GtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-------------- 259 (586)
T KOG0667|consen 197 GSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-------------- 259 (586)
T ss_pred cccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--------------
Confidence 8999999999999999999999984 3446778889999999997 4 389999999986
Q ss_pred CcCCeEEEEEecCCCChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC--CeEEecccc
Q 011627 77 KYRGSTYMVFEYMDHDLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG--NLKLADFGL 153 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g~L~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~--~vkL~DFG~ 153 (481)
.+++|||+|+++.+|.+++..+.. .|+...++.|+.|||.+|.+||+++|||+|||||||||.+-+ .|||+|||.
T Consensus 260 --r~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 260 --RNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred --ccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 889999999999999999987654 499999999999999999999999999999999999997644 599999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
|+... ....+++.+..|+||||+++ ..|+.++||||||||++||++|.++|++.++.+++..|+++.+.++...+
T Consensus 338 Sc~~~----q~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 338 SCFES----QRVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred ccccC----Ccceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98753 22336788999999999998 78999999999999999999999999999999999999999998875443
Q ss_pred ccCCCCCccccC-------CCchh-------------------------hhhhHHHHHh-hhcHHHHHHHHHhcccCCCC
Q 011627 234 PGVSKMPAYNHF-------KPSRT-------------------------MKRRVREVFR-HFDRHALELLEKMLMLDPSQ 280 (481)
Q Consensus 234 ~~~~~~~~~~~~-------~~~~~-------------------------~~~~~~~~~~-~~~~~~~~ll~~~L~~dP~~ 280 (481)
....+...+.+. ..+.. ..+.+..... .-...++|||++||..||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 322211100000 00000 0011111222 23456799999999999999
Q ss_pred CCCHHHHhcCCCCCCCCC
Q 011627 281 RISAKDALDSEYFWTDPL 298 (481)
Q Consensus 281 R~sa~eiL~h~~f~~~~~ 298 (481)
|+|+.++|+||||+...+
T Consensus 493 R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 493 RITPAQALNHPFLTGTSL 510 (586)
T ss_pred cCCHHHHhcCcccccccc
Confidence 999999999999976433
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-51 Score=388.86 Aligned_cols=272 Identities=35% Similarity=0.595 Sum_probs=226.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|+..++++.||||++-.+..- --+|+.||++++|||||++..+|...... ..-++
T Consensus 35 GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~-----------d~~~l 97 (364)
T KOG0658|consen 35 GSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTES-----------DEVYL 97 (364)
T ss_pred cccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCC-----------chhHH
Confidence 89999999999999999999998654321 12899999999999999999999874321 13467
Q ss_pred EEEEecCCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCeEEeccccccccc
Q 011627 83 YMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~ 158 (481)
.+||||+..+|...+.. .+.+++.-.++.+++||+.||.|||+.+|+||||||.|||+|.+ +.+||||||.|+.+.
T Consensus 98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 89999999999887773 45678999999999999999999999999999999999999976 889999999999875
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .+...++.+|..|+|||++.+...|+.++||||+|||+.||+.|++.|++++..+++..|+++.+.+.......+..
T Consensus 178 ~--~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 178 K--GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred c--CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 3 44457789999999999999999999999999999999999999999999999999999999999987654333221
Q ss_pred CCccccCCCchhhhhhHH-HHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVR-EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+..++...-...... .+....++++.||+.++|..+|++|.++.|+|.|+||..
T Consensus 256 --~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 256 --NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred --ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 1122221111111121 355778999999999999999999999999999999953
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=373.00 Aligned_cols=247 Identities=28% Similarity=0.406 Sum_probs=219.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||.|+++.+..||+.+|+|+|+.........+.+.+|+.|-+.|+||||+++.+.+.+ .+..
T Consensus 22 G~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~----------------~~~~ 85 (355)
T KOG0033|consen 22 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----------------ESFH 85 (355)
T ss_pred CchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc----------------ccee
Confidence 899999999999999999999998776555566788999999999999999999999887 6788
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~ 158 (481)
|||||+++| +|.+.+... .-++|..+..+++|||++|.|||.++|||||+||+|+||.... -|||+|||+|..+.
T Consensus 86 ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997 565555544 4589999999999999999999999999999999999996544 49999999998876
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.......++||+.|||||++.. .+|+..+|||++|||||.||.|.+||.+.+...++++|.......+...|+
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~---- 237 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD---- 237 (355)
T ss_pred --CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC----
Confidence 3445566889999999999986 689999999999999999999999999999999999998876666655554
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
++++++++||++||..||++|+|+.|+|+|||++.
T Consensus 238 ----------------------~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 238 ----------------------TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ----------------------cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 57889999999999999999999999999999954
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=385.45 Aligned_cols=273 Identities=42% Similarity=0.791 Sum_probs=229.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++..... .....+.+|+.++++|+|+||+++++++.. ...+
T Consensus 16 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~ 78 (288)
T cd07871 16 GTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT----------------ERCL 78 (288)
T ss_pred CCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC----------------CCeE
Confidence 89999999999999999999999765422 234467799999999999999999999976 5689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+.++|.+.+......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 79 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-~ 157 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-T 157 (288)
T ss_pred EEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC-C
Confidence 999999999998888766666899999999999999999999999999999999999999999999999999764322 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......+|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..++...+.+....|+.......+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 22334567999999999876567899999999999999999999999999999999999999999888888876654433
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
...................++.+++|||++||..||++|+|++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 322211111122223345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-50 Score=370.36 Aligned_cols=243 Identities=28% Similarity=0.413 Sum_probs=213.7
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
.|+||.|.+++++.++..+|+|++++... +-...+...+|..||+.+.||++++++..|.+ ..
T Consensus 54 tGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d----------------~~ 117 (355)
T KOG0616|consen 54 TGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD----------------NS 117 (355)
T ss_pred cCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc----------------CC
Confidence 48999999999999999999999987642 22234566789999999999999999999988 77
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
.+||||||+.|+.+..+.+..++|++..++.++.||+.||+|||+++|++|||||||||||.+|.+||+|||+|+....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 9999999999865555555556899999999999999999999999999999999999999999999999999987642
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
..-+.|||+.|+|||++.. +.|+.++|.|||||++|||+.|.+||...+...++++|++..-.
T Consensus 197 ---rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~------------- 259 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK------------- 259 (355)
T ss_pred ---cEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc-------------
Confidence 2445799999999999987 78999999999999999999999999999999999999864322
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
+...++.+++|||+++|+.|-.+|. -..||..|+||..
T Consensus 260 -----------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 260 -----------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred -----------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 1235888999999999999999994 5679999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=367.75 Aligned_cols=237 Identities=28% Similarity=0.427 Sum_probs=204.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceee-EEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE-IVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~-~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..|++.||+|.|...............|+.+|++|+|||||++++ .|.+ .+..
T Consensus 30 GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~---------------~~ev 94 (375)
T KOG0591|consen 30 GSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE---------------DNEV 94 (375)
T ss_pred CcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc---------------cchh
Confidence 89999999999999999999999977666666778889999999999999999998 4443 1445
Q ss_pred EEEEEecCC-CChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCcEEEcCCCCeEEecccc
Q 011627 82 TYMVFEYMD-HDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHV--NQ--VLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 82 ~~iV~Ey~~-g~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~--~g--iiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
++||||||+ |||...+. +....++|..+|.++.||+.||..||. .. |+||||||.||+|+.+|.|||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 899999998 57766554 355679999999999999999999999 45 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
++.+... .....+.+||+.||+||++.. ..|+.++|||||||++|||+.-.+||.+.+-.++..+|......+-
T Consensus 175 ~r~l~s~-~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~---- 248 (375)
T KOG0591|consen 175 GRFLSSK-TTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL---- 248 (375)
T ss_pred HhHhcch-hHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC----
Confidence 9988643 344566899999999999987 7899999999999999999999999999988888888865422111
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 284 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa 284 (481)
| -..+|..+..||..||..|++.||+.
T Consensus 249 ------p------------------~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 249 ------P------------------DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ------c------------------HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 1 03588899999999999999999985
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=386.11 Aligned_cols=250 Identities=30% Similarity=0.461 Sum_probs=211.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||+|+.+.||++||+|++++.. ...+.+..++.|-.||...++++||++|..|++ ..+
T Consensus 152 GAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD----------------~~~ 215 (550)
T KOG0605|consen 152 GAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD----------------KEY 215 (550)
T ss_pred ccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC----------------CCe
Confidence 899999999999999999999998774 334456778889999999999999999999998 779
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.| |+..++.+. ..|+++.++.|+.+++.||+.||++|+|||||||+|+|||..|+|||+|||++..+...
T Consensus 216 LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999986 666666654 47999999999999999999999999999999999999999999999999999643210
Q ss_pred C-----------------------C---C--------------------ccccccccccCCCchhhcCCCCCCCCCchhh
Q 011627 161 H-----------------------N---N--------------------TLTNRVITLWYRPPELLLGATKYGPAVDMWS 194 (481)
Q Consensus 161 ~-----------------------~---~--------------------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwS 194 (481)
. . . ...+.+||+-||||||+.+ ..|+..+|.||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHH
Confidence 0 0 0 0113488999999999998 57999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhc
Q 011627 195 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKML 274 (481)
Q Consensus 195 lGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 274 (481)
||||+||||.|.+||.+.+..++..+|+.. ......|.. ..++++++|||.+||
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nw---------r~~l~fP~~-----------------~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNW---------RETLKFPEE-----------------VDLSDEAKDLITRLL 427 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHH---------hhhccCCCc-----------------CcccHHHHHHHHHHh
Confidence 999999999999999999999999999753 222222211 135689999999999
Q ss_pred ccCCCCCC---CHHHHhcCCCCCCCC
Q 011627 275 MLDPSQRI---SAKDALDSEYFWTDP 297 (481)
Q Consensus 275 ~~dP~~R~---sa~eiL~h~~f~~~~ 297 (481)
. ||++|+ .++||.+||||+...
T Consensus 428 ~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 428 C-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred c-CHHHhcCcccHHHHhcCCccccCC
Confidence 9 999998 599999999996543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=379.85 Aligned_cols=275 Identities=41% Similarity=0.744 Sum_probs=224.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...... ....+.+|+.+++.++|+||+++++++.+ ...+
T Consensus 16 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~ 78 (303)
T cd07869 16 GSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHT----------------KETL 78 (303)
T ss_pred cCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEec----------------CCeE
Confidence 789999999999999999999997654322 33467799999999999999999999987 5689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+.++|.+.+......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 157 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-S 157 (303)
T ss_pred EEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-C
Confidence 999999999999888776667999999999999999999999999999999999999999999999999998754322 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-EAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......+|+.|+|||++.+...++.++||||||||+|+|++|..||.+.. ..+.+..++...+.+....|+.....+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 233445779999999998775668899999999999999999999998754 4567777777777777777877655443
Q ss_pred cccCCCchhhhhhHHHHHh--hhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFR--HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+............+...+. .+++++++||.+||+.||++|+|++|+|+|+||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 3221111111222222222 24678999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=380.01 Aligned_cols=252 Identities=30% Similarity=0.436 Sum_probs=210.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC------------CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE------------GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 70 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~------------~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~ 70 (481)
|.||.|.+|++..+++.||||++.+..... ...+++.+||.||++|.|+|||+++++..++.
T Consensus 108 G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~------ 181 (576)
T KOG0585|consen 108 GQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE------ 181 (576)
T ss_pred CccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc------
Confidence 899999999999999999999997553211 11247789999999999999999999998765
Q ss_pred CCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEec
Q 011627 71 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 150 (481)
Q Consensus 71 ~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 150 (481)
...+|||+|||..+-....-.....|++.+++.|++.++.||+|||..|||||||||+|+||+++|+|||+|
T Consensus 182 --------s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 182 --------SDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred --------cCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 668999999999655544433333399999999999999999999999999999999999999999999999
Q ss_pred ccccccccC----CCCCccccccccccCCCchhhcCC---CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 011627 151 FGLARSFSY----DHNNTLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 223 (481)
Q Consensus 151 FG~a~~~~~----~~~~~~~~~~gt~~Y~aPEvl~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 223 (481)
||.+..+.. .....+...+||+.|+|||++.+. ...+.+.|||||||+||.|+.|+.||-++...+++.+|.+
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 999986622 222344457899999999998762 3457899999999999999999999999999999999975
Q ss_pred hcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 224 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.--..++ .+.+..+++|||.+||.+||++|+++.||..|||...+
T Consensus 334 ~pL~fP~----------------------------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DPLEFPE----------------------------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred CcccCCC----------------------------cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 3211111 11356789999999999999999999999999999654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-49 Score=390.16 Aligned_cols=245 Identities=29% Similarity=0.484 Sum_probs=219.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+++.+.|.+.||||++.+....+.....+.+|++|+++|+|||||.+++.|+. ..++
T Consensus 13 Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt----------------~~~~ 76 (808)
T KOG0597|consen 13 GSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET----------------SAHL 76 (808)
T ss_pred CccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc----------------cceE
Confidence 899999999999999999999999887666667788999999999999999999999988 7799
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+|+|||.|+|..++.. +..++|+.++.|+.+++.||.|||+++|+|||+||.||||+..+.+|+||||+|+.+.. ..
T Consensus 77 ~vVte~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred EEEehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 99999999988777654 45799999999999999999999999999999999999999999999999999998763 34
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
...+...||+.|||||++.+ ..|+..+|+||||||+|||++|++||....-....+.|... +..|+.
T Consensus 155 ~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-----~v~~p~------- 221 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-----PVKPPS------- 221 (808)
T ss_pred eeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-----CCCCcc-------
Confidence 45667789999999999986 78999999999999999999999999998888888877542 222321
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
..+..+++||..+|.+||.+|+|..+++.|+|.+..
T Consensus 222 ------------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 222 ------------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ------------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 467789999999999999999999999999998654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=375.76 Aligned_cols=274 Identities=37% Similarity=0.647 Sum_probs=220.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++...........+.+|+.++++++|+||+++++++.. .+.+
T Consensus 12 g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 75 (287)
T cd07848 12 GAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR----------------RGKL 75 (287)
T ss_pred cCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec----------------CCEE
Confidence 789999999999999999999998765555556678899999999999999999999976 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++++..+......+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++..+.....
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999988877766556799999999999999999999999999999999999999999999999999987654333
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.+..+......+......+.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 33444578999999999986 56899999999999999999999999998888877777666555433222221111111
Q ss_pred ccCCC--chhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 243 NHFKP--SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 243 ~~~~~--~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..... ..............++.++++||++||+.||++|+|++++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 10000 0000111223345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=386.61 Aligned_cols=244 Identities=29% Similarity=0.529 Sum_probs=212.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+-|.||.|+.+.+++.||||.+++..... .+.+++|+.+|+.++|+|||++++.|.. .+.+
T Consensus 284 gaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv----------------~deL 345 (550)
T KOG0578|consen 284 GATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLV----------------GDEL 345 (550)
T ss_pred ccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcc----------------ccee
Confidence 778999999999999999999998875443 3467899999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+|||||++ +|.+.+... .|+|.+|..|++.+|.||+|||.++|+|||||.+|||++.+|+|||+|||++..+....
T Consensus 346 WVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999996 555555443 49999999999999999999999999999999999999999999999999998876544
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
. ...+.+||+.|||||++.. +.|++++||||||+++.||+.|++||-..+....+..|... +.+...
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk---------- 490 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK---------- 490 (550)
T ss_pred C-ccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC----------
Confidence 3 4566799999999999986 78999999999999999999999999998888888777542 222111
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...++|.+++|||.+||+.|+++|++|.|||+||||..
T Consensus 491 ----------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 ----------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ----------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 12368899999999999999999999999999999943
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=370.87 Aligned_cols=250 Identities=30% Similarity=0.506 Sum_probs=203.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++.++++++.+|||.+....... ...+.+|+.+|++|+|+|||++++...... ...+
T Consensus 28 Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--------------~~~~ 91 (313)
T KOG0198|consen 28 GSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRE--------------NDEY 91 (313)
T ss_pred ccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCcccccc--------------Ceee
Confidence 899999999999999999999998774332 556889999999999999999999744310 1368
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCeEEecccccccccC-
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSY- 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~- 159 (481)
+|+|||+.+ +|.+++.+....|+++.++.+.+||++||+|||++||||||||++||||+. ++.+||+|||++.....
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999985 777777765557999999999999999999999999999999999999999 69999999999987663
Q ss_pred -CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 160 -DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 160 -~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
..........||+.|||||++........++|||||||++.||+||+.||... ...+.+.++......+
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P--------- 242 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP--------- 242 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC---------
Confidence 22233455788999999999985223345999999999999999999999873 3333333332211111
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.+...++.++++||.+||..||++||||+++|+|+|...+
T Consensus 243 -------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 243 -------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1223578899999999999999999999999999999664
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=373.85 Aligned_cols=275 Identities=43% Similarity=0.798 Sum_probs=229.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++..... .....+.+|+.++++++|+||+++++++.. ++.+
T Consensus 17 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 79 (309)
T cd07872 17 GTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT----------------DKSL 79 (309)
T ss_pred cCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee----------------CCeE
Confidence 89999999999999999999999865432 234467789999999999999999999987 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++|...+......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 9999999999988887766678999999999999999999999999999999999999999999999999997643222
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......+|..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..+++..+.+....|+.......+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22233467899999999876567889999999999999999999999999999999999999888888888766543322
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...................++.++++||.+||..||++|+|+.|+|+|+||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 22211111112222334568899999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=369.06 Aligned_cols=291 Identities=48% Similarity=0.884 Sum_probs=244.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||+|+++...........+.+|+.++++++|+||+++++++.... .+.+
T Consensus 18 g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~ 83 (309)
T cd07845 18 GTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH--------------LDSI 83 (309)
T ss_pred cCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC--------------CCeE
Confidence 78999999999999999999999876555444556778999999999999999999987521 3568
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||++++|.+++......+++.+++.++.||+.||+|||+++++||||||+|||+++++.+||+|||++..+....
T Consensus 84 ~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~- 162 (309)
T cd07845 84 FLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA- 162 (309)
T ss_pred EEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-
Confidence 9999999999888887665679999999999999999999999999999999999999999999999999998765322
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
........+..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..+....+.+....|+....++..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 22233345788999999877567889999999999999999999999999999999999999988888888877665544
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKY 308 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~~~~~~~~~~ 308 (481)
..+.........+...+..++.++.+||.+||..||++|||++|+|.|+||...++++.+..++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~ 308 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTF 308 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCC
Confidence 433332222233344455678999999999999999999999999999999999998887766643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=363.42 Aligned_cols=274 Identities=40% Similarity=0.728 Sum_probs=221.7
Q ss_pred cceeEEEEEEEcc-CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc---CCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIK-TGEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~-tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++.. +++.||||+++.....+.....+.+|+.+++.+ +|+||+++++++..... ..
T Consensus 12 G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~-----------~~ 80 (290)
T cd07862 12 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT-----------DR 80 (290)
T ss_pred CCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC-----------CC
Confidence 8999999999965 468899999987655444455667888888776 69999999999864211 12
Q ss_pred CCeEEEEEecCCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...++|||||+.++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 4578999999999988877653 345899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
... .......+|..|+|||++.+ ..++.++|||||||++|||++|++||.+.++.+.+.++++..+.+....|+...
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred cCC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 432 23344567999999999976 578899999999999999999999999999999999999888777666666544
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.++..... .........+...++..+++||.+||+.||++|||+.|+|+||||
T Consensus 238 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFH---SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhcc---CCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 33221110 011122334455688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=350.62 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=212.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC------CcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE------GFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDG 75 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~------~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~ 75 (481)
|..++|-+|.++.|+..+|+|+|......+ ...+...+|+.||+++ -||+||++.+++++
T Consensus 28 gvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes------------- 94 (411)
T KOG0599|consen 28 GVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES------------- 94 (411)
T ss_pred cchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-------------
Confidence 455778899999999999999997653221 1223445799999999 59999999999998
Q ss_pred CCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 76 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 76 ~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
+..+++|+|+|..+.+.........+++.+.++||+||+++++|||.++||||||||+|||++++-++||+|||+|+
T Consensus 95 ---~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 95 ---DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred ---cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 66789999999854444444455679999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccccccCCCchhhcCC-----CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGA-----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 230 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 230 (481)
.+. ....+...|||+.|+|||.+... ..|+..+|+||+|||+|.||.|.+||-.....-++..|++.......
T Consensus 172 ~l~--~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 172 QLE--PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred ccC--CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 875 45567778999999999998642 34788999999999999999999999999999999999887766666
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..|. +++..++|||.+||+.||.+|+|++|+|.||||
T Consensus 250 peWa--------------------------dis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 250 PEWA--------------------------DISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred cchh--------------------------hccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 5554 577789999999999999999999999999999
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=372.23 Aligned_cols=282 Identities=37% Similarity=0.573 Sum_probs=217.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||+++...........+++|+.++++|+|+||+++++++..... .....+
T Consensus 11 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----------~~~~~~ 79 (338)
T cd07859 11 GSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-----------REFKDI 79 (338)
T ss_pred cCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC-----------CCCceE
Confidence 899999999999999999999987543333334567899999999999999999999875321 113468
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|||||||.++|...+... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 999999999988877654 3599999999999999999999999999999999999999999999999999976432221
Q ss_pred --CccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 163 --NTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 163 --~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
......++|..|+|||++.+. ..++.++||||||||+|+|++|+.||.+.+....+..+....+.+....+..+...
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 122345789999999998642 46789999999999999999999999998888877777766665543332221110
Q ss_pred CccccCC-CchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
....... ............+..++.++.+||.+||..||++|||++|+|+||||..-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0000000 00000011223344578889999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=371.00 Aligned_cols=246 Identities=30% Similarity=0.490 Sum_probs=224.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.|..|.+|+|.-||+.||||+|++.....-....++.|+..++.++|||||++|+++.. +..+
T Consensus 29 GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT----------------QTKl 92 (864)
T KOG4717|consen 29 GHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT----------------QTKL 92 (864)
T ss_pred CceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc----------------cceE
Confidence 899999999999999999999999887776667788999999999999999999999877 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-CCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~ 160 (481)
|||+|+-++ ||++++.+....++|+.++.||.||+.|+.|||+..+|||||||+||.+- .-|-|||.|||++-.|.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-- 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-- 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC--
Confidence 999999985 99999998888899999999999999999999999999999999998765 55789999999998764
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
....+++.||++.|-|||+|+++.+..+++||||||||||.|++|++||...++.+.+..|+.+....
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv------------ 238 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV------------ 238 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC------------
Confidence 45667889999999999999998777889999999999999999999999999999999998754332
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
..+++.+++|||.+||+.||.+|.|.++|..++|++..
T Consensus 239 ------------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 239 ------------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred ------------------chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 24689999999999999999999999999999999753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=360.31 Aligned_cols=274 Identities=40% Similarity=0.725 Sum_probs=222.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc---CCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|+++.+++.||||+++...........+.+|+.++++| +|+||+++++++.... ....
T Consensus 11 g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~-----------~~~~ 79 (288)
T cd07863 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR-----------TDRE 79 (288)
T ss_pred cCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc-----------CCCC
Confidence 8999999999999999999999987654444445667788888776 6999999999987532 1124
Q ss_pred CeEEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..+++||||+.++|..++.... ..+++.+++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 80 TKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred ceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 5789999999998888776533 358999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. .......+|..|+|||++.+ ..++.++|||||||++|+|++|+++|...+..+.+.+++...+.+....|+....
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 160 CQ--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred Cc--ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 22 22334567899999999976 5689999999999999999999999999999999999988877777666665433
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.+.... ..............++.++++||.+||..||++|+|+.|+|.|+||
T Consensus 237 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRGAF---SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccc---CCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 222111 0111233445556788899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=363.20 Aligned_cols=241 Identities=29% Similarity=0.496 Sum_probs=213.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+|-+|++...|+.||||.|+++.. .+.....+.+||+|+..|+|||||.+|++|++ ++.
T Consensus 64 GTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN----------------kdK 127 (668)
T KOG0611|consen 64 GTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN----------------KDK 127 (668)
T ss_pred CcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC----------------Cce
Confidence 8999999999999999999999988743 33345567799999999999999999999987 779
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+.|||||..+ +|.+++.+. ..|++.+++.|++||+.|+.|||.++++|||||.+|||||.++++||+|||++-.+.
T Consensus 128 IvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~-- 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA-- 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc--
Confidence 9999999985 677766654 479999999999999999999999999999999999999999999999999997765
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
....+.++||++.|.+||++.+..+-++.+|.|||||+||.|+.|..||++.+-..++.+|.......+.
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---------- 274 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---------- 274 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC----------
Confidence 4567788999999999999999766789999999999999999999999999999988888654332221
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
-+..+.-||+.||..||++|.|++||..|=|.
T Consensus 275 ---------------------~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 275 ---------------------TPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred ---------------------CCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 23468899999999999999999999999887
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=368.71 Aligned_cols=249 Identities=31% Similarity=0.463 Sum_probs=219.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC-CcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|.||.||+|+++.||+.+|+|++.+..... .....+.+|+.||++|. |+|||.++++|++ ..
T Consensus 46 G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~----------------~~ 109 (382)
T KOG0032|consen 46 GQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED----------------PD 109 (382)
T ss_pred CCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc----------------CC
Confidence 899999999999999999999998775432 23457889999999998 9999999999998 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC----CCeEEecccccc
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE----GNLKLADFGLAR 155 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~----~~vkL~DFG~a~ 155 (481)
.++||||+|.| .|++.+... .+++..+..+++||+.+++|||+.||+||||||+|||+... +.+|++|||+|.
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 89999999996 666666655 39999999999999999999999999999999999999654 369999999998
Q ss_pred cccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.... .......+||+.|+|||++.. ..|+..+||||+|||+|.|++|.+||.+.++......|...........|+
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~- 263 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD- 263 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc-
Confidence 8764 566778899999999999986 689999999999999999999999999999999998887766555555554
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~ 298 (481)
.++..+++||++||..||.+|+|+.++|+|||+.....
T Consensus 264 -------------------------~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 264 -------------------------DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred -------------------------ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 56779999999999999999999999999999976433
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=362.55 Aligned_cols=275 Identities=42% Similarity=0.779 Sum_probs=227.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||.++...... ....+.+|+.++++|+|+||+++++++.. .+.+
T Consensus 17 g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----------------~~~~ 79 (301)
T cd07873 17 GTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHT----------------EKSL 79 (301)
T ss_pred CcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEec----------------CCeE
Confidence 889999999999999999999997654322 34467789999999999999999999987 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++|...+......+++..++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred EEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 9999999999988887766678999999999999999999999999999999999999999999999999997643222
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+......+....|+.......+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22233456889999999877566888999999999999999999999999998899999888888877777765433222
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...................+++++++||.+||..||.+|+|++|+|+|+||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 22221111122223344568889999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=357.81 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=213.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|..|+||+|+...++..+|||++++.. .......++..|.+||++++||.+.++|..|+. +..
T Consensus 88 GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet----------------~~~ 151 (459)
T KOG0610|consen 88 GDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET----------------DKY 151 (459)
T ss_pred CCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec----------------cce
Confidence 678999999999999999999998774 334456677889999999999999999999998 778
Q ss_pred EEEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+|+|||||.| ||..++.+ ++..|+++.++.|+..++.||+|||..|||.||||||||||.++|+|.|+||.++.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999985 78877776 445699999999999999999999999999999999999999999999999999853211
Q ss_pred -----------------------------------C--------------------CCCccccccccccCCCchhhcCCC
Q 011627 160 -----------------------------------D--------------------HNNTLTNRVITLWYRPPELLLGAT 184 (481)
Q Consensus 160 -----------------------------------~--------------------~~~~~~~~~gt~~Y~aPEvl~~~~ 184 (481)
. ......+++||-.|+|||++.+ .
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~ 310 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-E 310 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-C
Confidence 0 0012234578999999999998 5
Q ss_pred CCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcH
Q 011627 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDR 264 (481)
Q Consensus 185 ~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (481)
.++.++|.|+|||+|||||.|+.||.+.+..+++..|+...-..+.. ..++.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~----------------------------~~vs~ 362 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE----------------------------PEVSS 362 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC----------------------------Ccchh
Confidence 78999999999999999999999999999999999997532211111 13677
Q ss_pred HHHHHHHHhcccCCCCCCC----HHHHhcCCCCCCCCC
Q 011627 265 HALELLEKMLMLDPSQRIS----AKDALDSEYFWTDPL 298 (481)
Q Consensus 265 ~~~~ll~~~L~~dP~~R~s----a~eiL~h~~f~~~~~ 298 (481)
+++|||+++|.+||++|+. |+||.+||||..-.+
T Consensus 363 ~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 363 AAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred HHHHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 8999999999999999998 999999999976444
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=378.85 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=214.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+|++|..+.|++.||||+++++. ...+.++..+.|..|+...+ ||.+++++..|+. ..
T Consensus 379 GsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT----------------~~ 442 (694)
T KOG0694|consen 379 GSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT----------------KE 442 (694)
T ss_pred CcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc----------------CC
Confidence 899999999999999999999999884 44556778899999999985 9999999999998 77
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
++|+||||+.|+....++ ....|++..++.|+..|+.||.|||++|||+||||.+|||||.+|.+||+|||+++.....
T Consensus 443 ~l~fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 999999999976644443 3357999999999999999999999999999999999999999999999999999864422
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.....++|||+.|||||++.+ ..|+.++|.|||||+|||||.|..||+++++++++..|......
T Consensus 522 -g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~------------- 586 (694)
T KOG0694|consen 522 -GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR------------- 586 (694)
T ss_pred -CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 335567899999999999987 78999999999999999999999999999999999999752111
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
....++.++.++|+++|..||++|.- +.+|..||||+.
T Consensus 587 -----------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 587 -----------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred -----------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 11247889999999999999999984 689999999965
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=369.64 Aligned_cols=244 Identities=26% Similarity=0.407 Sum_probs=204.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... .......+++|+.++++++|+||+++++++.. .+.
T Consensus 6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----------------~~~ 69 (323)
T cd05571 6 GTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT----------------HDR 69 (323)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc----------------CCE
Confidence 8999999999999999999999986532 22234567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|...+.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~- 147 (323)
T cd05571 70 LCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS- 147 (323)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-
Confidence 9999999986 55555543 45689999999999999999999999999999999999999999999999999875322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........++|+.|+|||++.+ ..++.++||||||||+|||++|+.||...+....+..+......
T Consensus 148 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------------- 213 (323)
T cd05571 148 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR------------- 213 (323)
T ss_pred CCCcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 1223344578999999999976 67899999999999999999999999988877766665421100
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
+...++.++.+||++||..||++|+ ++.+|++|+||..
T Consensus 214 -----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 214 -----------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred -----------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 1124678899999999999999999 8999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=364.78 Aligned_cols=273 Identities=36% Similarity=0.678 Sum_probs=212.3
Q ss_pred cceeEEEEEEEc--cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREI--KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++ .+++.||||++.... ....+.+|+.++++++|+||+++++++.+.. ..
T Consensus 12 G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------------~~ 73 (317)
T cd07868 12 GTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA--------------DR 73 (317)
T ss_pred CCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCC--------------Cc
Confidence 899999999975 477899999986442 2345779999999999999999999987522 45
Q ss_pred eEEEEEecCCCChhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----cCCCCeEE
Q 011627 81 STYMVFEYMDHDLTGLADRP--------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKL 148 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~--------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl----~~~~~vkL 148 (481)
.+|+||||+.++|..++... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||
T Consensus 74 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 74 KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 78999999999887765421 2358999999999999999999999999999999999999 45578999
Q ss_pred ecccccccccCCCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh---------HHH
Q 011627 149 ADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQ 217 (481)
Q Consensus 149 ~DFG~a~~~~~~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---------~~~ 217 (481)
+|||+|+.+..... ......++|+.|+|||++.+...++.++||||||||+|+|++|++||....+ .+.
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 99999987643221 2234457799999999998756789999999999999999999999976543 366
Q ss_pred HHHHHHhcCCCCCCCCccCCCCCccccCCC----ch----hhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 218 LSKIFELCGSPDETIWPGVSKMPAYNHFKP----SR----TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~----~~----~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+.+++...+.+....|.....++....... .. .............+.++.+||++||+.||++|+|++|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 778888888887777776554433211100 00 0000111111234667999999999999999999999999
Q ss_pred CCCC
Q 011627 290 SEYF 293 (481)
Q Consensus 290 h~~f 293 (481)
||||
T Consensus 314 hp~f 317 (317)
T cd07868 314 DPYF 317 (317)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=359.47 Aligned_cols=258 Identities=25% Similarity=0.396 Sum_probs=212.8
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
.|.-++||+|+.+.++++||||+++.++...+ ...+.+|+..++.++||||++++..|.. +..
T Consensus 36 ~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv----------------~~~ 98 (516)
T KOG0582|consen 36 VGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV----------------DSE 98 (516)
T ss_pred ccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe----------------cce
Confidence 36678999999999999999999999877665 6788999999999999999999999998 779
Q ss_pred EEEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+|+||.||.+ ++++++... ...|+|..|..|++++|.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999985 666666541 22499999999999999999999999999999999999999999999999998765543
Q ss_pred CCC---CccccccccccCCCchhh-cCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 160 DHN---NTLTNRVITLWYRPPELL-LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 160 ~~~---~~~~~~~gt~~Y~aPEvl-~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
... ..+.+.++|+.|||||++ .....|+.|+|||||||+.+||.+|..||.......++-..+. +.++...
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~--- 253 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLL--- 253 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCcc---
Confidence 221 122556889999999995 4445699999999999999999999999998888777655432 2222111
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
++. .-.+..+.++..++++|..||+.||++||||+++|+|+||+..
T Consensus 254 t~~---------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 254 TSG---------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred ccc---------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 111 1112334677799999999999999999999999999999653
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=359.66 Aligned_cols=273 Identities=44% Similarity=0.803 Sum_probs=226.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||+|+++...........+.+|+.++++++|+||+++++++.+ ...+
T Consensus 11 g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----------------~~~~ 74 (284)
T cd07839 11 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS----------------DKKL 74 (284)
T ss_pred cCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc----------------CCce
Confidence 789999999999999999999998765544455677899999999999999999999976 5678
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+|+||++++|.+.+......+++..++.++.||+.||.|||+++|+||||||+|||++.++++||+|||+++.+... .
T Consensus 75 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-~ 153 (284)
T cd07839 75 TLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-V 153 (284)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-C
Confidence 999999999998887766667999999999999999999999999999999999999999999999999999765432 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|..| |...+..+.+..++..+..+....|+.....+.
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 2233446688999999987755678999999999999999998776 566777788888888887777777766655544
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+..+.... ...........++.++++||.+||..||++|||++++|+|+||
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 234 YKPYPMYP-ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccCCCC-CcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 42222111 1112234455788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=377.56 Aligned_cols=282 Identities=33% Similarity=0.505 Sum_probs=220.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.+++.++|+||+++++++..... .....+
T Consensus 11 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----------~~~~~~ 79 (372)
T cd07853 11 GAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI-----------DPFEEI 79 (372)
T ss_pred CCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc-----------cccceE
Confidence 899999999999999999999987543333334577899999999999999999999976321 112378
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+.++|...+... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.......
T Consensus 80 ~lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 999999999888877654 4699999999999999999999999999999999999999999999999999986544333
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC-Cc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM-PA 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~ 241 (481)
.......+|..|+|||++.+...++.++||||||||+|||++|+.||.+.+..+.+..+.+..+.+....+...... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 34445567999999999987666889999999999999999999999999999999998887766543222111000 00
Q ss_pred -cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 -YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
................+...++.++.+||.+||..||++|+|+.|+|+|+||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 0000000000011112234568899999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=355.37 Aligned_cols=273 Identities=46% Similarity=0.853 Sum_probs=225.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++.....+.....+.+|+.++++++|+||+++++++.+ ...+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 74 (285)
T cd07861 11 GTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ----------------ESRL 74 (285)
T ss_pred cCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee----------------CCeE
Confidence 789999999999999999999998765544455677899999999999999999999987 6689
Q ss_pred EEEEecCCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDHDLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.++|...+.... ..+++..++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+...
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 75 YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred EEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9999999988877765432 46899999999999999999999999999999999999999999999999999765422
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+++..+.+....|+......
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1222334568899999998765667899999999999999999999999999888888888877777777777655444
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.+...... ............++.++++||++||..||++|||+.+|++|+||
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPK-WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccc-cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 33221111 11122333445689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=378.89 Aligned_cols=275 Identities=31% Similarity=0.505 Sum_probs=214.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++.... ....+|+.++++|+|+|||++++++...... .......+
T Consensus 77 G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~--------~~~~~~~l 142 (440)
T PTZ00036 77 GSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFK--------KNEKNIFL 142 (440)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccc--------cCCCceEE
Confidence 899999999999999999999886432 1345799999999999999999988653211 11123468
Q ss_pred EEEEecCCCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CeEEeccccccccc
Q 011627 83 YMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~ 158 (481)
+|||||+.+++..++. .....+++..++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+|+.+.
T Consensus 143 ~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 143 NVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred EEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 8999999998866554 3445699999999999999999999999999999999999999665 69999999998664
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. ......++|+.|+|||++.+...++.++||||||||+|||++|.+||.+.+..+.+.++....+.+....+....
T Consensus 223 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~- 299 (440)
T PTZ00036 223 AG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN- 299 (440)
T ss_pred CC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc-
Confidence 22 223345779999999998875678999999999999999999999999999999999998877765443322111
Q ss_pred CCccccCCCchhhhhhHHH-HHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVRE-VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+.+............+.. +....+.++++||.+||..||++|+|+.|+|+||||..
T Consensus 300 -~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 300 -PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred -hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 111111111111112222 22357889999999999999999999999999999964
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=353.47 Aligned_cols=276 Identities=44% Similarity=0.781 Sum_probs=234.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||++............+.+|+.++++++|+||+++++++.. ...+
T Consensus 11 g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~ 74 (286)
T cd07832 11 GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH----------------GSGF 74 (286)
T ss_pred CCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec----------------CCee
Confidence 789999999999999999999998765444455678899999999999999999999987 6688
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+.++|.+++......+++.+++.++.||+.+|+|||+++|+|+||||+||+++.++.++|+|||++........
T Consensus 75 ~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 75 VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999997788888776666799999999999999999999999999999999999999999999999999987654333
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|.++|...++.+.+..+......+....|+....+..+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 33444577999999999876566789999999999999999999999999998999999888888877778776665554
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
............+...+..++.++.+||.+||..||++|||++++|+|+||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 4333222222334455667789999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=360.90 Aligned_cols=244 Identities=30% Similarity=0.446 Sum_probs=204.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++... ........+.+|+.++++++|+||+++++++.+ .+.
T Consensus 4 G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~ 67 (312)
T cd05585 4 GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS----------------PEK 67 (312)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec----------------CCe
Confidence 899999999999999999999997542 122234567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|...+.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 68 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 68 LYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 9999999986 66666554 446999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+......
T Consensus 147 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~------------- 211 (312)
T cd05585 147 -DDKTNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR------------- 211 (312)
T ss_pred -CCccccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC-------------
Confidence 222344578999999999986 67899999999999999999999999988877777666432100
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI---SAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~---sa~eiL~h~~f~~ 295 (481)
+...++.++++||.+||..||++|+ ++.|+|+||||..
T Consensus 212 -----------------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 212 -----------------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred -----------------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 1124677899999999999999997 5899999999954
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=335.55 Aligned_cols=243 Identities=30% Similarity=0.473 Sum_probs=214.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|.||.||+|+.++++-.||||++.+.. .......++.+|++|-..|+||||+++|++|.+ ...
T Consensus 33 gkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd----------------~~r 96 (281)
T KOG0580|consen 33 GKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD----------------SKR 96 (281)
T ss_pred CccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec----------------cce
Confidence 789999999999999999999998764 333455677899999999999999999999998 778
Q ss_pred EEEEEecCC-CChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMD-HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~-g~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+||++||.. |.++..+.. ...++++...+.|++|++.||.|||.++||||||||+|+|++.++.+||+|||.+....
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999997 567766663 44569999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.....+.|||.-|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+++.+|.+.....+
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p---------- 242 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP---------- 242 (281)
T ss_pred --CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----------
Confidence 445566799999999999987 6889999999999999999999999999999999999976432222
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..++.++.|||.+||.++|.+|.+..|+++|||+..
T Consensus 243 --------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 --------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred --------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 357889999999999999999999999999999853
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=367.56 Aligned_cols=277 Identities=31% Similarity=0.497 Sum_probs=212.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.+++.++|+||+++++++...... .....+
T Consensus 32 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----------~~~~~~ 101 (359)
T cd07876 32 GAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL----------EEFQDV 101 (359)
T ss_pred CCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc----------ccccee
Confidence 8999999999999999999999976544444456778999999999999999999998753211 113468
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+++++...+.. .+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.... .
T Consensus 102 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~--~ 176 (359)
T cd07876 102 YLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT--N 176 (359)
T ss_pred EEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc--C
Confidence 99999999988776643 488999999999999999999999999999999999999999999999999975432 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC----
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK---- 238 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---- 238 (481)
.......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+.+..+.+....+.....
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 23344577999999999986 5788999999999999999999999999888877777776655443222111100
Q ss_pred ----CCccccCCCch----hhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 ----MPAYNHFKPSR----TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ----~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+.+....... .............+.++++||.+||..||++|+|+.|+|+||||..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00000000000 0000000111235678999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=362.80 Aligned_cols=244 Identities=25% Similarity=0.417 Sum_probs=203.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... .......+.+|+.+++.++|+||+++++++.. .+.
T Consensus 6 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~ 69 (328)
T cd05593 6 GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT----------------KDR 69 (328)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----------------CCE
Confidence 8999999999999999999999986532 22334567889999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|...+. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 70 ~~lv~Ey~~~g~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 70 LCFVMEYVNGGELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EEEEEeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 9999999986 4544443 4456999999999999999999999999999999999999999999999999998753321
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 149 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-------------- 212 (328)
T cd05593 149 -AATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-------------- 212 (328)
T ss_pred -ccccccccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc--------------
Confidence 223344578999999999976 5789999999999999999999999988877766655532110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
.+...++.++.+||++||..||++|+ ++.+|++|+||..
T Consensus 213 ----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 213 ----------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred ----------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 01124677899999999999999997 8999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=363.45 Aligned_cols=241 Identities=26% Similarity=0.393 Sum_probs=203.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++.... .......+.+|+.++++++|+||+++++++.+ .+.
T Consensus 29 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~ 92 (329)
T PTZ00263 29 GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD----------------ENR 92 (329)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc----------------CCE
Confidence 8999999999999999999999976532 22234567899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|.+.+.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999986 66666554 346899999999999999999999999999999999999999999999999999865322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+.++.+.... +
T Consensus 172 ----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-----------~- 234 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK-----------F- 234 (329)
T ss_pred ----cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC-----------C-
Confidence 223578999999999986 56789999999999999999999999988887777766532100 0
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
...++.++++||++||..||++|++ ++||++|+||..
T Consensus 235 ------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 235 ------------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred ------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 0125678999999999999999997 799999999954
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=363.17 Aligned_cols=277 Identities=35% Similarity=0.590 Sum_probs=217.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.+|++++|+||+++++++..... ......+
T Consensus 26 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----------~~~~~~~ 95 (343)
T cd07878 26 GAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS----------IENFNEV 95 (343)
T ss_pred CCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc----------ccccCcE
Confidence 899999999999999999999997654333334567789999999999999999999865321 1224568
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+++|++.++|..++.. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 96 ~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--- 170 (343)
T cd07878 96 YLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD--- 170 (343)
T ss_pred EEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC---
Confidence 99999998888776653 3599999999999999999999999999999999999999999999999999986542
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc-
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA- 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 241 (481)
.....++|..|+|||++.+...++.++||||||||+|+|++|+.||...+..+.+.++.+..+.+....+........
T Consensus 171 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred -CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 233457899999999998756789999999999999999999999999988888888877665554333222111000
Q ss_pred -cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 -YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+.... ...........+...++.+.+||.+||..||++|+|+.|+|+||||...
T Consensus 250 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 250 KYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00000 0000112333445677889999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=357.55 Aligned_cols=241 Identities=27% Similarity=0.393 Sum_probs=203.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++...... ......+.+|+.++++++|+||+++++++.+ ...
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~ 75 (291)
T cd05612 12 GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD----------------QRF 75 (291)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc----------------CCe
Confidence 89999999999999999999999754321 1234467789999999999999999998876 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~- 153 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD- 153 (291)
T ss_pred EEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-
Confidence 9999999985 66666554 34689999999999999999999999999999999999999999999999999976542
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.....++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+....+......
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~------------- 216 (291)
T cd05612 154 ---RTWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE------------- 216 (291)
T ss_pred ---CcccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC-------------
Confidence 1223568999999999876 56889999999999999999999999998887777776542110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
+...++..+++||++||+.||.+|++ ++|+++|+||..
T Consensus 217 -----------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 217 -----------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred -----------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 01235678999999999999999995 999999999954
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=361.42 Aligned_cols=244 Identities=27% Similarity=0.421 Sum_probs=203.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... .......+.+|+.++++++|+||++++++|.. .+.
T Consensus 6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----------------~~~ 69 (323)
T cd05595 6 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----------------HDR 69 (323)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec----------------CCE
Confidence 8999999999999999999999986532 22234566789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|...+. ....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 70 ~~lv~E~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 70 LCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 9999999986 5544443 3446899999999999999999999999999999999999999999999999998753221
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+....+..+......
T Consensus 149 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~------------- 213 (323)
T cd05595 149 -GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------------- 213 (323)
T ss_pred -CCccccccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 222334578999999999876 57899999999999999999999999988877776666432110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
+...+++++.+||.+||..||++|+ ++.++++|+||..
T Consensus 214 -----------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 214 -----------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred -----------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 1124678899999999999999998 9999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=368.93 Aligned_cols=268 Identities=26% Similarity=0.322 Sum_probs=205.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||+... ..+.+|+.++++|+|+|||+++++|.. ....
T Consensus 103 G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~~ 158 (391)
T PHA03212 103 GAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY----------------NKFT 158 (391)
T ss_pred CCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE----------------CCee
Confidence 8999999999999999999997542 246789999999999999999999986 6688
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+|||++.++|...+... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 159 ~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 999999999888777654 3689999999999999999999999999999999999999999999999999975433333
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhcCCCCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-------NEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||... .....+..++...+..+......
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 33445678999999999976 57899999999999999999999776543 23455666666655443222110
Q ss_pred CC-CCCc-c---ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 236 VS-KMPA-Y---NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 236 ~~-~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.. .+.. + ..........+........++.++.+||.+||..||++|||++|+|+|+||...
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 00 0000 0 000000000000111122467789999999999999999999999999999653
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=364.56 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=208.6
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
.|+||.||+|.+..|++.||+|+++++.... ....+..|+.+|..++++||.++|+.+.. ...
T Consensus 23 rGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d-eIediqqei~~Ls~~~~~~it~yygsyl~----------------g~~ 85 (467)
T KOG0201|consen 23 RGSFGEVYKAIDNKTKKVVAIKIIDLEEAED-EIEDIQQEISVLSQCDSPNITEYYGSYLK----------------GTK 85 (467)
T ss_pred ccccceeeeeeeccccceEEEEEechhhcch-hhHHHHHHHHHHHhcCcchHHhhhhheee----------------ccc
Confidence 4899999999999999999999999886544 45678899999999999999999999987 678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
++|+||||.|+....+.+....+.+.++..++++++.||.|||..+.+|||||..||||..+|.|||+|||.+..+....
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999975444444444456999999999999999999999999999999999999999999999999998776544
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
... .+++||+.||||||+.+ ..|+.++||||||++++||++|.+||.......++..|-+. .+ |
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~---~P----P------- 229 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS---AP----P------- 229 (467)
T ss_pred hcc-ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC---CC----C-------
Confidence 444 67899999999999986 68999999999999999999999999877664433333110 00 0
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..-..+++.+++||..||++||+.||||+++|+|.|++.
T Consensus 230 ---------------~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 230 ---------------RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ---------------ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 011257889999999999999999999999999999965
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=355.87 Aligned_cols=273 Identities=36% Similarity=0.686 Sum_probs=211.9
Q ss_pred cceeEEEEEEEcc--CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIK--TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++.. ++..||+|.++... ....+.+|+.++++++|+||+++++++.... +.
T Consensus 12 G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------------~~ 73 (317)
T cd07867 12 GTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHS--------------DR 73 (317)
T ss_pred CCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC--------------CC
Confidence 8999999999754 66899999986442 2335779999999999999999999986532 55
Q ss_pred eEEEEEecCCCChhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----cCCCCeEE
Q 011627 81 STYMVFEYMDHDLTGLADR--------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKL 148 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~--------~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl----~~~~~vkL 148 (481)
.+||||||+.++|...+.. ....+++..++.++.||+.||+|||+.+|+||||||+|||+ +.++.+||
T Consensus 74 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 74 KVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred eEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEE
Confidence 7899999999988776542 12348899999999999999999999999999999999999 45678999
Q ss_pred ecccccccccCCCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh---------HHH
Q 011627 149 ADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQ 217 (481)
Q Consensus 149 ~DFG~a~~~~~~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---------~~~ 217 (481)
+|||+++.+..... .......+|..|+|||++.+...++.++||||||||+|||++|++||....+ ...
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 99999987643221 1233456799999999998756689999999999999999999999976543 356
Q ss_pred HHHHHHhcCCCCCCCCccCCCCCccccCCCch--------hhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 218 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSR--------TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+.+++...+.+....|......+.+....... .............+..+.+||.+||..||.+|+|++|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 77788888888777777665544332211100 0000111111235677999999999999999999999999
Q ss_pred CCCC
Q 011627 290 SEYF 293 (481)
Q Consensus 290 h~~f 293 (481)
||||
T Consensus 314 hp~f 317 (317)
T cd07867 314 DPYF 317 (317)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=362.21 Aligned_cols=277 Identities=30% Similarity=0.495 Sum_probs=215.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||++............+.+|+.+++.++|+||+++++++..... ......+
T Consensus 35 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~----------~~~~~~~ 104 (364)
T cd07875 35 GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS----------LEEFQDV 104 (364)
T ss_pred CCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc----------ccccCeE
Confidence 899999999999999999999998654444445677899999999999999999998865321 1113468
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.+++...+.. .+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.... .
T Consensus 105 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~ 179 (364)
T cd07875 105 YIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 179 (364)
T ss_pred EEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC--C
Confidence 99999999988877653 478999999999999999999999999999999999999999999999999976532 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC----
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK---- 238 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---- 238 (481)
.......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+.++++..+.+....+.....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 22344577999999999987 6789999999999999999999999999999888888887666544322221111
Q ss_pred ----CCccccCCCchh----hhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 ----MPAYNHFKPSRT----MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ----~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+.+..+..... ............+.++++||.+||..||++|+|+.|+|+||||..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 010000000000 000001112234678999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=349.85 Aligned_cols=285 Identities=55% Similarity=0.957 Sum_probs=237.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|.++.+++.||||+++...........+.+|+.++++++|+||+++++++.+..... .-.+....+
T Consensus 18 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~------~~~~~~~~~ 91 (302)
T cd07864 18 GTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL------DFKKDKGAF 91 (302)
T ss_pred cCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh------hccccCCcE
Confidence 78999999999999999999999876555545567788999999999999999999987632000 001124489
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+++++...+......+++.++..++.||+.||+|||+++|+|+||||+||++++++.+||+|||++..+.....
T Consensus 92 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 171 (302)
T cd07864 92 YLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171 (302)
T ss_pred EEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc
Confidence 99999999988888776656799999999999999999999999999999999999999999999999999987654332
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
........+..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+.+.++.+....|+.....+.+
T Consensus 172 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T cd07864 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYF 251 (302)
T ss_pred cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccc
Confidence 22333455788999998876556789999999999999999999999999999999999999888888888877666655
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
...+......+.....+..++..+.+||.+||..||++|||++++++|+||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 252 NTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 544444444455566666789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=359.65 Aligned_cols=244 Identities=25% Similarity=0.400 Sum_probs=202.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... .......+.+|+++++.++|+||+++++++.. .+.
T Consensus 6 G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~----------------~~~ 69 (325)
T cd05594 6 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----------------HDR 69 (325)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc----------------CCE
Confidence 8999999999999999999999986532 22234566789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+||||||+.+ +|...+. ....+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~lv~E~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 70 LCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 9999999986 4544443 34469999999999999999999997 7999999999999999999999999999875432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......++|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+....+..+......
T Consensus 149 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~------------ 214 (325)
T cd05594 149 D-GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR------------ 214 (325)
T ss_pred C-CcccccccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC------------
Confidence 2 223334578999999999976 57899999999999999999999999988877666665321100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
+...++.++.+||++||+.||++|+ ++.++++|+||..
T Consensus 215 ------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred ------------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 0123677899999999999999997 9999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=356.63 Aligned_cols=244 Identities=25% Similarity=0.426 Sum_probs=203.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++.+++.||||+++... ..+.....+.+|+.+++.+ +|+||+++++++.+ .+
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~----------------~~ 69 (320)
T cd05590 6 GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT----------------PD 69 (320)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc----------------CC
Confidence 899999999999999999999998653 2223345667899999877 69999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~~iv~Ey~~~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 70 RLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred EEEEEEcCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 89999999986 56555543 34699999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+......
T Consensus 149 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------ 214 (320)
T cd05590 149 N-GKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV------------ 214 (320)
T ss_pred C-CCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC------------
Confidence 1 222344578999999999876 67899999999999999999999999999888887777532110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa------~eiL~h~~f~~ 295 (481)
....++.++++||++||+.||++|+++ +++++|+||..
T Consensus 215 ------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 215 ------------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred ------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 011356789999999999999999998 99999999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=349.92 Aligned_cols=276 Identities=50% Similarity=0.875 Sum_probs=229.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||.||+|++..+++.||||.++...........+.+|+.++++++|+||+++++++.... ...+
T Consensus 16 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--------------~~~~ 81 (293)
T cd07843 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN--------------LDKI 81 (293)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC--------------CCcE
Confidence 78999999999999999999999876555555556789999999999999999999987621 3689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++|.+++......+++.+++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+....
T Consensus 82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 9999999998888877655579999999999999999999999999999999999999999999999999998765332
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|..||...+..+.+.+++..++.+....|+....++..
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 22233456888999999876555789999999999999999999999999999999999998888888778776655544
Q ss_pred ccCCCchhhhhhHHHHHhh--hcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~--~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
............+...+.. ++..+.+||++||+.||++|||++|+|.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 3222211222222333333 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=358.05 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=206.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... .......+.+|+.+++.++|+||+++++++.+ .+.
T Consensus 12 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~----------------~~~ 75 (333)
T cd05600 12 GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD----------------DEY 75 (333)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc----------------CCE
Confidence 8999999999999999999999986532 22234567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|.+++.. ...+++.+++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999986 66666543 34689999999999999999999999999999999999999999999999999976542
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.....++|+.|+|||++.+ ..++.++||||||||+|||++|..||...+..+.+..+...........+
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------- 222 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY------- 222 (333)
T ss_pred ---ccCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCC-------
Confidence 3344578999999999987 57899999999999999999999999998887777766542211110000
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.. ....++.++.+||.+||..+|++|+++.+|++|+||..
T Consensus 223 --~~-------------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 223 --DD-------------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred --Cc-------------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 00 00246789999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=349.99 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=201.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++...... ......+.+|+.++++++|+||+++++++.+ .+.
T Consensus 11 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~----------------~~~ 74 (285)
T cd05631 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET----------------KDA 74 (285)
T ss_pred CCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc----------------CCe
Confidence 89999999999999999999999765322 2223456789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+|+||||+.+ +|...+.. ....+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||++..+..
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999999986 56555543 334689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.......++|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+........
T Consensus 155 --~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 221 (285)
T cd05631 155 --GETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ---------- 221 (285)
T ss_pred --CCeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc----------
Confidence 122334578999999999986 5789999999999999999999999988765443333332211100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
......++.++.+||++||+.||++|++ ++++++|+||..
T Consensus 222 ----------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 222 ----------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred ----------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 0112347889999999999999999997 899999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=347.33 Aligned_cols=273 Identities=44% Similarity=0.805 Sum_probs=222.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+++++.+++.||||.+....... ....+.+|++++++++|+||+++++++.+ ....
T Consensus 16 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 78 (291)
T cd07844 16 GSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHT----------------KKTL 78 (291)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEec----------------CCeE
Confidence 789999999999999999999997654322 23456789999999999999999999987 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+.++|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++.++++||+|||+++......
T Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 157 (291)
T cd07844 79 TLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS- 157 (291)
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence 9999999999988887766678999999999999999999999999999999999999999999999999987543221
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-EAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|+.||...+ ..+.+..+.+....+....|+.......
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 112223458889999998765568899999999999999999999998766 5677777888888877777777665544
Q ss_pred cccCCCchhhhhhHHHHHhhhc--HHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFD--RHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+............+......++ .++.+||.+||..||++|||+.++|.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 3333222111222333334455 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=348.46 Aligned_cols=273 Identities=48% Similarity=0.859 Sum_probs=223.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...........+.+|++++++++|+||+++++++.+ .+.+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 74 (284)
T cd07860 11 GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----------------ENKL 74 (284)
T ss_pred CCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc----------------CCcE
Confidence 789999999999999999999998765544455678899999999999999999999876 5678
Q ss_pred EEEEecCCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.++|...+... ...+++..++.++.||+.||+|||+++++|+||+|+||+++.++.+||+|||++..+...
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~- 153 (284)
T cd07860 75 YLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 153 (284)
T ss_pred EEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 999999998887776543 346899999999999999999999999999999999999999999999999998765422
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
........++..|+|||++.+...++.++|||||||++|+|++|+.||...++.+.+.++++..+.+....|+.....+.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 12223345688899999987655578899999999999999999999999999888888888888777777765544332
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+...-.. ............++.++++||.+||+.||++|||++++|+||||
T Consensus 234 ~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 234 YKPSFPK-WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHhhccc-ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 2111000 11122333345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=348.99 Aligned_cols=283 Identities=52% Similarity=0.923 Sum_probs=231.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|+++.+++.||||++............+.+|++++++++|+||+++++++.+..... ......+
T Consensus 19 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~--------~~~~~~~ 90 (311)
T cd07866 19 GTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS--------KRKRGSV 90 (311)
T ss_pred CCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc--------cccCceE
Confidence 78999999999999999999999876554444556789999999999999999999887633210 1225578
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+..++...+......+++.+++.++.||+++|+|||+++|+|+||||+|||+++++.+||+|||+++.......
T Consensus 91 ~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 170 (311)
T cd07866 91 YMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170 (311)
T ss_pred EEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCc
Confidence 99999999999888877666799999999999999999999999999999999999999999999999999976543221
Q ss_pred ----------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 011627 163 ----------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 232 (481)
Q Consensus 163 ----------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (481)
...+...++..|+|||++.+...++.++||||||||+|+|++|++||.+.+....++.++..+..+.+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (311)
T cd07866 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEET 250 (311)
T ss_pred ccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 1122345688899999987655688999999999999999999999999999999999999888877777
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
|+.....+..................+..++..+.+||.+||..||++|||+.|+|.|+||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 251 WPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred chhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 7765554443322222222233444556677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=347.91 Aligned_cols=280 Identities=47% Similarity=0.846 Sum_probs=231.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC---CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK---EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|.+..+++.||||+++..... ......+.+|++++++++|+||+++++++.+ .
T Consensus 11 g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~ 74 (298)
T cd07841 11 GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH----------------K 74 (298)
T ss_pred ccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec----------------C
Confidence 78999999999999999999999866433 2234456789999999999999999999987 5
Q ss_pred CeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 80 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
..+|+||||+.++|..++......+++..+..++.||++||.|||+++|+|+||||+|||++.++.+||+|||+++....
T Consensus 75 ~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 75 SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred CEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 68999999997788888766554799999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.. ........+..|+|||.+.+...++.++||||||||+|+|++|.++|...+..+.+.+++.....+....|+.....
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 155 PN-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CC-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 22 22233355788999999876567889999999999999999999999998888888888888777777777665554
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 301 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~~~ 301 (481)
..+...... ........+..++.++++||.+||..||++|+|++|+|+|+||...+.+..
T Consensus 234 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 234 PDYVEFKPF--PPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred ccccccccc--CCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 433322211 112233445667889999999999999999999999999999988766654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=363.75 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=200.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... .......+.+|+.++++++|+||+++++++.+ .+.
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----------------~~~ 75 (381)
T cd05626 12 GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD----------------KDN 75 (381)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec----------------CCE
Confidence 8999999999999999999999976532 22334567889999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999986 666665543 46899999999999999999999999999999999999999999999999998643211
Q ss_pred CC----------------------------------------------CccccccccccCCCchhhcCCCCCCCCCchhh
Q 011627 161 HN----------------------------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWS 194 (481)
Q Consensus 161 ~~----------------------------------------------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwS 194 (481)
.. ......+||+.|+|||++.+ ..++.++||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwS 233 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWS 233 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceee
Confidence 00 01123578999999999976 57899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhc
Q 011627 195 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKML 274 (481)
Q Consensus 195 lGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 274 (481)
||||+|||++|+.||...+..+...++....... ..+. ...++.++++||.+||
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------~~~~-----------------~~~~s~~~~dli~~ll 287 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------HIPP-----------------QVKLSPEAVDLITKLC 287 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------CCCC-----------------CCCCCHHHHHHHHHHc
Confidence 9999999999999999888776666664321110 0000 1136789999999966
Q ss_pred cc--CCCCCCCHHHHhcCCCCCC
Q 011627 275 ML--DPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 275 ~~--dP~~R~sa~eiL~h~~f~~ 295 (481)
.. ++..|+++.||++|+||..
T Consensus 288 ~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 288 CSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred cCcccccCCCCHHHHhcCcccCC
Confidence 54 4555999999999999954
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.64 Aligned_cols=246 Identities=29% Similarity=0.463 Sum_probs=220.7
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|+||.+++++++.+.+.|+||+|+.....+.....+..|+.+++++.|||||.++++|.+ ++.
T Consensus 14 ~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~----------------~~~ 77 (426)
T KOG0589|consen 14 RGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE----------------DGQ 77 (426)
T ss_pred ccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc----------------CCc
Confidence 3899999999999999999999999988777667788999999999999999999999998 555
Q ss_pred -EEEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 82 -TYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 82 -~~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+||||+||+| ++...+.+.. ..|+++.+..|+.||+.||.|||++.|+|||||..|||++.++.|||.|||+|+.+.
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999996 6777776655 569999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
... ....+.+||+.||+||++.+ .+|+.++|||||||++|||++-++.|.+.+-...+.+|+.....+..
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp-------- 227 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP-------- 227 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC--------
Confidence 543 34556789999999999987 78999999999999999999999999999999999999876644332
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
..++.+++.||+.||..+|..||++.++|.+|.+.
T Consensus 228 ---------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 228 ---------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ---------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 24678999999999999999999999999998763
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=345.33 Aligned_cols=277 Identities=68% Similarity=1.151 Sum_probs=238.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||+++...........+.+|+.++++++|+||+++++++.+.. .+.+
T Consensus 10 g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------------~~~~ 75 (287)
T cd07840 10 GTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--------------KGSI 75 (287)
T ss_pred CCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--------------CCcE
Confidence 78999999999999999999999877544445567889999999999999999999998621 2689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++|.+++......+++.+++.++.||+.||+|||+.+++|+||||+|||+++++.+||+|||++........
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 76 YMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred EEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 99999999998888877656799999999999999999999999999999999999999999999999999987654433
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..+.+.+..+....|+....+...
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 33444566888999998876556789999999999999999999999999999999999999988888888877766555
Q ss_pred ccCCCchhhhhhHHHHHhhh-cHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHF-DRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~-~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
............+...+..+ +.++.++|++||..||++||+++++++|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 55555555555555666665 9999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=355.10 Aligned_cols=244 Identities=26% Similarity=0.419 Sum_probs=204.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||+++.... .......+..|+++++.+ +|+||+++++++.+ .+
T Consensus 6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~----------------~~ 69 (321)
T cd05591 6 GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT----------------KD 69 (321)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----------------CC
Confidence 8999999999999999999999986532 233345667899999876 79999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 70 RLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred eEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 89999999986 55555543 34689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......++|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 149 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~----------- 215 (321)
T cd05591 149 N-GVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY----------- 215 (321)
T ss_pred C-CccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2 223344578999999999876 678999999999999999999999999999888887775421100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-------CHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-------SAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-------sa~eiL~h~~f~~ 295 (481)
...++.++.+||.+||..||++|+ ++.++++|+||..
T Consensus 216 -------------------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 216 -------------------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred -------------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 012567899999999999999999 9999999999944
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=360.93 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=201.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++.... .......+.+|+.++++++|+||+++++.+.+ ...
T Consensus 12 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~----------------~~~ 75 (363)
T cd05628 12 GAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD----------------KLN 75 (363)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec----------------CCe
Confidence 8999999999999999999999976432 22234567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|.+++.+ ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999986 66666554 347999999999999999999999999999999999999999999999999998754321
Q ss_pred CC----------------------------------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCC
Q 011627 161 HN----------------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 206 (481)
Q Consensus 161 ~~----------------------------------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~ 206 (481)
.. ......+||+.|+|||++.+ ..++.++||||||||+|||++|+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCC
Confidence 10 01123578999999999986 57899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCC---CCCC
Q 011627 207 PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPS---QRIS 283 (481)
Q Consensus 207 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~---~R~s 283 (481)
.||...+..+.+.++........ ++. ...++.++++||.+||. ++. .|++
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~~~---------~p~-----------------~~~~s~~~~~li~~l~~-~~~~r~~r~~ 286 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKETLI---------FPP-----------------EVPISEKAKDLILRFCC-EWEHRIGAPG 286 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcCccc---------CCC-----------------cCCCCHHHHHHHHHHcC-ChhhcCCCCC
Confidence 99999888888877764211110 000 01267789999999875 454 4579
Q ss_pred HHHHhcCCCCCC
Q 011627 284 AKDALDSEYFWT 295 (481)
Q Consensus 284 a~eiL~h~~f~~ 295 (481)
++||++||||..
T Consensus 287 ~~ei~~hp~f~~ 298 (363)
T cd05628 287 VEEIKTNPFFEG 298 (363)
T ss_pred HHHHhCCCCCCC
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=359.53 Aligned_cols=246 Identities=25% Similarity=0.401 Sum_probs=198.0
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCc--CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNE--KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++. .+++.||||++..... .......+.+|+.+++++ +|+||+++++++..
T Consensus 11 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-------------- 76 (332)
T cd05614 11 GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-------------- 76 (332)
T ss_pred cCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--------------
Confidence 899999999874 5889999999975421 222345677899999999 59999999999987
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.+.+||||||+.+ +|.+.+.+ ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++
T Consensus 77 --~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 77 --EAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred --CCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 6689999999986 66666554 3468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH----HHHHHHHHhcCCCCCC
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA----EQLSKIFELCGSPDET 231 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~~~~~ 231 (481)
.+...........++|..|+|||++.+...++.++||||||||+|||++|+.||...... .....+.....
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----- 228 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP----- 228 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC-----
Confidence 654333333345678999999999987556789999999999999999999999754322 22222221100
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
.+...++..+.+||.+||..||++|+ +++++++|+||..
T Consensus 229 -------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 229 -------------------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 01123677899999999999999999 8899999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=360.87 Aligned_cols=248 Identities=27% Similarity=0.416 Sum_probs=202.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++..... .......+.+|+.+++.++|+||+++++++.+ ...
T Consensus 12 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----------------~~~ 75 (364)
T cd05599 12 GAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD----------------ENY 75 (364)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----------------CCe
Confidence 8999999999999999999999986432 22234556789999999999999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+...
T Consensus 76 ~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred EEEEECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999986 56665554 346999999999999999999999999999999999999999999999999998754321
Q ss_pred CCC-------------------------------------ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHH
Q 011627 161 HNN-------------------------------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 203 (481)
Q Consensus 161 ~~~-------------------------------------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ell 203 (481)
... .....+||+.|+|||++.. ..++.++||||||||+|||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhh
Confidence 100 1112468999999999876 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC
Q 011627 204 NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 283 (481)
Q Consensus 204 tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s 283 (481)
+|..||...+..+.+..+....... ..+. ...+++++++||.+||. ||.+|++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~~~---------~~~~-----------------~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKETL---------QFPD-----------------EVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCcc---------CCCC-----------------CCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 9999999988877777665321110 0000 01367789999999996 9999998
Q ss_pred ---HHHHhcCCCCCC
Q 011627 284 ---AKDALDSEYFWT 295 (481)
Q Consensus 284 ---a~eiL~h~~f~~ 295 (481)
+.|+|+|+||..
T Consensus 287 ~~~~~~ll~h~~~~~ 301 (364)
T cd05599 287 NNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCHHHHhcCCCcCC
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=335.13 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=206.2
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
+|-.|+|-.|.++.|++.+|+|++... .++.+|++++-+. .|+|||.++++|++. .....
T Consensus 72 ~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs------------~~~rk 132 (400)
T KOG0604|consen 72 AGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENS------------YQGRK 132 (400)
T ss_pred cccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhh------------ccCce
Confidence 466799999999999999999998743 2567999988877 499999999999863 23367
Q ss_pred eEEEEEecCCCC-hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC---CCeEEecccccc
Q 011627 81 STYMVFEYMDHD-LTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE---GNLKLADFGLAR 155 (481)
Q Consensus 81 ~~~iV~Ey~~g~-L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~---~~vkL~DFG~a~ 155 (481)
.+.||||.|+|+ |+..+.. ....|+|.++..|++||..||.|||+.+|.||||||||+|.... ..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 899999999974 5554443 33459999999999999999999999999999999999999754 359999999998
Q ss_pred cccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCCC
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE----AEQLSKIFELCGSPDET 231 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~~~~~~~~ 231 (481)
... ....+.+.|.|+.|.|||++.. ..|+.++|+||||||+|.||+|.+||..+.- ..+..+|......+++.
T Consensus 213 ~t~--~~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 213 ETQ--EPGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccC--CCccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 653 3556777899999999998864 7799999999999999999999999987643 34566666555555554
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.| ..+|.+++|+|++||..+|++|+|++++++|||+...
T Consensus 290 EW--------------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 290 EW--------------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hH--------------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 44 4688899999999999999999999999999999654
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=346.10 Aligned_cols=283 Identities=53% Similarity=0.923 Sum_probs=226.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||++......+.....+.+|+.++++++|+||+++++++...... ........
T Consensus 23 g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--------~~~~~~~~ 94 (310)
T cd07865 23 GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP--------YNRYKGSF 94 (310)
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc--------ccCCCceE
Confidence 7999999999999999999999987655555555677899999999999999999998764321 12235678
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.+++.+.+......+++.+++.++.||+.||+|||+++++|+||||+|||++.++.+||+|||++..+.....
T Consensus 95 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 174 (310)
T cd07865 95 YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174 (310)
T ss_pred EEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcc
Confidence 99999999999888877666799999999999999999999999999999999999999999999999999976643221
Q ss_pred ---CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 163 ---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 163 ---~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|+.+|...+....+..+...++......|+.....
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (310)
T cd07865 175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKL 254 (310)
T ss_pred cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccch
Confidence 12233456888999999876555788999999999999999999999999988888888888887777777665443
Q ss_pred CccccCCCchhhhhhHHHHH--hhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..+................. ...+..+++||.+||..||++|||++|+|+|+||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 255 ELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 33222221111111111111 1246778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=352.47 Aligned_cols=244 Identities=26% Similarity=0.433 Sum_probs=200.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||+++.... ..........|..++..+ +|+||+++++++.. ..
T Consensus 6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----------------~~ 69 (316)
T cd05592 6 GSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT----------------KE 69 (316)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc----------------CC
Confidence 8999999999999999999999986532 222334556777777755 89999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 70 HLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred EEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 89999999986 55555543 44699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.. ......++|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 149 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------ 214 (316)
T cd05592 149 GE-GKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPH------------ 214 (316)
T ss_pred CC-CccccccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 22 23344578999999999986 56899999999999999999999999998887777766432110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH-HHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-KDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa-~eiL~h~~f~~ 295 (481)
+...++.++.+||.+||..||++|+++ .++++|+||..
T Consensus 215 ------------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 215 ------------------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred ------------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 011366789999999999999999986 58889999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=363.32 Aligned_cols=248 Identities=29% Similarity=0.446 Sum_probs=201.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||++..... .......+.+|+.++++++|+||++++++|.+ .+.
T Consensus 12 G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~----------------~~~ 75 (382)
T cd05625 12 GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD----------------KDN 75 (382)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe----------------CCE
Confidence 8999999999999999999999975432 22234567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999986 676666543 46899999999999999999999999999999999999999999999999998543210
Q ss_pred CC----------------------------------------------CccccccccccCCCchhhcCCCCCCCCCchhh
Q 011627 161 HN----------------------------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWS 194 (481)
Q Consensus 161 ~~----------------------------------------------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwS 194 (481)
.. ......+||+.|+|||++.+ ..++.++||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwS 233 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWS 233 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEe
Confidence 00 01123468999999999986 57899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhc
Q 011627 195 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKML 274 (481)
Q Consensus 195 lGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 274 (481)
||||+|||++|+.||...+..+...++........ .+ ....+++++++||.+|+
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---------~p-----------------~~~~~s~~~~~li~~l~ 287 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH---------IP-----------------PQAKLSPEASDLIIKLC 287 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC---------CC-----------------CcccCCHHHHHHHHHHc
Confidence 99999999999999999888777766653211110 00 01246788999999987
Q ss_pred ccCCCCCCC---HHHHhcCCCCCC
Q 011627 275 MLDPSQRIS---AKDALDSEYFWT 295 (481)
Q Consensus 275 ~~dP~~R~s---a~eiL~h~~f~~ 295 (481)
.||++|++ +.++++|+||..
T Consensus 288 -~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 288 -RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred -cCHhHcCCCCCHHHHhcCCCcCC
Confidence 59999997 999999999954
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=357.79 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=207.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... .......+.+|+.+++.++|+||+++++++.+ ...
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~----------------~~~ 75 (330)
T cd05601 12 GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD----------------KDN 75 (330)
T ss_pred ccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec----------------CCe
Confidence 8999999999999999999999986532 22334567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|.+++.+....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+...
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999975 777777665567999999999999999999999999999999999999999999999999999876533
Q ss_pred CCCccccccccccCCCchhhcC-----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 161 HNNTLTNRVITLWYRPPELLLG-----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.........+|+.|+|||++.. ...++.++||||||||+|+|++|+.||...+....+.++........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------ 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK------ 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC------
Confidence 3323334568999999999863 24578899999999999999999999998888877777754311100
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+. ...++.++++||.+||. ||++|+|++++++|+||..
T Consensus 230 ---~~~-----------------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 230 ---FPE-----------------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred ---CCC-----------------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 000 01367789999999998 9999999999999999954
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=357.00 Aligned_cols=241 Identities=25% Similarity=0.345 Sum_probs=202.2
Q ss_pred cceeEEEEEEEccCC-cEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTG-EIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg-~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..++ ..||||++..... .......+.+|+.+++.++|+||+++++++.+ .+
T Consensus 41 G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----------------~~ 104 (340)
T PTZ00426 41 GSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD----------------ES 104 (340)
T ss_pred cCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe----------------CC
Confidence 899999999987665 7899999975432 22334567789999999999999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|.+++.+ ...+++..+..++.||+.||+|||+++|+||||||+||||+.++++||+|||+++.+..
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 89999999975 66666554 34699999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.....++|+.|+|||++.+ ..++.++||||||||+|||++|+.||...+.......+......
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------ 246 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY------------ 246 (340)
T ss_pred ----CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC------------
Confidence 2234578999999999986 56889999999999999999999999988887777776532111
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
+...++..+.+||++||+.||++|+ +++++++||||..
T Consensus 247 ------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 247 ------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred ------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 0123667899999999999999996 8999999999964
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=351.70 Aligned_cols=244 Identities=25% Similarity=0.415 Sum_probs=200.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++.+++.||||+++.... ..........|+.++..+ +|+||+++++++.+ .+
T Consensus 6 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----------------~~ 69 (316)
T cd05620 6 GSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT----------------KE 69 (316)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe----------------CC
Confidence 8999999999999999999999986532 122344567788888765 89999999999987 67
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
++||||||+.+ +|...+.. ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 70 ~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 70 HLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred EEEEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 89999999986 66555544 45689999999999999999999999999999999999999999999999999874321
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........++|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+......
T Consensus 149 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~------------ 214 (316)
T cd05620 149 -GDNRASTFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPH------------ 214 (316)
T ss_pred -CCCceeccCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 1223345678999999999986 57899999999999999999999999988887776666431100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH-HHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-KDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa-~eiL~h~~f~~ 295 (481)
....++.++++||++||..||++|+++ +++++|+||..
T Consensus 215 ------------------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 215 ------------------YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred ------------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 001256789999999999999999998 58889999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=358.17 Aligned_cols=277 Identities=30% Similarity=0.500 Sum_probs=212.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||++............+.+|+.+++.++|+||+++++++...... .....+
T Consensus 28 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----------~~~~~~ 97 (355)
T cd07874 28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL----------EEFQDV 97 (355)
T ss_pred cCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc----------ccccee
Confidence 8999999999999999999999976544444456778999999999999999999998753211 113468
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+++++...+.. .+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.... .
T Consensus 98 ~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~--~ 172 (355)
T cd07874 98 YLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 172 (355)
T ss_pred EEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC--c
Confidence 99999999988776653 488999999999999999999999999999999999999999999999999976532 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC-----
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS----- 237 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~----- 237 (481)
.......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+++..+.+....+....
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 22344578999999999986 578999999999999999999999999988888777777665544322211110
Q ss_pred ---CCCccccCCCch----hhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 ---KMPAYNHFKPSR----TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ---~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..+.+....... .............+.++++||.+||..||++|||+.|+|+||||..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 000000000000 0000001112235678899999999999999999999999999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.29 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=200.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||++..... .......+.+|++++++++|+||++++++|.+ ...
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~----------------~~~ 75 (377)
T cd05629 12 GAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD----------------AQY 75 (377)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----------------CCe
Confidence 8999999999999999999999875432 22334567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|..++.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999975 67666654 346899999999999999999999999999999999999999999999999999643211
Q ss_pred CCC----------------------------------------------ccccccccccCCCchhhcCCCCCCCCCchhh
Q 011627 161 HNN----------------------------------------------TLTNRVITLWYRPPELLLGATKYGPAVDMWS 194 (481)
Q Consensus 161 ~~~----------------------------------------------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwS 194 (481)
... .....+||+.|+|||++.+ ..++.++||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS 233 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWS 233 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEe
Confidence 000 0012468999999999976 57899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhc
Q 011627 195 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKML 274 (481)
Q Consensus 195 lGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 274 (481)
||||+|||++|..||...+..+.+.++....... .++. ...++.++++||.+||
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------~~p~-----------------~~~~s~~~~dli~~lL 287 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRETL---------YFPD-----------------DIHLSVEAEDLIRRLI 287 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc---------CCCC-----------------CCCCCHHHHHHHHHHh
Confidence 9999999999999999888877777765321110 0010 0136778999999999
Q ss_pred ccCCCCC---CCHHHHhcCCCCCC
Q 011627 275 MLDPSQR---ISAKDALDSEYFWT 295 (481)
Q Consensus 275 ~~dP~~R---~sa~eiL~h~~f~~ 295 (481)
. +|.+| +|+.|++.|+||..
T Consensus 288 ~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 288 T-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred c-CHhhcCCCCCHHHHhcCCCcCC
Confidence 8 77765 59999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.75 Aligned_cols=242 Identities=27% Similarity=0.402 Sum_probs=201.4
Q ss_pred CcceeEEEEEEEccCCcE-EEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEI-VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~-vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
.|+||+||++.. .|+. ||||++............+.+|+.+|++|+|||||+|++++.++ ..
T Consensus 51 ~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~---------------~~ 113 (362)
T KOG0192|consen 51 SGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP---------------PG 113 (362)
T ss_pred cCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---------------CC
Confidence 389999999998 4555 99999987654443467889999999999999999999999873 22
Q ss_pred eEEEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCcEEEcCCC-CeEEeccccccc
Q 011627 81 STYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQ-VLHRDIKGSNLLIDNEG-NLKLADFGLARS 156 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~g-iiHrDLKp~NILl~~~~-~vkL~DFG~a~~ 156 (481)
.++|||||+.+ +|..++.. ....++...+..|+.||+.||+|||+++ |||||||++||||+.+. ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 68999999985 66666666 3677999999999999999999999999 99999999999999997 999999999987
Q ss_pred ccCCCCCccccccccccCCCchhhcC-CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
..... ...+...||..|||||++.+ ...|+.++||||||||+|||+||+.||...........+......+.
T Consensus 194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~------ 266 (362)
T KOG0192|consen 194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP------ 266 (362)
T ss_pred ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------
Confidence 54322 34444688999999999985 26799999999999999999999999999998666666643222111
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+...+++.+.+||.+|+..||++||+..+|+.
T Consensus 267 ----------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 ----------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ----------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11226778999999999999999999999974
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.31 Aligned_cols=248 Identities=28% Similarity=0.444 Sum_probs=201.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||++..... .......+.+|+.+|++++|+||+++++.+.+ ++.
T Consensus 12 G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----------------~~~ 75 (376)
T cd05598 12 GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD----------------KDN 75 (376)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc----------------CCE
Confidence 8999999999999999999999975422 22234567789999999999999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|..+...
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999985 666666543 46899999999999999999999999999999999999999999999999998543210
Q ss_pred CC------------------------------------------CccccccccccCCCchhhcCCCCCCCCCchhhHHHH
Q 011627 161 HN------------------------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 198 (481)
Q Consensus 161 ~~------------------------------------------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvi 198 (481)
.. ......+||+.|+|||++.+ ..++.++||||||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 233 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVI 233 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccce
Confidence 00 01123478999999999976 678999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCC
Q 011627 199 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 278 (481)
Q Consensus 199 l~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 278 (481)
+|||++|+.||...+..+...++........ .+ ....++.++.+||.+|+ .||
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---------~~-----------------~~~~~s~~~~~li~~l~-~~p 286 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWETTLH---------IP-----------------SQAKLSREASDLILRLC-CGA 286 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCcccc---------CC-----------------CCCCCCHHHHHHHHHHh-cCH
Confidence 9999999999999887776666543211100 00 01236778999999977 599
Q ss_pred CCCC---CHHHHhcCCCCCC
Q 011627 279 SQRI---SAKDALDSEYFWT 295 (481)
Q Consensus 279 ~~R~---sa~eiL~h~~f~~ 295 (481)
.+|+ |+.++++|+||..
T Consensus 287 ~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 287 EDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hhcCCCCCHHHHhCCCCcCC
Confidence 9999 9999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=358.50 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=205.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++.... .......+.+|+.+++.++|+||+++++++.+ ...
T Consensus 54 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~----------------~~~ 117 (370)
T cd05596 54 GAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD----------------DKY 117 (370)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec----------------CCE
Confidence 8999999999999999999999975422 22223456789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|..++.. ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999985 66666543 35899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCccccccccccCCCchhhcCC---CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
........++|+.|+|||++... ..++.++|||||||++|||++|+.||...+....+.++....... .++.
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~-- 270 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL---TFPD-- 270 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC---CCCC--
Confidence 32233456789999999998653 247889999999999999999999999988877777775421111 0110
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTD 296 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~sa~eiL~h~~f~~~ 296 (481)
...++.++++||++||..+|++ |+|++|+++|+||+..
T Consensus 271 ---------------------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 271 ---------------------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred ---------------------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 0136789999999999999988 9999999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=358.20 Aligned_cols=248 Identities=30% Similarity=0.455 Sum_probs=206.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++..... ......+.+|+.+++.++|+||+++++++.+ .+.
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~ 75 (350)
T cd05573 12 GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD----------------EEH 75 (350)
T ss_pred CCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec----------------CCe
Confidence 89999999999999999999999865322 2345567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+...
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999975 677766654 57999999999999999999999999999999999999999999999999999866433
Q ss_pred C----------------------------CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCC
Q 011627 161 H----------------------------NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK 212 (481)
Q Consensus 161 ~----------------------------~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 212 (481)
. ........+|+.|+|||++.+ ..++.++||||||||||+|++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 2 122334578999999999987 57899999999999999999999999998
Q ss_pred ChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-HHHHhcCC
Q 011627 213 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-AKDALDSE 291 (481)
Q Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-a~eiL~h~ 291 (481)
+..+...++....... ..+. ...++.++.+||.+||. ||.+|++ ++++|+|+
T Consensus 234 ~~~~~~~~i~~~~~~~---------~~p~-----------------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 234 TLQETYNKIINWKESL---------RFPP-----------------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CHHHHHHHHhccCCcc---------cCCC-----------------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 8877777775421111 0110 01267789999999997 9999999 99999999
Q ss_pred CCCC
Q 011627 292 YFWT 295 (481)
Q Consensus 292 ~f~~ 295 (481)
||..
T Consensus 287 ~~~~ 290 (350)
T cd05573 287 FFKG 290 (350)
T ss_pred CcCC
Confidence 9954
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=344.07 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=198.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||++++..+++.||||++...... ......+..|+.++++++|+||+++++++.. ...
T Consensus 4 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----------------~~~ 67 (280)
T cd05608 4 GGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT----------------KTD 67 (280)
T ss_pred CCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC----------------CCe
Confidence 89999999999999999999999755322 2223456789999999999999999999876 668
Q ss_pred EEEEEecCCC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
+||||||+.+ +|...+. .....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+
T Consensus 68 ~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 147 (280)
T cd05608 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147 (280)
T ss_pred EEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence 9999999986 5554442 23446899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........
T Consensus 148 ~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 218 (280)
T cd05608 148 KDGQ-SKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV------- 218 (280)
T ss_pred CCCC-ccccccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC-------
Confidence 4322 22334567999999999986 57889999999999999999999999876543222222211100000
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
.+...++.++.+||.+||+.||++|+ +++++++|+||..
T Consensus 219 -------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 219 -------------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred -------------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 01124778899999999999999999 8899999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.69 Aligned_cols=244 Identities=25% Similarity=0.411 Sum_probs=199.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHH-HHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~-il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||++..... .......+++|+. +++.++|+||+++++++.+ .+
T Consensus 6 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~----------------~~ 69 (323)
T cd05575 6 GSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----------------AD 69 (323)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe----------------CC
Confidence 8999999999999999999999975432 1222334555555 5678999999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 70 KLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred EEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 89999999986 55555543 45689999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+......
T Consensus 149 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------ 214 (323)
T cd05575 149 -HSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR------------ 214 (323)
T ss_pred -CCCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 2223344578999999999876 67899999999999999999999999988887777776532100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa----~eiL~h~~f~~ 295 (481)
+...++.++.+||++||+.||++|+++ .|+++|+||..
T Consensus 215 ------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 215 ------------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred ------------------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 012357789999999999999999988 69999999954
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=351.27 Aligned_cols=244 Identities=26% Similarity=0.439 Sum_probs=201.4
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCc--CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNE--KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|++. .+++.||||+++.... .......+.+|+.+++.++|+||++++++|..
T Consensus 7 G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--------------- 71 (323)
T cd05584 7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--------------- 71 (323)
T ss_pred cCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec---------------
Confidence 899999999974 5789999999975421 12223456789999999999999999999987
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
++.+||||||+.+ +|.+.+.+ ...+.+..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 72 -GGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred -CCeEEEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 6689999999986 55555543 44689999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.... .......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||...+....+..+......
T Consensus 150 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~--------- 218 (323)
T cd05584 150 SIHE-GTVTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN--------- 218 (323)
T ss_pred cccC-CCcccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 4322 222334578999999999876 56789999999999999999999999998887777766532110
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
+...++.++.+||.+||..||++|+ ++.++++|+||..
T Consensus 219 ---------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 219 ---------------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred ---------------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 0123567899999999999999999 8999999999964
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=349.97 Aligned_cols=244 Identities=27% Similarity=0.455 Sum_probs=202.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||+++... ........+.+|+.+++.+ +|+||+++++++.+ .+
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~----------------~~ 69 (318)
T cd05570 6 GSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT----------------KD 69 (318)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----------------CC
Confidence 889999999999999999999998653 2223345667899999988 69999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+. ....+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 70 RLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred EEEEEEcCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 89999999986 5555444 344799999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......++|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+......
T Consensus 149 ~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~------------ 214 (318)
T cd05570 149 G-GVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR------------ 214 (318)
T ss_pred C-CCcccceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 1 222334568999999999986 67899999999999999999999999988877776666432100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa-----~eiL~h~~f~~ 295 (481)
+...++.++.+||++||..||++|+|+ .++++|+||..
T Consensus 215 ------------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 215 ------------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred ------------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 012367789999999999999999999 99999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=355.30 Aligned_cols=246 Identities=25% Similarity=0.354 Sum_probs=200.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhc---CCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++.||||++..... .........+|..++.++ .|+||+++++++.+
T Consensus 4 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~---------------- 67 (330)
T cd05586 4 GTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT---------------- 67 (330)
T ss_pred CCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec----------------
Confidence 8999999999999999999999975421 222233455677777766 69999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...+||||||+.+ +|...+.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 68 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 68 DSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred CCeEEEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 6689999999986 56555543 456999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
... .......++|..|+|||++.+...++.++||||||||+|+|++|+.||...+..+.+..+.......
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------- 216 (330)
T cd05586 147 LTD-NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF--------- 216 (330)
T ss_pred CCC-CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 322 2233446789999999999765568999999999999999999999999888777766664211000
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI----SAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~----sa~eiL~h~~f~~ 295 (481)
+ ...++.++++||++||..||++|+ ++.++++|+||..
T Consensus 217 --~------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 217 --P------------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred --C------------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 0 012577899999999999999998 7999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=354.69 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=193.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++..... ......+.+|++++++++|+||+++++++.+ .+.+
T Consensus 85 G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 147 (353)
T PLN00034 85 GAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDH----------------NGEI 147 (353)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEecc----------------CCeE
Confidence 7999999999999999999999965432 2234567899999999999999999999976 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||++++.+.. ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+....
T Consensus 148 ~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 148 QVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred EEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 99999999754322 1235778889999999999999999999999999999999999999999999998764321
Q ss_pred CccccccccccCCCchhhcCC----CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 163 NTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
......++|..|+|||++... ...+.++||||||||+|||++|+.||......+....+.........
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 294 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP-------- 294 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC--------
Confidence 223345789999999987431 23456899999999999999999999854433222222211110000
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....++.++++||.+||..||++|+|+.|||+|+||..
T Consensus 295 ------------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 295 ------------------EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred ------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 011246778999999999999999999999999999955
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=356.42 Aligned_cols=250 Identities=26% Similarity=0.330 Sum_probs=204.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||+|+++.+++.||+|++..... .......+.+|+.+++.++|+||+++++++.+ ...
T Consensus 54 G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~----------------~~~ 117 (370)
T cd05621 54 GAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD----------------DKY 117 (370)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc----------------CCE
Confidence 8999999999999999999999975322 22223456789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|.+++... .+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|..+...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999985 677766443 5899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCccccccccccCCCchhhcCC---CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
........++|+.|+|||++... ..++.++|||||||++|+|++|+.||...+....+.++........ ++.
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~p~-- 270 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN---FPE-- 270 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---CCC--
Confidence 33333456789999999998753 2378899999999999999999999999888877777764321111 110
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTD 296 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~sa~eiL~h~~f~~~ 296 (481)
...++..+++||.+||..++.+ |+|+.|+++||||+..
T Consensus 271 ---------------------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 271 ---------------------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ---------------------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 0136778999999999866544 8999999999999653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=368.60 Aligned_cols=268 Identities=22% Similarity=0.328 Sum_probs=204.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCC------CccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE------NVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hp------nIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++..+++.||||+++... ........|+.++++++|. +|++++++|...
T Consensus 140 G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~------------- 203 (467)
T PTZ00284 140 GTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE------------- 203 (467)
T ss_pred ccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-------------
Confidence 899999999999999999999997432 1233456788888888654 488888888652
Q ss_pred CcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCC-----------
Q 011627 77 KYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEG----------- 144 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~----------- 144 (481)
..++|||||++.++|++++.+. ..+++..++.|+.||+.||+|||+ .+||||||||+||||+.++
T Consensus 204 --~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 204 --TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred --CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 4579999999998988877654 469999999999999999999998 5999999999999998765
Q ss_pred -----CeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 011627 145 -----NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 219 (481)
Q Consensus 145 -----~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 219 (481)
.+||+|||++.... ......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+.+.
T Consensus 281 ~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCCceEEECCCCccccCc----cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999886432 22345678999999999987 678999999999999999999999999999988888
Q ss_pred HHHHhcCCCCCCCCccCCC-----C-CccccCCCchhhhhhHHH------HH-hhhcHHHHHHHHHhcccCCCCCCCHHH
Q 011627 220 KIFELCGSPDETIWPGVSK-----M-PAYNHFKPSRTMKRRVRE------VF-RHFDRHALELLEKMLMLDPSQRISAKD 286 (481)
Q Consensus 220 ~i~~~~~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~------~~-~~~~~~~~~ll~~~L~~dP~~R~sa~e 286 (481)
.+.+..+.++..++..... + ......++... ...+.. .. ...+..++|||.+||..||++|+|++|
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTD-PKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCC-HHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 8888777654332211000 0 00000000000 000000 00 012467889999999999999999999
Q ss_pred HhcCCCCCC
Q 011627 287 ALDSEYFWT 295 (481)
Q Consensus 287 iL~h~~f~~ 295 (481)
||+||||..
T Consensus 435 ~L~Hp~~~~ 443 (467)
T PTZ00284 435 MTTHPYVLK 443 (467)
T ss_pred HhcCccccc
Confidence 999999965
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.92 Aligned_cols=272 Identities=46% Similarity=0.886 Sum_probs=225.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++..... .....+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 11 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 73 (284)
T cd07836 11 GTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT----------------ENKL 73 (284)
T ss_pred CCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee----------------CCcE
Confidence 78999999999999999999999866432 234567789999999999999999999987 5678
Q ss_pred EEEEecCCCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDHDLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
||||||+.++|.+++.... ..+++..+..++.||+.||+|||+++|+|+||||+||++++++.+||+|||++..+...
T Consensus 74 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 74 MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred EEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 9999999998888776533 45899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
. .......++..|++||++.+...++.++|||||||++|+|++|+.||...+..+.+.++++....+....|......+
T Consensus 154 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 154 V-NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred c-cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 2 222334568899999998765567889999999999999999999999999999999999888888777776665444
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.+....+.. .......+...++.+++++|.+||+.||++|++++++++|+||
T Consensus 233 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 233 EYKPTFPRY-PPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hhcccccCC-ChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 333211111 1122344455678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=350.55 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=196.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||+++..... ......+.+|+.+++++ +|+||++++++|.+ .+
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~----------------~~ 69 (329)
T cd05588 6 GSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT----------------ES 69 (329)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc----------------CC
Confidence 88999999999999999999999865322 22344577899999999 79999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|||||||.+ +|...+.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~~lv~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 70 RLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred EEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 89999999986 56555543 35799999999999999999999999999999999999999999999999999875321
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh--------HH-HHHHHHHhcCCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--------AE-QLSKIFELCGSPDE 230 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--------~~-~~~~i~~~~~~~~~ 230 (481)
........++|..|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+ ....+....
T Consensus 149 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----- 221 (329)
T cd05588 149 -PGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----- 221 (329)
T ss_pred -CCCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-----
Confidence 1223344678999999999986 6789999999999999999999999963211 11 111121100
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS------AKDALDSEYFWT 295 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s------a~eiL~h~~f~~ 295 (481)
..+...++.++.+||++||+.||++|+| ++++++|+||..
T Consensus 222 -------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 222 -------------------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 0011246778999999999999999987 789999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=348.55 Aligned_cols=243 Identities=28% Similarity=0.431 Sum_probs=199.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHH---HhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKIL---KKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il---~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++.||||+++... ........+.+|+.++ +.++|+||+++++++.+
T Consensus 10 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~---------------- 73 (324)
T cd05589 10 GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT---------------- 73 (324)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc----------------
Confidence 899999999999999999999998553 1222344566676665 45679999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
.+.+||||||+.+ +|...+.. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 6689999999986 55544433 36999999999999999999999999999999999999999999999999998753
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
... .......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+......
T Consensus 152 ~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~---------- 219 (324)
T cd05589 152 MGF-GDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR---------- 219 (324)
T ss_pred CCC-CCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence 321 222344678999999999876 57899999999999999999999999998888777776542111
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
....++.++.+||.+||..||++|+ ++.++++|+||..
T Consensus 220 --------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 220 --------------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred --------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 0123677899999999999999999 7999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=352.17 Aligned_cols=244 Identities=25% Similarity=0.432 Sum_probs=203.2
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||++++. .+++.||||+++...........+.+|++++++|+|+||+++++++.+ .
T Consensus 7 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~ 70 (318)
T cd05582 7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT----------------E 70 (318)
T ss_pred CCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc----------------C
Confidence 889999999874 688999999998654333334466789999999999999999999987 6
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.+||||||+.+ +|.+.+.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus 71 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 71 GKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred CEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 689999999985 66666544 3468999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. .......++|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+......
T Consensus 150 ~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~----------- 216 (318)
T cd05582 150 DH-EKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG----------- 216 (318)
T ss_pred CC-CCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 22 122334578999999999876 56789999999999999999999999988887777776532110
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
+...++.++.+||++||+.||++|++ +.++++|+||..
T Consensus 217 -------------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 217 -------------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred -------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 01236778999999999999999999 788999999954
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=337.21 Aligned_cols=274 Identities=35% Similarity=0.625 Sum_probs=214.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||++............+.+|+.++++++|+||+++++++.. ...+
T Consensus 12 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~ 75 (286)
T cd07847 12 GSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR----------------KRKL 75 (286)
T ss_pred cCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee----------------CCEE
Confidence 789999999999999999999987654433344567799999999999999999999987 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||++++++..+......+++..++.++.||+.+|+|||+++|+|+||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999999887777666556799999999999999999999999999999999999999999999999999987643221
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....................+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 2233456889999999876566889999999999999999999999988877776666544332211100000000000
Q ss_pred ccC-CCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 243 NHF-KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 243 ~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
... .+...........+..++..+.+||.+||..||++|||+.|++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 001111112334455678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=339.48 Aligned_cols=273 Identities=44% Similarity=0.742 Sum_probs=215.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||++..... ......+.+|+.+++.++|+||+++++++.. ....
T Consensus 16 g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----------------~~~~ 78 (291)
T cd07870 16 GSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT----------------KETL 78 (291)
T ss_pred cCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec----------------CCeE
Confidence 7899999999999999999999976532 2233466799999999999999999999986 5688
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+.++++..+......+++..++.++.||+.||+|||+++|+|+||||+|||++.++++||+|||+++......
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9999999999888776655668899999999999999999999999999999999999999999999999987643222
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|+.||...+. .+.+.++....+.+.+..|+....++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 1223345688999999987655678899999999999999999999976543 456666666666666666655554443
Q ss_pred cccCCCchhhhhhHHHHHhh--hcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+................+.. .+.++.+||.+||..||++|+|+.|+|.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 32211111111112222222 35689999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=346.86 Aligned_cols=271 Identities=24% Similarity=0.328 Sum_probs=202.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..++..||+|+++.... ......+.+|++++++++|+||+++++++.. .+.+
T Consensus 16 G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 78 (331)
T cd06649 16 GNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS----------------DGEI 78 (331)
T ss_pred CCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----------------CCEE
Confidence 8899999999999999999999986532 2234578899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999986 66655544 34689999999999999999999986 6999999999999999999999999998765322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+....+...........+.......
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence 2234567999999999986 568999999999999999999999998776655433221111000111111110000
Q ss_pred c------ccc---CCCchhhhhhHHHH---------HhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 A------YNH---FKPSRTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~------~~~---~~~~~~~~~~~~~~---------~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
. ... .............+ ...++.++++||.+||..||++|||+.|||+|+||..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 0 000 00000000000000 1146789999999999999999999999999999965
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=348.41 Aligned_cols=244 Identities=25% Similarity=0.441 Sum_probs=201.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCC-CccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHE-NVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hp-nIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||+++.... .......+..|+.+++.+.|+ +|+++++++.+ .+
T Consensus 11 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----------------~~ 74 (324)
T cd05587 11 GSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----------------MD 74 (324)
T ss_pred ccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc----------------CC
Confidence 8999999999999999999999986532 223345677899999999765 58888888876 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+.. ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.....
T Consensus 75 ~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 75 RLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 89999999986 66555543 34689999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......++|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+......
T Consensus 154 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~------------ 219 (324)
T cd05587 154 G-GKTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS------------ 219 (324)
T ss_pred C-CCceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 1 222334578999999999986 57899999999999999999999999998888877777542111
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa-----~eiL~h~~f~~ 295 (481)
+...++.++++||.+||..||++|+++ .++++|+||..
T Consensus 220 ------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 220 ------------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred ------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 012367789999999999999999976 89999999954
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=346.25 Aligned_cols=283 Identities=45% Similarity=0.835 Sum_probs=231.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC------------cchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG------------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 70 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~------------~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~ 70 (481)
|+||+||+|++..+++.||||+++....... ....+.+|++++++++|+||+++++++..
T Consensus 20 G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 91 (335)
T PTZ00024 20 GTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE-------- 91 (335)
T ss_pred CCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec--------
Confidence 8999999999999999999999875532220 12246789999999999999999999986
Q ss_pred CCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEec
Q 011627 71 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 150 (481)
Q Consensus 71 ~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 150 (481)
...+|+||||+.++|.+.+... ..+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|
T Consensus 92 --------~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 92 --------GDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred --------CCcEEEEEeccccCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECC
Confidence 6689999999999888877643 4689999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-------------CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHH
Q 011627 151 FGLARSFSYD-------------HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 217 (481)
Q Consensus 151 FG~a~~~~~~-------------~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 217 (481)
||++...... .........++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999765411 111222335578899999987755678999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 218 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
+..+++..+.+....|+....++.+..+... ...........++.++.+||.+||+.||++|+|++|+|.|+||+...
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPR--KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcC--CcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 9999988888877777766554443322221 12233444566788999999999999999999999999999998877
Q ss_pred CCCCCCC
Q 011627 298 LPCDPKS 304 (481)
Q Consensus 298 ~~~~~~~ 304 (481)
.+.+...
T Consensus 321 ~~~~~~~ 327 (335)
T PTZ00024 321 LPCDPSQ 327 (335)
T ss_pred CCCCccc
Confidence 7655443
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.71 Aligned_cols=244 Identities=27% Similarity=0.459 Sum_probs=200.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||+++.... .+........|+.+++.+ +|+||+++++++.+ .+
T Consensus 6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~----------------~~ 69 (316)
T cd05619 6 GSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT----------------KE 69 (316)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe----------------CC
Confidence 8999999999999999999999986532 122344566788888765 89999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+.. ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 70 ~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 70 NLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 89999999985 66666554 34689999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......++|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+......
T Consensus 149 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~------------ 214 (316)
T cd05619 149 G-DAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC------------ 214 (316)
T ss_pred C-CCceeeecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 1 122334578999999999976 57899999999999999999999999988877766665321100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK-DALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~-eiL~h~~f~~ 295 (481)
....++.++++||.+||..||++|+++. ++++|+||..
T Consensus 215 ------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 215 ------------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred ------------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 0012567899999999999999999996 8999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=339.96 Aligned_cols=278 Identities=44% Similarity=0.786 Sum_probs=223.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++...........+.+|+.+++++. |+||+++++++..... .....
T Consensus 12 g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~-----------~~~~~ 80 (295)
T cd07837 12 GTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK-----------NGKPS 80 (295)
T ss_pred cCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC-----------CCCce
Confidence 78999999999999999999998876554445567889999999995 6999999999876321 11235
Q ss_pred EEEEEecCCCChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCeEEeccccccc
Q 011627 82 TYMVFEYMDHDLTGLADRP----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~----~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~ 156 (481)
+|+||||++++|..++... ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999888776543 235899999999999999999999999999999999999998 88999999999976
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
+.... .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.++.+.+.+++.....+....|+..
T Consensus 161 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54321 22233356888999999876556789999999999999999999999999998888888887777777777665
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
............ .........+.++.++.+||.+||..||++|+|+.|+|.|+||.
T Consensus 240 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQW--KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcc--cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 544332211110 11223334456889999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.94 Aligned_cols=244 Identities=24% Similarity=0.378 Sum_probs=195.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||+|+++.... .......+.+|+.++.++ +|+||+++++++.. .+
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~----------------~~ 69 (329)
T cd05618 6 GSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----------------ES 69 (329)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe----------------CC
Confidence 8999999999999999999999986532 222344567899998877 79999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+. ....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~~lv~E~~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 70 RLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred EEEEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 89999999986 5554444 345699999999999999999999999999999999999999999999999999875332
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhcCCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---------EAEQLSKIFELCGSPDE 230 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~---------~~~~~~~i~~~~~~~~~ 230 (481)
. .......++|..|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+....
T Consensus 149 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 221 (329)
T cd05618 149 P-GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 221 (329)
T ss_pred C-CCccccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-----
Confidence 2 222344578999999999986 678999999999999999999999995311 111112221100
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS------AKDALDSEYFWT 295 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s------a~eiL~h~~f~~ 295 (481)
..+...++.++++||++||+.||++|++ +.++++||||+.
T Consensus 222 -------------------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 222 -------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 0012246778999999999999999998 589999999954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=349.37 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=199.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHH-HHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~-il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||++..... .......+.+|.. +++.++|+||+++++++.+ .+
T Consensus 6 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~----------------~~ 69 (325)
T cd05602 6 GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----------------AD 69 (325)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc----------------CC
Confidence 8999999999999999999999975432 1112234444544 5688899999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 70 KLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred eEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 89999999987 55555543 45689999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+......
T Consensus 149 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~------------ 214 (325)
T cd05602 149 -HNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ------------ 214 (325)
T ss_pred -CCCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC------------
Confidence 2223344578999999999986 67899999999999999999999999998888877776542110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHH----HHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK----DALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~----eiL~h~~f~~ 295 (481)
....++..+.+||.+||+.||.+|+++. ++++|+||..
T Consensus 215 ------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 215 ------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 1124677899999999999999999876 8999999943
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=338.60 Aligned_cols=273 Identities=51% Similarity=0.912 Sum_probs=224.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|++|+||+|++..+++.||||++............+.+|+.++++++|+||+++++++.+ ....
T Consensus 10 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~----------------~~~~ 73 (283)
T cd07835 10 GTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS----------------ENKL 73 (283)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc----------------CCeE
Confidence 789999999999999999999998765544455678899999999999999999999976 5689
Q ss_pred EEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||++++|.+++.... ..+++..+..++.||+.+|+|||+++++|+||+|+|||++.++.+||+|||++..+....
T Consensus 74 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 74 YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred EEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 9999999888887776543 468999999999999999999999999999999999999999999999999997653221
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+.++++....+....|+....++.
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1223335588899999887655678899999999999999999999999998888888888777777777766555443
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+....... ...........++.++.+||.+||+.||++|||++|+++|+||
T Consensus 233 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 233 YKPTFPKW-ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhcccc-cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 32211110 0112233345688899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=339.62 Aligned_cols=275 Identities=48% Similarity=0.856 Sum_probs=225.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+++++.+++.||||+++...........+.+|++++++++|+||+++++++.+ ...+
T Consensus 13 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 76 (294)
T PLN00009 13 GTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS----------------EKRL 76 (294)
T ss_pred CCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec----------------CCeE
Confidence 789999999999999999999997665444445577899999999999999999999987 5689
Q ss_pred EEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCeEEecccccccccCC
Q 011627 83 YMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+++++...+.... ..+++..++.++.||+.||+|||+++|+|+||||+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999999988887775433 34688899999999999999999999999999999999985 456999999999765322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+.+++...+.+....|.....++
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 2222334568899999998765567899999999999999999999999999888888898888888888888766655
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+....+. ............++.++.+||.+||+.||++||++.++|+|+||..
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 236 DYKSAFPK-WPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhhccc-CCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 54322111 0112223334567889999999999999999999999999999954
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=349.78 Aligned_cols=244 Identities=23% Similarity=0.368 Sum_probs=199.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHH-HHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~-il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||++..... .......+.+|.. +++.++|+||+++++++.. .+
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~----------------~~ 69 (325)
T cd05604 6 GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----------------TE 69 (325)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec----------------CC
Confidence 8999999999999999999999975522 2222334555655 4677999999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+. ....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 70 KLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred EEEEEEcCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 89999999986 4544443 445799999999999999999999999999999999999999999999999999875321
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........++|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+.++......
T Consensus 149 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~------------ 214 (325)
T cd05604 149 -QSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLV------------ 214 (325)
T ss_pred -CCCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCcc------------
Confidence 1223345678999999999976 67889999999999999999999999988877777766532100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa----~eiL~h~~f~~ 295 (481)
....++.++.+||++||..||++|+++ .++++|+||..
T Consensus 215 ------------------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 215 ------------------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred ------------------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 011356789999999999999999977 59999999954
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.54 Aligned_cols=244 Identities=23% Similarity=0.363 Sum_probs=197.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHH-HHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~-il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||++..... .......+.+|+. +++.++|+||+++++++.+ .+
T Consensus 6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~----------------~~ 69 (321)
T cd05603 6 GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT----------------AE 69 (321)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc----------------CC
Confidence 8999999999999999999999975432 2222334555554 6788999999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|||||||.+ +|...+. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 70 KLYFVLDYVNGGELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred EEEEEEcCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 89999999986 5544443 345689999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........++|+.|+|||++.+ ..++.++||||||||+|||++|+.||...+.......+......
T Consensus 149 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~------------ 214 (321)
T cd05603 149 -PEETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ------------ 214 (321)
T ss_pred -CCCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC------------
Confidence 1223344578999999999876 57899999999999999999999999988877766666431100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa----~eiL~h~~f~~ 295 (481)
+....+.++.+||.+||+.||++|+++ .++++|+||..
T Consensus 215 ------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 215 ------------------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred ------------------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 011356689999999999999999875 59999999953
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=353.72 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=202.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++... ........+.+|+.++..++|+||+++++.+.+ .+.
T Consensus 12 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----------------~~~ 75 (360)
T cd05627 12 GAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD----------------KRN 75 (360)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc----------------CCE
Confidence 899999999999999999999997543 223344567789999999999999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|.+++.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999986 66666554 346999999999999999999999999999999999999999999999999998754321
Q ss_pred CC----------------------------------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCC
Q 011627 161 HN----------------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 206 (481)
Q Consensus 161 ~~----------------------------------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~ 206 (481)
.. ......+||+.|+|||++.+ ..++.++||||||||+|||++|+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCC
Confidence 10 01123578999999999986 67899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC---C
Q 011627 207 PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI---S 283 (481)
Q Consensus 207 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~---s 283 (481)
.||...+..+.+.++....... .++. ...++.++++||.+|+. ||.+|+ +
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~~---------~~p~-----------------~~~~s~~~~~li~~l~~-~p~~R~~~~~ 286 (360)
T cd05627 234 PPFCSETPQETYRKVMNWKETL---------VFPP-----------------EVPISEKAKDLILRFCT-DSENRIGSNG 286 (360)
T ss_pred CCCCCCCHHHHHHHHHcCCCce---------ecCC-----------------CCCCCHHHHHHHHHhcc-ChhhcCCCCC
Confidence 9999988887777765321100 0000 01267789999999875 999998 5
Q ss_pred HHHHhcCCCCCC
Q 011627 284 AKDALDSEYFWT 295 (481)
Q Consensus 284 a~eiL~h~~f~~ 295 (481)
+.|+++||||..
T Consensus 287 ~~ei~~hp~f~~ 298 (360)
T cd05627 287 VEEIKSHPFFEG 298 (360)
T ss_pred HHHHhcCCCCCC
Confidence 899999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.71 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=204.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||++++..+++.||||+++... ........+.+|+.+++.++|+||+++++++.+ .++
T Consensus 12 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~ 75 (331)
T cd05597 12 GAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD----------------ENN 75 (331)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec----------------CCe
Confidence 899999999999999999999997532 222234457789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|.+++.+....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999975 777777665567999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 161 HNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
........++|+.|+|||++.. ...++.++|||||||++|+|++|+.||...+..+.+..+........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------- 228 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ------- 228 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc-------
Confidence 3222333468999999999863 24578899999999999999999999998887777776653211100
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWT 295 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~sa~eiL~h~~f~~ 295 (481)
++ .....++.++++||++||..++++ |+++.++++|+||..
T Consensus 229 --~~----------------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 229 --FP----------------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred --CC----------------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 00 001236788999999999765544 789999999999954
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=336.75 Aligned_cols=275 Identities=37% Similarity=0.679 Sum_probs=219.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||+++...........+.+|++++++++|+||+++++++.. .+.+
T Consensus 12 g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 75 (288)
T cd07833 12 GAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR----------------KGRL 75 (288)
T ss_pred cCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE----------------CCEE
Confidence 789999999999999999999998765555556678899999999999999999999987 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++++..+......+++.+++.++.||+.+|.|||+++++|+||+|+||++++++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99999999988777666656799999999999999999999999999999999999999999999999999987654433
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..+....+......+........+
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 23445667899999999987447889999999999999999999999988888777777666555443222222111111
Q ss_pred ccCC-CchhhhhhHHH-HHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 243 NHFK-PSRTMKRRVRE-VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 243 ~~~~-~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.... ........... ....++.++++||++||..||++|||++++++|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 1100 00000111111 223458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=352.02 Aligned_cols=250 Identities=26% Similarity=0.321 Sum_probs=203.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||+|++..... .......+.+|+.+++.++|+||+++++++.+ ...
T Consensus 54 G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~----------------~~~ 117 (371)
T cd05622 54 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD----------------DRY 117 (371)
T ss_pred cCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc----------------CCE
Confidence 8999999999999999999999975321 22223456789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|..++.. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999985 66666644 35899999999999999999999999999999999999999999999999999876533
Q ss_pred CCCccccccccccCCCchhhcCCC---CCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGAT---KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~---~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
........++|+.|+|||++.... .++.++||||||||+|||++|+.||...+....+.++........ ++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~--- 269 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---FP--- 269 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---CC---
Confidence 333334567899999999987532 378899999999999999999999999888877777754221111 10
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTD 296 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~sa~eiL~h~~f~~~ 296 (481)
....++.++++||.+||..++.+ |++++||++|+||+..
T Consensus 270 --------------------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 270 --------------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred --------------------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 01247788999999999844443 7899999999999664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=345.33 Aligned_cols=244 Identities=25% Similarity=0.430 Sum_probs=202.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||+++.... .......+..|+.++..+ .|++|+++++++.+ .+
T Consensus 11 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----------------~~ 74 (323)
T cd05616 11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT----------------MD 74 (323)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec----------------CC
Confidence 8999999999999999999999986532 222334567788888887 58899999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+.. ...+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 75 ~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 75 RLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 89999999985 66655544 34689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||...+..+.+..+.+.....
T Consensus 154 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------- 220 (323)
T cd05616 154 D-GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY----------- 220 (323)
T ss_pred C-CCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence 1 222334578999999999986 678999999999999999999999999988888877775421110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
...++.++.+||.+||..||++|++ ..++++|+||..
T Consensus 221 -------------------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 221 -------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred -------------------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 1236778999999999999999997 489999999954
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=358.68 Aligned_cols=267 Identities=23% Similarity=0.314 Sum_probs=199.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||.... ..+.+|+.+|++|+|+|||++++++.. .+..
T Consensus 180 G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~----------------~~~~ 235 (461)
T PHA03211 180 GSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV----------------GGLT 235 (461)
T ss_pred CCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE----------------CCEE
Confidence 8999999999999999999996432 245689999999999999999999876 6688
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|||||++.++|..++......+++.+++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 236 ~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 236 CLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99999999999988876656799999999999999999999999999999999999999999999999999986543222
Q ss_pred C-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCC-CCCC------hHHHHHHHHHhcCCCCCCCCc
Q 011627 163 N-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL-PGKN------EAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 163 ~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf-~~~~------~~~~~~~i~~~~~~~~~~~~~ 234 (481)
. .....++|..|+|||++.+ ..++.++||||||||||||++|..++ .... ....+.+++........ .++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~-~~~ 393 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD-EFP 393 (461)
T ss_pred cccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc-cCC
Confidence 1 1223568999999999987 57899999999999999999987543 3221 12344444443322111 111
Q ss_pred cCCCCCccccCC-----Cch-hhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFK-----PSR-TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..........+. ... .........+..++.++.+||.+||+.||++|||+.|||+|+||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 110000000000 000 0000001112246778999999999999999999999999999953
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=336.57 Aligned_cols=274 Identities=48% Similarity=0.820 Sum_probs=227.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|++|.||+|++..+++.+++|+++...........+.+|+.++++++|+||+++++++.+ ...+
T Consensus 10 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 73 (283)
T cd05118 10 GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH----------------KGDL 73 (283)
T ss_pred CCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc----------------CCCE
Confidence 789999999999999999999998665444455678899999999999999999999876 5689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+.+++...+......+++..+..++.||+.+|.|||+++|+|+||||+||+++.++.+||+|||.+.......
T Consensus 74 ~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 74 YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred EEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 9999999999888887766679999999999999999999999999999999999999999999999999997765332
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......++..|+|||.+.+...++.++|||||||++|+|++|+.+|...+..+.+.++.+....+....|.....+...
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 22333456888999999887547899999999999999999999999999999998888888777766666655442221
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
...................++.++++||.+||..||.+||++++++.|+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 111111111122244456789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=334.28 Aligned_cols=272 Identities=36% Similarity=0.609 Sum_probs=214.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||++++..+++.||||+++....... .....+|+.+++++. |+||+++++++.+.. .+.
T Consensus 10 g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--------------~~~ 74 (282)
T cd07831 10 GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRK--------------TGR 74 (282)
T ss_pred cccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCC--------------CCc
Confidence 7899999999999999999999876532222 234468999999995 999999999998721 367
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
++|||||+.+++++.+......+++.+++.++.||+.||+|||+++++||||||+||+++. +.+||+|||+++.....
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~- 152 (282)
T cd07831 75 LALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK- 152 (282)
T ss_pred EEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC-
Confidence 8999999999998888765567999999999999999999999999999999999999999 99999999999765432
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||++.....++.++|||||||++|||++|..||.+.+..+.+..+.+..+.+........... .
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 230 (282)
T cd07831 153 -PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS-R 230 (282)
T ss_pred -CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc-c
Confidence 22233456889999998765456788999999999999999999999999988888888776655443221111000 0
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
...+.........+......++.++++||.+||..||++|||++++|+|+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0111111111122333445678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=336.97 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=201.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||++++..+++.||||++...... ......+.+|+.++++|+|+||+++++++.+ ...
T Consensus 11 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~ 74 (285)
T cd05605 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----------------KDA 74 (285)
T ss_pred CCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC----------------CCe
Confidence 89999999999999999999999764322 2223456789999999999999999999876 568
Q ss_pred EEEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+||||||+.+ +|.+.+.. ....+++..+..++.||+.||.|||+++|+||||||+|||+++++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999985 56555543 234689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. ......+++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.....+.+........
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 221 (285)
T cd05605 155 G--ETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------- 221 (285)
T ss_pred C--CccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----------
Confidence 2 22234577999999999976 5788999999999999999999999988766544444432211100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
......++..+.+||.+||..||++|+ +++++++|+||..
T Consensus 222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 222 ----------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ----------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 011234778899999999999999999 9999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=334.38 Aligned_cols=273 Identities=50% Similarity=0.892 Sum_probs=230.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||.||+|++..+++.||+|++............+.+|+.++++++|+||+++++++.+ ...+
T Consensus 10 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~ 73 (282)
T cd07829 10 GTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT----------------ERKL 73 (282)
T ss_pred cCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc----------------CCce
Confidence 789999999999999999999998775455556678899999999999999999999987 5689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
++||||+.++|.+++.+....+++..+..++.||+.+|+|||+++|+|+||+|+||++++++.+||+|||++........
T Consensus 74 ~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 74 YLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred EEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 99999999998888877655799999999999999999999999999999999999999999999999999977643221
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......+..|+|||++.....++.++|||||||++|+|++|+.||...+..+.+.++...+..+.+..|.....+..+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 2333455788999999876557889999999999999999999999999999999999999888888888777665422
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.... ...........+..++..+.++|++||..||++||++++++.||||
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 233 KPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 2111 1111222344455668899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=342.46 Aligned_cols=244 Identities=26% Similarity=0.438 Sum_probs=201.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++.+++.||||+++.... .......+..|+.+++.+. |++|+++++++.+ .+
T Consensus 11 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----------------~~ 74 (323)
T cd05615 11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT----------------VD 74 (323)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec----------------CC
Confidence 8999999999999999999999986532 2223456678999999886 5678889998877 56
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+.. ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 75 RLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 89999999986 56555543 34699999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.. ......++|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~------------ 219 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS------------ 219 (323)
T ss_pred CC-ccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 21 22234568999999999976 57899999999999999999999999998888777777542111
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
....++.++++||.+||..||++|++ .+++++|+||..
T Consensus 220 ------------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 220 ------------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred ------------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 01235678999999999999999997 579999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=339.77 Aligned_cols=277 Identities=39% Similarity=0.727 Sum_probs=216.9
Q ss_pred cceeEEEEEEEcc--CCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIK--TGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~--tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|++.. +++.||||++.... ........+.+|+.++++++|+||+++++++.+.. .
T Consensus 11 g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------------~ 76 (316)
T cd07842 11 GTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA--------------D 76 (316)
T ss_pred CCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC--------------C
Confidence 7899999999998 89999999998643 22334557789999999999999999999998721 3
Q ss_pred CeEEEEEecCCCChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC----CCCeEEecc
Q 011627 80 GSTYMVFEYMDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN----EGNLKLADF 151 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~~~~~----~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~----~~~vkL~DF 151 (481)
..+||||||+++++.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+||
T Consensus 77 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 77 KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred ceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 68999999999888776542 2236899999999999999999999999999999999999999 889999999
Q ss_pred cccccccCCCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH---------HHHHH
Q 011627 152 GLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---------EQLSK 220 (481)
Q Consensus 152 G~a~~~~~~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---------~~~~~ 220 (481)
|+++.+..... ......++|..|+|||++.+...++.++|||||||++|+|++|+.||...+.. ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643222 11223466889999999877566889999999999999999999999876543 35667
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCC---ch----hhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 221 IFELCGSPDETIWPGVSKMPAYNHFKP---SR----TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~---~~----~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+++.+..+....|.....++.+..... .. .........+...+.++.+||.+||..||++|||+.|+++||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 777777666666655444444332100 00 00111111123678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=342.72 Aligned_cols=245 Identities=22% Similarity=0.375 Sum_probs=196.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||+++..... ......+.+|+.+++++ +|+||+++++++.+ .+
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----------------~~ 69 (327)
T cd05617 6 GSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT----------------TS 69 (327)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe----------------CC
Confidence 89999999999999999999999865322 22345677899999988 69999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|...+.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 70 ~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 70 RLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 89999999986 56555543 34699999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCCCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN------EAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~------~~~~~~~i~~~~~~~~~~~~ 233 (481)
. .......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.... ..+.+.++.... +
T Consensus 149 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~----- 219 (327)
T cd05617 149 P-GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--P----- 219 (327)
T ss_pred C-CCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--C-----
Confidence 1 223344678999999999976 678999999999999999999999996422 112222221110 0
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC------HHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS------AKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s------a~eiL~h~~f~~ 295 (481)
..+...++..+.+||.+||..||++|++ ++++++|+||..
T Consensus 220 ----------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 220 ----------------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 0011236778999999999999999998 579999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=345.20 Aligned_cols=276 Identities=32% Similarity=0.535 Sum_probs=212.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.++++++|+||++++++|...... .....+
T Consensus 27 g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~~~~ 96 (353)
T cd07850 27 GAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL----------EEFQDV 96 (353)
T ss_pred CCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc----------cccCcE
Confidence 7899999999999999999999875544433445677899999999999999999998753211 113468
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++|...+... +++..+..++.||+.||+|||+++|+||||||+|||++.++++||+|||+++.....
T Consensus 97 ~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-- 171 (353)
T cd07850 97 YLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 171 (353)
T ss_pred EEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC--
Confidence 999999999888877543 899999999999999999999999999999999999999999999999999765422
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC---
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM--- 239 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--- 239 (481)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+.++....+.+....+......
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 22334467889999999986 67899999999999999999999999998888888888776665543221111100
Q ss_pred -----Ccc-----ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 240 -----PAY-----NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 240 -----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
+.. ....................+.++++||.+||..||++|||+.|+|+|+||.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 000 0000000000000001223567789999999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=334.51 Aligned_cols=274 Identities=34% Similarity=0.631 Sum_probs=214.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+++++.++|+||+++++++.. ...+
T Consensus 12 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 75 (286)
T cd07846 12 GSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR----------------KKRL 75 (286)
T ss_pred CCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc----------------CCeE
Confidence 789999999999999999999987654444445567899999999999999999999976 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++++..+......+++.+++.++.||+.+|+|||+.+|+|+||+|+||++++++.+||+|||++..+....
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 9999999987766665555568999999999999999999999999999999999999999999999999987654322
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|+++|...+..+.+.++..................+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22334567889999999876556788999999999999999999999988887777777665443321110000000000
Q ss_pred cc-CCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 243 NH-FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 243 ~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.. ..+...........++.++..+++||.+||..||++||++.++|+|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 0000111122333455788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.99 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=196.4
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCC-CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
-|+||+||++++..+++.||+|++....... .....+..|++++++++|+||+++++++.+ ..
T Consensus 3 ~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~----------------~~ 66 (277)
T cd05607 3 KGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES----------------KT 66 (277)
T ss_pred CCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec----------------CC
Confidence 3899999999999999999999997543222 122345679999999999999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 81 STYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
++||||||+.+ +|.+.+.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+.
T Consensus 67 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~ 146 (277)
T cd05607 67 HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK 146 (277)
T ss_pred eEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecC
Confidence 89999999985 66655543 23358899999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+........
T Consensus 147 ~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 214 (277)
T cd05607 147 DG--KTITQRAGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE--------- 214 (277)
T ss_pred CC--ceeeccCCCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc---------
Confidence 32 22233567899999999986 4589999999999999999999999976543221112211100000
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa----~eiL~h~~f~~ 295 (481)
.......++.++++||.+||+.||++|+++ ++++.|+||..
T Consensus 215 ----------------~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 215 ----------------VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred ----------------cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 000112467889999999999999999999 67889999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=334.41 Aligned_cols=245 Identities=23% Similarity=0.402 Sum_probs=209.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|.|+++|.+||||.+..+.+ ...+++||.|+.+++.++||++|+.+-. ...+
T Consensus 44 GSYGSV~KAIH~EsG~v~AIK~VPV~sD----LQEIIKEISIMQQC~S~yVVKYYGSYFK----------------~sDL 103 (502)
T KOG0574|consen 44 GSYGSVHKAIHRESGHVLAIKKVPVDTD----LQEIIKEISIMQQCKSKYVVKYYGSYFK----------------HSDL 103 (502)
T ss_pred CcchHHHHHHHhccCcEEEEEecCccch----HHHHHHHHHHHHHcCCchhhhhhhhhcc----------------CCce
Confidence 8999999999999999999999986643 4578899999999999999999998765 5579
Q ss_pred EEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||+ |+..+.+..++..|++++|..+++..|.||+|||...-||||||..||||+.+|..||+|||.|-.+....
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999998 57777777777889999999999999999999999999999999999999999999999999998765433
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
....+.+||+.||||||+.. ..|+.++||||||++..||..|++||..-.. ++.|+.+-..++..+-
T Consensus 184 -AKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF~-------- 250 (502)
T KOG0574|consen 184 -AKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTFK-------- 250 (502)
T ss_pred -HhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCCC--------
Confidence 34455789999999999986 6789999999999999999999999975444 3445554444433220
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
....+++++.|||++||.++|++|-||.++++|+|++..
T Consensus 251 ----------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 251 ----------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred ----------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 123478899999999999999999999999999999654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=325.20 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=207.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+|+.|-.|.++.|+..||||+|.+.. .....++.+|++++..++ |+||+.++++|++ +..
T Consensus 89 GAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd----------------d~~ 150 (463)
T KOG0607|consen 89 GAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFED----------------DTR 150 (463)
T ss_pred ccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc----------------cce
Confidence 899999999999999999999998763 234568899999999995 9999999999998 778
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---eEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG~a~~~ 157 (481)
+|||||-|.| .|+..+.+. ..|++.++..+++.|+.||.|||.+||.||||||+|||...... ||||||.+...+
T Consensus 151 FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 9999999986 677766654 46999999999999999999999999999999999999876554 899999988654
Q ss_pred cCC------CCCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCC--------------
Q 011627 158 SYD------HNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKN-------------- 213 (481)
Q Consensus 158 ~~~------~~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~-------------- 213 (481)
... ..-.+.+.+|+..||||||..- ...|+.++|.||||||||.||+|.+||-+.-
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~ 309 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV 309 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence 321 1123456788999999998642 3568999999999999999999999997642
Q ss_pred -hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 011627 214 -EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292 (481)
Q Consensus 214 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~ 292 (481)
...+++.|.+....+++.. |.++|.+++|||..+|..|+.+|.++.++|.|||
T Consensus 310 CQ~~LFesIQEGkYeFPdkd--------------------------WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKD--------------------------WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HHHHHHHHHhccCCcCChhh--------------------------hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 2245555655555554444 4578999999999999999999999999999999
Q ss_pred CCCCC
Q 011627 293 FWTDP 297 (481)
Q Consensus 293 f~~~~ 297 (481)
+....
T Consensus 364 ~~~~~ 368 (463)
T KOG0607|consen 364 VQRCA 368 (463)
T ss_pred ccccc
Confidence 97643
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=347.83 Aligned_cols=265 Identities=25% Similarity=0.323 Sum_probs=197.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+.... ....|+.++++++|+||+++++++.. ....
T Consensus 77 G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 132 (357)
T PHA03209 77 GSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVS----------------GAIT 132 (357)
T ss_pred CCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEe----------------CCee
Confidence 89999999999999999999985422 33579999999999999999999987 5678
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|||||++.++|..++......+++.+++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.... .
T Consensus 133 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~ 210 (357)
T PHA03209 133 CMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--A 210 (357)
T ss_pred EEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc--C
Confidence 99999999999998877777899999999999999999999999999999999999999999999999999975332 1
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHhcCCCCCCC
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNE---------AEQLSKIFELCGSPDETI 232 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~ 232 (481)
.......+|..|+|||++.+ ..++.++||||||||+|||+++. .+|..... ...+.+++...+..+...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred cccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 22234568999999999986 57899999999999999999854 44443221 223334443333222211
Q ss_pred CccC-CC-CCccccCCCc--hhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 233 WPGV-SK-MPAYNHFKPS--RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 233 ~~~~-~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
.... .. ...+..+... .............++.++.+||.+||+.||++|||+.|||+||||+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 1000 00 0000000000 0000000011124677889999999999999999999999999995
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=340.22 Aligned_cols=279 Identities=38% Similarity=0.623 Sum_probs=216.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++..+++.||||+++.... ......+.+|+.++++++|+||+++++++..... .....+
T Consensus 16 G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----------~~~~~~ 83 (336)
T cd07849 16 GAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSF-----------ESFNDV 83 (336)
T ss_pred cCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccc-----------cccceE
Confidence 7899999999999999999999864322 2234567789999999999999999998876321 113568
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+|+||+.+++...+.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 84 YIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred EEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 99999999988877754 3589999999999999999999999999999999999999999999999999976543211
Q ss_pred --CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 163 --NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 163 --~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
......++|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+.......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence 122334678999999988765568899999999999999999999999988887777777766655443332221100
Q ss_pred c--cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 241 A--YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 241 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
. +....+ .............++.++.+||.+||..||++|||+.|+++|+||+.-
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 242 ARNYIKSLP-FKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhhHHhhcC-cCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0 000000 000111223344578899999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=342.36 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=204.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+++++.+++.||||++.... ........+.+|+.+++.++|+||+++++++.+ ...
T Consensus 12 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~ 75 (332)
T cd05623 12 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD----------------ENN 75 (332)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec----------------CCE
Confidence 899999999999999999999997532 222223456789999999999999999999987 668
Q ss_pred EEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+. ++|.+++.+....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+...
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999997 4787777665567999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 161 HNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
........++|+.|+|||++.. ...++.++|||||||++|||++|+.||...+..+.+.++....... .++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---~~p-- 230 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF---QFP-- 230 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc---cCC--
Confidence 3323334578999999999863 3457899999999999999999999999888877777765321100 000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWT 295 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~sa~eiL~h~~f~~ 295 (481)
.....++.++++||++||..++++ |++++|+++|+||..
T Consensus 231 --------------------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 231 --------------------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred --------------------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 011246789999999999765554 689999999999954
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=350.60 Aligned_cols=269 Identities=25% Similarity=0.306 Sum_probs=202.8
Q ss_pred cceeEEEEEEEc--cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREI--KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|.+. .+++.||||.+.... ...+|+.+|++|+|+||+++++++.. ..
T Consensus 103 G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~----------------~~ 159 (392)
T PHA03207 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRW----------------KS 159 (392)
T ss_pred CCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEee----------------CC
Confidence 899999999864 456889999886431 34689999999999999999999876 66
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
.+|||||++.++|..++. ....+++.+++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 160 ~~~lv~e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEEehhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 899999999999988774 3456999999999999999999999999999999999999999999999999999765432
Q ss_pred CC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCCCCCccC
Q 011627 161 HN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---EAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 161 ~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.. .......+|..|+|||++.. ..++.++||||||||+|||++|+.||.+.. ....+..+++.++..........
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 22 12234578999999999976 578999999999999999999999997654 34556666655443322111100
Q ss_pred CC--CCccccCCCchhhhhhHHHHH--hhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 237 SK--MPAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 237 ~~--~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.. ...+..+.............+ ..++.++.+||.+||..||++|||+.|+|.||||...
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00 000000000000000000111 2356789999999999999999999999999999654
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=352.18 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=210.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|.++.|+-..|.|+|...... ....++-||+||..++||+||++++.|.. .+.+
T Consensus 43 GAFGKVyKA~nket~~lAAaKvIetkseE--ELEDylVEIeILa~CdHP~ivkLl~ayy~----------------enkL 104 (1187)
T KOG0579|consen 43 GAFGKVYKAVNKETKLLAAAKVIETKSEE--ELEDYLVEIEILAECDHPVIVKLLSAYYF----------------ENKL 104 (1187)
T ss_pred ccchhhhhhhcccchhhhhhhhhcccchh--HHhhhhhhhhhhhcCCChHHHHHHHHHhc----------------cCce
Confidence 89999999999999999999999765433 46688899999999999999999998865 7899
Q ss_pred EEEEecCCCChhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g~L~~-~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+|+.|||.|+-.+ .+......|++++|..+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+.... ..
T Consensus 105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t 183 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-ST 183 (1187)
T ss_pred EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-hH
Confidence 9999999986554 445566679999999999999999999999999999999999999999999999999885432 22
Q ss_pred CCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
.....+++||++||||||+.. +.+|++++|||||||+|.||..+.+|....+...++-+|..-. ++..
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--PPTL------ 255 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPTL------ 255 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--CCcc------
Confidence 334566899999999999864 4679999999999999999999999999999988888875421 1100
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....+++..+.|||.+||.+||..||++++||+||||..
T Consensus 256 -------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 256 -------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred -------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 011356778999999999999999999999999999964
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=327.00 Aligned_cols=245 Identities=25% Similarity=0.395 Sum_probs=212.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+|-+|+.+.|++.||||+++++. ...+.+...+.|-.+|+..+||.+..+...|+. ++.
T Consensus 179 GTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt----------------~dr 242 (516)
T KOG0690|consen 179 GTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT----------------QDR 242 (516)
T ss_pred CccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc----------------Cce
Confidence 899999999999999999999998773 223345567789999999999999999999988 779
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+|+||||+.|+.+.........|+++..+.+-..|+.||.|||+++||.||||.+|+|||.+|++||.|||+++.-- ..
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~ 321 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KY 321 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc-cc
Confidence 99999999975555444445579999999999999999999999999999999999999999999999999997533 23
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.....++|||+.|+||||+.. ..|+.++|.|.+|||+|||++|+.||...+...+++.|+...-
T Consensus 322 g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--------------- 385 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--------------- 385 (516)
T ss_pred cceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc---------------
Confidence 445667899999999999986 7899999999999999999999999999998888888764211
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
.+...++++++.||.-+|.+||.+|. .++||.+|+||..
T Consensus 386 ---------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 386 ---------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred ---------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 12246889999999999999999997 7899999999954
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=329.22 Aligned_cols=247 Identities=32% Similarity=0.483 Sum_probs=203.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++..+++.||+|++..............+|+.++++++|+||+++++++.+ ...+
T Consensus 10 G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------------~~~~ 73 (260)
T PF00069_consen 10 GGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD----------------DNYL 73 (260)
T ss_dssp ESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE----------------SSEE
T ss_pred CCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc----------------cccc
Confidence 899999999999999999999999876554444445679999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
++||||+.+ +|.+++. ....+++.++..++.||+.+|++||+++|+|+||||+|||++.++.++|+|||++... ...
T Consensus 74 ~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~ 151 (260)
T PF00069_consen 74 YIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL-SEN 151 (260)
T ss_dssp EEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES-TST
T ss_pred ccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccc
Confidence 999999998 7777666 3346899999999999999999999999999999999999999999999999999764 223
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
........+|..|+|||++.....++.++||||||+++|+|++|..||...+..+....+......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-------------- 217 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-------------- 217 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT--------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc--------------
Confidence 344455677999999999873367899999999999999999999999987544444444322110
Q ss_pred cccCCCchhhhhhHHHHH---hhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 242 YNHFKPSRTMKRRVREVF---RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
...... .....++.+||++||+.||++|||++++++||||
T Consensus 218 ------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 218 ------------PLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ------------HHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ------------cccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 000000 1123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=339.31 Aligned_cols=281 Identities=35% Similarity=0.620 Sum_probs=221.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|+++.+++.||||++............+.+|+.++++|+|+||+++++++.... .....+
T Consensus 16 g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------------~~~~~~ 83 (334)
T cd07855 16 GAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG------------ADFKDV 83 (334)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC------------CCCceE
Confidence 78999999999999999999999866444445567788999999999999999999887532 114578
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+.++|...+... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 999999998888777654 3599999999999999999999999999999999999999999999999999976543221
Q ss_pred ---CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 163 ---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 163 ---~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
......+++..|+|||++.....++.++|||||||++|+|++|+.||...+....+..+....+.+....+......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 12233467889999999876456889999999999999999999999999888888888887776655444332211
Q ss_pred CccccC-CCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHF-KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.....+ ................++.++.+||.+||+.||++|||++++|.|+||..-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 000000 000000111233445678999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=340.94 Aligned_cols=281 Identities=41% Similarity=0.639 Sum_probs=220.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...........+.+|+.++++++|+||+++++++..... .....+
T Consensus 16 G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~-----------~~~~~~ 84 (337)
T cd07858 16 GAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR-----------EAFNDV 84 (337)
T ss_pred CCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc-----------cccCcE
Confidence 789999999999999999999987654333344567789999999999999999998875321 112468
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++|.+.+... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+++......
T Consensus 85 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 85 YIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred EEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 999999999888877654 469999999999999999999999999999999999999999999999999997654321
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......++..|+|||++.....++.++|||||||++|+|++|+.||.+.+....+..+.+..+.+....|.........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 22334567889999999875456889999999999999999999999998888888888877766655444222110000
Q ss_pred ccCCC-chhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 243 NHFKP-SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 243 ~~~~~-~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...+. ............+.++.++++||++||+.||++|||++++|+|+||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000 0000111223445788999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=345.00 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=210.8
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
.|.||+||-+++.+||+.||||+|++..........+.+|+.||..+.||.||.+.-.|+. .+.
T Consensus 574 SGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET----------------~er 637 (888)
T KOG4236|consen 574 SGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET----------------PER 637 (888)
T ss_pred CCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC----------------Cce
Confidence 3789999999999999999999998776555556788899999999999999999999988 668
Q ss_pred EEEEEecCCCChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CeEEecccccccc
Q 011627 82 TYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~ 157 (481)
+++|||-+.||.++.+.. ..++|++...+.++.|||.||.|||.++|+|+|||||||||.+.. ++||||||+|+++
T Consensus 638 vFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 638 VFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred EEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence 999999999998886664 556899999999999999999999999999999999999997643 5999999999998
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
... ....+.+||+.|+||||+.. +.|+.+.||||+|||+|.-|+|..||....+ +-.+|.+...-.+...
T Consensus 718 gEk--sFRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~P----- 787 (888)
T KOG4236|consen 718 GEK--SFRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNP----- 787 (888)
T ss_pred chh--hhhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCc-----
Confidence 743 33455789999999999987 6899999999999999999999999965433 3344433222222222
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
|+.++.+++|||..+|+..-++|.|+...|.|+|++.
T Consensus 788 ---------------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 788 ---------------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred ---------------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 4568889999999999999999999999999999954
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=347.17 Aligned_cols=245 Identities=26% Similarity=0.414 Sum_probs=210.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||.|+|..+.++||||++.... ...+....+++|+..|++|+|||+|.+.++|.. +..
T Consensus 37 GSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr----------------e~T 100 (948)
T KOG0577|consen 37 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR----------------EHT 100 (948)
T ss_pred CccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec----------------cch
Confidence 899999999999999999999998663 334456789999999999999999999999987 567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
.|||||||-|+-.+++.-....|-+.+|..|+.+.|.||+|||+.+.||||||..||||++.|.|||+|||.|...
T Consensus 101 aWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---- 176 (948)
T KOG0577|consen 101 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---- 176 (948)
T ss_pred HHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc----
Confidence 8999999998655555544457999999999999999999999999999999999999999999999999999654
Q ss_pred CCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
....+++||+.||||||++. ...|+-++|||||||+..||...++|+-..|....+..|......-..
T Consensus 177 -~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--------- 246 (948)
T KOG0577|consen 177 -APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--------- 246 (948)
T ss_pred -CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC---------
Confidence 34556899999999999874 346899999999999999999999999988888888877542110000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...+++.++.||.+||.+-|.+|||.+++|+|+|....
T Consensus 247 -------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 247 -------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred -------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 12477889999999999999999999999999999654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=339.23 Aligned_cols=270 Identities=23% Similarity=0.355 Sum_probs=200.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++..+++.+|+|++..... ......+.+|++++++++|+||++++++|.+ ++.+
T Consensus 16 g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 78 (333)
T cd06650 16 GNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS----------------DGEI 78 (333)
T ss_pred CCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEE----------------CCEE
Confidence 8899999999999999999999876532 2234567899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
||||||+.+ +|.+++.+ ...+++..+..++.||+.+|.|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999986 66666654 34689999999999999999999975 7999999999999999999999999998765322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--CCCCCCccCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS--PDETIWPGVSK 238 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 238 (481)
......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.. .++..... ...........
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred ---ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccC
Confidence 2233467999999999976 56889999999999999999999999876554332 22211110 00000000000
Q ss_pred -----CCccc-cCCCchhhhhhHHHH---------HhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 -----MPAYN-HFKPSRTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 -----~~~~~-~~~~~~~~~~~~~~~---------~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+..+. ..++.....+....+ ...++.++++||.+||+.||++|||++|+++|+||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 00000 000000000000000 0136788999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=337.80 Aligned_cols=275 Identities=21% Similarity=0.266 Sum_probs=200.4
Q ss_pred ceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEE
Q 011627 4 CISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 83 (481)
Q Consensus 4 ~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (481)
+|++||+++++.+++.||||+++...........+.+|+.+++.++|+||+++++++.. ++.+|
T Consensus 12 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----------------~~~~~ 75 (327)
T cd08227 12 DLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----------------DNELW 75 (327)
T ss_pred ceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE----------------CCEEE
Confidence 68999999999999999999998765444455567789999999999999999999987 66899
Q ss_pred EEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 84 MVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 84 iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+||||+.+ +|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+||+.+.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999985 666666432 3358999999999999999999999999999999999999999999999998754432111
Q ss_pred CC------ccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-CCCCC-
Q 011627 162 NN------TLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS-PDETI- 232 (481)
Q Consensus 162 ~~------~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~- 232 (481)
.. ......++..|+|||++.+. ..++.++||||||||+|+|++|+.||........+......... ..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 10 11122457789999998753 35889999999999999999999999876654443333221100 00000
Q ss_pred Cc------cCCCC---CccccCC-----CchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 233 WP------GVSKM---PAYNHFK-----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 233 ~~------~~~~~---~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
.+ ..... ....... ...............+++++++||++||+.||++|||++|+|+|+||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 00 00000 0000000 000000111223345788999999999999999999999999999994
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=340.10 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=203.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||++++..+++.||||++.... ........+.+|+.+++.++|+||+++++++.+ .+.
T Consensus 12 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~----------------~~~ 75 (331)
T cd05624 12 GAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD----------------ENY 75 (331)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----------------CCE
Confidence 899999999999999999999997532 122223456789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|..++.+....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+...
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999975 777777665567999999999999999999999999999999999999999999999999999776533
Q ss_pred CCCccccccccccCCCchhhcCC----CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
........++|+.|+|||++.+. ..++.++||||||||+|+|++|+.||...+..+.+.++........ ++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---~p-- 230 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FP-- 230 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc---CC--
Confidence 32223345789999999998642 3578899999999999999999999998887777776653211100 00
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWT 295 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~sa~eiL~h~~f~~ 295 (481)
.....++.++++||.+||..++++ |.+++++++|+||..
T Consensus 231 --------------------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 231 --------------------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred --------------------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 011236788999999999976655 579999999999953
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=323.90 Aligned_cols=245 Identities=27% Similarity=0.460 Sum_probs=198.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC---CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE---GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|++..+++.||||++....... .....+.+|++++++++|+||+++++++.+ .
T Consensus 13 g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~ 76 (263)
T cd06625 13 GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD----------------D 76 (263)
T ss_pred CCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc----------------C
Confidence 789999999999999999999987553222 123467789999999999999999999987 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++++||+|||+++...
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 689999999986 565555443 458999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcc--ccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 159 YDHNNTL--TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 159 ~~~~~~~--~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
....... ....++..|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+...++.......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 226 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP-------- 226 (263)
T ss_pred ccccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--------
Confidence 3211111 23456889999999987 568899999999999999999999998766655544443211000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.+...++..+.+||++||..||++|||+.|+|+|+||
T Consensus 227 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 227 --------------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0112467789999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=348.02 Aligned_cols=244 Identities=28% Similarity=0.462 Sum_probs=211.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|-|++|.++++..|+..||||+|++..........+.+|+++++.|+|||||+++.+.+. ...+
T Consensus 67 g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t----------------~~~l 130 (596)
T KOG0586|consen 67 GNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET----------------EATL 130 (596)
T ss_pred ceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee----------------ccee
Confidence 789999999999999999999999887666566678899999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.+ .+.+++. ...++.+..++.++.|++.+++|||+++|||||||.+||||+.+-++||+|||++..+. .
T Consensus 131 ylV~eya~~ge~~~yl~-~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLV-KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--Y 207 (596)
T ss_pred EEEEEeccCchhHHHHH-hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--c
Confidence 999999986 4555554 45578889999999999999999999999999999999999999999999999999886 4
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
...+.+.||++.|.|||++.+..+.++.+|+||||+|||.|+.|..||++.+-.+.-.+.+... ..+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-----------~rI-- 274 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-----------YRI-- 274 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-----------ecc--
Confidence 5567778999999999999997777899999999999999999999999877654433332111 111
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.-.++.++.+||+++|.++|.+|.+.++|++|.|...
T Consensus 275 -----------------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 275 -----------------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred -----------------cceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 1136778999999999999999999999999999853
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.39 Aligned_cols=266 Identities=27% Similarity=0.472 Sum_probs=206.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCC--CC----ccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--EN----VIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~h--pn----Iv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||.|-.+.|.++++.||||+++.. ..+.+..+-||++|.+|.+ |+ +|.+.++|
T Consensus 100 GtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF---------------- 160 (415)
T KOG0671|consen 100 GTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF---------------- 160 (415)
T ss_pred CcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh----------------
Confidence 89999999999999999999999843 3345677889999999942 22 45555444
Q ss_pred CcCCeEEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-------------
Q 011627 77 KYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN------------- 142 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~------------- 142 (481)
++.+++|||+|.++-++.+++.+++ ..++...|+.+.+||+++++|||+++++|.||||||||+.+
T Consensus 161 dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 161 DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 4589999999999999999888755 45999999999999999999999999999999999999842
Q ss_pred -------CCCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH
Q 011627 143 -------EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 215 (481)
Q Consensus 143 -------~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 215 (481)
+..|||+|||.|+...... ...+.|.-|+|||++++ ..|+..+||||+||||+||.+|..+|.+.++.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 2359999999998654322 45577999999999998 78999999999999999999999999999988
Q ss_pred HHHHHHHHhcCCCCCCC----------------CccCCCCCccccCCCchhhhhhHHHHHh---hhcHHHHHHHHHhccc
Q 011627 216 EQLSKIFELCGSPDETI----------------WPGVSKMPAYNHFKPSRTMKRRVREVFR---HFDRHALELLEKMLML 276 (481)
Q Consensus 216 ~~~~~i~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ll~~~L~~ 276 (481)
+.++.+..+++..+... |+..+.--. .+.....-+.+..... .-..++.|||++||..
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~---~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGK---SKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccccccc---chhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 88877777777554322 222211100 0000000111111111 2223588999999999
Q ss_pred CCCCCCCHHHHhcCCCCCC
Q 011627 277 DPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 277 dP~~R~sa~eiL~h~~f~~ 295 (481)
||.+|+|+.|+|.||||..
T Consensus 393 DP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFAR 411 (415)
T ss_pred CccccccHHHHhcCHHhhc
Confidence 9999999999999999964
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=336.50 Aligned_cols=281 Identities=39% Similarity=0.649 Sum_probs=225.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||++............+.+|+.+++.++|+||+++++++..... .....+
T Consensus 11 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----------~~~~~~ 79 (330)
T cd07834 11 GAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP-----------EDFNDV 79 (330)
T ss_pred CCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc-----------ccccce
Confidence 789999999999999999999998654434455678899999999999999999999877321 113478
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+.++|...+.+.. .+++..++.++.||+.||+|||+++|+|+||||+||||+.++.++|+|||++........
T Consensus 80 ~lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 9999999988877776544 799999999999999999999999999999999999999999999999999987654321
Q ss_pred --CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC--
Q 011627 163 --NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK-- 238 (481)
Q Consensus 163 --~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 238 (481)
.......++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+....+.+....|.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 2234456789999999998754789999999999999999999999999999999999988877766554432111
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...+... ...............++.++.+||.+||..||++|||++++|.|+||...
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 239 ARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 1111000 01111222344455688999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=354.45 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=203.0
Q ss_pred cceeEEEEEEEccC-CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKT-GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~t-g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||+|.+..+ ++.||+|++...... ....+.+|+.+|+.++|+|||++++++.. .+.
T Consensus 78 G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----------------~~~ 139 (478)
T PTZ00267 78 NPTTAAFVATRGSDPKEKVVAKFVMLNDER--QAAYARSELHCLAACDHFGIVKHFDDFKS----------------DDK 139 (478)
T ss_pred CCCcEEEEEEEcCCCCeEEEEEEcccCCHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEEE----------------CCE
Confidence 88999999999888 788999987654322 23456789999999999999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
+||||||+.+ +|.+.+.. ....+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 9999999985 67665432 3446899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 158 SYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 158 ~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
..... ......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+......+
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-------- 290 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-------- 290 (478)
T ss_pred CCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence 43222 22344578999999999876 678999999999999999999999999888877777765421110
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
....++.++++||.+||..||++||++.++|.|+|++
T Consensus 291 ---------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 291 ---------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred ---------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence 0113667899999999999999999999999999985
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=329.37 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=198.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC-CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||++.+..+++.||||++....... .....+.+|+.++++++|++|+.+++.+.+ .+.
T Consensus 11 G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----------------~~~ 74 (285)
T cd05630 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET----------------KDA 74 (285)
T ss_pred CCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec----------------CCE
Confidence 899999999999999999999987653222 223456789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+||||||+.+ +|.+.+.. ....+++.++..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 9999999985 66665543 233589999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...................
T Consensus 155 ~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----------- 220 (285)
T cd05630 155 G--QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------- 220 (285)
T ss_pred C--ccccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-----------
Confidence 1 22234578999999999976 568999999999999999999999998754322111111110000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
.......++.++++||++||+.||++|+| ++|+++|+||..
T Consensus 221 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 221 ---------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred ---------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 00112346778999999999999999999 999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.34 Aligned_cols=248 Identities=24% Similarity=0.396 Sum_probs=202.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC-CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||++++..+++.||+|++....... .....+.+|+.++++++|+||+.+++.+.. ++.
T Consensus 11 G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----------------~~~ 74 (285)
T cd05632 11 GGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET----------------KDA 74 (285)
T ss_pred CCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec----------------CCE
Confidence 889999999999999999999997653222 223456789999999999999999999877 668
Q ss_pred EEEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+|+||||+.+ +|.+.+.. ....+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 9999999986 56555543 234699999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+..........
T Consensus 155 --~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~-------- 223 (285)
T cd05632 155 --GESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV-------- 223 (285)
T ss_pred --CCcccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc--------
Confidence 122234578999999999976 578999999999999999999999998877665554443322111110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
....++.++.+||.+||+.||++|++ +.+++.|+||..
T Consensus 224 ------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 224 ------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred ------------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 11246778999999999999999999 889999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=353.18 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=207.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...........+.+|+.++..++|+||+++++.+...... .......+
T Consensus 43 G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~--------~~~~~~~i 114 (496)
T PTZ00283 43 GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR--------NPENVLMI 114 (496)
T ss_pred CCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc--------CcccceEE
Confidence 8999999999999999999999987655444456778999999999999999999887653211 01112357
Q ss_pred EEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+|||||+.+ +|.+.+.. ....+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.
T Consensus 115 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~ 194 (496)
T PTZ00283 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194 (496)
T ss_pred EEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeecc
Confidence 899999985 77766643 23468999999999999999999999999999999999999999999999999998654
Q ss_pred CCC-CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 159 YDH-NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 159 ~~~-~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
... .......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||...+..+.+..+......+
T Consensus 195 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~--------- 264 (496)
T PTZ00283 195 ATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP--------- 264 (496)
T ss_pred ccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC---------
Confidence 322 222334578999999999986 578999999999999999999999999888777776664321110
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+...++.++.+||.+||..||++||++.++|+|+|++.
T Consensus 265 --------------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 265 --------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred --------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 11246778999999999999999999999999999853
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=318.98 Aligned_cols=245 Identities=24% Similarity=0.402 Sum_probs=201.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+++++.+++.||||++............+.+|++++++++|+||+++++.+... +..+
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---------------~~~~ 75 (257)
T cd08223 11 GSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE---------------DGLL 75 (257)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC---------------CCEE
Confidence 7899999999999999999999986654444455678899999999999999999887541 4468
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+.+... ...+++.+++.++.||+.+|++||+++|+|+||||+||+++.++.+||+|||++..+...
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999985 666666542 345899999999999999999999999999999999999999999999999999766432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+...... .
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~---------- 221 (257)
T cd08223 156 C-DMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP--P---------- 221 (257)
T ss_pred C-CccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--C----------
Confidence 2 22334567889999999876 57889999999999999999999999887766655555331100 0
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
....++.++.+||.+||+.||++|||+.++++||||
T Consensus 222 -----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 222 -----------------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------------CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 012366789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=318.74 Aligned_cols=244 Identities=27% Similarity=0.405 Sum_probs=204.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.|++|.+............+.+|++++++++|+||+++++++.+ .+.+
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 74 (256)
T cd08529 11 GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD----------------KGKL 74 (256)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc----------------CCEE
Confidence 789999999999999999999998664444455677899999999999999999999987 5689
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+++... ...+++..++.++.||+.+|.|||+++|+|+||||+||+++.++.+||+|||+++.+...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999975 777766553 456899999999999999999999999999999999999999999999999998866432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
. .......++..|+|||++.. ..++.++||||||||+++|++|+.||...+..+...++.......
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 220 (256)
T cd08529 155 T-NFANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP------------ 220 (256)
T ss_pred c-chhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 2 22233467889999999876 568899999999999999999999999888766666654311000
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+...++.++.++|++||+.||++||++.++++|+|+
T Consensus 221 -----------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 221 -----------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 011356789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=335.70 Aligned_cols=236 Identities=27% Similarity=0.431 Sum_probs=202.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||+||+++... ...||+|.++..... ...+.+|+.||++|+|+|||++++++.. .+.+
T Consensus 217 G~FG~V~~g~~~~-~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~----------------~~pi 276 (468)
T KOG0197|consen 217 GQFGEVWLGKWNG-STKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTK----------------QEPI 276 (468)
T ss_pred CccceEEEEEEcC-CCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEec----------------CCce
Confidence 8899999999843 348999999865333 3477899999999999999999999987 4579
Q ss_pred EEEEecCC-CChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMD-HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~-g~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||||||. |+|++++.. ....+...+...++.||++|++||+++++|||||-..||||+++..+||+|||+|+....+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999998 689998886 5567999999999999999999999999999999999999999999999999999965544
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........-...|.|||++.- ..|+.++|||||||+|+||+| |+.||++.+..++++.+.+...-+.+
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P--------- 426 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP--------- 426 (468)
T ss_pred ceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---------
Confidence 4444444444778999999986 679999999999999999998 99999999999999999765433322
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHh
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL 288 (481)
..+++++-+|+..|+..+|++|||++.+.
T Consensus 427 --------------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 427 --------------------EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred --------------------CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 24778999999999999999999998765
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=336.15 Aligned_cols=253 Identities=28% Similarity=0.434 Sum_probs=201.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+-+.||+|+. .+...||+|++...........-+.+||.+|.+|+ |.+||+++++-.. ++.
T Consensus 372 GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~----------------d~~ 434 (677)
T KOG0596|consen 372 GGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT----------------DGY 434 (677)
T ss_pred CCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc----------------Cce
Confidence 78899999997 45567888887766666656677889999999995 9999999999776 779
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+||||||-+.||...+.....-+..-.++.|.+|+|.++.++|+.||||.||||.|+|+-. |.+||+|||+|..+..+.
T Consensus 435 lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 435 LYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 9999999999999998877666666689999999999999999999999999999999876 689999999998876543
Q ss_pred C-CccccccccccCCCchhhcCC----------CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 011627 162 N-NTLTNRVITLWYRPPELLLGA----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 230 (481)
Q Consensus 162 ~-~~~~~~~gt~~Y~aPEvl~~~----------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 230 (481)
. ....+.+||+.||+||.+... -..+.++||||||||||+|+.|++||..-. ..+.++..+...-.+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDPNHE 591 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCCCcc
Confidence 2 334556899999999998642 125678999999999999999999996432 233344333322222
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~ 299 (481)
..++.... ..++.++++.||..||++|||+.++|+|||+...+++
T Consensus 592 Iefp~~~~------------------------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 592 IEFPDIPE------------------------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP 636 (677)
T ss_pred ccccCCCC------------------------chHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence 22222221 1248999999999999999999999999999654443
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=322.19 Aligned_cols=274 Identities=41% Similarity=0.761 Sum_probs=216.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc---CCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|+++.+++.||||+++...........+.+|+.+++++ +|+||+++++++.+... ...
T Consensus 10 g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~-----------~~~ 78 (287)
T cd07838 10 GAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT-----------DRE 78 (287)
T ss_pred cCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC-----------CCC
Confidence 7899999999999999999999986654443445566788888777 59999999999987321 113
Q ss_pred CeEEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..+|++|||+.++|.+++.... ..+++..++.++.||+.||.|||+++++|+||||+||+++.++++||+|||++..+.
T Consensus 79 ~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 79 LKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred ceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 3589999999988877665533 358999999999999999999999999999999999999999999999999997764
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. .......++..|+|||++.+ ..++.++|||||||++|+|++|+++|...+..+.+.++++.........|+....
T Consensus 159 ~~--~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 159 FE--MALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred CC--cccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 32 22223356888999999986 5688999999999999999999999999999999999887666554444433221
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..... + ..............++..+.+||.+||..||++||++.|++.|+||
T Consensus 236 ~~~~~-~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSS-F--PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhh-c--ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11100 0 0011112244445678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=336.93 Aligned_cols=280 Identities=37% Similarity=0.610 Sum_probs=220.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||+||+|++..+++.||||++............+.+|+.++++++|+||+++++++...... .....+
T Consensus 26 g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~~~~ 95 (343)
T cd07851 26 GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL----------EDFQDV 95 (343)
T ss_pred CCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc----------cccccE
Confidence 7899999999999999999999876543333445677899999999999999999988653210 113458
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|||+||+.++|.+++.. ..+++..++.++.||+.+|.|||+++|+|+||||+||+++.++.+||+|||++......
T Consensus 96 ~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-- 171 (343)
T cd07851 96 YLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-- 171 (343)
T ss_pred EEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc--
Confidence 99999998888887765 36899999999999999999999999999999999999999999999999999765422
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.....++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..+.+....+.+..+.........
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred --ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 334466889999999876456789999999999999999999999999988888888887766555444333211000
Q ss_pred ccCC-CchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 011627 243 NHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298 (481)
Q Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~ 298 (481)
.... ............+..++.++.+||++||..||++|||+.+||.|+||.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 0000 0000011223344567899999999999999999999999999999975433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=322.71 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=201.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++..++..+++|.+...... ....+.+|+++++.++|+||+++++++.. .+..
T Consensus 16 g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----------------~~~~ 77 (282)
T cd06643 16 GAFGKVYKAQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYY----------------ENNL 77 (282)
T ss_pred CCCeEEEEEEECCCCeEEEEEEeCCCCHH--HHHHHHHHHHHHHHCCCCCeeeEEEEEee----------------CCEE
Confidence 78999999999999999999998654322 24467789999999999999999999987 5688
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.+ +|...+.+....+++..+..++.||+.+|.|||+.+|+|+||||+|||++.++.+||+|||++......
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~- 156 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 156 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-
Confidence 999999986 444555444557999999999999999999999999999999999999999999999999998764321
Q ss_pred CCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
........++..|+|||++.. ...++.++||||||||+|+|++|+.||...+..+.+..+........
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 228 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-------- 228 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC--------
Confidence 222333467899999999842 24577899999999999999999999988777666555543211000
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.....++.++.+||.+||..||++|||+.++++|+||...
T Consensus 229 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 229 -------------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 0012356789999999999999999999999999999653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.46 Aligned_cols=277 Identities=38% Similarity=0.619 Sum_probs=215.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||+|++..+++.||||++............+.+|+.+++++ +|+||+++++++.... ...
T Consensus 18 g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~--------------~~~ 83 (337)
T cd07852 18 GAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN--------------DKD 83 (337)
T ss_pred CCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC--------------Cce
Confidence 7899999999999999999999865433333344667899999999 9999999999986521 446
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+||||||+.++|...+... .+++..++.++.||+.+|+|||+++|+|+||||+||||+.++.+||+|||++..+....
T Consensus 84 ~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 8999999999888777654 68889999999999999999999999999999999999999999999999998664332
Q ss_pred C----CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 162 N----NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 162 ~----~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
. .......+|..|+|||++.+...++.++|||||||++|+|++|+.||......+.+.++....+.+....+....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 2 123334678899999998765668899999999999999999999999988888888877765544332222111
Q ss_pred CCCccccC-CCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHF-KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.......+ ..............+.++.++.+||.+||+.||++|||+.++++|+||..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 00000000 00000111223344557889999999999999999999999999999954
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=323.62 Aligned_cols=272 Identities=36% Similarity=0.630 Sum_probs=219.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++....... ......+|+..+++++ |+||+++++++.+ ++.
T Consensus 10 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~----------------~~~ 72 (283)
T cd07830 10 GTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE----------------NDE 72 (283)
T ss_pred CCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc----------------CCc
Confidence 789999999999999999999987553321 1234467999999999 9999999999877 668
Q ss_pred EEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
.|+||||+.++|.+.+.... ..+++.++..++.||+.+|.|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 73 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 73 LYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 89999999888888776654 46899999999999999999999999999999999999999999999999999765422
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......++..|+|||++.....++.++||||||+++++|++|+.+|...+..+.+.++....+.+....|.....+.
T Consensus 153 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 153 --PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred --CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 223345678899999998765667899999999999999999999999999999999888888777766665443222
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..................+...+.++++||++||..||++|||++|++.|+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 11111111111112233334457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.14 Aligned_cols=288 Identities=34% Similarity=0.585 Sum_probs=212.3
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|+||.||+|++..+++.||||++..... .....+.+|+.++++++|+||+++++++......... ..........
T Consensus 15 ~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~ 90 (342)
T cd07854 15 CGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE--DVGSLTELNS 90 (342)
T ss_pred CCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc--ccccccccce
Confidence 38899999999999999999999976543 2345678999999999999999999888763211000 0000111346
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~ 160 (481)
+|+||||+.++|...+.. ..+++..++.++.||+.||.|||+++|+||||||+|||++. +..+||+|||+++.+...
T Consensus 91 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~ 168 (342)
T cd07854 91 VYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168 (342)
T ss_pred EEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCc
Confidence 899999999888777654 35899999999999999999999999999999999999985 456899999999765322
Q ss_pred CC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 161 HN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 161 ~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. .......++..|+|||++.....++.++|||||||++|+|++|+.||...+..+.+..+...........+.....
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07854 169 YSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN 248 (342)
T ss_pred cccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 11 1122235688999999886656688999999999999999999999998888777777665433322211111100
Q ss_pred -CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 239 -MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
++.... ................++.++++||.+||..||++|+|+.|+|.|+||..-
T Consensus 249 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 249 VIPSFVR-NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hhhhhhh-hcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 000000 000111122333445688999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=327.30 Aligned_cols=277 Identities=27% Similarity=0.434 Sum_probs=218.0
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-----C---CCccceeeEEeCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-----H---ENVIKLKEIVTSPGPERDEQGRP 73 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-----h---pnIv~l~~~~~~~~~~~~~~~~~ 73 (481)
-|.|||||+|.|+.+.+.||||+++. .+.+.+..+.||++|++++ | ..||+|++.|...++.
T Consensus 88 WGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN------- 157 (590)
T KOG1290|consen 88 WGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN------- 157 (590)
T ss_pred ccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC-------
Confidence 38999999999999999999999984 3446778899999999994 2 4799999999986654
Q ss_pred CCCCcCCeEEEEEecCCCChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEc----------
Q 011627 74 DGNKYRGSTYMVFEYMDHDLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLID---------- 141 (481)
Q Consensus 74 ~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~---------- 141 (481)
..++|||||+++.+|+.+++..+. .++...++.|++|||.||.|||.. ||||.||||+||||.
T Consensus 158 -----G~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 158 -----GQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred -----CcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 779999999999999999988664 499999999999999999999976 999999999999981
Q ss_pred --------------------------------------------------------------------------------
Q 011627 142 -------------------------------------------------------------------------------- 141 (481)
Q Consensus 142 -------------------------------------------------------------------------------- 141 (481)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------CC----------------------------------------------------CC
Q 011627 142 ------------------------NE----------------------------------------------------GN 145 (481)
Q Consensus 142 ------------------------~~----------------------------------------------------~~ 145 (481)
.. -.
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 00 02
Q ss_pred eEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCC------CChHHHHH
Q 011627 146 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG------KNEAEQLS 219 (481)
Q Consensus 146 vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~------~~~~~~~~ 219 (481)
|||+|||.|+.+ ...++.-+.|..|+||||+++ ..|+..+||||++|++|||+||..+|.. ..+++.++
T Consensus 393 vKIaDlGNACW~----~khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 393 VKIADLGNACWV----HKHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred EEEeeccchhhh----hhhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 688888888764 455667788999999999998 6899999999999999999999999974 34678899
Q ss_pred HHHHhcCCCCCCCC----------ccCCCCCccccCCCchhhhhhHHH---HHhhhcHHHHHHHHHhcccCCCCCCCHHH
Q 011627 220 KIFELCGSPDETIW----------PGVSKMPAYNHFKPSRTMKRRVRE---VFRHFDRHALELLEKMLMLDPSQRISAKD 286 (481)
Q Consensus 220 ~i~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ll~~~L~~dP~~R~sa~e 286 (481)
.|+++++..+..+. .....+.....++.-... +.+.+ +...-..++.|||.-||+++|++|+||.+
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~-~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLY-EVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHH-HHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 99999988654331 111111111222211111 11111 11234456889999999999999999999
Q ss_pred HhcCCCCCCCCCC
Q 011627 287 ALDSEYFWTDPLP 299 (481)
Q Consensus 287 iL~h~~f~~~~~~ 299 (481)
+|+|||+...+.+
T Consensus 547 cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 547 CLKHPWLNPVAGP 559 (590)
T ss_pred HhcCccccCCCCC
Confidence 9999999765444
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=322.69 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=201.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++..+++.||+|+++..... ....+.+|++++++|+|+||+++++++.+ ...+
T Consensus 16 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 77 (280)
T cd06611 16 GAFGKVYKAQHKETGLFAAAKIIQIESEE--ELEDFMVEIDILSECKHPNIVGLYEAYFY----------------ENKL 77 (280)
T ss_pred CCCceEEEEEEcCCCcEEEEEEEeeCCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEec----------------CCeE
Confidence 78999999999999999999999754322 24567789999999999999999999987 6688
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.+ +|.+++.+....+++.+++.++.||+.+|.|||+++|+|+||||+||+++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (280)
T cd06611 78 WILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST- 156 (280)
T ss_pred EEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc-
Confidence 999999987 666666555557999999999999999999999999999999999999999999999999998765322
Q ss_pred CCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
........++..|+|||++.. ...++.++|||||||++|+|++|+.||...+....+.++........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 228 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-------- 228 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc--------
Confidence 222233467899999999752 24467899999999999999999999988776665555532110000
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....++.++.+||.+||..||++||++.++|+|+||..
T Consensus 229 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 229 -------------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred -------------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 001235678999999999999999999999999999954
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=319.84 Aligned_cols=245 Identities=23% Similarity=0.347 Sum_probs=195.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||+++..... ....+.+|+.+++.++|+||+++++++.. .+.+
T Consensus 20 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l~h~~ii~~~~~~~~----------------~~~~ 81 (267)
T cd06645 20 GTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGSYLR----------------RDKL 81 (267)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCeeeEEEEEEe----------------CCEE
Confidence 89999999999999999999999765322 23456789999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+++ +|.+++.. ...+++.+++.++.||+.+|.|||+++|+|+||||+|||++.++.+||+|||++..+...
T Consensus 82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd06645 82 WICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT- 159 (267)
T ss_pred EEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-
Confidence 999999986 66665543 346999999999999999999999999999999999999999999999999998765422
Q ss_pred CCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........++..|+|||++.. ...++.++|||||||++|+|++|..||........+..+...... ...+.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~----- 232 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ--PPKLK----- 232 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC--CCccc-----
Confidence 222334567999999998742 245788999999999999999999998766544433332211000 00000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~ 292 (481)
....++..+.+||.+||..||++|||+++|++|+|
T Consensus 233 ------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 233 ------------------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ------------------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00125667899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=332.63 Aligned_cols=277 Identities=36% Similarity=0.591 Sum_probs=214.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++......+.....+.+|+.++++++|+||+++++++...... .....+
T Consensus 26 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----------~~~~~~ 95 (342)
T cd07879 26 GAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG----------DEFQDF 95 (342)
T ss_pred cCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC----------CCCceE
Confidence 7899999999999999999999976544444455678999999999999999999998763211 113467
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+|+||+..++..... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~--- 169 (342)
T cd07879 96 YLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--- 169 (342)
T ss_pred EEEecccccCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC---
Confidence 9999999877665542 3589999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
......++..|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+....+.+....+.........
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 2233466889999999876456889999999999999999999999998888888888776654433222211110000
Q ss_pred ccCCC-chhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 243 NHFKP-SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 243 ~~~~~-~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
..... ...........+..++.++++||++||+.||++|+++.++|.|+||..-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 0001122333445678899999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=330.84 Aligned_cols=280 Identities=36% Similarity=0.593 Sum_probs=216.3
Q ss_pred cceeEEEEEEEccC--CcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKT--GEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~t--g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||++++..+ ++.||||++............+.+|+.+++++ +|+||+++++.+.... ...
T Consensus 11 G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~------------~~~ 78 (332)
T cd07857 11 GAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP------------GNF 78 (332)
T ss_pred cCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc------------ccC
Confidence 78999999999988 99999999876544443455678999999999 5999999998765321 013
Q ss_pred CeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 80 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
..+|+++||+.++|...+... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 79 ~~~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 79 NELYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred CcEEEEEecccCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 468999999999888877543 4689999999999999999999999999999999999999999999999999986543
Q ss_pred CCC---CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 160 DHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 160 ~~~---~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
... .......+|..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..++...+.+....+...
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 211 12233467999999998876556889999999999999999999999999988888888887776554332222
Q ss_pred CCCCccccCCC-chhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 237 SKMPAYNHFKP-SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
........... ..............++..+.+||.+||+.||++|+|+.|++.|+||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 11000000000 000011122233456789999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=323.97 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=199.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++..+++.|++|++..... .....+.+|+.++++++|+||+++++++.. ++.+
T Consensus 23 g~~g~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 84 (292)
T cd06644 23 GAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVKLLGAFYW----------------DGKL 84 (292)
T ss_pred CCCeEEEEEEECCCCceEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCcEeeeEEEEEe----------------CCeE
Confidence 8899999999999999999999875432 234567789999999999999999999986 5689
Q ss_pred EEEEecCCCC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g~-L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.++ |...+.+....+++..+..++.||+.+|+|||+++|+||||||+|||++.++++||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 9999999975 44455554556899999999999999999999999999999999999999999999999998654321
Q ss_pred CCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
........++..|+|||++.. ...++.++|||||||++|+|++|..||...+....+.++...... . .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~-----~- 235 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--T-----L- 235 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc--c-----C-
Confidence 122233466889999998852 244688999999999999999999999887765555444321100 0 0
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....++.++.+||.+||..||++||+++++++|+||..
T Consensus 236 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 236 -------------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred -------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 001135668999999999999999999999999999954
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=318.35 Aligned_cols=244 Identities=27% Similarity=0.530 Sum_probs=198.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC-------cchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG-------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 75 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~-------~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~ 75 (481)
|+||.||+|.+..+++.||||.+........ ....+.+|+.++++++|+||+++++++.+
T Consensus 11 g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------- 77 (267)
T cd06628 11 GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD------------- 77 (267)
T ss_pred CCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-------------
Confidence 7899999999999999999999875532211 22456789999999999999999999887
Q ss_pred CCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 76 NKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 76 ~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
....++||||+.+ +|..++.. ...+++..+..++.||+.+|+|||+++++|+||||+|||+++++.+||+|||++
T Consensus 78 ---~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 78 ---ADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred ---CCccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 5688999999986 56555544 346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-----CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 011627 155 RSFSYDHN-----NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 229 (481)
Q Consensus 155 ~~~~~~~~-----~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~ 229 (481)
+....... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+.++......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-- 230 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP-- 230 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCC--
Confidence 86642111 11122356889999999876 56788999999999999999999999877665554444321100
Q ss_pred CCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 230 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.+...++.++.+||++||+.||++||++.+|++|+||
T Consensus 231 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 231 ---------------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ---------------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0112366789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=318.35 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=197.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++..... ....+.+|+.+++++ +|+||+++++++...... .....
T Consensus 17 g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~----------~~~~~ 83 (272)
T cd06637 17 GTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP----------GMDDQ 83 (272)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC----------CCCcE
Confidence 7899999999999999999999975432 234677899999999 699999999998763221 11357
Q ss_pred EEEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+||||||+.+ +|.+++... ...+++..+..++.||+.+|+|||+++|+|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 8999999985 677666553 34689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 160 DHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
. ........++..|+|||++.. ...++.++|||||||++|+|++|+.||...........+... ....
T Consensus 164 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~---- 235 (272)
T cd06637 164 T-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PAPR---- 235 (272)
T ss_pred c-cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CCCC----
Confidence 2 223344567899999999863 235788999999999999999999999766554433332210 0000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.....++.++.+||.+||..||.+|||+.|+++|+||
T Consensus 236 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 236 ---------------------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ---------------------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0011356789999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=332.17 Aligned_cols=277 Identities=36% Similarity=0.598 Sum_probs=213.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++..+++.||||++............+.+|+.++++++|+||+++++++...... .....+
T Consensus 26 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~~~~ 95 (343)
T cd07880 26 GAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL----------DRFHDF 95 (343)
T ss_pred cCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc----------cccceE
Confidence 8899999999999999999999875443333445678999999999999999999998763211 012357
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+.++|..++.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~--- 170 (343)
T cd07880 96 YLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS--- 170 (343)
T ss_pred EEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc---
Confidence 99999998777776654 3589999999999999999999999999999999999999999999999999976532
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc-
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA- 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 241 (481)
......++..|+|||++.+...++.++|+|||||++|+|++|+.||...+....+.+++..........+........
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 171 -EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred -CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 222345688999999987644578999999999999999999999998888777777766544332221111111000
Q ss_pred -cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 -YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+....+ .............++.++.+||.+||..||++|+|+.+++.|+||...
T Consensus 250 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 250 NYVKKLP-RFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHhcc-ccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000 000112333446788899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=361.71 Aligned_cols=247 Identities=27% Similarity=0.420 Sum_probs=199.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||+|++............+++|+.+|++|+|+|||+++++|.+.. ...+
T Consensus 24 GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~--------------~~~l 89 (1021)
T PTZ00266 24 GRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA--------------NQKL 89 (1021)
T ss_pred CCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC--------------CCEE
Confidence 89999999999999999999999876555445667889999999999999999999987532 4579
Q ss_pred EEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCcEEEcC---------
Q 011627 83 YMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN-------QVLHRDIKGSNLLIDN--------- 142 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~-------giiHrDLKp~NILl~~--------- 142 (481)
|||||||.+ +|..++.. ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999985 77766653 234699999999999999999999985 4999999999999964
Q ss_pred --------CCCeEEecccccccccCCCCCccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCC
Q 011627 143 --------EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKN 213 (481)
Q Consensus 143 --------~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~ 213 (481)
...+||+|||++..+... ......++|+.|+|||++.+. ..++.++||||||||||+|++|+.||...+
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 234899999999765422 222345789999999998642 457899999999999999999999998776
Q ss_pred hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 214 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
....+..++....... ...++.++.+||.+||..||.+||++.++|.|+||
T Consensus 248 ~~~qli~~lk~~p~lp-----------------------------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 248 NFSQLISELKRGPDLP-----------------------------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred cHHHHHHHHhcCCCCC-----------------------------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 6554444332110000 01256789999999999999999999999999999
Q ss_pred C
Q 011627 294 W 294 (481)
Q Consensus 294 ~ 294 (481)
.
T Consensus 299 k 299 (1021)
T PTZ00266 299 K 299 (1021)
T ss_pred h
Confidence 5
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=333.09 Aligned_cols=242 Identities=21% Similarity=0.369 Sum_probs=187.5
Q ss_pred cceeEEEEEEE-----ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE-----IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++ ..+++.||||+++.... ......+++|+.+++++ +|+||+++++++...
T Consensus 18 G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~------------- 83 (338)
T cd05102 18 GAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKP------------- 83 (338)
T ss_pred CCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-------------
Confidence 89999999985 34567899999875432 22345678999999999 899999999988652
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCC------------------------------------------------------
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPG------------------------------------------------------ 101 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~------------------------------------------------------ 101 (481)
...+|+||||+.+ +|.+++....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 4468999999985 6766554321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCCC-cccccccccc
Q 011627 102 -------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLW 173 (481)
Q Consensus 102 -------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~ 173 (481)
..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++........ ......++..
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 24778899999999999999999999999999999999999999999999999765322211 1122344678
Q ss_pred CCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 011627 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 252 (481)
Q Consensus 174 Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (481)
|+|||++.+ ..++.++|||||||++|||++ |..||......+.+...+...... .
T Consensus 242 y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-----~------------------ 297 (338)
T cd05102 242 WMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-----R------------------ 297 (338)
T ss_pred ccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-----C------------------
Confidence 999999976 578999999999999999997 999998866544433332211000 0
Q ss_pred hhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 253 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 253 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.||++
T Consensus 298 -----~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 298 -----APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01235678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=325.18 Aligned_cols=268 Identities=23% Similarity=0.297 Sum_probs=200.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++..+++.||+|.+..... ......+.+|++++++++|+||+++++++.+ ++.+
T Consensus 12 G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 74 (308)
T cd06615 12 GNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYS----------------DGEI 74 (308)
T ss_pred CCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----------------CCEE
Confidence 8999999999999999999999875432 2234567899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
||||||+.+ +|.+++.+. ..+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.+||+|||++......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred EEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999986 666665443 568999999999999999999997 59999999999999999999999999998755322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.....+++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..... .++..... ...+.......
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~ 226 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVS--EGEAKESHRPV 226 (308)
T ss_pred ---ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccc--cccccCCcccc
Confidence 2234567899999999876 56889999999999999999999999876643332 22221110 00000000000
Q ss_pred c--cccCCCchhhhhhHHHH---------HhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 A--YNHFKPSRTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~--~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
. ................. ...++.++++||.+||..||++|||+++|++|+||..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 0 00000000000001100 1136788999999999999999999999999999954
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=353.51 Aligned_cols=275 Identities=27% Similarity=0.360 Sum_probs=194.3
Q ss_pred cceeEEEEEEEccCC-cEEEEEEee--------------c-CCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCC
Q 011627 3 VCISQVFMAREIKTG-EIVALKKIR--------------M-DNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg-~~vAvK~i~--------------~-~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~ 66 (481)
|+||+||+|..+... +.+++|.++ + ..........+.+|+.+|++|+|+|||++++++.+
T Consensus 159 G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---- 234 (501)
T PHA03210 159 GAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRS---- 234 (501)
T ss_pred CCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEEEE----
Confidence 899999999865433 222322111 1 01112233456789999999999999999999987
Q ss_pred CCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC
Q 011627 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPG----LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 142 (481)
Q Consensus 67 ~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~----~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~ 142 (481)
.+..|+|+|++.++++.++.... ......+++.|+.||+.||+|||+++||||||||+||||+.
T Consensus 235 ------------~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 235 ------------EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred ------------CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 56789999999998887765432 23456778899999999999999999999999999999999
Q ss_pred CCCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCC-CCC--CChHHHHH
Q 011627 143 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPG--KNEAEQLS 219 (481)
Q Consensus 143 ~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~p-f~~--~~~~~~~~ 219 (481)
++.+||+|||+++.+...........++|..|+|||++.+ ..++.++||||||||+|||+++..+ |.. .+....+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999998765433333344678999999999987 5789999999999999999998754 432 23445555
Q ss_pred HHHHhcCCCCCCCCccC-CCCCccccCCCchhhhhhHHHHH--hhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 220 KIFELCGSPDETIWPGV-SKMPAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 220 ~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+++......... ++.. .++..+............+...+ ..++..+.++|.+||..||++|||+.|+|.||||..
T Consensus 382 ~~~~~~~~~~~~-~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 382 KIIDSLSVCDEE-FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHhcccChhh-cCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 555444332221 1111 00000000000000001111111 236778999999999999999999999999999954
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=324.73 Aligned_cols=248 Identities=26% Similarity=0.434 Sum_probs=201.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++.+..+++.||||++...... ....+.+|+.++++++|+||+++++.+.. .+..
T Consensus 33 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----------------~~~~ 94 (292)
T cd06658 33 GSTGIVCIATEKHTGKQVAVKKMDLRKQQ--RRELLFNEVVIMRDYHHENVVDMYNSYLV----------------GDEL 94 (292)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecchHH--HHHHHHHHHHHHHhCCCCcHHHHHHheec----------------CCeE
Confidence 88999999999999999999998754322 24467899999999999999999999876 5688
Q ss_pred EEEEecCCCC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g~-L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.++ |.+++.. ..+++.++..++.||+.+|+|||+++|+||||||+||++++++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999875 4444432 358999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..+........ .
T Consensus 173 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~------- 239 (292)
T cd06658 173 -PKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV----K------- 239 (292)
T ss_pred -ccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc----c-------
Confidence 22233567899999999876 5688999999999999999999999988777665555432111000 0
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~ 299 (481)
....++..+.+||.+||..||++|||++|+|+|+||.....+
T Consensus 240 ----------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 240 ----------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred ----------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 011356789999999999999999999999999999765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=353.80 Aligned_cols=245 Identities=23% Similarity=0.408 Sum_probs=193.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeE-EeCCCCCCCCCCCCCCCCc-C
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEI-VTSPGPERDEQGRPDGNKY-R 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~-~~~~~~~~~~~~~~~~~~~-~ 79 (481)
|+|+.||+|++...+..||||++-.. .+.....+.+||++||+|+ |+|||.+++. ..... ... .
T Consensus 48 GGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~-----------~~~~~ 114 (738)
T KOG1989|consen 48 GGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS-----------SNNGV 114 (738)
T ss_pred CCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc-----------CCCce
Confidence 89999999999999899999998766 3335677889999999997 9999999994 32211 111 3
Q ss_pred CeEEEEEecCC-CChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 80 GSTYMVFEYMD-HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 80 ~~~~iV~Ey~~-g~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
-.++|+||||. ++|.+++.. ...+|++.+|.+||.|+++||.+||... |||||||-|||||+.++++||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 47899999999 588888874 2335999999999999999999999997 9999999999999999999999999986
Q ss_pred cccCCC-CC-------ccccccccccCCCchhhc--CCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 011627 156 SFSYDH-NN-------TLTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 225 (481)
Q Consensus 156 ~~~~~~-~~-------~~~~~~gt~~Y~aPEvl~--~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 225 (481)
-..... .. ......-|+.|+|||++. +....+.|+|||+|||+||.||....||+......++.--++
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~-- 272 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYS-- 272 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecccc--
Confidence 432111 00 001123389999999874 235689999999999999999999999987655433322221
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 011627 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292 (481)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~ 292 (481)
+|. +..++..+++||+.||+.||++||++.+++.+-+
T Consensus 273 -------------~P~-----------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 273 -------------FPP-----------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred -------------CCC-----------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 111 1357889999999999999999999999986543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=321.91 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=193.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++..... ......+.+|++++++++|+||+++++++.. .+..
T Consensus 12 g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 74 (279)
T cd06619 12 GNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFV----------------ENRI 74 (279)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE----------------CCEE
Confidence 7899999999999999999999976532 2234567899999999999999999999987 6678
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
+|||||+.+..+... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+...
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999999997655433 24788899999999999999999999999999999999999999999999999765422
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCCCCCccCCCC
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ---LSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.....++|..|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ...+............
T Consensus 149 -~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 220 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL------ 220 (279)
T ss_pred -cccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC------
Confidence 2334577999999999876 5689999999999999999999999965322110 0011111000000000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....++.++++||.+||..||++||+++|+++|+||..
T Consensus 221 ------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 221 ------------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred ------------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 01235678999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=312.71 Aligned_cols=244 Identities=27% Similarity=0.450 Sum_probs=206.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++..+++.+++|.+............+.+|+.++++++|+||+++++++.+ ...+
T Consensus 11 g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~ 74 (256)
T cd08221 11 GAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD----------------DNTL 74 (256)
T ss_pred cCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec----------------CCeE
Confidence 889999999999999999999998765444455678899999999999999999999987 5689
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
++||||+.+ +|.+.+.+. ...+++.++..++.||+.+|.|||+++++|+||||+||+++.++.+||+|||++......
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 999999985 777766554 456899999999999999999999999999999999999999999999999999766433
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.......
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------------ 220 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP------------ 220 (256)
T ss_pred cc-cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 21 2334567899999999876 457889999999999999999999999888777777664311000
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
....++.++.+||.+||..||++|||++|+|+|+|+
T Consensus 221 -----------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 -----------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 002367789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=317.67 Aligned_cols=280 Identities=35% Similarity=0.591 Sum_probs=226.6
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
+|+||.||.+.|..+|+.||+|++......-...+.+.+|+++|..++|.||+..+++.+.+... +-..
T Consensus 63 YGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d-----------fFqE 131 (449)
T KOG0664|consen 63 YGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS-----------FFQE 131 (449)
T ss_pred ccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch-----------HHHH
Confidence 59999999999999999999999865443333456788999999999999999999998875432 3447
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+|+|+|+|..||...+..+. .++.+.++-++.||+.||+|||+.+|+||||||.|+|++.+-.+||||||+|+....+.
T Consensus 132 iYV~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 89999999999998887654 69999999999999999999999999999999999999999999999999999877666
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
...++..+.|-.|+|||++.+...|+.++||||+|||+.||+..+-+|...+..+++..|.++++.+......--.+-..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 66777778899999999999999999999999999999999999999999999999999999998875322110000000
Q ss_pred cccCC---CchhhhhhHHHH--HhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 242 YNHFK---PSRTMKRRVREV--FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 242 ~~~~~---~~~~~~~~~~~~--~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
.+.. ........+-.+ ..+-..+..+++.+||..||++|++.++++.|+|.-
T Consensus 291 -~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 291 -NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred -HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 0000 000000000001 113345788999999999999999999999999974
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=357.80 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=219.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.|.+++++.|+++||+|++++.... ......|..|-.||---+.+-|+.++..|++ +.+
T Consensus 86 GaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD----------------~~~ 149 (1317)
T KOG0612|consen 86 GAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD----------------ERY 149 (1317)
T ss_pred cccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC----------------ccc
Confidence 89999999999999999999999875422 3334567789999999999999999999998 779
Q ss_pred EEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+. |||+.++.+-. ++++..++.|+..|+.||..||+.|+|||||||+|||||..|+|||+|||.+..+..+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 999999997 58999888776 8999999999999999999999999999999999999999999999999999988877
Q ss_pred CCCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 161 HNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
........+|||-|+|||+|.. ...|+..+|.|||||++|||+.|..||...+-.+++.+|+.......
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~------- 301 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS------- 301 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC-------
Confidence 7777788899999999999863 25689999999999999999999999999999999999986521110
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWTDPL 298 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s---a~eiL~h~~f~~~~~ 298 (481)
+|. .-.+|.++++||+++|. +++.|.. ++|+..||||....+
T Consensus 302 --FP~-----------------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 302 --FPD-----------------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred --CCc-----------------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 110 01388899999999875 7888887 999999999976544
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=335.17 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=201.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||-|+|..|...+|||.|...... +..-+..||.++++|+|.|||++++.+.+ ++++
T Consensus 586 GTYG~VYA~RD~~tqvrIaIKEIpekdsr--~~QPLhEEIaLH~~LrHkNIVrYLGs~se----------------nGf~ 647 (1226)
T KOG4279|consen 586 GTYGTVYAARDMDTQVRIAIKEIPEKDSR--EVQPLHEEIALHSTLRHKNIVRYLGSVSE----------------NGFF 647 (1226)
T ss_pred CceeEEEeeccccceeEEEeeecccccch--hhccHHHHHHHHHHHhhHhHHHHhhccCC----------------CCeE
Confidence 89999999999999999999999755443 34567899999999999999999999876 7788
Q ss_pred EEEEecCCC-ChhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRF--TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l--~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~ 158 (481)
-|+||-+.| +|.+++...-+++ +|..+..+.+|||+||.|||++.|||||||-+||||+. .|.+||+|||.++.+.
T Consensus 648 kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 648 KIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred EEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 999999986 5666666655566 88999999999999999999999999999999999975 6889999999998775
Q ss_pred CCCCCccccccccccCCCchhhcC-CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCCCCCccC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 236 (481)
.- +-...++.||+.|||||++.. ...|+.++|||||||++.||.||++||....... .+.++- +.
T Consensus 728 gi-nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-my----------- 794 (1226)
T KOG4279|consen 728 GI-NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-MY----------- 794 (1226)
T ss_pred cC-CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-ce-----------
Confidence 32 223344678999999999964 3569999999999999999999999997544322 222110 00
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+ .-..+...++.+++.||.+|+..||.+|++|+++|..||+.-.
T Consensus 795 -K---------------vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 795 -K---------------VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred -e---------------cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 0 0011234578899999999999999999999999999999654
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=323.43 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=203.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC-CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|.||+||+|++..+++.||||.+....... .....+.+|++++++++|+||+++++++.+ ...
T Consensus 12 g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~ 75 (316)
T cd05574 12 GDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT----------------ETY 75 (316)
T ss_pred CccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec----------------CCE
Confidence 789999999999999999999998654332 244567889999999999999999999876 668
Q ss_pred EEEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+||||||+.+ +|.+++... ...+++..++.++.||+.+|+|||+++++|+||||+||||+.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999986 777766543 35689999999999999999999999999999999999999999999999999875432
Q ss_pred CCC----------------------------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCC
Q 011627 160 DHN----------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG 211 (481)
Q Consensus 160 ~~~----------------------------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 211 (481)
... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 111 01112367888999999976 5678999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC----HHHH
Q 011627 212 KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS----AKDA 287 (481)
Q Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s----a~ei 287 (481)
.+....+..+...... ++. ...++.++++||.+||..||++|+| ++|+
T Consensus 235 ~~~~~~~~~~~~~~~~-----~~~-----------------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l 286 (316)
T cd05574 235 SNRDETFSNILKKEVT-----FPG-----------------------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286 (316)
T ss_pred CchHHHHHHHhcCCcc-----CCC-----------------------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence 8877766665421100 000 0125778999999999999999999 9999
Q ss_pred hcCCCCCCC
Q 011627 288 LDSEYFWTD 296 (481)
Q Consensus 288 L~h~~f~~~ 296 (481)
|.|+||...
T Consensus 287 l~~~~~~~~ 295 (316)
T cd05574 287 KQHPFFRGV 295 (316)
T ss_pred HcCchhhcC
Confidence 999999654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=328.49 Aligned_cols=277 Identities=22% Similarity=0.274 Sum_probs=200.6
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
.|+|++||+|++..+++.||||++..........+.+.+|+.+++.++|+||++++++|.. ...
T Consensus 10 ~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----------------~~~ 73 (328)
T cd08226 10 FCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT----------------GSW 73 (328)
T ss_pred ccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec----------------CCc
Confidence 4689999999999999999999998664443344677889999999999999999999987 567
Q ss_pred EEEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+|+||||+.+ ++.+++.+. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+||+.+.....
T Consensus 74 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 74 LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred eEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence 8999999985 666665543 23589999999999999999999999999999999999999999999999986543321
Q ss_pred CCCCc------cccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--
Q 011627 160 DHNNT------LTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE-- 230 (481)
Q Consensus 160 ~~~~~------~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~-- 230 (481)
..... .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||........+..++......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI 233 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence 11100 0011235679999998763 34789999999999999999999999887765555444332111000
Q ss_pred CCCccCCCCCc---------------cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 231 TIWPGVSKMPA---------------YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 231 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
..++....... ....................++..+++||++||..||++|||++|+|+|+||.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 00000000000 00000000000001112345778899999999999999999999999999994
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.48 Aligned_cols=241 Identities=27% Similarity=0.441 Sum_probs=201.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||++++..+++.||||++..... .......+.+|++++++++|+||+++++++.+ ...
T Consensus 12 g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~ 75 (290)
T cd05580 12 GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD----------------DSN 75 (290)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc----------------CCe
Confidence 7899999999999999999999875432 22234567899999999999999999999987 668
Q ss_pred EEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|+||||+. ++|.+.+... ..+++..+..++.||+.+|+|||+++|+|+||+|+||||+.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999996 5676666544 56999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
....+++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+......++......
T Consensus 155 ----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------- 216 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR------------- 216 (290)
T ss_pred ----CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcc-------------
Confidence 233467899999999876 56789999999999999999999999887766666655421100
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
+...++..++++|.+||..||++|+ +++|+++|+||..
T Consensus 217 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 217 -----------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred -----------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 0113567899999999999999999 9999999999954
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.67 Aligned_cols=240 Identities=15% Similarity=0.143 Sum_probs=193.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC-CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+++.||+++. +++.||||+++...... .....+.+|+.+|++++|+||+++++++.+.. .....
T Consensus 31 g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~------------~~~~~ 96 (283)
T PHA02988 31 NDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV------------DDLPR 96 (283)
T ss_pred CCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc------------cCCCc
Confidence 78999999987 79999999998654322 22356679999999999999999999987511 01346
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
++|||||+.+ +|.+++.+ ...+++.....++.||+.||.|||+. +++||||||+|||+++++.+||+|||+++....
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred eEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 8999999996 56665554 44689999999999999999999984 999999999999999999999999999976532
Q ss_pred CCCCccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .....+|..|+|||++.+. ..++.++|||||||++|||++|+.||...+..+.+..+......+..
T Consensus 176 ~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 243 (283)
T PHA02988 176 P----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL-------- 243 (283)
T ss_pred c----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--------
Confidence 1 1234678999999998652 46899999999999999999999999988877776666432211110
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++++||.+||+.||++|||++||++
T Consensus 244 --------------------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 244 --------------------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------------------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0135678999999999999999999999985
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=329.74 Aligned_cols=277 Identities=36% Similarity=0.580 Sum_probs=213.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++..+++.||||++............+.+|+.++++++|+||+++++++..... ......+
T Consensus 28 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~----------~~~~~~~ 97 (345)
T cd07877 28 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS----------LEEFNDV 97 (345)
T ss_pred cCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc----------ccccccE
Confidence 789999999999999999999997654333334567789999999999999999999865321 1113468
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+++|++.++|..++... .+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~lv~~~~~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~--- 172 (345)
T cd07877 98 YLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 172 (345)
T ss_pred EEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc---
Confidence 999999988887766543 589999999999999999999999999999999999999999999999999876432
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc-
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA- 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 241 (481)
......++..|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+...........+........
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 173 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred -cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 223346688999999987655688999999999999999999999998888887777776665544433322221000
Q ss_pred -cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 -YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+..... ..........+...+.++++||.+||..||++|+|+.++|+|+||..-
T Consensus 252 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 252 NYIQSLT-QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHHhc-ccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000000 000001112223467889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.43 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=193.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++..... ....+.+|+.++++++|+||+++++++.. ...+
T Consensus 20 g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~----------------~~~~ 81 (267)
T cd06646 20 GTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLS----------------REKL 81 (267)
T ss_pred CCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEe----------------CCEE
Confidence 78999999999999999999999754322 23457789999999999999999999986 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.+ +|.+++.. ...+++..+..++.||+.+|+|||+++|+||||||+||+++.++.+||+|||++..+...
T Consensus 82 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd06646 82 WICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT- 159 (267)
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc-
Confidence 999999986 56555543 346899999999999999999999999999999999999999999999999999765322
Q ss_pred CCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........++..|+|||++.. ...++.++|||||||++|||++|+.||...+..+....+...... ...+.
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~----- 232 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ--PPKLK----- 232 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC--CCCCc-----
Confidence 112233467889999998753 234678999999999999999999998655443322222110000 00000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~ 292 (481)
....++.++.+||++||..||++|||+++||+|.|
T Consensus 233 ------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 233 ------------------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ------------------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 01235678999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=320.75 Aligned_cols=244 Identities=28% Similarity=0.470 Sum_probs=200.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||+||++++..+++.||||.+...... ....+.+|+.+++.++|+||+++++++.. ...+
T Consensus 30 g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 91 (296)
T cd06655 30 GASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLV----------------GDEL 91 (296)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEec----------------CceE
Confidence 78999999999999999999999754322 34567899999999999999999999986 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+|+||+.+ +|..++.. ..+++.++..++.||+.+|+|||+++++|+||||+||+++.++.+||+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999986 45554433 258999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
. ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.... ....
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~----------- 235 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPEL----------- 235 (296)
T ss_pred c-cCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Cccc-----------
Confidence 1 2233467889999998876 567899999999999999999999999887766555543211 0000
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....++..+.+||++||..||++|+|+.+|+.|+||..
T Consensus 236 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 236 ---------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred ---------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 001236778999999999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=314.08 Aligned_cols=245 Identities=27% Similarity=0.467 Sum_probs=196.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC----CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK----EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~----~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|.+ .+++.+|||+++..... ......+.+|+.++++++|+||+++++++.+
T Consensus 11 g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------------- 73 (265)
T cd06631 11 GAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD---------------- 73 (265)
T ss_pred cCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec----------------
Confidence 78999999987 58899999998755322 1123457789999999999999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
.+.+|+||||+.+ +|.+++.+ ...+++..+..++.||+.+|+|||+.+|+|+||||+||+++.++.+||+|||++...
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 74 DNTISIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred CCeEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 5689999999986 56555544 346899999999999999999999999999999999999999999999999998764
Q ss_pred cCC-----CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 011627 158 SYD-----HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 232 (481)
Q Consensus 158 ~~~-----~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (481)
... .........++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 228 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP--- 228 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC---
Confidence 321 1112223457889999999876 5678999999999999999999999987665554433322111100
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.+...++.++.+||++||..||++||++.++|+|+||
T Consensus 229 ------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 229 ------------------------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0112467789999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=312.70 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=200.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.+|+|++...... ....+.+|+.++++++|+||+++++++.+ ...+
T Consensus 14 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~ 75 (262)
T cd06613 14 GTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLR----------------RDKL 75 (262)
T ss_pred CCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEe----------------CCEE
Confidence 78999999999999999999999865433 34678899999999999999999999877 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|++|||+.+ +|.+++......+++.+++.++.||+.+|+|||+++|+|+||||+||++++++.+||+|||++..+....
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999997 5555555554679999999999999999999999999999999999999999999999999997654321
Q ss_pred CCccccccccccCCCchhhcCC--CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.......++..|+|||++... ..++.++|||||||++|+|++|+.||...+.......+.........
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 225 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK--------- 225 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc---------
Confidence 122334678899999998652 26788999999999999999999999887765554444321000000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~ 292 (481)
......++.++.+||++||..||++|||+.+|+.|+|
T Consensus 226 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 ----------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0011235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=312.46 Aligned_cols=243 Identities=26% Similarity=0.403 Sum_probs=199.6
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|+||.||++++..+++.|++|.++.... ...+.+|++++++++|+||+++++++.+ ...
T Consensus 13 ~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------------~~~ 72 (256)
T cd06612 13 EGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFK----------------NTD 72 (256)
T ss_pred CCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeec----------------CCc
Confidence 37899999999999999999999875532 4578899999999999999999999987 568
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|+++||+.+ +|.+++......+++..++.++.||+.+|.|||+++|+|+||+|+||++++++.+||+|||++......
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999996 666666555567899999999999999999999999999999999999999999999999999866432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.. ......++..|+|||++.+ ..++.++||||||||+|+|++|+.||...+.......+.... .. .+
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~-~~------- 219 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP---PP-TL------- 219 (256)
T ss_pred cc-ccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC---CC-CC-------
Confidence 21 2223456889999999876 578899999999999999999999998766544333221100 00 00
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.....++.++.+||.+||+.||++|||++|+|+|+||
T Consensus 220 ----------------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 220 ----------------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ----------------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0112366789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=322.00 Aligned_cols=278 Identities=23% Similarity=0.287 Sum_probs=203.5
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
+|.++.||++++..+++.||||+++...........+.+|+.++++++|+||+++++++.+ .+.
T Consensus 10 ~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~----------------~~~ 73 (314)
T cd08216 10 FEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV----------------DSE 73 (314)
T ss_pred hcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec----------------CCe
Confidence 4678899999999999999999998764444456678899999999999999999999987 667
Q ss_pred EEEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.|++|||+.+ ++.+++... ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+||+.+.....
T Consensus 74 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 74 LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred EEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecc
Confidence 8999999985 565555542 34589999999999999999999999999999999999999999999999998875432
Q ss_pred CCC------CccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-C-CC
Q 011627 160 DHN------NTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS-P-DE 230 (481)
Q Consensus 160 ~~~------~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-~-~~ 230 (481)
... .......++..|+|||++... ..++.++|||||||++|+|++|+.||........+......... . ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence 111 111223457789999998753 34788999999999999999999999876655443322211100 0 00
Q ss_pred CCCccCCC-CCcc-ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 231 TIWPGVSK-MPAY-NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 231 ~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..++.... .... ...................++.++.+||.+||..||++|||++++|+|+||..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 00000000 0000 00000000111112223457788999999999999999999999999999953
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.15 Aligned_cols=247 Identities=26% Similarity=0.459 Sum_probs=201.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||+++..... ....+.+|+.+++.++|+||+++++++.. .+.+
T Consensus 32 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----------------~~~~ 93 (297)
T cd06659 32 GSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLV----------------GEEL 93 (297)
T ss_pred CCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheee----------------CCeE
Confidence 89999999999999999999999765332 24567899999999999999999999876 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.+ +|..++.. ..+++..++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+....
T Consensus 94 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 999999986 55544433 358999999999999999999999999999999999999999999999999987554322
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+.... ...+
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~-------- 237 (297)
T cd06659 172 -PKRKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP----PPKL-------- 237 (297)
T ss_pred -ccccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC----CCCc--------
Confidence 12233567899999999976 568899999999999999999999998877666655443210 0000
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~ 298 (481)
.....++.++.+||.+||..||++||+++++++|+||....+
T Consensus 238 ---------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 238 ---------------KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred ---------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 011235678999999999999999999999999999976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=319.65 Aligned_cols=248 Identities=22% Similarity=0.347 Sum_probs=198.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||+|.++..... .....+.+|+.++++++|+||+++++.+.. .+.+
T Consensus 12 g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~ 74 (286)
T cd06622 12 GNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGAFFI----------------EGAV 74 (286)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEeecccCH-HHHHHHHHHHHHHHhcCCCcHHhhhhheec----------------CCeE
Confidence 88999999999999999999998754322 223567899999999999999999999887 6689
Q ss_pred EEEEecCCC-ChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRP--GLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~--~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
|+||||+.+ +|..++... ...+++..+..++.||+.+|.|||+ ++|+|+||||+|||++.++.+||+|||++..+.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999987 555555442 2368999999999999999999997 599999999999999999999999999987653
Q ss_pred CCCCCccccccccccCCCchhhcCCC-----CCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~-----~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
.. ......++..|+|||++.+.. .++.++|||||||++|+|++|+.||...+.......+..........
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 229 (286)
T cd06622 155 AS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT-- 229 (286)
T ss_pred CC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC--
Confidence 22 223345688999999985422 35789999999999999999999998765554444433222111110
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+...++.++.+||.+||..||++||++.++++|+||...
T Consensus 230 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 230 ------------------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred ------------------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 112367789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.73 Aligned_cols=249 Identities=26% Similarity=0.377 Sum_probs=198.8
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
-|+||+||+|.+..+++.||||++...... ......+.+|++++++++|+||+++++++.. .+
T Consensus 3 ~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~ 66 (277)
T cd05577 3 KGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET----------------KD 66 (277)
T ss_pred CCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec----------------CC
Confidence 389999999999999999999999754322 2234456789999999999999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 81 STYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
.+||||||+.+ +|.+.+.+.. ..+++.++..++.||+.+|.|||+++++|+||+|+|||+++++.+||+|||++....
T Consensus 67 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 67 DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred eEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 89999999985 6766665433 358999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.......
T Consensus 147 ~--~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 213 (277)
T cd05577 147 G--GKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM---------- 213 (277)
T ss_pred c--CCccccccCCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc----------
Confidence 2 222233456888999999876 458899999999999999999999997765422222222110000
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
.......+++++.+||++||+.||++|+ ++.++++|+||+.
T Consensus 214 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 214 ----------------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred ----------------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 0011124678899999999999999999 9999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=314.57 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=203.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|.+..+++.+|+|++....... ....+.+|+++++.++|+||+++++.+.. ...+
T Consensus 12 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 74 (267)
T cd06610 12 GATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV----------------GDEL 74 (267)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee----------------CCEE
Confidence 789999999999999999999997654333 45678899999999999999999999876 6689
Q ss_pred EEEEecCCC-ChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 83 YMVFEYMDH-DLTGLADRP--GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~--~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
|||||++.+ +|.+++... ...+++..++.++.||+.+|+|||+++|+|+||||+||++++++.+||+|||++..+..
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999986 566665442 24689999999999999999999999999999999999999999999999999876654
Q ss_pred CCCC---ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 160 DHNN---TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 160 ~~~~---~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.... ......++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.++...... .+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~ 230 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP----SLETG 230 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC----CcCCc
Confidence 3222 1233457889999999876446889999999999999999999999877766555554432100 00000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..+..++.++++||.+||..||++|||+++|++||||
T Consensus 231 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 231 --------------------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------------------cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0023467889999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=314.71 Aligned_cols=247 Identities=27% Similarity=0.466 Sum_probs=195.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC---CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE---GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|.+..+++.||+|++....... .....+.+|+.++++++|+||+++++++.+.. .
T Consensus 13 g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------------~ 78 (266)
T cd06651 13 GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA--------------E 78 (266)
T ss_pred CCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC--------------C
Confidence 889999999999999999999987653222 22345778999999999999999999987522 4
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..++++|||+.+ +|.+.+... ..+++..++.++.||+.+|+|||+++|+|+||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 578999999986 666665543 358999999999999999999999999999999999999999999999999987653
Q ss_pred CCC--CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 159 YDH--NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 159 ~~~--~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
... ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+.++.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~---~~~----- 228 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP---TNP----- 228 (266)
T ss_pred cccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC---CCC-----
Confidence 211 111223456889999999876 568899999999999999999999998765554444332111 000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
.+...++..+.+|| +||..||++||+++||++||||.
T Consensus 229 --------------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 --------------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00123567788898 57778999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.38 Aligned_cols=246 Identities=23% Similarity=0.362 Sum_probs=193.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHH-HHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKI-LKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~i-l~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||+++++.+++.||||+++....... ...+..|+.+ ++.++|+||+++++++.. .+.
T Consensus 12 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~----------------~~~ 74 (283)
T cd06617 12 GAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFR----------------EGD 74 (283)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEec----------------CCc
Confidence 8999999999999999999999986543322 3355566665 666789999999999986 567
Q ss_pred EEEEEecCCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
+|+||||++++|.+++.. ....+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++..+
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 899999999887665543 334689999999999999999999997 9999999999999999999999999999765
Q ss_pred cCCCCCccccccccccCCCchhhcCC---CCCCCCCchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~ 233 (481)
... ...+...++..|+|||++.+. ..++.++|+|||||++|+|++|+.||... +..+.+..+.... ..
T Consensus 155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~--- 226 (283)
T cd06617 155 VDS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP---SP--- 226 (283)
T ss_pred ccc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC---CC---
Confidence 422 122334678899999988642 34688999999999999999999999643 2233333332110 00
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.++ ...++.++.+||.+||..||++|||+.++++|+||..
T Consensus 227 ----~~~------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 227 ----QLP------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred ----CCC------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 000 0136778999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=306.97 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=206.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+-|+||+++..++|...|||.++....++ ..++++..+.+..+.. +|+||+++++|.. +..
T Consensus 103 GtcG~V~k~~~rs~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~dcpyIV~c~GyFi~----------------n~d 165 (391)
T KOG0983|consen 103 GTCGQVWKMRFRSTGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGYFIT----------------NTD 165 (391)
T ss_pred CCccceEEEEEcccceEEEEEeecccCCHH-HHHHHHHhhhHHhhccCCCeeeeeeeEEee----------------Cch
Confidence 788999999999999999999998776555 3557777888776664 9999999999997 557
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
++|.||.|...+..++++-...++|..+-++...++.||.||.++ +|||||+||+|||||+.|+|||||||++-.+-..
T Consensus 166 V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 166 VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 889999999777677766666799999999999999999999755 9999999999999999999999999999766432
Q ss_pred CCCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
...+...|.+.|||||.+.- ...|+..+|||||||+|+||+||..||.+ +.+.+++.++.+.. ++. .+
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e--PP~--L~--- 316 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE--PPL--LP--- 316 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC--CCC--CC---
Confidence 33344577899999999853 24589999999999999999999999987 46788888887521 110 00
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....|++.+++|+..||.+|+.+||...++|+|+|+..
T Consensus 317 --------------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 317 --------------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred --------------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 01238889999999999999999999999999999954
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=316.85 Aligned_cols=243 Identities=23% Similarity=0.361 Sum_probs=190.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC-cchhHHHHH---HHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG-FPITAIREI---KILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~-~~~~~~~Ei---~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++.||||++........ .......|. .+++.+.|++|+++++++.+
T Consensus 5 g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---------------- 68 (278)
T cd05606 5 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---------------- 68 (278)
T ss_pred CCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec----------------
Confidence 8899999999999999999999976532211 112233343 34455679999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...+|+||||+.+ +|...+. ....+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+
T Consensus 69 ~~~~~~v~e~~~g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 69 PDKLSFILDLMNGGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred CCEEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 5689999999986 5554443 4457999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCCCCCc
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 234 (481)
... .....+++..|+|||++.+...++.++|||||||++|+|++|+.||..... ......+... ..
T Consensus 148 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~---- 216 (278)
T cd05606 148 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----AV---- 216 (278)
T ss_pred Ccc---CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc----CC----
Confidence 422 223346799999999987545688999999999999999999999987632 2221111100 00
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
.+...++.++.+||.+||..||++|+ ++.++++|+||..
T Consensus 217 ----------------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 217 ----------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred ----------------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 01123577899999999999999999 9999999999955
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=319.81 Aligned_cols=244 Identities=26% Similarity=0.455 Sum_probs=199.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++..+++.||||.+...... ....+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 31 g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~----------------~~~~ 92 (296)
T cd06654 31 GASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV----------------GDEL 92 (296)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe----------------CCEE
Confidence 78999999999999999999999865433 23567799999999999999999999986 5689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.+ +|.+++.. ..+++.++..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++.......
T Consensus 93 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred EEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999986 66666543 358999999999999999999999999999999999999999999999999987654221
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.... .+. +
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~---~-------- 236 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE---L-------- 236 (296)
T ss_pred -cccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCC---C--------
Confidence 22233467889999999876 567899999999999999999999998776654443332110 000 0
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....++..+.+||.+||..||++|||+.||++|+||..
T Consensus 237 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 237 ---------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred ---------------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 001236678999999999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=312.04 Aligned_cols=244 Identities=24% Similarity=0.454 Sum_probs=202.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++..+++.||||.+............+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 11 g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 74 (256)
T cd08218 11 GSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE----------------NGNL 74 (256)
T ss_pred CCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC----------------CCeE
Confidence 789999999999999999999998654333344578899999999999999999999976 6689
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
||||||+.+ +|.+.+... ...+++.++..++.||+.+|.|||+++++|+||+|+|||++.++.++|+|||++......
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999975 777766543 335889999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
. .......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+.+..+.......
T Consensus 155 ~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------------ 220 (256)
T cd08218 155 V-ELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP------------ 220 (256)
T ss_pred h-hhhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC------------
Confidence 1 11223356888999999876 567889999999999999999999998887777666654321100
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
....++.++.++|.+||+.||++||++.|+|+|+||
T Consensus 221 -----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 221 -----------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 012357789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=317.23 Aligned_cols=244 Identities=24% Similarity=0.368 Sum_probs=189.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC-cchhHHHHHHHHHh---cCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG-FPITAIREIKILKK---LQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~-~~~~~~~Ei~il~~---L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||.||++++..+++.||||+++....... ......+|..+++. .+|+||+.+++++..
T Consensus 5 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~---------------- 68 (279)
T cd05633 5 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT---------------- 68 (279)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec----------------
Confidence 8899999999999999999999976533221 12233455544444 479999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
.+.+|+||||+.+ +|...+. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 69 ~~~~~lv~e~~~~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 69 PDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred CCeEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 5688999999986 5554444 3446999999999999999999999999999999999999999999999999998755
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE--QLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~ 235 (481)
... ......+|..|+|||++.....++.++|||||||++|+|++|..||....... .+..... ...
T Consensus 148 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~------ 215 (279)
T cd05633 148 SKK---KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TVN------ 215 (279)
T ss_pred ccc---CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cCC------
Confidence 322 12234679999999998644567899999999999999999999997543221 1111110 000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
..+...++.++.+||++||..||++|+ |++++++|+||..
T Consensus 216 --------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 216 --------------------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred --------------------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 001124677899999999999999999 6999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.13 Aligned_cols=249 Identities=29% Similarity=0.520 Sum_probs=197.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC----CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||.||++++..+++.||||+++...... .....+.+|++++++|+|+||+++++++.+
T Consensus 11 g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------------- 74 (268)
T cd06630 11 GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE---------------- 74 (268)
T ss_pred cCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc----------------
Confidence 789999999999999999999997543221 134567889999999999999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CeEEeccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARS 156 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~ 156 (481)
.+.+++||||+.+ +|.+++.+ ...+++..+..++.||+.||.|||+++++|+||||+||+++.++ .+||+|||++..
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 6689999999986 55555543 34689999999999999999999999999999999999998776 599999999876
Q ss_pred ccCCCC---CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 157 FSYDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 157 ~~~~~~---~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
...... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 229 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA--- 229 (268)
T ss_pred cccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC---
Confidence 643211 11122356889999999876 56889999999999999999999999765443333333221100000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
..+...++.++.+||.+||..||++|||+.|+++|+||.
T Consensus 230 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 230 ----------------------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ----------------------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 011124677899999999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=314.56 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=201.6
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|+||.||++++..+++.||||++....... ....+.+|+.++++++|+||+++++++.+ ...
T Consensus 11 ~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~ 73 (274)
T cd06609 11 KGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-EIEDIQQEIQFLSQCRSPYITKYYGSFLK----------------GSK 73 (274)
T ss_pred CCCCeEEEEEEECCCCeEEEEEEeeccccch-HHHHHHHHHHHHHHcCCCCeeeeeEEEEE----------------CCe
Confidence 3889999999999999999999998654322 34467789999999999999999999987 568
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|+|+||+.+ +|.+.+... .+++..++.++.||+.+|.|||+.+++|+||+|+||++++++.++|+|||+++.+...
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999986 666666543 6899999999999999999999999999999999999999999999999999876533
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
. .......++..|+|||++.+ ..++.++||||||||+|+|++|+.||...+.......+..... ... .
T Consensus 152 ~-~~~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~--------~ 219 (274)
T cd06609 152 M-SKRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP--PSL--------E 219 (274)
T ss_pred c-cccccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC--CCC--------c
Confidence 2 22233466888999999986 4589999999999999999999999987765554444332100 000 0
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...++.++.++|.+||..||++|||++++++|+||..
T Consensus 220 ------------------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 220 ------------------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred ------------------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 0015678999999999999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=326.27 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=207.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||-|+-..||+-||+|++.+...+ ..-....++|..||.+++.+.||.+-..|+. ++.
T Consensus 196 GGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT----------------kd~ 259 (591)
T KOG0986|consen 196 GGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET----------------KDA 259 (591)
T ss_pred ccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC----------------CCc
Confidence 89999999999999999999998765322 2234467799999999999999999999988 778
Q ss_pred EEEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+|+||..|+| ||...+.+-+ ..|++..+..|+.+|+.||++||+.+||.|||||+|||||+.|+|+|+|+|+|+.+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~- 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP- 338 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC-
Confidence 9999999986 6666665533 359999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.......++||..|||||++.+ ..|+.+.|.|||||+||||+.|+.||....+..-.+.+-+.
T Consensus 339 -~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr--------------- 401 (591)
T KOG0986|consen 339 -EGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR--------------- 401 (591)
T ss_pred -CCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH---------------
Confidence 3445566799999999999987 56999999999999999999999999765443222222110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~~ 296 (481)
......+...+||+++++|.+.+|.+||++|. .+.++.+||||+.-
T Consensus 402 -----------~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 402 -----------TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred -----------HhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 01111223357999999999999999999997 67899999999753
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=312.86 Aligned_cols=246 Identities=25% Similarity=0.400 Sum_probs=200.9
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
-|+||.||+|++..+++.||||++...... ......+.+|+.+++.++|+||+++++++.+ ..
T Consensus 3 ~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~ 66 (262)
T cd05572 3 VGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD----------------KK 66 (262)
T ss_pred CCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc----------------CC
Confidence 388999999999999999999999765322 2344578899999999999999999999887 56
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|+||||+.+ +|.+.+.+. ..+++..+..++.||+.||+|||+++++|+||||+||+++.++.+||+|||++.....
T Consensus 67 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 67 YIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred ccEEEEecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 78999999985 666666543 4589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCCCCCccCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN--EAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
.. ......++..|++||++.. ..++.++|+|||||++|+|++|..||...+ ..+.+..+........
T Consensus 146 ~~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 214 (262)
T cd05572 146 GQ--KTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE-------- 214 (262)
T ss_pred cc--ccccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC--------
Confidence 22 2223466889999999875 568899999999999999999999998776 4444544432110000
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
....++.++++||.+||..||++|++ ++|+++|+||..
T Consensus 215 --------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 215 --------------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred --------------------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 00123668999999999999999999 999999999964
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=311.56 Aligned_cols=246 Identities=30% Similarity=0.457 Sum_probs=201.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|.+..+++.||+|++............+.+|+.++++++|+||+++++++.... ...+
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------------~~~~ 76 (265)
T cd08217 11 GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS--------------NQTL 76 (265)
T ss_pred CCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC--------------CCEE
Confidence 78999999999999999999999765444444556788999999999999999999886522 4578
Q ss_pred EEEEecCCC-ChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCcEEEcCCCCeEEecccc
Q 011627 83 YMVFEYMDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCH-----VNQVLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~---~~~l~~~~i~~i~~Qil~gL~~LH-----~~giiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
|++|||+.+ +|.+++... ...+++..++.++.||+.+|+||| +.+|+|+||||+||++++++.+||+|||+
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence 999999985 666665432 456899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
+........ ......++..|+|||++.. ..++.++|+|||||++|+|++|+.||...+.......+.....
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 227 (265)
T cd08217 157 AKILGHDSS-FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF------- 227 (265)
T ss_pred cccccCCcc-cccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-------
Confidence 987653221 1334567999999999876 5688999999999999999999999998875555444422100
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..+...++.++.+||.+||..||++|||+.+||+|||+
T Consensus 228 ----------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 228 ----------------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ----------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 00112466789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=335.23 Aligned_cols=232 Identities=25% Similarity=0.371 Sum_probs=191.0
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
.|+-|.||+++- .++.||||+++.- -..+|+.|++|+|+|||.|.++|.. .-.
T Consensus 134 SGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtq----------------sPc 186 (904)
T KOG4721|consen 134 SGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQ----------------SPC 186 (904)
T ss_pred cCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecC----------------Cce
Confidence 378899999986 6899999998632 1268999999999999999999987 558
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+|||||||..+-+..+.+....++......|.++|+.|+.|||.+.|||||||.-||||..++.|||+|||.++.....
T Consensus 187 yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 9999999996544444445557899999999999999999999999999999999999999999999999999877533
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.+...++||..|||||++.. .+.+.|+|||||||||||||||..||..-+...++.-+ +. . ...+
T Consensus 266 -STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----Gs--N-----sL~L-- 330 (904)
T KOG4721|consen 266 -STKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----GS--N-----SLHL-- 330 (904)
T ss_pred -hhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEec----cC--C-----cccc--
Confidence 55667899999999999986 78999999999999999999999999866553322111 00 0 0001
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~ 291 (481)
.+...+++-++-||+.||+-.|..||++.+||.|=
T Consensus 331 ---------------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 331 ---------------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ---------------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 12234677889999999999999999999999873
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=320.82 Aligned_cols=250 Identities=25% Similarity=0.327 Sum_probs=200.6
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
-|+||.||++++..+++.||||.+...... ......+.+|+.+++.++|+||+++++.+.. ..
T Consensus 11 ~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~ 74 (305)
T cd05609 11 NGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET----------------KR 74 (305)
T ss_pred cCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec----------------CC
Confidence 388999999999999999999998765321 2234466789999999999999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|+||||+.+ +|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 89999999986 56555544 34689999999999999999999999999999999999999999999999999864211
Q ss_pred CCC--------------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 011627 160 DHN--------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 225 (481)
Q Consensus 160 ~~~--------------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 225 (481)
... .......++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 100 01112356788999999876 568999999999999999999999999887777666654321
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCC
Q 011627 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWTD 296 (481)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s---a~eiL~h~~f~~~ 296 (481)
...... ...++.++.+||++||..||++|++ +.++|+|+||...
T Consensus 233 ~~~~~~---------------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 233 IEWPEG---------------------------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred cCCCCc---------------------------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 110000 0136778999999999999999997 7999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=314.89 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=196.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||+|++..... ....+..|+.+++++ +|+||+++++++...... .....
T Consensus 27 g~~~~v~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~----------~~~~~ 93 (282)
T cd06636 27 GTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP----------GHDDQ 93 (282)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecChH---HHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc----------CCCCE
Confidence 8899999999999999999999875432 234677899999999 699999999998653211 12568
Q ss_pred EEEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+||||||+.+ +|.+++... ...+++..++.++.||+.+|.|||+++|+|+||||+||+|++++.+||+|||++.....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 9999999986 666666542 34588999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 160 DHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.. .......++..|+|||++.. ...++.++|||||||++|+|++|+.||........+..+.... ...
T Consensus 174 ~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~---- 245 (282)
T cd06636 174 TV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---PPK---- 245 (282)
T ss_pred cc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC---CCC----
Confidence 21 22334567899999998863 2457889999999999999999999997665544333221110 000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.....++.++.+||++||..||.+|||+.|||+|+||
T Consensus 246 ---------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 246 ---------------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ---------------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0012467789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=317.12 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=196.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||++++..+++.||||++...... .....+.+|+.++.++. |+||+++++++.. ...
T Consensus 15 G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~----------------~~~ 77 (288)
T cd06616 15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR----------------EGD 77 (288)
T ss_pred CCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec----------------CCc
Confidence 78999999999999999999999865433 23456788999999996 9999999999876 557
Q ss_pred EEEEEecCCCChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 82 TYMVFEYMDHDLTGLAD----RPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~----~~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.+++|||+..++.++.. .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 89999999876544322 2235699999999999999999999975 999999999999999999999999999976
Q ss_pred ccCCCCCccccccccccCCCchhhcCC--CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
+.... ......++..|+|||++... ..++.++|||||||++|+|++|+.||...+. ....+.+..........
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~- 232 (288)
T cd06616 158 LVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILS- 232 (288)
T ss_pred hccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCC-
Confidence 54221 12233568899999998764 3688999999999999999999999976542 22222222211110000
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
......++.++.+||.+||..||++|||+++|++|+||+.
T Consensus 233 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 233 ---------------------NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ---------------------CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 0001236778999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=319.33 Aligned_cols=245 Identities=27% Similarity=0.422 Sum_probs=201.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||++++..+++.||||++...... ......+.+|+.++++++|+||+++++++.+ .+.
T Consensus 26 g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~----------------~~~ 89 (307)
T cd06607 26 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR----------------EHT 89 (307)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe----------------CCe
Confidence 78999999999999999999998754322 2233467799999999999999999999987 567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
.||||||+.+++.+++......+++..+..++.||+.+|.|||+++|+|+||+|+||+++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 90 AWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 899999999998887766555799999999999999999999999999999999999999999999999999865431
Q ss_pred CCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.....++..|+|||++.+ ...++.++|||||||++|+|++|+.||...+....+..+.... .. ..
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~--------~~ 234 (307)
T cd06607 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SP--------TL 234 (307)
T ss_pred ---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC--CC--------CC
Confidence 123456888999998752 2457889999999999999999999998877665544442110 00 00
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
....++.++++||.+||..||++||++.+|+.|+||...
T Consensus 235 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 235 ------------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ------------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 001256789999999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=314.82 Aligned_cols=272 Identities=35% Similarity=0.548 Sum_probs=217.1
Q ss_pred EEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 011627 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 86 (481)
Q Consensus 7 ~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~ 86 (481)
.|..|.|..+++.||+|++...........++.+|+.++..++|+|||+++.+|........ ...+|+||
T Consensus 31 ~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~----------~~e~y~v~ 100 (369)
T KOG0665|consen 31 IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE----------FQEVYLVM 100 (369)
T ss_pred eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH----------HHhHHHHH
Confidence 47788899999999999987665555556788899999999999999999999976432211 33679999
Q ss_pred ecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCCCccc
Q 011627 87 EYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 166 (481)
Q Consensus 87 Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 166 (481)
|||+.+|...+. ..++-..+..|+.|++.|++|||+.+|+||||||+||++..+..+||+|||+|+..... -.++
T Consensus 101 e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mt 175 (369)
T KOG0665|consen 101 ELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMT 175 (369)
T ss_pred HhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc--cccC
Confidence 999999888776 35788899999999999999999999999999999999999999999999999865422 4677
Q ss_pred cccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC--------
Q 011627 167 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK-------- 238 (481)
Q Consensus 167 ~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-------- 238 (481)
.++.|..|+|||++.+. .|...+||||+|||+.||++|+..|++.+..++..++.+.++.+++........
T Consensus 176 pyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~ 254 (369)
T KOG0665|consen 176 PYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVEN 254 (369)
T ss_pred chhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhc
Confidence 78889999999999985 489999999999999999999999999999999999999999987655332211
Q ss_pred CCccccCCCchhhh----hhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 239 MPAYNHFKPSRTMK----RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 239 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
.+.+.......... ....+-.+.-...++||+.+||..||++|+|+.|+|+||||+
T Consensus 255 ~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 255 RPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred ChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 11111100000000 000000112335689999999999999999999999999996
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=313.80 Aligned_cols=245 Identities=25% Similarity=0.448 Sum_probs=201.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++.+..+++.|+||+++..... ....+.+|+.+++.++|+||+++++++.. .+..
T Consensus 30 g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~~~h~~vv~~~~~~~~----------------~~~~ 91 (285)
T cd06648 30 GSTGIVCIATDKSTGRQVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHPNIVEMYSSYLV----------------GDEL 91 (285)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHHcCCCChheEEEEEEc----------------CCeE
Confidence 78999999999999999999998754322 24467899999999999999999999886 5678
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+|+||+.+ +|.+.+.. .++++.++..++.||+.+|+|||+++|+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred EEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 999999986 66555554 468999999999999999999999999999999999999999999999999887654322
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+.++..... .. ..
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~--~~--~~------- 236 (285)
T cd06648 170 P-RRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP--PK--LK------- 236 (285)
T ss_pred c-ccccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC--CC--Cc-------
Confidence 2 2233467889999999876 5688999999999999999999999988777666665543210 00 00
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
....++..+.+||.+||..||++|||+.++++|+||...
T Consensus 237 ----------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 237 ----------------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred ----------------ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 001256789999999999999999999999999999664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=322.87 Aligned_cols=271 Identities=39% Similarity=0.621 Sum_probs=212.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.||||++............+.+|+.++++++|+||++++++|... ...+
T Consensus 21 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---------------~~~~ 85 (328)
T cd07856 21 GAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP---------------LEDI 85 (328)
T ss_pred cCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC---------------CCcE
Confidence 7899999999999999999999876544333456777999999999999999999998652 3468
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|+||||+.++|..++.. ..+++..+..++.||++||.|||+++|+|+||||+|||++.++.+||+|||++.....
T Consensus 86 ~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--- 160 (328)
T cd07856 86 YFVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--- 160 (328)
T ss_pred EEEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---
Confidence 99999998888776654 3578889999999999999999999999999999999999999999999999875432
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC---
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM--- 239 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--- 239 (481)
......++..|+|||++.+...++.++|||||||++|+|++|+.||...+.......+.+..+.+....+......
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2233466888999998865456889999999999999999999999988877777666666655443322211110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
..+.... .............++.++++||.+||..||++|+|++++|.|+||...
T Consensus 240 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 240 RFVQSLP--KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHHhhcc--ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0000000 000111223344678899999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=319.58 Aligned_cols=244 Identities=27% Similarity=0.461 Sum_probs=197.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++..+++.||||.+...... ....+.+|+.+++.++|+||+++++++.. ...+
T Consensus 30 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~ 91 (297)
T cd06656 30 GASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV----------------GDEL 91 (297)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec----------------CCEE
Confidence 78999999999999999999999765433 23567789999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.+ +|.+++.+ ..+++.++..++.||+.+|.|||+.+|+|+||||+|||++.++.+||+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred EEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999986 56555543 358999999999999999999999999999999999999999999999999987654222
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+... ..+..
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~----------- 235 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL----------- 235 (297)
T ss_pred -cCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCCCC-----------
Confidence 22233467889999999876 56789999999999999999999999776553332221110 00000
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....++..+++||.+||..||++|++++++|+|+||..
T Consensus 236 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 236 ---------------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred ---------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 001236678899999999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=308.12 Aligned_cols=243 Identities=26% Similarity=0.408 Sum_probs=201.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|.+..+++.+|||++............+.+|+.++++++|+||+++++.+.. .+.+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~ 74 (256)
T cd08220 11 GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE----------------DKAL 74 (256)
T ss_pred cCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec----------------CCEE
Confidence 789999999999999999999998765444455678899999999999999999999876 6689
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CeEEecccccccccC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~ 159 (481)
++||||+.+ +|.+++... ...+++..+..++.||+.+|+|||+++|+|+||||+||+++.++ .+||+|||++.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999986 677766553 33589999999999999999999999999999999999998654 589999999986643
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.......
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 220 (256)
T cd08220 155 K--SKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP----------- 220 (256)
T ss_pred C--ccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC-----------
Confidence 2 12223467889999999876 567899999999999999999999998877666655553311100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+...++.++++||.+||..||++|||+.|+|.||||
T Consensus 221 ------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 221 ------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 011356789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=308.75 Aligned_cols=248 Identities=29% Similarity=0.492 Sum_probs=198.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++..+++.||||+++...........+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 11 G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------------~~~~ 74 (264)
T cd06626 11 GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH----------------REKV 74 (264)
T ss_pred CCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec----------------CCEE
Confidence 889999999999999999999998775544466788899999999999999999999876 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
++|+||+.+ +|.+.+.. ...+++..++.++.||+.+|.|||+++|+|+||||+||++++++.+||+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 75 YIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred EEEEecCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999986 55555544 4458999999999999999999999999999999999999999999999999998764332
Q ss_pred CCc---cccccccccCCCchhhcCCC--CCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 162 NNT---LTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 162 ~~~---~~~~~gt~~Y~aPEvl~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
... .....++..|+|||++.+.. .++.++|||||||++|+|++|+.||...+........... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~------ 226 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP------ 226 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC------
Confidence 211 11345688999999987632 2788999999999999999999999765432222221111 10000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
++ ....++..+.+||++||+.||++|||+.|++.|+|+
T Consensus 227 --~~-----------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 227 --IP-----------------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred --CC-----------------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 011346788999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=314.41 Aligned_cols=242 Identities=27% Similarity=0.439 Sum_probs=198.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC-CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||+|++..+++.||+|++....... .....+.+|++++++++|+||+++++++.+ ...
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~ 74 (258)
T cd05578 11 GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD----------------EEN 74 (258)
T ss_pred CCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC----------------CCe
Confidence 889999999999999999999998654322 345678899999999999999999999876 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|+|+||+.+ +|...+... ..+++.++..++.||+++|.|||+++++|+||||+||++++++.++|+|||++......
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999986 566555444 57899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCccCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--AEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. ......++..|+|||++.. ..++.++|+|||||++|+|++|+.||...+. .+.+...... ..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~--------- 218 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---AD--------- 218 (258)
T ss_pred c--cccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---cc---------
Confidence 2 2233567889999999876 5688999999999999999999999987764 2222222110 00
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH--HHHhcCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA--KDALDSEYF 293 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa--~eiL~h~~f 293 (481)
......++.++.++|.+||..||.+|+++ +|+++|+||
T Consensus 219 -----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 219 -----------------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -----------------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 00112356789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=312.26 Aligned_cols=251 Identities=24% Similarity=0.457 Sum_probs=196.9
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCC--------cchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEG--------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~--------~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~ 73 (481)
-|+||+||++++..+++.||||.++....... ....+.+|+.++++++|+||+++++++..
T Consensus 11 ~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------- 79 (272)
T cd06629 11 KGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT----------- 79 (272)
T ss_pred ccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-----------
Confidence 38899999999999999999999875322111 12356789999999999999999999876
Q ss_pred CCCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccc
Q 011627 74 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 152 (481)
Q Consensus 74 ~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG 152 (481)
...+++||||+.+ +|.+.+.+. ..+++..++.++.||+.+|.|||+++++|+||||+||+++.++.+||+|||
T Consensus 80 -----~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 80 -----EEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred -----CCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecc
Confidence 5678999999986 666665544 468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-CccccccccccCCCchhhcCCC-CCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 011627 153 LARSFSYDHN-NTLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 230 (481)
Q Consensus 153 ~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 230 (481)
+++....... .......++..|+|||++.... .++.++|+||||||+|+|++|..||...+..+.+..+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 230 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA--- 230 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC---
Confidence 9976532211 1123345688999999987633 4788999999999999999999999765554444333211100
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..++ ......++.++++||.+||..||++|||++++|+|+||
T Consensus 231 ~~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 231 PPIP---------------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CcCC---------------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0000 01112467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=309.68 Aligned_cols=240 Identities=23% Similarity=0.354 Sum_probs=191.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++..... .+....+.+|++++++++|+||+++++++.. ...+
T Consensus 6 g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 68 (252)
T cd05084 6 GNFGEVFSGRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----------------KQPI 68 (252)
T ss_pred ccCccEEEEEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC----------------CCCe
Confidence 7899999999999999999998864432 2234578899999999999999999999876 5678
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.+ +|.+.+.+....+++..++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++.......
T Consensus 69 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 69 YIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred EEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccc
Confidence 999999975 6776766555568999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcc-ccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTL-TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~-~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.... .....+..|+|||.+.+ ..++.++||||||||+|+|++ |..||...+.......+.......
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~----------- 216 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP----------- 216 (252)
T ss_pred ccccCCCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC-----------
Confidence 1110 11122456999999876 568899999999999999997 889998776655544443211000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++..+.+||.+||..||++|||+.++++
T Consensus 217 ------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 217 ------------------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01135678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=331.56 Aligned_cols=270 Identities=30% Similarity=0.501 Sum_probs=216.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCC------CCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH------ENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~h------pnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|-||+|..|+|..-+..||||+|+.... -.+.-++|++||++|+. -++++|+..|..
T Consensus 443 GvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-------------- 505 (752)
T KOG0670|consen 443 GVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-------------- 505 (752)
T ss_pred ceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--------------
Confidence 7799999999999999999999985432 23456789999999973 478999988865
Q ss_pred CcCCeEEEEEecCCCChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CeEEecccc
Q 011627 77 KYRGSTYMVFEYMDHDLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGL 153 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g~L~~~~~~--~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~ 153 (481)
.+++|||||-+.-+|.+++.+ .+..|....++.|+.||+.||..|..+||+|.||||+|||+++.. .+||||||.
T Consensus 506 --knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 506 --KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred --cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 889999999999999998876 334588889999999999999999999999999999999998765 589999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
|.... .+..+.+..+..|+|||++++ ..|+...|+||+||+||||.||+-.|++.+...++..++++.+..+....
T Consensus 584 A~~~~---eneitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 584 ASFAS---ENEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred ccccc---cccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 97654 455666777999999999998 78999999999999999999999999999999999999988887654322
Q ss_pred c----------cCCCCC--------------ccccCCCchhhhhhHHH------HHhhhcHHHHHHHHHhcccCCCCCCC
Q 011627 234 P----------GVSKMP--------------AYNHFKPSRTMKRRVRE------VFRHFDRHALELLEKMLMLDPSQRIS 283 (481)
Q Consensus 234 ~----------~~~~~~--------------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ll~~~L~~dP~~R~s 283 (481)
. ....+- ...+.++...+...+.. --..+-.++++||.+||.+||++|+|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 1 111100 01122222222211111 11233457999999999999999999
Q ss_pred HHHHhcCCCCCC
Q 011627 284 AKDALDSEYFWT 295 (481)
Q Consensus 284 a~eiL~h~~f~~ 295 (481)
..++|.||||+.
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999953
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=312.87 Aligned_cols=240 Identities=15% Similarity=0.219 Sum_probs=192.5
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||++.++ .++..||+|+++..... .....+.+|+.++++++|+||+++++++.. .
T Consensus 16 G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~ 78 (266)
T cd05064 16 GRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITR----------------G 78 (266)
T ss_pred cCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEec----------------C
Confidence 789999999875 45678999999765322 234567899999999999999999999976 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.+||||||+.+ +|.+++......+++..+..++.||+.||+|||+++++||||||+||||+.++.+||+|||.+....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 678999999986 5555665555578999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
...........++..|+|||++.+ ..++.++|||||||++|||++ |+.||...+..+.+..+.+....+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 228 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP--------- 228 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---------
Confidence 221111112234678999999876 678999999999999999775 999999888877776664321110
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++..+.+|+.+||..||++|||+++|++
T Consensus 229 --------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 --------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred --------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 01235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=363.88 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=207.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||.||.|.+.+||+..|+|.|+...........+.+|+++|..|+|||||++|++-.+ .+.+
T Consensus 1246 G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH----------------Rekv 1309 (1509)
T KOG4645|consen 1246 GTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH----------------REKV 1309 (1509)
T ss_pred cceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec----------------HHHH
Confidence 789999999999999999999998776555566678899999999999999999998766 7789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC-
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH- 161 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 161 (481)
+|.||||+++.+..+.+...-.++...+.+..|++.||.|||+.|||||||||+||||+.+|.+|++|||.|+.+....
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 9999999976666555555567888889999999999999999999999999999999999999999999998875432
Q ss_pred --CCccccccccccCCCchhhcCCC--CCCCCCchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCccC
Q 011627 162 --NNTLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKN-EAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 162 --~~~~~~~~gt~~Y~aPEvl~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
...+....||+.|||||++.+.+ ...-++||||||||+.||+||+.||...+ +..++..+-... .|
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh-~P-------- 1460 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH-KP-------- 1460 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC-CC--------
Confidence 23345678999999999998753 35678999999999999999999997654 334444442211 11
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+...++.+.+|||..||..||++|+++.|||+|.|-+.
T Consensus 1461 --------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1461 --------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred --------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 112348889999999999999999999999999998754
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=312.39 Aligned_cols=244 Identities=27% Similarity=0.412 Sum_probs=199.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|.+..+++.||+|++...... .....+.+|++++++++|+||+++++++.. .+.+
T Consensus 12 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~ 74 (265)
T cd06605 12 GNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYN----------------NGDI 74 (265)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeec----------------CCEE
Confidence 78999999999999999999998765432 344567899999999999999999999987 5689
Q ss_pred EEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||+||+. .+|.+++......+++..+..++.||+.+|+|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 57777776554679999999999999999999999 99999999999999999999999999998765422
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCCCCCCcc
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-----EAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
... ...++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+ ..+.+..+.... ....
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~--- 224 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRL--- 224 (265)
T ss_pred Hhh---cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC---CCCC---
Confidence 111 1567889999999876 578899999999999999999999997542 222333332110 0000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+ ...++.++++||.+||..||++|||+.+++.||||+.
T Consensus 225 ----~------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 225 ----P------------------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred ----C------------------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 0 0116778999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=307.25 Aligned_cols=244 Identities=28% Similarity=0.467 Sum_probs=199.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC---CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK---EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|.+..+++.|+||++...... ......+.+|+.++++++|+||+++++++.+ .
T Consensus 11 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~ 74 (258)
T cd06632 11 GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE----------------E 74 (258)
T ss_pred cCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec----------------C
Confidence 78999999999999999999998765422 2234567899999999999999999999876 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..+|+|+||+.+ +|.+++.+. ..+++..+..++.||+.+|+|||+++|+|+||+|+||+++.++.+||+|||++....
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 688999999986 666665443 468999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
... ......++..|++||.+.....++.++|+|||||++|+|++|+.||......+...++......
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL----------- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC-----------
Confidence 322 2334567889999999876333789999999999999999999999877655544443221100
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..+...++.++.+||++||..||++||++.++|.|+|+
T Consensus 221 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 -----------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -----------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00112367789999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=310.77 Aligned_cols=247 Identities=31% Similarity=0.526 Sum_probs=202.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||++++..+++.|+||++..... .......+.+|+.++++++|+||+++++.+.. ...
T Consensus 4 g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~ 67 (265)
T cd05579 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG----------------KKN 67 (265)
T ss_pred CCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec----------------CcE
Confidence 8899999999999999999999975532 22345677889999999999999999998876 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|+||||+.+ +|.+++.+.. .+++..+..++.||+.+|.|||+++++|+||+|+|||++.++.+||+|||++......
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 68 LYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred EEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 9999999986 6766665543 6899999999999999999999999999999999999999999999999998764322
Q ss_pred CC-------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 161 HN-------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 161 ~~-------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
.. .......++..|++||++.. ..++.++|||||||++|+|++|..||...+..+....+..... .|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~ 220 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-----EW 220 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-----CC
Confidence 11 12233456888999999876 4578999999999999999999999998887776666543110 11
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH---HHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA---KDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa---~eiL~h~~f~~ 295 (481)
+.. ..++.++.+||.+||..||++|||+ .++|+|+||..
T Consensus 221 ~~~-----------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 221 PED-----------------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred Ccc-----------------------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 100 0146789999999999999999999 99999999953
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=310.76 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=198.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.|++|++..... ....+.+|+.+++++ .|+||+++++++...... .....
T Consensus 17 g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~----------~~~~~ 83 (275)
T cd06608 17 GTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP----------GNDDQ 83 (275)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC----------CcceE
Confidence 7899999999999999999999876543 234678999999999 799999999999863310 11457
Q ss_pred EEEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
+||||||+.+ +|.+++.. .+..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 8999999996 55555443 2357899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccccccCCCchhhcCC----CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
... ........++..|+|||++... ..++.++||||||||+|+|++|+.||...+....+.++.... ...
T Consensus 164 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~-- 237 (275)
T cd06608 164 DST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PPT-- 237 (275)
T ss_pred ccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CCC--
Confidence 322 2223345678899999987542 346788999999999999999999998766555554443210 000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+ .....++.++++||.+||..||++|||+.|+++|||+
T Consensus 238 -----~-----------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 -----L-----------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -----C-----------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0012367789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=308.47 Aligned_cols=246 Identities=27% Similarity=0.463 Sum_probs=195.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC---CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE---GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||++++..+++.||||++....... .....+.+|+.++++++|+||+++++++.+.. .
T Consensus 13 g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------------~ 78 (265)
T cd06652 13 GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM--------------E 78 (265)
T ss_pred CCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC--------------C
Confidence 889999999999999999999987543222 12346678999999999999999999887532 3
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..+|+||||+.+ +|.+.+.+. ..+++..+..++.||+.+|+|||+++|+|+||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 478999999986 666655443 458999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 159 YDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 159 ~~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+.++.. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~----- 228 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTNP----- 228 (265)
T ss_pred cccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCCC-----
Confidence 2111 12223457889999999876 5688999999999999999999999987655544443321 11000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.....++..+.++|.+||. +|++||+++||++|+|+
T Consensus 229 --------------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 229 --------------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred --------------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 0112466789999999995 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=316.36 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=203.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.|+||++...... ......+.+|+.+++.++|+||+++++++.+ ...
T Consensus 32 g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~ 95 (313)
T cd06633 32 GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK----------------EHT 95 (313)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe----------------CCE
Confidence 78999999999999999999999765332 2233467789999999999999999999987 568
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
.||||||+.+++.+.+......+++.++..++.||+.+|.|||+++|+|+||||+||+++.++.+||+|||++....
T Consensus 96 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 89999999999888887666679999999999999999999999999999999999999999999999999986432
Q ss_pred CCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
......++..|+|||++.. ...++.++|||||||++|+|++|..||...+....+.++..... ..
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~--------- 239 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PT--------- 239 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CC---------
Confidence 1223467889999999852 24578899999999999999999999988776666655532110 00
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.....++..+++||.+||+.||.+||++.+++.|+||...
T Consensus 240 -----------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 240 -----------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred -----------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0011355679999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=307.34 Aligned_cols=244 Identities=27% Similarity=0.459 Sum_probs=199.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+++++.++..||+|.+............+.+|+.++++++|+||+++++++.+ ...+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~----------------~~~~ 74 (257)
T cd08225 11 GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE----------------NGRL 74 (257)
T ss_pred CCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc----------------CCeE
Confidence 789999999999999999999998764333344567799999999999999999999876 6689
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC-eEEecccccccccC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~-vkL~DFG~a~~~~~ 159 (481)
|+|+||+.+ +|.+.+.+. ...+++..+..++.||+.+|.|||+++|+|+||||+||++++++. +||+|||.+.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999975 777766543 235899999999999999999999999999999999999998864 69999999976643
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.. .......++..|+|||++.. ..++.++|+|||||++++|++|..||...+..+....+......
T Consensus 155 ~~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 220 (257)
T cd08225 155 SM-ELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA------------ 220 (257)
T ss_pred Cc-ccccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC------------
Confidence 22 22233457889999998876 56889999999999999999999999887766655544321100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.....++.+++++|.+||..||++|||+.|+++|+||
T Consensus 221 -----------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 221 -----------------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -----------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0012356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=298.46 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=194.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+|+-||++++..|++.||+|+|.+... +..+.+++|++..++++||||++++++...... .-....
T Consensus 32 GGfsfv~LV~~~s~~~~YAlKkI~c~~~--~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~-----------D~~~~~ 98 (302)
T KOG2345|consen 32 GGFSFVDLVKGLSTGHLYALKKILCHSQ--EDIEEALREIDNHRKFNSPNVLRLVDHQLREEK-----------DGKHEA 98 (302)
T ss_pred CCceeeeeecccCcccchhhheeeccch--HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc-----------cCceeE
Confidence 8999999999999999999999988762 246688999999999999999999998765221 125579
Q ss_pred EEEEecCC-CChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 83 YMVFEYMD-HDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 83 ~iV~Ey~~-g~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
||+++|.. |+|++.+.+ .+..+++.++..|+.+|+.||++||+.. +.||||||.|||+.+++.++|.|||.++.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999987 568776654 3345999999999999999999999998 99999999999999999999999999976
Q ss_pred ccCCCCC--------ccccccccccCCCchhhcCC--CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 011627 157 FSYDHNN--------TLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 226 (481)
Q Consensus 157 ~~~~~~~--------~~~~~~gt~~Y~aPEvl~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 226 (481)
....... ......+|..|+|||++.-. ...+.++|||||||+||+|+.|..||+. +++..+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~~Gg 249 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQQGG 249 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------HhhcCC
Confidence 5422111 11233669999999988643 2357899999999999999999999953 333222
Q ss_pred CCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 227 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
+....+...-..+|. ...++..+.+||++||+.||.+||++.+++.+
T Consensus 250 SlaLAv~n~q~s~P~-----------------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 250 SLALAVQNAQISIPN-----------------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eEEEeeeccccccCC-----------------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 221111111111110 01278899999999999999999999999864
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=313.57 Aligned_cols=244 Identities=27% Similarity=0.408 Sum_probs=202.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||++++..+++.||||++..... ..+....+.+|+.++++++|+||+++++++.+ ...
T Consensus 36 G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~ 99 (317)
T cd06635 36 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR----------------EHT 99 (317)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----------------CCe
Confidence 7899999999999999999999975532 22334567889999999999999999999987 567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
.||||||+.+++.+.+......+++.++..++.||+.+|.|||+++|+|+||+|+||+++.++.+||+|||++.....
T Consensus 100 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 100 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 899999999988887766566799999999999999999999999999999999999999999999999999865432
Q ss_pred CCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.....++..|+|||++.. ...++.++|||||||++|+|++|+.||...+....+..+........
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 244 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL---------- 244 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC----------
Confidence 223467889999998742 24578899999999999999999999988776666655543211000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....++..+++||.+||+.||.+||++.++++|+|+..
T Consensus 245 ------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 245 ------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 00135667999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=350.08 Aligned_cols=262 Identities=29% Similarity=0.410 Sum_probs=199.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCC--------------
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD-------------- 68 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~-------------- 68 (481)
|+||.||+|+++-+|+.||||+|.... ......++.+|+++|.+|+|||||++|..|.+......
T Consensus 490 GGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQ 568 (1351)
T KOG1035|consen 490 GGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQ 568 (1351)
T ss_pred CCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcc
Confidence 899999999999999999999999876 44456788999999999999999999988876433200
Q ss_pred --------------------------------------------------------CCC---CC----------------
Q 011627 69 --------------------------------------------------------EQG---RP---------------- 73 (481)
Q Consensus 69 --------------------------------------------------------~~~---~~---------------- 73 (481)
+++ ..
T Consensus 569 s~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~es 648 (1351)
T KOG1035|consen 569 SASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSES 648 (1351)
T ss_pred cCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhh
Confidence 000 00
Q ss_pred ------CCCC--------cCCeEEEEEecCCCChhhhhcCCCCCC-CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 74 ------DGNK--------YRGSTYMVFEYMDHDLTGLADRPGLRF-TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 74 ------~~~~--------~~~~~~iV~Ey~~g~L~~~~~~~~~~l-~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
+.+. ..-.+||-||||+.+++..+++.+... ....+++++++|++||.|+|+.|||||||||.||
T Consensus 649 s~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NI 728 (1351)
T KOG1035|consen 649 SESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNI 728 (1351)
T ss_pred hhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCccee
Confidence 0011 113689999999998888887766544 4778999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccccccccc-----------------CCCCCccccccccccCCCchhhcCCC--CCCCCCchhhHHHHH
Q 011627 139 LIDNEGNLKLADFGLARSFS-----------------YDHNNTLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIF 199 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~-----------------~~~~~~~~~~~gt~~Y~aPEvl~~~~--~~~~~~DiwSlGvil 199 (481)
+|+.++.|||+|||+|+... .......+..+||..|+|||++.+.. .|+.|+|||||||||
T Consensus 729 FLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVl 808 (1351)
T KOG1035|consen 729 FLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVL 808 (1351)
T ss_pred EEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHH
Confidence 99999999999999998621 01122567789999999999998765 699999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhc-CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCC
Q 011627 200 AELLNGKPILPGKNEAEQLSKIFELC-GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 278 (481)
Q Consensus 200 ~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 278 (481)
|||+. ||...-+ -...+..+- +..+.. ..++..--+.-..+|+.||+.||
T Consensus 809 FEM~y---PF~TsME--Ra~iL~~LR~g~iP~~------------------------~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 809 FEMLY---PFGTSME--RASILTNLRKGSIPEP------------------------ADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred HHHhc---cCCchHH--HHHHHHhcccCCCCCC------------------------cccccccchHHHHHHHHHhcCCC
Confidence 99986 4654433 222222211 111100 00111122356789999999999
Q ss_pred CCCCCHHHHhcCCCCC
Q 011627 279 SQRISAKDALDSEYFW 294 (481)
Q Consensus 279 ~~R~sa~eiL~h~~f~ 294 (481)
++||||.|+|++.||-
T Consensus 860 ~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 860 SKRPTATELLNSELLP 875 (1351)
T ss_pred ccCCCHHHHhhccCCC
Confidence 9999999999999983
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.57 Aligned_cols=245 Identities=27% Similarity=0.429 Sum_probs=192.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++..++..||+|.+...... ....+.+|+.++++++|+||+++++++.. .+.+
T Consensus 19 g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 80 (268)
T cd06624 19 GTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGSDSE----------------NGFF 80 (268)
T ss_pred CCceEEEEeEecCCCcEEEEEEecCCCHH--HHHHHHHHHHHHHhcCCCCeeeeeeeecc----------------CCEE
Confidence 78999999999999999999998755322 23467899999999999999999999877 5689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRF--TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l--~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~ 158 (481)
++||||+.+ +|.+.+......+ ++..+..++.||+.||+|||+++|+||||||+|||++. ++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999985 6766665543345 88889999999999999999999999999999999976 6689999999987653
Q ss_pred CCCCCccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
.. ........++..|+|||++... ..++.++|||||||++|+|++|+.||..................
T Consensus 161 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 229 (268)
T cd06624 161 GI-NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI---------- 229 (268)
T ss_pred cC-CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhcc----------
Confidence 21 1222234568899999998652 24788999999999999999999999754332211111000000
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
...+...++.++++||.+||..||++|||+.|++.||||
T Consensus 230 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 230 -----------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 001112467789999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=311.26 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=196.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++..+++.||+|++..... ......+.+|+++++.++|+||+++++++.. ...+
T Consensus 16 g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 78 (284)
T cd06620 16 GNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLN----------------ENNI 78 (284)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEec----------------CCEE
Confidence 7899999999999999999999875432 3345678899999999999999999999987 5689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.++.+..+......+++..+..++.+|+.+|.|||+ .+++|+||||+||++++++.++|+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 9999999974444444334568999999999999999999997 59999999999999999999999999998654321
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHhcCCCCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE--------QLSKIFELCGSPDETIW 233 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~ 233 (481)
.....+++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+ ....+...........
T Consensus 158 --~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL- 233 (284)
T ss_pred --ccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC-
Confidence 1223467899999999876 578899999999999999999999998655421 1111111000000000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
....++.++.+||.+||..||++|||+.|+++|+||...
T Consensus 234 ------------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 234 ------------------------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ------------------------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 001256789999999999999999999999999999553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=331.89 Aligned_cols=232 Identities=26% Similarity=0.421 Sum_probs=193.8
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
.|+|+.|..+.+..|++.+++|++..... ...+|+.++.+. +|+||+++++++.+ ..
T Consensus 332 ~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~----------------~~ 389 (612)
T KOG0603|consen 332 EGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYED----------------GK 389 (612)
T ss_pred CCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecC----------------Cc
Confidence 58999999999999999999999986622 234678777666 79999999999987 77
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE-cCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI-DNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl-~~~~~vkL~DFG~a~~~~~ 159 (481)
++|+|||++.+.++...+.....+. .++..|+.+|+.+|.|||++|||||||||+|||+ ++.++|+|+|||.++....
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 8999999999865544444433344 7888899999999999999999999999999999 5889999999999987653
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCCCCccCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA-EQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. ..+.+-|..|.|||++.. ..|+.++||||||++||+||+|+.||...... +++.+|. .+...
T Consensus 469 ~----~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~----~~~~s------- 532 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ----MPKFS------- 532 (612)
T ss_pred h----hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc----CCccc-------
Confidence 3 444566999999999985 78999999999999999999999999887666 3333331 11110
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..+|.+++|||+.||+.||.+|+++.+++.|+||
T Consensus 533 ---------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 ---------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 3588999999999999999999999999999999
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.95 Aligned_cols=240 Identities=28% Similarity=0.455 Sum_probs=198.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++..+++.||+|.++..... .....+.+|+.+++.++|+||+++++.+.+ .+.+
T Consensus 11 g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 73 (255)
T cd08219 11 GSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEA----------------DGHL 73 (255)
T ss_pred cCCeEEEEEEEcCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhCCCCCcceEEEEEEE----------------CCEE
Confidence 88999999999999999999999765432 234567789999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ ++.+.+.. ....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+...
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999985 77776654 3345899999999999999999999999999999999999999999999999999766432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
. .......++..|+|||++.+ ..++.++||||||+++|+|++|..||...+....+..+......+
T Consensus 154 ~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 219 (255)
T cd08219 154 G-AYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP------------ 219 (255)
T ss_pred c-cccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC------------
Confidence 2 22233567889999999876 568899999999999999999999999877766655553211100
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
+...++..+.+||.+||..||++|||+.+|+.-
T Consensus 220 -----------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -----------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011356678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=309.12 Aligned_cols=245 Identities=28% Similarity=0.408 Sum_probs=194.3
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHH-HhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKIL-KKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il-~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
-|+||.||+|++..+++.||||+++..... ......+..|..++ +.++|+||+++++++.+ .
T Consensus 6 ~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----------------~ 69 (260)
T cd05611 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS----------------K 69 (260)
T ss_pred cCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc----------------C
Confidence 388999999999999999999998754321 11122334455444 45589999999999987 6
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.+||||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++++|+||+|+|||++.++.+||+|||++....
T Consensus 70 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 70 DYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 689999999986 56555543 3468999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .....++..|+|||.+.+ ..++.++||||||+|+|+|++|..||...+.......+.........
T Consensus 149 ~-----~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 214 (260)
T cd05611 149 E-----NKKFVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE-------- 214 (260)
T ss_pred c-----cccCCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCC--------
Confidence 2 223456888999999887 45789999999999999999999999988877766655432111000
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s---a~eiL~h~~f~~ 295 (481)
.....++.++.+||.+||..||++|++ ++|+|+|+||..
T Consensus 215 ------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 215 ------------------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred ------------------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 011246788999999999999999995 479999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.48 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=196.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||+|++..+++.+|+|++..... ....+.+|+.+++++ +|+||+++++++..... ...+.
T Consensus 33 g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~-----------~~~~~ 98 (291)
T cd06639 33 GTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK-----------LVGGQ 98 (291)
T ss_pred CCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc-----------cCCCe
Confidence 7899999999999999999999865322 234667899999999 89999999999876321 11357
Q ss_pred EEEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
+|+||||+.+ +|.+++.. ....+++..++.++.||+.+|+|||+++|+|+||||+||+++.++.+||+|||++...
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 8999999986 66555432 3446899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccccccCCCchhhcCCC----CCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGAT----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~----~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
..... ......++..|+|||++.... .++.++||||||||+|+|++|+.||...+....+.++.+... ...
T Consensus 179 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~- 253 (291)
T cd06639 179 TSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP---PTL- 253 (291)
T ss_pred ccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC---CCC-
Confidence 42211 122345788999999886422 367899999999999999999999988776555554432110 000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
. ....++..+.+||.+||..||++||++.||++||||.
T Consensus 254 ---------~--------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 ---------L--------------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ---------C--------------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 0013456799999999999999999999999999983
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=327.46 Aligned_cols=241 Identities=22% Similarity=0.361 Sum_probs=188.4
Q ss_pred cceeEEEEEEEccCC-----cEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG-----EIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||.||+|++..++ +.||||+++..... +....+.+|+.+++.+ +|+|||++++++..
T Consensus 49 G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-------------- 113 (374)
T cd05106 49 GAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTH-------------- 113 (374)
T ss_pred CCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecC--------------
Confidence 789999999975544 57999999765332 2345678999999999 89999999999977
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCC-------------------------------------------------------
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRP------------------------------------------------------- 100 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~------------------------------------------------------- 100 (481)
.+.+|||||||.+ +|.+++...
T Consensus 114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 5678999999985 666654321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCCCcc-
Q 011627 101 --------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL- 165 (481)
Q Consensus 101 --------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~- 165 (481)
...+++.++..|+.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.+........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 12478889999999999999999999999999999999999999999999999976543222111
Q ss_pred ccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 011627 166 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244 (481)
Q Consensus 166 ~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 244 (481)
....++..|+|||++.. ..++.++|||||||++|+|++ |+.||........+.++.........
T Consensus 272 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~-------------- 336 (374)
T cd05106 272 GNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR-------------- 336 (374)
T ss_pred cCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--------------
Confidence 12234567999999876 678999999999999999997 99999876655444444322111000
Q ss_pred CCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++++||.+||..||++|||+.+|++
T Consensus 337 --------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 337 --------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred --------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0124678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=310.80 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=193.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... ....+.+|+.+++++ +|+||+++++++..... .....
T Consensus 29 g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-----------~~~~~ 94 (286)
T cd06638 29 GTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV-----------KNGDQ 94 (286)
T ss_pred CCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc-----------CCCCe
Confidence 7899999999999999999999864322 234567899999999 69999999998864211 12557
Q ss_pred EEEEEecCCC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
+|+||||+++ +|.+++. .....+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999986 5655443 23346899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCccccccccccCCCchhhcCC----CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
... ........++..|+|||++... ..++.++|||||||++|+|++|+.||...+....+.++.... ... +
T Consensus 175 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~~~--~ 249 (286)
T cd06638 175 TST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP--PPT--L 249 (286)
T ss_pred ccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC--CCc--c
Confidence 422 1222334678999999988531 347889999999999999999999998766544333321100 000 0
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.....++.++.+||.+||..||++|||+.|||+|+||
T Consensus 250 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 250 -----------------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -----------------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0001246679999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=303.88 Aligned_cols=244 Identities=33% Similarity=0.511 Sum_probs=204.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++..+++.||+|++............+.+|++++++++|+||+++++.+.. ...+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----------------~~~~ 74 (258)
T cd08215 11 GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE----------------KGKL 74 (258)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec----------------CCEE
Confidence 789999999999999999999998765544456678899999999999999999999987 5689
Q ss_pred EEEEecCCC-ChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~---~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+||+||+++ +|.+.+.+. ...+++.++..++.+|+.||.|||+++++|+||+|+||+++.++++||+|||++....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 999999986 676666553 3679999999999999999999999999999999999999999999999999997764
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
... .......++..|+|||.+.. ..++.++||||||+++++|++|+.||...+..+....+.......
T Consensus 155 ~~~-~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 222 (258)
T cd08215 155 STV-DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---------- 222 (258)
T ss_pred cCc-ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC----------
Confidence 332 12233467889999998876 568899999999999999999999998877665555543211000
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+...++.++.++|.+||..||++|||+.++|+||||
T Consensus 223 -------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 223 -------------------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 011356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=310.22 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=196.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||+|++...... .....+.+|++++++++|+||+++++++.+.. .+.+
T Consensus 12 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------------~~~~ 76 (287)
T cd06621 12 GAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDES--------------SSSI 76 (287)
T ss_pred CCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC--------------CCeE
Confidence 78999999999999999999999865332 34567889999999999999999999987532 4578
Q ss_pred EEEEecCCC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
||||||+++ +|.+++. .....+++..+..++.||+.+|+|||+.+++|+||+|+||+++.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999985 6655433 234468999999999999999999999999999999999999999999999999987553
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCCCCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-----EAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~ 233 (481)
... .....++..|+|||.+.+ ..++.++||||||||+|+|++|+.||.... ..+....+.....
T Consensus 157 ~~~---~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 225 (287)
T cd06621 157 NSL---AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN------- 225 (287)
T ss_pred ccc---cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-------
Confidence 222 123356888999999876 578899999999999999999999998652 2232222221000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+..... ......+++++.+||.+||..||++|||+.|+++|+||+.
T Consensus 226 ~~~~~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 226 PELKDE----------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred hhhccC----------------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 000000 0000124567899999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=314.92 Aligned_cols=247 Identities=21% Similarity=0.301 Sum_probs=188.2
Q ss_pred cceeEEEEEEEcc----------------CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCC
Q 011627 3 VCISQVFMAREIK----------------TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66 (481)
Q Consensus 3 G~fg~Vy~a~~~~----------------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~ 66 (481)
|+||.||+|++.. ++..||||++...... .....+.+|+.++++++|+||+++++++.+
T Consensus 16 G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---- 90 (304)
T cd05096 16 GQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-NARNDFLKEVKILSRLKDPNIIRLLGVCVD---- 90 (304)
T ss_pred cCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-HHHHHHHHHHHHHhhcCCCCeeEEEEEEec----
Confidence 8999999998643 3457999998754322 234567899999999999999999999987
Q ss_pred CCCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 011627 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPG------------------LRFTVPQIKCYMKQLLTGLHYCHVNQ 127 (481)
Q Consensus 67 ~~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~------------------~~l~~~~i~~i~~Qil~gL~~LH~~g 127 (481)
.+.+||||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+++
T Consensus 91 ------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 91 ------------EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred ------------CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 5578999999975 6666553321 23678889999999999999999999
Q ss_pred cccCCCCCCcEEEcCCCCeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh--
Q 011627 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-- 204 (481)
Q Consensus 128 iiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-- 204 (481)
|+||||||+||||+.++.+||+|||+++.+...... ......++..|+|||++.. ..++.++|||||||++|+|++
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999999765322211 1122344778999999876 578999999999999999986
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH
Q 011627 205 GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 284 (481)
Q Consensus 205 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa 284 (481)
+..||...+..+.+..+...........+. .....++..+.+||.+||..||++|||+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYL----------------------FRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccc----------------------cCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 567888777666655543321111000000 0012356789999999999999999999
Q ss_pred HHHhc
Q 011627 285 KDALD 289 (481)
Q Consensus 285 ~eiL~ 289 (481)
.+|.+
T Consensus 296 ~~i~~ 300 (304)
T cd05096 296 SDIHA 300 (304)
T ss_pred HHHHH
Confidence 99954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.25 Aligned_cols=245 Identities=25% Similarity=0.417 Sum_probs=198.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC---CCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|++..+++.||||+++..... .....+.+|+.+++++. |+||+++++++.+ .
T Consensus 12 g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~----------------~ 74 (277)
T cd06917 12 GAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGSYLK----------------G 74 (277)
T ss_pred cCCceEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee----------------C
Confidence 78999999999999999999998765332 23456778999999997 9999999999876 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..+||||||+.+ +|.+++.. ..+++..+..++.||+.+|.|||+.+|+|+||+|+||+++.++.++|+|||++..+.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 688999999986 56655543 268999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
... .......++..|+|||.+.....++.++|+|||||++|+|++|..||...+.......+... ... .
T Consensus 153 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~-------~ 221 (277)
T cd06917 153 QNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS---KPP-------R 221 (277)
T ss_pred CCc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC---CCC-------C
Confidence 332 22333467889999999876556789999999999999999999999876554333222110 000 0
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+. ...++.++.+||.+||..||++||++.|+++|+||+.
T Consensus 222 ~~------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 222 LE------------------DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred CC------------------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 00 0125678999999999999999999999999999955
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=306.61 Aligned_cols=238 Identities=21% Similarity=0.301 Sum_probs=193.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|.+..+++.||+|++..+.. ....+.+|+.++++++|+||+++++++.. ...+
T Consensus 17 g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 77 (263)
T cd05052 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR----------------EPPF 77 (263)
T ss_pred cccceEEEEEEecCCceEEEEEecCCch---HHHHHHHHHHHHHhCCCCChhheEEEEcC----------------CCCc
Confidence 7899999999999999999999874321 24567899999999999999999999876 5678
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
++||||+.+ +|.+++... ...+++..+..++.||+.+|+|||+++++||||||+|||+++++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999974 777766543 345899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
..........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------ 224 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM------------ 224 (263)
T ss_pred eeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC------------
Confidence 2211122233567999998876 578899999999999999998 99999987776665555321100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.....++.++.+||.+||..||++|||+.++++
T Consensus 225 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 225 -----------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 001236778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=304.87 Aligned_cols=237 Identities=22% Similarity=0.321 Sum_probs=192.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+++.+ ++..+|+|.+..... ....+.+|+.++++++|+||+++++++.+ ...+
T Consensus 15 G~~~~vy~~~~~-~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 74 (256)
T cd05114 15 GQFGVVHLGKWR-AQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQ----------------QKPL 74 (256)
T ss_pred CcCceEEEEEec-cCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEcc----------------CCCE
Confidence 889999999875 456899998764322 23467889999999999999999999876 5678
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.+ +|.+.+......+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++......
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 999999984 7777766544568999999999999999999999999999999999999999999999999987653222
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........++..|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+.+..+.+.......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------- 223 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---------- 223 (256)
T ss_pred eeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC----------
Confidence 222222234567999999876 578899999999999999999 99999988887777776542111000
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...+.++.+||.+||..||++|||++++++
T Consensus 224 -------------------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 224 -------------------KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -------------------CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 123557899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=309.30 Aligned_cols=230 Identities=22% Similarity=0.355 Sum_probs=185.1
Q ss_pred CCcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 1 MLVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 1 ~~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
+||.|++||+|+++.+++.||+|+++... ...+|...+....|+||+++++++.+ ..
T Consensus 2 ~~g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~----------------~~ 58 (237)
T cd05576 2 VLGVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS----------------ED 58 (237)
T ss_pred cccccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec----------------CC
Confidence 58999999999999999999999997643 22345666667789999999999987 56
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|.+.+.+. ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++..+..
T Consensus 59 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 59 SVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred eEEEEEecCCCCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 89999999986 676666543 3589999999999999999999999999999999999999999999999998865532
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. ......+..|+|||++.. ..++.++|||||||++|+|++|+.+|...... +. ..
T Consensus 138 ~----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~------------~~--- 192 (237)
T cd05576 138 S----CDGEAVENMYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----IN------------TH--- 192 (237)
T ss_pred c----cccCCcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc------------cc---
Confidence 2 222345778999998865 56789999999999999999999876432110 00 00
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYF 293 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa-----~eiL~h~~f 293 (481)
.. ..+...++..+++||++||+.||++|+++ +|+++||||
T Consensus 193 ---~~-----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 193 ---TT-----------LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ---cc-----------cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00 00112467789999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=304.84 Aligned_cols=238 Identities=21% Similarity=0.282 Sum_probs=191.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++. ++..+|||+++.... ....+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 15 G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 74 (256)
T cd05059 15 GQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTK----------------QRPI 74 (256)
T ss_pred CCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcC----------------CCce
Confidence 789999999885 567899999864322 23467789999999999999999999876 5678
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.+ +|.+++......+++..+..++.||+.+|+|||+++|+||||||+|||+++++.+||+|||+++......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 999999975 6777776555578999999999999999999999999999999999999999999999999987654222
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.........+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.......
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 221 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY------------ 221 (256)
T ss_pred ccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC------------
Confidence 111112223457999999876 578899999999999999999 899998877776665553221100
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....++.++.+|+.+||..+|++|||+.|+++.
T Consensus 222 -----------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 222 -----------------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -----------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 001356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=312.12 Aligned_cols=242 Identities=24% Similarity=0.383 Sum_probs=196.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++.+..+++.||||+++...... ....+.+|+.++++++|+||+++++++.. ...+
T Consensus 15 g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 77 (277)
T cd06642 15 GSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYITRYYGSYLK----------------GTKL 77 (277)
T ss_pred CCCeeEEEEEEcCCCeEEEEEEeccccchH-HHHHHHHHHHHHHcCCCCccHhhhccccc----------------CCce
Confidence 889999999999999999999987554322 34567899999999999999999999876 5678
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.+ +|.+.+.. ..+++..++.++.||+.+|.|||+++++|+||+|+||++++++.+||+|||++..+....
T Consensus 78 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999986 56555543 358999999999999999999999999999999999999999999999999997654321
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ++
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-------~~------- 219 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-------PP------- 219 (277)
T ss_pred -hhhhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-------CC-------
Confidence 12222456888999999876 568899999999999999999999997655544333221100 00
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
.....++.++.+||.+||..||++|||+.++++|+||.
T Consensus 220 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 220 ---------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred ---------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 00113566899999999999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.21 Aligned_cols=242 Identities=22% Similarity=0.329 Sum_probs=188.5
Q ss_pred cceeEEEEEEE-----ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE-----IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++ ..++..||||+++..... .....+.+|+.+|+.+ +|+||+++++++.+
T Consensus 46 G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-------------- 110 (375)
T cd05104 46 GAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGACTV-------------- 110 (375)
T ss_pred CccceEEEEEEeccccCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeeeecc--------------
Confidence 89999999974 456778999999754322 2345678999999999 89999999999987
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCC------------------------------------------------------
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPG------------------------------------------------------ 101 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~------------------------------------------------------ 101 (481)
.+..|+|||||.+ +|.+++....
T Consensus 111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 5678999999985 7766654321
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 102 --------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 102 --------------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 247788899999999999999999999999999999999999999999999998654322
Q ss_pred CCc-cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~-~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||........+.+.+.......
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 337 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML---------- 337 (375)
T ss_pred cccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC----------
Confidence 211 112233567999999976 578999999999999999998 8899987665544444332110000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.....+.++.+||.+||..||++|||+.||++.
T Consensus 338 ------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 338 ------------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 001245689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=309.22 Aligned_cols=244 Identities=27% Similarity=0.402 Sum_probs=199.1
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|+||+||+|++..+++.||||++...... .....+.+|+.++++++|+||+++++++.+ ...
T Consensus 14 ~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~ 76 (277)
T cd06640 14 KGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK----------------GTK 76 (277)
T ss_pred cCCCeEEEEEEEccCCEEEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----------------CCE
Confidence 378999999999999999999998754322 234567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|.+++.. ..+++.++..++.||+.+|+|||+++++|+||+|+||+++.++.++|+|||++..+...
T Consensus 77 ~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 9999999986 66665543 35899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
. .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.... .
T Consensus 155 ~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~------------ 218 (277)
T cd06640 155 Q-IKRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN--P------------ 218 (277)
T ss_pred c-cccccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC--C------------
Confidence 2 12223456888999999876 568899999999999999999999998776554443331100 0
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..+...++..+.+||.+||..||++||++.+++.|+||..
T Consensus 219 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 219 ---------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred ---------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 0011235678999999999999999999999999999954
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=312.60 Aligned_cols=244 Identities=26% Similarity=0.415 Sum_probs=200.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+++++.+++.||||.+..... .......+.+|+++++.++|+||+++++++.+ ...
T Consensus 26 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~ 89 (308)
T cd06634 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----------------EHT 89 (308)
T ss_pred CCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc----------------CCe
Confidence 7899999999999999999999875422 22234467789999999999999999999987 567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
.|+||||+.+++.+.+......+++..+..++.||+.+|.|||+++++|+||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred eEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 899999999988887766556689999999999999999999999999999999999999999999999999876532
Q ss_pred CCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.....++..|+|||++.+ ...++.++|||||||++|+|++|..||...+..+.+..+..... +.
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~---------- 233 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA---------- 233 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-CC----------
Confidence 223456889999999753 23578899999999999999999999977665555444432110 00
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....++..+++||++||..+|++||++.++++|+|+..
T Consensus 234 -----------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 234 -----------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -----------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 001136678999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=302.71 Aligned_cols=241 Identities=24% Similarity=0.398 Sum_probs=200.2
Q ss_pred cceeEEEEEEEccC---CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKT---GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|.+... +..||||+++...... ....+.+|+++++.++|+||+++++++.+ .
T Consensus 6 g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~ 68 (262)
T cd00192 6 GAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE----------------E 68 (262)
T ss_pred CCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC----------------C
Confidence 78999999999876 9999999998665433 35677899999999999999999999876 5
Q ss_pred CeEEEEEecCC-CChhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEec
Q 011627 80 GSTYMVFEYMD-HDLTGLADRP--------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 150 (481)
Q Consensus 80 ~~~~iV~Ey~~-g~L~~~~~~~--------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 150 (481)
..++|||||+. ++|.+.+... ...+++.+++.++.||+.||+|||+++|+|+||||+||+++.++.+||+|
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~d 148 (262)
T cd00192 69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISD 148 (262)
T ss_pred CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcc
Confidence 68999999995 5787777665 46799999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 011627 151 FGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSP 228 (481)
Q Consensus 151 FG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~ 228 (481)
||.+........ .......++..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~- 226 (262)
T cd00192 149 FGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL- 226 (262)
T ss_pred cccccccccccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 999987653321 12233455888999999876 478899999999999999999 69999988777776666431000
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.....++.++.++|.+||..||++|||+.|++++
T Consensus 227 ----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 227 ----------------------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ----------------------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0012357789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=305.43 Aligned_cols=239 Identities=20% Similarity=0.273 Sum_probs=191.8
Q ss_pred cceeEEEEEEE--ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMARE--IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~--~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||.||+|.+ +.+++.||||+++...........+.+|+.+++++.|+||+++++++.. .
T Consensus 6 G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----------------~ 68 (257)
T cd05116 6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-----------------E 68 (257)
T ss_pred cCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----------------C
Confidence 89999999964 5678999999987665444455678899999999999999999998753 3
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
..+|||||+.+ +|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 69 SWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred CcEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 56899999985 566666543 4689999999999999999999999999999999999999999999999999976543
Q ss_pred CCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 160 DHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 160 ~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.... .......+..|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+..... +.
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~------- 218 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-ME------- 218 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CC-------
Confidence 2221 1112233578999998865 568889999999999999998 9999998877766666542110 00
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||+.||++||++.+|.+
T Consensus 219 ---------------------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 219 ---------------------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ---------------------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 01136778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=309.70 Aligned_cols=241 Identities=22% Similarity=0.347 Sum_probs=194.3
Q ss_pred cceeEEEEEEEccCC-----cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG-----EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||.||+|.+..++ ..||+|.++.... ......+.+|+.++++++|+||+++++++.+
T Consensus 16 G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--------------- 79 (283)
T cd05048 16 GAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--------------- 79 (283)
T ss_pred ccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcC---------------
Confidence 889999999987665 7899999875432 2234467899999999999999999999876
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~ 141 (481)
....|++|||+.+ +|.+++.... ..+++..+..++.||+.||+|||+++++|+||||+|||++
T Consensus 80 -~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 -EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 5578999999985 7766665421 3578899999999999999999999999999999999999
Q ss_pred CCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011627 142 NEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLS 219 (481)
Q Consensus 142 ~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~ 219 (481)
+++.+||+|||+++....... .......+++.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999976532221 12233455788999999876 568999999999999999998 999999888777666
Q ss_pred HHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 220 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+...... .....++.++.+|+.+||+.||++||++.||+++
T Consensus 238 ~i~~~~~~-----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLL-----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcC-----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55421100 0112467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=328.47 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=207.6
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
+|+||+|.+++...|...||+|.+++.+ ........++.|..||..-+.+-||+||..|++ ++
T Consensus 639 vGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD----------------kd 702 (1034)
T KOG0608|consen 639 VGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD----------------KD 702 (1034)
T ss_pred ccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc----------------CC
Confidence 6999999999999999999999997653 333445567789999999999999999999998 78
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|+||||+.| |+..++++.+ -|.|+.++.|+..|.+|+++.|..|+|||||||+|||||.+|+|||.|||+++-|+-
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccccee
Confidence 99999999985 8888888765 599999999999999999999999999999999999999999999999999986542
Q ss_pred CCCC-----------------------------------------ccccccccccCCCchhhcCCCCCCCCCchhhHHHH
Q 011627 160 DHNN-----------------------------------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 198 (481)
Q Consensus 160 ~~~~-----------------------------------------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvi 198 (481)
..+. .....+||+.|+|||||.. ..|+..+|.||+|||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVI 860 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHH
Confidence 1110 0112478999999999987 678999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCC
Q 011627 199 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 278 (481)
Q Consensus 199 l~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 278 (481)
||||+.|++||...+..+.-.+++ .|.....++.+ .+++.++.+||.+++ .++
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~---------nw~~~l~~~~~-----------------~~ls~e~~~li~kLc-~sa 913 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVI---------NWRNFLHIPYQ-----------------GNLSKEALDLIQKLC-CSA 913 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeee---------ehhhccccccc-----------------cccCHHHHHHHHHHh-cCh
Confidence 999999999999988877665553 35544444433 247889999999865 467
Q ss_pred CCCC---CHHHHhcCCCCCCC
Q 011627 279 SQRI---SAKDALDSEYFWTD 296 (481)
Q Consensus 279 ~~R~---sa~eiL~h~~f~~~ 296 (481)
+.|+ -+.||..|+||+.-
T Consensus 914 d~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 914 DSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred hhhhcccchhhhhcCcccccc
Confidence 7776 56679999999753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.66 Aligned_cols=266 Identities=31% Similarity=0.539 Sum_probs=205.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|.||+||.+++..+++.++||+++... .+++.+|++||..|. |+|||++++++.++. ...
T Consensus 49 GKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~--------------Skt 109 (338)
T KOG0668|consen 49 GKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPE--------------SKT 109 (338)
T ss_pred ccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCcc--------------ccC
Confidence 789999999999999999999997553 347889999999997 999999999999865 446
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~ 159 (481)
..|||||++. |...+.. .|+.-.|+.++.+||.||.|||++||+|||+||.|+|||... .++|+|+|+|.....
T Consensus 110 paLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred chhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 7899999997 4443332 478889999999999999999999999999999999999764 599999999987642
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCcc---
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIWPG--- 235 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~--- 235 (481)
......++.+..|--||++..-..|+.+.|+|||||+|+.|+..+.| |.+.+..+++.+|...++.-...-.-.
T Consensus 186 --~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 --GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred --CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 22344456788999999999878899999999999999999997655 678888999999988776522100000
Q ss_pred CCCCCccccCCCchhhhhhHHHH-----HhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREV-----FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
+...+.+.+.... .....+..+ -..+++++.|||.++|..|-.+|+||+|++.||||.
T Consensus 264 i~Ldp~~~~i~~~-~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 264 IDLDPQFEDILGR-HSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred cCCChhHhhHhhc-cccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 0000011100000 000001111 113568999999999999999999999999999993
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=306.57 Aligned_cols=235 Identities=23% Similarity=0.381 Sum_probs=187.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+++++.+++.+|+|++....... .|+.++..+ +|+||+++++.+.. .+.
T Consensus 27 g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~----------------~~~ 83 (267)
T PHA03390 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT----------------LKG 83 (267)
T ss_pred CCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec----------------CCe
Confidence 889999999999999999999987543221 233333333 79999999999987 568
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~ 159 (481)
+|+||||+.+ +|.+++.... .+++.+++.++.||+.||.|||+.+++||||||+||+++.++ .++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999975 7777766543 799999999999999999999999999999999999999988 999999999876542
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCccCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ...+.... ....
T Consensus 163 ~-----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~-------- 227 (267)
T PHA03390 163 P-----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL-------- 227 (267)
T ss_pred C-----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC--------
Confidence 2 22356889999999976 5688999999999999999999999986544322 12221111 0000
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-AKDALDSEYFW 294 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-a~eiL~h~~f~ 294 (481)
...+.++..+.+||.+||+.||.+|++ +++||+|+||.
T Consensus 228 ------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 228 ------------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ------------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 111247889999999999999999996 59999999994
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=309.32 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=200.0
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|+||.||++.+..+++.||||++..... .....+.+|+.++++++|+||+++++++.. .+.
T Consensus 30 ~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~ 91 (292)
T cd06657 30 EGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV----------------GDE 91 (292)
T ss_pred CCCCeEEEEEEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEe----------------CCE
Confidence 37899999999999999999999864332 234567889999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
.|+||||+.+ +|.+++.. ..+++..+..++.||+.+|+|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 92 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 92 LWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 9999999987 45444332 35899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
. .......++..|++||.+.. ..++.++|+|||||++|+|++|..||...+..+.+..+....... +.
T Consensus 170 ~-~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~------ 237 (292)
T cd06657 170 V-PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK----LK------ 237 (292)
T ss_pred c-ccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc----cC------
Confidence 2 12233467889999998875 567899999999999999999999998877666555443211100 00
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
....++..+.++|.+||..||.+|+++.++|+|+||....
T Consensus 238 -----------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 238 -----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred -----------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 0113567889999999999999999999999999996643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=297.96 Aligned_cols=242 Identities=31% Similarity=0.476 Sum_probs=200.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||.||++++..+++.|++|+++.... .....+.+|+.++++++|+||+++++++.. ....
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 72 (253)
T cd05122 11 GGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK----------------KDEL 72 (253)
T ss_pred CCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec----------------CCeE
Confidence 7899999999999999999999986544 245678899999999999999999999987 5678
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
++++||+.+ +|.+.+......+++..+..++.||+.+|++||+++++|+||+|+||+++.++.+||+|||++.......
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 999999994 7776666554579999999999999999999999999999999999999999999999999997765332
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
. .....++..|++||.+.+ ..++.++||||||||+|+|++|+.||...+....+..+.... .....+
T Consensus 153 ~--~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~-------- 219 (253)
T cd05122 153 A--RNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG--PPGLRN-------- 219 (253)
T ss_pred c--ccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC--CCCcCc--------
Confidence 1 334567889999999876 457899999999999999999999998776555444443211 000000
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~ 292 (481)
...++..+.+||.+||..||++|||+.|+|+|+|
T Consensus 220 -----------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 220 -----------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -----------------ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0014678999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=325.30 Aligned_cols=246 Identities=24% Similarity=0.352 Sum_probs=212.5
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
+|+||.|-+++.+.....+|+|++++.. ......+.+..|-.||..++.+.||++|..|.+ ..
T Consensus 430 vGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd----------------~k 493 (732)
T KOG0614|consen 430 VGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD----------------SK 493 (732)
T ss_pred cCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc----------------ch
Confidence 5999999999987777779999998663 333345677899999999999999999999988 77
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
++||+||-|-| .++..+... +.|++..++.|+.-+++|++|||+++||.|||||+|+||+.+|-+||+|||+|+.+..
T Consensus 494 yvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 89999999975 666666554 5799999999999999999999999999999999999999999999999999998763
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
....-++|||+.|.|||+++. +.++.++|.|||||++||||+|.+||.+.+...++..|++...
T Consensus 573 --g~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------------- 636 (732)
T KOG0614|consen 573 --GRKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------------- 636 (732)
T ss_pred --CCceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-------------
Confidence 233345799999999999997 6789999999999999999999999999999999998876431
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
...+.++++..+.+||++++..+|.+|.- +.||.+|.||..
T Consensus 637 ---------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 637 ---------------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred ---------------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 11233568889999999999999999985 899999999943
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=307.95 Aligned_cols=243 Identities=30% Similarity=0.473 Sum_probs=201.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||.||++++..+++.||||++..... .......+.+|+.+++++. |+||+++++++.+ .+
T Consensus 12 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~----------------~~ 75 (280)
T cd05581 12 GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD----------------EE 75 (280)
T ss_pred CCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC----------------Cc
Confidence 7899999999999999999999976422 2223356778999999998 9999999999876 66
Q ss_pred eEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|+||||+. ++|.+++.+. ..+++..++.++.||+.+|.|||+++++|+||||+||+++.+++++|+|||++.....
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 8999999995 5777776654 3699999999999999999999999999999999999999999999999999986653
Q ss_pred CCC-------------------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011627 160 DHN-------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 220 (481)
Q Consensus 160 ~~~-------------------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 220 (481)
... .......++..|+|||++.. ..++.++|||||||++++|++|+.||...+....+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 321 12223456889999999876 5688899999999999999999999998887666666
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH----HHHhcCCCC
Q 011627 221 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYF 293 (481)
Q Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa----~eiL~h~~f 293 (481)
+....... ...++..+.+||.+||+.||++|||+ +++|+|+||
T Consensus 234 ~~~~~~~~------------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSF------------------------------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCC------------------------------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 54321111 11356789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=302.36 Aligned_cols=238 Identities=25% Similarity=0.355 Sum_probs=191.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++.. +..||||.+..... ....+.+|+.++++++|+||+++++++.+ ...+
T Consensus 15 G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 74 (256)
T cd05113 15 GQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTK----------------QRPI 74 (256)
T ss_pred cccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEcc----------------CCCc
Confidence 7899999998754 45699999874432 23467899999999999999999999876 4568
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.+ +|.+++......+++..++.++.||+.||+|||+++++|+||||+|||++.++.+||+|||+++......
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 999999975 6777666544578999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........++..|++||++.+ ..++.++|||||||++|+|++ |..||...+..+....+........
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 222 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR----------- 222 (256)
T ss_pred eeecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC-----------
Confidence 222222234677999999876 568899999999999999998 9999988777766666643211100
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....+..+++||.+||..||++|||+.+|+++
T Consensus 223 ------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 223 ------------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 01246689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.87 Aligned_cols=244 Identities=29% Similarity=0.473 Sum_probs=201.9
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|+||.||++++..+++.|+||.+......+.....+.+|++++++++|+||+++++++.+ .+.
T Consensus 10 ~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~ 73 (254)
T cd06627 10 RGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET----------------SDS 73 (254)
T ss_pred ccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe----------------CCE
Confidence 3789999999999999999999998765544456678899999999999999999999887 568
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|+||||+.+ +|.+++... ..+++..++.++.||+.+|.|||+++|+|+||||+||+++.++.+||+|||++......
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 74 LYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred EEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999986 566555543 57999999999999999999999999999999999999999999999999999876533
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+......++.... ..
T Consensus 153 ~~-~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~---------- 217 (254)
T cd06627 153 SK-DDASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD---HP---------- 217 (254)
T ss_pred cc-cccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC---CC----------
Confidence 22 1233466889999999876 457899999999999999999999998766554444432100 00
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.+...++.++.++|.+||..||++|||+.+++.|+||
T Consensus 218 ----------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 218 ----------------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ----------------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0112456789999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=328.42 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=201.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC--cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN--EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+|=+||+|.|..+|..||.-.++... .......++..|+.+|+.|+|+|||+||++|.+.. +.
T Consensus 51 GafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~--------------n~ 116 (632)
T KOG0584|consen 51 GAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD--------------NK 116 (632)
T ss_pred ccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC--------------Cc
Confidence 889999999999999999987665543 33334578899999999999999999999999843 46
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEEcC-CCCeEEecccccccc
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--QVLHRDIKGSNLLIDN-EGNLKLADFGLARSF 157 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~--giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~ 157 (481)
++.+|+|++..+.+..+++..++++...++.|++|||.||.|||++ -|||||||-+||||+. .|.|||+|+|+|+..
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 7899999998654444445556799999999999999999999998 5999999999999985 578999999999987
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCccC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
+... ....+||+.|||||++. ..|+..+||||||++++||+|+..||..- +...+++++.... .|
T Consensus 197 r~s~---aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi-KP-------- 262 (632)
T KOG0584|consen 197 RKSH---AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI-KP-------- 262 (632)
T ss_pred hccc---cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC-CH--------
Confidence 6433 33478999999999886 57999999999999999999999999754 4445555553321 00
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
..+.+--++++++||.+||.. .++|+|+.|+|+|+||..+
T Consensus 263 -------------------~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 263 -------------------AALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -------------------HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 011112367899999999999 9999999999999999876
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=301.42 Aligned_cols=246 Identities=25% Similarity=0.447 Sum_probs=196.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc---CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE---KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||++++..+++.||||++..... .......+.+|++++++++|+||+++++++.+.. .
T Consensus 13 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--------------~ 78 (264)
T cd06653 13 GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE--------------E 78 (264)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC--------------C
Confidence 7899999999999999999999865422 1223456778999999999999999999987632 4
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..+++||||+.+ +|.+.+... ..+++..++.++.||+.+|.|||+++++|+||||+||+++.++.++|+|||+++...
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 578999999986 566665543 358999999999999999999999999999999999999999999999999998654
Q ss_pred CCC--CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 159 YDH--NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 159 ~~~--~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
... ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+.+.++.. .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~----- 228 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTKP----- 228 (264)
T ss_pred cccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCCC-----
Confidence 311 112233457889999999876 5678999999999999999999999987766555544431 11000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.+...+++++.++|.+||+ ++.+|||+.+++.|||.
T Consensus 229 --------------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 --------------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --------------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0112467789999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=302.85 Aligned_cols=241 Identities=20% Similarity=0.331 Sum_probs=193.9
Q ss_pred cceeEEEEEEEccC---CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKT---GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|+++.+ ...||||+++..... .....+.+|+.++++++|+||+++++++.+ .
T Consensus 15 g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~ 77 (266)
T cd05033 15 GEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD-KQRLDFLTEASIMGQFDHPNIIRLEGVVTK----------------S 77 (266)
T ss_pred CccceEEEEEEccCCCCcceEEEEEcCCCCCh-HHHHHHHHHHHHHHhCCCCCcceEeEEEec----------------C
Confidence 89999999998754 458999998754322 234467789999999999999999999876 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.+||||||+.+ +|.+++......+++.++..++.||+.||+|||+++|+|+||||+||||+.++.+||+|||+++.+.
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 678999999986 7777776655679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCc-cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 159 YDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 159 ~~~~~~-~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
...... .....++..|+|||.+.. ..++.++|||||||++|+|++ |..||......+....+......+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 229 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP------- 229 (266)
T ss_pred ccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 211111 111233578999998876 568899999999999999998 9999987777666665543211100
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...++..+.+||.+||..||++||++.+|+++
T Consensus 230 ----------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 230 ----------------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ----------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01356689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=306.17 Aligned_cols=240 Identities=25% Similarity=0.396 Sum_probs=192.5
Q ss_pred cceeEEEEEEEcc-----CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIK-----TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||.||+|++.. +++.||||+++..... .....+.+|++++++++|+||+++++++..
T Consensus 16 g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------------- 79 (280)
T cd05049 16 GAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTE--------------- 79 (280)
T ss_pred cCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEec---------------
Confidence 7899999998753 4688999998754332 234578899999999999999999999987
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRP-------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 143 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~-------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~ 143 (481)
...+||||||+.+ +|.+++... ...+++..+..++.||+.+|.|||+++++||||||+|||++.+
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 5678999999985 666665432 2347889999999999999999999999999999999999999
Q ss_pred CCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011627 144 GNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 221 (481)
Q Consensus 144 ~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i 221 (481)
+.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999999975432211 11222344778999999876 578999999999999999998 99999888777766665
Q ss_pred HHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 222 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....... ....++..+.+||.+||..||++|||+.|+++
T Consensus 238 ~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQ-----------------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4211000 01136678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=325.07 Aligned_cols=242 Identities=19% Similarity=0.281 Sum_probs=200.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||+||++++. -.||||+++.+.-..+..+.+++|+.+||+-+|.||+=|.+++..+ .+
T Consensus 403 GsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-----------------~~ 462 (678)
T KOG0193|consen 403 GSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-----------------PL 462 (678)
T ss_pred ccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-----------------ce
Confidence 899999999983 3689999999877776788999999999999999999999999863 34
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC-
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD- 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~- 160 (481)
.||+-+|+| +|..++.-...+|.+...+.|++||++|+.|||.++|||||||..||||.+++.|||+|||++..-...
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 999999998 788887777778999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
....+....+...|||||++.. ..+|++.+||||||||+|||++|..||...+.+.++..+-+...
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l------------ 610 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL------------ 610 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc------------
Confidence 2233444566888999999863 46799999999999999999999999995555443332211100
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
..+...+..+.+.++++|+..|+.+++++||...+||.
T Consensus 611 -------------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 611 -------------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -------------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 11223344567789999999999999999999999986
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=299.90 Aligned_cols=243 Identities=28% Similarity=0.482 Sum_probs=201.4
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
-|+||.||++.+..+++.||+|+++..... ......+.+|+.++++++|+||+++++++.+ ..
T Consensus 3 ~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~ 66 (250)
T cd05123 3 KGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT----------------EE 66 (250)
T ss_pred CCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec----------------CC
Confidence 389999999999999999999999866432 2234567889999999999999999999876 66
Q ss_pred eEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|+||||+. ++|.+++... ..+++..+..++.||+.+|.|||+++++|+||||+||+++.++.++|+|||++.....
T Consensus 67 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 67 KLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred eeEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 8999999995 5777776554 3589999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.. .......++..|++||.+.+ ...+.++|+|||||++|+|++|..||...+.......+......
T Consensus 146 ~~-~~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 211 (250)
T cd05123 146 EG-SRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR------------ 211 (250)
T ss_pred CC-CcccCCcCCccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC------------
Confidence 21 22334566889999999876 55788999999999999999999999887776655555431000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH---HHHhcCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA---KDALDSEYF 293 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa---~eiL~h~~f 293 (481)
+...++.++.+||++||..||++|||+ +++++|+||
T Consensus 212 ------------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 ------------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ------------------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 011246789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.53 Aligned_cols=237 Identities=24% Similarity=0.346 Sum_probs=191.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|.+. +++.||||.++.... ....+.+|+.++++++|+||+++++++.. .+.+
T Consensus 17 g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 76 (261)
T cd05068 17 GQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTL----------------EEPI 76 (261)
T ss_pred cCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEec----------------CCCe
Confidence 789999999975 457899999875432 23467899999999999999999999876 5678
Q ss_pred EEEEecCC-CChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMD-HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~-g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+. ++|.+.+.... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999995 67877775543 46899999999999999999999999999999999999999999999999999876532
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
..........+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 225 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC---------- 225 (261)
T ss_pred cccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 2211111222457999998876 578899999999999999999 9999998887776666543211000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++..+.+||.+||..||++||++.+|++
T Consensus 226 -------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 226 -------------------PPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -------------------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0124568999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.41 Aligned_cols=245 Identities=31% Similarity=0.503 Sum_probs=202.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||.||++++..+++.|++|+++.... ....+.+|++++++++|+||+++++++.. ...+
T Consensus 30 g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 90 (286)
T cd06614 30 GASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV----------------GDEL 90 (286)
T ss_pred CCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE----------------CCEE
Confidence 7899999999999999999999986543 34567899999999999999999999987 5689
Q ss_pred EEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+|+||+. ++|.+++......+++.++..++.||+.+|.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999 57777776654479999999999999999999999999999999999999999999999999986554221
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
. ......++..|++||++.+ ..++.++||||||||+|+|++|+.||...+.......+........
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 236 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL------------ 236 (286)
T ss_pred h-hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------------
Confidence 1 1223346788999999876 5688999999999999999999999988776655555432110000
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....++.++.+||.+||+.||.+|||+.++|+|+||..
T Consensus 237 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 237 ---------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ---------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 001235678999999999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=312.30 Aligned_cols=240 Identities=20% Similarity=0.287 Sum_probs=189.7
Q ss_pred cceeEEEEEEEccCCcE----EEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEI----VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++. ||||+++.... ......+.+|+.+++.++|+||+++++++..
T Consensus 18 G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---------------- 80 (316)
T cd05108 18 GAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLT---------------- 80 (316)
T ss_pred CCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC----------------
Confidence 88999999998777664 89999864322 2234567889999999999999999999864
Q ss_pred CCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...++|+||+. ++|.+.+......+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+
T Consensus 81 -~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 24579999997 4788877766667899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
...... .......+..|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+.. .++........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~----- 232 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ----- 232 (316)
T ss_pred cCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCC-----
Confidence 532221 1122233678999999876 678999999999999999997 99999877655443 33321111000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...++.++.++|.+||..||++|||+.+++.+
T Consensus 233 -----------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 233 -----------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01245578999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.53 Aligned_cols=239 Identities=21% Similarity=0.343 Sum_probs=191.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++.+ .++..||+|+++..... .....+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 6 g~~g~vy~~~~-~~~~~~a~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 67 (250)
T cd05085 6 GNFGEVFKGTL-KDKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGVCTQ----------------RQPI 67 (250)
T ss_pred CCCceEEEEEe-cCCcEEEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCCcCeEEEEEec----------------CCcc
Confidence 89999999986 47889999998754322 233467789999999999999999999976 5578
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
++||||+.+ +|.+.+......+++..+..++.||+.+|.|||+++++|+||||+||+++.++.+||+|||++.......
T Consensus 68 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 68 YIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 999999975 7777666555568999999999999999999999999999999999999999999999999987543222
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.........+..|+|||++.. ..++.++|||||||++|+|++ |..||...+.......+...... .
T Consensus 148 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--~---------- 214 (250)
T cd05085 148 YSSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM--S---------- 214 (250)
T ss_pred cccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC--C----------
Confidence 111122233567999999875 568899999999999999998 99999888776665555321100 0
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.|+++
T Consensus 215 -----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 215 -----------------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 01135678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=297.84 Aligned_cols=248 Identities=31% Similarity=0.571 Sum_probs=200.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.|++|+++...........+.+|+.++++++|+||+++++++.+.. ...+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------------~~~~ 76 (260)
T cd06606 11 GSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE--------------KNTL 76 (260)
T ss_pred cCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC--------------CCeE
Confidence 78999999999999999999999876544445667889999999999999999999998621 2689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
++|+||+.+ +|.+++.... .+++..++.++.||+.+|+|||+++++|+||+|+||+++.++.+||+|||.+.......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 77 NIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 999999965 6666665443 79999999999999999999999999999999999999999999999999998765432
Q ss_pred CC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.. ......++..|++||.+.. ...+.++|||||||++|+|++|..||...+. ....+........
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~----------- 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSGE----------- 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccccCC-----------
Confidence 21 1233567889999999876 4588999999999999999999999987662 1122221110000
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
...+...++.++.+||.+||..||++||++.|+++|+||
T Consensus 222 --------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 222 --------------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 001112357789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.57 Aligned_cols=248 Identities=17% Similarity=0.235 Sum_probs=192.9
Q ss_pred cceeEEEEEEEccC---CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKT---GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|.+..+ +..||||+++...........+.+|+.++++++|+||+++++++...... ...
T Consensus 10 G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~ 79 (273)
T cd05035 10 GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL----------QKI 79 (273)
T ss_pred CCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc----------ccC
Confidence 89999999997654 48899999986544433445778999999999999999999988653210 113
Q ss_pred CeEEEEEecCCC-ChhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~-----~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
...++||||+.+ +|...+.. ....+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 357999999985 66555432 223589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 011627 154 ARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDET 231 (481)
Q Consensus 154 a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (481)
++.+...... .......+..|+|||++.. ..++.++||||||||+|||++ |..||...+..+.+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---- 234 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL---- 234 (273)
T ss_pred eeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 9865432211 1111233678999998865 678999999999999999999 89999887776666555321100
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.....++.++.++|.+||+.||++|||+.|++++
T Consensus 235 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -------------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -------------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012366789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=300.93 Aligned_cols=243 Identities=31% Similarity=0.471 Sum_probs=200.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++..+++.|+||++...... .....+.+|+.++++++|+||+++++++.. ...+
T Consensus 12 g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 74 (264)
T cd06623 12 GSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK----------------EGEI 74 (264)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc----------------CCeE
Confidence 78999999999999999999999866432 345678899999999999999999999987 5689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+++... ..+++..+..++.||+.+|.|||+ ++++|+||+|+||+++.++.++|+|||++..+...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999995 666666544 568999999999999999999999 99999999999999999999999999999876432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCCCCCccCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---EAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
.. ......++..|+|||.+.. ..++.++|+||||+++|+|++|+.||...+ ..+....+... ... .
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~~-~----- 222 (264)
T cd06623 154 LD-QCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PPP-S----- 222 (264)
T ss_pred CC-cccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CCC-C-----
Confidence 22 2223466889999999876 578899999999999999999999998774 33333333211 000 0
Q ss_pred CCCccccCCCchhhhhhHHHHHhh-hcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRH-FDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
.... ++..+.+||.+||..+|++|||+.++++|+||.
T Consensus 223 --------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~ 260 (264)
T cd06623 223 --------------------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260 (264)
T ss_pred --------------------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence 0112 667899999999999999999999999999994
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=300.65 Aligned_cols=239 Identities=20% Similarity=0.256 Sum_probs=189.9
Q ss_pred cceeEEEEEEEc--cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREI--KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||.||++++. .++..||||++..... ......+.+|+.++++|+|+||+++++++.. .
T Consensus 6 G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-----------------~ 67 (257)
T cd05115 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-----------------E 67 (257)
T ss_pred CCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-----------------C
Confidence 899999999765 4556799999875532 2334567899999999999999999998753 3
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+++||||+.+ +|.+++......+++..+..++.||+.+|+|||+++++||||||+|||++.++.+||+|||++..+..
T Consensus 68 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 68 ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred CeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 57999999985 67766665556799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCc--cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 160 DHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 160 ~~~~~--~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
..... .....++..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+....+...... .
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~------- 218 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL-D------- 218 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-C-------
Confidence 22211 111223578999999875 568899999999999999996 99999888777666555322100 0
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.....+.++.+||.+||..||++||++.+|++
T Consensus 219 ---------------------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 219 ---------------------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00135678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=301.05 Aligned_cols=237 Identities=23% Similarity=0.357 Sum_probs=195.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++.. ++.+|+|++...... ....+.+|+.+++.++|+||+++++++.+ ...+
T Consensus 17 g~~~~vy~~~~~~-~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 77 (261)
T cd05148 17 GYFGEVWEGLWKN-RVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAVCSV----------------GEPV 77 (261)
T ss_pred CCCccEEEeEecC-CCcEEEEeccccchh--hHHHHHHHHHHHhcCCCcchhheeeeEec----------------CCCe
Confidence 7899999999987 899999998765432 24467889999999999999999999887 5578
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+++... ...+++.++..++.||+.||.|||+++|+|+||||+||||++++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999985 787777653 345899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.. ......++..|++||++.. ..++.++|||||||++|+|++ |+.||...+..+.+..+......+
T Consensus 158 ~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 224 (261)
T cd05148 158 VY-LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP----------- 224 (261)
T ss_pred cc-cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC-----------
Confidence 21 1123344678999999876 578899999999999999998 899999888777777665321110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.++|.+||+.||++|||+.+|++
T Consensus 225 ------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 ------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01135678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.30 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=198.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++.+..+++.||||++...... .....+.+|+.++++++|+||+++++++.. ...+
T Consensus 15 G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 77 (277)
T cd06641 15 GSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK----------------DTKL 77 (277)
T ss_pred cCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEe----------------CCeE
Confidence 78999999999999999999998754332 234567789999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.+ +|...+.. ..+++..+..++.||+.+|.|||+++++|+||||+||+++.++.++|+|||++..+....
T Consensus 78 ~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999986 55555543 358999999999999999999999999999999999999999999999999987654221
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||.+.. ..++.++|+|||||++|+|++|..||...+.......+.... ..
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------------ 219 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--PP------------ 219 (277)
T ss_pred -hhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC--CC------------
Confidence 12223456888999998875 567889999999999999999999998766655554442210 00
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+...++.++.++|.+||..||++||++.+++.|+||..
T Consensus 220 ---------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 220 ---------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred ---------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 001135678999999999999999999999999999954
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.39 Aligned_cols=248 Identities=18% Similarity=0.239 Sum_probs=192.2
Q ss_pred cceeEEEEEEEccCCc--EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGE--IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||.||++++..+++ .||||.++...........+.+|+.++++++|+||+++++++...... ....
T Consensus 10 G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~~ 79 (272)
T cd05075 10 GEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES----------EGYP 79 (272)
T ss_pred ccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc----------cCCC
Confidence 7899999999988776 699999876544444456778899999999999999999987542110 1123
Q ss_pred eEEEEEecCCC-ChhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 81 STYMVFEYMDH-DLTGLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~-----~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
..++||||+.+ +|...+.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57999999985 66655432 2234899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 011627 155 RSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETI 232 (481)
Q Consensus 155 ~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (481)
+.+...... .......+..|++||++.. ..++.++|||||||++|+|++ |+.||...+..+....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---- 234 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK---- 234 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence 876432211 1112234678999999876 578999999999999999999 899998877766555553211000
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....++..+.+||.+||..||++|||+.+|+++
T Consensus 235 -------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 -------------------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011356678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=300.73 Aligned_cols=237 Identities=21% Similarity=0.369 Sum_probs=192.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|++. ++..||+|.+..... ....+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 17 g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 76 (261)
T cd05072 17 GQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTK----------------EEPI 76 (261)
T ss_pred cCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcC----------------CCCc
Confidence 789999999974 567899998764322 24577899999999999999999999876 5678
Q ss_pred EEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
||||||+.+ +|.+++.. ....+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||+++.....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999974 77776654 3446899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........++..|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+....+......+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------- 224 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP----------- 224 (261)
T ss_pred ceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2222223344678999999876 567889999999999999998 999999887777666664321100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||++++++
T Consensus 225 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 225 ------------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01135678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.09 Aligned_cols=241 Identities=29% Similarity=0.410 Sum_probs=191.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||+|++..+++.||||+++.... .......+.+|+.+++.++|+||+++++++.+ .+.
T Consensus 13 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~ 76 (267)
T cd08228 13 GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE----------------DNE 76 (267)
T ss_pred CCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE----------------CCe
Confidence 8899999999999999999999875432 22334467889999999999999999999987 568
Q ss_pred EEEEEecCCC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
+++||||+.+ +|.+++. .....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 8999999996 6655543 23345899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--AEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+....+ .....+..
T Consensus 157 ~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~----- 228 (267)
T cd08228 157 SSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPL----- 228 (267)
T ss_pred cchh-HHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCCC-----
Confidence 4321 12223467889999999876 5678999999999999999999999865432 2222222 21111110
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++..+.+||.+||..||++|||+.++++
T Consensus 229 ----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 229 ----------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred ----------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 01235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=314.52 Aligned_cols=243 Identities=21% Similarity=0.358 Sum_probs=188.1
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||.||+|++. .+++.||||+++..... .....+.+|+.+++++ +|+||+++++++...
T Consensus 18 G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~------------- 83 (337)
T cd05054 18 GAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-SEYKALMTELKILIHIGHHLNVVNLLGACTKP------------- 83 (337)
T ss_pred CcCceEEeccccccccccccceeeeeeccCCCCH-HHHHHHHHHHHHHHhhccCcchhheeeeEecC-------------
Confidence 899999999754 34588999999754322 2234677899999999 899999999988652
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCC-------------------------------------------------------
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRP------------------------------------------------------- 100 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~------------------------------------------------------- 100 (481)
...++++|||+.+ +|.+++...
T Consensus 84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4578999999986 565554321
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCCC-ccccccccccC
Q 011627 101 -----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWY 174 (481)
Q Consensus 101 -----~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y 174 (481)
...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...... ......++..|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 125788999999999999999999999999999999999999999999999999875432211 12223446789
Q ss_pred CCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 011627 175 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 253 (481)
Q Consensus 175 ~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (481)
+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+...+.......
T Consensus 242 ~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------ 296 (337)
T cd05054 242 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR------------------------ 296 (337)
T ss_pred cCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC------------------------
Confidence 99999986 678999999999999999998 9999987655444433322110000
Q ss_pred hHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 254 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 254 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....++.++.+|+.+||+.+|++||++.||++|
T Consensus 297 ----~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 ----APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011356689999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=309.09 Aligned_cols=244 Identities=27% Similarity=0.471 Sum_probs=197.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++.+..+++.||||.+...... ....+.+|+.++++++|+||+++++++.. .+..
T Consensus 30 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----------------~~~~ 91 (293)
T cd06647 30 GASGTVYTAIDVATGQEVAIKQMNLQQQP--KKELIINEILVMRENKHPNIVNYLDSYLV----------------GDEL 91 (293)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEeccccch--HHHHHHHHHHHHhhcCCCCeeehhheeee----------------CCcE
Confidence 78999999999999999999998754322 24567889999999999999999999876 5678
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+|+||+.+ +|.+++.+. .+++.++..++.||+.+|.|||+++++|+||||+||+++.++.+||+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999986 666665442 47899999999999999999999999999999999999999999999999987654222
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|++||++.. ..++.++|||||||++|+|++|+.||...+..+.+..+... ..+. +
T Consensus 170 -~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~---~-------- 235 (293)
T cd06647 170 -SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---L-------- 235 (293)
T ss_pred -cccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCCC---C--------
Confidence 22233467888999999876 56889999999999999999999999876654433322110 0000 0
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....++..+++||++||..||++||++.+++.|+||..
T Consensus 236 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 236 ---------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred ---------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 011235678999999999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=300.40 Aligned_cols=236 Identities=25% Similarity=0.408 Sum_probs=189.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+. .||||+++.... ....+.+|+.++++++|+||+++++++.+ ...
T Consensus 17 g~~~~v~~~~~~~~~-~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----------------~~~ 75 (262)
T cd05071 17 GCFGEVWMGTWNGTT-RVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----------------EPI 75 (262)
T ss_pred CCCCcEEEEEecCCc-eEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-----------------CCc
Confidence 899999999987664 599999875332 23467899999999999999999988743 356
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+++.+. ...+++..+..++.||+.+|+|||+++|+||||||+|||+++++.+||+|||+++.+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999985 777777643 335899999999999999999999999999999999999999999999999999766433
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........++..|+|||++.. ..++.++|||||||++|+|++ |..||......+.+..+......+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------- 223 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------- 223 (262)
T ss_pred ccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC-----------
Confidence 2222223345678999998875 568999999999999999999 888998887776666553211000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++..+.+||.+||+.||++|||++++++
T Consensus 224 ------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 224 ------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ------------------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00135678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=298.28 Aligned_cols=239 Identities=22% Similarity=0.333 Sum_probs=192.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|.+.. ++.||+|+++..... .....+.+|++++++++|+||+++++++.+ ....
T Consensus 6 g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 67 (251)
T cd05041 6 GNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ----------------KQPI 67 (251)
T ss_pred CCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec----------------CCCe
Confidence 7899999999977 999999998765433 234577899999999999999999999887 5678
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.+ +|.+.+......+++..+..++.+++.+|+|||+++++||||||+||||+.++.+||+|||++.......
T Consensus 68 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 68 YIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 999999975 6777766555568999999999999999999999999999999999999999999999999997653211
Q ss_pred CCcc-ccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTL-TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~-~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.... .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+.......+.......
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~----------- 215 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP----------- 215 (251)
T ss_pred ceeccccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC-----------
Confidence 1111 11223567999999876 578999999999999999999 889998777655555443211000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.|+++
T Consensus 216 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 216 ------------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 01135678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=298.84 Aligned_cols=242 Identities=23% Similarity=0.383 Sum_probs=200.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+++++.+++.+|||++............+.+|++++++++|+||+++++++.+ ....
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 74 (256)
T cd08530 11 GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD----------------GNKL 74 (256)
T ss_pred CCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc----------------CCEE
Confidence 789999999999999999999998765444445567899999999999999999999876 5689
Q ss_pred EEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
|+||||+.+ +|...+.+ ....+++..++.++.||+.||+|||+++++|+||+|+||+++.++.+||+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 999999975 66665543 23468999999999999999999999999999999999999999999999999997764
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. ......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 155 ~~---~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------- 219 (256)
T cd08530 155 KN---MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP----------- 219 (256)
T ss_pred cC---CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------
Confidence 33 2223456889999999876 56788999999999999999999999888766555444321100
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.+...++.+++++|.+||..||++|||+.++++||++
T Consensus 220 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 220 ------------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ------------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0011356789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=306.49 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=195.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++...... ....+.+|+.++.++. |+||+++++++.+ ...
T Consensus 26 g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----------------~~~ 88 (296)
T cd06618 26 GTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFIT----------------DSD 88 (296)
T ss_pred cCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeec----------------CCe
Confidence 789999999999999999999997553222 2345667887777774 9999999999987 567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|+||||+.+.+..++......+++..+..++.||+.+|+|||+ .+|+||||+|+||++++++.+||+|||++..+...
T Consensus 89 ~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 89 VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99999999988777776655579999999999999999999997 59999999999999999999999999998765432
Q ss_pred CCCccccccccccCCCchhhcCC---CCCCCCCchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCccC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.. .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||..... .+.+.++..... . .++.
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~--~~~~- 241 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP--P--SLPP- 241 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC--C--CCCC-
Confidence 21 2223467889999998753 2378899999999999999999999976433 344444432110 0 0000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...++.++.+||.+||..||++||++.++++|+||..
T Consensus 242 ----------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 242 ----------------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred ----------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0135678999999999999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=298.53 Aligned_cols=238 Identities=18% Similarity=0.252 Sum_probs=190.6
Q ss_pred cceeEEEEEEEccCC---cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTG---EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|++..++ ..||+|.+...... .....+.+|+.++++++|+||+++++++..
T Consensus 6 G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------- 67 (257)
T cd05060 6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG----------------- 67 (257)
T ss_pred cCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-----------------
Confidence 899999999886665 78999998765433 234567899999999999999999998753
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..+++||||+.+ +|.+++.... .+++..+..++.||+.+|+|||.++++|+||||+|||++.++.+||+|||+++.+.
T Consensus 68 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~ 146 (257)
T cd05060 68 EPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALG 146 (257)
T ss_pred CceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceee
Confidence 357999999975 6777665543 68999999999999999999999999999999999999999999999999998664
Q ss_pred CCCCCcc--ccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 159 YDHNNTL--TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 159 ~~~~~~~--~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
....... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 217 (257)
T cd05060 147 AGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-------- 217 (257)
T ss_pred cCCcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC--------
Confidence 3222111 11122467999999876 568999999999999999998 99999887776655555321100
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.....++..+++||.+||..||++|||+.++++
T Consensus 218 ---------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 218 ---------------------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=303.67 Aligned_cols=241 Identities=22% Similarity=0.313 Sum_probs=191.6
Q ss_pred cceeEEEEEEEccC-----CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKT-----GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||++++..+ ++.||||+++..... .....+.+|+.++++++|+||+++++++.+
T Consensus 16 G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--------------- 79 (283)
T cd05091 16 DRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-PLREEFKHEAMMRSRLQHPNIVCLLGVVTK--------------- 79 (283)
T ss_pred CCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---------------
Confidence 78999999998654 578999999754322 234567789999999999999999999987
Q ss_pred cCCeEEEEEecCCC-ChhhhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADR---------------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~---------------~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~ 141 (481)
...+++++||+.+ +|..++.. ....+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 80 -~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 80 -EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 5578999999985 56555431 123478889999999999999999999999999999999999
Q ss_pred CCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011627 142 NEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLS 219 (481)
Q Consensus 142 ~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~ 219 (481)
+++.+||+|||+++....... .......++..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999876532221 11223344778999999876 568899999999999999998 888998888777766
Q ss_pred HHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 220 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+......+ ....++..+.+||.+||+.||++||++++|+..
T Consensus 238 ~i~~~~~~~-----------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 238 MIRNRQVLP-----------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHcCCcCC-----------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 664321110 012366789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.67 Aligned_cols=241 Identities=20% Similarity=0.317 Sum_probs=189.9
Q ss_pred cceeEEEEEEEcc-----CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIK-----TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||.||+|.+.. +...||+|.+...... .....+.+|+.++++++|+||+++++++.+
T Consensus 17 g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------------- 80 (277)
T cd05036 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNIVRLIGVSFE--------------- 80 (277)
T ss_pred CCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc---------------
Confidence 7899999999987 7889999988654322 123467889999999999999999999876
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CeE
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPG------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLK 147 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~---~vk 147 (481)
....||||||+.+ +|.+++.... ..+++..+..++.||+.+|+|||+++++||||||+|||++.++ .+|
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 4567999999975 7777665432 2589999999999999999999999999999999999998765 599
Q ss_pred EecccccccccCCCCCc-cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 011627 148 LADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 225 (481)
Q Consensus 148 L~DFG~a~~~~~~~~~~-~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 225 (481)
|+|||+++.+....... ......+..|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+.+..+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 238 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998653211111 111223567999999976 568999999999999999997 999999877766555443211
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
. +. ....++..+.+||.+||..||++|||+.++|+|
T Consensus 239 ~------~~-----------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 R------LD-----------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred c------CC-----------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00 012356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=298.41 Aligned_cols=236 Identities=25% Similarity=0.403 Sum_probs=189.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|.+. ++..||+|+++..... ...+.+|+.++++++|+||+++++++.. ..+
T Consensus 17 g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----------------~~~ 75 (260)
T cd05070 17 GQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-----------------EPI 75 (260)
T ss_pred ccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-----------------CCc
Confidence 899999999875 6677999998754332 3467899999999999999999988743 347
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||++..+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 899999985 777766543 345899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........++..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+.+..+......+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 223 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP----------- 223 (260)
T ss_pred ccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2222222334567999998875 568899999999999999999 899998887777666654211000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.++++
T Consensus 224 ------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 224 ------------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ------------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 01235668999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=303.62 Aligned_cols=241 Identities=20% Similarity=0.338 Sum_probs=191.1
Q ss_pred cceeEEEEEEEc----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREI----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++. .+++.||+|.+...... .....+.+|+.++++++|+||+++++++..
T Consensus 16 g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------------- 78 (283)
T cd05090 16 CAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-QQWGEFQQEASLMAELHHPNIVCLLGVVTQ---------------- 78 (283)
T ss_pred cCCcceEEEEEecCCCCCcceEEEEeccCCCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEec----------------
Confidence 789999999853 45678999998754322 233567789999999999999999999887
Q ss_pred CCeEEEEEecCCC-ChhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRP----------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~----------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~ 141 (481)
....||||||+.+ +|.+++... ...+++.++..++.||+.||+|||+++|+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 5678999999985 676665321 12478889999999999999999999999999999999999
Q ss_pred CCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011627 142 NEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLS 219 (481)
Q Consensus 142 ~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~ 219 (481)
.++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999976532211 11223344677999999876 568999999999999999998 999998877666655
Q ss_pred HHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 220 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+....... ....++.++.+||.+||+.||++||++.+|+++
T Consensus 238 ~~~~~~~~~-----------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRKRQLLP-----------------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCC-----------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 553211000 011356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=299.89 Aligned_cols=240 Identities=23% Similarity=0.346 Sum_probs=193.2
Q ss_pred cceeEEEEEEEccCCc---EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|+++.+++ .+|||+++..... .....+.+|++++++++|+||+++++++.+ .
T Consensus 16 g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~ 78 (268)
T cd05063 16 GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNIIRLEGVVTK----------------F 78 (268)
T ss_pred CCCccEEEEEEecCCCCceEEEEEeccccCCH-HHHHHHHHHHHHHhcCCCCCeeEEEEEEcc----------------C
Confidence 7899999999987665 7999998754322 224567789999999999999999999976 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+..|+||||+.+ +|.+++......+++.++..++.|++.||+|||+++++|+||||+|||++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 578999999986 6666665555678999999999999999999999999999999999999999999999999997664
Q ss_pred CCCCCcccc--ccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 159 YDHNNTLTN--RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 159 ~~~~~~~~~--~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
......... ...+..|+|||++.. ..++.++|||||||++|||++ |+.||...+..+....+......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~------ 231 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA------ 231 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC------
Confidence 332222221 122457999999876 567899999999999999997 9999988877776666643211110
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++||++.+|++
T Consensus 232 -----------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 -----------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -----------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0125568899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=303.89 Aligned_cols=239 Identities=24% Similarity=0.384 Sum_probs=190.8
Q ss_pred cceeEEEEEEE-----ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE-----IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||++.+ ..++..+|+|.++.... .....+.+|+.++++++|+||+++++++..
T Consensus 16 G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------------- 78 (288)
T cd05093 16 GAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVE--------------- 78 (288)
T ss_pred cCCeeEEeeEeccCCCCCcceEEEEEecCCcCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEec---------------
Confidence 78999999986 34566799998875422 234567899999999999999999999986
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPG------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 144 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~ 144 (481)
.+.+|+||||+.+ +|.+++.... ..+++..+..++.||+.+|+|||+++++||||||+|||+++++
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 79 -GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred -CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 5678999999985 6666654321 2489999999999999999999999999999999999999999
Q ss_pred CeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011627 145 NLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 222 (481)
Q Consensus 145 ~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 222 (481)
.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999976532221 11122334678999999876 578899999999999999998 999998888777766664
Q ss_pred HhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...... ....++.++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVLQ-----------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcCC-----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 321000 01135678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=303.85 Aligned_cols=250 Identities=23% Similarity=0.400 Sum_probs=196.2
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCc--CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNE--KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||.||+|++. .+++.||+|+++.... .......+.+|+.+++++ +|+||+++++++..
T Consensus 11 G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-------------- 76 (290)
T cd05613 11 GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-------------- 76 (290)
T ss_pred CCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--------------
Confidence 789999999985 5899999999975432 222345667899999999 59999999999876
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
+..+||||||+.+ +|.+.+... ..+++..+..++.||+.+|.|||+++++||||||+|||++.++.+||+|||++.
T Consensus 77 --~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 77 --DTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 6688999999986 666665543 468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
.+............++..|+|||++... ..++.++||||||||+|+|++|..||...+.......+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 229 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP---- 229 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC----
Confidence 7654333333345678999999998652 24678999999999999999999999754433222222221100000
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
.....++..+.+||++||..||++|+ +++++++|+||..
T Consensus 230 ----------------------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 230 ----------------------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred ----------------------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 00123667899999999999999997 8999999999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=308.09 Aligned_cols=245 Identities=24% Similarity=0.403 Sum_probs=210.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+|.+|..+.|.+.||||+++++. ...+..+..+.|-++|... +-|.++.++.+|+. -+
T Consensus 360 GSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT----------------mD 423 (683)
T KOG0696|consen 360 GSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT----------------MD 423 (683)
T ss_pred CccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh----------------hh
Confidence 899999999999999999999998773 2333455667899998887 56889999999988 56
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
.+|+||||+.|+-+.+.+..-++|.|..+..++..|+.||-|||++|||.||||.+|||||.+|+|||+|||+++.-- .
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~ 502 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-F 502 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc-c
Confidence 899999999975555555556689999999999999999999999999999999999999999999999999997432 2
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
...+..+.|||+-|+|||++.- .+|+.++|.||+||+|||||.|++||++.++.+++..|.+..-.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs------------- 568 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS------------- 568 (683)
T ss_pred CCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc-------------
Confidence 3445566899999999998874 78999999999999999999999999999999999999764322
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
..+.+|.++.++++.+|.+.|.+|.. -.+|-.|+||+.
T Consensus 569 -----------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 569 -----------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred -----------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 22468889999999999999999984 378999999954
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=301.21 Aligned_cols=239 Identities=20% Similarity=0.277 Sum_probs=189.6
Q ss_pred cceeEEEEEEEccCCcE----EEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEI----VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++. ||||+++..... .....+.+|+.+++.++|+||+++++++..
T Consensus 18 G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---------------- 80 (279)
T cd05109 18 GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-KANKEILDEAYVMAGVGSPYVCRLLGICLT---------------- 80 (279)
T ss_pred CCCceEEEEEEecCCCccceEEEEEEecCCCCH-HHHHHHHHHHHHHHhcCCCCCceEEEEEcC----------------
Confidence 88999999998888774 899998754322 234567789999999999999999998864
Q ss_pred CCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...+++|||+. ++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 24679999997 5788777665567999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
...... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||...........+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~------ 231 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLP------ 231 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCC------
Confidence 432211 1112233677999999876 568899999999999999998 8999987666554443322 11100
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.++|.+||..||++||++.++++
T Consensus 232 ----------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 ----------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ----------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00135667899999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=299.34 Aligned_cols=241 Identities=29% Similarity=0.403 Sum_probs=191.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||++++..+++.||||++..... .......+.+|+.+++.++|+||+++++++.+ .+.
T Consensus 13 g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~ 76 (267)
T cd08229 13 GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----------------DNE 76 (267)
T ss_pred cCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe----------------CCe
Confidence 7899999999999999999998875432 22234567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
+++||||+.+ +|.+++.. ....+++..++.++.||+.+|.|||+++++|+||||+||+++.++.++|+|||++..+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 8999999986 66665542 3345899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA--EQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 235 (481)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +....+... ..+.
T Consensus 157 ~~~~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~------ 227 (267)
T cd08229 157 SSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPP------ 227 (267)
T ss_pred ccCC-cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-CCCC------
Confidence 4322 22233467889999999876 56788999999999999999999999755432 222222111 0000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
. ....++.++.+||.+||..||++|||+.+|++
T Consensus 228 ~---------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 228 L---------------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred C---------------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0 01236778999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=297.02 Aligned_cols=237 Identities=25% Similarity=0.418 Sum_probs=189.6
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|+||+||+|.+..+ ..+|||++..... ....+.+|+.++++++|+||+++++++.. +.
T Consensus 16 ~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----------------~~ 74 (260)
T cd05069 16 QGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-----------------EP 74 (260)
T ss_pred CcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----------------CC
Confidence 388999999998665 4689998864432 23467889999999999999999988743 34
Q ss_pred EEEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.|+||||+.+ +|.+++... ...+++..+..++.||+.||+|||+++|+|+||||+|||+++++.+||+|||+++.+..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 6899999985 787777543 33488999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
..........++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+......+
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------- 223 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP---------- 223 (260)
T ss_pred CcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 22222222344678999998875 568899999999999999999 999999888777666654321000
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++..+.+||++||..||++||+++++++
T Consensus 224 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 224 -------------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01135678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=295.43 Aligned_cols=240 Identities=23% Similarity=0.403 Sum_probs=195.8
Q ss_pred cceeEEEEEEEccCC----cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTG----EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||.||++++..++ +.||+|+++...... ....+..|+.+++.++|+||+++++++.+
T Consensus 10 g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------------- 72 (258)
T smart00219 10 GAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-QIEEFLREARIMRKLDHPNIVKLLGVCTE---------------- 72 (258)
T ss_pred CCCcceEEEEecCCCCCCCceEEEEEccCCCChH-HHHHHHHHHHHHHhcCCCchheEEEEEcC----------------
Confidence 889999999998876 999999997554322 34577899999999999999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~-l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.+..|++|||+.+ +|.+.+...... +++.++..++.||+.+|+|||+++++|+||||+||++++++.+||+|||+++.
T Consensus 73 ~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 73 EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCcee
Confidence 5678999999985 777776654433 89999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.............++..|+|||.+.. ..++.++|||||||++|+|++ |..||...+..+.+..+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------- 224 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP------- 224 (258)
T ss_pred cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-------
Confidence 65332211112235788999999865 678999999999999999998 889998877777666654321100
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.++|.+||..||++|||+.|+++
T Consensus 225 ----------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 225 ----------------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----------------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 00125678999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=295.71 Aligned_cols=237 Identities=23% Similarity=0.376 Sum_probs=192.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++. ++..||||++..... ....+.+|+.++++++|+||+++++++.. ...+
T Consensus 17 g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 76 (261)
T cd05034 17 GQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSE----------------EEPI 76 (261)
T ss_pred CcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeec----------------CCce
Confidence 789999999975 557899999875432 24578899999999999999999999876 5578
Q ss_pred EEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+++++|+||||+||+|++++.+||+|||+++.+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999985 7777766533 46899999999999999999999999999999999999999999999999999776432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
..........+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......+.
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 225 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---------- 225 (261)
T ss_pred hhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 2111122233568999999876 568899999999999999998 9999998887777777643211110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.++|.+||..||++||+++++++
T Consensus 226 -------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 226 -------------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0124567999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=301.21 Aligned_cols=241 Identities=18% Similarity=0.282 Sum_probs=188.4
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||++++. .+++.||||+++..... .....+.+|+.+++.++|+||+++++++.+
T Consensus 17 G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--------------- 80 (277)
T cd05062 17 GSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQ--------------- 80 (277)
T ss_pred ccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---------------
Confidence 889999999875 34578999998643221 223457799999999999999999999876
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeE
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPG---------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 147 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~---------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vk 147 (481)
....++||||+.+ +|.+++.... ..++...+..++.||+.||+|||+++++|+||||+|||++.++.+|
T Consensus 81 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 81 -GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred -CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 5678999999985 6666554321 2357788999999999999999999999999999999999999999
Q ss_pred EecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 011627 148 LADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 225 (481)
Q Consensus 148 L~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 225 (481)
|+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+.+..+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999998754322111 1112344778999999876 568999999999999999999 789998887776665554311
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
... ....++..+.+||.+||..||++|||+.|++++
T Consensus 239 ~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LLD-----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCC-----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 001356689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=295.84 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=190.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++.+. +++.+|||++...... ...+.+|++++++++|+||+++++++.. ...+
T Consensus 15 g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 74 (256)
T cd05112 15 GQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE----------------RSPI 74 (256)
T ss_pred cccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc----------------CCce
Confidence 789999999885 4678999998744322 3467889999999999999999999876 5578
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+.+ +|.+++......+++..++.++.||+.+|+|||+++++|+||||+||+++.++.+||+|||+++......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 999999986 5666665555568999999999999999999999999999999999999999999999999987653222
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.........+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+.+..+.+......
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 222 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK----------- 222 (256)
T ss_pred ccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC-----------
Confidence 221222234668999999876 568899999999999999998 9999988777766666532110000
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....+.++.+|+.+||..||++|||+.|+++.
T Consensus 223 ------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 223 ------------------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ------------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 01245689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.98 Aligned_cols=241 Identities=28% Similarity=0.412 Sum_probs=191.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.||+|.+..+++.||||.++..... ......+.+|++++++++|+||+++++++.. .+.
T Consensus 13 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~----------------~~~ 76 (267)
T cd08224 13 GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE----------------NNE 76 (267)
T ss_pred CCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec----------------CCe
Confidence 88999999999999999999998754322 2235677899999999999999999999987 567
Q ss_pred EEEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
.++||||+.+ +|..++.. ....+++.++..++.||+.+|.|||+++|+|+||||+||+++.++.++|+|||++..+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 8999999985 77666542 3345899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--AEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+....+.... ++
T Consensus 157 ~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~- 226 (267)
T cd08224 157 SSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-------YP- 226 (267)
T ss_pred cCCC-cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC-------CC-
Confidence 4322 12233467888999999876 5688999999999999999999999965432 12222221100 00
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.. ....++..+.++|.+||..||++|||+.+|++
T Consensus 227 --~~------------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 227 --PL------------------PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred --CC------------------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 01146678999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=297.03 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=198.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+|++..++.+|+..|||.|+..+. +....+++.|++...+- +++|||+||+..-. ++.
T Consensus 75 G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~----------------EGd 137 (361)
T KOG1006|consen 75 GAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS----------------EGD 137 (361)
T ss_pred CcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc----------------CCc
Confidence 8999999999999999999999998765 23456778888866555 79999999999876 667
Q ss_pred EEEEEecCCCChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 82 TYMVFEYMDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~----~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.||.||+|+-++..+... ...+++|..+-.|..-++.||.||... .||||||||+||||+..|.|||||||++-.
T Consensus 138 cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 138 CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 899999999876554432 345699999999999999999999755 999999999999999999999999999876
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCC-CCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCCCCCCc
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC-GSPDETIWP 234 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 234 (481)
+.. .-..+.-.|...|||||.+..... |+.++|+||||++|||+.||+.|+..=+ .+++++.... +.++....+
T Consensus 218 Lv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 218 LVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--SVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred HHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--HHHHHHHHHHcCCCCeecCc
Confidence 542 223344577889999999975444 8999999999999999999998886533 2444443322 222111110
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
. .--+++..++.||..||.+|-+.||...++++++|++.
T Consensus 294 ~----------------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 294 K----------------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred c----------------------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 0 00147788999999999999999999999999999965
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=298.45 Aligned_cols=240 Identities=23% Similarity=0.343 Sum_probs=192.6
Q ss_pred cceeEEEEEEEccCCc---EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|+++.+++ .+|||.++..... .....+.+|+.++++++|+||+++++++.. .
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~ 77 (267)
T cd05066 15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIHLEGVVTK----------------S 77 (267)
T ss_pred cCCCceEEEEEecCCCCceEEEEEECCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEec----------------C
Confidence 7899999999875554 7999998754322 234567889999999999999999999976 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.+||||||+.+ +|.+++......+++.++..++.||+.||.|||+++++||||||+|||++.++.+||+|||++..+.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 678999999985 6777776655678999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCccc--cccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 159 YDHNNTLT--NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 159 ~~~~~~~~--~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.......+ ....+..|+|||++.+ ..++.++|+|||||++|+|++ |..||...+..+....+.+....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 230 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA------ 230 (267)
T ss_pred cccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC------
Confidence 33221111 1223567999999976 568999999999999999886 9999988777666665543211000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++..+.+||.+||+.+|++||++.++++
T Consensus 231 -----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 231 -----------------------PMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -----------------------CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0125668899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=295.15 Aligned_cols=236 Identities=22% Similarity=0.386 Sum_probs=190.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|.+. +++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+.+
T Consensus 17 G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----------------~~~~ 75 (260)
T cd05067 17 GQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-----------------QEPI 75 (260)
T ss_pred CccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-----------------cCCc
Confidence 899999999864 678899999875432 2346789999999999999999998874 3357
Q ss_pred EEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+.+.. ....+++.++..++.||+.+|+|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999974 77776654 3346899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........++..|+|||++.. ..++.++|||||||++|+|++ |+.||.+.+..+....+......+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----------- 223 (260)
T ss_pred CcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-----------
Confidence 2222223344678999999876 567899999999999999999 999999887766666553221100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||++++++
T Consensus 224 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 ------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01135668999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=305.17 Aligned_cols=239 Identities=25% Similarity=0.327 Sum_probs=186.1
Q ss_pred cceeEEEEEEEccCCcE--EEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEI--VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~--vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..++.. +|+|.+.... .......+.+|+.+++++ +|+||+++++++.+ .
T Consensus 18 G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~----------------~ 80 (303)
T cd05088 18 GNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----------------R 80 (303)
T ss_pred CCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC----------------C
Confidence 78999999999888765 4666654322 222345677899999999 89999999999976 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 143 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~ 143 (481)
+.+|+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||||+.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 678999999974 7777664321 257899999999999999999999999999999999999999
Q ss_pred CCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011627 144 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 222 (481)
Q Consensus 144 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 222 (481)
+.+||+|||++....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred CcEEeCccccCcccchhh--hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 999999999986432111 1111123567999998876 568899999999999999998 999998777666555442
Q ss_pred HhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
... .+. ....++.++.+||.+||+.||++||++.++|.+
T Consensus 238 ~~~------~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGY------RLE-----------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCC------cCC-----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 000 001256689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=316.46 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=187.1
Q ss_pred cceeEEEEEEEccC-----CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKT-----GEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++... ...||||+++.... ......+++|+++|++|. |+||+++++++.+
T Consensus 48 G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-------------- 112 (400)
T cd05105 48 GAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTK-------------- 112 (400)
T ss_pred CCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--------------
Confidence 89999999997543 35799999975432 223457889999999996 9999999999976
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCC-------------------------------------------------------
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRP------------------------------------------------------- 100 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~------------------------------------------------------- 100 (481)
...+|||||||.+ +|.+++...
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 113 --SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred --CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 5678999999985 666554321
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 011627 101 ----------------------------------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 140 (481)
Q Consensus 101 ----------------------------------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl 140 (481)
...+++.++..++.||+.||+|||+++|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 1237788899999999999999999999999999999999
Q ss_pred cCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 011627 141 DNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQL 218 (481)
Q Consensus 141 ~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~ 218 (481)
+.++.+||+|||+++.+..... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||........+
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 9999999999999976543221 11222345778999999876 578999999999999999997 99999876554443
Q ss_pred HHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 219 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.........+. ....++.++.+||.+||..||++|||+.+|.+
T Consensus 350 ~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 350 YNKIKSGYRMA----------------------------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHhcCCCCC----------------------------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 33322110000 01236678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.46 Aligned_cols=235 Identities=18% Similarity=0.246 Sum_probs=184.0
Q ss_pred CcceeEEEEEEEccCCcE-------EEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGEI-------VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~-------vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
-|+||+||+|.+..+++. ||+|++.... ......+.+|+.+++.++|+||+++++++..
T Consensus 5 ~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~------------ 70 (258)
T cd05078 5 QGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC------------ 70 (258)
T ss_pred cccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe------------
Confidence 389999999998766544 8888876432 2234467789999999999999999999986
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC--------
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-------- 145 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~-------- 145 (481)
....++||||+.+ +|..++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 71 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~ 146 (258)
T cd05078 71 ----GDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPF 146 (258)
T ss_pred ----CCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCce
Confidence 4567999999986 666676665557899999999999999999999999999999999999987765
Q ss_pred eEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHh
Q 011627 146 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFEL 224 (481)
Q Consensus 146 vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~-~pf~~~~~~~~~~~i~~~ 224 (481)
+||+|||++..... .....++..|+|||++.+...++.++|||||||++|+|++|. .||...+........ ..
T Consensus 147 ~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~ 220 (258)
T cd05078 147 IKLSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-ED 220 (258)
T ss_pred EEecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hc
Confidence 69999999865431 122456888999999976556789999999999999999984 666655544332221 11
Q ss_pred cCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 225 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
... +...++.++.+||.+||+.||++|||+++|++.
T Consensus 221 ~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 RHQ------------------------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ccc------------------------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 000 001234578999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=302.58 Aligned_cols=241 Identities=25% Similarity=0.410 Sum_probs=190.5
Q ss_pred cceeEEEEEEEccCC-----cEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG-----EIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||.||++++..+. ..||+|++....... ....+.+|+.+++++ +|+||+++++++..
T Consensus 23 g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-------------- 87 (293)
T cd05053 23 GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-------------- 87 (293)
T ss_pred cccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-HHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--------------
Confidence 789999999987544 789999987543322 234677999999999 89999999999976
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADR---------------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 140 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~---------------~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl 140 (481)
.+.+|+||||+.+ +|..++.. ....+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 88 --~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 88 --EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred --CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 5678999999975 66666532 23468999999999999999999999999999999999999
Q ss_pred cCCCCeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 011627 141 DNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQL 218 (481)
Q Consensus 141 ~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~ 218 (481)
+.++.+||+|||+++.+...... ......++..|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 99999999999999865432111 1112233567999999876 578899999999999999997 99999887776665
Q ss_pred HHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 219 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
..+...... . ....++.++.+||.+||..||++|||+.|++++
T Consensus 245 ~~~~~~~~~--~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 245 KLLKEGYRM--E---------------------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHcCCcC--C---------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 554321100 0 001356689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=294.34 Aligned_cols=240 Identities=21% Similarity=0.322 Sum_probs=194.0
Q ss_pred cceeEEEEEEEcc-CCc--EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIK-TGE--IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~-tg~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++.. +++ .||||+++..... .....+.+|+.++++++|+||+++++++..
T Consensus 6 g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------- 67 (257)
T cd05040 6 GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT----------------- 67 (257)
T ss_pred cCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-----------------
Confidence 8999999999866 333 6899999876543 345678899999999999999999998864
Q ss_pred CeEEEEEecCC-CChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 80 GSTYMVFEYMD-HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 80 ~~~~iV~Ey~~-g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
..+++||||+. ++|.+.+.... ..+++..++.++.||+.||+|||+++++|+||||+|||++.++.+||+|||+++.+
T Consensus 68 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 68 HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccc
Confidence 36799999997 47777776544 46899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 158 SYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 158 ~~~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
...... ......++..|+|||.+.. ..++.++|||||||++|+|++ |+.||...+..+.+..+...... +.
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----~~ 221 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-----LE 221 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-----CC
Confidence 432211 1112345778999998876 568899999999999999998 99999888887777666431100 00
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++..+.+||.+||..+|++|||+.|+++
T Consensus 222 -----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 222 -----------------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -----------------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00125668999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=297.26 Aligned_cols=235 Identities=20% Similarity=0.256 Sum_probs=180.8
Q ss_pred CcceeEEEEEEEcc------------CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCC
Q 011627 2 LVCISQVFMAREIK------------TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 69 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~------------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~ 69 (481)
-|+||+||+++... ....|++|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~------- 75 (262)
T cd05077 5 RGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR------- 75 (262)
T ss_pred cCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-------
Confidence 38999999998532 23358889876543 2234467789999999999999999999876
Q ss_pred CCCCCCCCcCCeEEEEEecCCCChh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---
Q 011627 70 QGRPDGNKYRGSTYMVFEYMDHDLT-GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN--- 145 (481)
Q Consensus 70 ~~~~~~~~~~~~~~iV~Ey~~g~L~-~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~--- 145 (481)
+...+|||||++++.+ .++......+++..+..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 76 ---------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~ 146 (262)
T cd05077 76 ---------DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGE 146 (262)
T ss_pred ---------CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCC
Confidence 4567999999997544 444444456999999999999999999999999999999999999987664
Q ss_pred ----eEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHH-hCCCCCCCCChHHHHHH
Q 011627 146 ----LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSK 220 (481)
Q Consensus 146 ----vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ell-tG~~pf~~~~~~~~~~~ 220 (481)
+||+|||++..... .....++..|+|||++.....++.++|||||||++|+|+ +|..||......+.. .
T Consensus 147 ~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~ 220 (262)
T cd05077 147 CGPFIKLSDPGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-R 220 (262)
T ss_pred CCceeEeCCCCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-H
Confidence 89999999865431 123456888999998875467899999999999999998 588888765543322 2
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 221 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
+...... .....+.++.+||.+||..||++||++.+||++
T Consensus 221 ~~~~~~~------------------------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 221 FYEGQCM------------------------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHhcCcc------------------------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 2111000 001134578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=335.23 Aligned_cols=136 Identities=26% Similarity=0.433 Sum_probs=119.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... .......+.+|+.+++.++|+||++++.++.. ...
T Consensus 15 G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----------------~~~ 78 (669)
T cd05610 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS----------------ANN 78 (669)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE----------------CCE
Confidence 8999999999999999999999975432 22234567789999999999999999999876 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
+||||||+.+ +|..++... ..+++..++.|+.||+.||+|||.++||||||||+||||+.++.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999975 676666543 468999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=302.45 Aligned_cols=239 Identities=25% Similarity=0.301 Sum_probs=187.8
Q ss_pred cceeEEEEEEEccCCc--EEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGE--IVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..++. .+++|.++.... ......+.+|+.+++++ +|+||+++++++.+ .
T Consensus 13 g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----------------~ 75 (297)
T cd05089 13 GNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACEN----------------R 75 (297)
T ss_pred CCcceEEEEEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEcc----------------C
Confidence 8999999999988775 468887763222 12234678899999999 79999999999876 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 143 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~ 143 (481)
+.+|+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||||+.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 578999999974 7776664321 248889999999999999999999999999999999999999
Q ss_pred CCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011627 144 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 222 (481)
Q Consensus 144 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 222 (481)
+.+||+|||++....... .......+..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+.+.++.
T Consensus 156 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~ 232 (297)
T cd05089 156 LASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232 (297)
T ss_pred CeEEECCcCCCcccccee--ccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 999999999986432111 1111122557999999876 568899999999999999997 999999888777666553
Q ss_pred HhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...... ....++.++.+||.+||..||.+|||++++++.
T Consensus 233 ~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 233 QGYRME-----------------------------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred cCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 211000 012367789999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.29 Aligned_cols=246 Identities=17% Similarity=0.279 Sum_probs=191.2
Q ss_pred cceeEEEEEEEcc-----CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIK-----TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||.||+|+++. .+..||||+++..... .....+.+|+.++++++|+||+++++++.+
T Consensus 17 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------------- 80 (288)
T cd05061 17 GSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCHHVVRLLGVVSK--------------- 80 (288)
T ss_pred CCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---------------
Confidence 8999999997653 3458999988644322 123456789999999999999999999876
Q ss_pred cCCeEEEEEecCC-CChhhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeE
Q 011627 78 YRGSTYMVFEYMD-HDLTGLADRPG---------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 147 (481)
Q Consensus 78 ~~~~~~iV~Ey~~-g~L~~~~~~~~---------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vk 147 (481)
....|+||||+. ++|.+++.... ..++...+..++.||+.||.|||+++|+||||||+|||++.++.+|
T Consensus 81 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 81 -GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred -CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 457899999997 47777665321 2356778899999999999999999999999999999999999999
Q ss_pred EecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 011627 148 LADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 225 (481)
Q Consensus 148 L~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 225 (481)
|+|||+++....... .......++..|+|||.+.+ ..++.++|||||||++|||++ +..||...+..+.+..+....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875432211 11122234678999999876 568899999999999999998 788998877766665553211
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc------CCCCCC
Q 011627 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD------SEYFWT 295 (481)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~------h~~f~~ 295 (481)
. +. ....++..+.+||.+||+.||++|||+.++++ |+||..
T Consensus 239 ~------~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 239 Y------LD-----------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred C------CC-----------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 0 00 00124568999999999999999999999986 888853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=298.15 Aligned_cols=239 Identities=18% Similarity=0.251 Sum_probs=186.9
Q ss_pred cceeEEEEEEEccCCcE----EEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEI----VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++. |++|++..... ......+..|+.++++++|+||+++++++..
T Consensus 18 G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---------------- 80 (279)
T cd05111 18 GVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPG---------------- 80 (279)
T ss_pred cCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEECC----------------
Confidence 89999999999888874 66676643222 2233466778889999999999999998743
Q ss_pred CCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
..+++|+||+. ++|.+++......+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+++.+
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 34688999997 5888888766667999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
..... .......++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.........+ .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~----- 232 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQ----- 232 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCC-----
Confidence 43221 12223345678999999876 568999999999999999998 99999887665543333 21110000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+++.+||..||++|||+.|+++
T Consensus 233 -----------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 233 -----------------------PQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0113456889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=300.98 Aligned_cols=247 Identities=19% Similarity=0.295 Sum_probs=192.4
Q ss_pred cceeEEEEEEEccCC----------------cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCC
Q 011627 3 VCISQVFMAREIKTG----------------EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg----------------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~ 66 (481)
|+||.||+|++..++ ..||+|++...... .....+.+|+.++++++|+||+++++++..
T Consensus 16 G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 90 (296)
T cd05051 16 GQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIARLLGVCTV---- 90 (296)
T ss_pred CCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEeEEEEEEec----
Confidence 899999999987654 45799998765433 234567789999999999999999999976
Q ss_pred CCCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 011627 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPG----------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 135 (481)
Q Consensus 67 ~~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~----------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp 135 (481)
+..+++||||+.+ +|..++.+.. ..+++..++.++.||+.||+|||+++|+||||||
T Consensus 91 ------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 91 ------------DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred ------------CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 5678999999985 6666654432 2589999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh--CCCCCCCC
Q 011627 136 SNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPILPGK 212 (481)
Q Consensus 136 ~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt--G~~pf~~~ 212 (481)
+|||++.++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|+|++ +..||...
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999999876532211 11223345778999999876 568999999999999999998 77888877
Q ss_pred ChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 213 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+..+.+..+............ ......++.++.+||.+||+.||++|||+.||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIY----------------------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhcccccccccc----------------------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 777766665432211100000 0001235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=297.24 Aligned_cols=240 Identities=18% Similarity=0.291 Sum_probs=190.5
Q ss_pred cceeEEEEEEEccC-----CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKT-----GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||.||++.++.. +..||+|++...... .....+.+|+.+++.++|+||+++++++..
T Consensus 17 g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--------------- 80 (277)
T cd05032 17 GSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIEFLNEASVMKEFNCHHVVRLLGVVST--------------- 80 (277)
T ss_pred CCCceEEEEEEeccCCCCcceeEEEEecCCccCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEcC---------------
Confidence 89999999998754 488999998644322 223467789999999999999999999987
Q ss_pred cCCeEEEEEecCC-CChhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeE
Q 011627 78 YRGSTYMVFEYMD-HDLTGLADRP---------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 147 (481)
Q Consensus 78 ~~~~~~iV~Ey~~-g~L~~~~~~~---------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vk 147 (481)
...+|+||||+. ++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+|
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 567899999997 4776665432 12367889999999999999999999999999999999999999999
Q ss_pred EecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 011627 148 LADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 225 (481)
Q Consensus 148 L~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 225 (481)
|+|||+++.+..... .......++..|+|||++.. ..++.++|||||||++|||++ |..||...+..+.+..+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 999999876543221 11223345788999999875 568899999999999999998 999998887766665553110
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.. . ....++.++.+||.+||..||++|||+.+|++
T Consensus 239 -~~-~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 -HL-D---------------------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred -CC-C---------------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 0 00124668999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=294.94 Aligned_cols=241 Identities=22% Similarity=0.296 Sum_probs=186.2
Q ss_pred cceeEEEEEEEcc---CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIK---TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|.+.. +...||||++..... ......+.+|+.+++.++|+||+++++++... +
T Consensus 6 g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---------------~ 69 (262)
T cd05058 6 GHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS---------------E 69 (262)
T ss_pred cCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecC---------------C
Confidence 7899999999754 345799998854322 12345677899999999999999999977542 3
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+..++||||+.+ +|.+++.+....+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+++.+.
T Consensus 70 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 70 GSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCcccccccc
Confidence 457899999984 7777776555567888889999999999999999999999999999999999999999999997653
Q ss_pred CCCC---CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 159 YDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 159 ~~~~---~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
.... .......++..|+|||++.. ..++.++|||||||++|||++ |.+||...+..+....+...... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~-~----- 222 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL-L----- 222 (262)
T ss_pred CCcceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-C-----
Confidence 2211 11112234678999998876 578899999999999999999 56778776666555444321000 0
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++..+.+|+.+||..||++||++.|+++
T Consensus 223 -----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 223 -----------------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -----------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00125668999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.72 Aligned_cols=241 Identities=23% Similarity=0.345 Sum_probs=190.3
Q ss_pred cceeEEEEEEE-----ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE-----IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||.||++.+ ..++..||||+++.... ......+.+|+.+++++ +|+||+++++++..
T Consensus 46 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-------------- 110 (302)
T cd05055 46 GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTI-------------- 110 (302)
T ss_pred cCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEec--------------
Confidence 88999999986 34556899999875432 22344678899999999 79999999999976
Q ss_pred CcCCeEEEEEecCC-CChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 77 KYRGSTYMVFEYMD-HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~-g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
.+.+||||||+. ++|.+++.... ..+++.++..++.||+.+|+|||+++|+|+||||+|||++.++.+||+|||++
T Consensus 111 --~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 111 --GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 557899999998 47777765433 33899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 011627 155 RSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETI 232 (481)
Q Consensus 155 ~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (481)
+.+...... ......++..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+.+.+.........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--- 264 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--- 264 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC---
Confidence 765432211 1112244678999999876 568899999999999999998 9999988776655544433110000
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.|+++
T Consensus 265 -------------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 265 -------------------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00135678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=333.57 Aligned_cols=244 Identities=25% Similarity=0.327 Sum_probs=189.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++..... +.....+.+|+.++++++|+||+++++++.+ .+.
T Consensus 13 GgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d----------------~~~ 76 (932)
T PRK13184 13 GGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD----------------GDP 76 (932)
T ss_pred CCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee----------------CCE
Confidence 89999999999999999999999765322 2234567899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEec
Q 011627 82 TYMVFEYMDH-DLTGLADRP----------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 150 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~----------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 150 (481)
+|+||||+++ +|.+++... ...++...+..++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 9999999986 666655421 12356678899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCC-----------------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC
Q 011627 151 FGLARSFSYDHN-----------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN 213 (481)
Q Consensus 151 FG~a~~~~~~~~-----------------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 213 (481)
||+++....... ......+||+.|+|||++.+ ..++.++||||||||+|||++|+.||...+
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 999986521110 11122468999999999886 578999999999999999999999998755
Q ss_pred hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 214 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
..+...... ...+.. ...+..++..+.+++.+||..||++|++..+.|.+
T Consensus 236 ~~ki~~~~~--i~~P~~-------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 236 GRKISYRDV--ILSPIE-------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhhh--ccChhh-------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 433222110 000000 00112467789999999999999999887666543
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=301.27 Aligned_cols=239 Identities=24% Similarity=0.364 Sum_probs=189.6
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||.||+|++. .+...+++|.+...... ....+.+|+.++++++|+||+++++++..
T Consensus 16 g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------------- 78 (291)
T cd05094 16 GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA--ARKDFQREAELLTNLQHEHIVKFYGVCGD--------------- 78 (291)
T ss_pred cCCCeEEEeEeeccCCCCcceeeEEEecCCccHH--HHHHHHHHHHHHhcCCCCCcceEEEEEcc---------------
Confidence 789999999854 35567899988644321 23467799999999999999999999976
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~ 141 (481)
...+++||||+.+ +|.+++... ...+++..++.++.||+.+|+|||+++|+||||||+|||++
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 79 -GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 5578999999975 676665432 23488999999999999999999999999999999999999
Q ss_pred CCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011627 142 NEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLS 219 (481)
Q Consensus 142 ~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~ 219 (481)
.++.+||+|||+++....... .......++..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+.+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999976533221 11223345788999999876 568899999999999999998 999998887777665
Q ss_pred HHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 220 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.+....... ....++..+.+||.+||..||++|||+.++++
T Consensus 237 ~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQGRVLE-----------------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCCCCC-----------------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 543211000 00125678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=296.96 Aligned_cols=238 Identities=25% Similarity=0.321 Sum_probs=186.8
Q ss_pred cceeEEEEEEEccCCcE--EEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEI--VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~--vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||++++..++.. +++|.++.... ......+.+|+.+++++ +|+||+++++++.. .
T Consensus 6 g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----------------~ 68 (270)
T cd05047 6 GNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEH----------------R 68 (270)
T ss_pred CCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEec----------------C
Confidence 88999999999888764 58887763322 22344677899999999 79999999999986 5
Q ss_pred CeEEEEEecCC-CChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC
Q 011627 80 GSTYMVFEYMD-HDLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 143 (481)
Q Consensus 80 ~~~~iV~Ey~~-g~L~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~ 143 (481)
+.+|+||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++++||||||+|||++.+
T Consensus 69 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~ 148 (270)
T cd05047 69 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 148 (270)
T ss_pred CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC
Confidence 57899999997 47777665322 247899999999999999999999999999999999999999
Q ss_pred CCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011627 144 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 222 (481)
Q Consensus 144 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 222 (481)
+.+||+|||++....... .......+..|+|||++.. ..++.++|||||||++|||++ |..||...+..+.+..+.
T Consensus 149 ~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~ 225 (270)
T cd05047 149 YVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 225 (270)
T ss_pred CeEEECCCCCccccchhh--hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh
Confidence 999999999986332111 1111223567999999875 678899999999999999997 999998877666655542
Q ss_pred HhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
..... + ....++.++.+||.+||..||.+|||+.+++.
T Consensus 226 ~~~~~--~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 226 QGYRL--E---------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCC--C---------------------------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 21000 0 00125668899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=298.74 Aligned_cols=239 Identities=25% Similarity=0.386 Sum_probs=189.2
Q ss_pred cceeEEEEEEE-----ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE-----IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||.||+++. ..++..+|+|.+..... .....+.+|+++++.++|+||+++++++.+
T Consensus 16 g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------------- 78 (280)
T cd05092 16 GAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIVRFYGVCTE--------------- 78 (280)
T ss_pred ccCCeEEEeEEecCCCCCCceEEEEEecCcCCH--HHHHHHHHHHHHHhcCCCCCCceEEEEEec---------------
Confidence 78999999974 34567899998764432 234567899999999999999999999887
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPG--------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 142 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~--------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~ 142 (481)
...+|+||||+.+ +|.+++.... ..+++..+..++.||+.||+|||+++|+|+||||+|||+++
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 79 -GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred -CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 5578999999985 6666654322 24788999999999999999999999999999999999999
Q ss_pred CCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011627 143 EGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSK 220 (481)
Q Consensus 143 ~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~ 220 (481)
++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 99999999999875532211 11122234678999999876 568899999999999999998 9999988777766655
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 221 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+....... ....++..+.+||.+||..||++||++.||++
T Consensus 237 ~~~~~~~~-----------------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRELE-----------------------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccCC-----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 53321100 00135678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=295.88 Aligned_cols=239 Identities=21% Similarity=0.326 Sum_probs=190.6
Q ss_pred cceeEEEEEEEccC---CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKT---GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|.+..+ ...||||++..... ......+.+|+.++++++|+||+++++++.+
T Consensus 17 g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------- 78 (270)
T cd05056 17 GQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE----------------- 78 (270)
T ss_pred ccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----------------
Confidence 89999999998654 35689998865432 2234577899999999999999999998864
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
...||||||+.+ +|.+++.+....+++..+..++.||+.||+|||+++++|+||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 246899999974 7877776655568999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
............+..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+.+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 228 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP--------- 228 (270)
T ss_pred cccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---------
Confidence 332111122223567999998875 568899999999999999986 999998888776665553211000
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.++++
T Consensus 229 --------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 229 --------------------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred --------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01235678999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=296.19 Aligned_cols=240 Identities=23% Similarity=0.351 Sum_probs=191.8
Q ss_pred cceeEEEEEEEccCCc---EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.||+|+++.+++ .||||++..... +.....+.+|+.++++++|+||+++++++.+ .
T Consensus 15 g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----------------~ 77 (269)
T cd05065 15 GEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----------------S 77 (269)
T ss_pred CCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEECC----------------C
Confidence 8899999999987765 599999875422 2234577899999999999999999999876 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..+++||||+.+ +|.+++......+++.++..++.||+.||+|||+++++|+||||+||||+.++.+||+|||++....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 678999999986 6666666555678999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCC-cccccc---ccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 159 YDHNN-TLTNRV---ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 159 ~~~~~-~~~~~~---gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
..... ...... .+..|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---- 232 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP---- 232 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC----
Confidence 32211 111111 2457999999876 578899999999999999886 9999988877776666632111000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++..+.++|.+||..||++||++.+|+.
T Consensus 233 -------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 233 -------------------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0135667899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=299.73 Aligned_cols=240 Identities=26% Similarity=0.406 Sum_probs=189.7
Q ss_pred cceeEEEEEEEc----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREI----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||.||+|... ..+..|+||+++.... ......+.+|++++++++|+||+++++++..
T Consensus 10 G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~---------------- 72 (259)
T PF07714_consen 10 GSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS-EEEEEEFLNEIQILRKLRHPNIVKLYGFCIE---------------- 72 (259)
T ss_dssp ESSEEEEEEEEESTTTSSEEEEEEEEESTTSS-HHHHHHHHHHHHHHHTHSBTTBE-EEEEEES----------------
T ss_pred CCCcEEEEEEEEcccCCCCEEEEEEEeccccc-cccceeeeecccccccccccccccccccccc----------------
Confidence 899999999987 4567899999965322 2235688899999999999999999999986
Q ss_pred CCeEEEEEecCC-CChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 79 RGSTYMVFEYMD-HDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 79 ~~~~~iV~Ey~~-g~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.+.++||||||. ++|.+.+... ...+++.++..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++..
T Consensus 73 ~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 73 NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 556899999998 4787777765 56799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 157 FSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 157 ~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
...... ...........|+|||++.. ..++.++||||||+++|||++ ++.||...+..+...++.+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~------ 225 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP------ 225 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT------
T ss_pred ccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccce------
Confidence 622111 12222345778999999876 458999999999999999999 789999888888777774322111
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++..+.+||.+||..||++|||+.+|++
T Consensus 226 -----------------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 226 -----------------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -----------------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -----------------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11246778999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.03 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=192.0
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCc--CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNE--KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||++++. .+++.||||+++.... .......+.+|+.+++++ +|+||+++++.+..
T Consensus 11 G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-------------- 76 (288)
T cd05583 11 GAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-------------- 76 (288)
T ss_pred CCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--------------
Confidence 789999999864 5778999999875422 222344667899999999 59999999999876
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
...+||||||+.+ +|.+.+.. ...+++..++.++.||+.+|.|||+.+++|+||||+||+++.++.++|+|||+++
T Consensus 77 --~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 77 --DTKLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred --CCEEEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 6689999999986 66665544 3468999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCccccccccccCCCchhhcCCC-CCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
.+............++..|+|||++.+.. ..+.++||||||+++|+|++|..||...+.......+.+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 229 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP---- 229 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC----
Confidence 76433322223345788999999986532 2678999999999999999999999654322221222111000000
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s---a~eiL~h~~f~~ 295 (481)
.....++..+.+||.+||+.||++||| +.++|+|+||..
T Consensus 230 ----------------------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 230 ----------------------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred ----------------------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 011235678999999999999999998 567799999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=297.62 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=187.1
Q ss_pred cceeEEEEEEE----ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMARE----IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||.||+|+. ..+++.||||.++..... .....+.+|+.++++++|+||+++++++.+..
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------------- 79 (284)
T cd05079 15 GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGICTEDG-------------- 79 (284)
T ss_pred CCceeEEEEEEccCCCCccceEEEEEcCccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--------------
Confidence 89999999984 567899999998755322 23457789999999999999999999987632
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...++|||||+.+ +|.+++.+....+++..+..++.||+.+|+|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 3468999999975 676666554446899999999999999999999999999999999999999999999999999866
Q ss_pred cCCCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
...... ......++..|+|||++.+ ..++.++||||||||+|+|++++.++..... .+.+. .+........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~~---~~~~~~~~~~- 232 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKM---IGPTHGQMTV- 232 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc--hhhhh---cccccccccH-
Confidence 432211 1123345678999999876 5688999999999999999998765432111 00000 0000000000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.... ..............++.++.+||.+||+.||++|||+.+++++
T Consensus 233 -------~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 233 -------TRLV-RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -------HHHH-HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0000 0000000001123467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.29 Aligned_cols=245 Identities=17% Similarity=0.255 Sum_probs=184.7
Q ss_pred cceeEEEEEEEcc--CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIK--TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|.... ....+|+|.+..... ......+++|+.+++.++|+||+++++.+.. ..
T Consensus 6 G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~----------------~~ 68 (269)
T cd05042 6 GWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIE----------------SI 68 (269)
T ss_pred cCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECC----------------CC
Confidence 8999999997533 445788887764432 2234467789999999999999999999876 56
Q ss_pred eEEEEEecCCC-ChhhhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 81 STYMVFEYMDH-DLTGLADRPG----LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~----~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.+||||||+.+ +|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 69 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 148 (269)
T cd05042 69 PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLAL 148 (269)
T ss_pred ceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEecccccc
Confidence 78999999985 6766665432 224677889999999999999999999999999999999999999999999986
Q ss_pred cccCCCC-CccccccccccCCCchhhcC------CCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 011627 156 SFSYDHN-NTLTNRVITLWYRPPELLLG------ATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGS 227 (481)
Q Consensus 156 ~~~~~~~-~~~~~~~gt~~Y~aPEvl~~------~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 227 (481)
....... .......++..|+|||++.. ...++.++|||||||++|||++ |..||....+.+.+..+......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc
Confidence 5322111 11122234677999999753 1346789999999999999999 78899888777766665442211
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 228 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
..... .....++..+.+++..|+ .||++|||++||++
T Consensus 229 ~~~~~------------------------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 229 KLPKP------------------------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cCCCC------------------------cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 10000 011236677888999988 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=298.69 Aligned_cols=240 Identities=20% Similarity=0.319 Sum_probs=187.5
Q ss_pred cceeEEEEEEEcc-----CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIK-----TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|++.. ....+++|++...... .....+.+|+.+++.++|+||+++++.+..
T Consensus 11 g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------------- 74 (290)
T cd05045 11 GEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVNHPHVIKLYGACSQ--------------- 74 (290)
T ss_pred cCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCCEeeEEEEEec---------------
Confidence 8899999999754 2367899988654322 123567889999999999999999999876
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRP-----------------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 133 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~-----------------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDL 133 (481)
.+..|+||||+.+ +|.+++... ...+++..+..++.||+.+|+|||+++|+||||
T Consensus 75 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~di 153 (290)
T cd05045 75 -DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL 153 (290)
T ss_pred -CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 5578999999985 665554321 124788999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCC
Q 011627 134 KGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 211 (481)
Q Consensus 134 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~ 211 (481)
||+||||++++.+||+|||+++.+...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999765322211 1122234678999999876 568899999999999999998 9999988
Q ss_pred CChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 212 KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....+....+...... + ....++.++.+||.+||+.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~------~-----------------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGYRM------E-----------------------RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCCCC------C-----------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7766655544321100 0 01235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.12 Aligned_cols=241 Identities=24% Similarity=0.395 Sum_probs=190.4
Q ss_pred cceeEEEEEEEc-------cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-------KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~-------~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||.||+|++. .++..||+|++...... .....+.+|+.+++.+ +|+||+++++++..
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~------------ 92 (304)
T cd05101 26 GCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ------------ 92 (304)
T ss_pred cCCceEEEEEEeccCCCCCCcceeEEeeecccccch-HHHHHHHHHHHHHHhhccCCCchheeEEEec------------
Confidence 889999999853 23457999998754322 2345678999999999 89999999999987
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
...+|+||||+.+ +|.+++.+. ...++...+..++.||+.||.|||+++|+||||||+||
T Consensus 93 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 93 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 5678999999985 776666542 23478888999999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCCCc-cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 216 (481)
||+.++.+||+|||+++.+....... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999998764322211 122334678999999876 568899999999999999998 888998887776
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....+...... . ....++.++++||.+||..+|++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~--~---------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 248 LFKLLKEGHRM--D---------------------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHcCCcC--C---------------------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 66655321100 0 011366789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=299.63 Aligned_cols=247 Identities=20% Similarity=0.312 Sum_probs=188.9
Q ss_pred cceeEEEEEEEccCC--------------cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCC
Q 011627 3 VCISQVFMAREIKTG--------------EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 68 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg--------------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~ 68 (481)
|+||.||+|++..++ ..||||+++.... ......+.+|++++++++|+||+++++++..
T Consensus 16 G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~------ 88 (295)
T cd05097 16 GQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLLGVCVS------ 88 (295)
T ss_pred CCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC------
Confidence 899999999986543 3589999875432 2234467889999999999999999999976
Q ss_pred CCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 011627 69 EQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPG-----------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 136 (481)
Q Consensus 69 ~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~-----------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~ 136 (481)
.+.+|+||||+.+ +|.+++.... ..+++..+..++.||+.||+|||+++++|+||||+
T Consensus 89 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 89 ----------DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred ----------CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 5678999999985 6666554321 13688899999999999999999999999999999
Q ss_pred cEEEcCCCCeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh--CCCCCCCCC
Q 011627 137 NLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPILPGKN 213 (481)
Q Consensus 137 NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt--G~~pf~~~~ 213 (481)
|||+++++.+||+|||++..+...... ......++..|+|||++.. ..++.++|||||||++|+|++ +..||...+
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999999765322111 1122234678999999876 568999999999999999988 667888877
Q ss_pred hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 214 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
..+.+..+...........+. .....++..+++||.+||..||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYL----------------------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccC----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 766666554322111000000 001125678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=305.10 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=202.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-----cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-----EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-----~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+|++||+|.|....+.||||+-.... .++.+.+.+.+|..|++.|.|+.||++|++|.-.
T Consensus 474 GGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-------------- 539 (775)
T KOG1151|consen 474 GGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-------------- 539 (775)
T ss_pred ccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec--------------
Confidence 899999999999999999999976553 3344566778999999999999999999999762
Q ss_pred cCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEEcC---CCCeEEeccc
Q 011627 78 YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--QVLHRDIKGSNLLIDN---EGNLKLADFG 152 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~--giiHrDLKp~NILl~~---~~~vkL~DFG 152 (481)
...+|-|+|||+|+.+++..+...-+++.+++.|+-||+.||.||.+. -|||-||||.||||.+ -|.|||.|||
T Consensus 540 -tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 -TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred -cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 567899999999977777777777899999999999999999999976 6999999999999954 4679999999
Q ss_pred ccccccCCCCC------ccccccccccCCCchhhcCC---CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 011627 153 LARSFSYDHNN------TLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 223 (481)
Q Consensus 153 ~a~~~~~~~~~------~~~~~~gt~~Y~aPEvl~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 223 (481)
+++++..+... ......||.||++||.+.-. ...+.++||||+|||+|.++.|+.||..+-.... |++
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd---ILq 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD---ILQ 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH---HHh
Confidence 99988765433 22234679999999998642 3478899999999999999999999986644322 222
Q ss_pred hcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 224 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
......... ..| ...+.++.++++||++||...-++|+.+.++..||||.
T Consensus 696 eNTIlkAtE----------VqF-----------P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 696 ENTILKATE----------VQF-----------PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hhchhccee----------ccC-----------CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 111100000 000 00124788999999999999999999999999999994
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.14 Aligned_cols=240 Identities=22% Similarity=0.347 Sum_probs=190.0
Q ss_pred cceeEEEEEEEccCC------cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG------EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||.||++++.... +.||||.+..... ......+.+|+.+++.++|+||+++++++..
T Consensus 6 g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------------- 70 (269)
T cd05044 6 GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-------------- 70 (269)
T ss_pred ccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--------------
Confidence 789999999987544 7899998865432 2234577899999999999999999999876
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-----
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADR------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----- 144 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~------~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~----- 144 (481)
....|+||||+.+ +|.+.+.. ....+++.++..++.||+.+|+|||+++++|+||||+|||++.++
T Consensus 71 --~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~ 148 (269)
T cd05044 71 --NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADR 148 (269)
T ss_pred --CCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCc
Confidence 5578999999984 77766643 223478899999999999999999999999999999999999877
Q ss_pred CeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011627 145 NLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 222 (481)
Q Consensus 145 ~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 222 (481)
.+||+|||++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.
T Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 227 (269)
T cd05044 149 VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227 (269)
T ss_pred ceEECCcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh
Confidence 899999999875532211 11122344778999999876 568999999999999999998 999998877766555542
Q ss_pred HhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
..... .....++..+.+||.+||..+|++||++.++++
T Consensus 228 ~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 228 AGGRL-----------------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cCCcc-----------------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 21000 011235678999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=295.34 Aligned_cols=242 Identities=21% Similarity=0.373 Sum_probs=191.7
Q ss_pred cceeEEEEEEEccC-----CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKT-----GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~t-----g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|+++.+ .+.|++|.+..... ......+.+|+.++++++|+||+++++++.+
T Consensus 16 g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------------- 79 (275)
T cd05046 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--------------- 79 (275)
T ss_pred cceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECC---------------
Confidence 89999999997643 46799998764332 2245578899999999999999999999876
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEE
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPG--------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKL 148 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~--------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL 148 (481)
....|+||||+.+ +|.+++.... ..+++..+..++.||+.+|+|||+++|+||||||+||||+.++.+||
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 80 -AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred -CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 5578999999985 6766665433 15899999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 011627 149 ADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGS 227 (481)
Q Consensus 149 ~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 227 (481)
+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~-- 235 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-- 235 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC--
Confidence 9999987543322223333455778999998876 467889999999999999998 888998776666555543211
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 228 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
..|. ....++..+.++|.+||..||++|||+.|+++.
T Consensus 236 ---~~~~-----------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 ---LELP-----------------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---cCCC-----------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0011 011366789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=297.98 Aligned_cols=234 Identities=20% Similarity=0.261 Sum_probs=180.6
Q ss_pred cceeEEEEEEEccC------------------------CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceee
Q 011627 3 VCISQVFMAREIKT------------------------GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE 58 (481)
Q Consensus 3 G~fg~Vy~a~~~~t------------------------g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~ 58 (481)
|+||.||++....+ ...||+|++..... .....+.+|+.+++.++|+||+++++
T Consensus 6 G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv~~~~ 83 (274)
T cd05076 6 GTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLAFVHG 83 (274)
T ss_pred ccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 89999999985322 23588888864322 23346778999999999999999999
Q ss_pred EEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 011627 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 137 (481)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~-L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~N 137 (481)
++.+ ....||||||+.++ |..++.+....+++..+..++.||+.||+|||+++|+||||||+|
T Consensus 84 ~~~~----------------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~N 147 (274)
T cd05076 84 VCVR----------------GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKN 147 (274)
T ss_pred EEEe----------------CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCccc
Confidence 9987 55789999999975 544554445678999999999999999999999999999999999
Q ss_pred EEEcCCC-------CeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHH-hCCCCC
Q 011627 138 LLIDNEG-------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL-NGKPIL 209 (481)
Q Consensus 138 ILl~~~~-------~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ell-tG~~pf 209 (481)
|||+..+ .+||+|||++...... ....++..|+|||++.+...++.++|||||||++|||+ +|+.||
T Consensus 148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 222 (274)
T cd05076 148 ILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL 222 (274)
T ss_pred EEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCc
Confidence 9997643 3899999988643211 22356788999998876566899999999999999985 699999
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 210 PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 210 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
......+....+ ...... ....+.++.+||.+||..||++|||+.+||+
T Consensus 223 ~~~~~~~~~~~~-~~~~~~------------------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 223 KERTPSEKERFY-EKKHRL------------------------------PEPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred cccChHHHHHHH-HhccCC------------------------------CCCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 876654433222 110000 0113356899999999999999999999987
Q ss_pred C
Q 011627 290 S 290 (481)
Q Consensus 290 h 290 (481)
+
T Consensus 272 ~ 272 (274)
T cd05076 272 D 272 (274)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=291.14 Aligned_cols=232 Identities=22% Similarity=0.375 Sum_probs=190.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||+|.+ .++.||||+++.... ...++.+|+.++++++|+||+++++++.+ ....
T Consensus 17 g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~ 75 (256)
T cd05039 17 GEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ----------------GNPL 75 (256)
T ss_pred CCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC----------------CCCe
Confidence 78999999987 489999999976543 34578899999999999999999999876 5578
Q ss_pred EEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+++.... ..+++..++.++.||+.+|.|||+++|+|+||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 999999985 7777765543 25899999999999999999999999999999999999999999999999999866322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.. ....+..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+....+.... ..
T Consensus 156 ~~----~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~----------- 218 (256)
T cd05039 156 QD----SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-RM----------- 218 (256)
T ss_pred cc----cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC-----------
Confidence 11 2234667999999875 568889999999999999997 999998877666555443210 00
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.....++.++.+||.+||..||++|||+.|+++
T Consensus 219 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 -----------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -----------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 001235678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=300.25 Aligned_cols=240 Identities=23% Similarity=0.379 Sum_probs=188.0
Q ss_pred cceeEEEEEEEcc-------CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIK-------TGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||.||+|++.. +...||+|+++..... .....+.+|+.+++++ +|+||+++++++.+
T Consensus 23 G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~------------ 89 (314)
T cd05099 23 GCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHKNIINLLGVCTQ------------ 89 (314)
T ss_pred CCcccEEEeeecccCCccCCcceEEEEEecCCCCCh-HHHHHHHHHHHHHHhccCCCCeeeEEEEEcc------------
Confidence 8899999998643 3457999998754322 2345677899999999 69999999999876
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
.+.+|+||||+.+ +|.+++... ...+++.++..++.||+.||.|||+++|+||||||+||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 90 ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 5578999999985 676665432 13488899999999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 216 (481)
|++.++.+||+|||+++........ .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999765422111 1111223467999999876 578899999999999999999 899998877766
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.+..+..... .. ....++.++++||.+||..||++|||+.|+++
T Consensus 245 ~~~~~~~~~~--~~---------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 245 LFKLLREGHR--MD---------------------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHcCCC--CC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 6665532110 00 01135668999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.83 Aligned_cols=242 Identities=22% Similarity=0.315 Sum_probs=189.5
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||.||+|++. .+++.||||+++..... .....+++|+.+|.+|. |+|||++++++..
T Consensus 48 G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-------------- 112 (401)
T cd05107 48 GAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTK-------------- 112 (401)
T ss_pred CCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--------------
Confidence 899999999953 45678999999765322 22346789999999997 9999999999977
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCC------------------------------------------------------
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPG------------------------------------------------------ 101 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~------------------------------------------------------ 101 (481)
.+.+|||||||.+ +|.+++.+..
T Consensus 113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 5578999999985 7766654321
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 102 -------------------------------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 102 -------------------------------------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
..+++..+..|+.||+.||+|||+++|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 1367778899999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 216 (481)
|+++++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||......+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999999976532221 11223356788999999876 568899999999999999998 889998766555
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+...+.....+. ....++.++.+||.+||..||++||++.||++.
T Consensus 350 ~~~~~~~~~~~~~----------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFYNAIKRGYRMA----------------------------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4444332110000 012356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.52 Aligned_cols=241 Identities=25% Similarity=0.394 Sum_probs=188.6
Q ss_pred cceeEEEEEEEcc-------CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIK-------TGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||+||+|++.. +...||+|+++.... ......+.+|+.+++++ +|+||+++++++..
T Consensus 29 G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~------------ 95 (307)
T cd05098 29 GCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ------------ 95 (307)
T ss_pred CCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec------------
Confidence 7899999998753 235799999976432 22345677899999999 79999999999977
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
.+.+|+||||+.+ +|.+++.... ..++..++..++.||+.||+|||+++++||||||+||
T Consensus 96 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 96 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 5678999999985 7777765421 2488899999999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCCCc-cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 216 (481)
|++.++.+||+|||+++.+....... ......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 99999999999999987654221111 111223568999999876 568899999999999999998 889998777655
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....+.... . . .....++.++.+||.+||..||++|||+.+++++
T Consensus 251 ~~~~~~~~~-~-~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEGH-R-M---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCC-C-C---------------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 555442210 0 0 0011356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=295.59 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=185.1
Q ss_pred cceeEEEEEE----EccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAR----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||++. ...+++.||+|+++..... .....+.+|+.+|++++|+||+++++++....
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------------- 79 (283)
T cd05080 15 GHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-QNTSGWKKEINILKTLYHENIVKYKGCCSEQG-------------- 79 (283)
T ss_pred CCCcEEEEeeEccccCCCCceEEEEEeccccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--------------
Confidence 8899998865 4467889999998765321 23456778999999999999999999886521
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...+||||||+.+ +|.+++... .+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 3468999999986 566555442 5899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCc--cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCCCCCc
Q 011627 158 SYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG-SPDETIWP 234 (481)
Q Consensus 158 ~~~~~~~--~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~ 234 (481)
....... .....++..|+|||++.. ..++.++|||||||++|+|++|..||...... +..+..... ......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhh
Confidence 4322111 112234667999999876 56889999999999999999999988654321 111110000 00000000
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
... . ..........++.++.+|+.+||..||++|||+++|++
T Consensus 235 ~~~-----~--------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELL-----E--------RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhh-----h--------cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000 0 00000012346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=290.43 Aligned_cols=232 Identities=21% Similarity=0.358 Sum_probs=186.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++.. +++.||+|.++... ....+.+|+.++++++|+||+++++++... ...+
T Consensus 17 g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---------------~~~~ 75 (256)
T cd05082 17 GEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---------------KGGL 75 (256)
T ss_pred cCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC---------------CCce
Confidence 78999999976 58889999986432 234678999999999999999999976541 4568
Q ss_pred EEEEecCCC-ChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+++..... .+++..+..++.||+.+|+|||+++|+||||||+|||+++++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999985 77777665333 4889999999999999999999999999999999999999999999999998754322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .....+..|+|||++.. ..++.++||||||||+|+|++ |+.||...+..+....+......
T Consensus 156 ~----~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------ 218 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM------------ 218 (256)
T ss_pred C----CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC------------
Confidence 1 22334667999999876 568899999999999999997 99999877766655554321000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.....++..+.+||.+||..||++|||+.++++
T Consensus 219 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 219 -----------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001235778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.56 Aligned_cols=243 Identities=23% Similarity=0.372 Sum_probs=184.7
Q ss_pred cceeEEEEEEE-----ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE-----IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++ ..+++.||||+++..... .....+.+|+.++.++ +|+||+++++++...
T Consensus 18 G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~------------- 83 (343)
T cd05103 18 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP------------- 83 (343)
T ss_pred CccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeecC-------------
Confidence 89999999985 456789999999754322 2345678999999999 689999999988652
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCC------------------------------------------------------
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPG------------------------------------------------------ 101 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~------------------------------------------------------ 101 (481)
...++||||||.+ +|.+++....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4468999999985 6665554211
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCCC-ccccc
Q 011627 102 ------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNR 168 (481)
Q Consensus 102 ------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~ 168 (481)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++++||+|||++..+...... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 23677888999999999999999999999999999999999999999999999765322111 11122
Q ss_pred cccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 011627 169 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 247 (481)
Q Consensus 169 ~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (481)
.++..|+|||++.+ ..++.++|||||||++|+|++ |..||........+...+.......
T Consensus 242 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------ 302 (343)
T cd05103 242 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------------------ 302 (343)
T ss_pred CCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC------------------
Confidence 34667999999876 578899999999999999997 9999977544333322221110000
Q ss_pred chhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 248 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....++.++.+++.+||..||++|||+.||++|
T Consensus 303 ----------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001245678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=291.86 Aligned_cols=245 Identities=20% Similarity=0.244 Sum_probs=183.6
Q ss_pred cceeEEEEEEEc--cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREI--KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||.||++... .++..+|+|.++...... ....+.+|+.++++++|+||+++++++.+ ..
T Consensus 6 G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~ 68 (269)
T cd05087 6 GWFGKVILGEVNSGYTPAQVVVKELRVSASVQ-EQMKFLEEAQPYRSLQHSNLLQCLGQCTE----------------VT 68 (269)
T ss_pred cCCceEEEEEEcCCCCceEEEEEecCCCCChH-HHHHHHHHHHHHHhCCCCCEeeEEEEEcC----------------CC
Confidence 899999999864 456789999987654322 23467889999999999999999999876 45
Q ss_pred eEEEEEecCCC-ChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 81 STYMVFEYMDH-DLTGLADRP----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~----~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.+++||||+.+ +|.+++... ...+++..+..++.||+.||+|||+++++||||||+|||++.++++||+|||+++
T Consensus 69 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~ 148 (269)
T cd05087 69 PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSH 148 (269)
T ss_pred CcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccc
Confidence 68999999985 666665432 2245677888999999999999999999999999999999999999999999986
Q ss_pred cccCCCC-CccccccccccCCCchhhcCC------CCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 011627 156 SFSYDHN-NTLTNRVITLWYRPPELLLGA------TKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGS 227 (481)
Q Consensus 156 ~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~------~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 227 (481)
....... .......++..|+|||++.+. ..++.++|||||||++|||++ |+.||...+..+.+.........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL 228 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC
Confidence 5432211 112233557889999998642 135789999999999999996 99999877665544433221100
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 228 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.... + .+...++..+.+||.+|+ .||++|||++||+.
T Consensus 229 ~~~~--------~----------------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 KLPK--------P----------------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCC--------C----------------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0000 0 000124567889999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=292.20 Aligned_cols=243 Identities=27% Similarity=0.428 Sum_probs=193.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC---cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||++++..++..+++|+++... ........+.+|+.++++++|+||+++++++.+ .
T Consensus 11 g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~ 74 (260)
T cd08222 11 GSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE----------------R 74 (260)
T ss_pred CCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc----------------C
Confidence 899999999998888877777765432 222233456689999999999999999999876 5
Q ss_pred CeEEEEEecCCC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
...++||||+.+ +|..++. .....+++.+++.++.||+.||.|||+++++|+||||+||++++ +.+||+|||++.
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~ 153 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSR 153 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCcee
Confidence 578999999986 5555443 23456899999999999999999999999999999999999976 569999999987
Q ss_pred cccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+......++.... ..
T Consensus 154 ~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~------ 223 (260)
T cd08222 154 LLMGSC-DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP--TP------ 223 (260)
T ss_pred ecCCCc-ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC--CC------
Confidence 654221 22223456888999998865 567889999999999999999999998776666555543210 00
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.....++.++.+||.+||..||++||++.|+++||||
T Consensus 224 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 ---------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0012466789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=295.67 Aligned_cols=240 Identities=23% Similarity=0.361 Sum_probs=189.1
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||.||+|++. .++..||||++...... .....+.+|+.++++++|+||+++++++.+
T Consensus 16 g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--------------- 79 (288)
T cd05050 16 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDHPNIVKLLGVCAV--------------- 79 (288)
T ss_pred cccccEEEEEEcccCCCCcceeEEEEecCCCcCH-HHHHHHHHHHHHHHhcCCCchheEEEEEcC---------------
Confidence 789999999975 36789999998754322 223467789999999999999999999876
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRP---------------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 135 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~---------------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp 135 (481)
...+|+||||+.+ +|.+++... ...+++.++..++.||+.||+|||+++++||||||
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 5578999999985 776666432 12478889999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCC
Q 011627 136 SNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKN 213 (481)
Q Consensus 136 ~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~ 213 (481)
+|||++.++.+||+|||++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999875432211 11122234667999999876 568999999999999999997 888998877
Q ss_pred hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 214 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
..+.+..+..... ++ ....++.++.+||.+||+.||++|||+.||++
T Consensus 238 ~~~~~~~~~~~~~------~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNV------LS-----------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCC------CC-----------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7766655532110 00 01135678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=294.50 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=185.6
Q ss_pred cceeEEEEEE----EccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAR----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+++ +..+++.||||++..... .....+.+|+.++++++|+||+++++++...+
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------------- 78 (284)
T cd05081 15 GNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-------------- 78 (284)
T ss_pred CCCceEEEEEecCCcCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC--------------
Confidence 7899999998 456889999999875432 23456789999999999999999999876522
Q ss_pred CCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...+||||||+. ++|.+++.+....+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 446899999997 5787777665556899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcc--ccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNNTL--TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~~~--~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
........ .....+..|+|||++.+ ..++.++|||||||++|||+++..++..... .....+...... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~ 234 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQG--QMIVYH 234 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhccccccc--ccchHH
Confidence 43221111 11123456999999876 5688999999999999999998766543221 111111000000 000000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+.. ... ..........++.++.+||.+||..||++|||+.||++
T Consensus 235 ---~~~--~~~-----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 235 ---LIE--LLK-----NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ---HHH--HHh-----cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 000 00000011346778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.18 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=208.2
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
.|.||+||+++++.+++.+|||+...+.+.+ +.+..|.+||+.+ .|||++.++++|.-... -..+
T Consensus 29 ~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~-----------~~~D 94 (953)
T KOG0587|consen 29 NGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDP-----------GNGD 94 (953)
T ss_pred eccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecC-----------CCCC
Confidence 5899999999999999999999998775443 3667899999998 59999999999886432 2267
Q ss_pred eEEEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 81 STYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
.+|||||||.+ +..+++.. .+.++.|+.|..|++.+|.||.+||.+.++|||||-.|||++.++.|||+|||.+..+.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 89999999986 55555554 25579999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCCccccccccccCCCchhhcCC----CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
.. .....+.+||+.||||||+... ..|+..+|+|||||+..||.-|.+|+...-....+-+| ...|+..
T Consensus 175 sT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPk--- 247 (953)
T KOG0587|consen 175 ST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPK--- 247 (953)
T ss_pred cc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCcc---
Confidence 33 3445567899999999999763 34788999999999999999999999877665544433 2222211
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..-+++++.++.|||..||.+|..+||+..++|+|||++.
T Consensus 248 ---------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 ---------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ---------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 1123468889999999999999999999999999999963
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=301.74 Aligned_cols=241 Identities=25% Similarity=0.387 Sum_probs=188.9
Q ss_pred cceeEEEEEEEccCC-------cEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG-------EIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||.||+|++...+ ..||+|+++..... .....+.+|+.+++++ +|+||+++++++.+
T Consensus 23 G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~------------ 89 (334)
T cd05100 23 GCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ------------ 89 (334)
T ss_pred ccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-HHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc------------
Confidence 789999999875432 36899988754322 2345778999999999 79999999999976
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
.+.+|+||||+.+ +|.+++.+. ...++...+..++.||+.||+|||+++|+||||||+||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 90 ----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 5678999999975 776665432 22478888999999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 216 (481)
||+.++.+||+|||+++.+...... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999765432111 1111233567999999976 578899999999999999998 889998887776
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+..+...... + ....++.++.+||.+||..+|++|||+.|++++
T Consensus 245 ~~~~~~~~~~~------~-----------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 245 LFKLLKEGHRM------D-----------------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHcCCCC------C-----------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66555321100 0 011356689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=288.31 Aligned_cols=236 Identities=21% Similarity=0.364 Sum_probs=188.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++.+. .+..+|+|++..... ....+.+|++++++++|+||+++++++.+ ...
T Consensus 17 g~~~~vy~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----------------~~~ 75 (260)
T cd05073 17 GQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK-----------------EPI 75 (260)
T ss_pred ccceEEEEEEec-CCccEEEEecCCChh---HHHHHHHHHHHHHhcCCCCcceEEEEEcC-----------------CCe
Confidence 789999999864 556799998874321 24567889999999999999999998864 357
Q ss_pred EEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+++.. ....+++..+..++.||+.+|.|||+++++|+||||+||+++.++.+||+|||++..+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999974 78777755 3345788899999999999999999999999999999999999999999999999766432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........++..|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+....+.......
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------- 223 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP----------- 223 (260)
T ss_pred CcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC-----------
Confidence 2222222334677999999876 568889999999999999998 999999887766665553211000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.++|.+||..||++||++.++++
T Consensus 224 ------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 224 ------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ------------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 01235678999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.41 Aligned_cols=239 Identities=25% Similarity=0.398 Sum_probs=201.2
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|+-. .+...||||.++...+. ....+|.||++++..|+|+|||+|++++.+
T Consensus 497 gaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-~~~~dF~REaeLla~l~H~nIVrLlGVC~~--------------- 560 (774)
T KOG1026|consen 497 GAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-QARQDFRREAELLAELQHPNIVRLLGVCRE--------------- 560 (774)
T ss_pred chhhhhhhhhccCCCCCccceehhHhhhcccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEEcc---------------
Confidence 899999999953 34578999999865433 246789999999999999999999999998
Q ss_pred cCCeEEEEEecCC-CChhhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC
Q 011627 78 YRGSTYMVFEYMD-HDLTGLADRPG-------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 143 (481)
Q Consensus 78 ~~~~~~iV~Ey~~-g~L~~~~~~~~-------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~ 143 (481)
++-+|||||||. |||..+++... ..|+..+...|+.||+.|++||-++.+|||||-..|+||.++
T Consensus 561 -~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 561 -GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred -CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 667899999998 68888776421 228889999999999999999999999999999999999999
Q ss_pred CCeEEecccccccccCCCCCc-cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011627 144 GNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 221 (481)
Q Consensus 144 ~~vkL~DFG~a~~~~~~~~~~-~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i 221 (481)
..|||+|||+++.+=..+... .....-..+||+||.++- .+|+.++||||+||||||+++ |+.||.+.+..++++.|
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 999999999998653222222 223344778999999986 789999999999999999998 99999999999999998
Q ss_pred HHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHh
Q 011627 222 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288 (481)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL 288 (481)
.+. .+....+..+.++.+|+..|++.+|++||+++||-
T Consensus 719 ~~g-----------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAG-----------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcC-----------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 642 11223346788999999999999999999999984
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=294.59 Aligned_cols=247 Identities=20% Similarity=0.316 Sum_probs=187.5
Q ss_pred CcceeEEEEEEEcc----------------CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCC
Q 011627 2 LVCISQVFMAREIK----------------TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~----------------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~ 65 (481)
-|+||+||+|++.. +...||||+++.... ......+.+|+.++++++|+||+++++++..
T Consensus 15 ~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--- 90 (296)
T cd05095 15 EGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIRLLAVCIT--- 90 (296)
T ss_pred CCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence 38999999997543 345799999875432 2234567899999999999999999999987
Q ss_pred CCCCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 011627 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPG----------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 134 (481)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~----------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLK 134 (481)
...+|+||||+.+ +|.+++.... ..+++..+..++.||+.||+|||+++|+|+|||
T Consensus 91 -------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 91 -------------SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred -------------CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 5578999999975 7776665422 237788999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEecccccccccCCCCCc-cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh--CCCCCCC
Q 011627 135 GSNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPILPG 211 (481)
Q Consensus 135 p~NILl~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt--G~~pf~~ 211 (481)
|+||||+.++.+||+|||+++.+....... ......+..|++||++.+ ..++.++|||||||++|||++ +..||..
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999997653222111 112233678999998876 568999999999999999998 7788887
Q ss_pred CChHHHHHHHHHhcCCCCC-CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 212 KNEAEQLSKIFELCGSPDE-TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 212 ~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.+..+.+....+....... ..++ ....++..+.+||.+||+.||++|||+.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRDQGRQVYLP-----------------------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhhccccccCC-----------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7666655443221100000 0000 01135568999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.60 Aligned_cols=239 Identities=21% Similarity=0.297 Sum_probs=190.5
Q ss_pred cceeEEEEEEEccCCc----EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|.++.+++ .||+|++..... ......+.+|+.++++++|+||+++++++..
T Consensus 18 g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------------- 80 (279)
T cd05057 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS---------------- 80 (279)
T ss_pred CCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec----------------
Confidence 8999999999887776 589998765532 2234567789999999999999999999864
Q ss_pred CCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...++||||+. ++|.+.+......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 36799999997 4788777766667999999999999999999999999999999999999999999999999999866
Q ss_pred cCCCCCc-cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~~-~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
....... ......+..|+|||.+.. ..++.++|||||||++|||++ |+.||......+....+........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 232 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ------ 232 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC------
Confidence 4222111 111223567999998865 578899999999999999998 9999988877665555532110000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....+..+.++|.+||..||++|||+.++++
T Consensus 233 -----------------------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 233 -----------------------PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -----------------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0124457899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=288.30 Aligned_cols=231 Identities=22% Similarity=0.301 Sum_probs=181.1
Q ss_pred cceeEEEEEEEccCC----------cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG----------EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 72 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg----------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~ 72 (481)
|+||.||++.+..++ ..|++|++...... ...+.+|+.++++++|+||+++++++..
T Consensus 6 G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 72 (259)
T cd05037 6 GTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR---------- 72 (259)
T ss_pred cccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec----------
Confidence 889999999998877 35788877644322 4577899999999999999999998864
Q ss_pred CCCCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-------
Q 011627 73 PDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG------- 144 (481)
Q Consensus 73 ~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~------- 144 (481)
...+|||||+.+ +|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 73 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~ 145 (259)
T cd05037 73 -------DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVP 145 (259)
T ss_pred -------CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCce
Confidence 235899999986 56666555444789999999999999999999999999999999999999887
Q ss_pred CeEEecccccccccCCCCCccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011627 145 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 222 (481)
Q Consensus 145 ~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 222 (481)
.+||+|||++..... .....++..|+|||++... ..++.++|||||||++|+|++ |..||...+..+......
T Consensus 146 ~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~ 220 (259)
T cd05037 146 FIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ 220 (259)
T ss_pred eEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh
Confidence 799999999976532 1223457789999998764 368899999999999999999 577787665333222221
Q ss_pred HhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
. . ..++ . .....+.+||.+||..||++|||+.++++
T Consensus 221 ~-~-----~~~~----~---------------------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 221 D-Q-----HRLP----M---------------------PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred c-C-----CCCC----C---------------------CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 0 0000 0 01157899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=291.42 Aligned_cols=241 Identities=20% Similarity=0.288 Sum_probs=189.1
Q ss_pred cceeEEEEEEEcc----CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIK----TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||.||+|.+.. +++.|++|++.... .......+.+|+.++++|+|+||+++++++...
T Consensus 17 g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--------------- 80 (280)
T cd05043 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIED--------------- 80 (280)
T ss_pred cCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---------------
Confidence 8999999999976 36889999886432 222345677899999999999999999987652
Q ss_pred CCeEEEEEecCC-CChhhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEec
Q 011627 79 RGSTYMVFEYMD-HDLTGLADRPG-------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 150 (481)
Q Consensus 79 ~~~~~iV~Ey~~-g~L~~~~~~~~-------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 150 (481)
....++++||+. ++|.+++.... ..+++..+..++.||+.||+|||+++++|+||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 346789999998 46766654421 3589999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 011627 151 FGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSP 228 (481)
Q Consensus 151 FG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~ 228 (481)
||+++.+...... ......++..|+|||++.+ ..++.++|||||||++|++++ |+.||...+..+....+.... .
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~- 237 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R- 237 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C-
Confidence 9999765322211 1122334677999999876 568999999999999999998 999998877666554443211 0
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+.. ...++.++.++|.+||..||++|||+.++++
T Consensus 238 ----~~~-----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 ----LAQ-----------------------PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ----CCC-----------------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 0124668999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=295.29 Aligned_cols=239 Identities=20% Similarity=0.270 Sum_probs=187.1
Q ss_pred cceeEEEEEEEccCCc----EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||.||++++..+++ .||+|++..... ......+.+|+.++++++|+||+++++++..
T Consensus 18 G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---------------- 80 (303)
T cd05110 18 GAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLS---------------- 80 (303)
T ss_pred CCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcC----------------
Confidence 8999999999988887 468888764432 2223457789999999999999999998864
Q ss_pred CCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...++++||+. ++|.+.+......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 23579999998 5787777665556899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
...... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+ ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~----- 232 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLPQ----- 232 (303)
T ss_pred cCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCC-----
Confidence 432221 1122344678999999876 568899999999999999997 88999876654433332 21100000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....+..+.++|.+||..||++||++.++++
T Consensus 233 -----------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 233 -----------------------PPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred -----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0124557899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.97 Aligned_cols=241 Identities=23% Similarity=0.408 Sum_probs=193.1
Q ss_pred cceeEEEEEEEcc-CCcEEEEEEeecCCc--------CCCcchhHHHHHHHHHh-cCCCCccceeeEEeCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIK-TGEIVALKKIRMDNE--------KEGFPITAIREIKILKK-LQHENVIKLKEIVTSPGPERDEQGR 72 (481)
Q Consensus 3 G~fg~Vy~a~~~~-tg~~vAvK~i~~~~~--------~~~~~~~~~~Ei~il~~-L~hpnIv~l~~~~~~~~~~~~~~~~ 72 (481)
|+||.||++++.. +++.+|||++..... ......++.+|+.++++ ++|+||+++++++.+
T Consensus 11 G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~---------- 80 (269)
T cd08528 11 GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE---------- 80 (269)
T ss_pred CCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc----------
Confidence 7899999999988 789999999864421 12233456778888875 799999999999987
Q ss_pred CCCCCcCCeEEEEEecCCC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCeE
Q 011627 73 PDGNKYRGSTYMVFEYMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLK 147 (481)
Q Consensus 73 ~~~~~~~~~~~iV~Ey~~g-~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~vk 147 (481)
++.+|+||||+.+ +|.+++. .....+++..++.++.||+.+|.|||+ .+++|+||||+|||++.++.+|
T Consensus 81 ------~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~ 154 (269)
T cd08528 81 ------NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT 154 (269)
T ss_pred ------CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEE
Confidence 6689999999986 5655542 344568999999999999999999996 6899999999999999999999
Q ss_pred EecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 011627 148 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 227 (481)
Q Consensus 148 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 227 (481)
|+|||++....... ......++..|++||++.+ ..++.++|||||||++|+|++|+.||...+.......+......
T Consensus 155 l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 155 ITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred Eecccceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 99999997654322 3344567889999999986 56899999999999999999999999887776666555432111
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 228 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
+.. ...++.++.+||.+||..||++||++.|+..+
T Consensus 232 ~~~----------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 232 PLP----------------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCC----------------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 000 01356789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=287.72 Aligned_cols=245 Identities=16% Similarity=0.259 Sum_probs=183.3
Q ss_pred cceeEEEEEEEccCC--cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTG--EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg--~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+++...+. ..+++|.++..... .....+.+|+.+++.++|+||+++++.+.+ ..
T Consensus 6 G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----------------~~ 68 (268)
T cd05086 6 GWFGKVLLSEIYTDTGVARVVVKELKANASS-KEQNEFLQQGDPYRILQHPNILQCLGQCVE----------------AI 68 (268)
T ss_pred CcCceEEEEEEEcCCCcceEEEEEecCCCCh-HHHHHHHHHHHHHhccCCcchhheEEEecC----------------CC
Confidence 889999999864332 35667766544322 234578899999999999999999999986 55
Q ss_pred eEEEEEecCCC-ChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 81 STYMVFEYMDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~---~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.+||||||+.+ +|.+++.+. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 69 PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred ccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccc
Confidence 78999999985 777666542 22467778899999999999999999999999999999999999999999999864
Q ss_pred ccCCC-CCccccccccccCCCchhhcCC------CCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 011627 157 FSYDH-NNTLTNRVITLWYRPPELLLGA------TKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSP 228 (481)
Q Consensus 157 ~~~~~-~~~~~~~~gt~~Y~aPEvl~~~------~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~ 228 (481)
..... .......+++..|+|||++... ..++.++|||||||++|||++ +..||...++.+.+..+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc
Confidence 32111 1122334668899999987531 235788999999999999997 577888877777666654321110
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.+.. .+...+++.+.+||.+|+ .||++||++.+|++
T Consensus 229 ---~~~~---------------------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 ---LFKP---------------------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ---cCCC---------------------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000 001125667899999999 78999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.66 Aligned_cols=240 Identities=21% Similarity=0.370 Sum_probs=201.5
Q ss_pred cceeEEEEEEEccCCc-----EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGE-----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||.||.+.-..... .||||.++...+ +.....+++|..++++++|||||++++++.+
T Consensus 703 G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--------------- 766 (1025)
T KOG1095|consen 703 GAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--------------- 766 (1025)
T ss_pred ccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecC---------------
Confidence 8999999999754433 389998876543 3346789999999999999999999999988
Q ss_pred cCCeEEEEEecCC-CChhhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEec
Q 011627 78 YRGSTYMVFEYMD-HDLTGLADRP------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 150 (481)
Q Consensus 78 ~~~~~~iV~Ey~~-g~L~~~~~~~------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 150 (481)
....+|++|||+ |||+.++.+. ...++...+..|+.||+.|++||+++.+|||||...|+||+....|||+|
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 456799999998 5999999887 55699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCccccc-cccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 011627 151 FGLARSFSYDHNNTLTNR-VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSP 228 (481)
Q Consensus 151 FG~a~~~~~~~~~~~~~~-~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~ 228 (481)
||+|+.+-.......... .-...|||||.+.. ..|+.++|||||||+|||+++ |..||...+..+++....+.....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence 999995543322222222 23578999999986 789999999999999999998 999999999999888766543111
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
. ...+++.+.+||..|++.+|++||++.+|++
T Consensus 925 ~-----------------------------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 P-----------------------------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred C-----------------------------CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 1 1246778999999999999999999999986
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=285.37 Aligned_cols=230 Identities=24% Similarity=0.394 Sum_probs=185.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++. .+++.||||+++... ....+.+|+.++++++|+||+++++++.. +..
T Consensus 17 g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----------------~~~ 73 (254)
T cd05083 17 GEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH-----------------NGL 73 (254)
T ss_pred CCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----------------CCc
Confidence 7899999986 478899999987542 23467899999999999999999999864 236
Q ss_pred EEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 999999985 7777776433 35899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
......+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+....+.... .+.
T Consensus 154 ----~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~---------- 217 (254)
T cd05083 154 ----VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-RME---------- 217 (254)
T ss_pred ----CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-CCC----------
Confidence 122233567999998875 578899999999999999997 999998887766555443210 000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||++||..+|++||++.++++
T Consensus 218 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 218 ------------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ------------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00135678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=299.57 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=186.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC-e
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG-S 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~-~ 81 (481)
|+||.||++.-.. +..||||+++...... ...+.+|+.++.+++|+|||+++++|.+ .+ +
T Consensus 86 Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e----------------~~~~ 146 (361)
T KOG1187|consen 86 GGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLE----------------GGEH 146 (361)
T ss_pred CCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEec----------------CCce
Confidence 8899999998744 4899999877654432 3358999999999999999999999997 44 5
Q ss_pred EEEEEecCC-CChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 82 TYMVFEYMD-HDLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQ---VLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~-g~L~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~g---iiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.+||+|||. |+|.+.+..... .+++....+|+.+++.||+|||... |||||||++|||||.+.+.||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 899999998 588888777665 8999999999999999999999864 99999999999999999999999999965
Q ss_pred ccCCCCCccccc-cccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCC--CCC
Q 011627 157 FSYDHNNTLTNR-VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---EAEQLSKIFELCGS--PDE 230 (481)
Q Consensus 157 ~~~~~~~~~~~~-~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~--~~~ 230 (481)
.... ....... .||..|+|||.+.. ...+.++|||||||+|+||++|+.+.+... +............. ..+
T Consensus 227 ~~~~-~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~e 304 (361)
T KOG1187|consen 227 GPEG-DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLRE 304 (361)
T ss_pred CCcc-ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhh
Confidence 5431 2222222 78999999998875 578999999999999999999998877543 11111111111111 000
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
..-+.... . ... .. ..-..+..+..+|+..++++||++.|+++
T Consensus 305 iiD~~l~~--------~--~~~-~~-----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 305 IVDPRLKE--------G--EYP-DE-----KEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred eeCCCccC--------C--CCC-hH-----HHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00000000 0 000 00 11123778999999999999999999764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.81 Aligned_cols=241 Identities=20% Similarity=0.297 Sum_probs=199.7
Q ss_pred cceeEEEEEEEccCCc---E-EEEEEeecC-CcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGE---I-VALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~---~-vAvK~i~~~-~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+++-+..+. . ||||..+.. ...++....+++|.+++++|+|+|||+||++...
T Consensus 168 GaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--------------- 232 (474)
T KOG0194|consen 168 GAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--------------- 232 (474)
T ss_pred ccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC---------------
Confidence 8999999999876533 3 899998863 3445567788999999999999999999999987
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
+.-+|||||+|.| +|.+++.+....++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++.
T Consensus 233 -~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 233 -EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred -CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 5678999999986 88888888777799999999999999999999999999999999999999999899999999876
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.... ............|+|||.+.. ..|+.++||||+||++||+++ |..||.+.+..++..+|.........
T Consensus 312 ~~~~-~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~----- 384 (474)
T KOG0194|consen 312 GSQY-VMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI----- 384 (474)
T ss_pred Ccce-eeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC-----
Confidence 4311 111111134678999999986 589999999999999999998 88999999999999998542211111
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....+.++..++.+|+..||++|+|+.++.+
T Consensus 385 -----------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 385 -----------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -----------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 0134567889999999999999999999864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=288.71 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=188.6
Q ss_pred cceeEEEEEEEc----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREI----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||.||+++.. .+++.||||+++..... .....+.+|++++++++|+||+++++++...+
T Consensus 15 g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~-------------- 79 (284)
T cd05038 15 GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG-------------- 79 (284)
T ss_pred CCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC--------------
Confidence 789999999964 45889999999865433 23557889999999999999999999887632
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
....++||||+.+ +|.+++......+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 4578999999975 777777665556999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCc--cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHH-----------HHHHHHh
Q 011627 158 SYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-----------LSKIFEL 224 (481)
Q Consensus 158 ~~~~~~~--~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-----------~~~i~~~ 224 (481)
....... ......+..|++||.+.. ..++.++|||||||++|||++|..||........ ...+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 5221111 112234567999998876 5788999999999999999999988765322110 1111111
Q ss_pred cCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 225 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...... ......++.++.+||.+||..||++|||+.||++
T Consensus 239 ~~~~~~-------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 239 LKEGER-------------------------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHcCCc-------------------------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000000 0001235578999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.45 Aligned_cols=268 Identities=22% Similarity=0.280 Sum_probs=175.7
Q ss_pred cceeEEEEEEEccC----CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKT----GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~t----g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+ ++.||||++......+ .... +.++...+.+++.++..+..... ...
T Consensus 143 G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~--e~l~~~~~~~~~~~~~~~~~~~~----------~~~ 206 (566)
T PLN03225 143 GAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMN--ERVRRACPNSCADFVYGFLEPVS----------SKK 206 (566)
T ss_pred CCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHH--HHHHhhchhhHHHHHHhhhcccc----------ccc
Confidence 89999999999999 9999999876432111 1111 12222233444444443332110 122
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLR-------------------FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~-------------------l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
...++|||||+.+ +|.+++...... .....+..++.||+.||+|||+++|+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 5678999999986 566655433211 12345778999999999999999999999999999
Q ss_pred EEcC-CCCeEEecccccccccCCCCCccccccccccCCCchhhcCCC---------------------CCCCCCchhhHH
Q 011627 139 LIDN-EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT---------------------KYGPAVDMWSVG 196 (481)
Q Consensus 139 Ll~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~---------------------~~~~~~DiwSlG 196 (481)
||+. ++.+||+|||+|+.+...........++|+.|+|||++.... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9986 578999999999876544444445567899999999764321 234567999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhccc
Q 011627 197 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLML 276 (481)
Q Consensus 197 vil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 276 (481)
||||||+++.. ...+....+.+++..+... ...|..... .. .........+++...+.++.|||.+||.+
T Consensus 367 viL~el~~~~~--~~~~~~~~~~~~l~~~~~~-~~~~~~~~~------~~-~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 367 LIFLQMAFPNL--RSDSNLIQFNRQLKRNDYD-LVAWRKLVE------PR-ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHhCcC--CCchHHHHHHHHHHhcCCc-HHHHHHhhc------cc-cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999998654 4444444555554433221 111111100 00 00000111122333455677999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 011627 277 DPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 277 dP~~R~sa~eiL~h~~f~~~ 296 (481)
||++|||++++|+||||...
T Consensus 437 dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred CcccCCCHHHHhCCcCcCCC
Confidence 99999999999999999754
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=287.60 Aligned_cols=247 Identities=19% Similarity=0.250 Sum_probs=189.5
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|.+. .+++.||||++............+.+|++++++++|+||+++++++...... ...
T Consensus 10 g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~----------~~~ 79 (273)
T cd05074 10 GEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK----------GRL 79 (273)
T ss_pred CCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCC----------Ccc
Confidence 789999999865 3678999999976544443455678999999999999999999988753211 012
Q ss_pred CeEEEEEecCCC-ChhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~-----~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
...++++||+.+ +|..++.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 245788999974 66554432 123478999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 011627 154 ARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDET 231 (481)
Q Consensus 154 a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (481)
++....... ........+..|++||.+.. ..++.++|||||||++|+|++ |+.||...+..+....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--- 235 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK--- 235 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC---
Confidence 986532211 11122234678999999876 567899999999999999999 899998877766555543211000
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+ ...++..+.+|+.+||..+|++|||+.++++
T Consensus 236 -~-------------------------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 236 -Q-------------------------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred -C-------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0125668999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=278.60 Aligned_cols=242 Identities=40% Similarity=0.672 Sum_probs=197.3
Q ss_pred ceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEE
Q 011627 4 CISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 83 (481)
Q Consensus 4 ~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (481)
+||.||++++..+++.||+|++........ ...+.+|++++++++|+||+++++++.. ....+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------------~~~~~ 63 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED----------------EDKLY 63 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee----------------CCEEE
Confidence 589999999999999999999986544321 4578899999999999999999999876 56889
Q ss_pred EEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 84 MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 84 iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
+++||+.+ +|..++.... .++...+..++.+|+.+|.+||+.+|+|+||+|+||++++++.++|+|||++.......
T Consensus 64 l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~- 141 (244)
T smart00220 64 LVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG- 141 (244)
T ss_pred EEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence 99999997 7777665543 38999999999999999999999999999999999999999999999999998764321
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
......++..|++||.+.. ..++.++||||||+++++|++|..||.. .+....+..+.........
T Consensus 142 -~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 208 (244)
T smart00220 142 -LLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP----------- 208 (244)
T ss_pred -ccccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-----------
Confidence 3334566889999999875 5678899999999999999999999987 4443333333221111000
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
....++.++.++|.+||..||++||++.++++|+||
T Consensus 209 ----------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 209 ----------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ----------------ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 000156689999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=310.08 Aligned_cols=197 Identities=29% Similarity=0.417 Sum_probs=166.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||.||++++++||+.||||.++..... ...+...+|+++||+|+|+|||+++++-++... ..-...-
T Consensus 24 Ga~g~V~rgrnketG~~vAvK~~~~~~~~-r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~----------~~~~~~~ 92 (732)
T KOG4250|consen 24 GAFGNVYRGRNKETGRLVAVKTFNKESSL-RPRERWCREIEILKKLNHPNIVKLFDIEETKFL----------GLVTRLP 92 (732)
T ss_pred CccceeeeecccccccchhHHhhhhhccc-chHHHHHHHHHHHHHcCchhhhhhcccCCcccc----------Ccccccc
Confidence 89999999999999999999999876433 235567799999999999999999988655221 1114456
Q ss_pred EEEEecCCC-ChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc--CCC--CeEEecccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID--NEG--NLKLADFGLAR 155 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~--~~~--~vkL~DFG~a~ 155 (481)
.+|||||.+ +|...+.++. ..|++.++..++..|..||.|||++||+||||||.||++- .+| ..||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 899999985 7777777643 4599999999999999999999999999999999999984 234 37999999999
Q ss_pred cccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCC
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK 212 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 212 (481)
.+. .+..+++.+||..|.+||++.....|+..+|.|||||++|+++||..||...
T Consensus 173 el~--d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 173 ELD--DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cCC--CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 875 4457888999999999999985578999999999999999999999999643
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=287.06 Aligned_cols=249 Identities=17% Similarity=0.157 Sum_probs=179.9
Q ss_pred cceeEEEEEEEccC---CcEEEEEEeecCCcCCCc---------chhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCC
Q 011627 3 VCISQVFMAREIKT---GEIVALKKIRMDNEKEGF---------PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 70 (481)
Q Consensus 3 G~fg~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~---------~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~ 70 (481)
|+||+||+|++..+ ++.+|+|+.......... ......++..++.+.|+||++++++......
T Consensus 23 G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~----- 97 (294)
T PHA02882 23 GGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRC----- 97 (294)
T ss_pred CCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecC-----
Confidence 89999999999888 778888876544321100 0112233445566789999999987654210
Q ss_pred CCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEec
Q 011627 71 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 150 (481)
Q Consensus 71 ~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 150 (481)
.....++++|++..++...+... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 98 -------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 98 -------RMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred -------CceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 02245789998877776655443 2467888999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCC------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH-
Q 011627 151 FGLARSFSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE- 223 (481)
Q Consensus 151 FG~a~~~~~~~~------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~- 223 (481)
||+|+.+..... .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+....+.....
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999987642211 11223468999999999886 6789999999999999999999999987743222211111
Q ss_pred -hcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 224 -LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...... .........+.++.+++..|+..||++||+..+|++
T Consensus 249 ~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 DFIKRLH------------------------EGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHhh------------------------hhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000000 000011245678999999999999999999999975
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=278.65 Aligned_cols=244 Identities=23% Similarity=0.386 Sum_probs=199.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC-CcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+|.+|.++++++|.+.||+|+++++...+ +....+..|..++..- +||.+|-++.+|+. ..
T Consensus 261 gsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt----------------es 324 (593)
T KOG0695|consen 261 GSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT----------------ES 324 (593)
T ss_pred cchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc----------------cc
Confidence 889999999999999999999998773222 2344566788888877 79999999999988 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+++|.||+.| +|...+.+. .+|+++.++.+...|+.||.|||++|||.||||.+|||||.+|++||.|+|+++.--.
T Consensus 325 rlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred eEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 89999999986 666555544 4699999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCC-------CChHHH-HHHHHHhcCCCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-------KNEAEQ-LSKIFELCGSPDET 231 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~-------~~~~~~-~~~i~~~~~~~~~~ 231 (481)
. .....++|||+.|+|||++.+ ..|+.++|.|+|||+++||+.|+.||+- .+.++. +..|++.
T Consensus 404 ~-gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek------- 474 (593)
T KOG0695|consen 404 P-GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK------- 474 (593)
T ss_pred C-CcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-------
Confidence 3 344556899999999999998 6899999999999999999999999962 122222 3333221
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC------CHHHHhcCCCCCC
Q 011627 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI------SAKDALDSEYFWT 295 (481)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~------sa~eiL~h~~f~~ 295 (481)
...+.+.++-.+..+|+..|++||.+|. ...|+..|+||+.
T Consensus 475 -----------------------qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 475 -----------------------QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred -----------------------cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 1112234566778899999999999996 5689999999963
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.01 Aligned_cols=267 Identities=23% Similarity=0.324 Sum_probs=177.7
Q ss_pred cceeEEEEEEEc----------------cCCcEEEEEEeecCCcC------------CCcchhHHHHHHHHHhcCCCCc-
Q 011627 3 VCISQVFMAREI----------------KTGEIVALKKIRMDNEK------------EGFPITAIREIKILKKLQHENV- 53 (481)
Q Consensus 3 G~fg~Vy~a~~~----------------~tg~~vAvK~i~~~~~~------------~~~~~~~~~Ei~il~~L~hpnI- 53 (481)
|+||+||++.+. ..++.||||+++..... ....+..+.|+.++.+++|.++
T Consensus 156 GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~ 235 (507)
T PLN03224 156 GNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIA 235 (507)
T ss_pred CCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccch
Confidence 899999999753 34568999998754321 0112234457888888877654
Q ss_pred ----cceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCC-----------------------CCCC
Q 011627 54 ----IKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPG-----------------------LRFT 105 (481)
Q Consensus 54 ----v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~-----------------------~~l~ 105 (481)
++++++|..... ++...++..+|||||+.+ +|.+++.... ..++
T Consensus 236 ~~~~~~~lg~~~~~~~--------~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~ 307 (507)
T PLN03224 236 AASCAEYLGYFTSNTA--------DGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD 307 (507)
T ss_pred hhhhhhhhhhcccccc--------cccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence 667777654211 122225678999999985 6655554211 1245
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCCCccccccccccCCCchhhcCCCC
Q 011627 106 VPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185 (481)
Q Consensus 106 ~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~ 185 (481)
+..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||+++.+.............|+.|+|||++.....
T Consensus 308 ~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~ 387 (507)
T PLN03224 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQS 387 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCC
Confidence 67889999999999999999999999999999999999999999999997654322222222234789999998864211
Q ss_pred -------------------CC--CCCchhhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 011627 186 -------------------YG--PAVDMWSVGCIFAELLNGKP-ILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243 (481)
Q Consensus 186 -------------------~~--~~~DiwSlGvil~elltG~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 243 (481)
++ .+.||||+|||+|+|+++.. +|..........+.. ......|.......
T Consensus 388 ~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~----~~~~~~~r~~~~~~--- 460 (507)
T PLN03224 388 CPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY----DNDLNRWRMYKGQK--- 460 (507)
T ss_pred CCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc----cchHHHHHhhcccC---
Confidence 11 24799999999999999874 665322111110000 00001111110000
Q ss_pred cCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCC---CCCCCHHHHhcCCCCC
Q 011627 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP---SQRISAKDALDSEYFW 294 (481)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP---~~R~sa~eiL~h~~f~ 294 (481)
..-..+..++++++|||++||..++ .+|+|++|+|+||||.
T Consensus 461 ----------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 461 ----------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred ----------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 0001234578899999999999876 6899999999999994
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=285.02 Aligned_cols=246 Identities=22% Similarity=0.288 Sum_probs=198.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|-||+|.+|.- ....+||||+++.+..+. ....+.+||++|.+|+|||||+++++|.. ++.+
T Consensus 549 GqFGEVhLCev-eg~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqLkhPNIveLvGVC~~----------------DePi 610 (807)
T KOG1094|consen 549 GQFGEVHLCEV-EGPLKVAVKILRPDATKN-ARNDFLKEIKILSRLKHPNIVELLGVCVQ----------------DDPL 610 (807)
T ss_pred cccceeEEEEe-cCceEEEEeecCcccchh-HHHHHHHHHHHHhccCCCCeeEEEeeeec----------------CCch
Confidence 78999999986 336899999998765443 35688999999999999999999999988 6789
Q ss_pred EEEEecCC-CChhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMD-HDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~-g~L~~~~~~~~~~-l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||+||++ |||..++.+.... +......+|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+-..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999998 6888877765333 355566779999999999999999999999999999999999999999999854322
Q ss_pred CC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh--CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 161 HN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 161 ~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt--G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
.. ......+-...|||+|.++- .+++.++|+|+||+++||+++ ...||...++++..+..-++..........
T Consensus 691 ~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l--- 766 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL--- 766 (807)
T ss_pred CceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec---
Confidence 22 22222344788999999886 689999999999999999864 778999988888887776655443322211
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....-++..+.+||.+|+..|-++|||.+++..
T Consensus 767 -------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 767 -------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 112246778999999999999999999999854
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=278.88 Aligned_cols=270 Identities=31% Similarity=0.488 Sum_probs=201.4
Q ss_pred CcceeEEEEEEEcc---CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIK---TGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
.|+|++||++.+.. ..+.||+|.|..... ...+.+|+++|..+ -+.||+++.+++..
T Consensus 46 eGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn--------------- 106 (418)
T KOG1167|consen 46 EGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN--------------- 106 (418)
T ss_pred ccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc---------------
Confidence 48999999999988 889999999986654 34788999999999 59999999998876
Q ss_pred cCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCeEEeccccccc
Q 011627 78 YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARS 156 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~ 156 (481)
++.+++||||++++-...+.. .++..+++.+++.++.||.++|.+|||||||||.|||.+.. +.-.|+|||+|..
T Consensus 107 -nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 107 -NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred -CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 779999999999865554443 37789999999999999999999999999999999999864 5689999999972
Q ss_pred ccCC-------C------------------------------------CCccccccccccCCCchhhcCCCCCCCCCchh
Q 011627 157 FSYD-------H------------------------------------NNTLTNRVITLWYRPPELLLGATKYGPAVDMW 193 (481)
Q Consensus 157 ~~~~-------~------------------------------------~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~Diw 193 (481)
.... . .....++.||+.|+||||+.....-+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 1100 0 00112357799999999999877788999999
Q ss_pred hHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCC--------CCCC--CCccCC--CCCc----cccCC-----Cchhh
Q 011627 194 SVGCIFAELLNGKPILP-GKNEAEQLSKIFELCGS--------PDET--IWPGVS--KMPA----YNHFK-----PSRTM 251 (481)
Q Consensus 194 SlGvil~elltG~~pf~-~~~~~~~~~~i~~~~~~--------~~~~--~~~~~~--~~~~----~~~~~-----~~~~~ 251 (481)
|.|||++.+++++.||- ..++.+.+..|..+.+. .... .|.... .+++ +.... ..+..
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999987764 45555555555433332 1111 333111 1111 11111 00000
Q ss_pred hhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 252 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 252 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
........+.++..+.|||.+||..||.+|+||+|+|+|+||.
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 0112222345667899999999999999999999999999995
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=301.78 Aligned_cols=241 Identities=28% Similarity=0.395 Sum_probs=184.7
Q ss_pred cceeE-EEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQ-VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~-Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+-|+ ||++.. .++.||||.+-.+ +...+.+||..|+.- +|+|||++|..-.+ ..
T Consensus 520 Gs~Gt~Vf~G~y--e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d----------------~q 576 (903)
T KOG1027|consen 520 GSNGTVVFRGVY--EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQD----------------RQ 576 (903)
T ss_pred CCCCcEEEEEee--CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccC----------------Cc
Confidence 45555 898887 7889999987533 344678999999999 59999999977655 77
Q ss_pred eEEEEEecCCCChhhhhcCC--CCCCCH-HHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---C--CCeEEeccc
Q 011627 81 STYMVFEYMDHDLTGLADRP--GLRFTV-PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---E--GNLKLADFG 152 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~--~~~l~~-~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~---~--~~vkL~DFG 152 (481)
++||++|+|.++|.+++... ...+.. -..+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||
T Consensus 577 F~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg 656 (903)
T KOG1027|consen 577 FLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG 656 (903)
T ss_pred eEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence 99999999999999988874 111111 345788999999999999999999999999999976 3 368999999
Q ss_pred ccccccCCCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCC
Q 011627 153 LARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPD 229 (481)
Q Consensus 153 ~a~~~~~~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~~~~~ 229 (481)
+++.+..... ....+..||-.|+|||++... .-+.++||||||||+|+.++| ..||...-+.+ ..|.......
T Consensus 657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L- 732 (903)
T KOG1027|consen 657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTL- 732 (903)
T ss_pred cccccCCCcchhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccce-
Confidence 9998765433 234455779999999999874 446799999999999999985 89997653322 2222110000
Q ss_pred CCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 230 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.. +...-+.+++|||.+||..||..||+|.++|.||+||..
T Consensus 733 -------------~~-------------L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 733 -------------VH-------------LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred -------------ee-------------eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 00 000111279999999999999999999999999999964
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=286.09 Aligned_cols=240 Identities=22% Similarity=0.311 Sum_probs=199.6
Q ss_pred cceeEEEEEEEccC-Cc--EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKT-GE--IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~t-g~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||.|+++.++.. |+ .||||+++.+.... ....+++|+.+|.+|+|+|+|++|+++.+
T Consensus 121 GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~----------------- 182 (1039)
T KOG0199|consen 121 GSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD----------------- 182 (1039)
T ss_pred cceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-----------------
Confidence 89999999998654 33 48999998775543 56789999999999999999999999985
Q ss_pred CeEEEEEecCC-CChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 80 GSTYMVFEYMD-HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 80 ~~~~iV~Ey~~-g~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
..+.||||++. |+|++.+.+ ....|-...+..|+.||+.|+.||.++++|||||-..||||-....|||+|||+.+.+
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 25689999998 578887776 4446888999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 158 SYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 158 ~~~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
...... ..........|+|||.|.- ..|+.++|||++||+||||++ |+.||.+.+...++++|-+....
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL------- 334 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL------- 334 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC-------
Confidence 643222 1122334678999999975 789999999999999999998 88999999999998888422111
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.-.+.++.++.+++..|+..+|++|||+.+|.+.
T Consensus 335 ----------------------pRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 335 ----------------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ----------------------CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1123578889999999999999999999998643
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=282.88 Aligned_cols=240 Identities=22% Similarity=0.338 Sum_probs=199.4
Q ss_pred CcceeEEEEEEEccC--Cc--EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKT--GE--IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~t--g~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
.|.||.||++....- |+ .||||.-+.+...+ ..+.++.|..+++.++|||||++++++.+
T Consensus 399 ~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~~e--------------- 462 (974)
T KOG4257|consen 399 EGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVCVE--------------- 462 (974)
T ss_pred CCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeeeec---------------
Confidence 488999999986432 33 48888877654443 47789999999999999999999999985
Q ss_pred cCCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 78 YRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 78 ~~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.-.|||||++. |.|..++..+...|+......|+.||+.+|.|||+..+|||||-..|||+....-|||+|||+++.
T Consensus 463 --~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 463 --QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred --cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 36799999998 678888888888899999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
+..+.....+...-...|||||.+.- ..++.++|||-|||++||++. |..||.+-...+++-.|.+....+
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------- 612 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------- 612 (974)
T ss_pred ccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC-------
Confidence 87554433333333667999998865 679999999999999999886 999999888777766664322211
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
..+++++.+..|+.+|+..||.+||++.+|..
T Consensus 613 ----------------------~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 613 ----------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ----------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 12357888999999999999999999998864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=294.63 Aligned_cols=240 Identities=22% Similarity=0.329 Sum_probs=209.7
Q ss_pred cceeEEEEEEEccCC---cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTG---EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|-||+|++++-+..+ ..||||.++..... ....+|+.|..||-+++|||||+|.+++.. .
T Consensus 640 GEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte-kqrrdFL~EAsIMGQFdHPNIIrLEGVVTk----------------s 702 (996)
T KOG0196|consen 640 GEFGEVCSGRLKLPGKREITVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIRLEGVVTK----------------S 702 (996)
T ss_pred ccccceecccccCCCCcceeEEEeeeccCccH-HHHhhhhhhhhhcccCCCCcEEEEEEEEec----------------C
Confidence 779999999988766 46999999866433 356689999999999999999999999987 5
Q ss_pred CeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
.-+.||+|||+ |.|..+++.+++.|+.-++.-+++.|+.|++||-++++|||||...||||+.+-.+||+|||+++.+.
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 67899999998 57888888888999999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCccccccc--cccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 159 YDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 159 ~~~~~~~~~~~g--t~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
++.....++.-| ...|.|||++.- .+++.++||||+|||+||.++ |..||-..++.+++..|.+....|+..
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm---- 857 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM---- 857 (996)
T ss_pred cCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC----
Confidence 655444444333 678999999975 789999999999999999886 999999999999999998766555442
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+++..+..|+..|+++|-.+||.+.+|+.
T Consensus 858 -------------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 858 -------------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred -------------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 36678999999999999999999999975
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=279.56 Aligned_cols=237 Identities=20% Similarity=0.286 Sum_probs=197.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.||.||.+.+++-.-.||||.++.+ ...+..+++|..+++.++|||+|+++++|.. .--+
T Consensus 278 GQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~----------------EpPF 338 (1157)
T KOG4278|consen 278 GQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH----------------EPPF 338 (1157)
T ss_pred Ccccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhcc----------------CCCe
Confidence 67999999999999999999998744 3346789999999999999999999999987 5568
Q ss_pred EEEEecCC-CChhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMD-HDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~-g~L~~~~~~~~~~-l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||+|||- |+|++++.+.+.. ++.-.+..++.||..|++||..+++|||||-..|+|+.++-.|||+|||+++.+..+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999997 7999999886654 566667788899999999999999999999999999999999999999999988755
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........-...|.|||-|.- +.++.++|||+|||+|||+.| |-.||++-+-..++..+.+.. ..+
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-RM~---------- 486 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-RMD---------- 486 (1157)
T ss_pred ceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-ccc----------
Confidence 4443333344678999998864 678999999999999999988 889999987665554443211 000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHh
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL 288 (481)
-...+++.+.+|++.|++.+|.+||++.||-
T Consensus 487 ------------------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 487 ------------------GPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred ------------------CCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 1125778899999999999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=249.43 Aligned_cols=203 Identities=22% Similarity=0.326 Sum_probs=170.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||.|-+.++..+|...|+|.++...... ...+.++|+.+..+. .+|++|+||+.... .+.
T Consensus 57 GayG~vekmrh~~sg~imAvKri~~tvn~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~r----------------egd 119 (282)
T KOG0984|consen 57 GAYGVVEKMRHIQSGTIMAVKRIRATVNSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFR----------------EGD 119 (282)
T ss_pred CccchhhheeeccCCeEEEEeeehhhcChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhc----------------ccc
Confidence 789999999999999999999998764432 356777898887666 69999999998766 678
Q ss_pred EEEEEecCCCChhhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDHDLTGLA---DRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~---~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
++|.||.|+-+|..+. ...+..++|..+-+|+..++.||.|||++ .|||||+||+||||+.+|+|||||||++-.+
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999999998765544 35677899999999999999999999987 9999999999999999999999999999766
Q ss_pred cCCCCCccccccccccCCCchhhcCC---CCCCCCCchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHh
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFEL 224 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~---~~~~~~~DiwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~ 224 (481)
.+... .+...|.-.|||||.+... ..|+.++||||||+++.||.+++.||+. .++.+++.++++.
T Consensus 200 ~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 200 VDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 43322 2223566789999988542 3589999999999999999999999974 6788888888764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=284.39 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=202.8
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
.|+||.||+|||+.+++..|+|++++.-.. ...-+..||-+++..+|+|||.+++.+.. ...
T Consensus 25 sgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr----------------~dk 86 (829)
T KOG0576|consen 25 SGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLR----------------RDK 86 (829)
T ss_pred CCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhh----------------hcC
Confidence 389999999999999999999999987433 24456789999999999999999998876 668
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
++|+||||+++.+..+..--+.+++.+|..+++..+.+|+|||+.|-+|||||-.|||+++.+.+||+|||.+-.+...
T Consensus 87 lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh-
Confidence 9999999998766666666678999999999999999999999999999999999999999999999999998766532
Q ss_pred CCccccccccccCCCchhhc--CCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~--~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.....+++||+.||||||.. ....|...+|||++|+...|+-.-.+|....-....+..+..-...++..
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l-------- 237 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL-------- 237 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc--------
Confidence 33455689999999999853 23468999999999999999988777765554444443332211111100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+-..++++.+.+|++.+|.++|++|||++.+|.|+|...
T Consensus 238 -----------------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 238 -----------------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred -----------------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 001135667899999999999999999999999999843
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=277.89 Aligned_cols=189 Identities=28% Similarity=0.365 Sum_probs=165.9
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCC------CcchhHHHHHHHHHhcC---CCCccceeeEEeCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKE------GFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGR 72 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~------~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~~~~~~ 72 (481)
-|+||+|++|.+++....|+||.|.+++--. ...-++-.||.||..|+ |+||++++++|++
T Consensus 571 ~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd---------- 640 (772)
T KOG1152|consen 571 EGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED---------- 640 (772)
T ss_pred ccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec----------
Confidence 3899999999999999999999998664221 12234447999999998 9999999999998
Q ss_pred CCCCCcCCeEEEEEecCCC--ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEec
Q 011627 73 PDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 150 (481)
Q Consensus 73 ~~~~~~~~~~~iV~Ey~~g--~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 150 (481)
++++||+||--.. ||++++... ..++|.+++.|++|++.|+++||+.||||||||-|||+++.+|.+||+|
T Consensus 641 ------dd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 ------DDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred ------CCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 7799999998874 777776654 4699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCC
Q 011627 151 FGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP 210 (481)
Q Consensus 151 FG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~ 210 (481)
||.|... .+..+..++||..|.|||++.+..+.+..-|||+|||+||.++....||.
T Consensus 714 fgsaa~~---ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYT---KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhh---cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998654 46778888999999999999997778899999999999999999888874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=301.96 Aligned_cols=241 Identities=21% Similarity=0.305 Sum_probs=176.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++.... ...+|++++++++|||||++++++.+ ....
T Consensus 701 G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~----------------~~~~ 758 (968)
T PLN00113 701 GKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRS----------------EKGA 758 (968)
T ss_pred CCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEc----------------CCCC
Confidence 8899999999999999999999864322 22367999999999999999999987 4567
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH---VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH---~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
||||||+.+ +|.+++. .+++.++..|+.||+.||+||| +.+|+||||||+||+++.++..++. |+.+....
T Consensus 759 ~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 999999985 6666664 3788999999999999999999 6699999999999999998887776 66554322
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcC-CCCCCCCccC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA-EQLSKIFELCG-SPDETIWPGV 236 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~-~~~~~~~~~~ 236 (481)
. .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+........ ......|-.
T Consensus 834 ~-----~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 906 (968)
T PLN00113 834 T-----DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID- 906 (968)
T ss_pred c-----CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC-
Confidence 1 122366899999999876 67899999999999999999999998543211 11111111100 000000000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
+. .... .........++.+++.+||..||++|||+.|+++.
T Consensus 907 ---~~---~~~~-------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 907 ---PS---IRGD-------VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ---cc---ccCC-------CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00 0000 00001123467899999999999999999999863
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=278.10 Aligned_cols=241 Identities=24% Similarity=0.368 Sum_probs=193.9
Q ss_pred CcceeEEEEEEEc----c---CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREI----K---TGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRP 73 (481)
Q Consensus 2 ~G~fg~Vy~a~~~----~---tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~ 73 (481)
.|+||+|+++.-. . ....||||.++..... .....+..|+++|+.+ .|+||+.+++.+..
T Consensus 306 ~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~----------- 373 (609)
T KOG0200|consen 306 EGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ----------- 373 (609)
T ss_pred cccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-----------
Confidence 4899999999843 1 1457999998866555 4567889999999999 69999999999987
Q ss_pred CCCCcCCeEEEEEecCC-CChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 011627 74 DGNKYRGSTYMVFEYMD-HDLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 137 (481)
Q Consensus 74 ~~~~~~~~~~iV~Ey~~-g~L~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~N 137 (481)
.+.+++|+||+. |+|+.++.... ..++...+..++.||+.|++||++..+|||||-..|
T Consensus 374 -----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 374 -----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred -----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 668899999998 68888887665 348899999999999999999999999999999999
Q ss_pred EEEcCCCCeEEecccccccccCCCCCccccccc--cccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCC-
Q 011627 138 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKN- 213 (481)
Q Consensus 138 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g--t~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~- 213 (481)
|||..+..+||+|||+|+..............+ ...|||||.+.. ..|+.++||||+||+||||++ |..||++-.
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999998654333322222222 345999999987 789999999999999999998 889998855
Q ss_pred hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 214 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
..+.++.+.+.... ....++++++.++++.|+..+|++||+..++.+
T Consensus 528 ~~~l~~~l~~G~r~-----------------------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 528 TEELLEFLKEGNRM-----------------------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 44444433221110 011246788999999999999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=233.91 Aligned_cols=211 Identities=38% Similarity=0.607 Sum_probs=179.5
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|.+|+||++++..+++.++||++....... ....+.+|+.+++.++|++|+++++++.. ...
T Consensus 3 ~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------------~~~ 65 (215)
T cd00180 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED----------------ENH 65 (215)
T ss_pred cCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec----------------CCe
Confidence 3889999999998889999999998654321 23578899999999999999999999987 468
Q ss_pred EEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCeEEecccccccccC
Q 011627 82 TYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~ 159 (481)
.+++||++. .+|..++......++...++.++.+++.+|++||+.+++|+||+|.||+++. ++.++|+||+.+.....
T Consensus 66 ~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~ 145 (215)
T cd00180 66 LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145 (215)
T ss_pred EEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence 899999999 5777776654346899999999999999999999999999999999999999 89999999999976643
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
... ..........|++||.+.....++.++|+|+||+++++|
T Consensus 146 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------- 187 (215)
T cd00180 146 DKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------- 187 (215)
T ss_pred Ccc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------
Confidence 221 123345688899999987633678999999999999999
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~ 291 (481)
.++.++|.+||..||++|+++.++++++
T Consensus 188 ------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1578999999999999999999999873
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=257.56 Aligned_cols=186 Identities=22% Similarity=0.280 Sum_probs=151.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc--CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL--QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L--~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|.||.||+|+- +++.||||++.... ...+.+|.+|++.. +|+||++|+..-+... ....
T Consensus 221 Grfg~V~KaqL--~~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t------------~~~~ 281 (534)
T KOG3653|consen 221 GRFGCVWKAQL--DNRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGT------------ADRM 281 (534)
T ss_pred Cccceeehhhc--cCceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCC------------cccc
Confidence 89999999986 67999999998653 23566777777655 7999999998755421 1155
Q ss_pred eEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCcEEEcCCCCeEEec
Q 011627 81 STYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN---------QVLHRDIKGSNLLIDNEGNLKLAD 150 (481)
Q Consensus 81 ~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~---------giiHrDLKp~NILl~~~~~vkL~D 150 (481)
.++||+||.. |+|.+++... .++..+..+++..++.||+|||+. .|+|||||..||||.++.++.|+|
T Consensus 282 eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 7899999998 6888887764 589999999999999999999963 599999999999999999999999
Q ss_pred ccccccccCCC-CCccccccccccCCCchhhcCCCCCC-----CCCchhhHHHHHHHHHhCCCCC
Q 011627 151 FGLARSFSYDH-NNTLTNRVITLWYRPPELLLGATKYG-----PAVDMWSVGCIFAELLNGKPIL 209 (481)
Q Consensus 151 FG~a~~~~~~~-~~~~~~~~gt~~Y~aPEvl~~~~~~~-----~~~DiwSlGvil~elltG~~pf 209 (481)
||+|..+.... .......+||.+|||||+|.+...+. .++||||+|.|||||++....+
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99998876432 23334478999999999998865554 3689999999999999876544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=291.52 Aligned_cols=210 Identities=18% Similarity=0.170 Sum_probs=151.9
Q ss_pred HHhcCC-CCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 011627 45 LKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123 (481)
Q Consensus 45 l~~L~h-pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~L 123 (481)
++.++| .||+++++.|...... ......++++||+++.+|.+++......+++.+++.|++||+.||+||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l 96 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLD---------GLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAA 96 (793)
T ss_pred cchhhHHHHHHHhhcccCCcccc---------ccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHH
Confidence 345666 6888999988553211 112456889999999999999877666799999999999999999999
Q ss_pred HhCCcccCCCCCCcEEEcCC-------------------CCeEEecccccccccCCCC---------------Ccccccc
Q 011627 124 HVNQVLHRDIKGSNLLIDNE-------------------GNLKLADFGLARSFSYDHN---------------NTLTNRV 169 (481)
Q Consensus 124 H~~giiHrDLKp~NILl~~~-------------------~~vkL~DFG~a~~~~~~~~---------------~~~~~~~ 169 (481)
|++||+||||||+||||+.. +.+||+|||+++....... ......+
T Consensus 97 H~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (793)
T PLN00181 97 HSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAM 176 (793)
T ss_pred HhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccC
Confidence 99999999999999999654 3456666666653211000 0011235
Q ss_pred ccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 011627 170 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 249 (481)
Q Consensus 170 gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (481)
+|+.|||||++.+ ..++.++||||||||||||+++.++|.... ..+..+..... +.
T Consensus 177 gt~~Y~APE~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-~~-------------------- 232 (793)
T PLN00181 177 EMSWYTSPEEDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-PP-------------------- 232 (793)
T ss_pred CCcceEChhhhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-Ch--------------------
Confidence 7889999999887 568999999999999999999888765322 12222211100 00
Q ss_pred hhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 250 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
........+.+++.+||..||.+||++.|||+|+||..
T Consensus 233 --------~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 233 --------QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred --------hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 00011234678999999999999999999999999964
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=249.39 Aligned_cols=243 Identities=22% Similarity=0.312 Sum_probs=175.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHh--cCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKK--LQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|.||+||+++. .|+.||||++...++. ...||.+|++. |+|+||+.|+..-.... ..-.
T Consensus 222 GRyGEVwrG~w--rGe~VAVKiF~srdE~-----SWfrEtEIYqTvmLRHENILgFIaaD~~~~------------gs~T 282 (513)
T KOG2052|consen 222 GRFGEVWRGRW--RGEDVAVKIFSSRDER-----SWFRETEIYQTVMLRHENILGFIAADNKDN------------GSWT 282 (513)
T ss_pred ccccceeeccc--cCCceEEEEecccchh-----hhhhHHHHHHHHHhccchhhhhhhccccCC------------CceE
Confidence 89999999998 7999999999866544 34577777765 59999999997644311 1144
Q ss_pred eEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEcCCCCeEEecc
Q 011627 81 STYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--------QVLHRDIKGSNLLIDNEGNLKLADF 151 (481)
Q Consensus 81 ~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~--------giiHrDLKp~NILl~~~~~vkL~DF 151 (481)
.+|||.||.+ |+|.+++.+ ..++.+.+.+++..++.||++||.. .|.|||||..|||+..++.+.|+||
T Consensus 283 QLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 7999999998 688888877 4689999999999999999999953 4999999999999999999999999
Q ss_pred cccccccCC---CCCccccccccccCCCchhhcCCCCC-----CCCCchhhHHHHHHHHHhC----------CCCCCCC-
Q 011627 152 GLARSFSYD---HNNTLTNRVITLWYRPPELLLGATKY-----GPAVDMWSVGCIFAELLNG----------KPILPGK- 212 (481)
Q Consensus 152 G~a~~~~~~---~~~~~~~~~gt~~Y~aPEvl~~~~~~-----~~~~DiwSlGvil~elltG----------~~pf~~~- 212 (481)
|+|...... .....+.++||..|||||+|...... -..+||||||+|+||++.. ..||..-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999876543 23355678999999999999753221 1358999999999999753 2444321
Q ss_pred ---ChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHh
Q 011627 213 ---NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288 (481)
Q Consensus 213 ---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL 288 (481)
...+.+.+++-. +..++..+......+ .=..+..|++.|+..||.-|.||--|.
T Consensus 441 p~DPs~eeMrkVVCv------------------~~~RP~ipnrW~s~~----~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCV------------------QKLRPNIPNRWKSDP----ALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCCHHHHhcceee------------------cccCCCCCcccccCH----HHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 122222222110 111111111111111 112466799999999999999987654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=259.82 Aligned_cols=240 Identities=20% Similarity=0.252 Sum_probs=194.9
Q ss_pred CcceeEEEEEEEccCCc----EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
-|+||+||++...-.++ .||||++...... ...+.+++|+.+|.+|+|+|++++++++...
T Consensus 706 sgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-~~s~e~LdeAl~masldHpnl~RLLgvc~~s-------------- 770 (1177)
T KOG1025|consen 706 SGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-KASIELLDEALRMASLDHPNLLRLLGVCMLS-------------- 770 (1177)
T ss_pred cccceeEEeeeEecCCceecceeEEEEeeccCCc-hhhHHHHHHHHHHhcCCCchHHHHhhhcccc--------------
Confidence 38999999999887776 4788877654332 3456788999999999999999999999863
Q ss_pred cCCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 78 YRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 78 ~~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.+-||++|+. |.|++++...+..+-......|..||++|+.|||..+++||||-..||||..-..+||.|||+|+.
T Consensus 771 ---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 771 ---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred ---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 3679999998 689999998888899999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCccccc-cccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 157 FSYDHNNTLTNR-VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 157 ~~~~~~~~~~~~-~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
+..+........ .-...|||=|.+.. ..|+.++||||+||++|||+| |..|+.+....++-..+..... .
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-L------ 919 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-L------ 919 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-C------
Confidence 765544333221 22566899998875 789999999999999999998 9999998877665443322111 0
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...+..+-++.-++.+||..|+..||+++++..
T Consensus 920 ----------------------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 920 ----------------------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ----------------------CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 011235567889999999999999999998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=229.46 Aligned_cols=203 Identities=36% Similarity=0.578 Sum_probs=168.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|.|++||++++..+++.+|||.+...... .....+.+|++++++++|+||+++++++.. ....
T Consensus 10 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----------------~~~~ 72 (225)
T smart00221 10 GAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED----------------PEPL 72 (225)
T ss_pred CCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec----------------CCce
Confidence 78999999999999999999999866433 235577899999999999999999999876 5678
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
++++|++.+ +|.+.+......+++..+..++.+++.+|.+||+++++|+||+++||+++.++.++|+|||++..+....
T Consensus 73 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 73 YLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred EEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 999999997 7777766544338999999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCC-CChH-HHHHHHH
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEA-EQLSKIF 222 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~-~~~~-~~~~~i~ 222 (481)
........++..|++||++.....++.++|+|+||+++++|++|+.||.. .+.. .+...+.
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 11334456688899999884335678899999999999999999999977 4444 4444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=233.51 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=181.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|.||.+-+|+|+.++..++||.+...... ...+.+|...--.| .|.|||.-|++.-.. .+.
T Consensus 35 G~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt---------------~d~ 96 (378)
T KOG1345|consen 35 GRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQT---------------SDA 96 (378)
T ss_pred cceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhc---------------Cce
Confidence 89999999999999999999999865432 45778888877777 489999988764331 457
Q ss_pred EEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC--CCCeEEeccccccccc
Q 011627 82 TYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFS 158 (481)
Q Consensus 82 ~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~ 158 (481)
+++++||+. |||.+.+... .+-|.-.+.++.|+++||.|||++++||||||.+||||-+ ..+|||||||+.+...
T Consensus 97 YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 889999998 6888777664 4788889999999999999999999999999999999954 3369999999987643
Q ss_pred CCCCCccccccccccCCCchhhcCC----CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
. ......-+..|.+||++... ....+.+|||.||||+|.+|+|+.||......+.-..-++. |.
T Consensus 175 ~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~--------w~ 242 (378)
T KOG1345|consen 175 T----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ--------WL 242 (378)
T ss_pred c----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH--------Hh
Confidence 2 11112236779999987532 23578899999999999999999999854332211111110 00
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCC---CCHHHHhcCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR---ISAKDALDSEY 292 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R---~sa~eiL~h~~ 292 (481)
.- ....+...|+.+++.+..+.++-|..++++| .++++.....|
T Consensus 243 ~r--------------k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 243 KR--------------KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred cc--------------cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 00 0113345566799999999999999999999 44444444444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=271.89 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=200.4
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeec----CCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRM----DNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~----~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
.|+||.|+.+......+.++.|..+. ......+...+..|+.+-.+|.|+||+..+.++.+
T Consensus 328 ~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--------------- 392 (601)
T KOG0590|consen 328 SGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--------------- 392 (601)
T ss_pred ecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh---------------
Confidence 47888888888888888788776652 22223333346679999999999999988888776
Q ss_pred cCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 78 YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
....+-+||||..||+.++... ..++..++.++++||+.||+|||+.||.|||||++|++++.++.+||+|||.+..+
T Consensus 393 -~~~~~~~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 393 -IDGILQSMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred -cccchhhhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceee
Confidence 2233344999999777777654 46899999999999999999999999999999999999999999999999999888
Q ss_pred cCCCC---CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 158 SYDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 158 ~~~~~---~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
..... ......+|+-.|+|||++.+...-....||||+|+|++.|++|+.||......+... ..
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~----------- 537 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KT----------- 537 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hh-----------
Confidence 76544 345667889999999999885444567999999999999999999997654433221 00
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...............++..++.+.+.+|.+||+.||.+|+|+++|++.+||+..
T Consensus 538 --------~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 538 --------NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred --------hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 000111112233445566788899999999999999999999999999999754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=215.86 Aligned_cols=165 Identities=19% Similarity=0.225 Sum_probs=127.8
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCCCccccccc
Q 011627 91 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 170 (481)
Q Consensus 91 g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 170 (481)
|+|.+++......+++.+++.|+.||+.||+|||+++ ||+|||++.++.+|+ ||+++..... ...+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCC
Confidence 4677777665667999999999999999999999998 999999999999999 9998765422 1267
Q ss_pred cccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 011627 171 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA-EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 249 (481)
Q Consensus 171 t~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (481)
|+.|+|||++.+ ..++.++||||||||+|||++|+.||...... ..+..+......... ..
T Consensus 67 ~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~-------------- 128 (176)
T smart00750 67 DPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP---RD-------------- 128 (176)
T ss_pred cccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc---cc--------------
Confidence 999999999987 67899999999999999999999999765443 333333322111000 00
Q ss_pred hhhhhHHHHHhhhcH--HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 250 TMKRRVREVFRHFDR--HALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 250 ~~~~~~~~~~~~~~~--~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
......++. ++++||.+||..||++|||+.|+++|+|+
T Consensus 129 ------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 129 ------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 000112333 68999999999999999999999999987
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=220.14 Aligned_cols=242 Identities=18% Similarity=0.227 Sum_probs=190.5
Q ss_pred CcceeEEEEEEEccCC-----cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTG-----EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
=|.||.||.+..++.. +.|.+|.++.. ..+.....++.|..+|..+.|+|+..+..+..+.
T Consensus 294 EGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~------------- 359 (563)
T KOG1024|consen 294 EGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED------------- 359 (563)
T ss_pred cCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-------------
Confidence 4899999999765433 34566666533 3333456777899999999999999999988762
Q ss_pred CcCCeEEEEEecCC-CChhhhhc-----CCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEE
Q 011627 77 KYRGSTYMVFEYMD-HDLTGLAD-----RPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKL 148 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~-g~L~~~~~-----~~~--~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL 148 (481)
....++++.+++ ++|..++. +.. ..++..++..++.||..|++|||+.+|||.||...|++||+.-+|||
T Consensus 360 --~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 360 --YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred --cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 345678888887 67777766 222 24777788899999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCCcccccc-ccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 011627 149 ADFGLARSFSYDHNNTLTNRV-ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCG 226 (481)
Q Consensus 149 ~DFG~a~~~~~~~~~~~~~~~-gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~ 226 (481)
+|=.+++.+.......+.... -...||++|.+.. ..|+.++|+|||||++|||+| |+.|+..-+..++..-+.+...
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR 516 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence 999999876543333222222 2677999999986 789999999999999999998 9999999999888776654321
Q ss_pred CCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 227 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.-.+ -++++++-.++..|+..+|++||+.+++..
T Consensus 517 laQP-----------------------------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 LAQP-----------------------------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ecCC-----------------------------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1111 147889999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-24 Score=211.23 Aligned_cols=254 Identities=31% Similarity=0.473 Sum_probs=196.0
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCC-cchhHHHHHHHHHhcCCC-CccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEG-FPITAIREIKILKKLQHE-NVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~-~~~~~~~Ei~il~~L~hp-nIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
.|+|+.||++.+. +.+++|.+........ ....+.+|+.+++.+.|+ +|+++++++.. .
T Consensus 10 ~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----------------~ 70 (384)
T COG0515 10 EGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD----------------E 70 (384)
T ss_pred CCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec----------------C
Confidence 3789999999997 8899999987755543 566788999999999988 79999999965 4
Q ss_pred CeEEEEEecCCCChhhhhcCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CeEEecccccc
Q 011627 80 GSTYMVFEYMDHDLTGLADRPGL---RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLAR 155 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~~~~~~~~---~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~ 155 (481)
...++++|++.+..+..+..... .+.+..+..++.|++.+|.|+|+.+++||||||+||+++..+ .++|+|||++.
T Consensus 71 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 71 GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 45899999999744433333332 689999999999999999999999999999999999999988 69999999998
Q ss_pred cccCCCCC-----ccccccccccCCCchhhcCC--CCCCCCCchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhc
Q 011627 156 SFSYDHNN-----TLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSKIFELC 225 (481)
Q Consensus 156 ~~~~~~~~-----~~~~~~gt~~Y~aPEvl~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~ 225 (481)
.+...... .....++|..|++||++.+. ..+....|+||+|+++++++++..||..... .......+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 230 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence 65433322 34667889999999999863 4678899999999999999999999887764 33333333322
Q ss_pred CCC-CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 226 GSP-DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 226 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
... ..... ... .. ......+.+++.+++..+|..|.+..+.+.+.|...
T Consensus 231 ~~~~~~~~~------------~~~---~~------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 231 PTPSLASPL------------SPS---NP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred CCccccccc------------Ccc---cc------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 211 00000 000 00 223356889999999999999999999998866643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-24 Score=212.22 Aligned_cols=243 Identities=22% Similarity=0.199 Sum_probs=181.1
Q ss_pred cceeEEEEEEEccCC-cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCC----CCccceeeEEe-CCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG-EIVALKKIRMDNEKEGFPITAIREIKILKKLQH----ENVIKLKEIVT-SPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~h----pnIv~l~~~~~-~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|.+..++ +.+|+|+......... ..+..|+.+++.+.. .++..+++... .
T Consensus 29 G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~-------------- 92 (322)
T KOG1164|consen 29 GGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST-------------- 92 (322)
T ss_pred cCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC--------------
Confidence 899999999998885 6889998876533321 156789999999973 57888887773 3
Q ss_pred CcCCeEEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-----CCeEEec
Q 011627 77 KYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-----GNLKLAD 150 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~-----~~vkL~D 150 (481)
...-||||+.++.+|.+++.... ..|+...+..|+.|++.+|++||+.|++||||||+|+++... ..++|+|
T Consensus 93 --~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 93 --EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred --CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 55789999999999999886544 789999999999999999999999999999999999999765 3599999
Q ss_pred ccccc--cccCCCCC------c-cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 011627 151 FGLAR--SFSYDHNN------T-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221 (481)
Q Consensus 151 FG~a~--~~~~~~~~------~-~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 221 (481)
||+|+ .+...... . .....||..|+++.+..+ ...+.+.|+|||+.++.+|+.|..||..........++
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 99999 33222211 1 223458999999999987 67899999999999999999999999766543333333
Q ss_pred HHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 222 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
........... .....+.++.+++..+-..+...+|....+..
T Consensus 250 ~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 250 EKDPRKLLTDR-------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHHhhhhcccc-------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 22111100000 11123345666666666678888887766543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-26 Score=233.20 Aligned_cols=236 Identities=23% Similarity=0.345 Sum_probs=193.5
Q ss_pred cceeEEEEEEE---ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMARE---IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~---~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||.|++++. ...+..+|+|+.++.............|..++..++ |+.+|++...|+.
T Consensus 5 g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt---------------- 68 (612)
T KOG0603|consen 5 GSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT---------------- 68 (612)
T ss_pred CCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc----------------
Confidence 78999998874 356788999999877544433335567889999997 9999999999988
Q ss_pred CCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 79 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 79 ~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+..+++++++..++.+.........+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++|+.|||+++.+-
T Consensus 69 ~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 69 DGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred ccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhH
Confidence 67899999999974444444444568888999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
..... |||..|||||++. .+..++|.||+|++.|+|++|..||.. +++.+|....-.
T Consensus 149 ~~~~~-----cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~----------- 205 (612)
T KOG0603|consen 149 KEKIA-----CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE----------- 205 (612)
T ss_pred hhhhc-----ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC-----------
Confidence 32222 8899999999987 357889999999999999999999988 666666542211
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWTD 296 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~~ 296 (481)
....++.++.+++..|+..+|..|.- +.|+++|+||+..
T Consensus 206 -------------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 206 -------------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred -------------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 12346778999999999999999974 5899999999753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=214.87 Aligned_cols=154 Identities=21% Similarity=0.173 Sum_probs=116.9
Q ss_pred cceeEEEEEEEcc-CCcEEEEEEeecCCc---CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIK-TGEIVALKKIRMDNE---KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~-tg~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++.. +++.||||++..... .......+.+|+++|++|+|+||+..+..
T Consensus 29 G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~------------------- 89 (365)
T PRK09188 29 DVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA------------------- 89 (365)
T ss_pred cCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-------------------
Confidence 8999999999886 788889998763311 12234567899999999999999863321
Q ss_pred CCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI-KGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDL-Kp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
.+..|||||||.+..+..+.. .. ...++.||+.+|.|||++||+|||| ||+|||++.++++||+|||+|+.+
T Consensus 90 ~~~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred cCCcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 124699999999754443221 11 2468899999999999999999999 999999999999999999999876
Q ss_pred cCCCCC-------ccccccccccCCCchhhcC
Q 011627 158 SYDHNN-------TLTNRVITLWYRPPELLLG 182 (481)
Q Consensus 158 ~~~~~~-------~~~~~~gt~~Y~aPEvl~~ 182 (481)
...... ..++.+++..|+|||.+.-
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 543211 1245567888999998753
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=196.09 Aligned_cols=193 Identities=23% Similarity=0.332 Sum_probs=164.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|.||.+|++++.-+++.||||.-....+.. ++..|....+.|. .+.|..+|.+-.+ ..+
T Consensus 39 GsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vYYFGqe----------------G~~ 98 (449)
T KOG1165|consen 39 GSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQE----------------GKY 98 (449)
T ss_pred CcceeeecccccccCceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCceeeeccc----------------cch
Confidence 899999999999999999999877654443 6778999999995 7888888866554 446
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-----CeEEeccccccc
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-----NLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-----~vkL~DFG~a~~ 156 (481)
-.||||+++.+|.+++.-++.+|+...+..+++|++.-++|+|++.+|.|||||+|+||..-+ .|.|+|||+|+.
T Consensus 99 NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 99 NILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 689999999999999999999999999999999999999999999999999999999996433 499999999998
Q ss_pred ccCCCCC------ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH
Q 011627 157 FSYDHNN------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 216 (481)
Q Consensus 157 ~~~~~~~------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 216 (481)
+...... ...+..||..||+-...++ ..-+...|+-|||.|++++|-|..||.+.....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred hcCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 7654322 2234577999999998888 567899999999999999999999998765443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=188.87 Aligned_cols=236 Identities=23% Similarity=0.280 Sum_probs=182.0
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCC-CCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~h-pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
.|+||.+|++.+..+|+.||||+-+..... -++..|.++.+.|++ ..|..+..+..+ ..
T Consensus 25 sGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e----------------~~ 84 (341)
T KOG1163|consen 25 SGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTE----------------KD 84 (341)
T ss_pred CCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccc----------------cc
Confidence 489999999999999999999987654332 267789999999975 566667666665 55
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCeEEecccccccc
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSF 157 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~ 157 (481)
+-.||||++..+|.+++.-....|+...+..++-|++.-|+|+|.+++|||||||+|+|+.- ...+.|+|||+|+.+
T Consensus 85 ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 85 YNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 67999999999999999988889999999999999999999999999999999999999853 235999999999877
Q ss_pred cCCCC------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCC
Q 011627 158 SYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE---QLSKIFELCGSP 228 (481)
Q Consensus 158 ~~~~~------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~~~~ 228 (481)
..... ..-.+..||..|.+-....+ ..-+...|+-|+|.+|..+..|..||.+..... -.++|.+...+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s- 242 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS- 242 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC-
Confidence 54221 22344578999999888776 456788999999999999999999998865443 34444432111
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 283 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s 283 (481)
..+..+-+.++.++.-.|.-|=.+--++-|.
T Consensus 243 ------------------------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 243 ------------------------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred ------------------------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 1122333456667777777666555555553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=185.98 Aligned_cols=135 Identities=19% Similarity=0.177 Sum_probs=103.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCc------------------------chhHHHHHHHHHhcCCCCccceee
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGF------------------------PITAIREIKILKKLQHENVIKLKE 58 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~------------------------~~~~~~Ei~il~~L~hpnIv~l~~ 58 (481)
|+||+||+|.+. +|+.||||+++........ .....+|+.++.+|.+++|.....
T Consensus 8 G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~ 86 (190)
T cd05147 8 GKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEP 86 (190)
T ss_pred ccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcE
Confidence 899999999997 8999999999865321111 012235999999999888754433
Q ss_pred EEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCc
Q 011627 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC-HVNQVLHRDIKGSN 137 (481)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~L-H~~giiHrDLKp~N 137 (481)
+... ..+|||||++++.+.........+++..+..++.||+.+|.+| |+.||+||||||+|
T Consensus 87 ~~~~------------------~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~N 148 (190)
T cd05147 87 ILLK------------------SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYN 148 (190)
T ss_pred EEec------------------CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 3211 1289999999854432222234689999999999999999999 79999999999999
Q ss_pred EEEcCCCCeEEecccccccc
Q 011627 138 LLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 138 ILl~~~~~vkL~DFG~a~~~ 157 (481)
||+++ +.++|+|||+|...
T Consensus 149 Ili~~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 149 LLYHD-GKLYIIDVSQSVEH 167 (190)
T ss_pred EEEEC-CcEEEEEccccccC
Confidence 99984 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=217.00 Aligned_cols=211 Identities=27% Similarity=0.435 Sum_probs=156.7
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|+||-||+++|+.|.+.+|+ ++++.+. ||+ ||..+-+ .
T Consensus 93 ngAygavylvrh~~trqrfa~-kiNkq~l-------------ilR-----nilt~a~----------------------n 131 (1205)
T KOG0606|consen 93 NGAYGAVYLVRHKETRQRFAM-KINKQNL-------------ILR-----NILTFAG----------------------N 131 (1205)
T ss_pred cCCCCceeeeeccccccchhh-cccccch-------------hhh-----ccccccC----------------------C
Confidence 389999999999999999999 4443321 111 1222221 1
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
.+.| +|-..++... +.++.+. +.+++|||+-+|+|||+||+|+||+.-|++|+.|||+++......
T Consensus 132 pfvv-----gDc~tllk~~-g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 132 PFVV-----GDCATLLKNI-GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ccee-----chhhhhcccC-CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 2233 3333333322 2344333 778999999999999999999999999999999999987543211
Q ss_pred CC--------------ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 011627 162 NN--------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 227 (481)
Q Consensus 162 ~~--------------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 227 (481)
.. .-...|+|+.|+||||+.. ..|+..+|.|++|+|+||++.|+.||.+++.++++.+++...
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-- 274 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-- 274 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh--
Confidence 11 1122488999999999986 679999999999999999999999999999999999887643
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCC
Q 011627 228 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI---SAKDALDSEYFWT 295 (481)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~---sa~eiL~h~~f~~ 295 (481)
..|+.-. .....+++++|.++|..+|..|. .+-++..|.||..
T Consensus 275 ---i~wpE~d----------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 275 ---IEWPEED----------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred ---ccccccC----------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 2333221 13667999999999999999996 6778889999954
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-23 Score=219.08 Aligned_cols=237 Identities=27% Similarity=0.374 Sum_probs=167.9
Q ss_pred ceeEEEEEEEccCCcEEEEEEeecCCcCC--CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 4 CISQVFMAREIKTGEIVALKKIRMDNEKE--GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 4 ~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~--~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
.|=+|.+|++. .-.|+||++-+....- ....+.++|++ ++.+++||++.+..+... +..
T Consensus 35 RFlKv~r~k~~--eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t----------------~kA 95 (1431)
T KOG1240|consen 35 RFLKVARAKDR--EGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT----------------DKA 95 (1431)
T ss_pred hhhhhhhccCC--CceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh----------------hHH
Confidence 45667777763 3358999886543221 12234455666 677799999999877554 556
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc--cC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF--SY 159 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~--~~ 159 (481)
.|||-+|+..+|.+.+..+. -+.+-+.+.|+.|||.||.-||..||+|+|||.|||||+.=..+.|.||..-+.. ..
T Consensus 96 AylvRqyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHHHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 79999999999998877654 3788889999999999999999999999999999999999888999999865432 22
Q ss_pred CCCCcccccccc----ccCCCchhhcCCC---------C-CCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 011627 160 DHNNTLTNRVIT----LWYRPPELLLGAT---------K-YGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 224 (481)
Q Consensus 160 ~~~~~~~~~~gt----~~Y~aPEvl~~~~---------~-~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~ 224 (481)
+....++-++-| .-|+|||.+.... . .+++.||||+|||++||++ |+++|. +.++++.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------LSQL~aY 247 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------LSQLLAY 247 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------HHHHHhH
Confidence 222222222223 2399999986521 1 5678999999999999988 788885 2222211
Q ss_pred cCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhh-hcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 225 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH-FDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
. ... .......... -+..++.||..|++.||++|.+|++.|+.
T Consensus 248 r------------------~~~-----~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 R------------------SGN-----ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred h------------------ccC-----ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 000 0000111111 12368899999999999999999999976
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-23 Score=197.26 Aligned_cols=238 Identities=19% Similarity=0.248 Sum_probs=143.8
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcC----------CCCccceeeEEeCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQ----------HENVIKLKEIVTSPGPERDEQ 70 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~----------hpnIv~l~~~~~~~~~~~~~~ 70 (481)
.|+|+.||.++|.+|++.+|||+...... .....+++.+|.-....+. |-.++..+++.........-.
T Consensus 22 ~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~ 101 (288)
T PF14531_consen 22 KGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFE 101 (288)
T ss_dssp EETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEE
T ss_pred cCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCccee
Confidence 47899999999999999999999876642 2223445555554444432 223444444444321100000
Q ss_pred CCCCCCCcCC-----eEEEEEecCCCChhhhhcC----CCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 011627 71 GRPDGNKYRG-----STYMVFEYMDHDLTGLADR----PGLR--FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 139 (481)
Q Consensus 71 ~~~~~~~~~~-----~~~iV~Ey~~g~L~~~~~~----~~~~--l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NIL 139 (481)
...... ..+++|+-+.+||..++.. .... +.......+..|++..+++||..||+|+||||+|||
T Consensus 102 ----~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfl 177 (288)
T PF14531_consen 102 ----RGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFL 177 (288)
T ss_dssp ----ECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEE
T ss_pred ----cCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEE
Confidence 000011 3478889898888765442 1111 222223446699999999999999999999999999
Q ss_pred EcCCCCeEEecccccccccCCCCCccccccccccCCCchhhcCC-------CCCCCCCchhhHHHHHHHHHhCCCCCCCC
Q 011627 140 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-------TKYGPAVDMWSVGCIFAELLNGKPILPGK 212 (481)
Q Consensus 140 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~-------~~~~~~~DiwSlGvil~elltG~~pf~~~ 212 (481)
++.+|.++|+||+........ ......+..|.+||+.... ..++.+.|.|+||+++|.|++++.||...
T Consensus 178 l~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 178 LDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp E-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred EcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 999999999999987654321 1113346789999977432 24788999999999999999999999765
Q ss_pred ChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCC
Q 011627 213 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281 (481)
Q Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 281 (481)
.........++ .. .++++.+++||+.||+.||.+|
T Consensus 254 ~~~~~~~~~f~---------------------------------~C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 254 SPEADPEWDFS---------------------------------RC-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GGGSTSGGGGT---------------------------------TS-S---HHHHHHHHHHT-SSGGGS
T ss_pred Cccccccccch---------------------------------hc-CCcCHHHHHHHHHHccCCcccC
Confidence 43211100000 01 1477889999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=180.39 Aligned_cols=135 Identities=19% Similarity=0.188 Sum_probs=105.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCc------------------------chhHHHHHHHHHhcCCCCccceee
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGF------------------------PITAIREIKILKKLQHENVIKLKE 58 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~------------------------~~~~~~Ei~il~~L~hpnIv~l~~ 58 (481)
|+||+||+|++. +|+.||||+++........ .....+|+..+.++.|++|.....
T Consensus 8 G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 86 (190)
T cd05145 8 GKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEP 86 (190)
T ss_pred CCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceE
Confidence 899999999987 9999999999865321000 112347899999999998865554
Q ss_pred EEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCC
Q 011627 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGS 136 (481)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~-L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~ 136 (481)
+... ..||||||+++. +..... ....+++..+..++.||+.+|.+||+ +||+||||||+
T Consensus 87 ~~~~------------------~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~ 147 (190)
T cd05145 87 ILLK------------------KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEY 147 (190)
T ss_pred EEec------------------CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChh
Confidence 4432 238999999975 322222 23457888999999999999999999 99999999999
Q ss_pred cEEEcCCCCeEEeccccccccc
Q 011627 137 NLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 137 NILl~~~~~vkL~DFG~a~~~~ 158 (481)
|||++ ++.++|+|||+|+...
T Consensus 148 NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 148 NILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred hEEEE-CCCEEEEEcccceecC
Confidence 99999 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=180.21 Aligned_cols=167 Identities=14% Similarity=0.208 Sum_probs=122.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC-Ccchh------HHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE-GFPIT------AIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 75 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~-~~~~~------~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~ 75 (481)
|+||.||++.+ ++..+|||+++...... ..... +.+|+..+.+|.|++|..+.+++...... .
T Consensus 42 ~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~--------~ 111 (232)
T PRK10359 42 IDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK--------T 111 (232)
T ss_pred CCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc--------c
Confidence 78999999655 57789999997553222 22222 46899999999999999999997753211 1
Q ss_pred CCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 76 NKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 76 ~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
..+.+..+|||||++| +|.+. . .+++ ..+.+|+.+|..||+.|++||||||+|||++.++ ++|+|||.+
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~-~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~ 181 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDM-P----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGK 181 (232)
T ss_pred ccccCCeEEEEEEECCccHHHh-h----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCc
Confidence 1235678999999998 45443 1 2333 3466999999999999999999999999999988 999999988
Q ss_pred ccccCCCCCccccccccccCCCch-hhcCCCCCCCCCchhhHHHHHHHHHh
Q 011627 155 RSFSYDHNNTLTNRVITLWYRPPE-LLLGATKYGPAVDMWSVGCIFAELLN 204 (481)
Q Consensus 155 ~~~~~~~~~~~~~~~gt~~Y~aPE-vl~~~~~~~~~~DiwSlGvil~ellt 204 (481)
........ -+ .++. ..|+.++|+||||+++..+..
T Consensus 182 ~~~~e~~a--------------~d~~vle-r~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 182 RCTAQRKA--------------KDRIDLE-RHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred ccccchhh--------------HHHHHHH-hHhcccccccceeEeehHHHH
Confidence 65431111 11 2222 457789999999999877654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=171.72 Aligned_cols=182 Identities=14% Similarity=0.046 Sum_probs=130.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC--cchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG--FPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~--~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+|+++.. .+..++.+.+........ ....+.+|+++|++|. |++|.+++++.
T Consensus 13 ~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------------------- 71 (218)
T PRK12274 13 DTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------------------- 71 (218)
T ss_pred CCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-------------------
Confidence 78999998776 778888777765433211 1124678999999995 57899998752
Q ss_pred CeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI-KGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDL-Kp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..|++|||+.|..+..... . ....++.|++.+|++||++||+|||| ||+|||++.++.++|+|||+|....
T Consensus 72 -~~~lvmeyI~G~~L~~~~~------~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 72 -GRHLDRSYLAGAAMYQRPP------R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred -CEEEEEeeecCccHHhhhh------h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 3599999999865432211 1 12357889999999999999999999 7999999999999999999998554
Q ss_pred CCCCC----c--------cccccccccCCCchhhcCCCCCC-CCCchhhHHHHHHHHHhCCCCCCCCC
Q 011627 159 YDHNN----T--------LTNRVITLWYRPPELLLGATKYG-PAVDMWSVGCIFAELLNGKPILPGKN 213 (481)
Q Consensus 159 ~~~~~----~--------~~~~~gt~~Y~aPEvl~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~ 213 (481)
..... . ..-...++.|++|+...-....+ ...+.++.|+-+|.++|+..++-+.+
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 22210 0 00112377788887543222223 45688899999999999987765443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=179.21 Aligned_cols=207 Identities=18% Similarity=0.245 Sum_probs=145.6
Q ss_pred CCCCccceeeEEeCCCCCCCC------C-----CCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHH
Q 011627 49 QHENVIKLKEIVTSPGPERDE------Q-----GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLL 117 (481)
Q Consensus 49 ~hpnIv~l~~~~~~~~~~~~~------~-----~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil 117 (481)
+|||||++..+|.+.-...-+ + -.+.+......+|+||....++|..++..+. .+.....-++.|+|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHH
Confidence 499999999999874322100 0 1112344566899999999999998887654 57777888999999
Q ss_pred HHHHHHHhCCcccCCCCCCcEEEcCC--C--CeEEecccccccccCC-----CCCccccccccccCCCchhhcCCCC---
Q 011627 118 TGLHYCHVNQVLHRDIKGSNLLIDNE--G--NLKLADFGLARSFSYD-----HNNTLTNRVITLWYRPPELLLGATK--- 185 (481)
Q Consensus 118 ~gL~~LH~~giiHrDLKp~NILl~~~--~--~vkL~DFG~a~~~~~~-----~~~~~~~~~gt~~Y~aPEvl~~~~~--- 185 (481)
+|+.|||++||.|||||.+||||.-+ + .+.|+|||.+.....- -.......-|....||||+......
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998433 2 4899999987532210 0111122344667899998764210
Q ss_pred --CCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhc
Q 011627 186 --YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFD 263 (481)
Q Consensus 186 --~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (481)
--.++|.|++|.+.||++....||....+...-.+-+.. ..+......++
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe----------------------------~qLPalp~~vp 483 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE----------------------------SQLPALPSRVP 483 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh----------------------------hhCCCCcccCC
Confidence 124789999999999999999999874443221111111 11112233577
Q ss_pred HHHHHHHHHhcccCCCCCCCHH
Q 011627 264 RHALELLEKMLMLDPSQRISAK 285 (481)
Q Consensus 264 ~~~~~ll~~~L~~dP~~R~sa~ 285 (481)
+.+++|+..+|+.||++|++..
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hHHHHHHHHHhcCCccccCCcc
Confidence 8899999999999999999753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=166.91 Aligned_cols=130 Identities=18% Similarity=0.205 Sum_probs=100.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-----CCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-----QHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-----~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+|+.||. +..+... +||++...... ....+.+|+.+++.| +|+||+++++++++...
T Consensus 13 G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g------------ 75 (210)
T PRK10345 13 GRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG------------ 75 (210)
T ss_pred CCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC------------
Confidence 89999995 7777766 69998764322 345788999999999 57999999999987321
Q ss_pred cCCeEE-EEEecCC---CChhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccCCCCCCcEEEcC----CCCeEE
Q 011627 78 YRGSTY-MVFEYMD---HDLTGLADRPGLRFTVPQIKCYMKQLLTGL-HYCHVNQVLHRDIKGSNLLIDN----EGNLKL 148 (481)
Q Consensus 78 ~~~~~~-iV~Ey~~---g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL-~~LH~~giiHrDLKp~NILl~~----~~~vkL 148 (481)
.+.++ +||||++ ++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++. +.+++|
T Consensus 76 -~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 76 -TGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred -CeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 23434 7899955 4788887553 46665 46688888888 9999999999999999999974 337999
Q ss_pred eccccc
Q 011627 149 ADFGLA 154 (481)
Q Consensus 149 ~DFG~a 154 (481)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-21 Score=206.44 Aligned_cols=252 Identities=29% Similarity=0.414 Sum_probs=198.0
Q ss_pred cceeEEEEEEEc-cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREI-KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~-~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+|+.|-++.+. .+...+|+|.+........+...+..|+.+-+.+. |.|++++++...+ ..
T Consensus 31 gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~----------------~~ 94 (601)
T KOG0590|consen 31 GSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS----------------PR 94 (601)
T ss_pred cccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC----------------Cc
Confidence 677788777764 44566888888766555556666778999999997 9999999998876 56
Q ss_pred eEEEEEecCCC-ChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEcCCC-CeEEeccccccc
Q 011627 81 STYMVFEYMDH-DLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNLLIDNEG-NLKLADFGLARS 156 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH-~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~ 156 (481)
..++++||..+ ++.+.+...+. .++...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+|+.|||+|..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 78999999886 45554425554 6788899999999999999999 99999999999999999999 999999999998
Q ss_pred ccC--CCCCccccccc-cccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 157 FSY--DHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 157 ~~~--~~~~~~~~~~g-t~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
+.. .........++ ++.|+|||.+.+........|+||+|+++..+++|..|+......+... ..|
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-----------~~~ 243 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-----------SSW 243 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-----------eee
Confidence 876 33345556688 9999999999876677889999999999999999998886544322100 000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.... .......|..++..+.+++.++|..++..|.+.+++..++|+..
T Consensus 244 ~~~~--------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 244 KSNK--------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccc--------------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000 01112344567888999999999999999999999999999965
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-20 Score=187.92 Aligned_cols=180 Identities=28% Similarity=0.462 Sum_probs=132.6
Q ss_pred CCeEEEEEecCCC-ChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~--~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
..++||.|++|.. .|.+.+.+ .....+...+..+++||..+++| ++.+||||||.||++..+..+||.|||+..
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 5679999999996 45554432 23346778899999999999999 999999999999999999999999999998
Q ss_pred cccCCC-----CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 011627 156 SFSYDH-----NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 230 (481)
Q Consensus 156 ~~~~~~-----~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 230 (481)
...... ....+..++|.+||+||.+.+ ..|+.++||||||+||+||+.- |. +..+....... ..+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~---f~--T~~er~~t~~d----~r~ 474 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQ---FS--TQFERIATLTD----IRD 474 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHH---hc--cHHHHHHhhhh----hhc
Confidence 776544 335566788999999999997 6899999999999999999972 11 11111111110 111
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..|+ ..+..-.++-.+||..||...|.+||++.+.-.|.|.
T Consensus 475 g~ip----------------------~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 475 GIIP----------------------PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CCCC----------------------hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1111 1111122346689999999999999977776666653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.9e-20 Score=169.72 Aligned_cols=230 Identities=17% Similarity=0.217 Sum_probs=175.8
Q ss_pred eeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEE
Q 011627 5 ISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYM 84 (481)
Q Consensus 5 fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 84 (481)
-|+.|+++. .|..+++|+++...........+..|.-.|+-+.||||+.+++.+.++ -++.+
T Consensus 203 sgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp----------------pnlv~ 264 (448)
T KOG0195|consen 203 SGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP----------------PNLVI 264 (448)
T ss_pred Ccccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC----------------CCceE
Confidence 467888887 455678888887766666667788899999999999999999999874 46889
Q ss_pred EEecCC-CChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCCeEEe--ccccccccc
Q 011627 85 VFEYMD-HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLA--DFGLARSFS 158 (481)
Q Consensus 85 V~Ey~~-g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~--DFG~a~~~~ 158 (481)
+..||. ++|+.++.... .-++..++.+++..|+.|++|||+.. |.---|....|+||++-+.+|. |--++ |.
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--fq 342 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--FQ 342 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--ee
Confidence 999998 57877776533 34778899999999999999999984 4445688899999998876664 33222 11
Q ss_pred CCCCCccccccccccCCCchhhcCCCC--CCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~--~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
...+.-.+.||+||.+..... --.++|+|||.++|+||.|...||..-...+.--+|.-.
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale------------ 404 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE------------ 404 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc------------
Confidence 112334889999999986432 235799999999999999999999988887765555311
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHh
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL 288 (481)
.....+.+.++..+..|+.-|++.||.+||....|+
T Consensus 405 ----------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 405 ----------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 011123346788899999999999999999887654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.9e-19 Score=168.15 Aligned_cols=137 Identities=15% Similarity=0.159 Sum_probs=103.1
Q ss_pred CcceeEEEEEE-EccCCcEEEEEEeecCCcCCC----------------------cchhHHHHHHHHHhcCCCCccceee
Q 011627 2 LVCISQVFMAR-EIKTGEIVALKKIRMDNEKEG----------------------FPITAIREIKILKKLQHENVIKLKE 58 (481)
Q Consensus 2 ~G~fg~Vy~a~-~~~tg~~vAvK~i~~~~~~~~----------------------~~~~~~~Ei~il~~L~hpnIv~l~~ 58 (481)
-|+||+||+|. +..+|+.||||+++....... ....+.+|+.++++|.+. ++.+..
T Consensus 38 ~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~-~i~~p~ 116 (237)
T smart00090 38 TGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA-GVPVPK 116 (237)
T ss_pred cCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc-CCCCCe
Confidence 38999999999 778999999999986532100 012245899999999763 343333
Q ss_pred EEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCc
Q 011627 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ-VLHRDIKGSN 137 (481)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g-iiHrDLKp~N 137 (481)
++.. . ..||||||+.++.+.........+...++..++.||+.+|.+||+.| |+||||||+|
T Consensus 117 ~~~~----------------~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 117 PIAW----------------R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred eeEe----------------c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 3322 1 23899999998544333322334667778899999999999999999 9999999999
Q ss_pred EEEcCCCCeEEecccccccc
Q 011627 138 LLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 138 ILl~~~~~vkL~DFG~a~~~ 157 (481)
||++ ++.++|+|||+|...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 788999999998643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.8e-19 Score=190.82 Aligned_cols=180 Identities=20% Similarity=0.275 Sum_probs=144.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC---CCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|.+.. ++.||||+-+....++-+.. .+++.+|+ -+.|+.+...+.- .
T Consensus 709 g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~-----~q~~~RLk~~~~~~~~~~~~a~~~----------------~ 766 (974)
T KOG1166|consen 709 GSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC-----LQVMERLKPQMLPSIMHISSAHVF----------------Q 766 (974)
T ss_pred ccceEEEEeecCC-CcEEEEEeecCCCceeeeeh-----HHHHHhhchhhhcchHHHHHHHcc----------------C
Confidence 8999999999977 99999999887776654432 23344444 3445555444332 5
Q ss_pred CeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-------CCCeEEecc
Q 011627 80 GSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-------EGNLKLADF 151 (481)
Q Consensus 80 ~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-------~~~vkL~DF 151 (481)
+..+||+||.+ |+|++++. ....+++..+..|+.|+|..|++||..+|||+||||+|+||.. +--++|+||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 56789999999 57888877 5557999999999999999999999999999999999999953 224999999
Q ss_pred cccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCC
Q 011627 152 GLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 206 (481)
Q Consensus 152 G~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~ 206 (481)
|.+..+.--.. ..+...+.|-.+-++|+..+ +.|++.+|.|.|+-+++.||.|+
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 99976654333 46666778999999999887 79999999999999999999996
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.6e-18 Score=173.95 Aligned_cols=205 Identities=23% Similarity=0.309 Sum_probs=155.0
Q ss_pred HHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 011627 45 LKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123 (481)
Q Consensus 45 l~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~L 123 (481)
|+.+.|.|+.+|++.+.+ ...+++|.+||. |+|.+.+......++.-....+++.|+.||.||
T Consensus 1 l~~l~h~n~~~f~g~~~~----------------~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~yl 64 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD----------------GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYL 64 (484)
T ss_pred CcccchhhhhhheeeEec----------------CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHH
Confidence 467899999999999987 568899999998 688888887777889989999999999999999
Q ss_pred HhCCc-ccCCCCCCcEEEcCCCCeEEecccccccccC-CCCCccccccccccCCCchhhcCCCC------CCCCCchhhH
Q 011627 124 HVNQV-LHRDIKGSNLLIDNEGNLKLADFGLARSFSY-DHNNTLTNRVITLWYRPPELLLGATK------YGPAVDMWSV 195 (481)
Q Consensus 124 H~~gi-iHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~~~gt~~Y~aPEvl~~~~~------~~~~~DiwSl 195 (481)
|...| .|+.|+..|+++|....+||.|||+...... ..........-...|.|||++..... .+.+.||||+
T Consensus 65 h~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 65 HNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred hcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 98866 9999999999999999999999999866532 01111111223566999999876311 3667999999
Q ss_pred HHHHHHHHhCCCCCCCCCh----HHHHHHHHHhc-CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHH
Q 011627 196 GCIFAELLNGKPILPGKNE----AEQLSKIFELC-GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELL 270 (481)
Q Consensus 196 Gvil~elltG~~pf~~~~~----~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 270 (481)
|+|++|+++...||..... .+.+.++.... ....+.+|. ...+.+++..++
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~------------------------~~e~~~~l~~l~ 200 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL------------------------LNELPPELLLLV 200 (484)
T ss_pred HHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh------------------------hhhcchHHHHHH
Confidence 9999999999999986332 23444443300 001111100 013455799999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 011627 271 EKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 271 ~~~L~~dP~~R~sa~eiL~ 289 (481)
+.|+..+|++||+++++-.
T Consensus 201 ~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 201 ARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HHhcccChhhCccHHHHHh
Confidence 9999999999999998853
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-17 Score=152.08 Aligned_cols=131 Identities=22% Similarity=0.233 Sum_probs=98.4
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCC--------------------CcchhHHHHHHHHHhcCCCC--ccceeeE
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKE--------------------GFPITAIREIKILKKLQHEN--VIKLKEI 59 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~--------------------~~~~~~~~Ei~il~~L~hpn--Iv~l~~~ 59 (481)
-|+||.||++.+. +++.||||+++...... .......+|+.++.++.|.+ +...++
T Consensus 25 ~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~- 102 (198)
T cd05144 25 VGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID- 102 (198)
T ss_pred cCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee-
Confidence 3899999999874 89999999987543110 00113567999999998874 333332
Q ss_pred EeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 011627 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 139 (481)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NIL 139 (481)
....++||||+.+..+..+.. ......++.+|+.+|.+||+.+|+|+||||+||+
T Consensus 103 -------------------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nil 157 (198)
T cd05144 103 -------------------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNIL 157 (198)
T ss_pred -------------------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEE
Confidence 123489999999844333221 1346778899999999999999999999999999
Q ss_pred EcCCCCeEEecccccccccC
Q 011627 140 IDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 140 l~~~~~vkL~DFG~a~~~~~ 159 (481)
|+.++.++|+|||++..+..
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.8e-17 Score=151.31 Aligned_cols=130 Identities=18% Similarity=0.233 Sum_probs=103.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC------cchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|++|.||++++ ++..|+||+......... ....+.+|+.++..+.|++|.....++..
T Consensus 7 G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-------------- 70 (211)
T PRK14879 7 GAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-------------- 70 (211)
T ss_pred CceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--------------
Confidence 89999999987 788899998654322111 11346689999999999998877766654
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
....+|||||++| +|.+++... .. ....++.+|+.+|.+||+.+++|+||+|+|||++ ++.++|+|||++.
T Consensus 71 --~~~~~lv~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 71 --PENFIIVMEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred --CCCCEEEEEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 3456899999987 565555432 12 7888999999999999999999999999999999 7789999999885
Q ss_pred c
Q 011627 156 S 156 (481)
Q Consensus 156 ~ 156 (481)
.
T Consensus 143 ~ 143 (211)
T PRK14879 143 F 143 (211)
T ss_pred C
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=148.21 Aligned_cols=128 Identities=16% Similarity=0.221 Sum_probs=96.9
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCC------cchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEG------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 75 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~ 75 (481)
-|+||+||+++. ++..|++|+......... ...++.+|+++++.+.|.+|....-++..
T Consensus 4 ~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~------------- 68 (199)
T TIGR03724 4 KGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD------------- 68 (199)
T ss_pred CCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-------------
Confidence 389999999984 678899998653321110 12455689999999998876554444433
Q ss_pred CCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 76 NKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 76 ~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
....+|||||+++ +|.+.+.... . .++.+|+.+|.+||+.+++|+||+|+|||++ ++.++|+|||++
T Consensus 69 ---~~~~~lv~e~~~g~~l~~~~~~~~-------~-~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 69 ---PDNKTIVMEYIEGKPLKDVIEEGN-------D-ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred ---CCCCEEEEEEECCccHHHHHhhcH-------H-HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 3356899999987 5555443211 1 7899999999999999999999999999999 788999999998
Q ss_pred cc
Q 011627 155 RS 156 (481)
Q Consensus 155 ~~ 156 (481)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 64
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-16 Score=145.08 Aligned_cols=131 Identities=21% Similarity=0.253 Sum_probs=92.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchh----------------------HHHHHHHHHhcCCCC--ccceee
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPIT----------------------AIREIKILKKLQHEN--VIKLKE 58 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~----------------------~~~Ei~il~~L~hpn--Iv~l~~ 58 (481)
|+||+||+|++. +++.||||+++........... ...|...+.++.+.. +.+.+.
T Consensus 8 G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 86 (187)
T cd05119 8 GKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPID 86 (187)
T ss_pred ccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEe
Confidence 899999999986 8999999998754321111111 135666666664433 333332
Q ss_pred EEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC-hhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCC
Q 011627 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-LTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKG 135 (481)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~-L~~-~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp 135 (481)
+ ...+|||||+.++ +.. .+.... .. .++..++.+++.+|.+||. .+|+|+||||
T Consensus 87 ~--------------------~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p 143 (187)
T cd05119 87 L--------------------NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSE 143 (187)
T ss_pred c--------------------CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCCh
Confidence 2 1348999999973 211 111110 11 6788999999999999999 9999999999
Q ss_pred CcEEEcCCCCeEEeccccccccc
Q 011627 136 SNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 136 ~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+|||++ ++.++|+|||.+....
T Consensus 144 ~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 144 YNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hhEEEE-CCcEEEEECccccccc
Confidence 999999 8899999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.8e-17 Score=165.48 Aligned_cols=245 Identities=20% Similarity=0.231 Sum_probs=192.4
Q ss_pred cceeEEEEEEE--ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMARE--IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~--~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|.++.||.++. ..+...+|+|.-+...........-++|+...++++ |+|.++.+..++. .
T Consensus 127 g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~----------------~ 190 (524)
T KOG0601|consen 127 GSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG----------------S 190 (524)
T ss_pred CCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc----------------C
Confidence 88999999998 899999999986554443333445568999888884 9999998888887 6
Q ss_pred CeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCcEEEcCC-CCeEEeccccc
Q 011627 80 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLT----GLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLA 154 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~----gL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a 154 (481)
+.++|-+|+|+..+..+......-+++..++.++.+++. ||.++|...++|-|+||+||++..+ ..+++.||++.
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 788999999999999988887777899999999999999 9999999999999999999999998 88999999999
Q ss_pred ccccCCCCCcc----ccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 011627 155 RSFSYDHNNTL----TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 230 (481)
Q Consensus 155 ~~~~~~~~~~~----~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 230 (481)
..+........ ....+...|++||++.+ -++.+.||++||.++.+..++...+.... .
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~----------------~ 332 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGK----------------N 332 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCC----------------C
Confidence 88764332111 11255778999998875 57899999999999999988765543320 0
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
..|...... ....++....+.++..++..||+.|+..|+++..+++|.++.
T Consensus 333 ~~W~~~r~~-------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 333 SSWSQLRQG-------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred CCccccccc-------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 111111100 011223334566777799999999999999999999999985
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.7e-16 Score=164.75 Aligned_cols=126 Identities=16% Similarity=0.185 Sum_probs=95.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC--cC----CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN--EK----EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~--~~----~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||++++.. +.+++|+..... .. ......+.+|++++++++|++|+..+.++.+
T Consensus 344 G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-------------- 407 (535)
T PRK09605 344 GAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-------------- 407 (535)
T ss_pred CCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--------------
Confidence 8899999998743 344444432111 11 0112456789999999999999887766654
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
....+|||||+++ +|.+.+. ....++.+|+.+|.+||+.+|+||||||+|||+ +++.++|+|||+++
T Consensus 408 --~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 408 --PEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred --CCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 3356899999987 5555443 457789999999999999999999999999999 56789999999986
Q ss_pred c
Q 011627 156 S 156 (481)
Q Consensus 156 ~ 156 (481)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.2e-15 Score=143.89 Aligned_cols=135 Identities=17% Similarity=0.181 Sum_probs=99.5
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCc-----C------CCcchhHHHHHHHHHhcCCCCc--cceeeEEeCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNE-----K------EGFPITAIREIKILKKLQHENV--IKLKEIVTSPGPERD 68 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-----~------~~~~~~~~~Ei~il~~L~hpnI--v~l~~~~~~~~~~~~ 68 (481)
.|+.|+||++.. .++.++||.+..... . ......+.+|+.++++|.|.+| ++.+.+.....
T Consensus 42 ~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~---- 115 (239)
T PRK01723 42 AKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH---- 115 (239)
T ss_pred CCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec----
Confidence 478899999987 478899998853210 0 1123467789999999998885 66666543311
Q ss_pred CCCCCCCCCcCCeEEEEEecCCC--ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCe
Q 011627 69 EQGRPDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 146 (481)
Q Consensus 69 ~~~~~~~~~~~~~~~iV~Ey~~g--~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~v 146 (481)
......+||||++.+ +|..++.. ..+++. .+.+|+.+|.+||++||+||||||+|||++.++.+
T Consensus 116 --------~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 116 --------GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred --------CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCE
Confidence 002234699999986 56555543 235543 35789999999999999999999999999988899
Q ss_pred EEeccccccc
Q 011627 147 KLADFGLARS 156 (481)
Q Consensus 147 kL~DFG~a~~ 156 (481)
+|+|||.++.
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999998854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.7e-15 Score=128.92 Aligned_cols=125 Identities=22% Similarity=0.225 Sum_probs=102.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCC--CCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--ENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~h--pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|.++.||++++.. ..++||++..... ...+.+|+.+++.|.+ ..+.+++.++.. .+
T Consensus 9 g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~----------------~~ 66 (155)
T cd05120 9 GLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES----------------DG 66 (155)
T ss_pred ccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC----------------CC
Confidence 7899999999844 7899999865433 3467899999999976 488888877654 35
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN---QVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~---giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
..|++|||+.+..+..+ +......++.+++.+|++||.. +++|+||+++|||++..+.++|+||++++.
T Consensus 67 ~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 67 WSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 68999999987544322 5556778899999999999985 799999999999999988999999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.1e-15 Score=160.67 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=186.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC-cchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG-FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~-~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
++|+.++.++-..++...++|+..+...... ....+..+-.++-...+|.+++.+-.+.. ...
T Consensus 815 ~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~----------------rsP 878 (1205)
T KOG0606|consen 815 GSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC----------------RSP 878 (1205)
T ss_pred CCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC----------------CCC
Confidence 6788888888888888888887654432221 12233344444444556777766554332 456
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
++||++|+++ +|...+.... ..+++-++.++..+..++++||...++|||++|.|+|+..++..++.||++.......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 8999999975 6666655544 5788888889999999999999999999999999999999999999999844321110
Q ss_pred ------------------------------CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCC
Q 011627 161 ------------------------------HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP 210 (481)
Q Consensus 161 ------------------------------~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~ 210 (481)
........++|+.|.+||.+.+ ......+|.|++|++++|.++|.+||.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0011223467999999999988 567889999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHH---HH
Q 011627 211 GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK---DA 287 (481)
Q Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~---ei 287 (481)
.......+..|... ...|+.... ..+.++.+++.++|..++.+|..+. ++
T Consensus 1037 a~tpq~~f~ni~~~-----~~~~p~g~~----------------------~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~ 1089 (1205)
T KOG0606|consen 1037 AETPQQIFENILNR-----DIPWPEGPE----------------------EGSYEAQDLINRLLTEEPTQRLGAKGAAEV 1089 (1205)
T ss_pred CcchhhhhhccccC-----CCCCCCCcc----------------------ccChhhhhhhhhhhccCchhccCccccccc
Confidence 99888877766543 333443322 3567899999999999999999888 88
Q ss_pred hcCCCCCCCC
Q 011627 288 LDSEYFWTDP 297 (481)
Q Consensus 288 L~h~~f~~~~ 297 (481)
..|+||....
T Consensus 1090 k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1090 KGHPFFQDVD 1099 (1205)
T ss_pred ccCCccCCCC
Confidence 9999996543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.5e-13 Score=138.23 Aligned_cols=169 Identities=21% Similarity=0.328 Sum_probs=128.8
Q ss_pred EEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 011627 10 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 89 (481)
Q Consensus 10 ~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~ 89 (481)
.+..+.++..|.|++++.... .....+.+-++.|+.|+||||+++++.++. .+++|||+|.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~----------------~~~~ylvTErV 91 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE----------------EGTLYLVTERV 91 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc----------------cCceEEEeecc
Confidence 466778999999999887655 345567789999999999999999999987 67899999998
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCCCccccc
Q 011627 90 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 168 (481)
Q Consensus 90 ~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH-~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 168 (481)
.. |...+.+ +....+..-+.||+.||.||| +.+++|++|.-+.|+|+..|+.||++|.++........ .....
T Consensus 92 ~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~ 165 (690)
T KOG1243|consen 92 RP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSL 165 (690)
T ss_pred cc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccc
Confidence 74 1112221 346678888999999999997 66899999999999999999999999998865432211 01111
Q ss_pred cccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhC
Q 011627 169 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 205 (481)
Q Consensus 169 ~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG 205 (481)
.---.|..|+.+.. -....|.|-|||++++++.|
T Consensus 166 ~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 166 YLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 11233667765432 12567999999999999998
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.1e-12 Score=130.01 Aligned_cols=216 Identities=18% Similarity=0.234 Sum_probs=160.9
Q ss_pred eEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEE
Q 011627 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 85 (481)
Q Consensus 6 g~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 85 (481)
.+.|+|...-+|..|++|.++.+... ...+...-+++++++.|.|||.|.++|..... .+..+++|
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF------------~D~Slvlv 355 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTF------------GDLSLVLV 355 (655)
T ss_pred ceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhcc------------CcceEEEE
Confidence 46899999999999999999544332 23344567889999999999999999984221 26689999
Q ss_pred EecCCC--ChhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEe
Q 011627 86 FEYMDH--DLTGLADR--------------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLA 149 (481)
Q Consensus 86 ~Ey~~g--~L~~~~~~--------------~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~ 149 (481)
++|..+ +|.++... .+...+|..+|.|+.||..||.++|+.|+..+-|.+.+||++.+-+|+|.
T Consensus 356 YDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS 435 (655)
T KOG3741|consen 356 YDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRIS 435 (655)
T ss_pred EecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEe
Confidence 999985 56654432 22347789999999999999999999999999999999999998889999
Q ss_pred cccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 011627 150 DFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 229 (481)
Q Consensus 150 DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~ 229 (481)
-.|+...+..+.. |.+.. -.+-|.=.||.+++.|.||..-
T Consensus 436 ~C~i~Dvl~~d~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~n--------------------- 475 (655)
T KOG3741|consen 436 GCGIMDVLQEDPT---------------EPLES----QQQNDLRDLGLLLLALATGTEN--------------------- 475 (655)
T ss_pred cccceeeecCCCC---------------cchhH----HhhhhHHHHHHHHHHHhhcccc---------------------
Confidence 8887755442220 11222 2456999999999999998521
Q ss_pred CCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 230 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.++........+..+...++.+++++|.-+...++++ -++.+++.+
T Consensus 476 --------------s~~~d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 476 --------------SNRTDSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --------------cccccchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 0011111122234455678889999999999999987 688888754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=9.7e-13 Score=120.71 Aligned_cols=135 Identities=16% Similarity=0.140 Sum_probs=94.4
Q ss_pred cceeEEEEEEEcc------CCcEEEEEEeecCCc-----------CCC---------cc----hhHHHHHHHHHhcCC--
Q 011627 3 VCISQVFMAREIK------TGEIVALKKIRMDNE-----------KEG---------FP----ITAIREIKILKKLQH-- 50 (481)
Q Consensus 3 G~fg~Vy~a~~~~------tg~~vAvK~i~~~~~-----------~~~---------~~----~~~~~Ei~il~~L~h-- 50 (481)
|.=+.||.|.... .+..+|||+.+.... ... .. ....+|+..|++|..
T Consensus 8 GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl~~~G 87 (197)
T cd05146 8 GKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRMQKAG 87 (197)
T ss_pred CcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHHHHcC
Confidence 5557899998653 357999998763310 000 01 122379999999964
Q ss_pred CCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcc
Q 011627 51 ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC-HVNQVL 129 (481)
Q Consensus 51 pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~L-H~~gii 129 (481)
-++.+.+.+.. -+|||||++++.+....-.+..+++.++..++.+++.+|..| |..|||
T Consensus 88 v~vP~pi~~~~--------------------~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glV 147 (197)
T cd05146 88 IPCPEVVVLKK--------------------HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLV 147 (197)
T ss_pred CCCCeEEEecC--------------------CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCee
Confidence 35555665422 389999998742211111122356667788899999999998 899999
Q ss_pred cCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 130 HRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 130 HrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
|+||++.|||+++ +.++|+||+.|....
T Consensus 148 HGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999999974 679999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=9e-14 Score=145.89 Aligned_cols=144 Identities=21% Similarity=0.293 Sum_probs=88.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC--------------------------------CCcchhHHHHHHHHHhcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK--------------------------------EGFPITAIREIKILKKLQH 50 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~--------------------------------~~~~~~~~~Ei~il~~L~h 50 (481)
|++|+||+|+.+.+|+.||||+++..... .++...+.+|+.+.+..
T Consensus 130 aSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea-- 207 (537)
T PRK04750 130 ASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREA-- 207 (537)
T ss_pred CCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHH--
Confidence 78999999999888999999999744210 01122233344443333
Q ss_pred CCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhh--hcCCCC---CCCHHHHHHHHHHHHHHHHHHH
Q 011627 51 ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL--ADRPGL---RFTVPQIKCYMKQLLTGLHYCH 124 (481)
Q Consensus 51 pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~--~~~~~~---~l~~~~i~~i~~Qil~gL~~LH 124 (481)
.|+.++.+.|.+........ --.++....+|||||++| .+.+. +...+. .+.+..+..++.||+
T Consensus 208 ~N~~~~~~~f~~~~~v~VP~---v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 208 ANASQLRRNFEDSDMLYVPE---VYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHccCCCCeecce---eecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 24444433332211000000 000124456899999998 44332 222221 244555666666665
Q ss_pred hCCcccCCCCCCcEEEcCCC----CeEEeccccccccc
Q 011627 125 VNQVLHRDIKGSNLLIDNEG----NLKLADFGLARSFS 158 (481)
Q Consensus 125 ~~giiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~ 158 (481)
..|++|+|+||.||+++.++ .++++|||++..+.
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 58999999999999999888 89999999997664
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.7e-14 Score=134.94 Aligned_cols=242 Identities=17% Similarity=0.211 Sum_probs=152.9
Q ss_pred EEEEEEccCCcEEEEEEeecCCcCCCcchhHHHH--HHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEE
Q 011627 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIRE--IKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 85 (481)
Q Consensus 8 Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~E--i~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 85 (481)
||++.+.+.|..|+.-.+.....++-....-.++ +.-|..|.|-|||+++.+|.+... .....+.++
T Consensus 82 v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~-----------~e~~rviFi 150 (458)
T KOG1266|consen 82 VYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKY-----------EEKPRVIFI 150 (458)
T ss_pred HHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhccccc-----------ccccceEEE
Confidence 5666677777666655543322111111111122 334455579999999999987432 125568899
Q ss_pred EecCC-CChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEEcCCCCeEEeccccccc---
Q 011627 86 FEYMD-HDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN--QVLHRDIKGSNLLIDNEGNLKLADFGLARS--- 156 (481)
Q Consensus 86 ~Ey~~-g~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~--giiHrDLKp~NILl~~~~~vkL~DFG~a~~--- 156 (481)
.||++ +.+..++++ +...+.....++|+.||+.||.|||+. -|+|.+|..+.|++..++-|||.--.....
T Consensus 151 teymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s 230 (458)
T KOG1266|consen 151 TEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPS 230 (458)
T ss_pred EecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchh
Confidence 99998 566555554 444588888999999999999999998 599999999999999988888763221110
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
+............+-+.|.+||.=.- ...+-++|||++|...++|..+.-- -......+.-..|....
T Consensus 231 ~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i---------- 299 (458)
T KOG1266|consen 231 VNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI---------- 299 (458)
T ss_pred hhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe----------
Confidence 00000000111233567889985433 4567789999999999999876521 11111111111111100
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
+..-...-+++|.+||+-.|..|+++.++|.|+...
T Consensus 300 -----------------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 300 -----------------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred -----------------------eeccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 000111235799999999999999999999999863
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1e-12 Score=136.16 Aligned_cols=137 Identities=23% Similarity=0.317 Sum_probs=87.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC--------------------------------Ccc------hhHHHHHHH
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE--------------------------------GFP------ITAIREIKI 44 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~--------------------------------~~~------~~~~~Ei~i 44 (481)
|++|+||+|+. .+|+.||||+.+...... ++. ..+.+|...
T Consensus 128 aSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n 206 (437)
T TIGR01982 128 ASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAAN 206 (437)
T ss_pred eehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHH
Confidence 78999999986 479999999986432110 000 022334444
Q ss_pred HHhcC----CCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHH-
Q 011627 45 LKKLQ----HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLT- 118 (481)
Q Consensus 45 l~~L~----hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~- 118 (481)
+.++. +.+-+.+-.++.+ +....+|||||++| ++.+........+. ...++..++.
T Consensus 207 ~~~~~~~~~~~~~v~vP~v~~~---------------~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~ 268 (437)
T TIGR01982 207 ASELGENFKNDPGVYVPEVYWD---------------RTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARS 268 (437)
T ss_pred HHHHHHhcCCCCCEEeCCEehh---------------hcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHH
Confidence 44442 3333333333332 13345899999997 44433321111122 3345555555
Q ss_pred HHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 119 gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
.+..+|..|++|+|+||.||+++.++.++|+|||++..+.
T Consensus 269 ~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 269 FLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 4678899999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.9e-12 Score=116.66 Aligned_cols=121 Identities=17% Similarity=0.156 Sum_probs=88.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCcc-ceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVI-KLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv-~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|.++.||+++. .++.|+||+...... ......+|+.+++.+.+.+++ +++.+... .
T Consensus 9 G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~------------------~ 65 (170)
T cd05151 9 GMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE------------------T 65 (170)
T ss_pred cccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC------------------C
Confidence 66789999986 478899998764422 123567899999999765554 44443321 2
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV-----LHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~gi-----iHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
-++||||+++..+.... .....++.+|+.+|+.||..++ +|+||+++|||++ ++.++|+||+.+.
T Consensus 66 ~~lv~e~i~G~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 66 GVLITEFIEGSELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CeEEEEecCCCcccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 37999999984332210 1124467899999999999985 9999999999999 5689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.5e-13 Score=139.49 Aligned_cols=237 Identities=21% Similarity=0.192 Sum_probs=165.8
Q ss_pred ceeEEEEEEEc-cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 4 CISQVFMAREI-KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 4 ~fg~Vy~a~~~-~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
.|+.|+.+... .++-.|++|.+.............+.|+.++..| .|.+++..+..|.. ...
T Consensus 277 ~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~----------------~r~ 340 (524)
T KOG0601|consen 277 NFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ----------------LRQ 340 (524)
T ss_pred ccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc----------------ccc
Confidence 45555555433 5667788887655443333334456788888877 59999998888776 456
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCeEEecccccccccCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~~~ 160 (481)
.||-.|||++....+.......+++...+++..|++.++.++|+..++|+|+||+||++.++ +..++.||+.++.+...
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 67999999875555544444458889999999999999999999999999999999999886 78999999998753211
Q ss_pred CCCccccccccccCC-CchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYR-PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~-aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .....+-++. ..|++.....+..++|++||+..+.+.+++...-...... ..|... .+
T Consensus 421 ~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~-------------~~ 480 (524)
T KOG0601|consen 421 S----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSG-------------DT 480 (524)
T ss_pred c----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecc-------------cc
Confidence 1 1112233444 3666666677889999999999999999987432211110 000000 00
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+ .......++..+.+.++..|+..|+.+.++..|.-|
T Consensus 481 p-----------------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 481 P-----------------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred c-----------------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0 001223578889999999999999999999888755
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.21 E-value=1e-10 Score=106.90 Aligned_cols=127 Identities=24% Similarity=0.291 Sum_probs=82.9
Q ss_pred EEEEEEEccCCcEEEEEEeecCCc-----------CCC-------------cchhHHHHHHHHHhcCCC--CccceeeEE
Q 011627 7 QVFMAREIKTGEIVALKKIRMDNE-----------KEG-------------FPITAIREIKILKKLQHE--NVIKLKEIV 60 (481)
Q Consensus 7 ~Vy~a~~~~tg~~vAvK~i~~~~~-----------~~~-------------~~~~~~~Ei~il~~L~hp--nIv~l~~~~ 60 (481)
.||.|.. .+++.+|||+.+.... ... ....+.+|.++|.++..- ++.+.+++-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899987 5677999999764310 000 013445799999999866 456666553
Q ss_pred eCCCCCCCCCCCCCCCCcCCeEEEEEecCC--CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCcccCCCCCCc
Q 011627 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMD--HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY-CHVNQVLHRDIKGSN 137 (481)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~--g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~-LH~~giiHrDLKp~N 137 (481)
.. +|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|
T Consensus 80 ~~--------------------~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~N 137 (188)
T PF01163_consen 80 RN--------------------VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYN 137 (188)
T ss_dssp TT--------------------EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTS
T ss_pred CC--------------------EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhh
Confidence 22 79999999 64333333221 2244677788888885555 579999999999999
Q ss_pred EEEcCCCCeEEecccccccc
Q 011627 138 LLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 138 ILl~~~~~vkL~DFG~a~~~ 157 (481)
||++++ .+.|+||+.|...
T Consensus 138 Ilv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 138 ILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EEEETT-CEEE--GTTEEET
T ss_pred EEeecc-eEEEEecCcceec
Confidence 999987 8999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.7e-10 Score=102.27 Aligned_cols=136 Identities=18% Similarity=0.185 Sum_probs=96.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC------cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN------EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~------~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+=+.|+++.. .|+.++||.-.... +..-...+.++|+++|.++.--.|.--.-+|.+
T Consensus 18 GAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-------------- 81 (229)
T KOG3087|consen 18 GAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-------------- 81 (229)
T ss_pred cceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe--------------
Confidence 56677787765 88898888532111 111122455679999999976566555555555
Q ss_pred CcCCeEEEEEecCCC--ChhhhhcCCCCCCCHHHH-HHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---eEEec
Q 011627 77 KYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQI-KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLAD 150 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g--~L~~~~~~~~~~l~~~~i-~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~---vkL~D 150 (481)
...-.|+|||+++ .+.+++......-++++. ..+++.|-+.|.-||.++|||+||..+||+|..++. +.|+|
T Consensus 82 --~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 82 --TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred --cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEe
Confidence 2234789999998 666666553333333333 788999999999999999999999999999987664 58999
Q ss_pred cccccc
Q 011627 151 FGLARS 156 (481)
Q Consensus 151 FG~a~~ 156 (481)
||++..
T Consensus 160 fgls~~ 165 (229)
T KOG3087|consen 160 FGLSSV 165 (229)
T ss_pred ecchhc
Confidence 999854
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.7e-10 Score=106.02 Aligned_cols=138 Identities=17% Similarity=0.183 Sum_probs=98.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCC--CccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE--NVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hp--nIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|.++.||++... +|+.++||+....... .....+.+|+++++.|.+. .+.+++.+..... ..+
T Consensus 9 G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-------------~~~ 73 (223)
T cd05154 9 GQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-------------VLG 73 (223)
T ss_pred CccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-------------ccC
Confidence 778999999874 3689999998654332 1344678999999999764 3566666654311 123
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV----------------------------------- 125 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~----------------------------------- 125 (481)
..++||||+++..+...... ..+++.....++.+|+..|..||+
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD 152 (223)
T ss_pred CceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence 56899999998533322211 246777777788888888888873
Q ss_pred ---------------------CCcccCCCCCCcEEEcC--CCCeEEeccccccc
Q 011627 126 ---------------------NQVLHRDIKGSNLLIDN--EGNLKLADFGLARS 156 (481)
Q Consensus 126 ---------------------~giiHrDLKp~NILl~~--~~~vkL~DFG~a~~ 156 (481)
..++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.1e-09 Score=104.10 Aligned_cols=130 Identities=18% Similarity=0.100 Sum_probs=89.6
Q ss_pred cCCcEEEEEEeecCCcCC---------CcchhHHHHHHHHHhcCCCCccc--eeeEEeCCCCCCCCCCCCCCCCcCCeEE
Q 011627 15 KTGEIVALKKIRMDNEKE---------GFPITAIREIKILKKLQHENVIK--LKEIVTSPGPERDEQGRPDGNKYRGSTY 83 (481)
Q Consensus 15 ~tg~~vAvK~i~~~~~~~---------~~~~~~~~Ei~il~~L~hpnIv~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (481)
-.|+.|.||........+ .-...+.+|...+.+|..-+|.. .+.+.+... +......+
T Consensus 43 ~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~-----------~~~~~~s~ 111 (268)
T PRK15123 43 LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGS-----------NPATRTSF 111 (268)
T ss_pred ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecC-----------CCccceeE
Confidence 367889999764332111 00114779999999986444433 333443210 00023468
Q ss_pred EEEecCCC--ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-------CCCeEEecccc
Q 011627 84 MVFEYMDH--DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-------EGNLKLADFGL 153 (481)
Q Consensus 84 iV~Ey~~g--~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-------~~~vkL~DFG~ 153 (481)
||||++++ +|.+++... ....+......++.+|+..+.-||.+||+|+||++.||||+. +..+.|+||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 99999997 566655421 234567788899999999999999999999999999999975 45799999998
Q ss_pred cc
Q 011627 154 AR 155 (481)
Q Consensus 154 a~ 155 (481)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 74
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2e-09 Score=96.05 Aligned_cols=128 Identities=17% Similarity=0.185 Sum_probs=85.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEe-ecCCcCCC-----cchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKI-RMDNEKEG-----FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i-~~~~~~~~-----~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+=+.|+.+.. -+..+++|.- .+.-..+. -..+..+|+.++.++.--.|..-+-++.+
T Consensus 7 GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-------------- 70 (204)
T COG3642 7 GAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-------------- 70 (204)
T ss_pred CcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--------------
Confidence 66677887744 3444555542 11111111 12344579999999975554443333333
Q ss_pred CcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 77 KYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
...-.|+|||++|.++....... ...+++.+-.-+.-||.+||+|+||.++||++...+ +.++|||++..
T Consensus 71 --~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 71 --PDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred --CCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 22457999999997766333322 145667777778889999999999999999998865 99999999853
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.1e-10 Score=119.75 Aligned_cols=157 Identities=23% Similarity=0.323 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEecccccccccCCCCCcc------cc--ccccccCCCchhhcC
Q 011627 112 YMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL------TN--RVITLWYRPPELLLG 182 (481)
Q Consensus 112 i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~------~~--~~gt~~Y~aPEvl~~ 182 (481)
=+.+...||.|+|.. ++||++|.|++|.++..+.+||+-|+++..........+ .. ..-...|.|||++..
T Consensus 104 nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345566999999976 999999999999999999999999999876543111111 01 122567999999987
Q ss_pred CCCCCCCCchhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhh
Q 011627 183 ATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 261 (481)
Q Consensus 183 ~~~~~~~~DiwSlGvil~ell-tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (481)
...+.++|+|||||++|.+. .|+..|...+.......-....... .......
T Consensus 184 -~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~--------------------------~~~~s~~ 236 (700)
T KOG2137|consen 184 -TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG--------------------------AFGYSNN 236 (700)
T ss_pred -ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc--------------------------ccccccc
Confidence 66789999999999999998 5777676654433322221110000 0001146
Q ss_pred hcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 262 FDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 262 ~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
++.++++-|.++|..|...|+++.+++..+||..
T Consensus 237 ~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 237 LPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred CcHHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 8889999999999999999999999999999954
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.3e-08 Score=93.37 Aligned_cols=109 Identities=20% Similarity=0.225 Sum_probs=82.3
Q ss_pred chhHHHHHHHHHhcCCCC--ccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC--ChhhhhcCCCCCCCHHHHH
Q 011627 35 PITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIK 110 (481)
Q Consensus 35 ~~~~~~Ei~il~~L~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g--~L~~~~~~~~~~l~~~~i~ 110 (481)
..++.+|...+..|..-. +.+.+.+.+... +- ....+||+|++++ +|.+++..... ++.....
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-----------~~-~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~ 121 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRK-----------GG-GYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRR 121 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-----------CC-ceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHH
Confidence 346788999988886433 344444444311 00 1356899999987 56666654322 6777888
Q ss_pred HHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CeEEeccccccc
Q 011627 111 CYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARS 156 (481)
Q Consensus 111 ~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~ 156 (481)
.++.+|...+.-||.+||+|+||++.|||++.++ .+.|+||+.++.
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999999999999999887 799999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.3e-08 Score=94.46 Aligned_cols=130 Identities=22% Similarity=0.264 Sum_probs=94.8
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCc--------------C------CCcchhHHHHHHHHHhcCCC--CccceeeE
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNE--------------K------EGFPITAIREIKILKKLQHE--NVIKLKEI 59 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~--------------~------~~~~~~~~~Ei~il~~L~hp--nIv~l~~~ 59 (481)
+|.=|.||.|.+. .+..+|||+-+.... + .-....+.+|.++|.+|... .|.+.+++
T Consensus 101 vGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~ 179 (304)
T COG0478 101 VGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW 179 (304)
T ss_pred cCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc
Confidence 4667899999985 788999997542210 0 01124556899999999755 66666543
Q ss_pred EeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 011627 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 139 (481)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NIL 139 (481)
+.-++||||++|-.+..+. ++...+..++..|++-+.-+-..||||+||+.-|||
T Consensus 180 --------------------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIl 234 (304)
T COG0478 180 --------------------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNIL 234 (304)
T ss_pred --------------------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEE
Confidence 2448999999985443221 234456667777777777777999999999999999
Q ss_pred EcCCCCeEEecccccccc
Q 011627 140 IDNEGNLKLADFGLARSF 157 (481)
Q Consensus 140 l~~~~~vkL~DFG~a~~~ 157 (481)
++++|.+.|+||--+...
T Consensus 235 V~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred EecCCCEEEEeCcccccC
Confidence 999999999999876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.3e-07 Score=85.62 Aligned_cols=140 Identities=15% Similarity=0.140 Sum_probs=98.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC---cC-CCcchhHHHHHHHHHhcCCCC--ccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN---EK-EGFPITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~---~~-~~~~~~~~~Ei~il~~L~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+-|.|+.... .|+.+-||.-.... .. ..-..++.+|+..|++|..-+ +.+.. ++... ..
T Consensus 29 gG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~-----------k~ 94 (216)
T PRK09902 29 NGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAV-----------KI 94 (216)
T ss_pred CCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeee-----------cc
Confidence 77888998764 44478888764111 01 223468889999999996433 33333 22110 00
Q ss_pred CcCCeEEEEEecCCC--ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC--eEEecc
Q 011627 77 KYRGSTYMVFEYMDH--DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN--LKLADF 151 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g--~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~--vkL~DF 151 (481)
...-..+||+|-+++ +|.+.+.+.. .+.+..+...++.+|...|.-||+.|+.|+|+.+.|||++.++. |+++||
T Consensus 95 ~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDl 174 (216)
T PRK09902 95 EGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDL 174 (216)
T ss_pred CCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEh
Confidence 013356899998885 7776664422 24677788899999999999999999999999999999987677 999999
Q ss_pred ccccc
Q 011627 152 GLARS 156 (481)
Q Consensus 152 G~a~~ 156 (481)
.-++.
T Consensus 175 Ek~r~ 179 (216)
T PRK09902 175 EKSRR 179 (216)
T ss_pred hccch
Confidence 87653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.3e-07 Score=86.89 Aligned_cols=134 Identities=16% Similarity=0.187 Sum_probs=92.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC-----------------c-----chhHHHHHHHHHhcC--CCCccceee
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG-----------------F-----PITAIREIKILKKLQ--HENVIKLKE 58 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~-----------------~-----~~~~~~Ei~il~~L~--hpnIv~l~~ 58 (481)
|.=+.||+|.. .++..||||+++....... . .....+|+..|+++. +-.+.+-+.
T Consensus 59 GKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~ 137 (268)
T COG1718 59 GKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIA 137 (268)
T ss_pred CcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCcee
Confidence 45578999886 5789999999874421100 0 122346888888874 334445555
Q ss_pred EEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCc
Q 011627 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSN 137 (481)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~N 137 (481)
++.. .|||||+..+..-.=.-.+..+...++..+..++++.+.-|-. .++||+||+.-|
T Consensus 138 ~~~n--------------------VLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyN 197 (268)
T COG1718 138 FRNN--------------------VLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYN 197 (268)
T ss_pred ecCC--------------------eEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhh
Confidence 4432 7999999865211111122234444788889999999998877 899999999999
Q ss_pred EEEcCCCCeEEeccccccccc
Q 011627 138 LLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 138 ILl~~~~~vkL~DFG~a~~~~ 158 (481)
||+. ++.+.|+||+-|....
T Consensus 198 iL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 198 ILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred eEEE-CCeEEEEECccccccC
Confidence 9999 7789999999987654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.4e-07 Score=90.90 Aligned_cols=129 Identities=13% Similarity=0.125 Sum_probs=97.0
Q ss_pred eEEEEEecCCC--Chhhhhc---C--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccc
Q 011627 81 STYMVFEYMDH--DLTGLAD---R--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 81 ~~~iV~Ey~~g--~L~~~~~---~--~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
.+-++|..+.+ ....++. + .-..+.++.+.++.+.|+.+.+.||..|.+-+|+.++|||+.+++.|.|+|-..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 47788888876 2222222 1 112377888999999999999999999999999999999999999999998654
Q ss_pred cccccCCCCCccccccccccCCCchhhcCC----CCCCCCCchhhHHHHHHHHHhC-CCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNG-KPILPG 211 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~----~~~~~~~DiwSlGvil~elltG-~~pf~~ 211 (481)
-..- .........++...|.+||.-.-. ..-+...|.|.|++++|+||.| +.||.+
T Consensus 164 fqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 164 FQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 3221 223334445778999999965411 2235678999999999999986 899976
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.2e-08 Score=103.87 Aligned_cols=236 Identities=15% Similarity=0.089 Sum_probs=159.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCC-ccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN-VIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpn-Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
++++++++.|...+...+ .+++... ....-++++|.+++||| .+..++-... +..
T Consensus 253 ~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~----------------E~~ 308 (829)
T KOG0576|consen 253 GALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDG----------------EDY 308 (829)
T ss_pred HHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCc----------------ccc
Confidence 678899999998887776 8877654 23446899999999999 4444433322 667
Q ss_pred EEEEEecCCCC--hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g~--L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|++++++.. ...........+.+-++..+.+.-+.+|++||+.--+|+| ||+..+ +..|+.||+....+..
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc
Confidence 89999999865 3333333333455556677778888999999998889998 777766 5699999999877653
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.. ...+..+|+.++|||+... ..+....|.|++++-..+|.-|.+|-...- ....-.+..
T Consensus 384 ~~--~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~---------------~~~~~~g~~-- 443 (829)
T KOG0576|consen 384 TM--KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP---------------AVLPMIGNG-- 443 (829)
T ss_pred cc--ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCc---------------cccCCCCCC--
Confidence 32 3445677999999998876 678889999999987777777766543300 000000000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
+ +....... ..|.... -.++...||...|..|...-.++.|.+|..-+
T Consensus 444 p--~s~~L~~~------~aw~~~~--~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 444 P--NSPMLTDK------SAWSPVF--HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred C--Cccccchh------hhcCccc--ccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 0 00000000 1111111 11588899999999999999999999996543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.8e-07 Score=83.87 Aligned_cols=67 Identities=21% Similarity=0.388 Sum_probs=51.2
Q ss_pred CCeEEEEEecCCCC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 79 RGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 79 ~~~~~iV~Ey~~g~-L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
....+|||||++|- |.+... +++ .+...|+++|.-||+.|++|+|+.|.|+++++++ ++++||+..+
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 44667999999984 333221 222 2445677889999999999999999999999765 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.4e-06 Score=91.53 Aligned_cols=76 Identities=16% Similarity=0.355 Sum_probs=51.0
Q ss_pred CCeEEEEEecCCC-Chhhh--hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGL--ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~--~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.+.-.|+|||++| .+.+. +.. ..++...+...+.+++ +..+-..|++|.|..|.||+++.++.+.+.|||+..
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCccee
Confidence 3455899999998 33332 222 2344333332222221 233345899999999999999999999999999987
Q ss_pred ccc
Q 011627 156 SFS 158 (481)
Q Consensus 156 ~~~ 158 (481)
.+.
T Consensus 314 ~l~ 316 (517)
T COG0661 314 RLD 316 (517)
T ss_pred cCC
Confidence 654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=9.9e-06 Score=76.71 Aligned_cols=128 Identities=15% Similarity=0.081 Sum_probs=75.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCC--ccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|.-+.||+. .+..+++|+..... ....+.+|.++++.+..-. +.+.+.+... .+
T Consensus 12 G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~----------------~~ 67 (226)
T TIGR02172 12 GGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVED----------------GG 67 (226)
T ss_pred CCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEec----------------CC
Confidence 666789973 35567888876432 2335688999999996443 4566666654 44
Q ss_pred eEEEEEecCCCC--hhhhhc---------------------CCC-CCCCHHH-HHHHHHH----------HHHH-HHHHH
Q 011627 81 STYMVFEYMDHD--LTGLAD---------------------RPG-LRFTVPQ-IKCYMKQ----------LLTG-LHYCH 124 (481)
Q Consensus 81 ~~~iV~Ey~~g~--L~~~~~---------------------~~~-~~l~~~~-i~~i~~Q----------il~g-L~~LH 124 (481)
...+|||+++|. +...+. ... ....... ...+..+ +... ..+|.
T Consensus 68 ~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~ 147 (226)
T TIGR02172 68 RLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIK 147 (226)
T ss_pred eeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHH
Confidence 568899999984 111110 000 0011111 0011000 1111 11222
Q ss_pred ----hCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 125 ----VNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 125 ----~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
...++|+|+.|.||++++++ +.|+||+.+.
T Consensus 148 ~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 148 EVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred hCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 12478999999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1e-05 Score=77.49 Aligned_cols=67 Identities=13% Similarity=0.053 Sum_probs=45.5
Q ss_pred cce-eEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCI-SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~f-g~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|.. +.||++.. .++.+.||+..... ...+.+|+.+++.|. +--+.+++.+... .+
T Consensus 9 g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----------------~~ 65 (244)
T cd05150 9 GQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD----------------DG 65 (244)
T ss_pred CCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec----------------CC
Confidence 555 67999875 34688888875432 225678999999984 4334456665544 33
Q ss_pred eEEEEEecCCCC
Q 011627 81 STYMVFEYMDHD 92 (481)
Q Consensus 81 ~~~iV~Ey~~g~ 92 (481)
.-+||||+++|.
T Consensus 66 ~~~lv~e~i~G~ 77 (244)
T cd05150 66 RAWLLTSAVPGV 77 (244)
T ss_pred ccEEEEEeeCCc
Confidence 568999999884
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.5e-06 Score=77.53 Aligned_cols=71 Identities=21% Similarity=0.268 Sum_probs=47.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCC--ccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|..+.||++.... ..++||+.... .....+.+|+.+++.|.... +.+++...... ....
T Consensus 8 G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~-------------~~~~ 68 (239)
T PF01636_consen 8 GFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD-------------EFNG 68 (239)
T ss_dssp SSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET-------------EETS
T ss_pred CCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc-------------cccc
Confidence 5678899998744 59999997644 23446778999999986443 45666543321 1144
Q ss_pred eEEEEEecCCCC
Q 011627 81 STYMVFEYMDHD 92 (481)
Q Consensus 81 ~~~iV~Ey~~g~ 92 (481)
..+++|+++.+.
T Consensus 69 ~~~~~~~~i~g~ 80 (239)
T PF01636_consen 69 FPYLLMEYIPGR 80 (239)
T ss_dssp EEEEEEEEESSE
T ss_pred cceEEEEEeccc
Confidence 589999999984
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.6e-06 Score=94.19 Aligned_cols=201 Identities=19% Similarity=0.230 Sum_probs=132.8
Q ss_pred HHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC-eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHH
Q 011627 39 IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG-STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLL 117 (481)
Q Consensus 39 ~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil 117 (481)
..|++.+.++.|.|++.++.+-.+.. ..+ .+.+..|+|...........-..++...++.+..+++
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~-------------~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~ 296 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERL-------------FRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLL 296 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhh-------------cchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHh
Confidence 35777788889999999988765521 122 2334457777633333333444688889999999999
Q ss_pred HHHHHHHhCCcccCCCCCC---cEEEcCCCCeEEe--cccccccccCCCCCccccccccccCCCchhhcCCCCCC--CCC
Q 011627 118 TGLHYCHVNQVLHRDIKGS---NLLIDNEGNLKLA--DFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG--PAV 190 (481)
Q Consensus 118 ~gL~~LH~~giiHrDLKp~---NILl~~~~~vkL~--DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~--~~~ 190 (481)
+||.|+|+..+.|.-|..+ +..++.++.+.+. ||+.+..+.... .......+..+.++|.+.. ..+. ...
T Consensus 297 ~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--~~~~~~~~~~~~~~e~~~~-~~~~~~r~~ 373 (1351)
T KOG1035|consen 297 EGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--KSFSDLLAEIRNADEDLKE-NTAKKSRLT 373 (1351)
T ss_pred hhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcc--cchhhcCcccccccccccc-ccchhhhhh
Confidence 9999999996655544444 3334455566666 888877654322 2222344667888887754 3333 346
Q ss_pred chhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhh-hcHHHHHH
Q 011627 191 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH-FDRHALEL 269 (481)
Q Consensus 191 DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l 269 (481)
|+|++|..+..+..+...-... ..+. .+... +..+..++
T Consensus 374 dL~~lgll~~~~~~~~~i~~~~------~~~~----------------------------------~~l~~~~~~~~~d~ 413 (1351)
T KOG1035|consen 374 DLWCLGLLLLQLSQGEDISEKS------AVPV----------------------------------SLLDVLSTSELLDA 413 (1351)
T ss_pred HHHHHHHHHhhhhhcCcccccc------cchh----------------------------------hhhccccchhhhhh
Confidence 9999999999998875321100 0000 01111 11267899
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 270 LEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 270 l~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+.+|+.-|.++|+++.+++.|+|.+.
T Consensus 414 ~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 414 LPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhcchhhhhccchhhhhhchhccc
Confidence 99999999999999999999999854
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1e-05 Score=84.81 Aligned_cols=76 Identities=21% Similarity=0.302 Sum_probs=51.3
Q ss_pred CCeEEEEEecCCC---ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC----CCCeEEecc
Q 011627 79 RGSTYMVFEYMDH---DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN----EGNLKLADF 151 (481)
Q Consensus 79 ~~~~~iV~Ey~~g---~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~----~~~vkL~DF 151 (481)
...-.|+||||+| +-++.+.+.+ ++...+...+.++. ++-|-..|++|+|=.|.||+++. +.++.|.||
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDh 349 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDH 349 (538)
T ss_pred CcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcc
Confidence 3356899999998 3334444433 55544443333332 12334578999999999999984 567999999
Q ss_pred ccccccc
Q 011627 152 GLARSFS 158 (481)
Q Consensus 152 G~a~~~~ 158 (481)
|+...+.
T Consensus 350 Gl~~~is 356 (538)
T KOG1235|consen 350 GLYAVIS 356 (538)
T ss_pred ccccccc
Confidence 9987654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.2e-05 Score=69.96 Aligned_cols=121 Identities=22% Similarity=0.202 Sum_probs=84.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|++|.||++.. .|..+|+|+-+.+.. ...+..|.++|..+.-.++..=+-.+- ..
T Consensus 33 G~~s~Vyl~~~--~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg-------------------~~ 87 (201)
T COG2112 33 GTTSVVYLGEW--RGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYG-------------------ED 87 (201)
T ss_pred ccccEEEEeec--cCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEec-------------------hh
Confidence 78999999997 677999999876543 347889999999998877765332221 23
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-CCcEEEcCCCCeEEeccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK-GSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLK-p~NILl~~~~~vkL~DFG~a~~ 156 (481)
++.|||++| .|.+..... + +.-+..+++.---|-..||-|..|. |..++|.++..+.|+||..|+.
T Consensus 88 ~i~me~i~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhcCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 577999998 555544321 1 2223345555445677799999886 5555555555899999998863
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=5.1e-05 Score=85.41 Aligned_cols=76 Identities=20% Similarity=0.271 Sum_probs=48.9
Q ss_pred cceeEEEEEEEccCC--cEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCc--cceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG--EIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENV--IKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg--~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnI--v~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|.+..+|++.....+ ..++||+........ ....+.+|+++|+.|. |.+| .+++.++.+...
T Consensus 49 G~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v------------ 115 (822)
T PLN02876 49 GQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV------------ 115 (822)
T ss_pred CCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc------------
Confidence 556688988764332 467777765332111 2346779999999995 6665 666666654211
Q ss_pred cCCeEEEEEecCCCC
Q 011627 78 YRGSTYMVFEYMDHD 92 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g~ 92 (481)
.+..||||||++|.
T Consensus 116 -~G~~flVME~v~G~ 129 (822)
T PLN02876 116 -IGTAFYIMEYLEGR 129 (822)
T ss_pred -CCCceEEEEecCCc
Confidence 24568999999984
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.4e-05 Score=78.97 Aligned_cols=174 Identities=25% Similarity=0.346 Sum_probs=117.2
Q ss_pred chhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHH
Q 011627 35 PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMK 114 (481)
Q Consensus 35 ~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~ 114 (481)
..+++-...+++.+.|+|...++++.... .....+|||+++-++.+.+..... -...
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~---------------~~r~IVV~e~~~~Sled~~~~~~l--~~~s------ 82 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGK---------------HERVIVVMEHYTMSLEDILKTGNL--KDES------ 82 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCc---------------cceEEEEehhhccchHHHHHhccc--chhh------
Confidence 34677788999999999999999887541 234889999999998887765431 1111
Q ss_pred HHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhh
Q 011627 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 194 (481)
Q Consensus 115 Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwS 194 (481)
++ .+++.|- | .++++| -++.. | | ....+++||||
T Consensus 83 -~~-------~~~~~~~-----~-------~~~~td-~~~t~-----------------~--~------~~~~pKsdVws 116 (725)
T KOG1093|consen 83 -LL-------AHGVLHL-----N-------IIYITD-HFLTK-----------------Y--P------SPIGPKSDVWS 116 (725)
T ss_pred -hc-------cccccee-----h-------hhhccc-ccccc-----------------C--C------CCCCcchhhhh
Confidence 11 2222222 1 244444 11100 0 1 11225899999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhc
Q 011627 195 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKML 274 (481)
Q Consensus 195 lGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 274 (481)
+|.|+.++..|...+......+.++.+......... .........+...++...++++.+|+
T Consensus 117 l~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~------------------~~~~a~e~~~~~~~d~~~~~~~~~c~ 178 (725)
T KOG1093|consen 117 LGFIILELYLGISLEAELTESEYLEILLKYYTDDQE------------------LLSTAMEHLIQLLADKKRLPLLKKCL 178 (725)
T ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchh------------------HHHHHHHHHHHHhhhHhHHHHhccCC
Confidence 999999999999999888888888877654322211 11111122444567888999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCC
Q 011627 275 MLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 275 ~~dP~~R~sa~eiL~h~~f~~ 295 (481)
-..|..|+...++.++.-|..
T Consensus 179 ~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 179 WLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred ccccccccchhHHhcCccHHH
Confidence 999999999999999998854
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.4e-05 Score=70.83 Aligned_cols=99 Identities=25% Similarity=0.191 Sum_probs=78.9
Q ss_pred HHHHHHHHhcCC-CCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhhhc--CCCCCCCHHHHHHHHH
Q 011627 39 IREIKILKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLAD--RPGLRFTVPQIKCYMK 114 (481)
Q Consensus 39 ~~Ei~il~~L~h-pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~~~--~~~~~l~~~~i~~i~~ 114 (481)
..|.-+++.|.+ +++.++++++-. ++|.||... .+..... ..-...++....+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--------------------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~ 66 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--------------------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIAL 66 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--------------------EEEEEeecCccccccccccccccccCHHHHHHHHH
Confidence 368999999976 699999999854 789999985 4432110 1112368889999999
Q ss_pred HHHHHHHHHHh---CCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 115 QLLTGLHYCHV---NQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 115 Qil~gL~~LH~---~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
++++.+++|+. ..+.-+|++++||-|++++++|++|...+...
T Consensus 67 ~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 67 QLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999987 35788999999999999999999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.92 E-value=7.5e-05 Score=73.77 Aligned_cols=134 Identities=18% Similarity=0.257 Sum_probs=92.5
Q ss_pred ceeEEEEEEEccCCcEEEEEEeecCC----c--------------------CCCcchhHHHHHHHHHhcCCCCccceeeE
Q 011627 4 CISQVFMAREIKTGEIVALKKIRMDN----E--------------------KEGFPITAIREIKILKKLQHENVIKLKEI 59 (481)
Q Consensus 4 ~fg~Vy~a~~~~tg~~vAvK~i~~~~----~--------------------~~~~~~~~~~Ei~il~~L~hpnIv~l~~~ 59 (481)
.=+.||.|.. .+|+.+|||+++... . .......+.+|+.-|++|+...|.--.-+
T Consensus 156 KEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePI 234 (520)
T KOG2270|consen 156 KEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPI 234 (520)
T ss_pred ccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCce
Confidence 3456999876 678889999875321 0 01111334578999999976554332222
Q ss_pred EeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCcE
Q 011627 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC-HVNQVLHRDIKGSNL 138 (481)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~L-H~~giiHrDLKp~NI 138 (481)
.. . .-+|||++++.+-+-.-.-.+..++...+..+-.|++.-+.-| |.+++||.||.--|+
T Consensus 235 lL-----------------k-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~ 296 (520)
T KOG2270|consen 235 LL-----------------K-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL 296 (520)
T ss_pred ee-----------------e-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence 21 1 2379999999754443333344578888999989998888888 567999999999999
Q ss_pred EEcCCCCeEEecccccccc
Q 011627 139 LIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~ 157 (481)
|+-+ |.|.|+|.+-+...
T Consensus 297 Lyhd-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 297 LYHD-GKLYIIDVSQSVEH 314 (520)
T ss_pred eEEC-CEEEEEEccccccC
Confidence 9865 67999999877644
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00012 Score=70.57 Aligned_cols=128 Identities=20% Similarity=0.291 Sum_probs=72.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCcc-ceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVI-KLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv-~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|-...+|++. .+++.++||+....... ......+|..+++.+....++ +++.+..
T Consensus 7 G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~~~-------------------- 62 (256)
T TIGR02721 7 GLTNRSWRIE--HPGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILVNE-------------------- 62 (256)
T ss_pred cCcCCeEEEE--eCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEEeC--------------------
Confidence 3445789886 46778889876543221 112457899999999754443 3333221
Q ss_pred EEEEEecCCCChhhhh------------------cCC---CCCCCH-HHHHHHHHHH---------HHHHHHHHh-----
Q 011627 82 TYMVFEYMDHDLTGLA------------------DRP---GLRFTV-PQIKCYMKQL---------LTGLHYCHV----- 125 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~------------------~~~---~~~l~~-~~i~~i~~Qi---------l~gL~~LH~----- 125 (481)
-++||||++|...... ... ...++. ..+..+..++ ...++.+-.
T Consensus 63 ~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 142 (256)
T TIGR02721 63 HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPA 142 (256)
T ss_pred CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCC
Confidence 1689999987322110 000 111221 1222222122 111222211
Q ss_pred ---CCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 126 ---NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 126 ---~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
..++|+|+.+.|||++.++ ++|+||..|.
T Consensus 143 ~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 143 PLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CCCCeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 2589999999999999876 8999999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.0002 Score=68.04 Aligned_cols=29 Identities=21% Similarity=0.466 Sum_probs=26.0
Q ss_pred CcccCCCCCCcEEEcC-CCCeEEecccccc
Q 011627 127 QVLHRDIKGSNLLIDN-EGNLKLADFGLAR 155 (481)
Q Consensus 127 giiHrDLKp~NILl~~-~~~vkL~DFG~a~ 155 (481)
.++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 6999999999999998 5779999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00011 Score=70.02 Aligned_cols=29 Identities=28% Similarity=0.405 Sum_probs=24.9
Q ss_pred CcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 127 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 127 giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.++|+|+.+.|||++++...-|+||+.|.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 58999999999999876555799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00034 Score=64.57 Aligned_cols=116 Identities=17% Similarity=0.202 Sum_probs=80.7
Q ss_pred EccCCcEEEEEEeecCC--------------cCCCcchhHHHHHHHHHhcC------CCCccceeeEEeCCCCCCCCCCC
Q 011627 13 EIKTGEIVALKKIRMDN--------------EKEGFPITAIREIKILKKLQ------HENVIKLKEIVTSPGPERDEQGR 72 (481)
Q Consensus 13 ~~~tg~~vAvK~i~~~~--------------~~~~~~~~~~~Ei~il~~L~------hpnIv~l~~~~~~~~~~~~~~~~ 72 (481)
-...+...+||+++... ..........+|+..+..+. +..|.+++++.+.
T Consensus 19 ~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT---------- 88 (199)
T PF10707_consen 19 QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVET---------- 88 (199)
T ss_pred ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEec----------
Confidence 34556678999988765 11112456678888888777 7899999999998
Q ss_pred CCCCCcCCeEEEEEecCC---C----ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-
Q 011627 73 PDGNKYRGSTYMVFEYMD---H----DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG- 144 (481)
Q Consensus 73 ~~~~~~~~~~~iV~Ey~~---g----~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~- 144 (481)
+..+-+|+|.+. | +|.+++.+. .+++ .+...|-+-.+||-++.|+.+||+|.||++....
T Consensus 89 ------~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 89 ------NLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred ------CCceEEEEEEEECCCCCcCccHHHHHHcC--CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 556788888873 2 355555332 3554 3333344556788999999999999999996433
Q ss_pred ---CeEEec
Q 011627 145 ---NLKLAD 150 (481)
Q Consensus 145 ---~vkL~D 150 (481)
.+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00024 Score=70.31 Aligned_cols=29 Identities=34% Similarity=0.495 Sum_probs=26.0
Q ss_pred CcccCCCCCCcEEEcCC----CCeEEecccccc
Q 011627 127 QVLHRDIKGSNLLIDNE----GNLKLADFGLAR 155 (481)
Q Consensus 127 giiHrDLKp~NILl~~~----~~vkL~DFG~a~ 155 (481)
.++|+||.+.|||++.+ +.++|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 68999999999999985 789999999873
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=5.7e-06 Score=93.43 Aligned_cols=157 Identities=11% Similarity=0.023 Sum_probs=115.0
Q ss_pred hHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhhhhcCCCC---CCCHHHHHHH
Q 011627 37 TAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGL---RFTVPQIKCY 112 (481)
Q Consensus 37 ~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~-g~L~~~~~~~~~---~l~~~~i~~i 112 (481)
..+.|..-+++..|.++...+.-+.... ....|++++|+. |++...+.+... .+...-+.+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~--------------s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~ 1340 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSE--------------STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLR 1340 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCC--------------ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHH
Confidence 3345555666778999888776554422 446689999998 567776665332 2455556666
Q ss_pred HHHHHHHHHHHHhC-----CcccCCCCCCcEEEcCCCCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCC
Q 011627 113 MKQLLTGLHYCHVN-----QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 187 (481)
Q Consensus 113 ~~Qil~gL~~LH~~-----giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~ 187 (481)
.++.+....-+|+. -.+|++||+-|.+|..+.++|+.++|+.+... .........++++.|+++++... -.++
T Consensus 1341 ~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~-ik~t 1418 (2724)
T KOG1826|consen 1341 HKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNE-IKFT 1418 (2724)
T ss_pred HHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHH-Hhhh
Confidence 66667777777754 27999999999999999999999999998322 22334445677889999997765 5677
Q ss_pred CCCchhhHHHHHHHHHhCCCCC
Q 011627 188 PAVDMWSVGCIFAELLNGKPIL 209 (481)
Q Consensus 188 ~~~DiwSlGvil~elltG~~pf 209 (481)
.++|+|..++.+|++..+..+|
T Consensus 1419 ~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1419 KRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hHHHHHHHHHHHHHHhcccHHH
Confidence 8899999999999998876555
|
|
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00075 Score=71.44 Aligned_cols=6 Identities=33% Similarity=-0.003 Sum_probs=2.7
Q ss_pred CCCCCC
Q 011627 277 DPSQRI 282 (481)
Q Consensus 277 dP~~R~ 282 (481)
|..-|+
T Consensus 417 Dy~~rp 422 (1102)
T KOG1924|consen 417 DYYIRP 422 (1102)
T ss_pred hhhhhH
Confidence 444454
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0005 Score=63.21 Aligned_cols=129 Identities=23% Similarity=0.256 Sum_probs=81.6
Q ss_pred eEEEEEEEccCCcEEEEEEeecC---Cc--------C-C-------CcchhHHHHHHHHHhc---CCCCc--cceeeEEe
Q 011627 6 SQVFMAREIKTGEIVALKKIRMD---NE--------K-E-------GFPITAIREIKILKKL---QHENV--IKLKEIVT 61 (481)
Q Consensus 6 g~Vy~a~~~~tg~~vAvK~i~~~---~~--------~-~-------~~~~~~~~Ei~il~~L---~hpnI--v~l~~~~~ 61 (481)
|.||+++. .|+.||||+++.. .. . + .+..-+..|-+..-+| .++.+ |++++++.
T Consensus 52 ~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~ 129 (207)
T PF13095_consen 52 GYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLL 129 (207)
T ss_pred eEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEE
Confidence 78999887 7889999994321 10 0 0 1223445677766666 45666 99999986
Q ss_pred CCCCCCCCCC--CCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 011627 62 SPGPERDEQG--RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 139 (481)
Q Consensus 62 ~~~~~~~~~~--~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NIL 139 (481)
-...+...+. ........-...||.||+.... .++.. -+.+|+.-|..+|..||+-+|+|+.|..
T Consensus 130 L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~k~gI~~~Dv~~~ny~ 196 (207)
T PF13095_consen 130 LTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILHKLGIVPRDVKPRNYR 196 (207)
T ss_pred EchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHHHCCeeeccCcccccc
Confidence 5321111000 0011122334578999887543 12322 3456777888999999999999999996
Q ss_pred EcCCCCeEEeccccc
Q 011627 140 IDNEGNLKLADFGLA 154 (481)
Q Consensus 140 l~~~~~vkL~DFG~a 154 (481)
.=||+|||.+
T Consensus 197 -----~G~lvDfs~~ 206 (207)
T PF13095_consen 197 -----GGKLVDFSSS 206 (207)
T ss_pred -----CCEEEecccC
Confidence 4699999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00093 Score=66.61 Aligned_cols=30 Identities=27% Similarity=0.389 Sum_probs=25.9
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 126 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.++||+|+++.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999976556899999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0008 Score=66.75 Aligned_cols=30 Identities=30% Similarity=0.427 Sum_probs=26.8
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 126 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00011 Score=71.60 Aligned_cols=129 Identities=19% Similarity=0.234 Sum_probs=85.8
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCc-------CC-------------CcchhHHHHHHHHHhcCC-C-CccceeeE
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNE-------KE-------------GFPITAIREIKILKKLQH-E-NVIKLKEI 59 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-------~~-------------~~~~~~~~Ei~il~~L~h-p-nIv~l~~~ 59 (481)
+|.=|.||++-+ ..|..+++|+-++... +. -....+.+|+..|+.|.. - -|.+.+++
T Consensus 102 VGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpiD~ 180 (465)
T KOG2268|consen 102 VGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKPIDH 180 (465)
T ss_pred cccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 456678999887 5678889996542210 00 012344579999998853 2 23344443
Q ss_pred EeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
. ..++|||++.+ -|.....-. .+..+...|+.-+--|..+|+||+|..-=||
T Consensus 181 ~--------------------RH~Vvmelv~g~Pl~~v~~v~-------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 181 N--------------------RHCVVMELVDGYPLRQVRHVE-------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNI 233 (465)
T ss_pred c--------------------ceeeHHHhhcccceeeeeecC-------ChHHHHHHHHHHHHHHHHcCceecccchhee
Confidence 2 44899999997 333322111 2344455566666778899999999999999
Q ss_pred EEcCCCCeEEeccccccccc
Q 011627 139 LIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~ 158 (481)
+|++++.++++||=-.....
T Consensus 234 mv~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 234 MVKDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred EEecCCCEEEeechHhhccC
Confidence 99999999999997654443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0029 Score=62.54 Aligned_cols=70 Identities=13% Similarity=0.046 Sum_probs=46.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCC---CCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH---ENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~h---pnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|..+.||...+ ++..+.+|+.+... ....+.+|...|+.|.. -.|.++++++.... ..
T Consensus 25 G~~~~vy~~~~--~~~~~~~k~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~-------------~~ 85 (297)
T PRK10593 25 QPYAALWALYD--SQGNPMPLMARSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ-------------SP 85 (297)
T ss_pred ccceeEEEEEc--CCCCEEEEEecccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC-------------cC
Confidence 67788998864 23356777743211 12367799999999953 35677777665421 13
Q ss_pred CeEEEEEecCCC
Q 011627 80 GSTYMVFEYMDH 91 (481)
Q Consensus 80 ~~~~iV~Ey~~g 91 (481)
+..+||||++++
T Consensus 86 g~~~LVmE~i~G 97 (297)
T PRK10593 86 GPDVLLLERLRG 97 (297)
T ss_pred CCeEEEEeccCC
Confidence 457999999986
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0014 Score=64.56 Aligned_cols=134 Identities=13% Similarity=0.040 Sum_probs=74.0
Q ss_pred eeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCC--ccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 5 ISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 5 fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
-..||++.. ++..++||+.... ....+..|+.+++.|.+.. +.+++..... .. .....+..
T Consensus 27 ~n~~y~v~~--~~~~~vLr~~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g---------~~-~~~~~~~~ 89 (296)
T cd05153 27 ENTNYFVTT--DSGRYVLTLFEKV-----SAEELPFFLALLDHLAERGLPVPRPIADRDG---------EY-LSELAGKP 89 (296)
T ss_pred ccceEEEEe--CCCcEEEEEcCCC-----ChHhccHHHHHHHHHHHCCCCCCccccCCCC---------cE-eeeeCCce
Confidence 367888764 4457889987641 1235667899888885443 3344322100 00 00124567
Q ss_pred EEEEecCCCChhhh-----hc----------C--CCCC-------C-C--HHHHH--------HHHHHHHHHHHHHHh--
Q 011627 83 YMVFEYMDHDLTGL-----AD----------R--PGLR-------F-T--VPQIK--------CYMKQLLTGLHYCHV-- 125 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~-----~~----------~--~~~~-------l-~--~~~i~--------~i~~Qil~gL~~LH~-- 125 (481)
++|+|+++|..... +. . .... . . ..... .....+...+.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999998732211 00 0 0000 0 0 00000 011112233444432
Q ss_pred -----CCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 126 -----NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 126 -----~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.+++|+|+.+.|||++++..+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999987767899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0025 Score=67.63 Aligned_cols=6 Identities=17% Similarity=0.446 Sum_probs=2.3
Q ss_pred HHHHHH
Q 011627 116 LLTGLH 121 (481)
Q Consensus 116 il~gL~ 121 (481)
|+.+|.
T Consensus 212 iIrClk 217 (1102)
T KOG1924|consen 212 IIRCLK 217 (1102)
T ss_pred HHHHHH
Confidence 333333
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0034 Score=64.21 Aligned_cols=71 Identities=18% Similarity=0.040 Sum_probs=47.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecC-----CcCCCcchhHHHHHHHHHhcC---CCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMD-----NEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~-----~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|-+..||++.+...++.|+||..... ........+...|.+.|+.+. -..+.+++.+-
T Consensus 37 Gn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-------------- 102 (401)
T PRK09550 37 GNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-------------- 102 (401)
T ss_pred CceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--------------
Confidence 66788999998544468999985421 111223456678899888873 24566676653
Q ss_pred CCCcCCeEEEEEecCCC
Q 011627 75 GNKYRGSTYMVFEYMDH 91 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g 91 (481)
....++|||+++.
T Consensus 103 ----~~~~~lVME~L~~ 115 (401)
T PRK09550 103 ----EELAVTVMEDLSD 115 (401)
T ss_pred ----CCCCEEEEecCCC
Confidence 2345899999875
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0025 Score=63.93 Aligned_cols=27 Identities=33% Similarity=0.660 Sum_probs=24.3
Q ss_pred cccCCCCCCcEEEcC-CCCeEEeccccc
Q 011627 128 VLHRDIKGSNLLIDN-EGNLKLADFGLA 154 (481)
Q Consensus 128 iiHrDLKp~NILl~~-~~~vkL~DFG~a 154 (481)
++|+||.+.|||+++ ++.++|+||..|
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEccccc
Confidence 799999999999975 467999999987
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.003 Score=63.78 Aligned_cols=29 Identities=24% Similarity=0.495 Sum_probs=25.6
Q ss_pred CcccCCCCCCcEEEcC-CCCeEEecccccc
Q 011627 127 QVLHRDIKGSNLLIDN-EGNLKLADFGLAR 155 (481)
Q Consensus 127 giiHrDLKp~NILl~~-~~~vkL~DFG~a~ 155 (481)
.++|+||++.|||+++ ++.++|+||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 6899999999999986 4679999999874
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.002 Score=60.17 Aligned_cols=29 Identities=38% Similarity=0.676 Sum_probs=20.7
Q ss_pred CcccCCCCCCcEEE-cCCCCeEEecccccc
Q 011627 127 QVLHRDIKGSNLLI-DNEGNLKLADFGLAR 155 (481)
Q Consensus 127 giiHrDLKp~NILl-~~~~~vkL~DFG~a~ 155 (481)
-++|+||.+.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 778899999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG0921 consensus Dosage compensation complex, subunit MLE [Transcription] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.003 Score=68.33 Aligned_cols=22 Identities=27% Similarity=0.291 Sum_probs=11.3
Q ss_pred CCCCCCCCCCCCCCCC-CCCCCC
Q 011627 437 PRGPASGYGVGPQSYS-QSGQYG 458 (481)
Q Consensus 437 ~~~~~~~~~~~~~~~~-~~~~~~ 458 (481)
-|+-|+|++.+|+++. ++|++|
T Consensus 1235 frnnggGdyrnpgggyrgsGGfg 1257 (1282)
T KOG0921|consen 1235 FRNNGGGDYRNPGGGYRGSGGFG 1257 (1282)
T ss_pred cccCCCCCCCCCCCCccCCCCcC
Confidence 3444566666665443 444444
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0053 Score=60.82 Aligned_cols=29 Identities=21% Similarity=0.403 Sum_probs=25.5
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 126 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999988 678999999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0068 Score=59.21 Aligned_cols=30 Identities=27% Similarity=0.494 Sum_probs=25.3
Q ss_pred CcccCCCCCCcEEEcCCCC-eEEeccccccc
Q 011627 127 QVLHRDIKGSNLLIDNEGN-LKLADFGLARS 156 (481)
Q Consensus 127 giiHrDLKp~NILl~~~~~-vkL~DFG~a~~ 156 (481)
.++|+|+++.|||+++++. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998853
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0035 Score=62.23 Aligned_cols=104 Identities=21% Similarity=0.277 Sum_probs=72.0
Q ss_pred CCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
..+.|++|++-.+.+...-. -..+++..|+++.+..|+-+..+ .+-||||...||||+ +|+|-|+||-+++.
T Consensus 298 ~~y~yl~~kdhgt~is~ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl- 370 (488)
T COG5072 298 TLYLYLHFKDHGTPISIIKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL- 370 (488)
T ss_pred ceEEEEEEecCCceeeeeec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec-
Confidence 44678888887766543221 35678899999999888888766 799999999999999 89999999999983
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHH
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 196 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlG 196 (481)
........ -...--|-.+.|. -+..-|||-+-
T Consensus 371 ~~~q~~is-----y~rldhp~lF~G~--dd~QFeIYrlM 402 (488)
T COG5072 371 SYSQGIIS-----YNRLDHPDLFNGV--DDYQFEIYRLM 402 (488)
T ss_pred ccCCceee-----ccccCchhhhcCc--cceeeeHHHHH
Confidence 32222211 1223345555542 25566766653
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.014 Score=57.79 Aligned_cols=30 Identities=30% Similarity=0.424 Sum_probs=27.4
Q ss_pred CcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 127 giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.++|+|+.+.||+|+..+-+=|+||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 479999999999999988899999999864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.029 Score=55.69 Aligned_cols=30 Identities=20% Similarity=0.225 Sum_probs=27.5
Q ss_pred CcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 127 giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
+++|+|+.++|||++.++.+.|+||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999988999999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.036 Score=57.80 Aligned_cols=27 Identities=30% Similarity=0.544 Sum_probs=23.5
Q ss_pred CcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 127 QVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 127 giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
-++|.|+-+.|||+++++ ++|+||..|
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYA 311 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYS 311 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeeccc
Confidence 589999999999887554 999999876
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.066 Score=54.87 Aligned_cols=69 Identities=10% Similarity=0.072 Sum_probs=44.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecC-----CcCCCcchhHHHHHHHHHhcC---CCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMD-----NEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~-----~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|-...||++.+ .+..|+||.-... ........+...|...|+.+. -..|.+++.+..+
T Consensus 43 Gn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded------------ 108 (418)
T PLN02756 43 GNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT------------ 108 (418)
T ss_pred CceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC------------
Confidence 34456899887 3456889976522 111223456667788887774 2477778877654
Q ss_pred CCCcCCeEEEEEecCCC
Q 011627 75 GNKYRGSTYMVFEYMDH 91 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g 91 (481)
..+|+||++++
T Consensus 109 ------~~vlvME~L~~ 119 (418)
T PLN02756 109 ------MALIGMRYLEP 119 (418)
T ss_pred ------CCEEEEeecCC
Confidence 34788999976
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.035 Score=56.77 Aligned_cols=28 Identities=29% Similarity=0.333 Sum_probs=24.0
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 126 ~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
..++|.||-+.|||++++ .++|+||..|
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEeccc
Confidence 468999999999997654 5999999876
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.067 Score=61.70 Aligned_cols=31 Identities=39% Similarity=0.641 Sum_probs=26.2
Q ss_pred CCcccCCCCCCcEEEcCCC--CeE-Eeccccccc
Q 011627 126 NQVLHRDIKGSNLLIDNEG--NLK-LADFGLARS 156 (481)
Q Consensus 126 ~giiHrDLKp~NILl~~~~--~vk-L~DFG~a~~ 156 (481)
.++||.|+.++|||++.++ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.11 Score=52.43 Aligned_cols=71 Identities=14% Similarity=0.012 Sum_probs=45.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEee----c-CCcCCCcchhHHHHHHHHHhcC--CC-CccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIR----M-DNEKEGFPITAIREIKILKKLQ--HE-NVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~----~-~~~~~~~~~~~~~Ei~il~~L~--hp-nIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|-...||++.+...++.|+||.-. . .....-...+...|...|+.+. .| .+.+++.+-
T Consensus 6 GnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------------- 71 (370)
T TIGR01767 6 GNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------------- 71 (370)
T ss_pred CceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--------------
Confidence 344679999985444689999753 2 1223444556677888888874 34 455555543
Q ss_pred CCCcCCeEEEEEecCCC
Q 011627 75 GNKYRGSTYMVFEYMDH 91 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g 91 (481)
.....+|||++..
T Consensus 72 ----~e~~~~vMEdL~~ 84 (370)
T TIGR01767 72 ----TEMAVTVMEDLSH 84 (370)
T ss_pred ----cccceehHhhCcc
Confidence 3345799999864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.045 Score=53.68 Aligned_cols=67 Identities=15% Similarity=0.071 Sum_probs=40.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC---CCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|....+|++. .+++.+.||+-... ....+..|..-|+.|. --.+.+++.+... .
T Consensus 28 G~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~----------------~ 84 (288)
T PF03881_consen 28 GDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEY----------------D 84 (288)
T ss_dssp SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-----------------S
T ss_pred CChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee----------------c
Confidence 5667888877 67889999987622 2236778999888884 3345666766554 2
Q ss_pred CeEEEEEecCCCC
Q 011627 80 GSTYMVFEYMDHD 92 (481)
Q Consensus 80 ~~~~iV~Ey~~g~ 92 (481)
+.-||||||++..
T Consensus 85 ~~~fLlle~l~~~ 97 (288)
T PF03881_consen 85 DDAFLLLEFLEMG 97 (288)
T ss_dssp SCCEEEEE-----
T ss_pred CCceEEEEeecCC
Confidence 3349999998743
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.062 Score=54.78 Aligned_cols=71 Identities=17% Similarity=0.057 Sum_probs=45.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEe----ecCCcCCCcchhHHHHHHHHHhcC--CC-CccceeeEEeCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKI----RMDNEKEGFPITAIREIKILKKLQ--HE-NVIKLKEIVTSPGPERDEQGRPDG 75 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i----~~~~~~~~~~~~~~~Ei~il~~L~--hp-nIv~l~~~~~~~~~~~~~~~~~~~ 75 (481)
|-..-||++.+...++.|+||.- +......-...+...|.++|+.+. .| .+.+++.+-
T Consensus 40 GnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--------------- 104 (409)
T PRK12396 40 GNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--------------- 104 (409)
T ss_pred CceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC---------------
Confidence 33466999998444678999964 322333444566777999999874 34 455565543
Q ss_pred CCcCCeEEEEEecCCC
Q 011627 76 NKYRGSTYMVFEYMDH 91 (481)
Q Consensus 76 ~~~~~~~~iV~Ey~~g 91 (481)
.....+|||++..
T Consensus 105 ---~e~~~~vMEdL~~ 117 (409)
T PRK12396 105 ---SVMNCCVMEDLSD 117 (409)
T ss_pred ---cHHhhHHHHhCcc
Confidence 2345788988853
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.015 Score=56.97 Aligned_cols=83 Identities=22% Similarity=0.243 Sum_probs=50.1
Q ss_pred CCCcCCeEEEEEecCCCChhh----hhcCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCCCcEEEcCCC--
Q 011627 75 GNKYRGSTYMVFEYMDHDLTG----LADRPGLRFTVPQIKCYMKQLLTGLHYCH----VNQVLHRDIKGSNLLIDNEG-- 144 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g~L~~----~~~~~~~~l~~~~i~~i~~Qil~gL~~LH----~~giiHrDLKp~NILl~~~~-- 144 (481)
...++..-.||+.++.++-.. ...+.+..--.+-++.++.||+.-.-.+- ...++|-||||+||||-+..
T Consensus 243 n~~ydrGnIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~ 322 (444)
T PHA03111 243 NYLYDRGNIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEP 322 (444)
T ss_pred cccccCCcEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCc
Confidence 344455667888887653221 11122222233456778888865443332 34799999999999985433
Q ss_pred ----------------CeEEecccccccc
Q 011627 145 ----------------NLKLADFGLARSF 157 (481)
Q Consensus 145 ----------------~vkL~DFG~a~~~ 157 (481)
.++|.||.+|+..
T Consensus 323 i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 323 ISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred EEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 2567778777654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 481 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-82 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-82 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-82 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-81 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-67 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-67 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-67 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-67 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-67 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-67 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-67 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-67 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-67 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-67 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-67 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-67 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-67 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-67 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-67 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-67 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-67 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-67 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-67 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-67 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-67 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-67 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-67 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-67 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-67 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-67 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-67 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-67 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-67 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-67 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-67 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-67 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-67 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-67 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-66 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-63 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-63 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-63 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-62 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-62 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-59 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-58 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-58 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-57 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-57 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-56 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-52 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-52 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-52 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-51 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-51 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-51 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-50 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-44 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-43 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-43 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-43 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-43 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-43 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-43 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-43 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-43 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-43 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-43 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-43 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-43 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-43 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-43 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-43 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-43 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-43 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-43 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-43 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-43 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-43 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-43 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-42 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-42 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-42 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-42 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-42 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-42 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-42 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-42 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-42 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-42 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-42 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-42 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-42 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-42 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-42 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-42 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-42 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-42 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-42 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-42 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-42 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-42 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-42 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-41 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-41 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-41 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-41 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-41 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-41 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-41 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-41 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-41 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-41 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-41 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-41 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-41 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-41 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-41 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-41 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-41 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-41 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-41 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-41 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-41 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-41 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-41 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-41 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-41 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-41 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-41 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-41 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-41 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-41 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-41 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-41 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-41 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-41 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-41 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-41 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-41 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-41 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-40 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-40 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-40 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-40 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-40 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-40 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-40 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-39 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-39 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-39 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-38 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-38 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-36 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-36 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-35 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-35 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-35 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-35 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-35 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-35 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-35 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-35 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-35 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-35 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-35 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-35 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-35 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-35 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-35 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-34 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-34 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-34 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-33 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-33 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-32 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-31 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-31 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-31 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-31 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-30 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-30 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-30 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-30 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-30 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-30 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-30 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-30 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-30 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-30 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-30 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-30 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-30 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-30 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-30 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-30 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-30 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-29 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-29 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-29 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-29 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-29 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-29 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-29 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-29 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-29 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-29 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-29 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-29 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-29 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-28 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-28 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-28 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-27 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-27 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-25 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-25 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-23 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-23 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-23 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-23 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-23 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-23 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-23 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-22 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-22 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-22 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-22 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-22 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-22 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-22 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-22 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-22 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-22 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-22 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-22 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-20 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-20 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-20 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-20 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-20 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-20 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-20 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-20 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-20 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-20 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-19 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-19 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-19 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-16 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-13 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-07 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-04 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 556 bits (1434), Expect = 0.0
Identities = 154/328 (46%), Positives = 212/328 (64%), Gaps = 15/328 (4%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+VF AR KTG+ VALKK+ M+NEKEGFPITA+REIKIL+ L+HENV+ L EI +
Sbjct: 31 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
N+ +GS Y+VF++ +HDL GL ++FT+ +IK M+ LL GL+Y H
Sbjct: 91 --------PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 142
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY---DHNNTLTNRVITLWYRPPELLLG 182
N++LHRD+K +N+LI +G LKLADFGLAR+FS N TNRV+TLWYRPPELLLG
Sbjct: 143 NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
YGP +D+W GCI AE+ PI+ G E QL+ I +LCGS +WP V Y
Sbjct: 203 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY 262
Query: 243 NHFKPSRTMKRRVREVFRHF--DRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPC 300
+ + KR+V++ + + D +AL+L++K+L+LDP+QRI + DAL+ ++FW+DP+P
Sbjct: 263 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322
Query: 301 DPKSLPKYE--SSHEYQTKKRRQQQRQH 326
D K + S EY RR+ H
Sbjct: 323 DLKGMLSTHLTSMFEYLAPPRRKHHHHH 350
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 508 bits (1311), Expect = 0.0
Identities = 129/343 (37%), Positives = 184/343 (53%), Gaps = 28/343 (8%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNE---KEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
V+ AR+ T +IVA+KKI++ + K+G TA+REIK+L++L H N+I L +
Sbjct: 25 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH- 83
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+ + +VF++M+ DL + L T IK YM L GL Y
Sbjct: 84 ---------------KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
H + +LHRD+K +NLL+D G LKLADFGLA+SF N T++V+T WYR PELL GA
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGA 187
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
YG VDMW+VGCI AELL P LPG ++ +QL++IFE G+P E WP + +P Y
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 303
FK + +F L+L++ + + +P RI+A AL +YF P P
Sbjct: 248 TFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 305
Query: 304 SLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPP 346
LP+ E ++Q A KR++ + G LP
Sbjct: 306 QLPRPNCPVE-----TLKEQSNPALAIKRKRTEALE-QGGLPK 342
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 487 bits (1256), Expect = e-173
Identities = 124/335 (37%), Positives = 175/335 (52%), Gaps = 27/335 (8%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ + T +VALK+IR+++E EG P TAIRE+ +LK L+H N++ L +I+ +
Sbjct: 17 TVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT---- 71
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
S +VFEY+D DL D G + +K ++ QLL GL YCH
Sbjct: 72 ------------EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
+VLHRD+K NLLI+ G LKLADFGLAR+ S T N V+TLWYRPP++LLG+T Y
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
+DMW VGCIF E+ G+P+ PG EQL IF + G+P E WPG+ + +
Sbjct: 179 STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 306
+ + D +LL K+L + RISA+DA+ +F + LP
Sbjct: 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK--LP 296
Query: 307 KYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPH 341
S K+ + Q+ + HH H
Sbjct: 297 DTTSIFA--LKEIQLQKE-----ASLRSAHHHHHH 324
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-168
Identities = 117/317 (36%), Positives = 175/317 (55%), Gaps = 24/317 (7%)
Query: 7 QVFMAREIK-TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTS 62
+VF AR++K G VALK++R+ +EG P++ IRE+ +L+ L+ H NV++L ++ T
Sbjct: 26 KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLH 121
+R+ +VFE++D DLT D+ P IK M QLL GL
Sbjct: 86 SRTDRE-----------TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
+ H ++V+HRD+K N+L+ + G +KLADFGLAR +S LT+ V+TLWYR PE+LL
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVLL 192
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
++ Y VD+WSVGCIFAE+ KP+ G ++ +QL KI ++ G P E WP +P
Sbjct: 193 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 301
S + + + D +LL K L +P++RISA AL YF +
Sbjct: 252 QAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308
Query: 302 --PKSLPKYESSHEYQT 316
LP +++ E T
Sbjct: 309 NLDSHLPPSQNTSELNT 325
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 473 bits (1220), Expect = e-167
Identities = 119/294 (40%), Positives = 172/294 (58%), Gaps = 19/294 (6%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
VF A+ +T EIVALK++R+D++ EG P +A+REI +LK+L+H+N+++L +++ S
Sbjct: 17 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS---- 72
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+VFE+ D DL D +K ++ QLL GL +CH
Sbjct: 73 ------------DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
VLHRD+K NLLI+ G LKLA+FGLAR+F + V+TLWYRPP++L GA Y
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 187 GPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
++DMWS GCIFAEL N G+P+ PG + +QL +IF L G+P E WP ++K+P Y +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 246 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299
P + V + +LL+ +L +P QRISA++AL YF P
Sbjct: 240 -PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 469 bits (1210), Expect = e-166
Identities = 119/317 (37%), Positives = 182/317 (57%), Gaps = 29/317 (9%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ TG VALK++++D+E EG P TAIREI ++K+L+HEN+++L +++ +
Sbjct: 20 TVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT---- 74
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR-----FTVPQIKCYMKQLLTGLH 121
+VFE+MD+DL D + + +K + QLL GL
Sbjct: 75 ------------ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
+CH N++LHRD+K NLLI+ G LKL DFGLAR+F NT ++ V+TLWYR P++L+
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVVTLWYRAPDVLM 181
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
G+ Y ++D+WS GCI AE++ GKP+ PG N+ EQL IF++ G+P+E++WP V+K+P
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241
Query: 242 YNHFKPSRTMKRRVREVFRH-----FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296
YN R R +R+V + D + ++ L +L L+P R+SAK AL +F
Sbjct: 242 YNPNIQQRP-PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300
Query: 297 PLPCDPKSLPKYESSHE 313
+ H
Sbjct: 301 YHHASMGGSRSHHHHHH 317
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 467 bits (1204), Expect = e-165
Identities = 120/291 (41%), Positives = 178/291 (61%), Gaps = 18/291 (6%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ A++ G IVALK+IR+D E EG P TAIREI +LK+L H N++ L +++ S
Sbjct: 36 VVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS---- 90
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+VFE+M+ DL + D QIK Y+ QLL G+ +CH +
Sbjct: 91 ------------ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
++LHRD+K NLLI+++G LKLADFGLAR+F + T+ V+TLWYR P++L+G+ KY
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
+VD+WS+GCIFAE++ GKP+ PG + +QL KIF + G+P+ WP V ++P +
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297
K+ + F + ++LL ML DP++RISA+DA++ YF
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 463 bits (1194), Expect = e-164
Identities = 122/287 (42%), Positives = 174/287 (60%), Gaps = 19/287 (6%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ A+ GE ALKKIR++ E EG P T IREI ILK+L+H N++KL +++ +
Sbjct: 17 VVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT---- 71
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+ +VFE++D DL L D K ++ QLL G+ YCH
Sbjct: 72 ------------KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
+VLHRD+K NLLI+ EG LK+ADFGLAR+F T+ ++TLWYR P++L+G+ KY
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
+D+WSVGCIFAE++NG P+ PG +EA+QL +IF + G+P+ WP V+++P Y+
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 247 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ D ++LL KML LDP+QRI+AK AL+ YF
Sbjct: 239 TVYE-PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 459 bits (1184), Expect = e-162
Identities = 119/298 (39%), Positives = 178/298 (59%), Gaps = 23/298 (7%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V+ A + T E VA+K+IR+++E+EG P TAIRE+ +LK+LQH N+I+LK ++
Sbjct: 49 EVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH---- 104
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+++FEY ++DL D+ ++ IK ++ QL+ G+++CH
Sbjct: 105 ------------NHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSR 151
Query: 127 QVLHRDIKGSNLLID-----NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
+ LHRD+K NLL+ LK+ DFGLAR+F T+ +ITLWYRPPE+LL
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEIITLWYRPPEILL 210
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
G+ Y +VD+WS+ CI+AE+L P+ PG +E +QL KIFE+ G PD+T WPGV+ +P
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299
+ P K R + D L+LL ML +DP +RISAK+AL+ YF +
Sbjct: 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 456 bits (1175), Expect = e-161
Identities = 116/304 (38%), Positives = 165/304 (54%), Gaps = 26/304 (8%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEG---FPITAIREIKILKKLQ---HENVIKLKEIV 60
V+ AR+ +G VALK +R+ N G PI+ +RE+ +L++L+ H NV++L ++
Sbjct: 24 TVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTG 119
+ +R+ +VFE++D DL D P IK M+Q L G
Sbjct: 84 ATSRTDRE-----------IKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 179
L + H N ++HRD+K N+L+ + G +KLADFGLAR +S + LT V+TLWYR PE+
Sbjct: 133 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVVVTLWYRAPEV 190
Query: 180 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
LL +T Y VDMWSVGCIFAE+ KP+ G +EA+QL KIF+L G P E WP +
Sbjct: 191 LLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 249
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299
P R V+ V + +LL +ML +P +RISA AL Y D
Sbjct: 250 PRGAFPPRGP---RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN 306
Query: 300 CDPK 303
P+
Sbjct: 307 --PE 308
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 454 bits (1170), Expect = e-160
Identities = 98/310 (31%), Positives = 151/310 (48%), Gaps = 18/310 (5%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
VF R TG+IVA+KK + A+REI++LK+L+H N++ L E+
Sbjct: 18 VVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR---- 73
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+ ++VFEY DH + DR +K Q L +++CH +
Sbjct: 74 ------------KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
+HRD+K N+LI +KL DFG AR + ++ + V T WYR PELL+G T+Y
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
GP VD+W++GC+FAELL+G P+ PGK++ +QL I + G S ++ K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 247 -PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 305
P + F + AL LL+ L +DP++R++ + L YF D
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKE 300
Query: 306 PKYESSHEYQ 315
+ + Y
Sbjct: 301 HDKPAENLYF 310
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 452 bits (1165), Expect = e-159
Identities = 89/308 (28%), Positives = 151/308 (49%), Gaps = 18/308 (5%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V R TG IVA+KK ++ + A+REIK+LK+L+HEN++ L E+
Sbjct: 40 MVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC------ 93
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
K + Y+VFE++DH + + ++ Y+ Q++ G+ +CH +
Sbjct: 94 ----------KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 186
++HRDIK N+L+ G +KL DFG AR+ + + V T WYR PELL+G KY
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 187 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 246
G AVD+W++GC+ E+ G+P+ PG ++ +QL I G+ +K P + +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 247 -PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 305
P + + + ++L +K L +DP +R + L ++F D
Sbjct: 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQE 322
Query: 306 PKYESSHE 313
+ + +
Sbjct: 323 LQLKVQKD 330
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 426 bits (1097), Expect = e-147
Identities = 114/387 (29%), Positives = 187/387 (48%), Gaps = 65/387 (16%)
Query: 8 VFMAR--EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V+ A+ + K + ALK+I E G ++A REI +L++L+H NVI L+++ S
Sbjct: 37 VYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQKVFLSHAD 92
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGL--------ADRPGLRFTVPQIKCYMKQLL 117
+++F+Y +HDL + A++ ++ +K + Q+L
Sbjct: 93 R--------------KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 118 TGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTN---RVI 170
G+HY H N VLHRD+K +N+L+ G +K+AD G AR F+ L + V+
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVV 197
Query: 171 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKI 221
T WYR PELLLGA Y A+D+W++GCIFAELL +PI + E +QL +I
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257
Query: 222 FELCGSPDETIWPGVSKMPAYNHFKP--------SRTMKRRVREVFRHFDRHALELLEKM 273
F + G P + W + KMP ++ + ++ + + + D A LL+K+
Sbjct: 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317
Query: 274 LMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP------------KYESSHEYQTKKRRQ 321
L +DP +RI+++ A+ YF DPLP + E + K ++Q
Sbjct: 318 LTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQ 377
Query: 322 QQRQHEEATKRQKLHHPQPHGRLPPIQ 348
QQ + + H + PP++
Sbjct: 378 QQGNNHTNGTGHPGNQDSSHTQGPPLK 404
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-108
Identities = 104/377 (27%), Positives = 166/377 (44%), Gaps = 39/377 (10%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V+ A+ +GE+VA+KK+ D + RE++I++KL H N+++L+ S G ++
Sbjct: 70 VYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGEKK 123
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCH 124
DE +V +Y+ + +A R V +K YM QL L Y H
Sbjct: 124 DEV----------YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 125 VNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
+ HRDIK NLL+D + LKL DFG A+ + + + +YR PEL+ GA
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGA 231
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
T Y ++D+WS GC+ AELL G+PI PG + +QL +I ++ G+P ++ P Y
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYT 289
Query: 244 HFKPSRTMKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP--- 297
FK + +VFR A+ L ++L P+ R++ +A +F DP
Sbjct: 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 349
Query: 298 LPCDPKSLPKYE-SSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHW 356
LP + + ++ E + A + P S
Sbjct: 350 LPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTN--------ATAASDAN 401
Query: 357 SGPNHPMNNAPPPVPGG 373
+G NNA
Sbjct: 402 TGDRGQTNNAASASASN 418
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-106
Identities = 99/349 (28%), Positives = 162/349 (46%), Gaps = 32/349 (9%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
VF A+ +++ E VA+KK+ D + RE++I++ ++H NV+ LK S G ++
Sbjct: 56 VFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMRIVKHPNVVDLKAFFYSNGDKK 108
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCH 124
DE +V EY+ + + + + IK YM QLL L Y H
Sbjct: 109 DEV----------FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 125 VNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
+ HRDIK NLL+D G LKL DFG A+ + + + +YR PEL+ GA
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRYYRAPELIFGA 216
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
T Y +D+WS GC+ AEL+ G+P+ PG++ +QL +I ++ G+P ++ P Y
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN--PNYM 274
Query: 244 HFKPSRTMKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP--- 297
K + +VFR A++L+ ++L PS R++A +AL +F
Sbjct: 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEAR 334
Query: 298 LPCDPKSLPKYE-SSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLP 345
+P + P + + E + + + A H P
Sbjct: 335 MPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSRGIDVHNFQP 383
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = e-100
Identities = 88/299 (29%), Positives = 144/299 (48%), Gaps = 36/299 (12%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPG 64
S+VF A I E V +K ++ +K+ REIKIL+ L+ N+I L +IV P
Sbjct: 50 SEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGPNIITLADIVKDPV 104
Query: 65 PERDEQGRPDGNKYRGSTYMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+VFE+ + D L T I+ YM ++L L YC
Sbjct: 105 SRTP--------------ALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 146
Query: 124 HVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
H ++HRD+K N++ID+E L+L D+GLA Y RV + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEYNVRVASRYFKGPELLVD 204
Query: 183 ATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
Y ++DMWS+GC+ A ++ K P G + +QL +I ++ G+ D + +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 242 YNHFKPS--RTMKRRVREVFRHFDRH-----ALELLEKMLMLDPSQRISAKDALDSEYF 293
F R ++R ++H AL+ L+K+L D R++A++A++ YF
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 4e-97
Identities = 104/390 (26%), Positives = 161/390 (41%), Gaps = 75/390 (19%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V A + +VA+KKI E +REI IL +L H++V+K+ +IV E
Sbjct: 68 HVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+ ++ Y+V E D D L R + T IK + LL G+ Y H
Sbjct: 128 KFDE-----------LYVVLEIADSDFKKLF-RTPVYLTELHIKTLLYNLLVGVKYVHSA 175
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN----------------------- 163
+LHRD+K +N L++ + ++K+ DFGLAR+ Y N
Sbjct: 176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKN 235
Query: 164 ---TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-----------GKPIL 209
LT V+T WYR PEL+L Y A+D+WS+GCIFAELLN P+
Sbjct: 236 LKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295
Query: 210 PGKN--------------------EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 249
PG + +QL+ IF + G+P E + K A + +
Sbjct: 296 PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355
Query: 250 TMKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLP 306
+ + E F A+ LL++ML+ +P++RI+ + L +F + +
Sbjct: 356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA-EVETNATE 414
Query: 307 KYESSHEYQTKKRRQQQRQ--HEEATKRQK 334
K Q R +E +
Sbjct: 415 KVRLPFNDWMNMDEPQLRYAFVKEIQRYHP 444
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 7e-97
Identities = 91/332 (27%), Positives = 156/332 (46%), Gaps = 40/332 (12%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V +I++G+ ALKK+ D P RE+ I+K L H N+IKL + + G E
Sbjct: 23 VCEVFDIESGKRFALKKVLQD------PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76
Query: 68 DEQGRPDGNKYRGST----------------------YMVFEYMDHDLTGLAD---RPGL 102
+ +P + + ++ EY+ L + R G
Sbjct: 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGR 136
Query: 103 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDH 161
+ I Y+ QL + + H + HRDIK NLL++ + LKL DFG A+
Sbjct: 137 SIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196
Query: 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
+ + + +YR PEL+LGAT+Y P++D+WS+GC+F EL+ GKP+ G+ +QL +I
Sbjct: 197 PSV--AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRI 254
Query: 222 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF-DRHALELLEKMLMLDPSQ 280
++ G+P + ++ P Y + + R++ A++LLE++L +P
Sbjct: 255 IQIMGTPTKEQMIRMN--PHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312
Query: 281 RISAKDALDSEYFWTDPLPCDPKSLPKYESSH 312
RI+ +A+ +F D L + +S+
Sbjct: 313 RINPYEAMAHPFF--DHLR-NSYESEVKNNSN 341
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 7e-97
Identities = 91/314 (28%), Positives = 139/314 (44%), Gaps = 34/314 (10%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPG 64
V + +E TG VA+KK+ D P RE++I++ L H N+++L+ + G
Sbjct: 39 VQLGKEKSTGMSVAIKKVIQD------PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLH 121
Y +V EY+ L R + IK ++ QL+ +
Sbjct: 93 ERDRRD------IY---LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG 143
Query: 122 YCHVN--QVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
H+ V HRDIK N+L++ G LKL DFG A+ S N + + +YR PE
Sbjct: 144 CLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV--AYICSRYYRAPE 201
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
L+ G Y AVD+WSVGCIFAE++ G+PI G N A QL +I + G P + ++
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN- 260
Query: 239 MPAYNHFK----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF- 293
P++ + + A +LL +L P +R+ +AL YF
Sbjct: 261 -PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 294 -WTDPLPCDPKSLP 306
DP P +
Sbjct: 320 ELHDPATKLPNNKD 333
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 4e-94
Identities = 103/296 (34%), Positives = 158/296 (53%), Gaps = 13/296 (4%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
VF A + + VA+KKI + + + A+REIKI+++L H+N++K+ EI+ G +
Sbjct: 27 VFSAVDNDCDKRVAIKKIVLTDPQ--SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 127
+ S Y+V EYM+ DL + ++ L + +M QLL GL Y H
Sbjct: 85 TDDVGSLTEL--NSVYIVQEYMETDLANVLEQGPL--LEEHARLFMYQLLRGLKYIHSAN 140
Query: 128 VLHRDIKGSNLLIDNEG-NLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELLLGAT 184
VLHRD+K +NL I+ E LK+ DFGLAR Y H L+ ++T WYR P LLL
Sbjct: 141 VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN 200
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP-DETIWPGVSKMPAYN 243
Y A+DMW+ GCIFAE+L GK + G +E EQ+ I E +E +S +P Y
Sbjct: 201 NYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYI 260
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 297
+ + + ++ R A++ LE++L P R++A++AL Y ++ P
Sbjct: 261 RNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 4e-93
Identities = 86/296 (29%), Positives = 132/296 (44%), Gaps = 26/296 (8%)
Query: 15 KTGEIVALKKIRMDNEKEGFPIT---------AIREIKILKKLQHENVIKLKEIVTSPGP 65
G VA+K++ +REI++L H N++ L++I
Sbjct: 44 SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+ Y+V E M DL + + + I+ +M +L GLH H
Sbjct: 104 PAMHK-----------LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE 152
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
V+HRD+ N+L+ + ++ + DF LAR + D N T+ V WYR PEL++
Sbjct: 153 AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKG 210
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
+ VDMWS GC+ AE+ N K + G QL+KI E+ G+P S A ++
Sbjct: 211 FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL 270
Query: 246 KPSRTMKRRV--REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 297
+ S + V D AL+L+ KML +P +RIS + AL YF DP
Sbjct: 271 RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 1e-92
Identities = 109/313 (34%), Positives = 167/313 (53%), Gaps = 20/313 (6%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V A + VA+KKI E + + +REIKIL + +HEN+I + +I+ +P
Sbjct: 41 GMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
E+ + Y+V + M+ DL L L + I ++ Q+L GL Y H
Sbjct: 100 EQMKD-----------VYIVQDLMETDLYKLLKTQHL--SNDHICYFLYQILRGLKYIHS 146
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGA 183
VLHRD+K SNLL++ +LK+ DFGLAR DH++T LT V T WYR PE++L +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
Y ++D+WSVGCI AE+L+ +PI PGK+ +QL+ I + GSP + + + A N
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266
Query: 244 HFKPSRTMKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPC 300
+ + +F + D AL+LL+KML +P +RI + AL Y + DP
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP-SD 325
Query: 301 DPKSLPKYESSHE 313
+P + ++ E
Sbjct: 326 EPIAEAPFKFDME 338
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 2e-92
Identities = 103/313 (32%), Positives = 164/313 (52%), Gaps = 21/313 (6%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V A + ++GE VA+KK+ + E F A RE+ +LK +QHENVI L ++ T
Sbjct: 38 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
R+ Y+V +M DL + F+ +I+ + Q+L GL Y H
Sbjct: 98 LRNFYD----------FYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYIHS 144
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
V+HRD+K NL ++ + LK+ DFGLAR + +T V+T WYR PE++L
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLARHA----DAEMTGYVVTRWYRAPEVILSWMH 200
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y VD+WSVGCI AE+L GK + GK+ +QL++I ++ G P ++ A ++
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 260
Query: 246 KPSRTMKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDP 302
+ R+ ++F A +LLEKML LD +R++A AL +F + DP +
Sbjct: 261 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP-EEET 319
Query: 303 KSLPKYESSHEYQ 315
++ ++ S E++
Sbjct: 320 EAQQPFDDSLEHE 332
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 2e-92
Identities = 107/330 (32%), Positives = 162/330 (49%), Gaps = 40/330 (12%)
Query: 7 QVFMAREIKTGEIVALKKIR-MDNEKEGFPITA---IREIKILKKLQHENVIKLKEIVTS 62
V A TGEIVA+KKI D P+ A +REIKILK +HEN+I + I
Sbjct: 26 VVCSATHKPTGEIVAIKKIEPFDK-----PLFALRTLREIKILKHFKHENIITIFNIQRP 80
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
E + Y++ E M DL + L + I+ ++ Q L +
Sbjct: 81 DSFENFNE-----------VYIIQELMQTDLHRVISTQML--SDDHIQYFIYQTLRAVKV 127
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS---------YDHNNTLTNRVITLW 173
H + V+HRD+K SNLLI++ +LK+ DFGLAR + + V T W
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP--DET 231
YR PE++L + KY A+D+WS GCI AEL +PI PG++ QL IF + G+P D
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247
Query: 232 IWPGVSKMPAYNHFKPSRTMKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290
+ + A + K + ++F + ++LL++ML+ DP++RI+AK+AL+
Sbjct: 248 LR-CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 291 EYF--WTDPL---PCDPKSLPKYESSHEYQ 315
Y + DP +P +E H +
Sbjct: 307 PYLQTYHDPNDEPEGEPIPPSFFEFDHYKE 336
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 1e-90
Identities = 101/344 (29%), Positives = 161/344 (46%), Gaps = 36/344 (10%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V A + +TG VA+KK+ + E F A RE+++LK ++HENVI L ++ T
Sbjct: 39 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
D Y+V +M DL L L +I+ + Q+L GL Y H
Sbjct: 99 LDDFTD----------FYLVMPFMGTDLGKLMKHEKL--GEDRIQFLVYQMLKGLRYIHA 146
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
++HRD+K NL ++ + LK+ DFGLAR + +T V+T WYR PE++L +
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVILNWMR 202
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y VD+WSVGCI AE++ GK + G + +QL +I ++ G+P + A N+
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262
Query: 246 KPSRTMKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPL---P 299
K ++++ + + A+ LLEKML+LD QR++A +AL YF D
Sbjct: 263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 322
Query: 300 CDP-------KSLPK-------YESSHEYQTKKRRQQQRQHEEA 329
Y+ ++ ++ + E
Sbjct: 323 VQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETP 366
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 5e-89
Identities = 110/339 (32%), Positives = 164/339 (48%), Gaps = 26/339 (7%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V A + KTG VA+KK+ + RE+++LK ++HENVI L ++ T
Sbjct: 43 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+ Y+V M DL + L T ++ + Q+L GL Y H
Sbjct: 103 LEEFND----------VYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHS 150
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
++HRD+K SNL ++ + LK+ DFGLAR + + +T V T WYR PE++L
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVATRWYRAPEIMLNWMH 206
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y VD+WSVGCI AELL G+ + PG + +QL I L G+P + +S A N+
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 246 KPSRTMKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDP 302
+ M + VF + A++LLEKML+LD +RI+A AL YF + DP D
Sbjct: 267 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DE 324
Query: 303 KSLPKYESSHEYQTKKRRQ-QQRQHEEATKRQKLHHPQP 340
Y+ S E + + + ++E P P
Sbjct: 325 PVADPYDQSLESRDLLIDEWKSLTYDEVIS----FVPPP 359
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 1e-85
Identities = 100/409 (24%), Positives = 172/409 (42%), Gaps = 73/409 (17%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V++A + T + VA+KK+ E +REI IL +L+ + +I+L +++
Sbjct: 41 YVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 126
+ ++ Y+V E D DL L + + T IK + LL G ++ H +
Sbjct: 101 KFDE-----------LYIVLEIADSDLKKLF-KTPIFLTEEHIKTILYNLLLGENFIHES 148
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---------------------L 165
++HRD+K +N L++ + ++K+ DFGLAR+ + + + L
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208
Query: 166 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-----------KPILPG--- 211
T+ V+T WYR PEL+L Y ++D+WS GCIFAELLN P+ PG
Sbjct: 209 TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSC 268
Query: 212 --------------KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-VR 256
K+ +QL+ IF + G+P E ++K + K K ++
Sbjct: 269 FPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLK 328
Query: 257 EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP---LPCDPKSLPKYESS 311
+ + + LLE ML +P++RI+ ALD Y K + ++
Sbjct: 329 QKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDW 388
Query: 312 HEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPN 360
+ R +E HP+ H ++ P+
Sbjct: 389 MVLSETQLR--YIFLKEVQS----FHPELVIPSVFTIHENNFYNNEKPS 431
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 3e-84
Identities = 98/386 (25%), Positives = 171/386 (44%), Gaps = 34/386 (8%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V A + VA+KK+ + + A RE+ ++K + H+N+I L + T
Sbjct: 76 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+ Q Y+V E MD +L + ++ + Q+L G+ + H
Sbjct: 136 LEEFQ----------DVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHS 182
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
++HRD+K SN+++ ++ LK+ DFGLAR+ + +T V+T +YR PE++LG
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG-MG 239
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE----TIWPGVSKMPA 241
Y VD+WSVGCI E++ K + PG++ +Q +K+ E G+P + P V
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 242 YNHFKPSRTMKRR--------VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
T + E + A +LL KML++DP++RIS DAL Y
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 294 --WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQ--HEEATK-RQKLHHPQPHGRLPPIQ 348
W DP + Y+ + + + ++ ++ ++E +K + G+ P
Sbjct: 360 NVWYDPAEVEAPPPQIYDKQLD-EREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSG 418
Query: 349 HAGQSHHWSGPNHPMNNAPPPVPGGP 374
A S P+ +N+
Sbjct: 419 AAVNSSESLPPSSSVNDISSMSTDQT 444
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 5e-84
Identities = 111/377 (29%), Positives = 174/377 (46%), Gaps = 59/377 (15%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGP 65
V+ + + +TGE+VA+KKI + REI IL +L HEN++ L ++
Sbjct: 24 IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVL----- 78
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
R D ++ Y+VF+YM+ DL + L + + QL+ + Y H
Sbjct: 79 ------RADNDR---DVYLVFDYMETDLHAVIRANIL--EPVHKQYVVYQLIKVIKYLHS 127
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY--------------------DHNNTL 165
+LHRD+K SN+L++ E ++K+ADFGL+RSF D L
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 166 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 225
T+ V T WYR PE+LLG+TKY +DMWS+GCI E+L GKPI PG + QL +I +
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247
Query: 226 GSP-DETIW--------------PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRH--ALE 268
P +E + ++ N K + ++ D + AL+
Sbjct: 248 DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307
Query: 269 LLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQ- 325
LL+K+L +P++RISA DAL + + +P +P K R
Sbjct: 308 LLDKLLQFNPNKRISANDALKHPFVSIFHNP-NEEPNCDHIITIPINDNVKHSIDDYRNL 366
Query: 326 -HEEATKRQKLHHPQPH 341
+ E ++R++ H
Sbjct: 367 VYSEISRRKRELISNKH 383
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-83
Identities = 91/353 (25%), Positives = 159/353 (45%), Gaps = 39/353 (11%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V A + VA+KK+ + + A RE+ ++K + H+N+I L + T
Sbjct: 39 GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+ Q Y+V E MD +L + ++ + Q+L G+ + H
Sbjct: 99 LEEFQD----------VYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHS 145
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
++HRD+K SN+++ ++ LK+ DFGLAR+ + +T V+T +YR PE++LG
Sbjct: 146 AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG-MG 202
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS-------- 237
Y VD+WSVGCI E++ G + PG + +Q +K+ E G+P +
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262
Query: 238 KMPAYNHFKPSR----TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P Y + + + E + A +LL KML++D S+RIS +AL Y
Sbjct: 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322
Query: 294 --WTDPL---PCDPKSLPKYESSHEYQTKKRRQQQRQ--HEEATKRQKLHHPQ 339
W DP P + + + + ++ ++ ++E + HH
Sbjct: 323 NVWYDPSEAEAPPP---KIPDKQLD-EREHTIEEWKELIYKEVMDLEHHHHHH 371
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 4e-65
Identities = 67/302 (22%), Positives = 110/302 (36%), Gaps = 48/302 (15%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
QV AR A+KKIR EK T + E+ +L L H+ V++
Sbjct: 20 GQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNHQYVVRYYAAWLERRN 76
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
++ EY + L L L + +Q+L L Y H
Sbjct: 77 FVKPMTAVKKKST---LFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH 133
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS-------------YDHNNTLTNRVIT 171
++HRD+K N+ ID N+K+ DFGLA++ ++ LT+ + T
Sbjct: 134 SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGT 193
Query: 172 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 231
Y E+L G Y +DM+S+G IF E++ P G L K+ +
Sbjct: 194 AMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPD 251
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291
K +++ ++ DP++R A+ L+S
Sbjct: 252 FDDNKMK--------------------------VEKKIIRLLIDHDPNKRPGARTLLNSG 285
Query: 292 YF 293
+
Sbjct: 286 WL 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-60
Identities = 74/318 (23%), Positives = 119/318 (37%), Gaps = 61/318 (19%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--ENVIKLKEIVTSP 63
S+VF + +I A+K + ++ + EI L KLQ + +I+L + +
Sbjct: 42 SKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
YMV E + DL + + K Y K +L +H
Sbjct: 101 Q----------------YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI 143
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG 182
H + ++H D+K +N LI + G LKL DFG+A D + + + + T+ Y PPE +
Sbjct: 144 HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 183 A----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE-T 231
+K P D+WS+GCI + GK P + Q+SK+ + E
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE 260
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291
K ++L+ L DP QRIS + L
Sbjct: 261 FPDIPEKD--------------------------LQDVLKCCLKRDPKQRISIPELLAHP 294
Query: 292 YFWTDPLPCDPKSLPKYE 309
Y P + + E
Sbjct: 295 YVQIQTHPVNQMAKGTTE 312
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-59
Identities = 64/291 (21%), Positives = 115/291 (39%), Gaps = 45/291 (15%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
QVF A+ G+ +K+++ +NEK A RE+K L KL H N++
Sbjct: 25 GQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDHVNIVHYNGCWDGFDY 78
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+ + + ++ E+ D L + R G + +Q+ G+ Y
Sbjct: 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI 138
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
H ++++RD+K SN+ + + +K+ DFGL S ++ T TL Y PE +
Sbjct: 139 HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDGKRTRSKGTLRYMSPEQISS- 195
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
YG VD++++G I AELL+ ++ + + + +
Sbjct: 196 QDYGKEVDLYALGLILAELLHVCD--TAFETSKFFTDLRD-------------GIISD-- 238
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294
FD+ LL+K+L P R + + L + W
Sbjct: 239 -----------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-59
Identities = 77/348 (22%), Positives = 126/348 (36%), Gaps = 62/348 (17%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--ENVIKLKEIVTSP 63
S+VF + +I A+K + ++ + EI L KLQ + +I+L +
Sbjct: 23 SKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY---- 77
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
E +Q YMV E + DL + + K Y K +L +H
Sbjct: 78 --EITDQ----------YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI 124
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG 182
H + ++H D+K +N LI + G LKL DFG+A D + + + + T+ Y PPE +
Sbjct: 125 HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 183 ----------ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE-T 231
+K P D+WS+GCI + GK P + Q+SK+ + E
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE 241
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291
K ++L+ L DP QRIS + L
Sbjct: 242 FPDIPEK--------------------------DLQDVLKCCLKRDPKQRISIPELLAHP 275
Query: 292 YFWTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQ 339
Y P + +Y + + + L+
Sbjct: 276 YVQIQTHP-VNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHY 322
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 9e-57
Identities = 76/347 (21%), Positives = 128/347 (36%), Gaps = 60/347 (17%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--ENVIKLKEIVTSP 63
S+VF + +I A+K + ++ + EI L KLQ + +I+L +
Sbjct: 70 SKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY---- 124
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
E +Q YMV E + DL + + K Y K +L +H
Sbjct: 125 --EITDQ----------YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI 171
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG 182
H + ++H D+K +N LI + G LKL DFG+A D + + + + + Y PPE +
Sbjct: 172 HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 183 A----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 232
+K P D+WS+GCI + GK P + Q+SK+ + E
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE 288
Query: 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292
+P ++ ++L+ L DP QRIS + L Y
Sbjct: 289 FP-------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323
Query: 293 FWTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQ 339
P + +Y + + + L+
Sbjct: 324 VQIQTHP-VNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHY 369
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-53
Identities = 67/351 (19%), Positives = 125/351 (35%), Gaps = 57/351 (16%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+ + + + G +K+I + + RE+ +L ++H N+++ +E
Sbjct: 38 GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--- 94
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYC 123
GS Y+V +Y + DL + + G+ F QI + Q+ L +
Sbjct: 95 -------------NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
H ++LHRDIK N+ + +G ++L DFG+AR + + T +Y PE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICEN- 199
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
Y D+W++GC+ EL K + + KI
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI---------------------- 237
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY-------FWTD 296
+ V H+ L+ ++ +P R S L+ + F +
Sbjct: 238 -------ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSP 290
Query: 297 PLPCDPKSLPKYESSHEYQTKKRRQQQRQH-EEATKRQKLHHPQPHGRLPP 346
L + L + +R Q+ QK+ P +P
Sbjct: 291 QLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPL 341
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-53
Identities = 60/307 (19%), Positives = 105/307 (34%), Gaps = 50/307 (16%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPG 64
+ VF R KTG++ A+K + P+ RE ++LKKL H+N++KL I
Sbjct: 23 ANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR-----PGLRFTVPQIKCYMKQLL 117
++ E+ L + ++ ++
Sbjct: 81 TRH--------------KVLIMEFC----PCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 118 TGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 173
G+++ N ++HR+IK N++ D + KL DFG AR + + + T
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEE 180
Query: 174 YRPPELLLGAT-------KYGPAVDMWSVGCIFAELLNGKP----ILPGKNEAEQLSKIF 222
Y P++ A KYG VD+WS+G F G + E + KI
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI- 239
Query: 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 282
+ G P I + + + + +L +L D +
Sbjct: 240 -ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ---VLLTPVLANILEADQEKCW 295
Query: 283 SAKDALD 289
Sbjct: 296 GFDQFFA 302
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 8e-53
Identities = 93/332 (28%), Positives = 147/332 (44%), Gaps = 63/332 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE------NVIKLKEI 59
QV A + K + VALK +R NEK F A EI+IL+ L+ + NVI + E
Sbjct: 111 GQVVKAYDHKVHQHVALKMVR--NEKR-FHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL-TGLADRPGLRFTVPQIKCYMKQLLT 118
+R M FE + +L + F++P ++ + +L
Sbjct: 168 F----------------TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEG--NLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
L H N+++H D+K N+L+ +G +K+ DFG S Y+H + + + +YR
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQ-RVYTYIQSRFYRA 267
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE------ 230
PE++LGA +YG +DMWS+GCI AELL G P+LPG++E +QL+ + EL G P +
Sbjct: 268 PEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326
Query: 231 ----------------TIWPGVSKMPAYNHFKPSRTMK------RRVREVFRHFDRHAL- 267
T+ N + R R + D
Sbjct: 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 268 ELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299
+ L++ L DP+ R++ AL + LP
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWL-RRRLP 417
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 5e-52
Identities = 80/351 (22%), Positives = 137/351 (39%), Gaps = 72/351 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-----------HENVI 54
S V++A+++ VA+K +R + + A EIK+L+++ +++
Sbjct: 33 STVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89
Query: 55 KLKEIVTSPGPERDEQGRPDGNKYRGSTY----MVFEYMDHDLTGLADR-PGLRFTVPQI 109
KL D ++G MVFE + +L L + + +
Sbjct: 90 KLL----------------DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 110 KCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNE------GNLKLADFGLARSFSYDHN 162
K KQLL GL Y H ++H DIK N+L++ +K+AD G A +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDE 190
Query: 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK------NEAE 216
+ TN + T YR PE+LLGA +G D+WS C+ EL+ G + + +
Sbjct: 191 H-YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248
Query: 217 QLSKIFELCGSPDETIWPGVSKMPAYNHF-------KPSRTMKRRVRE--------VFRH 261
+++I EL G + + F + +K E +
Sbjct: 249 HIAQIIELLGELPSYL---LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 262 FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSH 312
+ + L ML LDP +R A ++ + D L + +P E
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEEIRVPDRELYG 355
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-51
Identities = 84/355 (23%), Positives = 143/355 (40%), Gaps = 87/355 (24%)
Query: 6 SQVFMAREIKTGEIVALK-----KIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEI 59
+V +A E KT + VA+K K + + +E P + EI+ILKKL H +IK+K
Sbjct: 24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMK 114
+ Y+V E M G L D+ R K Y
Sbjct: 84 FDAE-----------------DYYIVLELM----EGGELFDKVVGNK-RLKEATCKLYFY 121
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVIT 171
Q+L + Y H N ++HRD+K N+L+ ++ +K+ DFG ++ + + T
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGT 179
Query: 172 LWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILP---GKNEAEQLSKI----F 222
Y PE+L+ Y AVD WS+G I L+G P P + + +I +
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQITSGKY 237
Query: 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 282
+W VS+ AL+L++K+L++DP R
Sbjct: 238 NF----IPEVWAEVSE--------------------------KALDLVKKLLVVDPKARF 267
Query: 283 SAKDALDSEYFWTDPLPCDPKSLPKYESSH--------EYQTKKRRQQQRQHEEA 329
+ ++AL + + + + L E+ + T ++R ++ + E A
Sbjct: 268 TTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGA 322
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-51
Identities = 59/290 (20%), Positives = 96/290 (33%), Gaps = 54/290 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPG 64
+VF R + G + A+K+ + E+ +K+ QH ++L++ G
Sbjct: 71 GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
Y+ E L + G Q+ Y++ L L + H
Sbjct: 131 ----------------ILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGA 183
++H D+K +N+ + G KL DFGL Y PELL G
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPELLQG- 230
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
YG A D++S+G E+ LP + E ++ + G G+S
Sbjct: 231 -SYGTAADVFSLGLTILEVACNME-LP--HGGEGWQQLRQ--GYLPPEFTAGLSS----- 279
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+L ML DP R +A+ L
Sbjct: 280 ---------------------ELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-51
Identities = 43/308 (13%), Positives = 85/308 (27%), Gaps = 47/308 (15%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKE------ 58
S VF+ R+++ E ALK M E + + +L E+ + ++
Sbjct: 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 59 ---IVTSPG-PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR------PGLRFTVPQ 108
V P + + + ++ DL L +
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 109 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 168
+ QL+ ++H NL I +G L L D
Sbjct: 196 LHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK----VGTRGPAS 251
Query: 169 VITLWYRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKP--ILPGKNEAEQLSKIFELC 225
+ + Y P E L + A++ W +G + L +
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 285
D + + +P + L+ + L D +R+
Sbjct: 312 PGTDSLAFGSCTPLPDF-----------------------VKTLIGRFLNFDRRRRLLPL 348
Query: 286 DALDSEYF 293
+A+++ F
Sbjct: 349 EAMETPEF 356
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-51
Identities = 67/297 (22%), Positives = 118/297 (39%), Gaps = 54/297 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+ R G+I+ K++ + E + E+ +L++L+H N+++ + +
Sbjct: 20 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII---- 75
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL---ADRPGLRFTVPQIKCYMKQLLTGLH 121
D + Y+V EY + DL + + + M QL L
Sbjct: 76 --DRTN--------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 122 YCH-----VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
CH + VLHRD+K +N+ +D + N+KL DFGLAR ++D + T V T +Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMS 184
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
PE + Y D+WS+GC+ EL P ++ E KI
Sbjct: 185 PEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--------------- 228
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ + R + + E++ +ML L R S ++ L++
Sbjct: 229 --------------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-51
Identities = 58/311 (18%), Positives = 105/311 (33%), Gaps = 57/311 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTS 62
VF A+ A+K+IR + +E +RE+K L KL+H +++
Sbjct: 19 GVVFEAKNKVDDCNYAIKRIRLPNRELARE----KVMREVKALAKLEHPGIVRYFNAWL- 73
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL--ADRPGLRFTVPQIKCYMKQLLTG 119
E++ + + + Y+ + +L Q+
Sbjct: 74 ---EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-----------NTLTNR 168
+ + H ++HRD+K SN+ + +K+ DFGL + D T +
Sbjct: 131 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190
Query: 169 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 228
V T Y PE + G Y VD++S+G I ELL P L+ +
Sbjct: 191 VGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDV------- 240
Query: 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
+ +F +++ ML P +R A + +
Sbjct: 241 ----------------------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINII 278
Query: 289 DSEYFWTDPLP 299
++ F P
Sbjct: 279 ENAVFEDLDFP 289
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 8e-51
Identities = 80/293 (27%), Positives = 126/293 (43%), Gaps = 61/293 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V + R+ T A+K IR + + E+ +LK L H N++KL +
Sbjct: 51 GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF----- 105
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLH 121
D Y Y+V E G L D R F +KQ+L+G+
Sbjct: 106 -------EDKRNY----YLVMEC----YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVT 150
Query: 122 YCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
Y H + ++HRD+K NLL+++ + +K+ DFGL+ F ++ + R+ T +Y PE
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPE 208
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGV 236
+L KY D+WS+G I LL G P G+ + E L K+ G W V
Sbjct: 209 VLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYTFDSPEWKNV 264
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
S+ A +L+++ML D +RISA+ AL+
Sbjct: 265 SE--------------------------GAKDLIKQMLQFDSQRRISAQQALE 291
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 8e-51
Identities = 57/327 (17%), Positives = 113/327 (34%), Gaps = 69/327 (21%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPG 64
V E + + K ++ +G + +EI IL +H N++ L E S
Sbjct: 19 GIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARHRNILHLHESFESME 74
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTG 119
M+FE++ +G + +R +I Y+ Q+
Sbjct: 75 ----------------ELVMIFEFI----SGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
L + H + + H DI+ N++ + +K+ +FG AR + Y P
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAP 172
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIW 233
E+ A DMWS+G + LL+G P + + + I + E +
Sbjct: 173 EVHQH-DVVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENI--MNAEYTFDEEAF 227
Query: 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+S A++ ++++L+ + R++A +AL +
Sbjct: 228 KEISI--------------------------EAMDFVDRLLVKERKSRMTASEALQHPWL 261
Query: 294 WTDPLPCDPKSLPKYESSHEYQTKKRR 320
K + + Y T ++
Sbjct: 262 KQKIERVSTKVIRTLKHRRYYHTLIKK 288
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 64/295 (21%), Positives = 114/295 (38%), Gaps = 59/295 (20%)
Query: 12 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQ 70
R + VA+K+I + A RE+++L++ +H NVI+ E+D Q
Sbjct: 43 RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCT------EKDRQ 91
Query: 71 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 130
Y+ E L ++ + ++Q +GL + H ++H
Sbjct: 92 ----------FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141
Query: 131 RDIKGSNLLIDNEGN-----LKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGA 183
RD+K N+LI ++DFGL + + + + + T + PE+L
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 184 TK--YGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
K VD++S GC+F ++ G + + +
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----------------GAC 245
Query: 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295
+ + P +H D A EL+EKM+ +DP +R SAK L +FW+
Sbjct: 246 SLDCLHPE-----------KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-50
Identities = 71/381 (18%), Positives = 123/381 (32%), Gaps = 44/381 (11%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPG 64
V TGE VA+K+ R + + EI+I+KKL H NV+ +E+
Sbjct: 28 GYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVP--QIKCYMKQLLTGLH 121
+ EY + DL ++ + I+ + + + L
Sbjct: 86 KLAPND----------LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
Y H N+++HRD+K N+++ K+ D G A+ D T V TL Y PE
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPE 193
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
LL KY VD WS G + E + G + Q + ++ ++
Sbjct: 194 LLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF----- 293
++ P+ + L+ MLM QR + + F
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLE------RWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306
Query: 294 ----------WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGR 343
+ + E+ ++ ++ EE Q +
Sbjct: 307 ILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLA-LNSA 365
Query: 344 LPPIQHAGQSHHWSGPNHPMN 364
P Q+ G +
Sbjct: 366 QPLTQYVIDCTVIDGRQGEGD 386
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 84/297 (28%), Positives = 134/297 (45%), Gaps = 61/297 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V ++ T + A+K I + K T +RE+++LKKL H N++KL EI+
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL----- 90
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLH 121
E D + + Y+V E TG L D R F+ +KQ+ +G+
Sbjct: 91 ---E----DSSSF----YIVGEL----YTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 122 YCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
Y H + ++HRD+K N+L+++ + ++K+ DFGL+ F N + +R+ T +Y PE
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPE 193
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGV 236
+L G Y D+WS G I LL+G P GKNE + L ++ G W +
Sbjct: 194 VLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQWRTI 249
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
S A +L+ KML PS RI+A L+ +
Sbjct: 250 SD--------------------------DAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-50
Identities = 66/331 (19%), Positives = 124/331 (37%), Gaps = 65/331 (19%)
Query: 8 VFMAREIKTGEIVALK---KIRMDNEKEGFPITAI------------REIKILKKLQHEN 52
+ + + + ALK K ++ +++ E++I+ +++E
Sbjct: 47 IILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104
Query: 53 VIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD--------HDLTGLADRPGLRF 104
+ + I+T+ ++ Y+++EYM+ L
Sbjct: 105 CLTCEGIITNY------------DEV----YIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 105 TVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
+ IKC +K +L Y H + HRD+K SN+L+D G +KL+DFG + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DK 205
Query: 164 TLTNRVITLWYRPPELLLGATKY-GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 222
+ T + PPE + Y G VD+WS+G + +P F
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV--VP-----------F 252
Query: 223 ELCGSPDET---IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPS 279
L S E I + P + ++ ++ L+ L +P+
Sbjct: 253 SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312
Query: 280 QRISAKDALDSEYF---WTDPLPCDPKSLPK 307
+RI+++DAL E+ + L K L K
Sbjct: 313 ERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-50
Identities = 87/298 (29%), Positives = 139/298 (46%), Gaps = 62/298 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPG 64
+V + ++ TG+ A+K I K+ ++ RE+++LK+L H N++KL E
Sbjct: 40 GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF---- 95
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGL 120
D + Y+V E TG L D R F+ ++Q+L+G+
Sbjct: 96 --------EDKGYF----YLVGEV----YTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 121 HYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
Y H N+++HRD+K NLL+++ + N+++ DFGL+ F + + + +++ T +Y P
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 197
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPG 235
E+L G Y D+WS G I LL+G P G NE + L K+ G W
Sbjct: 198 EVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFELPQWKK 253
Query: 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
VS+ A +L+ KML PS RISA+DALD E+
Sbjct: 254 VSE--------------------------SAKDLIRKMLTYVPSMRISARDALDHEWI 285
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 4e-50
Identities = 68/359 (18%), Positives = 119/359 (33%), Gaps = 56/359 (15%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPG 64
+ VF R KTG++ A+K + P+ RE ++LKKL H+N++KL I
Sbjct: 23 ANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR-----PGLRFTVPQIKCYMKQLL 117
++ E+ L + ++ ++
Sbjct: 81 TRH--------------KVLIMEFC----PCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 118 TGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 173
G+++ N ++HR+IK N++ D + KL DFG AR + + + T
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEE 180
Query: 174 YRPPELLLGAT-------KYGPAVDMWSVGCIFAELLNGKP----ILPGKNEAEQLSKIF 222
Y P++ A KYG VD+WS+G F G + E + KI
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 282
S + P + + R +L +L D +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCS-----LSRGLQVLLTPVLANILEADQEKCW 295
Query: 283 SAKDALDSEYFWTDPLPCDPKSLPKYES----SHEYQTKKRRQQ--QRQHEEATKRQKL 335
+ SL + + H Y T + +Q + + Q+L
Sbjct: 296 GFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQEL 354
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-49
Identities = 82/333 (24%), Positives = 133/333 (39%), Gaps = 69/333 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE------NVIKLKEI 59
QV A + E VA+K I+ N K+ F A E+++L+ + ++ LK
Sbjct: 68 GQVVKAYDRVEQEWVAIKIIK--N-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLT 118
+R +VFE + ++L L R ++ + + +Q+ T
Sbjct: 125 FM----------------FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 119 GLHYCHVN--QVLHRDIKGSNLLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWY 174
L + ++H D+K N+L+ N +K+ DFG S + + + +Y
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQ-RIYQYIQSRFY 224
Query: 175 RPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD----- 229
R PE+LLG Y A+DMWS+GCI E+ G+P+ G NE +Q++KI E+ G P
Sbjct: 225 RSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283
Query: 230 ---------------------------ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF 262
E PG K+ + RR E
Sbjct: 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343
Query: 263 DRHA--LELLEKMLMLDPSQRISAKDALDSEYF 293
+ +L+ +ML DP RI AL +F
Sbjct: 344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 64/328 (19%), Positives = 119/328 (36%), Gaps = 61/328 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V E TG + K I + + + EI I+ +L H +I L +
Sbjct: 65 GVVHRCVEKATGRVFVAKFINTPYPLDKYTV--KNEISIMNQLHHPKLINLHDAFEDKY- 121
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGL 120
++ E++ +G L DR + + ++ YM+Q GL
Sbjct: 122 ---------------EMVLILEFL----SGGELFDRIAAEDYKMSEAEVINYMRQACEGL 162
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
+ H + ++H DIK N++ + + +K+ DFGLA + + + T + PE
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPE 220
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
++ G DMW++G + LL+G G+++ E L + DE + VS
Sbjct: 221 IVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW-TDP 297
A + ++ +L +P +R++ DAL+ W
Sbjct: 280 --------------------------EAKDFIKNLLQKEPRKRLTVHDALEHP--WLKGD 311
Query: 298 LPCDPKSLPKYESSHEYQTKKRRQQQRQ 325
+P + Q K +
Sbjct: 312 HSNLTSRIPSSRYNKIRQKIKEKYADWP 339
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 82/296 (27%), Positives = 116/296 (39%), Gaps = 69/296 (23%)
Query: 6 SQVFMAREIKTGEIVALKKI---RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTS 62
+V +A + T A KKI +++ +EI+I+K L H N+I+L E
Sbjct: 23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-----FKQEIEIMKSLDHPNIIRLYETFE- 76
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLT 118
D Y+V E TG L +R F MK +L+
Sbjct: 77 -----------DNTDI----YLVMELC----TGGELFERVVHKRVFRESDAARIMKDVLS 117
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYR 175
+ YCH V HRD+K N L + LKL DFGLA F + +V T +Y
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYV 175
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIW 233
P++L G YGP D WS G + LL G P ++E + KI G+ E W
Sbjct: 176 SPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDW 231
Query: 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
VS A L+ ++L P QRI++ AL+
Sbjct: 232 LNVSP--------------------------QAESLIRRLLTKSPKQRITSLQALE 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 81/309 (26%), Positives = 130/309 (42%), Gaps = 74/309 (23%)
Query: 6 SQVFMAREIKTGEIVALKKI---RMDNEKEGFPITAI--------REIKILKKLQHENVI 54
+V + +E A+K I + D + I EI +LK L H N+I
Sbjct: 50 GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109
Query: 55 KLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQI 109
KL ++ D + Y+V E+ G L ++ +F
Sbjct: 110 KLFDVF------------EDKKYF----YLVTEF----YEGGELFEQIINRH-KFDECDA 148
Query: 110 KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTLT 166
MKQ+L+G+ Y H + ++HRDIK N+L++N N+K+ DFGL+ F + L
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLR 206
Query: 167 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 226
+R+ T +Y PE+L KY D+WS G I LL G P G+N+ + + K+ G
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV--EKG 262
Query: 227 SPD--ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 284
W +S A EL++ ML D ++R +A
Sbjct: 263 KYYFDFNDWKNISD--------------------------EAKELIKLMLTYDYNKRCTA 296
Query: 285 KDALDSEYF 293
++AL+S +
Sbjct: 297 EEALNSRWI 305
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-49
Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 80/318 (25%)
Query: 11 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDE 69
+ G VA+K++ +D A+ EIK+L + H NVI+ E +
Sbjct: 33 FQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHPNVIRYYCS------ETTD 81
Query: 70 QGRPDGNKYRGSTYMVFEYMDHDL------TGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+ Y+ E + +L ++D ++Q+ +G+ +
Sbjct: 82 R----------FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 124 HVNQVLHRDIKGSNLLIDNEG-------------NLKLADFGLARSFSYDH---NNTLTN 167
H +++HRD+K N+L+ + ++DFGL + L N
Sbjct: 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 168 RVITLWYRPPELLLGAT------KYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQ--L 218
T +R PELL + + ++D++S+GC+F +L GK K E +
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 219 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 278
IF L + A +L+ +M+ DP
Sbjct: 252 RGIFSL-DEMKCLHDRSLIA--------------------------EATDLISQMIDHDP 284
Query: 279 SQRISAKDALDSEYFWTD 296
+R +A L FW
Sbjct: 285 LKRPTAMKVLRHPLFWPK 302
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 4e-49
Identities = 83/294 (28%), Positives = 132/294 (44%), Gaps = 63/294 (21%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V ++ T + A+K I + K T +RE+++LKKL H N++KL EI+
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE---- 91
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGL 120
D + + Y+V E TG L D RF+ +KQ+ +G+
Sbjct: 92 --------DSSSF----YIVGELY----TGGELFDEIIKRK-RFSEHDAARIIKQVFSGI 134
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
Y H + ++HRD+K N+L++++ ++K+ DFGL+ F N + +R+ T +Y P
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAP 192
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPG 235
E+L G Y D+WS G I LL+G P GKNE + L ++ G W
Sbjct: 193 EVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQWRT 248
Query: 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+S A +L+ KML PS RI+A L+
Sbjct: 249 ISD--------------------------DAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-49
Identities = 74/295 (25%), Positives = 117/295 (39%), Gaps = 64/295 (21%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
S V TG A K I RE +I +KLQH N+++L + +
Sbjct: 20 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES- 78
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLH 121
Y+VF+ + TG L + R ++ ++Q+L +
Sbjct: 79 ---------------FHYLVFDLV----TGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
YCH N ++HR++K NLL+ ++ +KLADFGLA + + T Y PE
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPE 177
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWP 234
+L Y VD+W+ G I LL G P P +++ ++I G+ D W
Sbjct: 178 VLKK-DPYSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAYDYPSPEWD 232
Query: 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
V+ A L++ ML ++P +RI+A AL
Sbjct: 233 TVTP--------------------------EAKSLIDSMLTVNPKKRITADQALK 261
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-49
Identities = 70/319 (21%), Positives = 116/319 (36%), Gaps = 63/319 (19%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPIT---AIREIKILKKLQHENVIKLKE---- 58
V +A E +T I A+K + + ++ P E++++KKL H N+ +L E
Sbjct: 40 GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99
Query: 59 -----IVT---------------SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD 98
+V + E ++ + G +
Sbjct: 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159
Query: 99 RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI--DNEGNLKLADFGLARS 156
I M+Q+ + LHY H + HRDIK N L + +KL DFGL++
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219
Query: 157 F---SYDHNNTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKPILPGK 212
F + +T + T ++ PE+L + YGP D WS G + LL G PG
Sbjct: 220 FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV 279
Query: 213 NEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELL 270
N+A+ +S++ L + +S A +LL
Sbjct: 280 NDADTISQV--LNKKLCFENPNYNVLSP--------------------------LARDLL 311
Query: 271 EKMLMLDPSQRISAKDALD 289
+L + +R A AL
Sbjct: 312 SNLLNRNVDERFDAMRALQ 330
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-49
Identities = 72/299 (24%), Positives = 107/299 (35%), Gaps = 71/299 (23%)
Query: 6 SQVFMAREIKTGEIVALKKI---RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTS 62
V + E +G +K I R E EI++LK L H N+IK+ E+
Sbjct: 36 GDVHLVEERSSGLERVIKTINKDRSQVPMEQI----EAEIEVLKSLDHPNIIKIFEVFE- 90
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR------PGLRFTVPQIKCYMK 114
D + Y+V E G L +R G + + MK
Sbjct: 91 -----------DYHNM----YIVMETC----EGGELLERIVSAQARGKALSEGYVAELMK 131
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVIT 171
Q++ L Y H V+H+D+K N+L + +K+ DFGLA F + TN T
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGT 189
Query: 172 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD-E 230
Y PE+ D+WS G + LL G G + E K P+
Sbjct: 190 ALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYA 245
Query: 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
++ A++LL++ML DP +R SA L
Sbjct: 246 VECRPLTP--------------------------QAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 7e-49
Identities = 75/305 (24%), Positives = 120/305 (39%), Gaps = 62/305 (20%)
Query: 8 VFMAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
F + T E+ A K K + + ++ EI I + L H++V+
Sbjct: 31 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGFHGFFEDND 88
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
++V E L L R T P+ + Y++Q++ G Y
Sbjct: 89 ----------------FVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL 131
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLL 181
H N+V+HRD+K NL ++ + +K+ DFGLA YD + T Y PE+L
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLS 188
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
+ VD+WS+GCI LL GKP E +I + +P
Sbjct: 189 K-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----------NEYSIP- 235
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 301
+H + A L++KML DP+ R + + L+ E+F + +
Sbjct: 236 ------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI--- 274
Query: 302 PKSLP 306
P LP
Sbjct: 275 PARLP 279
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-49
Identities = 79/302 (26%), Positives = 122/302 (40%), Gaps = 71/302 (23%)
Query: 6 SQVFMAREIKTGEIVALKKI--RMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTS 62
S V +TG+ A+K + G + RE I L+H ++++L E +S
Sbjct: 38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR------PGLRFTVPQIKCYMK 114
G YMVFE+M G L G ++ YM+
Sbjct: 98 DG----------------MLYMVFEFM----DGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVIT 171
Q+L L YCH N ++HRD+K +L+ +N +KL FG+A + RV T
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGT 196
Query: 172 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD 229
+ PE++ YG VD+W G I LL+G G E ++FE + G
Sbjct: 197 PHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYK 250
Query: 230 --ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 287
W +S+ A +L+ +MLMLDP++RI+ +A
Sbjct: 251 MNPRQWSHISE--------------------------SAKDLVRRMLMLDPAERITVYEA 284
Query: 288 LD 289
L+
Sbjct: 285 LN 286
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-48
Identities = 76/303 (25%), Positives = 120/303 (39%), Gaps = 68/303 (22%)
Query: 8 VFMAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
V+ A I TG VA+K K M K G E+KI +L+H ++++L
Sbjct: 27 VYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84
Query: 65 PERDEQGRPDGNKYRGSTYMVFEY------MDHDLTGLADRPGLRFTVPQIKCYMKQLLT 118
Y+V E + L +R F+ + + +M Q++T
Sbjct: 85 ----------------YVYLVLEMCHNGEMNRY----LKNRVK-PFSENEARHFMHQIIT 123
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRP 176
G+ Y H + +LHRD+ SNLL+ N+K+ADFGLA H TL T Y
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG---TPNYIS 180
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
PE+ + +G D+WS+GC+F LL G+P L+K+
Sbjct: 181 PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----------AD 228
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296
+MP A +L+ ++L +P+ R+S LD + +
Sbjct: 229 YEMP-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269
Query: 297 PLP 299
Sbjct: 270 SST 272
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 78/305 (25%), Positives = 127/305 (41%), Gaps = 75/305 (24%)
Query: 6 SQVFMAREIKTGEIVALK-----KIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEI 59
+V +A E KT + VA++ K + + +E P + EI+ILKKL H +IK+K
Sbjct: 149 GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMK 114
+ Y+V E M G L D+ R K Y
Sbjct: 209 FDAE-----------------DYYIVLELM----EGGELFDKVVGNK-RLKEATCKLYFY 246
Query: 115 QLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVIT 171
Q+L + Y H N ++HRD+K N+L+ + + +K+ DFG ++ + + T
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGT 304
Query: 172 LWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILP---GKNEAEQLSKIFELCG 226
Y PE+L+ Y AVD WS+G I L+G P P + + +I G
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--TSG 360
Query: 227 SPD--ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 284
+ +W VS+ AL+L++K+L++DP R +
Sbjct: 361 KYNFIPEVWAEVSE--------------------------KALDLVKKLLVVDPKARFTT 394
Query: 285 KDALD 289
++AL
Sbjct: 395 EEALR 399
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-48
Identities = 72/333 (21%), Positives = 130/333 (39%), Gaps = 67/333 (20%)
Query: 6 SQVFMAREIKTGEIVALK---KIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVT 61
+ V RE TG A K K + + G I RE+ IL+++ H NVI L ++
Sbjct: 26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLL 117
+ ++ E + +G L D + + ++KQ+L
Sbjct: 86 NRT----------------DVVLILELV----SGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 118 TGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 173
G++Y H ++ H D+K N+++ ++KL DFGLA + N T
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPE 183
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDET 231
+ PE++ G DMWS+G I LL+G P G + E L+ I + DE
Sbjct: 184 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITSVSYDFDEE 240
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291
+ S+ A + + K+L+ + +R++ ++AL
Sbjct: 241 FFSHTSE--------------------------LAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 292 YFWTDPLPCDPKSLPKYESSHEYQTKKRRQQQR 324
W P+ + + + +K+ ++R
Sbjct: 275 --WITPVDNQQAMVRRESVVNLENFRKQYVRRR 305
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 66/335 (19%), Positives = 121/335 (36%), Gaps = 71/335 (21%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE-----NVIKLKEIV 60
+V + + I + A+K +R N + + +A E ILKK+Q++ N++K
Sbjct: 49 GRVLLCQHIDNKKYYAVKVVR--N-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLTG 119
Y ++FE + L + R F + IK Y ++L
Sbjct: 106 M----------------YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 120 LHYCHVNQVLHRDIKGSN-LLIDNEG------------------------NLKLADFGLA 154
L+Y + H D+K N LL D +KL DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-- 207
Query: 155 RSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 214
++ + + + T YR PE++L + + DMWS GC+ AEL G +
Sbjct: 208 -CATFKSDY-HGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264
Query: 215 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFK---------PSRTMKRRVREVFRHF--- 262
E L+ + + + + +K + + + ++ V +
Sbjct: 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324
Query: 263 ----DRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ L +L +DP+ R S + L ++
Sbjct: 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-48
Identities = 69/304 (22%), Positives = 114/304 (37%), Gaps = 71/304 (23%)
Query: 6 SQVFMAREIKTGEIVALKKI-------RMDNEKEGFPITAIREIKILKKL-QHENVIKLK 57
S V T + A+K I E + ++E+ IL+K+ H N+I+LK
Sbjct: 31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90
Query: 58 EIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCY 112
+ + ++VF+ M L D + + +
Sbjct: 91 DTYETNT----------------FFFLVFDLM----KKGELFDYLTEKV-TLSEKETRKI 129
Query: 113 MKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 172
M+ LL + H ++HRD+K N+L+D++ N+KL DFG + D L T
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTP 187
Query: 173 WYRPPELLLGA-----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 227
Y PE++ + YG VDMWS G I LL G P + + L I + G+
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGN 245
Query: 228 PD--ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 285
W S +L+ + L++ P +R +A+
Sbjct: 246 YQFGSPEWDDYSD--------------------------TVKDLVSRFLVVQPQKRYTAE 279
Query: 286 DALD 289
+AL
Sbjct: 280 EALA 283
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-48
Identities = 70/300 (23%), Positives = 125/300 (41%), Gaps = 69/300 (23%)
Query: 6 SQVFMAREIKTGEIVALKKI---RMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVT 61
+ V R+ TG+ A K I R+ + + G I RE+ IL++++H N+I L +I
Sbjct: 19 AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE 78
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLL 117
+ ++ E + +G L D T + ++KQ+L
Sbjct: 79 NKT----------------DVVLILELV----SGGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNE----GNLKLADFGLARSFSYDHNNTLTNRVITLW 173
G+HY H ++ H D+K N+++ ++ +KL DFG+A + N N T
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPE 176
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD-- 229
+ PE++ G DMWS+G I LL+G P G+ + E L+ I + D
Sbjct: 177 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTNI--SAVNYDFD 231
Query: 230 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
E + S+ A + + ++L+ DP +R++ +L+
Sbjct: 232 EEYFSNTSE--------------------------LAKDFIRRLLVKDPKRRMTIAQSLE 265
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-48
Identities = 72/296 (24%), Positives = 119/296 (40%), Gaps = 61/296 (20%)
Query: 6 SQVFMAREIKTGEIVALKKI---RMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVT 61
+ V RE TG A K I R + + G I RE+ ILK++QH NVI L E+
Sbjct: 25 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 84
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLL 117
+ ++ E + G L D T + ++KQ+L
Sbjct: 85 NKT----------------DVILILELV----AGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNE----GNLKLADFGLARSFSYDHNNTLTNRVITLW 173
G++Y H Q+ H D+K N+++ + +K+ DFGLA D N N T
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPE 182
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233
+ PE++ G DMWS+G I LL+G G + E L+ + + ++ +
Sbjct: 183 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
S A + + ++L+ DP +R++ +D+L
Sbjct: 242 SNTSA--------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 7e-48
Identities = 72/333 (21%), Positives = 130/333 (39%), Gaps = 67/333 (20%)
Query: 6 SQVFMAREIKTGEIVALKKI---RMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVT 61
+ V RE TG A K I + + G I RE+ IL+++ H N+I L ++
Sbjct: 26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLL 117
+ ++ E + +G L D + + ++KQ+L
Sbjct: 86 NRT----------------DVVLILELV----SGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 118 TGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 173
G++Y H ++ H D+K N+++ ++KL DFGLA + N T
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPE 183
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDET 231
+ PE++ G DMWS+G I LL+G P G + E L+ I + DE
Sbjct: 184 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITAVSYDFDEE 240
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291
+ S+ A + + K+L+ + +R++ ++AL
Sbjct: 241 FFSQTSE--------------------------LAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 292 YFWTDPLPCDPKSLPKYESSHEYQTKKRRQQQR 324
W P+ + + + KK+ ++R
Sbjct: 275 --WITPVDTQQAMVRRESVVNLENFKKQYVRRR 305
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 9e-48
Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 73/298 (24%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
S+VF+ ++ TG++ ALK I + EI +LKK++HEN++ L++I S
Sbjct: 23 SEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST-- 78
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGL 120
Y Y+V + + +G L DR G +T ++Q+L+ +
Sbjct: 79 ----------THY----YLVMQLV----SGGELFDRILERG-VYTEKDASLVIQQVLSAV 119
Query: 121 HYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
Y H N ++HRD+K NLL + + + DFGL++ + N ++ T Y P
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTPGYVAP 176
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI------FELCGSPDET 231
E+L Y AVD WS+G I LL G P + E++ KI FE SP
Sbjct: 177 EVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE---SPF-- 230
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
W +S+ A + + +L DP++R + + AL
Sbjct: 231 -WDDISE--------------------------SAKDFICHLLEKDPNERYTCEKALS 261
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-47
Identities = 72/318 (22%), Positives = 118/318 (37%), Gaps = 64/318 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-----EKEGFPITAIREIKILKKLQHENVIKLKEIV 60
S+V+ A + G VALKK+++ + + I+EI +LK+L H NVIK
Sbjct: 46 SEVYRAACLLDGVPVALKKVQIFDLMDAKARA----DCIKEIDLLKQLNHPNVIKYYASF 101
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQL 116
+V E D + + + Y QL
Sbjct: 102 IE----------------DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYR 175
+ L + H +V+HRDIK +N+ I G +KL D GL R FS T + ++ T +Y
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYM 203
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235
PE + Y D+WS+GC+ E+ + P + L + + I
Sbjct: 204 SPERIHE-NGYNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCKK-------IEQC 253
Query: 236 -VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294
+P+ +H+ S ++ +L+ + DP +R D
Sbjct: 254 DYPPLPS-DHY--SEELR---------------QLVNMCINPDPEKRPDVTYVYDVAKRM 295
Query: 295 TDPLPCDPKSLPKYESSH 312
C SL + H
Sbjct: 296 H---ACTASSLEHHHHHH 310
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-47
Identities = 69/331 (20%), Positives = 124/331 (37%), Gaps = 69/331 (20%)
Query: 6 SQVFMAREIKTG-EIVALKKIRMDNEKEGFPITAIREIKILKKLQHE------NVIKLKE 58
+V + K G VA+K ++ N + A EI++L+ L +++ E
Sbjct: 28 GKVVECIDHKAGGRHVAVKIVK--NVDR-YCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84
Query: 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLL 117
+ G +VFE + G F + I+ Q+
Sbjct: 85 WFE----------------HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGN-------------------LKLADFGLARSFS 158
+++ H N++ H D+K N+L +K+ DFG S +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SAT 185
Query: 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 218
YD + + V T YR PE++L + D+WS+GCI E G + P + E L
Sbjct: 186 YDDEH-HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 219 SKIFELCGSPDETI----------------WPGVSKMPAYNHFKPSRTMKRRVREVFRHF 262
+ + + G + + W S Y + + +K +
Sbjct: 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY-VSRACKPLKEFML-SQDVE 301
Query: 263 DRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+L++KML DP++RI+ ++AL +F
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-47
Identities = 73/293 (24%), Positives = 116/293 (39%), Gaps = 60/293 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
S V TG A K I RE +I +KLQH N+++L + +
Sbjct: 43 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES- 101
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLH 121
Y+VF+ + TG L + R ++ ++Q+L +
Sbjct: 102 ---------------FHYLVFDLV----TGGELFEDIVAREFYSEADASHCIQQILESIA 142
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
YCH N ++HR++K NLL+ ++ +KLADFGLA + + T Y PE
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPE 200
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGV 236
+L Y VD+W+ G I LL G P +++ ++I G+ D W V
Sbjct: 201 VLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTV 257
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+ A L++ ML ++P +RI+A AL
Sbjct: 258 TP--------------------------EAKSLIDSMLTVNPKKRITADQALK 284
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-47
Identities = 74/288 (25%), Positives = 117/288 (40%), Gaps = 53/288 (18%)
Query: 8 VFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V++ARE ++ I+ALK + EK G RE++I L+H N+++L
Sbjct: 25 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH----- 79
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
D + Y++ EY + + +F + Y+ +L L YCH
Sbjct: 80 -------DATRV----YLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 127
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
+V+HRDIK NLL+ + G LK+ADFG + L TL Y PPE++ G
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEMIEGRM- 183
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
+ VD+WS+G + E L GKP E +I P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-----------VEFTFP----- 227
Query: 246 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
A +L+ ++L +PSQR ++ L+ +
Sbjct: 228 --------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 77/339 (22%), Positives = 126/339 (37%), Gaps = 76/339 (22%)
Query: 8 VFMAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
F + T E+ A K K + + ++ EI I + L H++V+
Sbjct: 57 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGFHGFFEDND 114
Query: 65 PERDEQGRPDGNKYRGSTYMVFEY------MDHDLTGLADRPGLRFTVPQIKCYMKQLLT 118
++V E ++ R T P+ + Y++Q++
Sbjct: 115 ----------------FVFVVLELCRRRSLLEL----HKRRK--ALTEPEARYYLRQIVL 152
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRP 176
G Y H N+V+HRD+K NL ++ + +K+ DFGLA YD L T Y
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG---TPNYIA 209
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
PE+L + VD+WS+GCI LL GKP E +I +
Sbjct: 210 PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----------NE 257
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296
+P +H + A L++KML DP+ R + + L+ E+F +
Sbjct: 258 YSIP-------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298
Query: 297 PLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKL 335
+ P LP R + + R+ L
Sbjct: 299 YI---PARLP----ITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-47
Identities = 67/330 (20%), Positives = 122/330 (36%), Gaps = 66/330 (20%)
Query: 6 SQVFMAREIKTGEIVALKKI--RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
V E TG A K + +++KE +EI+ + L+H ++ L +
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDKETV----RKEIQTMSVLRHPTLVNLHDAFEDD 226
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLT 118
M++E+M +G L ++ + + + YM+Q+
Sbjct: 227 N----------------EMVMIYEFM----SGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
GL + H N +H D+K N++ LKL DFGL D ++ T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAA 324
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWP 234
PE+ G G DMWSVG + LL+G G+N+ E L + + ++ +
Sbjct: 325 PEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--KSCDWNMDDSAFS 381
Query: 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294
G+S+ + + K+L+ DP+ R++ AL+ +
Sbjct: 382 GISE--------------------------DGKDFIRKLLLADPNTRMTIHQALEHPWLT 415
Query: 295 TDPLPCDPKSLPKYESSHEYQTKKRRQQQR 324
P +P + + K +
Sbjct: 416 PGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 445
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 63/295 (21%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
S V ++ G+ A I RE +I + L+H N+++L + ++
Sbjct: 25 SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--- 81
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLH 121
G Y++F+ + TG L + R ++ ++Q+L +
Sbjct: 82 -------------EGHHYLIFDLV----TGGELFEDIVAREYYSEADASHCIQQILEAVL 124
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
+CH V+HR++K NLL+ ++ +KLADFGLA + T Y PE
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPE 183
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWP 234
+L YG VD+W+ G I LL G P P +++ +I G+ D W
Sbjct: 184 VLRK-DPYGKPVDLWACGVILYILLVGYP--PFWDEDQHRLYQQI--KAGAYDFPSPEWD 238
Query: 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
V+ A +L+ KML ++PS+RI+A +AL
Sbjct: 239 TVTP--------------------------EAKDLINKMLTINPSKRITAAEALK 267
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 55/300 (18%), Positives = 98/300 (32%), Gaps = 61/300 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
S V + + G ALK+I +++ A RE + + H N+++L
Sbjct: 43 SYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFNHPNILRLVAYCLRERG 100
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
+ E +++ + + G T QI + + GL
Sbjct: 101 AKHE------------AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--------TLW 173
H HRD+K +N+L+ +EG L D G + + T+
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 174 YRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 231
YR PEL D+WS+GC+ ++ G+ P +++ ++
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG--P-----------YDMVFQKGDS 255
Query: 232 ---IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
+P S + +LL M+ +DP QR L
Sbjct: 256 VALAVQNQLSIPQSPRH--SSALW---------------QLLNSMMTVDPHQRPHIPLLL 298
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 65/333 (19%), Positives = 116/333 (34%), Gaps = 67/333 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPG 64
+ V TG+ A K ++ + + EI +L+ + VI L E+ +
Sbjct: 43 AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLT 118
++ EY G + + +KQ+L
Sbjct: 103 ----------------EIILILEYA----AGGEIFSLCLPELAEMVSENDVIRLIKQILE 142
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNE---GNLKLADFGLARSFSYDHNNTLTNRVITLWYR 175
G++Y H N ++H D+K N+L+ + G++K+ DFG++R H L + T Y
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYL 200
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ET 231
PE+L A DMW++G I LL P G++ E I + D E
Sbjct: 201 APEILNY-DPITTATDMWNIGIIAYMLLTHTS--PFVGEDNQETYLNI--SQVNVDYSEE 255
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291
+ VS+ A + ++ +L+ +P +R +A+ L
Sbjct: 256 TFSSVSQ--------------------------LATDFIQSLLVKNPEKRPTAEICLSHS 289
Query: 292 YFWTDPLPCDPKSLPKYESSHEYQTKKRRQQQR 324
+ SS R + +
Sbjct: 290 WLQQWDFENLFHPEETSSSSQTQDHSVRSSEDK 322
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 71/350 (20%), Positives = 130/350 (37%), Gaps = 72/350 (20%)
Query: 6 SQVFMARE-IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE------NVIKLKE 58
+V + + VALK IR N + A EI +LKK++ + + + +
Sbjct: 33 GKVVECLDHARGKSQVALKIIR--N-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSD 89
Query: 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLL 117
+ G + FE + + + + +P ++ QL
Sbjct: 90 WFN----------------FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 118 TGLHYCHVNQVLHRDIKGSN-LLIDNEG------------------NLKLADFGLARSFS 158
L + H NQ+ H D+K N L +++E ++++ADFG S +
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SAT 190
Query: 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 218
+DH + T V T YRPPE++L + D+WS+GCI E G + E L
Sbjct: 191 FDHEH-HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 219 SKIFELCGSPDETIWPGVSKMPAYNHF--------------KPSRTMKRRVREVFRH--- 261
+ ++ G + + + +F + + + ++
Sbjct: 249 VMMEKILGPIPSHM---IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305
Query: 262 FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESS 311
+L+ +ML DP+QRI+ +AL +F P + S
Sbjct: 306 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFF-AGLTPEERSFHTSRNPS 354
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-46
Identities = 63/298 (21%), Positives = 110/298 (36%), Gaps = 67/298 (22%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPG 64
+V +TG+ ALK + D+ K A +E+ + +++ + ++
Sbjct: 43 GKVLECFHRRTGQKCALKLLY-DSPK------ARQEVDHHWQASGGPHIVCILDVYE--- 92
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLT 118
+ + + ++ E M G + +R FT + M+ + T
Sbjct: 93 ---------NMHHGKRCLLIIMECM----EGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYR 175
+ + H + + HRD+K NLL ++ LKL DFG A+ N L T +Y
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET---TQNALQTPCYTPYYV 196
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ET 231
PE+L G KY + DMWS+G I LL G P + G
Sbjct: 197 APEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
W VS+ A +L+ +L DP++R++ ++
Sbjct: 256 EWSEVSE--------------------------DAKQLIRLLLKTDPTERLTITQFMN 287
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-46
Identities = 81/324 (25%), Positives = 121/324 (37%), Gaps = 62/324 (19%)
Query: 6 SQVFMAREIKTGEIVALKKI--RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
QV E TG +A K I R +KE EI ++ +L H N+I+L + S
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEV----KNEISVMNQLDHANLIQLYDAFESK 158
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLT 118
+V EY+ G L DR T +MKQ+
Sbjct: 159 N----------------DIVLVMEYV----DGGELFDRIIDESYNLTELDTILFMKQICE 198
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
G+ + H +LH D+K N+L N +K+ DFGLAR + L T +
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLA 256
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
PE++ DMWSVG I LL+G G N+AE L+ I ++ + +
Sbjct: 257 PEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI 315
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296
S+ A E + K+L+ + S RISA +AL +
Sbjct: 316 SE--------------------------EAKEFISKLLIKEKSWRISASEALKHPWLSDH 349
Query: 297 PLPCDPKSLPKYESSHEYQTKKRR 320
L + K + Q +
Sbjct: 350 KLHSRLSAQKKKNRGSDAQDFVTK 373
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-46
Identities = 77/305 (25%), Positives = 121/305 (39%), Gaps = 53/305 (17%)
Query: 8 VFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V++ARE + I+ALK + EKEG REI+I L+H N++++
Sbjct: 30 VYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK-- 87
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
Y++ E+ +L + G RF + +M++L LHYCH
Sbjct: 88 --------------RIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHE 132
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
+V+HRDIK NLL+ +G LK+ADFG + T+ TL Y PPE++ G
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TLDYLPPEMIEG-KT 188
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
+ VD+W G + E L G P + E +I K P
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-----------VDLKFP----- 232
Query: 246 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 305
+ +L+ K+L P QR+ K ++ + + P
Sbjct: 233 --------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVY 278
Query: 306 PKYES 310
+S
Sbjct: 279 QSTQS 283
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-45
Identities = 66/303 (21%), Positives = 110/303 (36%), Gaps = 70/303 (23%)
Query: 6 SQVFMAREIKTGEIVALKKIR------MDNEKEGFPITAIREIKILKKL-QHENVIKLKE 58
S V TG A+K + + E RE IL+++ H ++I L +
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167
Query: 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYM 113
S ++VF+ M L D + + + M
Sbjct: 168 SYESSS----------------FMFLVFDLM----RKGELFDYLTEKV-ALSEKETRSIM 206
Query: 114 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 173
+ LL + + H N ++HRD+K N+L+D+ ++L+DFG + + L T
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPG 264
Query: 174 YRPPELLLGA-----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 228
Y PE+L + YG VD+W+ G I LL G P + + L I + G
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEGQY 322
Query: 229 D--ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 286
W S +L+ ++L +DP R++A+
Sbjct: 323 QFSSPEWDDRSS--------------------------TVKDLISRLLQVDPEARLTAEQ 356
Query: 287 ALD 289
AL
Sbjct: 357 ALQ 359
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-44
Identities = 66/298 (22%), Positives = 112/298 (37%), Gaps = 66/298 (22%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPG 64
+V +T E ALK ++ D K RE+++ + +++++ ++
Sbjct: 76 GKVLQIFNKRTQEKFALKMLQ-DCPKAR------REVELHWRASQCPHIVRIVDVYE--- 125
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLT 118
+ R +V E + G + DR FT + MK +
Sbjct: 126 ---------NLYAGRKCLLIVMECL----DGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYR 175
+ Y H + HRD+K NLL ++ LKL DFG A+ +N+LT T +Y
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPYYV 230
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ET 231
PE+L G KY + DMWS+G I LL G P + + G +
Sbjct: 231 APEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
W VS+ L+ +L +P+QR++ + ++
Sbjct: 290 EWSEVSE--------------------------EVKMLIRNLLKTEPTQRMTITEFMN 321
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-44
Identities = 85/296 (28%), Positives = 125/296 (42%), Gaps = 69/296 (23%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
S V+ ++ T + ALK ++ +K+ EI +L +L H N+IKLKEI +P
Sbjct: 67 SIVYRCKQKGTQKPYALKVLKKTVDKKIV----RTEIGVLLRLSHPNIIKLKEIFETPT- 121
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGL 120
+V E + TG L DR G ++ +KQ+L +
Sbjct: 122 ---------------EISLVLELV----TGGELFDRIVEKG-YYSERDAADAVKQILEAV 161
Query: 121 HYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
Y H N ++HRD+K NLL + LK+ADFGL++ +H + T Y P
Sbjct: 162 AYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAP 219
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ETIW 233
E+L G YGP VDMWSVG I LL G P +E +F L W
Sbjct: 220 EILRG-CAYGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMFRRILNCEYYFISPWW 275
Query: 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
VS +A +L+ K+++LDP +R++ AL
Sbjct: 276 DEVSL--------------------------NAKDLVRKLIVLDPKKRLTTFQALQ 305
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-44
Identities = 73/300 (24%), Positives = 108/300 (36%), Gaps = 74/300 (24%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPG 64
S T A+K I EI+IL + QH N+I LK++
Sbjct: 36 SVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGK 89
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGL 120
Y+V E M G L D+ + F+ + + + +
Sbjct: 90 ----------------YVYVVTELM----KGGELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 121 HYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
Y H V+HRD+K SN+L N ++++ DFG A+ N L T +
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCYTANFVA 188
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKP---ILPGKNEAEQLSKI----FELCGSPD 229
PE+L Y A D+WS+G + +L G P E L++I F L G
Sbjct: 189 PEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY- 246
Query: 230 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
W VS A +L+ KML +DP QR++A L
Sbjct: 247 ---WNSVSD--------------------------TAKDLVSKMLHVDPHQRLTAALVLR 277
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 74/316 (23%), Positives = 120/316 (37%), Gaps = 78/316 (24%)
Query: 8 VFMAREIKTGEIVALK---KIRMDNEKEGFPITAI---------------------REIK 43
V +A A+K K ++ + +EI
Sbjct: 29 VKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88
Query: 44 ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG-LADRPGL 102
ILKKL H NV+KL E++ P YMVFE ++ G + + P L
Sbjct: 89 ILKKLDHPNVVKLVEVLDDPN--------------EDHLYMVFELVNQ---GPVMEVPTL 131
Query: 103 -RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161
+ Q + Y + L+ G+ Y H +++HRDIK SNLL+ +G++K+ADFG++ F
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GS 190
Query: 162 NNTLTNRVITLWYRPPELLLGATK-Y-GPAVDMWSVGCIFAELLNGKPILP--GKNEAEQ 217
+ L+N V T + PE L K + G A+D+W++G + G+ P +
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ--CPFMDERIMCL 248
Query: 218 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 277
SKI + P +L+ +ML +
Sbjct: 249 HSKIKS-----------QALEFPDQPDIAED-----------------LKDLITRMLDKN 280
Query: 278 PSQRISAKDALDSEYF 293
P RI + +
Sbjct: 281 PESRIVVPEIKLHPWV 296
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-43
Identities = 74/336 (22%), Positives = 123/336 (36%), Gaps = 73/336 (21%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPG 64
S K+ + A+K I E +EI LK + H N++KL E+
Sbjct: 25 SICRKCVHKKSNQAFAVKIISKRMEANTQ-----KEITALKLCEGHPNIVKLHEVFHDQL 79
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGL 120
T++V E + G L +R + F+ + M++L++ +
Sbjct: 80 ----------------HTFLVMELL----NGGELFERIKKKKHFSETEASYIMRKLVSAV 119
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
+ H V+HRD+K NLL +E +K+ DFG AR N L TL Y P
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPCFTLHYAAP 178
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS---KIFE--LCGSPD--E 230
E LL Y + D+WS+G I +L+G+ + + + +I + G
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290
W VS+ A +L++ +L +DP++R+ +
Sbjct: 238 EAWKNVSQ--------------------------EAKDLIQGLLTVDPNKRLKMSGLRYN 271
Query: 291 EYFW---TDPLPCDPKSLPKYESSHEYQTKKRRQQQ 323
E W L +P P S +
Sbjct: 272 E--WLQDGSQLSSNPLMTPDILGSSGAAVHTCVKAT 305
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 72/314 (22%), Positives = 125/314 (39%), Gaps = 54/314 (17%)
Query: 8 VFMAREIKTGEIVALKKI--RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V + +T A+K + + +EI++L++L+H+NVI+L +++ +
Sbjct: 21 VKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK 80
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCH 124
++ YMV EY + + D P RF V Q Y QL+ GL Y H
Sbjct: 81 QK--------------MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGA 183
++H+DIK NLL+ G LK++ G+A + + ++T + ++PPE+ G
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 184 TKY-GPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
+ G VD+WS G + G P G N + I + G +P
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGL--YPFEGDNIYKLFENIGK-----------GSYAIP 233
Query: 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD-PLP 299
+LL+ ML +P++R S + +F P
Sbjct: 234 -------------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274
Query: 300 CDPKSLPKYESSHE 313
P +P + +
Sbjct: 275 EAPVPIPPSPDTKD 288
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-43
Identities = 59/298 (19%), Positives = 100/298 (33%), Gaps = 87/298 (29%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPG 64
+V +T E ALK ++ D K RE+++ + Q +++++ ++
Sbjct: 32 GKVLQIFNKRTQEKFALKMLQ-DCPKAR------REVELHWRASQCPHIVRIVDVYE--- 81
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLT 118
+ R +V E + G + DR FT + MK +
Sbjct: 82 ---------NLYAGRKCLLIVMECL----DGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYR 175
+ Y H + HRD+K NLL ++ LKL DFG A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------- 167
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ET 231
E KY + DMWS+G I LL G P + + G +
Sbjct: 168 -KETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
W VS+ L+ +L +P+QR++ + ++
Sbjct: 225 EWSEVSE--------------------------EVKMLIRNLLKTEPTQRMTITEFMN 256
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-43
Identities = 55/296 (18%), Positives = 99/296 (33%), Gaps = 72/296 (24%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V ++ +TG A+KK+R++ + E+ L ++ L G
Sbjct: 73 EVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLY------GAV 119
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
R+ + E ++ L + + Y+ Q L GL Y
Sbjct: 120 REG----------PWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEY 165
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNNTLTNRVITL----WYRPP 177
H ++LH D+K N+L+ ++G+ L DFG A D + + P
Sbjct: 166 LHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237
E+++G VD+WS C+ +LNG P W
Sbjct: 226 EVVMG-KPCDAKVDIWSSCCMMLHMLNGCH--P----------------------WTQYF 260
Query: 238 KMPAY----NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+ P + P R + + +++ L +P R SA +
Sbjct: 261 RGPLCLKIASEPPPIREIPPSCAPLTAQA-------IQEGLRKEPVHRASAMELRR 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-42
Identities = 81/291 (27%), Positives = 123/291 (42%), Gaps = 57/291 (19%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ R++ +A+K+I + + P+ EI + K L+H+N IV G
Sbjct: 37 IVYAGRDLSNQVRIAIKEIPERDSRYSQPL--HEEIALHKHLKHKN------IVQYLGSF 88
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLH 121
+ G + E + L L + G L+ I Y KQ+L GL
Sbjct: 89 SEN----------GFIKIFMEQVPGGSLSAL--LRSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 122 YCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPEL 179
Y H NQ++HRDIKG N+LI+ G LK++DFG ++ + N T TL Y PE+
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAPEI 194
Query: 180 LLGATK-YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
+ + YG A D+WS+GC E+ GKP P E + +F++ G+ K
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAMFKV----------GMFK 242
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+ P E+ A + K DP +R A D L
Sbjct: 243 VH------P---------EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-42
Identities = 54/311 (17%), Positives = 93/311 (29%), Gaps = 77/311 (24%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPG 64
VF + G I A+K+ + A+RE+ L QH +V++
Sbjct: 25 GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-- 82
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGL 120
+ EY + D R F ++K + Q+ GL
Sbjct: 83 --------------DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNL-------------------KLADFGLARSFSYDH 161
Y H ++H DIK SN+ I K+ D G S
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--S 186
Query: 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
+ E+L + P D++++ +P LP +Q +I
Sbjct: 187 PQVEEG---DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-LP--RNGDQWHEI 240
Query: 222 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
+ ++P + + + ELL+ M+ DP +R
Sbjct: 241 RQ-------------GRLP----------------RIPQVLSQEFTELLKVMIHPDPERR 271
Query: 282 ISAKDALDSEY 292
SA +
Sbjct: 272 PSAMALVKHSV 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 2e-41
Identities = 59/342 (17%), Positives = 108/342 (31%), Gaps = 88/342 (25%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE-------- 58
VF A+ A+K+IR+ N + +RE+K L KL+H +++
Sbjct: 21 VVFEAKNKVDDCNYAIKRIRLPNRELARE-KVMREVKALAKLEHPGIVRYFNAWLETPPE 79
Query: 59 ---------------------------------IVTSPGPERDEQGRPDGNKYRGSTYMV 85
P ++ G+ + + Y+
Sbjct: 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQ 139
Query: 86 FEYMDH-DLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 142
+ +L +R Q+ + + H ++HRD+K SN+
Sbjct: 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM 199
Query: 143 EGNLKLADFGLARSFSYD-----------HNNTLTNRVITLWYRPPELLLGATKYGPAVD 191
+ +K+ DFGL + D T T +V T Y PE + G Y VD
Sbjct: 200 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVD 258
Query: 192 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 251
++S+G I ELL ++ +
Sbjct: 259 IFSLGLILFELLY--SFSTQMERVRIITDV-----------------------------R 287
Query: 252 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ +F +++ ML P++R A D +++ F
Sbjct: 288 NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 4e-41
Identities = 43/331 (12%), Positives = 97/331 (29%), Gaps = 68/331 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIRE----IKILKKLQHENVIKLK---- 57
A + +TGE + I ++E +++L+ ++++ K+
Sbjct: 87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146
Query: 58 ---EIVTSPGPERDEQGRPDGNKYR-GSTYMVFEYMDHDLTGLAD------RPGLRFTVP 107
++V P ++ + R D S + ++ M +L +
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 206
Query: 108 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 167
Q++ L H ++H ++ ++++D G + L F +
Sbjct: 207 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVV 261
Query: 168 RVITLWYRPPELL----------LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 217
++ + PPEL T + D W++G + + +
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG 321
Query: 218 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 277
IF C ++ + LLE L
Sbjct: 322 SEWIFRSC----------------------------------KNIPQPVRALLEGFLRYP 347
Query: 278 PSQRISAKDALDSEYFWTDPLPCDPKSLPKY 308
R+ A+++ + +LP Y
Sbjct: 348 KEDRLLPLQAMETPEY-EQLRTELSAALPLY 377
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-41
Identities = 75/310 (24%), Positives = 130/310 (41%), Gaps = 54/310 (17%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
++V +AR I TG VA+K I RE++I+K L H N++KL E++ +
Sbjct: 29 AKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK- 87
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+ Y++ EY ++ G R + + +Q+++ + YCH
Sbjct: 88 ---------------TLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH 131
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
+++HRD+K NLL+D + N+K+ADFG + F+ L Y PEL G
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFCGAPPYAAPELFQGKK 189
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
GP VD+WS+G I L++G LP G+N E ++ G ++P
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGS--LPFDGQNLKELRERVLR-----------GKYRIP-- 234
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 302
+ LL++ L+L+P +R + + + + +
Sbjct: 235 -----------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 277
Query: 303 KSLPKYESSH 312
K + E
Sbjct: 278 KPFVEPELDI 287
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 88/310 (28%), Positives = 124/310 (40%), Gaps = 67/310 (21%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V +A T E VA+K + M P +EI I K L HENV+K
Sbjct: 23 VQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG---- 77
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHYC 123
N Y+ EY +G L DR P + P + + QL+ G+ Y
Sbjct: 78 --------NIQ----YLFLEYC----SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG 182
H + HRDIK NLL+D NLK++DFGLA F Y++ L N++ TL Y PELL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILP---GKNEAEQLSKIFELCGSPDETIWPGVSKM 239
+ VD+WS G + +L G+ LP + ++ S E
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKE----------KKTYLN 229
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299
P ++ D L LL K+L+ +PS RI+ D ++
Sbjct: 230 P------------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY------ 265
Query: 300 CDPKSLPKYE 309
K L K
Sbjct: 266 --NKPLKKGA 273
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 64/319 (20%), Positives = 116/319 (36%), Gaps = 85/319 (26%)
Query: 6 SQVFMAREIKTGEIVALKKI--RMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTS 62
++V + T + A+K I + + + RE+++L + Q H NV++L E
Sbjct: 27 ARVQTCINLITSQEYAVKIIEKQPGHIRSRV----FREVEMLYQCQGHRNVLELIEFFE- 81
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLT 118
+ +++ Y+VFE M G + R F + ++ + +
Sbjct: 82 -----------EEDRF----YLVFEKM----RGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDH------NNTLTNRV 169
L + H + HRD+K N+L ++ +K+ DF L + L
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 170 ITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 225
+ Y PE++ A+ Y D+WS+G I LL+G P G+ ++ E C
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 226 GSPDETI---------------WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELL 270
+ + W +S A +L+
Sbjct: 243 PACQNMLFESIQEGKYEFPDKDWAHISC--------------------------AAKDLI 276
Query: 271 EKMLMLDPSQRISAKDALD 289
K+L+ D QR+SA L
Sbjct: 277 SKLLVRDAKQRLSAAQVLQ 295
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 53/291 (18%), Positives = 102/291 (35%), Gaps = 49/291 (16%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ + +T VA +++ + E ++LK LQH N+++ +
Sbjct: 41 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE----- 95
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
K + +V E M L R + ++ + +Q+L GL + H
Sbjct: 96 -------STVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT 147
Query: 126 NQ--VLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
++HRD+K N+ I G++K+ D GLA + + T + PE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEM--Y 202
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
KY +VD+++ G E+ + A Q+ + G +
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFDKVAI----- 256
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ +E + + +R S KD L+ +F
Sbjct: 257 --------------PEVKEI-------IEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-39
Identities = 67/347 (19%), Positives = 118/347 (34%), Gaps = 67/347 (19%)
Query: 7 QVFMAREIKTGEIVALK-----KIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIV 60
V+ A + + + V +K K+ D E + + EI IL +++H N+IK+ +I
Sbjct: 39 FVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLT 118
+ G +V E DL DR R P +QL++
Sbjct: 99 ENQG----------------FFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVS 141
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
+ Y + ++HRDIK N++I + +KL DFG A T+ Y PE
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCGTIEYCAPE 199
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
+L+G GP ++MWS+G L+ + P +L + E
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEE--NP----FCELEETVE-----------AAIH 242
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD-- 296
P + + L+ +L P +R + + + +
Sbjct: 243 PP-------------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283
Query: 297 --PLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPH 341
+ S R + + Q+L + H
Sbjct: 284 LADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGH 330
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 85/294 (28%), Positives = 121/294 (41%), Gaps = 59/294 (20%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
V +A T E VA+K + M P +EI I K L HENV+K
Sbjct: 23 VQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG---- 77
Query: 68 DEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHYC 123
N Y+ EY +G L DR P + P + + QL+ G+ Y
Sbjct: 78 --------NIQ----YLFLEYC----SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG 182
H + HRDIK NLL+D NLK++DFGLA F Y++ L N++ TL Y PELL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILP---GKNEAEQLSKIFELCGSPDETIWPGVSKM 239
+ VD+WS G + +L G+ LP + ++ S E
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKE----------KKTYLN 229
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P ++ D L LL K+L+ +PS RI+ D ++
Sbjct: 230 P------------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-39
Identities = 77/312 (24%), Positives = 129/312 (41%), Gaps = 59/312 (18%)
Query: 8 VFMAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
V +A KT + VALK + + + REI LK L+H ++IKL +++T+P
Sbjct: 25 VKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKLYDVITTPT 82
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
MV EY +L R T + + + +Q++ + YCH
Sbjct: 83 ----------------DIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH 125
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
++++HRD+K NLL+D+ N+K+ADFGL+ + + L + Y PE++ G
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKL 183
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
GP VD+WS G + +L G+ LP + K+ V MP
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR--LPFDDEFIPNLFKKVNS-----------CVYVMP-- 228
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD-PLPCD 301
A L+ +M++ DP QRI+ ++ +F + P
Sbjct: 229 -----------------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLR 271
Query: 302 PKSLPKYESSHE 313
P + +
Sbjct: 272 PMEEVQGSYADS 283
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 69/302 (22%), Positives = 111/302 (36%), Gaps = 65/302 (21%)
Query: 7 QVFMAREIKTGEIVALK---KIRMDNEKEGFPITAI-REIKILKKLQHE--NVIKLKEIV 60
V+ + VA+K K R+ + E T + E+ +LKK+ VI+L +
Sbjct: 58 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLT 118
P + + ++ E + DL G + + Q+L
Sbjct: 118 ERP------------DSF----VLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLE 160
Query: 119 GLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
+ +CH VLHRDIK N+LID N G LKL DFG + + T+ T Y PP
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPP 217
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237
E + +G + +WS+G + +++ G +P FE DE I G
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGD--IP-----------FEH----DEEIIRGQV 260
Query: 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297
+ L+ L L PS R + ++ + +
Sbjct: 261 FFR-------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301
Query: 298 LP 299
LP
Sbjct: 302 LP 303
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 80/292 (27%), Positives = 125/292 (42%), Gaps = 59/292 (20%)
Query: 8 VFMAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
V + TG VA+K + ++ + I REI+ LK +H ++IKL +++++P
Sbjct: 27 VKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKLYQVISTPT 84
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+MV EY+ +L + G R + + +Q+L+ + YC
Sbjct: 85 ----------------DFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYC 127
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
H + V+HRD+K N+L+D N K+ADFGL S L + Y PE++ G
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGL--SNMMSDGEFLRTSCGSPNYAAPEVISGR 185
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
GP VD+WS G I LL G LP ++ KI GV +P
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGT--LPFDDEHVPTLFKKIRG-----------GVFYIP- 231
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ +R LL ML +DP +R + KD + E+F
Sbjct: 232 ------------------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 68/342 (19%), Positives = 119/342 (34%), Gaps = 69/342 (20%)
Query: 6 SQVFMAREIKTGEIVALKKI-RMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSP 63
+ V+ A+++ +G ALK++ + EK I+E+ +KKL H N+++ +
Sbjct: 42 AFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGHPNIVQFCSAASIG 98
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD-----RPGLRFTVPQIKCYMKQLLT 118
E D + L + + + Q
Sbjct: 99 KEESD-----------TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 119 GLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT---------- 166
+ + H + ++HRD+K NLL+ N+G +KL DFG A + S+ + + +
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 167 -NRVITLWYRPPEL--LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 223
R T YR PE+ L G D+W++GCI L + P FE
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH--P-----------FE 254
Query: 224 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 283
I G +P ++ L+ ML ++P +R+S
Sbjct: 255 --DGAKLRIVNGKYSIPPHDTQ--YTVFHS---------------LIRAMLQVNPEERLS 295
Query: 284 AKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQ 325
+ + +PKS P E + R
Sbjct: 296 IAEVVHQLQEIAAARNVNPKS-PITELLEQNGGYGSATLSRG 336
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 70/294 (23%), Positives = 113/294 (38%), Gaps = 59/294 (20%)
Query: 8 VFMAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
+ R+ T E+VA+K + +E REI + L+H N+++ KE++ +P
Sbjct: 36 ARLMRDKLTKELVAVKYIERGAAIDEN------VQREIINHRSLRHPNIVRFKEVILTP- 88
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
++ EY +L G RF+ + + + +QLL+G+ YC
Sbjct: 89 -----------THL----AIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYC 132
Query: 124 HVNQVLHRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
H Q+ HRD+K N L+D LK+ DFG ++S + V T Y PE+LL
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLL 190
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKM 239
G D+WS G +L G P E K + I +
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEEPRDYRKTI-------QRILSVKYSI 241
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P P L+ ++ + DP+ RIS + +F
Sbjct: 242 PDDIRISPE-----------------CCHLISRIFVADPATRISIPEIKTHSWF 278
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 90/416 (21%), Positives = 150/416 (36%), Gaps = 82/416 (19%)
Query: 8 VFMAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
V + + TG VA+K + ++ + I REI+ LK +H ++IKL +++++P
Sbjct: 32 VKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKLYQVISTPS 89
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+MV EY+ +L + G R + + +Q+L+G+ YC
Sbjct: 90 ----------------DIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYC 132
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
H + V+HRD+K N+L+D N K+ADFGL+ S L + Y PE++ G
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGR 190
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
GP VD+WS G I LL G LP + KI + G+ P
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICD-----------GIFYTP- 236
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 301
++ + + LL+ ML +DP +R + KD + E+F D
Sbjct: 237 ------------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYL 278
Query: 302 PKSLPKYESSH----------------EYQTKKRRQQQRQHEEAT-------KRQKLHHP 338
P Y S+ E + + + +++ +
Sbjct: 279 FPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNE 338
Query: 339 QPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPS 394
L P V P H P ++
Sbjct: 339 AKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVR 394
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 65/365 (17%), Positives = 106/365 (29%), Gaps = 59/365 (16%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V +AR TGE V +++I ++ E+ + K H N++
Sbjct: 42 TVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP----------- 90
Query: 67 RDEQGRPDGNKYRGS------TYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQL 116
YR + ++V +M DL + I ++ +
Sbjct: 91 -----------YRATFIADNELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGV 137
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWY 174
L L Y H +HR +K S++LI +G + L+ S + +
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 175 RP----PELLL-GATKYGPAVDMWSVGCIFAELLNGKP-------------IL---PGKN 213
PE+L Y D++SVG EL NG L
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257
Query: 214 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKM 273
EL SP ++ R F H +E+
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 274 LMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKY-ESSHEYQTKKRRQQQRQHEEATKR 332
L +P R SA L+ +F ++LP+ + Q Q
Sbjct: 318 LQRNPDARPSASTLLNHSFF-KQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLV 376
Query: 333 QKLHH 337
L
Sbjct: 377 TNLEE 381
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 65/320 (20%), Positives = 107/320 (33%), Gaps = 69/320 (21%)
Query: 7 QVFMAREIKTGEIVALK---KIRMDNEKEGFPITAI-REIKILKKL----QHENVIKLKE 58
VF + VA+K + R+ E+ +L K+ H VI+L +
Sbjct: 46 TVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105
Query: 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQL 116
+ + +V E DL G +C+ Q+
Sbjct: 106 WFETQ------------EGF----MLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQV 148
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYR 175
+ + +CH V+HRDIK N+LID G KL DFG + H+ T+ T Y
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG---ALLHDEPYTDFDGTRVYS 205
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235
PPE + + +WS+G + +++ G +P FE D+ I
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGD--IP-----------FER----DQEILEA 248
Query: 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF-- 293
P H L+ + L PS R S ++ L +
Sbjct: 249 ELHFP-------------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289
Query: 294 WTDPLPCDPKSLPKYESSHE 313
+ +P +P +
Sbjct: 290 PAEDVPLNPSKGGPAPLAWS 309
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 75/295 (25%), Positives = 120/295 (40%), Gaps = 67/295 (22%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V+ A+ +TG + A K I +E+E I EI+IL H ++KL
Sbjct: 34 KVYKAKNKETGALAAAKVIETKSEEELEDY--IVEIEILATCDHPYIVKLL--------- 82
Query: 67 RDEQGRPDGNKYRGST-YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
G Y +++ E+ + DR T PQI+ +Q+L L+
Sbjct: 83 --------GAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALN 131
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPE 178
+ H +++HRD+K N+L+ EG+++LADFG S + TL R + T ++ PE
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 179 LLLGATK----YGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233
+++ T Y D+WS+G I E+ +P N L KI
Sbjct: 188 VVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEPPHHELNPMRVLLKI------------ 234
Query: 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
+K P+ + FR F L+ L +P R SA L
Sbjct: 235 ---AKSDP-----PTLLTPSKWSVEFRDF-------LKIALDKNPETRPSAAQLL 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 74/329 (22%), Positives = 137/329 (41%), Gaps = 70/329 (21%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ A +TG+IVA+K++ ++++ + I+EI I+++ +V+K
Sbjct: 44 SVYKAIHKETGQIVAIKQVPVESDLQEI----IKEISIMQQCDSPHVVKYY--------- 90
Query: 67 RDEQGRPDGNKYRGST-YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
G+ ++ + ++V EY D+ L ++ T +I ++ L GL
Sbjct: 91 --------GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLE 139
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPE 178
Y H + +HRDIK N+L++ EG+ KLADFG + +T+ R + T ++ PE
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGTPFWMAPE 195
Query: 179 LLLGATKYGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237
++ Y D+WS+G I A E+ GKP + + I
Sbjct: 196 VIQEIG-YNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMI---------------P 238
Query: 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297
P P+ + F F +++ L+ P QR +A L + +
Sbjct: 239 TNPP-----PTFRKPELWSDNFTDF-------VKQCLVKSPEQRATATQLLQHPFVRS-- 284
Query: 298 LPCDPKSL-PKYESSHEYQTKKRRQQQRQ 325
L + + + K++ QQR+
Sbjct: 285 -AKGVSILRDLINEAMDVKLKRQESQQRE 312
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 73/331 (22%), Positives = 127/331 (38%), Gaps = 66/331 (19%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGP 65
V+ AR+++ E+VA+KK+ ++ I +E++ L+KL+H N I+ +
Sbjct: 69 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR-------- 120
Query: 66 ERDEQGRPDGNKYRGST-YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
G R T ++V EY + L + +I L GL Y H
Sbjct: 121 ---------GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLL 181
+ ++HRD+K N+L+ G +KL DFG A + + V T ++ PE++L
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVIL 223
Query: 182 GATK--YGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
+ Y VD+WS+G I EL KP L N L I ++
Sbjct: 224 AMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI---------------AQ 267
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298
E FR+F ++ L P R +++ L +
Sbjct: 268 NE------SPALQSGHWSEYFRNF-------VDSCLQKIPQDRPTSEVLLKHRFVLR--- 311
Query: 299 PCDPKSL-PKYESSHEYQTKKRRQQQRQHEE 328
P + + + + + Q R+ ++
Sbjct: 312 ERPPTVIMDLIQRTKDAVRELDNLQYRKMKK 342
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 45/330 (13%), Positives = 89/330 (26%), Gaps = 57/330 (17%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIR-EIKILKKLQ----------HENVI 54
A + +TGE + I ++ E+ L+ L+ H I
Sbjct: 92 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151
Query: 55 KLKEIVTSPGPERDEQGRPDGNKYR-GSTYMVFEYMDHDLTGLAD------RPGLRFTVP 107
++V P ++ + R D S + ++ M +L +
Sbjct: 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 211
Query: 108 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 167
Q++ L H ++H ++ ++++D G + L F + +
Sbjct: 212 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGR 271
Query: 168 RVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 223
+L T A D W++G + IF
Sbjct: 272 GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR 331
Query: 224 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 283
C +P LLE L R+
Sbjct: 332 SC-----------KNIPQP-----------------------VRALLEGFLRYPKEDRLL 357
Query: 284 AKDALDSEYFWTDPLPCDPKSLPKYESSHE 313
A+++ + +LP Y++ E
Sbjct: 358 PLQAMETP-EYEQLRTELSAALPLYQTDGE 386
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 73/292 (25%), Positives = 129/292 (44%), Gaps = 68/292 (23%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V+ A ++ TG+ VA++++ + + + I I EI ++++ ++ N++
Sbjct: 35 TVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVN----------- 81
Query: 67 RDEQGRPDGNKYRGSTY------MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTG 119
Y S +V EY+ LT + QI ++ L
Sbjct: 82 -----------YLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQA 128
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPP 177
L + H NQV+HRDIK N+L+ +G++KL DFG + + + +T+ V T ++ P
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAP 185
Query: 178 ELLLGATKYGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
E++ YGP VD+WS+G I A E++ G+P P NE L ++ + +
Sbjct: 186 EVVTR-KAYGPKVDIWSLG-IMAIEMIEGEP--PYLNE-NPLRALYLIATNG-------- 232
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
P ++ +FR F L + L +D +R SAK+ L
Sbjct: 233 ---------TPELQNPEKLSAIFRDF-------LNRCLEMDVEKRGSAKELL 268
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 73/292 (25%), Positives = 125/292 (42%), Gaps = 68/292 (23%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V +ARE +G VA+K + + ++ + E+ I++ QH NV++
Sbjct: 60 IVCLAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHFNVVE----------- 106
Query: 67 RDEQGRPDGNKYRGSTY------MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTG 119
S ++ E++ LT + + +R QI + +L
Sbjct: 107 -----------MYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQA 153
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPP 177
L Y H V+HRDIK ++L+ +G +KL+DFG S D +L V T ++ P
Sbjct: 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAP 210
Query: 178 ELLLGATKYGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
E++ + Y VD+WS+G I E+++G+P P ++ + + L SP
Sbjct: 211 EVISR-SLYATEVDIWSLG-IMVIEMVDGEP--PYFSD-SPVQAMKRLRDSP-------- 257
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
P +V V R F LE+ML+ DP +R +A++ L
Sbjct: 258 ---------PPKLKNSHKVSPVLRDF-------LERMLVRDPQERATAQELL 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 9e-33
Identities = 48/308 (15%), Positives = 106/308 (34%), Gaps = 49/308 (15%)
Query: 6 SQVFMAR-----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIV 60
+QV+ A + K + LK + N E F I + ++ LK +K
Sbjct: 79 AQVYEATQGDLNDAKNKQKFVLKVQKPANPWE-FYIG-TQLMERLKPSMQHMFMKFYSAH 136
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-----LTGLADRPGLRFTVPQIKCYMKQ 115
++ + +V E + + + P + + +
Sbjct: 137 ----------------LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLI-----------DNEGNLKLADFGLARSFS-YDHNN 163
+L + H +++H DIK N ++ D L L D G + +
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 164 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIF 222
T + T ++ E+L + +D + V +L G + + + + +F
Sbjct: 241 IFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 223 ELCGSPDETIWPGVSK----MPAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLD 277
P +W +P +H +++++++VF +H+ L ++++L
Sbjct: 300 R--RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLL 357
Query: 278 PSQRISAK 285
+ S K
Sbjct: 358 LECKRSRK 365
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 72/368 (19%), Positives = 128/368 (34%), Gaps = 103/368 (27%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ--------HENVIKLK 57
S V+++ +I+ + VA+K ++ E + TA+ EI++LK ++ E V++L
Sbjct: 51 STVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107
Query: 58 EIVTSPGPERDEQGRPDGNKYRGS-TYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQ 115
+ G G+ MVFE + H L + +P +K ++Q
Sbjct: 108 DDFKISGVN-------------GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 116 LLTGLHYCH-VNQVLHRDIKGSNLLIDNE------------------------------- 143
+L GL Y H +++H DIK N+L+
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 144 ------------------GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
+K+AD G A + T YR E+L+G+
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGS-G 269
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKN------EAEQLSKIFELCGSPDETIWPGVSKM 239
Y D+WS C+ EL G + + + + ++ I EL G +
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 240 PAY----------NHFKPSRTMKRRVREVFRHFDRH----ALELLEKMLMLDPSQRISAK 285
+ KP + V + + + + L ML L P +R +A
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEK--YEWSQEEAAGFTDFLLPMLELIPEKRATAA 387
Query: 286 DALDSEYF 293
+ L +
Sbjct: 388 ECLRHPWL 395
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 65/306 (21%), Positives = 118/306 (38%), Gaps = 46/306 (15%)
Query: 8 VFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 67
VF +G ++A K I ++ + IRE+++L + ++
Sbjct: 49 VFKVSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFY---------- 97
Query: 68 DEQGRPDGNKYRGST-YMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYC 123
G Y + E+MD G D + R + ++ GL Y
Sbjct: 98 -------GAFYSDGEISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 124 HVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLL 181
+++HRD+K SN+L+++ G +KL DFG++ +++ N + T Y PE L
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 203
Query: 182 GATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
G T Y D+WS+G E+ G+ PI P + +L ++ G ET +
Sbjct: 204 G-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 241 AYNHFKPSRTMKRRVREVFRH-------------FDRHALELLEKMLMLDPSQRISAKDA 287
N F + E+ + F + + K L+ +P++R K
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322
Query: 288 LDSEYF 293
+ +
Sbjct: 323 MVHAFI 328
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 60/305 (19%), Positives = 109/305 (35%), Gaps = 61/305 (20%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V A E VA+K+I ++ + ++EI+ + + H N++
Sbjct: 30 VVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAMSQCHHPNIVS----------- 77
Query: 67 RDEQGRPDGNKYRGS------TYMVFEYMD----HDLTGLADRPGLR----FTVPQIKCY 112
Y S ++V + + D+ G I
Sbjct: 78 -----------YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 113 MKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 172
++++L GL Y H N +HRD+K N+L+ +G++++ADFG++ + + T T
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 173 WYRP----PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 228
P PE++ Y D+WS G EL G + L + +
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---ND 243
Query: 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
++ GV + S FR + L DP +R +A + L
Sbjct: 244 PPSLETGVQDKEMLKKYGKS----------FRKM-------ISLCLQKDPEKRPTAAELL 286
Query: 289 DSEYF 293
++F
Sbjct: 287 RHKFF 291
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 38/210 (18%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+VF + +T ++VA+K I ++ ++ +EI +L + V K
Sbjct: 37 EVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYY--------- 86
Query: 67 RDEQGRPDGNKYRGST-YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
G+ + + +++ EY+ DL PG QI ++++L GL
Sbjct: 87 --------GSYLKDTKLWIIMEYLGGGSALDLL----EPG-PLDETQIATILREILKGLD 133
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPE 178
Y H + +HRDIK +N+L+ G +KLADFG+A + +T R V T ++ PE
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKRNTFVGTPFWMAPE 189
Query: 179 LLLGATKYGPAVDMWSVGCIFA-ELLNGKP 207
++ + Y D+WS+G I A EL G+P
Sbjct: 190 VIKQSA-YDSKADIWSLG-ITAIELARGEP 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 72/335 (21%), Positives = 132/335 (39%), Gaps = 62/335 (18%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGP 65
QV+ R +KTG++ A+K + + ++E +EI +LKK H N+ P
Sbjct: 39 QVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHHRNIATYYGAFIKKNP 95
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
+ ++V E+ DL + + G I +++L GL
Sbjct: 96 PGMDD----------QLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICREILRGLS 143
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPE 178
+ H ++V+HRDIKG N+L+ +KL DFG++ T+ R + T ++ PE
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----RTVGRRNTFIGTPYWMAPE 199
Query: 179 LLLGATK----YGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233
++ Y D+WS+G I A E+ G P L + L I
Sbjct: 200 VIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRALFLI------------ 246
Query: 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ P R ++ + F+ F +E L+ + SQR + + + +
Sbjct: 247 ---PRNP------APRLKSKKWSKKFQSF-------IESCLVKNHSQRPATEQLMKHPFI 290
Query: 294 WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEE 328
P + K + + K+ + + ++E
Sbjct: 291 RDQPNERQVRIQLK-DHIDRTKKKRGEKDETEYEY 324
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 67/292 (22%), Positives = 119/292 (40%), Gaps = 57/292 (19%)
Query: 6 SQVFMAREIKTGEIVALK---KIRMDNEKEGFPITAIR-EIKILKKLQHENVIKLKEIVT 61
S V +ARE+ T A+K K + E + + + E ++ +L H +KL
Sbjct: 44 STVVLARELATSREYAIKILEKRHIIKENK---VPYVTRERDVMSRLDHPFFVKLY---- 96
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGL 120
+D++ Y Y + +L + G F + Y ++++ L
Sbjct: 97 --FTFQDDE----------KLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSAL 143
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR-VITLWYRPPEL 179
Y H ++HRD+K N+L++ + ++++ DFG A+ S + N V T Y PEL
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 180 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
L + D+W++GCI +L+ G P NE KI + E +P
Sbjct: 204 LTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-----LEYDFP----- 252
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291
F A +L+EK+L+LD ++R+ ++
Sbjct: 253 --------------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 284
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 70/331 (21%), Positives = 123/331 (37%), Gaps = 62/331 (18%)
Query: 17 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
+ VA+K+I ++E++ F I E++ L ++ H N++KL +P
Sbjct: 31 AKDVAIKQIESESERKAF----IVELRQLSRVNHPNIVKLYGACLNP------------- 73
Query: 77 KYRGSTYMVFEYMDH-DLTGL--ADRPGLRFTVPQIKCYMKQLLTGLHYCH---VNQVLH 130
+V EY + L + P +T + Q G+ Y H ++H
Sbjct: 74 -----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 131 RDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 189
RD+K NLL+ G LK+ DFG A D +TN + + PE+ G + Y
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEG-SNYSEK 183
Query: 190 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 249
D++S G I E++ + P F+ G P I V +N +P
Sbjct: 184 CDVFSWGIILWEVITRR--KP-----------FDEIGGPAFRIMWAV-----HNGTRP-- 223
Query: 250 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS-EYFWTDPLPCDPKSLPKY 308
+ ++ + L+ + DPSQR S ++ + + D
Sbjct: 224 -------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC 276
Query: 309 ESSHEYQTKKRRQQQRQHEEATKRQKLHHPQ 339
+ S R + E + + H +
Sbjct: 277 QHSLPPGEDGRVEPYVDFAEFYRLWSVDHGE 307
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 61/299 (20%), Positives = 102/299 (34%), Gaps = 66/299 (22%)
Query: 7 QVFMAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+V + + +TG++ A+K + E F E +L + +L
Sbjct: 76 EVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF----REERDVLVNGDRRWITQLH---- 127
Query: 62 SPGPERDEQGRPDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQL 116
+ Y+V EY DL L + G R + Y+ ++
Sbjct: 128 ----------------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
+ + H +HRDIK N+L+D G+++LADFG D V T Y
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 177 PELLLG------ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 230
PE+L YGP D W++G E+ G+ + AE KI
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH------- 284
Query: 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+ +P + A + +++ L+ P R+ A D
Sbjct: 285 --YKEHLSLPLVD----------------EGVPEEARDFIQR-LLCPPETRLGRGGAGD 324
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 60/292 (20%), Positives = 117/292 (40%), Gaps = 63/292 (21%)
Query: 7 QVFMAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+VF + TG++ A KK+ +G A+ E KIL K+ ++ L
Sbjct: 200 EVFACQMKATGKLYACKKLNKKRLKKRKGYQG----AMVEKKILAKVHSRFIVSLAYAFE 255
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMD------HDLTGLADRPGLRFTVPQIKCYMKQ 115
+ +V M+ H + + + F P+ Y Q
Sbjct: 256 TKT----------------DLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRAIFYTAQ 297
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 175
+++GL + H +++RD+K N+L+D++GN++++D GLA T T +
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFM 356
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235
PELLLG +Y +VD +++G E++ + + E + ++ +
Sbjct: 357 APELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------ 403
Query: 236 VSKMPAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQRISAKD 286
R +++ V + F + + E +L DP +R+ +D
Sbjct: 404 -------------RVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRLGFRD 440
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 59/298 (19%), Positives = 102/298 (34%), Gaps = 69/298 (23%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKL-QHENVIK-----LKEI 59
QV+ R KTG ++A+K++R KE I ++ ++ K +++ +
Sbjct: 40 QVWKMRFRKTGHVIAVKQMRRSGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGTFITN- 96
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTG 119
++ E M L R + ++
Sbjct: 97 --------------------TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 120 LHYCH-VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRP 176
L+Y + V+HRD+K SN+L+D G +KL DFG++ + Y
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKDRSAGCAAYMA 192
Query: 177 PE----LLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDET 231
PE Y D+WS+G EL G+ K + E L+K+ + P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP--- 247
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
P +P + F F+ F ++ L D +R L+
Sbjct: 248 --P---LLPGHMGFSGD----------FQSF-------VKDCLTKDHRKRPKYNKLLE 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 39/202 (19%), Positives = 82/202 (40%), Gaps = 21/202 (10%)
Query: 20 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79
VA+K + + E+ +L+K +H N++ T+P
Sbjct: 49 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---------------- 92
Query: 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138
+V ++ + L +F + ++ +Q G+ Y H ++HRD+K +N+
Sbjct: 93 -QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNI 151
Query: 139 LIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSV 195
+ + +K+ DFGLA S + ++ + PE++ + Y D+++
Sbjct: 152 FLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 211
Query: 196 GCIFAELLNGKPILPGKNEAEQ 217
G + EL+ G+ N +Q
Sbjct: 212 GIVLYELMTGQLPYSNINNRDQ 233
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 41/231 (17%)
Query: 7 QVFMAREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPG 64
V +G+I+A+K+IR +EKE + + ++ ++ + +++
Sbjct: 37 SVNKMVHKPSGQIMAVKRIRSTVDEKEQKQL--LMDLDVVMRSSDCPYIVQFY------- 87
Query: 65 PERDEQGRPDGNKYRGST-YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTG 119
G +R ++ E M + + +
Sbjct: 88 ----------GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 120 LHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFG----LARSFSYDHNNTLTNRVITLWY 174
L++ N +++HRDIK SN+L+D GN+KL DFG L S + T Y
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA------KTRDAGCRPY 191
Query: 175 RPPELLLGATK---YGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKI 221
PE + + Y D+WS+G EL G+ P + +QL+++
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 48/222 (21%), Positives = 90/222 (40%), Gaps = 37/222 (16%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEK--EGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
Q +TGE++ +K++ +E+ F ++E+K+++ L+H NV+K ++
Sbjct: 24 GQAIKVTHRETGEVMVMKELIRFDEETQRTF----LKEVKVMRCLEHPNVLKFIGVLYKD 79
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
+ EY+ L G+ ++ Q + K + +G+ Y
Sbjct: 80 KR----------------LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP------ 176
H ++HRD+ N L+ N+ +ADFGLAR + R + R
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 177 -------PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG 211
PE++ G Y VD++S G + E++ P
Sbjct: 184 GNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 56/305 (18%), Positives = 101/305 (33%), Gaps = 74/305 (24%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKL-QHENVIKLKEIVTSPG 64
V R + +G+I+A+K+IR + + ++ I + +
Sbjct: 22 VVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVDCPFTVTFY------- 72
Query: 65 PERDEQGRPDGNKYRGST-YMVFEYMDHDLTGLAD------RPGLRFTVPQIKCYMKQLL 117
G +R ++ E MD T L G + ++
Sbjct: 73 ----------GALFREGDVWICMELMD---TSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 118 TGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFG----LARSFSYDHNNTLTNRVITL 172
L + H V+HRD+K SN+LI+ G +K+ DFG L + D +
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------AGCK 173
Query: 173 WYRPPELLLG---ATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSP 228
Y PE + Y D+WS+G EL + +QL ++ +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPS 231
Query: 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
P ++PA + F F F + L + +R + + +
Sbjct: 232 -----P---QLPA-DKFSAE----------FVDF-------TSQCLKKNSKERPTYPELM 265
Query: 289 DSEYF 293
+F
Sbjct: 266 QHPFF 270
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 59/297 (19%), Positives = 100/297 (33%), Gaps = 64/297 (21%)
Query: 7 QVFMAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+V + + ++ A+K + E F E +L + + L
Sbjct: 89 EVAVVKLKNADKVFAMKILNKWEMLKRAETACF----REERDVLVNGDSKWITTLH---- 140
Query: 62 SPGPERDEQGRPDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQL 116
Y + Y+V +Y DL L + R + Y+ ++
Sbjct: 141 ----------------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
+ + H +HRDIK N+L+D G+++LADFG D + V T Y
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 177 PELLL----GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 232
PE+L G +YGP D WS+G E+L G+ ++ E KI
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN--------- 295
Query: 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+ P +A +L+ + L+ R+ D
Sbjct: 296 HKERFQFPTQ----------------VTDVSENAKDLIRR-LICSREHRLGQNGIED 335
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 41/215 (19%), Positives = 81/215 (37%), Gaps = 36/215 (16%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAI-----REIKILKKLQHENVIKLKEIV 60
V R +K +VA+K + + + + + RE+ I+ L H N++KL ++
Sbjct: 33 GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTG 119
+P MV E++ DL M + G
Sbjct: 93 HNP------------------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 120 LHYCHVN--QVLHRDIKGSNLLIDNEG-----NLKLADFGLARSFSYDHNNTLTNRVITL 172
+ Y ++HRD++ N+ + + K+ADFGL++ ++++ +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNF 190
Query: 173 WYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGK 206
+ PE + + Y D +S I +L G+
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 54/283 (19%), Positives = 109/283 (38%), Gaps = 58/283 (20%)
Query: 7 QVFMAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+V + TG++ A KK+ + A+ E +IL+K+ V+ L
Sbjct: 199 EVCACQVRATGKMYACKKLEKKRIKKRKGEAM----ALNEKQILEKVNSRFVVSLAYAYE 254
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL-TGLADRPGLRFTVPQIKCYMKQLLTG 119
+ + +V M+ DL + F + Y ++ G
Sbjct: 255 TKD----------------ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 179
L H ++++RD+K N+L+D+ G+++++D GLA T+ RV T+ Y PE+
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRVGTVGYMAPEV 356
Query: 180 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
+ +Y + D W++GC+ E++ G+ + + + ++
Sbjct: 357 VKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---------------- 399
Query: 240 PAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQR 281
+ + F A L ++L DP++R
Sbjct: 400 ---------LVKEVPEE--YSERFSPQARSLCSQLLCKDPAER 431
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 52/328 (15%), Positives = 87/328 (26%), Gaps = 67/328 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN------EKEGFPITAIREIKILKKLQ---------H 50
+VF VA+K I ++ + + EI I K+L
Sbjct: 34 GEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT 91
Query: 51 ENVIKLKE--IVTSPGPERDEQGRPDGNKYRGS------------TYMVFEYMDHDLTGL 96
E I L V P + N +GS ++V E+ L
Sbjct: 92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG-IDL 150
Query: 97 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
++ K + QL L + + HRD+ N+L+ KL +
Sbjct: 151 EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
Query: 156 SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 215
S + L + Y + +F ++ + + G +
Sbjct: 211 SSTIPSCG---------------LQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG--DG 253
Query: 216 EQLSKIFELCGSPDETIWPGVSKMPAYNHF----------KPSRTMKRRVREVFRHFDRH 265
+ I+ L + W P N K + + R
Sbjct: 254 DYQFDIYRLMKKENNNRWGEYH--PYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK 311
Query: 266 ALELLEKMLMLDPSQRISAKDALDSEYF 293
E ML SA D L
Sbjct: 312 IQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 60/289 (20%), Positives = 109/289 (37%), Gaps = 66/289 (22%)
Query: 7 QVFMAREIKTGEIVALK-----KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+V + ++ T ++ A+K K NE +E++I++ L+H ++ L
Sbjct: 30 KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN----VFKELQIMQGLEHPFLVNLW---- 81
Query: 62 SPGPERDEQGRPDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQL 116
Y +MV + + DL + F +K ++ +L
Sbjct: 82 ----------------YSFQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICEL 124
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
+ L Y +++HRD+K N+L+D G++ + DF +A + +T T Y
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTKPYMA 182
Query: 177 PELLL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234
PE+ Y AVD WS+G ELL G+ ++ + +I
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-STSSKEIVHT-------FET 234
Query: 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 283
V P + + + LL+K+L +P QR S
Sbjct: 235 TVVTYP-------------------SAWSQEMVSLLKKLLEPNPDQRFS 264
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 42/207 (20%)
Query: 17 GEIVALKKIRMDNEKEGFPITA--IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 74
G+ VA+K R D +++ +E K+ L+H N+I L+ +
Sbjct: 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN--------- 80
Query: 75 GNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH---VNQ 127
+V E+ + + L+ + R + + Q+ G++Y H +
Sbjct: 81 -------LCLVMEFARGGPLNRV--LSGK---RIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 128 VLHRDIKGSNLLIDNEG--------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 179
++HRD+K SN+LI + LK+ DFGLAR H T + + PE+
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYAWMAPEV 185
Query: 180 LLGATKYGPAVDMWSVGCIFAELLNGK 206
+ + + D+WS G + ELL G+
Sbjct: 186 IRA-SMFSKGSDVWSYGVLLWELLTGE 211
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 44/243 (18%), Positives = 89/243 (36%), Gaps = 50/243 (20%)
Query: 20 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79
VA++ I ++ + E RE+ ++ +HENV+ SP
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH-------------- 103
Query: 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138
++ L + + V + + ++++ G+ Y H +LH+D+K N+
Sbjct: 104 --LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNV 161
Query: 139 LIDNEGNLKLADFGLAR----SFSYDHNNTLTNRVITLWYRPPELLLGATK--------Y 186
DN G + + DFGL + + L + L + PE++ + +
Sbjct: 162 FYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF 220
Query: 187 GPAVDMWSVGCIFAELL--------------------NGKPILPGKNEAEQLSKIFELCG 226
D++++G I+ EL KP L +++S I C
Sbjct: 221 SKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCW 280
Query: 227 SPD 229
+ +
Sbjct: 281 AFE 283
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 6 SQVFMAREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
S V++A + VA+K I + EKE RE+ +L H+N++ +
Sbjct: 25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS----MIDVD 80
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+E Y+V EY++ L+ + G +V + Q+L G+ +
Sbjct: 81 ---EEDDCY---------YLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHA 127
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG 182
H +++HRDIK N+LID+ LK+ DFG+A++ S + + T TN V+ T+ Y PE G
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKP 207
D++S+G + E+L G+P
Sbjct: 187 EAT-DECTDIYSIGIVLYEMLVGEP 210
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 29/198 (14%), Positives = 66/198 (33%), Gaps = 30/198 (15%)
Query: 17 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
G + +K +++ + E L+ H NV+ + SP P +
Sbjct: 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---------PAPH 83
Query: 77 KYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV--NQVLH 130
++ +M +++ L + Q + + G+ + H +
Sbjct: 84 -----PTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPR 136
Query: 131 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGP 188
+ +++ID + +++ + SF R+ + PE L
Sbjct: 137 HALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRR 190
Query: 189 AVDMWSVGCIFAELLNGK 206
+ DMWS + EL+ +
Sbjct: 191 SADMWSFAVLLWELVTRE 208
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 58/287 (20%), Positives = 108/287 (37%), Gaps = 66/287 (22%)
Query: 7 QVFMAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHEN---VIKLKE 58
+V+ R+ TG++ A+K + M + A+ E +L + + ++ +
Sbjct: 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGET----LALNERIMLSLVSTGDCPFIVCMSY 259
Query: 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLL 117
+P + + M+ DL + G F+ ++ Y +++
Sbjct: 260 AFHTPD----------------KLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEII 302
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
GL + H V++RD+K +N+L+D G+++++D GLA FS + V T Y P
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAP 359
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKP---ILPGKNEAEQLSKIFELCGSPDETIWP 234
E+L Y + D +S+GC+ +LL G K++ E P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----MAVELP 414
Query: 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
F LLE +L D ++R
Sbjct: 415 -------------------------DSFSPELRSLLEGLLQRDVNRR 436
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 57/224 (25%), Positives = 82/224 (36%), Gaps = 31/224 (13%)
Query: 7 QVFMAREIKTGEIVALKKIRMD-----NEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+V + R T ++ A+K + ++ F E I+ V++L
Sbjct: 84 EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF----WEERDIMAFANSPWVVQLFYAFQ 139
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGL 120
YMV EYM DL L + Y +++ L
Sbjct: 140 DDR----------------YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLAL 181
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 180
H +HRD+K N+L+D G+LKLADFG + + V T Y PE+L
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 181 L---GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221
G YG D WSVG E+L G + SKI
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 44/206 (21%), Positives = 80/206 (38%), Gaps = 29/206 (14%)
Query: 6 SQVFMAR-EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
+++A G V LK + + A+ E + L ++ H +++++ V
Sbjct: 94 GWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLRFTVPQIKCYMKQLLTGLHY 122
D G Y+V EY+ G L G + V + Y+ ++L L Y
Sbjct: 153 RHGDPVG-----------YIVMEYVG----GQSLKRSKGQKLPVAEAIAYLLEILPALSY 197
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLL 181
H +++ D+K N+++ E LKL D G + T ++ PE++
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI------NSFGYLYGTPGFQAPEIVR 250
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKP 207
A D+++VG A L P
Sbjct: 251 TGP--TVATDIYTVGRTLAALTLDLP 274
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 67/284 (23%), Positives = 117/284 (41%), Gaps = 66/284 (23%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREI-------KILKKLQHENVIKLKEI 59
+V + + ++G A+K + + +++I +IL+ + ++KL+
Sbjct: 56 RVMLVKHKESGNHYAMKILDKQK------VVKLKQIEHTLNEKRILQAVNFPFLVKLE-- 107
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLT 118
+D + YMV EY+ ++ R G RF+ P + Y Q++
Sbjct: 108 ----FSFKDNS----------NLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVL 152
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
Y H +++RD+K NLLID +G +++ DFG A+ TL T PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWTLCG---TPEALAPE 208
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
++L Y AVD W++G + E+ G P P A+Q +I+E I G +
Sbjct: 209 IILS-KGYNKAVDWWALGVLIYEMAAGYP--P--FFADQPIQIYEK-------IVSGKVR 256
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 282
P HF +LL +L +D ++R
Sbjct: 257 FP-------------------SHFSSDLKDLLRNLLQVDLTKRF 281
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 39/221 (17%)
Query: 17 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
E VA+K + +++ E+ L ++HEN+++ + + +++G
Sbjct: 47 NEYVAVKIFPIQDKQSWQ---NEYEVYSLPGMKHENILQF---IGA-----EKRGTSVDV 95
Query: 77 KYRGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLT---GLHYCHVNQ----- 127
+++ + + G L+D L+ V T GL Y H +
Sbjct: 96 DL----WLITAFHEK---GSLSDF--LKANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 128 -----VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLL 181
+ HRDIK N+L+ N +ADFGLA F + T+ + T Y PE+L
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 182 GA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 218
GA +DM+++G + EL + G + L
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 23/195 (11%)
Query: 17 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
G VA+K + + +RE+ I+K+L+H N++ VT P
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN----------- 108
Query: 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVP--QIKCYMKQLLTGLHYCHVN--QVLHR 131
+V EY+ L L + G R + + + G++Y H ++HR
Sbjct: 109 -----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163
Query: 132 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 191
++K NLL+D + +K+ DFGL+R + + T + PE+L D
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSD 221
Query: 192 MWSVGCIFAELLNGK 206
++S G I EL +
Sbjct: 222 VYSFGVILWELATLQ 236
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 70/293 (23%), Positives = 111/293 (37%), Gaps = 65/293 (22%)
Query: 7 QVFMAREIKTGEIVA---LKK--IRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+V + RE TG A L+K I +E + E ++L+ +H + LK
Sbjct: 20 KVILVREKATGRYYAMKILRKEVIIAKDEVA----HTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGL 120
+ V EY + +L R FT + + Y ++++ L
Sbjct: 76 THD----------------RLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSAL 118
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPE 178
Y H V++RDIK NL++D +G++K+ DFGL + D T T Y PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPE 175
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
+L YG AVD W +G + E++ G+ ++ I +E +P
Sbjct: 176 VLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFP---- 225
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI--SAKDALD 289
R A LL +L DP QR+ DA +
Sbjct: 226 ---------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 22/205 (10%)
Query: 6 SQVFMAREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
V+ A + IVALK + + F RE + +LQ +V+
Sbjct: 48 GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV---------- 97
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
P D G DG Y+ ++ DL + R G P+ ++Q+ + L
Sbjct: 98 PIHD-FGEIDG-----QLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAA 150
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG 182
H HRD+K N+L+ + L DFG+A + + D T + TL+Y PE
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSE 209
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKP 207
+ D++++ C+ E L G P
Sbjct: 210 SHA-TYRADIYALTCVLYECLTGSP 233
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 7e-23
Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 60/280 (21%)
Query: 7 QVFMAREIKTGEIVALKKIRMDN---EKEGFPITAIR-EIKILKKLQHENVIKLKEIVTS 62
+V + R G A+K ++ + K+ + E +L + H +I++
Sbjct: 21 RVHLIRSRHNGRYYAMKVLKKEIVVRLKQ---VEHTNDERLMLSIVTHPFIIRMW----- 72
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
G +D Q +M+ +Y++ +L L + RF P K Y ++ L
Sbjct: 73 -GTFQDAQ----------QIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALE 120
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
Y H +++RD+K N+L+D G++K+ DFG A+ D TL T Y PE++
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYTLCG---TPDYIAPEVVS 176
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
Y ++D WS G + E+L G N + KI E +P
Sbjct: 177 T-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-----AELRFP------- 223
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
F+ +LL +++ D SQR
Sbjct: 224 ------------------PFFNEDVKDLLSRLITRDLSQR 245
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-23
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 6 SQVFMAREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
S+V +AR+++ VA+K +R D F + RE + L H ++ V G
Sbjct: 26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA----VYDTG 81
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
G Y+V EY+D L + G T + + L++
Sbjct: 82 EAETPAGP--------LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS 132
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVI-TLWYRPPELLL 181
H N ++HRD+K +N++I +K+ DFG+AR+ + N+ T T VI T Y PE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKP 207
G + D++S+GC+ E+L G+P
Sbjct: 193 GDSV-DARSDVYSLGCVLYEVLTGEP 217
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 68/291 (23%), Positives = 117/291 (40%), Gaps = 68/291 (23%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+VF+A KT + A IK LKK + V+ + V E
Sbjct: 32 KVFLAEFKKTNQFFA--------------------IKALKK---DVVLMDDD-VECTMVE 67
Query: 67 RDEQGRPDGN------KY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQ 115
+ + + + + V EY++ DL +F + + Y +
Sbjct: 68 KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAE 126
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 175
++ GL + H +++RD+K N+L+D +G++K+ADFG+ + T T T Y
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYI 185
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235
PE+LLG KY +VD WS G + E+L G+ G++E E I D +P
Sbjct: 186 APEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPFYP- 238
Query: 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 286
R ++ A +LL K+ + +P +R+ +
Sbjct: 239 ------------------------RWLEKEAKDLLVKLFVREPEKRLGVRG 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 59/294 (20%), Positives = 96/294 (32%), Gaps = 48/294 (16%)
Query: 17 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
GE VA+K E F EI ++HEN++ +
Sbjct: 60 GEKVAVKVFFTTEEASWF---RETEIYQTVLMRHENILGFIAADIKGTGSWTQ------- 109
Query: 77 KYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ----- 127
Y++ +Y + +D L + ++GL + H
Sbjct: 110 -----LYLITDYHENGSLYDY--LKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 128 ---VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPPELLL 181
+ HRD+K N+L+ G +AD GLA F D N RV T Y PPE+L
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 182 GAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
+ + DM+S G I E+ E + E + V
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV 279
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290
+PS + E R +L+ + +P+ R++A +
Sbjct: 280 ----CIKKLRPSFPNRWSSDECLRQM----GKLMTECWAHNPASRLTALRVKKT 325
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 7 QVFMAR----EIKTGEIVALKKIRMD--NEKEGFPITAIREIKILKKLQHENVIKLKEIV 60
V M R + TGE+VA+KK++ F REI+ILK LQH+N++K K +
Sbjct: 25 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEILKSLQHDNIVKYKGVC 80
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTG 119
S G + ++ EY+ + L + R ++ Y Q+ G
Sbjct: 81 YSAGRR--------------NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRP 176
+ Y + +HRD+ N+L++NE +K+ DFGL + D + WY
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-A 185
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELL 203
PE L +K+ A D+WS G + EL
Sbjct: 186 PESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 65/292 (22%), Positives = 115/292 (39%), Gaps = 62/292 (21%)
Query: 7 QVFMAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+V + +E TG A+K ++ +E + E ++L+ +H + LK
Sbjct: 163 KVILVKEKATGRYYAMKILKKEVIVAKDEVA----HTLTENRVLQNSRHPFLTALKYSFQ 218
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGL 120
+ V EY + +L R F+ + + Y ++++ L
Sbjct: 219 THD----------------RLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSAL 261
Query: 121 HYCHVNQ-VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 179
Y H + V++RD+K NL++D +G++K+ DFGL + D T T Y PE+
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEV 320
Query: 180 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
L YG AVD W +G + E++ G+ ++ + I +E +P
Sbjct: 321 LED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFP----- 369
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI--SAKDALD 289
R A LL +L DP QR+ ++DA +
Sbjct: 370 --------------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 401
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 7 QVFMAR----EIKTGEIVALKKIRMD--NEKEGFPITAIREIKILKKLQHENVIKLKEIV 60
V M R + TGE+VA+KK++ F REI+ILK LQH+N++K K +
Sbjct: 56 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEILKSLQHDNIVKYKGVC 111
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTG 119
S G + ++ EY+ + L + R ++ Y Q+ G
Sbjct: 112 YSAGRR--------------NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRP 176
+ Y + +HRD+ N+L++NE +K+ DFGL + D + WY
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-A 216
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELL 203
PE L +K+ A D+WS G + EL
Sbjct: 217 PESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 48/201 (23%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141
+++ +Y++ +L + RFT +++ Y+ +++ L + H +++RDIK N+L+D
Sbjct: 135 HLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 193
Query: 142 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFA 200
+ G++ L DFGL++ F D + T+ Y P+++ G + AVD WS+G +
Sbjct: 194 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 253
Query: 201 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 260
ELL G E ++I I P +
Sbjct: 254 ELLTGASPFTVDGEKNSQAEISRR-------ILKSEPPYP-------------------Q 287
Query: 261 HFDRHALELLEKMLMLDPSQR 281
A +L++++LM DP +R
Sbjct: 288 EMSALAKDLIQRLLMKDPKKR 308
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 65/298 (21%), Positives = 114/298 (38%), Gaps = 74/298 (24%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V ++ T E+ A +KILKK + VI+ + V E
Sbjct: 35 KVMLSERKGTDELYA--------------------VKILKK---DVVIQDDD-VECTMVE 70
Query: 67 RDEQGRPDGN------KY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQ 115
+ P Y V EY++ DL + G RF P Y +
Sbjct: 71 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAE 129
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLW 173
+ GL + +++RD+K N+++D+EG++K+ADFG+ + +D T T T
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT---FCGTPD 186
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233
Y PE++ YG +VD W+ G + E+L G+ G++E E I E +
Sbjct: 187 YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-----HNVAY 240
Query: 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI--SAKDALD 289
P + + A+ + + ++ P +R+ + D
Sbjct: 241 P-------------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 72/288 (25%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V +AR +TG++ A +K+LKK + +++ + V E
Sbjct: 38 KVMLARVKETGDLYA--------------------VKVLKK---DVILQDDD-VECTMTE 73
Query: 67 RDEQGRPDGN------KY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQ 115
+ + + V E+++ DL + RF + + Y +
Sbjct: 74 KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAE 132
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLW 173
+++ L + H +++RD+K N+L+D+EG+ KLADFG+ + + T T T
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT---FCGTPD 189
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233
Y PE+L YGPAVD W++G + E+L G +NE + I DE ++
Sbjct: 190 YIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVY 243
Query: 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
P A +L+ + +P+ R
Sbjct: 244 P-------------------------TWLHEDATGILKSFMTKNPTMR 266
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 7 QVFMAR----EIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEI 59
+V + R TGE VA+K ++ N +EI+IL+ L HEN++K K I
Sbjct: 36 KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL----KKEIEILRNLYHENIVKYKGI 91
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLT 118
T G ++ E++ L + + + Q Y Q+
Sbjct: 92 CTEDGGN--------------GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYR 175
G+ Y Q +HRD+ N+L+++E +K+ DFGL ++ D +R + WY
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY- 196
Query: 176 PPELLLGATKYGPAVDMWSVG 196
PE L+ +K+ A D+WS G
Sbjct: 197 APECLM-QSKFYIASDVWSFG 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 65/293 (22%), Positives = 109/293 (37%), Gaps = 72/293 (24%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V +AR A +K+L+K + ++K KE E
Sbjct: 53 KVLLARHKAEEVFYA--------------------VKVLQK---KAILKKKE-EKHIMSE 88
Query: 67 RDEQGRPDGN------KY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQ 115
R+ + + + Y V +Y++ +L R F P+ + Y +
Sbjct: 89 RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAE 147
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLW 173
+ + L Y H +++RD+K N+L+D++G++ L DFGL + ++ T T T
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST---FCGTPE 204
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233
Y PE+L Y VD W +G + E+L G P +N AE I
Sbjct: 205 YLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-----KPLQL 258
Query: 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 286
+ A LLE +L D ++R+ AKD
Sbjct: 259 K-------------------------PNITNSARHLLEGLLQKDRTKRLGAKD 286
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 53/285 (18%), Positives = 104/285 (36%), Gaps = 42/285 (14%)
Query: 17 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
GE VA+K E+ EI L+HEN++ +
Sbjct: 65 GEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ------- 114
Query: 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ-------- 127
++V +Y +H L +R + TV + +GL + H+
Sbjct: 115 -----LWLVSDYHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167
Query: 128 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPPELLLGAT 184
+ HRD+K N+L+ G +AD GLA + +RV T Y PE+L +
Sbjct: 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227
Query: 185 -----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
+ D++++G +F E+ I + + + D ++ + K+
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP---YYDLVPSDPSVEE-MRKV 283
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 284
+P+ + + E R +++ + + + R++A
Sbjct: 284 VCEQKLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTA 324
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 68/300 (22%), Positives = 130/300 (43%), Gaps = 75/300 (25%)
Query: 7 QVFMAREI---KTGEIVALKKIR----MDNEKEGFPITAIR-EIKILKKLQHENVIKLKE 58
+VF R++ TG+I A+K ++ + N K+ + E IL++++H ++ L
Sbjct: 32 KVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD---TAHTKAERNILEEVKHPFIVDLI- 87
Query: 59 IVTSPGPERDEQGRPDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYM 113
Y G Y++ EY+ +L +R G F Y+
Sbjct: 88 -------------------YAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYL 127
Query: 114 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--T 171
++ L + H +++RD+K N++++++G++KL DFGL + +D T T T
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---FCGT 184
Query: 172 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 231
+ Y PE+L+ + + AVD WS+G + ++L G P G+N + + KI + +
Sbjct: 185 IEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-----CKL 238
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI--SAKDALD 289
P + + A +LL+K+L + + R+ DA +
Sbjct: 239 NLP-------------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGE 273
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 45/211 (21%), Positives = 74/211 (35%), Gaps = 44/211 (20%)
Query: 17 GEIVALKKIRMDNEKEGFPITAIREIKI--LKKLQHENVIKLKEIVTSPGPERDEQGRPD 74
GE VA+K +EK RE ++ L+HEN++ + +
Sbjct: 31 GENVAVKIFSSRDEKS-----WFRETELYNTVMLRHENILGFIASDMTSRHSSTQ----- 80
Query: 75 GNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--- 127
+++ Y + +D L + + +GL + H+
Sbjct: 81 -------LWLITHYHEMGSLYDY--LQLTT---LDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 128 -----VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPEL 179
+ HRD+K N+L+ G +AD GLA S N RV T Y PE+
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 180 LLGAT-----KYGPAVDMWSVGCIFAELLNG 205
L VD+W+ G + E+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 7e-21
Identities = 61/285 (21%), Positives = 110/285 (38%), Gaps = 65/285 (22%)
Query: 7 QVFMAREIK---TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
+VF+ ++I ++ A+K ++ K + E IL ++ H ++KL
Sbjct: 39 KVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH------ 92
Query: 64 GPERDEQGRPDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLT 118
Y G Y++ +++ DL + FT +K Y+ +L
Sbjct: 93 --------------YAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELAL 137
Query: 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRP 176
L + H +++RD+K N+L+D EG++KL DFGL++ + T+ Y
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGTVEYMA 194
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
PE++ + + D WS G + E+L G GK+ E ++ I L
Sbjct: 195 PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI--LKAKL-------- 243
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
MP + A LL + +P+ R
Sbjct: 244 -GMP-------------------QFLSPEAQSLLRMLFKRNPANR 268
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 9e-21
Identities = 55/292 (18%), Positives = 94/292 (32%), Gaps = 45/292 (15%)
Query: 17 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
VA+K N + + I + ++H+N+ + IV D +
Sbjct: 36 ERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARF--IVGDERVTADGRMEY--- 87
Query: 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH---------VN 126
+V EY + L + GL Y H
Sbjct: 88 ------LLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHTELPRGDHYKP 139
Query: 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-------NNTLTNRVITLWYRPPEL 179
+ HRD+ N+L+ N+G ++DFGL+ + + +N + V T+ Y PE+
Sbjct: 140 AISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV 199
Query: 180 LLGA------TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233
L GA VDM+++G I+ E+ L + F+
Sbjct: 200 LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNH---- 255
Query: 234 PGVSKMPAYNHFKPSR-TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 284
P M + R +E E +E D R++A
Sbjct: 256 PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK-ETIEDCWDQDAEARLTA 306
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 9e-21
Identities = 43/201 (21%), Positives = 84/201 (41%), Gaps = 26/201 (12%)
Query: 7 QVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V+ K VA+K ++ D E E F ++E ++K+++H N+++L + T P
Sbjct: 235 EVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPP 290
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYC 123
Y++ E+M + +L L + + + Q+ + + Y
Sbjct: 291 ----------------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLG 182
+HR++ N L+ +K+ADFGL+R + D + W P L
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 183 ATKYGPAVDMWSVGCIFAELL 203
K+ D+W+ G + E+
Sbjct: 395 --KFSIKSDVWAFGVLLWEIA 413
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 7 QVFMAR----EIKTGEIVALKKIRMD--NEKEGFPITAIREIKILKKLQHENVIKLKEIV 60
V + R TG +VA+K+++ +++ F REI+ILK L + ++K + +
Sbjct: 38 SVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF----QREIQILKALHSDFIVKYRGVS 93
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTG 119
PG + S +V EY+ L R R ++ Y Q+ G
Sbjct: 94 YGPGRQ--------------SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRP 176
+ Y + +HRD+ N+L+++E ++K+ADFGLA+ D + + WY
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-A 198
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELL 203
PE L + D+WS G + EL
Sbjct: 199 PESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 7e-20
Identities = 64/286 (22%), Positives = 112/286 (39%), Gaps = 68/286 (23%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V ++ T E+ A +KILKK + VI+ + V E
Sbjct: 356 KVMLSERKGTDELYA--------------------VKILKK---DVVIQDDD-VECTMVE 391
Query: 67 RDEQGRPDGNKY----------RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQ 115
+ P + Y V EY++ DL + G RF P Y +
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAE 450
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 175
+ GL + +++RD+K N+++D+EG++K+ADFG+ + +D T T T Y
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYI 509
Query: 176 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235
PE++ YG +VD W+ G + E+L G+ G++E E I E +P
Sbjct: 510 APEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-----HNVAYP- 562
Query: 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
+ + A+ + + ++ P +R
Sbjct: 563 ------------------------KSMSKEAVAICKGLMTKHPGKR 584
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 35/202 (17%)
Query: 7 QVFMAR----EIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEI 59
+V + TGE+VA+K ++ + G+ +EI IL+ L HE++IK K
Sbjct: 46 KVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW----KQEIDILRTLYHEHIIKYKGC 101
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL-TGLADRPGLRFTVPQIKCYMKQLL 117
G S +V EY+ L L + Q+ + +Q+
Sbjct: 102 CEDAGAA--------------SLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQIC 144
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WY 174
G+ Y H +HRD+ N+L+DN+ +K+ DFGLA++ H + + WY
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 175 RPPELLLGATKYGPAVDMWSVG 196
PE L K+ A D+WS G
Sbjct: 205 -APECLK-EYKFYYASDVWSFG 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 45/197 (22%), Positives = 82/197 (41%), Gaps = 32/197 (16%)
Query: 7 QVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V+ K VA+K ++ D E E F ++E ++K+++H N+++L + T P
Sbjct: 28 EVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPP 83
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYC 123
Y++ E+M + +L L + + + Q+ + + Y
Sbjct: 84 ----------------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPEL 179
+HRD+ N L+ +K+ADFGL+R +T T W PE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWT-APES 183
Query: 180 LLGATKYGPAVDMWSVG 196
L K+ D+W+ G
Sbjct: 184 LA-YNKFSIKSDVWAFG 199
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 20 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78
VA+K ++ E F ++E +++KKL+HE +++L +V+ P
Sbjct: 211 VAIKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVS---------EEP----- 252
Query: 79 RGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 136
Y+V EYM L L G +PQ+ Q+ +G+ Y +HRD++ +
Sbjct: 253 ---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 309
Query: 137 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAVDMWSV 195
N+L+ K+ADFGLAR + + W P L G ++ D+WS
Sbjct: 310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSF 367
Query: 196 GCIFAELLN-GKPILPGKNEAEQLSKI 221
G + EL G+ PG E L ++
Sbjct: 368 GILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 43/192 (22%), Positives = 75/192 (39%), Gaps = 28/192 (14%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
V + G VA+K I+ D + F + E ++ +L+H N+++L ++
Sbjct: 36 DVMLGD--YRGNKVAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVEEKG- 88
Query: 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
Y+V EYM L L R + + + + Y
Sbjct: 89 --------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
N +HRD+ N+L+ + K++DFGL + S + ++ W PE L
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWT-APEALR-EK 189
Query: 185 KYGPAVDMWSVG 196
K+ D+WS G
Sbjct: 190 KFSTKSDVWSFG 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 5e-19
Identities = 91/500 (18%), Positives = 149/500 (29%), Gaps = 101/500 (20%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGP 65
++++ I+T E VA+K + + E KI + LQ + ++ G
Sbjct: 22 EIYLGTNIQTNEEVAIKLENVKTKHPQLL----YESKIYRILQGGTGIPNVRWF----GV 73
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
E D +V + + L L + + ++ + Q++ + + H
Sbjct: 74 EGD------------YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 126 NQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
LHRDIK N L+ + + DFGLA+ + D + T++ I YR + L G
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTS---THQHIP--YRENKNLTG 175
Query: 183 ATKY-----------GPAVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFE--- 223
+Y D+ S+G + L G LP + ++ KI E
Sbjct: 176 TARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS--LPWQGLKAGTKKQKYEKISEKKV 233
Query: 224 ------LC-GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLML 276
LC G P E F + + L
Sbjct: 234 ATSIEALCRGYPTE----------------------------FASYFHYCRSL------- 258
Query: 277 DPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLH 336
D D Y L D ++ + + + QQ Q A R H
Sbjct: 259 ------RFDDKPDYSYLKR--LFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGH 310
Query: 337 HPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSGN 396
P G PP + ++ P G S +
Sbjct: 311 GAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIASVGTLAKQKAPVGNDASFS 370
Query: 397 QSGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQ 456
+ + N G+ G S P R P+ AS S Q
Sbjct: 371 KEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDASPGAFRRTSGPQKSS 430
Query: 457 YGNSAAGRGPNQMGGSRNQQ 476
NSA + + S N +
Sbjct: 431 PVNSAEPKHSSSARHSSNVK 450
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 41/182 (22%), Positives = 72/182 (39%), Gaps = 26/182 (14%)
Query: 17 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
G VA+K I+ D + F + E ++ +L+H N+++L ++
Sbjct: 216 GNKVAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVEEKG----------- 260
Query: 77 KYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 134
Y+V EYM L L R + + + + Y N +HRD+
Sbjct: 261 ----GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 135 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 194
N+L+ + K++DFGL + S + ++ W P L K+ D+WS
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWTAPEALREK--KFSTKSDVWS 371
Query: 195 VG 196
G
Sbjct: 372 FG 373
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 49/196 (25%), Positives = 79/196 (40%), Gaps = 30/196 (15%)
Query: 8 VFMAREIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
VF R +VA+K R + K F ++E +ILK+ H N+++L + T
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQYSHPNIVRLIGVCT--- 182
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
Q +P Y+V E + D G R V + + G+ Y
Sbjct: 183 -----QKQP--------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELL 180
+HRD+ N L+ + LK++DFG++R D + + + W PE L
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWT-APEAL 287
Query: 181 LGATKYGPAVDMWSVG 196
+Y D+WS G
Sbjct: 288 N-YGRYSSESDVWSFG 302
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 64/300 (21%), Positives = 106/300 (35%), Gaps = 87/300 (29%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V + R KT I A +K++KK E V ++ + E
Sbjct: 24 KVLLVRLKKTDRIYA--------------------MKVVKK---ELVNDDED-IDWVQTE 59
Query: 67 RD--EQGRPD----GNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQ 115
+ EQ G + V EY++ DL R + + Y +
Sbjct: 60 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAE 118
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-----NRVI 170
+ L+Y H +++RD+K N+L+D+EG++KL D+G+ + + T T N
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN--- 175
Query: 171 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP---------ILPGKNEAEQLSKI 221
Y PE+L G YG +VD W++G + E++ G+ E I
Sbjct: 176 ---YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231
Query: 222 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
E + P R A +L+ L DP +R
Sbjct: 232 LE-----KQIRIP-------------------------RSLSVKAASVLKSFLNKDPKER 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 63/300 (21%), Positives = 106/300 (35%), Gaps = 87/300 (29%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+V + R KT I A ++++KK E V ++ + E
Sbjct: 67 KVLLVRLKKTDRIYA--------------------MRVVKK---ELVNDDED-IDWVQTE 102
Query: 67 RD--EQGRPD----GNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQ 115
+ EQ G + V EY++ DL R + + Y +
Sbjct: 103 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAE 161
Query: 116 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-----NRVI 170
+ L+Y H +++RD+K N+L+D+EG++KL D+G+ + + T T N
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN--- 218
Query: 171 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP---------ILPGKNEAEQLSKI 221
Y PE+L G YG +VD W++G + E++ G+ E I
Sbjct: 219 ---YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274
Query: 222 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
E + P R A +L+ L DP +R
Sbjct: 275 LE-----KQIRIP-------------------------RSLSVKAASVLKSFLNKDPKER 304
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
IKT LK + ++ F + E I+ + H N+I+L+ +VT + +P
Sbjct: 78 IKT-----LKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVT--------KSKP 120
Query: 74 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
+V EYM++ L + +FTV Q+ ++ + +G+ Y +HRD
Sbjct: 121 --------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 133 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGP 188
+ N+LI++ K++DFGL R D W PE + K+
Sbjct: 173 LAARNILINSNLVCKVSDFGLGR-VLEDDPEAAYTTRGGKIPIRWT-SPEAIA-YRKFTS 229
Query: 189 AVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 221
A D+WS G + E+++ G+ + + + +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 4e-18
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 20 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78
VA+K ++ E F ++E +++KKL+HE +++L +V+ P
Sbjct: 294 VAIKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVS---------EEP----- 335
Query: 79 RGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 136
Y+V EYM L L G +PQ+ Q+ +G+ Y +HRD++ +
Sbjct: 336 ---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 392
Query: 137 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAVDMWSV 195
N+L+ K+ADFGLAR + + W P L G ++ D+WS
Sbjct: 393 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSF 450
Query: 196 GCIFAELLN-GKPILPGKNEAEQLSKI 221
G + EL G+ PG E L ++
Sbjct: 451 GILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 31/185 (16%)
Query: 20 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
VA+K ++ + ++ F + E I+ + H N+I+L+ +VT +GR
Sbjct: 80 VAIKALKAGYTERQRRDF----LSEASIMGQFDHPNIIRLEGVVT--------RGRL--- 124
Query: 77 KYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 134
+V EYM++ L L G +FT+ Q+ ++ + G+ Y +HRD+
Sbjct: 125 -----AMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178
Query: 135 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPAVD 191
N+L+D+ K++DFGL+R D + T + W PE + + A D
Sbjct: 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APEAIA-FRTFSSASD 236
Query: 192 MWSVG 196
+WS G
Sbjct: 237 VWSFG 241
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 7e-18
Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 34/197 (17%)
Query: 7 QVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V + + + VA+K IR +E F I E +++ KL H +++L + P
Sbjct: 23 LVHLGYWLNKDK-VAIKTIREGAMSEEDF----IEEAEVMMKLSHPKLVQLYGVCLEQAP 77
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+V E+M+H L+ L + G F + + G+ Y
Sbjct: 78 ----------------ICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYL 120
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPEL 179
V+HRD+ N L+ +K++DFG+ R + ++ T+ T W PE+
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWA-SPEV 176
Query: 180 LLGATKYGPAVDMWSVG 196
++Y D+WS G
Sbjct: 177 FS-FSRYSSKSDVWSFG 192
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 9e-18
Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 34/197 (17%)
Query: 7 QVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V+M VA+K ++ + + F + E ++K+LQH+ +++L +VT
Sbjct: 28 EVWMGY-YNGHTKVAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAVVT---- 78
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYC 123
P Y++ EYM++ L L G++ T+ ++ Q+ G+ +
Sbjct: 79 -----QEP--------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPEL 179
+HRD++ +N+L+ + + K+ADFGLAR +N T R W PE
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWT-APEA 181
Query: 180 LLGATKYGPAVDMWSVG 196
+ + D+WS G
Sbjct: 182 IN-YGTFTIKSDVWSFG 197
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 42/192 (21%), Positives = 84/192 (43%), Gaps = 31/192 (16%)
Query: 20 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76
VA+K ++ + ++ F + E I+ + H N+I+L+ +++ + +P
Sbjct: 76 VAIKTLKAGYTEKQRVDF----LGEAGIMGQFSHHNIIRLEGVIS--------KYKP--- 120
Query: 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 135
++ EYM++ L F+V Q+ ++ + G+ Y +HRD+
Sbjct: 121 -----MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175
Query: 136 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVD 191
N+L+++ K++DFGL+R D W PE + K+ A D
Sbjct: 176 RNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT-APEAIS-YRKFTSASD 232
Query: 192 MWSVGCIFAELL 203
+WS G + E++
Sbjct: 233 VWSFGIVMWEVM 244
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 31/183 (16%)
Query: 20 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78
VA+K I+ + ++ F I E K++ L HE +++L + T P
Sbjct: 51 VAIKMIKEGSMSEDEF----IEEAKVMMNLSHEKLVQLYGVCTKQRP------------- 93
Query: 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 137
+++ EYM + L RF Q+ K + + Y Q LHRD+ N
Sbjct: 94 ---IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 150
Query: 138 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMW 193
L++++G +K++DFGL+R ++ T+ V + W PPE+L+ +K+ D+W
Sbjct: 151 CLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWS-PPEVLM-YSKFSSKSDIW 205
Query: 194 SVG 196
+ G
Sbjct: 206 AFG 208
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 42/183 (22%), Positives = 77/183 (42%), Gaps = 31/183 (16%)
Query: 20 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78
VA+K I+ + ++ F +E + + KL H ++K + + + P
Sbjct: 35 VAVKMIKEGSMSEDEF----FQEAQTMMKLSHPKLVKFYGVCS--------KEYP----- 77
Query: 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 137
Y+V EY+ + L G Q+ + G+ + +Q +HRD+ N
Sbjct: 78 ---IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN 134
Query: 138 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMW 193
L+D + +K++DFG+ R Y ++ + V T W PE+ KY D+W
Sbjct: 135 CLVDRDLCVKVSDFGMTR---YVLDDQYVSSVGTKFPVKWS-APEVFH-YFKYSSKSDVW 189
Query: 194 SVG 196
+ G
Sbjct: 190 AFG 192
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 36/143 (25%), Positives = 59/143 (41%), Gaps = 27/143 (18%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
+KT KK + KE F + E I+K L H +++KL I+
Sbjct: 45 VKT-----CKKDCTLDNKEKF----MSEAVIMKNLDHPHIVKLIGIIE------------ 83
Query: 74 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
T+++ E + +L +R V + Y Q+ + Y +HRD
Sbjct: 84 -----EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRD 138
Query: 133 IKGSNLLIDNEGNLKLADFGLAR 155
I N+L+ + +KL DFGL+R
Sbjct: 139 IAVRNILVASPECVKLGDFGLSR 161
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 38/188 (20%), Positives = 70/188 (37%), Gaps = 34/188 (18%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
IK LK+ + E +RE +I+ +L + +++L + +
Sbjct: 42 IKV-----LKQGTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAE---------- 82
Query: 74 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
+ +V E L V + + Q+ G+ Y +HRD
Sbjct: 83 -------ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 133 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGP 188
+ N+L+ N K++DFGL+++ ++ T R WY P + K+
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFR--KFSS 192
Query: 189 AVDMWSVG 196
D+WS G
Sbjct: 193 RSDVWSYG 200
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 41/186 (22%), Positives = 73/186 (39%), Gaps = 32/186 (17%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
IKT K D+ +E F ++E +++ H +++KL ++T
Sbjct: 423 IKT-----CKNCTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITEN---------- 463
Query: 74 DGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 131
+++ E +L L R + + Y QL T L Y + +HR
Sbjct: 464 -------PVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 132 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAV 190
DI N+L+ + +KL DFGL+R + + + W P + ++ A
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR--RFTSAS 573
Query: 191 DMWSVG 196
D+W G
Sbjct: 574 DVWMFG 579
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 33/184 (17%)
Query: 20 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78
VA+K ++ + E F + E ++K LQH+ ++KL +VT
Sbjct: 215 VAVKTMKPGSMSVEAF----LAEANVMKTLQHDKLVKLHAVVT----------------- 253
Query: 79 RGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 136
+ Y++ E+M L L G + +P++ + Q+ G+ + +HRD++ +
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 313
Query: 137 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDM 192
N+L+ K+ADFGLAR +N T R W P + G + D+
Sbjct: 314 NILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFG--SFTIKSDV 368
Query: 193 WSVG 196
WS G
Sbjct: 369 WSFG 372
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 8e-17
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 58/214 (27%)
Query: 17 GEIVALKKIRMDNEKEG------FPITAIREIKILKKLQHENVIKL----KEIVTSPGPE 66
VA+KK+ + F +EIK++ K QHEN+++L + G +
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQF----DQEIKVMAKCQHENLVELLGFSSD-----GDD 104
Query: 67 RDEQGRPDGNKYRGSTYMVFEYM-----DHDLTGLADRPGL----RFTVPQIKCYMKQLL 117
+V+ YM L+ L P L R K
Sbjct: 105 L---------------CLVYVYMPNGSLLDRLSCLDGTPPLSWHMR---------CKIAQ 140
Query: 118 ---TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLW 173
G+++ H N +HRDIK +N+L+D K++DFGLAR+ +T+R++ T
Sbjct: 141 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA 200
Query: 174 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 207
Y PE L G + P D++S G + E++ G P
Sbjct: 201 YMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 8e-17
Identities = 37/187 (19%), Positives = 73/187 (39%), Gaps = 36/187 (19%)
Query: 20 VALKKIRMD----NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 75
VA+K ++ + K+ + E ++++L + ++++ I +
Sbjct: 47 VAVKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIGICEAE------------ 90
Query: 76 NKYRGSTYMVFEYMDHDLTG-LAD--RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
S +V E + G L + I + Q+ G+ Y + +HRD
Sbjct: 91 -----SWMLVMEMAEL---GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 142
Query: 133 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPA 189
+ N+L+ + K++DFGL+++ D N WY PE + K+
Sbjct: 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECIN-YYKFSSK 200
Query: 190 VDMWSVG 196
D+WS G
Sbjct: 201 SDVWSFG 207
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 50/227 (22%), Positives = 90/227 (39%), Gaps = 42/227 (18%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66
+++A E A ++++ ++ G E+K +++ ++ IK +
Sbjct: 52 LIYLAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKDCIKKW----IERKQ 104
Query: 67 RDEQGRP----------DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQL 116
D G P G YR +MV E + DL ++ + G F + ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYR---FMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRM 160
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 174
L L Y H N+ +H DIK +NLL+ N + LAD+GL+ + ++
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC----PNGNHKQYQ--E 214
Query: 175 RPPELLLGATKY-------GPAV----DMWSVGCIFAELLNGKPILP 210
P + G ++ G A+ D+ +G L GK LP
Sbjct: 215 NPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK--LP 259
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 24/182 (13%)
Query: 20 VALKKIRMDNEKEGFPITA-IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78
VA+K ++ D + + IRE+ + L H N+I+L +V +P
Sbjct: 49 VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--------------- 93
Query: 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 137
MV E L + F + + Y Q+ G+ Y + +HRD+ N
Sbjct: 94 --PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN 151
Query: 138 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPAVDMWS 194
LL+ +K+ DFGL R+ + ++ + + W PE L + A D W
Sbjct: 152 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-APESLK-TRTFSHASDTWM 209
Query: 195 VG 196
G
Sbjct: 210 FG 211
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 32/186 (17%), Positives = 66/186 (35%), Gaps = 31/186 (16%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
IK L++ + + E ++ + + +V +L I +
Sbjct: 49 IKE-----LREATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTS---------- 89
Query: 74 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
+ ++ + M L + + Q+ G++Y +++HRD
Sbjct: 90 -------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142
Query: 133 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAV 190
+ N+L+ ++K+ DFGLA+ + +V W E +L Y
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESIL-HRIYTHQS 200
Query: 191 DMWSVG 196
D+WS G
Sbjct: 201 DVWSYG 206
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 30/216 (13%), Positives = 57/216 (26%), Gaps = 50/216 (23%)
Query: 6 SQVFMAREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
Q + A + VAL + + + L ++ V ++ ++V
Sbjct: 45 LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV---- 100
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+ +V E++ L +AD + M+ L
Sbjct: 101 ---HTRAGG---------LVVAEWIRGGSLQEVADTSPSPVGAIRA---MQSLAAAADAA 145
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
H V S + + +G++ LA P
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA----- 179
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 219
P D+ +G LL + LP L+
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 42/187 (22%), Positives = 74/187 (39%), Gaps = 34/187 (18%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
IKT K D+ +E F ++E +++ H +++KL ++T
Sbjct: 48 IKT-----CKNCTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITEN---------- 88
Query: 74 DGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 131
+++ E +L L R + + Y QL T L Y + +HR
Sbjct: 89 -------PVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHR 140
Query: 132 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPA 189
DI N+L+ + +KL DFGL+R D + ++ W P + ++ A
Sbjct: 141 DIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR--RFTSA 197
Query: 190 VDMWSVG 196
D+W G
Sbjct: 198 SDVWMFG 204
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 54/254 (21%), Positives = 94/254 (37%), Gaps = 58/254 (22%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGP 65
+++ +I GE VA+K + + E KI K +Q + ++ G
Sbjct: 24 DIYLGTDIAAGEEVAIKLECVKTKHPQLH----IESKIYKMMQGGVGIPTIRWC----GA 75
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
E D MV E + L L + +F++ + Q+++ + Y H
Sbjct: 76 EGD------------YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 126 NQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
+HRD+K N L+ + + DFGLA+ + + T++ I YR + L G
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR----DARTHQHIP--YRENKNLTG 177
Query: 183 ATKY-----------GPAVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFE--- 223
+Y D+ S+G + G LP + ++ +I E
Sbjct: 178 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS--LPWQGLKAATKRQKYERISEKKM 235
Query: 224 ------LC-GSPDE 230
LC G P E
Sbjct: 236 STPIEVLCKGYPSE 249
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 32/162 (19%), Positives = 61/162 (37%), Gaps = 28/162 (17%)
Query: 7 QVFMAREIKTGEI---VALKKIRMDN----EKEGFPITAIREIKILKKLQHENVIKLKEI 59
V + VA+K +++DN E E F + E +K H NVI+L +
Sbjct: 49 SVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF----LSEAACMKDFSHPNVIRLLGV 104
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL-----TGLADRPGLRFTVPQIKCYM 113
+ ++ +M + DL + + + +M
Sbjct: 105 CIEMSSQG-----------IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 114 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
+ G+ Y LHRD+ N ++ ++ + +ADFGL++
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 33/162 (20%), Positives = 62/162 (38%), Gaps = 27/162 (16%)
Query: 7 QVFMAR---EIKTGEIVALKKIRMD----NEKEGFPITAIREIKILKKLQHENVIKLKEI 59
V A+ E + VA+K ++ D ++ E F +RE +K+ H +V KL +
Sbjct: 38 SVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF----LREAACMKEFDHPHVAKLVGV 93
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL-----TGLADRPGLRFTVPQIKCYM 113
+ ++ +M H DL + + +M
Sbjct: 94 SLRSRAKGRL----------PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 114 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
+ G+ Y +HRD+ N ++ + + +ADFGL+R
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 35/188 (18%), Positives = 64/188 (34%), Gaps = 36/188 (19%)
Query: 20 VALKKIRMD--NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77
V LK + N E F ++ KL H++++ + G
Sbjct: 43 VLLKVLDKAHRNYSESF----FEAASMMSKLSHKHLVLNYGVCV--------CGDE---- 86
Query: 78 YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 136
+V E++ L + + KQL +H+ N ++H ++
Sbjct: 87 ----NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAK 142
Query: 137 NLLIDNEGNL--------KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 188
N+L+ E + KL+D G++ + + + W PPE +
Sbjct: 143 NILLIREEDRKTGNPPFIKLSDPGISITV-LPKDIL---QERIPWV-PPECIENPKNLNL 197
Query: 189 AVDMWSVG 196
A D WS G
Sbjct: 198 ATDKWSFG 205
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 39/143 (27%), Positives = 62/143 (43%), Gaps = 25/143 (17%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
IK+ L +I + E F +RE +++ L H NV+ L I+ P
Sbjct: 54 IKS-----LSRITEMQQVEAF----LREGLLMRGLNHPNVLALIGIMLPPEG-------- 96
Query: 74 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
+++ YM H DL P TV + + Q+ G+ Y + +HRD
Sbjct: 97 -------LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRD 149
Query: 133 IKGSNLLIDNEGNLKLADFGLAR 155
+ N ++D +K+ADFGLAR
Sbjct: 150 LAARNCMLDESFTVKVADFGLAR 172
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 30/152 (19%), Positives = 63/152 (41%), Gaps = 35/152 (23%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
IKT + + E+ F + E ++K+ +V++L +V+ QG+P
Sbjct: 60 IKT-----VNEAASMRERIEF----LNEASVMKEFNCHHVVRLLGVVS--------QGQP 102
Query: 74 DGNKYRGSTYMVFEYMDH-DL---------TGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
T ++ E M DL + ++ ++ ++ G+ Y
Sbjct: 103 --------TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
+ N+ +HRD+ N ++ + +K+ DFG+ R
Sbjct: 155 NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 7e-16
Identities = 39/143 (27%), Positives = 59/143 (41%), Gaps = 25/143 (17%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
+K+ L +I E F + E I+K H NV+ L I
Sbjct: 58 VKS-----LNRITDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICL------------ 96
Query: 74 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
+ GS +V YM H DL TV + + Q+ G+ Y + +HRD
Sbjct: 97 ---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRD 153
Query: 133 IKGSNLLIDNEGNLKLADFGLAR 155
+ N ++D + +K+ADFGLAR
Sbjct: 154 LAARNCMLDEKFTVKVADFGLAR 176
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 52/240 (21%), Positives = 88/240 (36%), Gaps = 50/240 (20%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGP 65
++ + + + T E VA+K M + E + K+L + + ++ GP
Sbjct: 24 ELRLGKNLYTNEYVAIKLEPMKSRAPQLH----LEYRFYKQLGSGDGIPQVYYF----GP 75
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
MV E + L L D F++ + QL++ + Y H
Sbjct: 76 CGK------------YNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 126 NQVLHRDIKGSNLLIDNEGNLK-----LADFGLARSFSYDHNNTLTNRVITLWYRPPELL 180
+++RD+K N LI GN + DF LA+ + D T + I YR + L
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY-IDPE---TKKHIP--YREHKSL 177
Query: 181 LGATKY-----------GPAVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFEL 224
G +Y D+ ++G +F L G LP E+ KI +
Sbjct: 178 TGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS--LPWQGLKADTLKERYQKIGDT 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 51/256 (19%), Positives = 89/256 (34%), Gaps = 60/256 (23%)
Query: 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGP 65
+F + + VA+K ++ E + K L + + G
Sbjct: 25 VIFEGTNLLNNQQVAIKFEPRRSDAPQLR----DEYRTYKLLAGCTGIPNVYYF----GQ 76
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
E +V + + L L D G +F+V + KQ+L + H
Sbjct: 77 EGL------------HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 126 NQVLHRDIKGSNLLIDNEGNLK-----LADFGLARSFSYDHNNTLTNRVITLWYRPPELL 180
+++RDIK N LI + + DFG+ + + + +T + I YR + L
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR----DPVTKQHIP--YREKKNL 178
Query: 181 LGATKY-----------GPAVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFE- 223
G +Y D+ ++G +F L G LP ++ +I E
Sbjct: 179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS--LPWQGLKAATNKQKYERIGEK 236
Query: 224 --------LC-GSPDE 230
LC G P+E
Sbjct: 237 KQSTPLRELCAGFPEE 252
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 36/187 (19%), Positives = 68/187 (36%), Gaps = 32/187 (17%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
IK LK+ + E +RE +I+ +L + +++L + +
Sbjct: 368 IKV-----LKQGTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAE---------- 408
Query: 74 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
+ +V E L V + + Q+ G+ Y +HR+
Sbjct: 409 -------ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 133 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPA 189
+ N+L+ N K++DFGL+++ D + WY P + K+
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSR 519
Query: 190 VDMWSVG 196
D+WS G
Sbjct: 520 SDVWSYG 526
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 38/143 (26%), Positives = 59/143 (41%), Gaps = 25/143 (17%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
+K+ L +I E F + E I+K H NV+ L I
Sbjct: 122 VKS-----LNRITDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICL------------ 160
Query: 74 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
+ GS +V YM H DL TV + + Q+ G+ + + +HRD
Sbjct: 161 ---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRD 217
Query: 133 IKGSNLLIDNEGNLKLADFGLAR 155
+ N ++D + +K+ADFGLAR
Sbjct: 218 LAARNCMLDEKFTVKVADFGLAR 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 40/175 (22%), Positives = 63/175 (36%), Gaps = 42/175 (24%)
Query: 7 QVFMAREIKTGE--IVA---LKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIV 60
QV AR K G A +K+ ++ F E+++L KL H N+I L
Sbjct: 40 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF----AGELEVLCKLGHHPNIINLLGAC 95
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL---------------TGLADRPGLRF 104
G Y+ EY H +L +A+
Sbjct: 96 EHRGY----------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 105 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159
+ Q+ + + G+ Y Q +HRD+ N+L+ K+ADFGL+R
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 194
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 32/186 (17%), Positives = 66/186 (35%), Gaps = 31/186 (16%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
IK L++ + + E ++ + + +V +L I +
Sbjct: 49 IKE-----LREATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTS---------- 89
Query: 74 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 132
+ ++ + M L + + Q+ G++Y +++HRD
Sbjct: 90 -------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142
Query: 133 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAV 190
+ N+L+ ++K+ DFGLA+ + +V W E +L Y
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESIL-HRIYTHQS 200
Query: 191 DMWSVG 196
D+WS G
Sbjct: 201 DVWSYG 206
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 39/158 (24%), Positives = 61/158 (38%), Gaps = 41/158 (25%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
IKT LK +E F E + +LQH NV+ L +VT + +P
Sbjct: 44 IKT-----LKDKAEGPLREEF----RHEAMLRARLQHPNVVCLLGVVT--------KDQP 86
Query: 74 DGNKYRGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQLL 117
M+F Y H DL T P + Q+
Sbjct: 87 --------LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIA 138
Query: 118 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
G+ Y + V+H+D+ N+L+ ++ N+K++D GL R
Sbjct: 139 AGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 32/187 (17%), Positives = 67/187 (35%), Gaps = 33/187 (17%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
IK ++ + + + L H ++++L +
Sbjct: 47 IKV-----IEDKSGRQSFQAV----TDHMLAIGSLDHAHIVRLLGLCPGS---------- 87
Query: 74 DGNKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 131
S +V +Y+ L + G + + Q+ G++Y + ++HR
Sbjct: 88 -------SLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLEEHGMVHR 139
Query: 132 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPA 189
++ N+L+ + +++ADFG+A D L + + W E + KY
Sbjct: 140 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALESIH-FGKYTHQ 197
Query: 190 VDMWSVG 196
D+WS G
Sbjct: 198 SDVWSYG 204
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 37/181 (20%), Positives = 66/181 (36%), Gaps = 52/181 (28%)
Query: 7 QVFMAR--EIKTGE---IVA---LKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE 58
+V A +K VA LK+ +E + E +LK++ H +VIKL
Sbjct: 38 KVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL----LSEFNVLKQVNHPHVIKLYG 93
Query: 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL-----------------------T 94
+ GP ++ EY + L +
Sbjct: 94 ACSQDGP----------------LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 95 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154
L T+ + + Q+ G+ Y +++HRD+ N+L+ +K++DFGL+
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 155 R 155
R
Sbjct: 198 R 198
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 40/174 (22%), Positives = 65/174 (37%), Gaps = 44/174 (25%)
Query: 7 QVFMAR-----EIKTGEIVA---LKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLK 57
QV A + T VA LK+ +E + E+KIL + H NV+ L
Sbjct: 42 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL----MSELKILIHIGHHLNVVNLL 97
Query: 58 EIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL---------------TGLADRPG 101
T + G P ++ E+ +L D
Sbjct: 98 GACT-------KPGGP--------LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 102 LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
T+ + CY Q+ G+ + + +HRD+ N+L+ + +K+ DFGLAR
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 48/251 (19%), Positives = 85/251 (33%), Gaps = 54/251 (21%)
Query: 7 QVFMAR-----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+++A + + +K DN E+K ++ I+
Sbjct: 50 CIYLADMNSSESVGSDAPCVVKVEPSDNGP------LFTELKFYQRAAKPEQIQKWIRTR 103
Query: 62 SPGPERDEQGRP----------DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKC 111
G P +G YR +M+ + DL + + RF+ +
Sbjct: 104 KLKY----LGVPKYWGSGLHDKNGKSYR---FMIMDRFGSDLQKIYEANAKRFSRKTVLQ 156
Query: 112 YMKQLLTGLHYCHVNQVLHRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNNTLTNRV 169
++L L Y H ++ +H DIK SNLL++ N + L D+GLA + ++
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY-CPEG---VHKA 212
Query: 170 ITLWYRPPELLLGATKY-------GPAV----DMWSVGCIFAELLNGKPILP-----GKN 213
P G ++ G A D+ +G + L G LP
Sbjct: 213 YA--ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH--LPWEDNLKDP 268
Query: 214 EAEQLSKIFEL 224
+ + SKI
Sbjct: 269 KYVRDSKIRYR 279
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 42/172 (24%), Positives = 69/172 (40%), Gaps = 43/172 (25%)
Query: 7 QVFMAR-----EIKTGEIVALKKIR--MDNEKEGFPITAIREIKILKKLQHENVIKLKEI 59
+VF+A K +VA+K ++ ++ F RE ++L LQHE+++K +
Sbjct: 30 KVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF----QREAELLTNLQHEHIVKFYGV 85
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL---------------TGLADRPGLR 103
G P MVFEYM H DL G +
Sbjct: 86 CG--------DGDP--------LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
+ Q+ Q+ +G+ Y +HRD+ N L+ +K+ DFG++R
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 40/172 (23%), Positives = 62/172 (36%), Gaps = 43/172 (25%)
Query: 7 QVFMA-----REIKTGEIVA---LKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLK 57
+V A + VA LK +EKE + E+KI+ L QHEN++ L
Sbjct: 61 KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----MSELKIMSHLGQHENIVNLL 116
Query: 58 EIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL-------------TGLADRPGLR 103
T GP ++ EY + DL
Sbjct: 117 GACTHGGP----------------VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
+ + + Q+ G+ + +HRD+ N+L+ N K+ DFGLAR
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 47/176 (26%)
Query: 7 QVFMAR-------EIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKL-QHENVIK 55
QV MA + K VA+K ++ + + + E++++K + +H+N+I
Sbjct: 50 QVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIGKHKNIIN 105
Query: 56 LKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL---------------TGLADR 99
L T GP Y++ EY +L +
Sbjct: 106 LLGACTQDGP----------------LYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 100 PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
P + T + QL G+ Y + +HRD+ N+L+ +K+ADFGLAR
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 37/176 (21%), Positives = 69/176 (39%), Gaps = 47/176 (26%)
Query: 7 QVFMAR-------EIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKL-QHENVIK 55
QV +A + VA+K ++ + + I E++++K + +H+N+I
Sbjct: 84 QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL----ISEMEMMKMIGKHKNIIN 139
Query: 56 LKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL---------------TGLADR 99
L T GP Y++ EY +L +
Sbjct: 140 LLGACTQDGP----------------LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 100 PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
P + + + Q+ G+ Y + +HRD+ N+L+ + +K+ADFGLAR
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 37/176 (21%), Positives = 66/176 (37%), Gaps = 47/176 (26%)
Query: 7 QVFMA--REIKTGE---IVALKKIR---MDNEKEGFPITAIREIKILKKL-QHENVIKLK 57
+V A + + VA+K ++ E+E + E+K+L L H N++ L
Sbjct: 38 KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL----MSELKVLSYLGNHMNIVNLL 93
Query: 58 EIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL-----------------TGLADR 99
T GP T ++ EY + DL + +
Sbjct: 94 GACTIGGP----------------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 100 PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
L + + + Q+ G+ + +HRD+ N+L+ + K+ DFGLAR
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 41/176 (23%), Positives = 67/176 (38%), Gaps = 47/176 (26%)
Query: 7 QVFMAR-------EIKTGEIVA---LKKIRMDNEKEGFPITAIREIKILKKL-QHENVIK 55
QV MA + K VA LK + + + E++++K + +H+N+I
Sbjct: 96 QVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIGKHKNIIN 151
Query: 56 LKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL---------------TGLADR 99
L T GP Y++ EY +L +
Sbjct: 152 LLGACTQDGP----------------LYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 100 PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
P + T + QL G+ Y + +HRD+ N+L+ +K+ADFGLAR
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 37/153 (24%)
Query: 20 VALKKIR--MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77
VA+K ++ ++ ++ F RE ++L LQH+++++ + T +GRP
Sbjct: 74 VAVKALKEASESARQDF----QREAELLTMLQHQHIVRFFGVCT--------EGRP---- 117
Query: 78 YRGSTYMVFEYMDH-DL--------------TGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
MVFEYM H DL G D + Q+ Q+ G+ Y
Sbjct: 118 ----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
+HRD+ N L+ +K+ DFG++R
Sbjct: 174 LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 33/152 (21%), Positives = 57/152 (37%), Gaps = 35/152 (23%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
+KT L ++ + ++ F + E I+ K H+N+++ + Q P
Sbjct: 65 VKT-----LPEVCSEQDELDF----LMEALIISKFNHQNIVRCIGVSL--------QSLP 107
Query: 74 DGNKYRGSTYMVFEYMDH-DLTG--LADRP----GLRFTVPQIKCYMKQLLTGLHYCHVN 126
+++ E M DL RP + + + + G Y N
Sbjct: 108 --------RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 159
Query: 127 QVLHRDIKGSNLLIDNEGN---LKLADFGLAR 155
+HRDI N L+ G K+ DFG+AR
Sbjct: 160 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 43/180 (23%)
Query: 14 IKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG--PERD 68
++ G VALK+ ++ +E F EI+ L +H +++ L G ER+
Sbjct: 60 LRDGAKVALKRRTPESSQGIEE-F----ETEIETLSFCRHPHLVSLI------GFCDERN 108
Query: 69 EQGRPDGNKYRGSTYMVFEYM------DHDLTGLADRPGLRFTVPQIKCYMKQLL---TG 119
E ++++YM H L G +D P + + Q ++ + G
Sbjct: 109 EMI------------LIYKYMENGNLKRH-LYG-SDLPTMSMSWEQ---RLEICIGAARG 151
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPE 178
LHY H ++HRD+K N+L+D K+ DFG+++ + L+ V TL Y PE
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE 211
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 33/166 (19%), Positives = 62/166 (37%), Gaps = 49/166 (29%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
+K LK+ + + F RE ++ + + N++KL + G+P
Sbjct: 82 VKM-----LKEEASADMQADF----QREAALMAEFDNPNIVKLLGVCA--------VGKP 124
Query: 74 DGNKYRGSTYMVFEYMDH-DL-----------------------TGLADRPGLRFTVPQI 109
++FEYM + DL ++ + +
Sbjct: 125 --------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 176
Query: 110 KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155
C +Q+ G+ Y + +HRD+ N L+ +K+ADFGL+R
Sbjct: 177 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 33/152 (21%), Positives = 57/152 (37%), Gaps = 35/152 (23%)
Query: 14 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73
+KT L ++ + ++ F + E I+ K H+N+++ + Q P
Sbjct: 106 VKT-----LPEVCSEQDELDF----LMEALIISKFNHQNIVRCIGVSL--------QSLP 148
Query: 74 DGNKYRGSTYMVFEYMDH-DLTG--LADRP----GLRFTVPQIKCYMKQLLTGLHYCHVN 126
+++ E M DL RP + + + + G Y N
Sbjct: 149 --------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200
Query: 127 QVLHRDIKGSNLLIDNEGN---LKLADFGLAR 155
+HRDI N L+ G K+ DFG+AR
Sbjct: 201 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 52/234 (22%), Positives = 98/234 (41%), Gaps = 58/234 (24%)
Query: 14 IKTGEIVALKKIRMD----NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 69
+ G +VA+K+++ + E + F E++++ H N+++L+ + ER
Sbjct: 51 LADGTLVAVKRLKEERTQGGELQ-F----QTEVEMISMAVHRNLLRLRGFCMT-PTER-- 102
Query: 70 QGRPDGNKYRGSTYMVFEYM-----DHDLTGLAD-RPGL----RFTVPQIKCYMKQLL-- 117
+V+ YM L + +P L R + L
Sbjct: 103 -------------LLVYPYMANGSVASCLRERPESQPPLDWPKR---------QRIALGS 140
Query: 118 -TGLHYCHVN---QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVI-T 171
GL Y H + +++HRD+K +N+L+D E + DFGLA+ D+ +T +T V T
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGT 198
Query: 172 LWYRPPE-LLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFE 223
+ + PE L G K D++ G + EL+ G + + + + +
Sbjct: 199 IGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 40/181 (22%), Positives = 68/181 (37%), Gaps = 52/181 (28%)
Query: 7 QVFMAR-----EIKTGEIVA---LKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLK 57
+V A + VA LK+ +E+E + E+K++ +L HEN++ L
Sbjct: 60 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL----MSELKMMTQLGSHENIVNLL 115
Query: 58 EIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL----------------------T 94
T GP Y++FEY + DL
Sbjct: 116 GACTLSGP----------------IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 95 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154
+ T + C+ Q+ G+ + +HRD+ N+L+ + +K+ DFGLA
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 155 R 155
R
Sbjct: 220 R 220
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 38/249 (15%), Positives = 76/249 (30%), Gaps = 50/249 (20%)
Query: 7 QVFMAREIKTGEIVALKK-----IRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
++ A T + + +++D + + K LQ KL
Sbjct: 57 ILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYST-- 114
Query: 62 SPGPERDEQGRP-------DGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYM 113
P +KYR ++V + L D P + +
Sbjct: 115 ------PLLAIPTCMGFGVHQDKYR---FLVLPSLGRSLQSALDVSPKHVLSERSVLQVA 165
Query: 114 KQLLTGLHYCHVNQVLHRDIKGSNLLI--DNEGNLKLADFGLARSFSYDHNNTLTNRVIT 171
+LL L + H N+ +H ++ N+ + +++ + LA +G A + + + +
Sbjct: 166 CRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY------CPSGKHVA 219
Query: 172 LWYRPPELLLGATKY-------GPAV----DMWSVGCIFAELLNGKPILP-----GKNEA 215
G ++ G D+ S+G + L G LP E
Sbjct: 220 YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF--LPWTNCLPNTED 277
Query: 216 EQLSKIFEL 224
K +
Sbjct: 278 IMKQKQKFV 286
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 2e-09
Identities = 21/134 (15%), Positives = 30/134 (22%), Gaps = 4/134 (2%)
Query: 336 HHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSG 395
HH + R+ P Q Q + P PP YG+ PP GA
Sbjct: 3 HHKK---RVYP-QAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQ 58
Query: 396 NQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSG 455
Q Q + + P G + Q +
Sbjct: 59 QQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAA 118
Query: 456 QYGNSAAGRGPNQM 469
+ M
Sbjct: 119 PAYGQPSAAMGQNM 132
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 4e-07
Identities = 11/148 (7%), Positives = 20/148 (13%)
Query: 331 KRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGAN 390
K++ Q + + G P
Sbjct: 5 KKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTP 64
Query: 391 RYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQS 450
+Q + P P + Q
Sbjct: 65 AQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQP 124
Query: 451 YSQSGQYGNSAAGRGPNQMGGSRNQQYG 478
+ GQ P +
Sbjct: 125 SAAMGQNMRPMNQLYPIDLLTELPPPIT 152
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 6e-07
Identities = 14/123 (11%), Positives = 20/123 (16%), Gaps = 3/123 (2%)
Query: 359 PNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPY 418
P + P + P+ P Y P+ G Q
Sbjct: 10 PQAQLQYGQNATPLQQP-AQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQ 68
Query: 419 PPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYG 478
Q A M Q G + + Q
Sbjct: 69 LHQ--QIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSA 126
Query: 479 WQQ 481
Sbjct: 127 AMG 129
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 38/193 (19%), Positives = 65/193 (33%), Gaps = 56/193 (29%)
Query: 22 LKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPE-------------- 66
LK+ +E + E+KIL + H NV+ L T PG
Sbjct: 60 LKEGATHSEHRAL----MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 115
Query: 67 ---RDEQGRPDGNKYRGSTYMVF-EYMDHDLTGLADR----------------------- 99
R ++ K +G+ + +Y+ L R
Sbjct: 116 TYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175
Query: 100 ----------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLA 149
T+ + CY Q+ G+ + + +HRD+ N+L+ + +K+
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 150 DFGLARSFSYDHN 162
DFGLAR D +
Sbjct: 236 DFGLARDIYKDPD 248
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 1e-05
Identities = 31/131 (23%), Positives = 41/131 (31%), Gaps = 3/131 (2%)
Query: 350 AGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQ 409
G S + + N PP GG G H G P GG P G GG+ P+ GG
Sbjct: 14 TGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHG---GGWGQPHGGGW 70
Query: 410 GGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQM 469
G + + G + P + A G G SA R
Sbjct: 71 GQPHGGGGWGQGGTHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSRPLIHF 130
Query: 470 GGSRNQQYGWQ 480
G +Y +
Sbjct: 131 GSDYEDRYYRE 141
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 3e-04
Identities = 26/140 (18%), Positives = 36/140 (25%), Gaps = 8/140 (5%)
Query: 345 PPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNP 404
++ Q G H P G H G + GG + + GG+
Sbjct: 26 GGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGG---WGQPHGGGGWGQG 82
Query: 405 NRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSG----QYGNS 460
+ P A AG G G G + +Y
Sbjct: 83 G-THGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSRPLIHFGSDYEDRYYRE 141
Query: 461 AAGRGPNQMGGSRNQQYGWQ 480
R PNQ+ QY Q
Sbjct: 142 NMHRYPNQVYYRPVDQYSNQ 161
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 40.2 bits (93), Expect = 7e-04
Identities = 23/111 (20%), Positives = 29/111 (26%), Gaps = 3/111 (2%)
Query: 368 PPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPY 427
P GG P G NRYP Q GG GG G G + Q G +
Sbjct: 6 PKPGGGWNTGGSRYPGQGSPGGNRYPP--QGGGGWGQPHGG-GWGQPHGGGWGQPHGGGW 62
Query: 428 AGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYG 478
G G+G G + + + G
Sbjct: 63 GQPHGGGWGQPHGGGGWGQGGTHGQWNKPSKPKTNMKHVAGAAAAGAVVGG 113
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 481 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.59 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.71 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.47 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.46 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.45 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.44 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.39 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.35 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.11 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.09 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.95 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.88 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.58 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.54 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.19 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.92 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.23 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.11 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=469.67 Aligned_cols=246 Identities=26% Similarity=0.440 Sum_probs=214.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.||+.||||+++..... ....+.+|+.+|++|+|||||+++++|.+ .+.+
T Consensus 85 G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----------------~~~~ 146 (346)
T 4fih_A 85 GSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV----------------GDEL 146 (346)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEE
Confidence 89999999999999999999999866433 34567899999999999999999999998 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||++ +|.+++.+ ..+++.+++.|+.||+.||+|||+++||||||||+||||+.+++|||+|||+|+.+...
T Consensus 147 ~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 223 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 223 (346)
T ss_dssp EEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC-
Confidence 999999996 66666654 36999999999999999999999999999999999999999999999999999876533
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.....+.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+++..|....... ..
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~~---------- 291 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-LK---------- 291 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CS----------
T ss_pred CCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-CC----------
Confidence 334556799999999999976 679999999999999999999999999999999888886532110 00
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
.+..+++++++||.+||..||++|+|++|||+||||+...
T Consensus 292 ----------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 292 ----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp ----------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 1235788999999999999999999999999999997643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-60 Score=456.78 Aligned_cols=244 Identities=28% Similarity=0.466 Sum_probs=200.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.|++.||||++++... .......+.+|+.+|++|+|||||+++++|.+ .+.
T Consensus 24 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----------------~~~ 87 (275)
T 3hyh_A 24 GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS----------------KDE 87 (275)
T ss_dssp ---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSE
T ss_pred CcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----------------CCE
Confidence 8999999999999999999999986643 33445678899999999999999999999987 678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+|||||||+++|++.+.+. ..+++.+++.|++||+.||+|||+++|+||||||+||||+.++++||+|||+|+....
T Consensus 88 ~~ivmEy~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 164 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-- 164 (275)
T ss_dssp EEEEEECCCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence 9999999999999888764 4699999999999999999999999999999999999999999999999999986542
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.....+.+||+.|||||++.+...++.++||||||||+|+|++|+.||.+.+..+++.++.+.....
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~------------- 231 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL------------- 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------------
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 3344567899999999999875556789999999999999999999999999888888876532111
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+.+++++++||++||+.||++|+|++|+|+||||+.
T Consensus 232 -----------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 232 -----------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1246789999999999999999999999999999965
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-59 Score=477.54 Aligned_cols=285 Identities=36% Similarity=0.577 Sum_probs=234.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.||+.||||+++...........+++|+++|++|+|||||++++++..... ....+.+
T Consensus 65 G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----------~~~~~~~ 134 (398)
T 4b99_A 65 GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP----------YGEFKSV 134 (398)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC----------TTTCCCE
T ss_pred ccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc----------cccCCEE
Confidence 899999999999999999999998665444455678899999999999999999999876321 1225689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC--
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-- 160 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-- 160 (481)
|||||||+++|.+++.+. ..+++.+++.|++||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+...
T Consensus 135 ~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~ 213 (398)
T 4b99_A 135 YVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 213 (398)
T ss_dssp EEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-----
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcc
Confidence 999999999988888664 47999999999999999999999999999999999999999999999999999876432
Q ss_pred -CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 -HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 -~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
......+.+||+.|||||++.+...|+.++||||||||+|||++|++||.+.+..+++..|+...+.+....|......
T Consensus 214 ~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~ 293 (398)
T 4b99_A 214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE 293 (398)
T ss_dssp --CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----
T ss_pred ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhh
Confidence 2334566799999999999988667899999999999999999999999999999999999999999887776654332
Q ss_pred CccccCC-CchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 011627 240 PAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298 (481)
Q Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~ 298 (481)
....... ........+..++..++++++|||.+||..||++|+|++|+|+||||+....
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 294 RVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 2110000 0001122345566788999999999999999999999999999999976433
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-60 Score=472.08 Aligned_cols=246 Identities=24% Similarity=0.428 Sum_probs=211.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||++++..........+.+|+.+|++|+|||||+++++|++ ++.+
T Consensus 35 G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~----------------~~~~ 98 (350)
T 4b9d_A 35 GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE----------------NGSL 98 (350)
T ss_dssp ----CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE----------------CCEE
Confidence 899999999999999999999998775554456678899999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||||||++ +|.+++... ...+++.+++.|+.||+.||+|||+++||||||||+||||+.+++|||+|||+|+.+...
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999985 788877643 445899999999999999999999999999999999999999999999999999876421
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.....+.+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.+|......+.
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~----------- 245 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV----------- 245 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-----------
T ss_pred -cccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-----------
Confidence 123345689999999999987 6799999999999999999999999999999999998876422110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...++.++++||.+||+.||++|||++|||+|+||+.
T Consensus 246 ------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 246 ------------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 1247889999999999999999999999999999964
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=461.14 Aligned_cols=245 Identities=27% Similarity=0.421 Sum_probs=214.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.|++.||||++++.. ........+.+|+++|++|+|||||+++++|++ ++.
T Consensus 43 G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----------------~~~ 106 (311)
T 4aw0_A 43 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----------------DEK 106 (311)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSE
T ss_pred ccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----------------CCE
Confidence 899999999999999999999998653 233345678899999999999999999999998 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||++ +|.+++.+. ..+++.+++.|+.||+.||+|||+++||||||||+||||+.+++|||+|||+|+.+...
T Consensus 107 ~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999986 777777653 46999999999999999999999999999999999999999999999999999887543
Q ss_pred C-CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 H-NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~-~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .....+.+||+.|||||++.+ ..|+.++||||||||||+|++|+.||.+.+..+++.+|.+.....
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------- 253 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF----------- 253 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-----------
T ss_pred CCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2 334556799999999999987 678999999999999999999999999999999999987642111
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD------ALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e------iL~h~~f~~ 295 (481)
...+++++++||.+||+.||++|+|++| |++||||..
T Consensus 254 -------------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 254 -------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp -------------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred -------------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 1246789999999999999999999987 589999965
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=471.56 Aligned_cols=245 Identities=26% Similarity=0.445 Sum_probs=213.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.||+.||||+++..... ....+.+|+.+|++|+|||||+++++|.+ .+.+
T Consensus 162 G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----------------~~~~ 223 (423)
T 4fie_A 162 GSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV----------------GDEL 223 (423)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEE----------------CCEE
Confidence 89999999999999999999999876433 35578899999999999999999999998 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||++ +|.+++.. ..+++.+++.|++||+.||+|||+++||||||||+||||+.+++|||+|||+|+.+...
T Consensus 224 ~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~- 300 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 300 (423)
T ss_dssp EEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-
T ss_pred EEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-
Confidence 999999996 66666543 35999999999999999999999999999999999999999999999999999876533
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.....+.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|...... ...
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~---------- 368 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLK---------- 368 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCS----------
T ss_pred CccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCc----------
Confidence 334566799999999999986 67999999999999999999999999999999988888653211 110
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.+..+++++++||.+||..||++|+|++|||+||||+..
T Consensus 369 ----------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 369 ----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ----------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 112478899999999999999999999999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-58 Score=446.90 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=204.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||++............+.+|+.+|++|+|||||+++++|.+.. ..+..+
T Consensus 37 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~------------~~~~~~ 104 (290)
T 3fpq_A 37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV------------KGKKCI 104 (290)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE------------TTEEEE
T ss_pred CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc------------CCCcEE
Confidence 89999999999999999999999876544444567889999999999999999999997521 114578
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcC-CCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDN-EGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g--iiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~ 158 (481)
|||||||++ +|.+++.+ ...+++.+++.|+.||+.||+|||+++ ||||||||+||||+. ++++||+|||+|+...
T Consensus 105 ~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999986 66666654 346999999999999999999999998 999999999999985 7899999999997643
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.....+.+||+.|||||++.+ .|+.++||||||||||||+||+.||...+....+.+.+.....+
T Consensus 184 ---~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~---------- 248 (290)
T 3fpq_A 184 ---ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 248 (290)
T ss_dssp ---TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred ---CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC----------
Confidence 334456789999999999865 58999999999999999999999998766555444433211000
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..+...+++++++||.+||..||++|||++|||+||||+.
T Consensus 249 -----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0112346778999999999999999999999999999964
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=451.09 Aligned_cols=244 Identities=25% Similarity=0.419 Sum_probs=204.0
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++. .+++.||||+++...........+.+|+.+|++|+|||||+++++|.+ .
T Consensus 35 G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----------------~ 98 (304)
T 3ubd_A 35 GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT----------------E 98 (304)
T ss_dssp GGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE----------------T
T ss_pred CCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----------------C
Confidence 899999999984 578999999998664433344567899999999999999999999998 6
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.+|||||||++ +|.+++.+. ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+...
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred CEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 789999999986 677766543 469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. ......+.+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.+|.+.....
T Consensus 178 ~-~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------- 245 (304)
T 3ubd_A 178 D-HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---------- 245 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------
T ss_pred C-CCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC----------
Confidence 2 2334456789999999999987 679999999999999999999999999999999999887532111
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
...+++++++||++||+.||++|+| ++||++||||+.
T Consensus 246 --------------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 246 --------------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp --------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred --------------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 1247889999999999999999998 489999999954
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-57 Score=447.94 Aligned_cols=241 Identities=24% Similarity=0.305 Sum_probs=203.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.||+.||||+++.+.. ..+|+.+|++|+|||||+++++|.+ .+.+
T Consensus 69 G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~----------------~~~~ 125 (336)
T 4g3f_A 69 GSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVRE----------------GPWV 125 (336)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEE
Confidence 8999999999999999999999986432 2479999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~ 160 (481)
|||||||++ +|.+++.+. ..|++.+++.|+.||+.||+|||+++||||||||+||||+.++ ++||+|||+|+.+...
T Consensus 126 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999986 777766543 4699999999999999999999999999999999999999987 5999999999876533
Q ss_pred CCC----ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 161 HNN----TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 161 ~~~----~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
... .....+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.+|.....
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------- 273 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP---------- 273 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC----------
T ss_pred CcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC----------
Confidence 211 2234579999999999987 6799999999999999999999999998888777777764210
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA-------------LDSEYFWT 295 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~ei-------------L~h~~f~~ 295 (481)
....++..+++++++||.+||..||++|||+.|| |+|||+..
T Consensus 274 -----------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 274 -----------------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp -----------------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred -----------------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 0111234588899999999999999999999997 67999854
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-55 Score=440.79 Aligned_cols=269 Identities=26% Similarity=0.438 Sum_probs=206.2
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|+++ .+++.||||++.... ...++.+|+++|+++ +|||||+++++|.+
T Consensus 32 G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~---------------- 91 (361)
T 4f9c_A 32 GTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK---------------- 91 (361)
T ss_dssp CSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE----------------
T ss_pred ccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE----------------
Confidence 899999999985 468899999986542 345778999999999 69999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCeEEeccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARS 156 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~ 156 (481)
.+++|||||||++ +|.+++. .+++.+++.|++||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+.
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 6799999999985 7777663 48999999999999999999999999999999999999876 7899999999976
Q ss_pred ccCCC---------------------------CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCC
Q 011627 157 FSYDH---------------------------NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL 209 (481)
Q Consensus 157 ~~~~~---------------------------~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf 209 (481)
..... ....++.+||+.|||||++.+...|+.++||||||||+|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 53221 122345689999999999987667999999999999999999999887
Q ss_pred -CCCChHHHHHHHHHhcCCCCCCCCccC--------CCCCc------------cc----cCCCchhhhhhHHHHHhhhcH
Q 011627 210 -PGKNEAEQLSKIFELCGSPDETIWPGV--------SKMPA------------YN----HFKPSRTMKRRVREVFRHFDR 264 (481)
Q Consensus 210 -~~~~~~~~~~~i~~~~~~~~~~~~~~~--------~~~~~------------~~----~~~~~~~~~~~~~~~~~~~~~ 264 (481)
.+.++.+++.+|+...+.+....+... ...+. .. ...............+..+++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 567788889988877664321111000 00000 00 000000001111234567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 265 HALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 265 ~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+++|||++||+.||++|+|++|+|+||||+.
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999964
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=423.03 Aligned_cols=256 Identities=22% Similarity=0.319 Sum_probs=188.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++.... +.....+.+|+.+|++|+|||||+++++|.+....... .......++
T Consensus 16 G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~----~~~~~~~~l 90 (299)
T 4g31_A 16 GGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL----QPSSPKVYL 90 (299)
T ss_dssp CC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------------CEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc----cccCCCcEE
Confidence 8999999999999999999999986542 22345788999999999999999999999863311000 001123468
Q ss_pred EEEEecCCC-ChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 83 YMVFEYMDH-DLTGLADRPGL--RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~--~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
|||||||.+ +|.+++..... ...+..++.|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+.+..
T Consensus 91 ~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~ 170 (299)
T 4g31_A 91 YIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170 (299)
T ss_dssp EEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCC
Confidence 999999985 67776654332 245667899999999999999999999999999999999999999999999987653
Q ss_pred CCC-----------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 011627 160 DHN-----------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 228 (481)
Q Consensus 160 ~~~-----------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 228 (481)
... ...++.+||+.|||||++.+ ..|+.++||||||||||||++ ||... .+....+......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~~~~- 243 (299)
T 4g31_A 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDVRNL- 243 (299)
T ss_dssp ---------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHTT-
T ss_pred CccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHHhcC-
Confidence 221 12345689999999999987 679999999999999999996 67543 2223322221110
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....+...++.+++||++||+.||++|||+.|||+|+||+.
T Consensus 244 -------------------------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 244 -------------------------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp -------------------------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred -------------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 011234456778899999999999999999999999999964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=455.71 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=219.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.||+.||||++...... ....+.+|+.+|++|+|||||+++++|.+ .+.+
T Consensus 168 G~fg~V~~~~~~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----------------~~~~ 229 (573)
T 3uto_A 168 GAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFED----------------DNEM 229 (573)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEC----------------SSEE
T ss_pred ccCeEEEEEEECCCCCEEEEEEEeccchh--hHHHHHHHHHHHHhCCCCCCCeEEEEEEE----------------CCEE
Confidence 89999999999999999999999865432 24567899999999999999999999988 7789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC--CCeEEecccccccccC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE--GNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~--~~vkL~DFG~a~~~~~ 159 (481)
|||||||++ +|++++.+....|++.+++.|++||+.||+|||+++|+||||||+||||+.+ +.+||+|||+|+.+..
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999985 7888887766789999999999999999999999999999999999999864 7899999999987653
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.......+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+++.+|...........
T Consensus 310 --~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------- 379 (573)
T 3uto_A 310 --KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA------- 379 (573)
T ss_dssp --TSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG-------
T ss_pred --CCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc-------
Confidence 344556789999999999987 6789999999999999999999999999999999999876543333222
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 301 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~~~ 301 (481)
+..+++++++||++||..||++|+|+.|||+||||+....+..
T Consensus 380 -------------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 380 -------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp -------------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred -------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence 2357889999999999999999999999999999987655443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=415.38 Aligned_cols=243 Identities=18% Similarity=0.269 Sum_probs=195.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++. ..||||+++...........+.+|+.+|++|+|||||++++++.+ +.+
T Consensus 47 G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----------------~~~ 106 (307)
T 3omv_A 47 GSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-----------------DNL 106 (307)
T ss_dssp CSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----------------SSC
T ss_pred CCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-----------------CeE
Confidence 899999999864 359999998665544456678899999999999999999998753 357
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||++ +|.+++......+++.++..|+.||+.||+|||+++||||||||+||||++++++||+|||+|+......
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999985 7888887766789999999999999999999999999999999999999999999999999998764322
Q ss_pred -CCccccccccccCCCchhhcCC--CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 162 -NNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 162 -~~~~~~~~gt~~Y~aPEvl~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.......+||+.|||||++.+. ..|+.++||||||||||||+||+.||.+.+....+..++......+. ..
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-----~~- 260 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-----LS- 260 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-----ST-
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-----cc-
Confidence 2344556899999999999742 35899999999999999999999999987776666555443211110 00
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.....++.++.+||.+||+.||++|||+.||++
T Consensus 261 ------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 261 ------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp ------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 112347789999999999999999999998864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=407.63 Aligned_cols=275 Identities=44% Similarity=0.819 Sum_probs=233.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++. +++.||||+++...........+.+|+.++++|+|+||+++++++.+ ...+
T Consensus 32 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~ 94 (311)
T 3niz_A 32 GTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS----------------ERCL 94 (311)
T ss_dssp CSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC----------------SSCE
T ss_pred CCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc----------------CCEE
Confidence 899999999995 59999999998776555556778899999999999999999999987 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|||||||+++|.+.+......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+... .
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~ 173 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-V 173 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-C
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-c
Confidence 999999999999988887777999999999999999999999999999999999999999999999999999876432 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
......++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+.+++...+.+....|+....++.+
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 33444578999999999987667899999999999999999999999999999999999999999988888877665443
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...................++.++++||++||..||++|||++|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 32222222233445566778999999999999999999999999999999964
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=412.56 Aligned_cols=240 Identities=24% Similarity=0.355 Sum_probs=193.6
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|++. .+++.||||+++... ......+.+|+++|++|+|||||++++++.+
T Consensus 52 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--------------- 114 (329)
T 4aoj_A 52 GAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTE--------------- 114 (329)
T ss_dssp CSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---------------
T ss_pred CCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---------------
Confidence 899999999864 478999999997543 2235678899999999999999999999987
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRP--------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 142 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~--------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~ 142 (481)
.+.+|||||||++ +|.+++.+. ...+++.++..|+.||+.||+|||+++||||||||+||||+.
T Consensus 115 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 115 -GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 5679999999985 777766542 235899999999999999999999999999999999999999
Q ss_pred CCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011627 143 EGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSK 220 (481)
Q Consensus 143 ~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~ 220 (481)
++++||+|||+|+.+..... ...+..++|+.|||||++.+ ..|+.++||||||||||||+| |+.||...+..+.+..
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999987643322 23344678999999999987 679999999999999999998 8999999999888888
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 221 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
+.+...... ...+++++.+||.+||+.||++|||++||+++
T Consensus 273 i~~g~~~~~-----------------------------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGRELER-----------------------------PRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCCCCC-----------------------------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCCCC-----------------------------cccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 765321110 12467889999999999999999999999853
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=409.60 Aligned_cols=238 Identities=24% Similarity=0.366 Sum_probs=198.3
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|++. .+++.||||+++.... .....+.+|+++|++|+|||||++++++.+
T Consensus 24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--------------- 86 (299)
T 4asz_A 24 GAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVE--------------- 86 (299)
T ss_dssp --CCCEEEEEECSCC----CEEEEEEEECSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECS---------------
T ss_pred CCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh--HHHHHHHHHHHHHHhCCCCCCccEEEEEee---------------
Confidence 899999999875 4688999999975432 235678899999999999999999999987
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRP------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 144 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~ 144 (481)
.+.+|||||||++ +|.+++.+. ...+++.++..|+.||+.||+|||+++||||||||+||||+.++
T Consensus 87 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 87 -GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 5689999999985 777777542 34699999999999999999999999999999999999999999
Q ss_pred CeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011627 145 NLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 222 (481)
Q Consensus 145 ~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 222 (481)
++||+|||+|+........ .....++|+.|||||++.+ ..|+.++||||||||||||+| |+.||.+.+..+++..+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999866433222 2233468999999999987 679999999999999999998 899999999998888886
Q ss_pred HhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHh
Q 011627 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288 (481)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL 288 (481)
+...... ...+++++.+||.+||+.||++|||++||+
T Consensus 245 ~~~~~~~-----------------------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 245 QGRVLQR-----------------------------PRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCCC-----------------------------CccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 5321110 124678899999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=441.97 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=200.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHH---HHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIRE---IKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~E---i~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|+++.||+.||||++++... .......+.+| +.+++.++|||||+++++|++
T Consensus 200 G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~---------------- 263 (689)
T 3v5w_A 200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---------------- 263 (689)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----------------
T ss_pred ccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----------------
Confidence 8999999999999999999999976532 11222333444 566677789999999999998
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
.+.+|||||||.| +|..++.+. ..|++..++.|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 6789999999986 677766543 46999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCCCCCc
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 234 (481)
.. ....+.+||+.|||||++.....|+.++||||||||||||++|++||.+.+. .++...+......
T Consensus 343 ~~---~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~------- 412 (689)
T 3v5w_A 343 SK---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 412 (689)
T ss_dssp SS---CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC-------
T ss_pred CC---CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC-------
Confidence 53 2345579999999999997546799999999999999999999999976432 3334444321100
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
++..+++++++||.+||..||++|++ ++||++||||+.
T Consensus 413 -----------------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 413 -----------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred -----------------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 11247889999999999999999998 799999999964
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=406.46 Aligned_cols=241 Identities=23% Similarity=0.317 Sum_probs=200.7
Q ss_pred cceeEEEEEEE-----ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE-----IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|+. ..+++.||||+++.... ......+.+|+.++++|+|||||++++++.+
T Consensus 37 G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--------------- 100 (308)
T 4gt4_A 37 DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTK--------------- 100 (308)
T ss_dssp CSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS---------------
T ss_pred CCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE---------------
Confidence 89999999985 35778999999975533 3345678999999999999999999999987
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~ 141 (481)
.+.+|||||||++ +|.+++... ...+++.++..|+.||+.||+|||+++||||||||+||||+
T Consensus 101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 5578999999985 787777542 23589999999999999999999999999999999999999
Q ss_pred CCCCeEEecccccccccCCC-CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011627 142 NEGNLKLADFGLARSFSYDH-NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLS 219 (481)
Q Consensus 142 ~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~ 219 (481)
+++++||+|||+|+.+.... ....+..++|+.|||||++.+ ..|+.++||||||||||||+| |+.||.+.+..+++.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999998764332 233455688999999999986 679999999999999999998 899999999988888
Q ss_pred HHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 220 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+......+. ...++.++.+||.+||+.||++|||++||+++
T Consensus 259 ~i~~~~~~~~-----------------------------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLPC-----------------------------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCC-----------------------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7754221110 12467789999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=398.06 Aligned_cols=275 Identities=42% Similarity=0.772 Sum_probs=236.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...........+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 13 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 76 (292)
T 3o0g_A 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----------------DKKL 76 (292)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe----------------CCEE
Confidence 899999999999999999999998876666566788899999999999999999999987 6789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||++++++..+......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+... .
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 155 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-V 155 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-C
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-c
Confidence 999999999999988877778999999999999999999999999999999999999999999999999999876432 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
......++|+.|+|||++.+...++.++||||||||+|+|++|..| |...+..+.+..+++..+.+....|+.....+.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 3344567799999999998755689999999999999999987655 788888999999999999999988888776655
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+....... ...........++.++++||++||+.||++|||++|+|+||||..
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 236 YKPYPMYP-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCC-TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccccccc-CCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 44332211 112223344568899999999999999999999999999999964
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=403.27 Aligned_cols=291 Identities=51% Similarity=0.916 Sum_probs=242.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.++++|+|+||+++++++....... ....+.+
T Consensus 28 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~--------~~~~~~~ 99 (351)
T 3mi9_A 28 GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY--------NRCKGSI 99 (351)
T ss_dssp CSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----------------CEE
T ss_pred CCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc--------ccCCceE
Confidence 89999999999999999999999877666666778889999999999999999999998743211 1125679
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC--
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-- 160 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-- 160 (481)
|||||||+++|...+......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 100 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 179 (351)
T 3mi9_A 100 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179 (351)
T ss_dssp EEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSS
T ss_pred EEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccccc
Confidence 999999999999988887778999999999999999999999999999999999999999999999999999876432
Q ss_pred -CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 -HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 -~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+...++......|+.....
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 259 (351)
T 3mi9_A 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259 (351)
T ss_dssp SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccc
Confidence 2233455678999999999987667899999999999999999999999999999999999999999988888877655
Q ss_pred CccccCCCchhhhhhHHHHHh--hhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFR--HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 301 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~~~ 301 (481)
..+................+. ..++++++||.+||..||++|+|++|+|+|+||+..+.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 260 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp GGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred hhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 444433332222222222222 35788999999999999999999999999999988766543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=394.27 Aligned_cols=274 Identities=45% Similarity=0.814 Sum_probs=229.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++ .+++.||||+++...........+.+|+.++++|+|+||+++++++.+ .+.+
T Consensus 13 G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 75 (288)
T 1ob3_A 13 GTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----------------KKRL 75 (288)
T ss_dssp ETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----------------SSCE
T ss_pred CCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc----------------CCeE
Confidence 89999999999 789999999998776555556778899999999999999999999987 5689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++|.+++......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+... .
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 154 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-V 154 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-c
Confidence 999999999999888877678999999999999999999999999999999999999999999999999999876432 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
......++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+.++++..+.+....|+.....+.+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 23344577999999999987566899999999999999999999999999999999999999888888888876654443
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....... ...........++.++++||++||..||++|||++|+|+|+||+.
T Consensus 235 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 235 DPNFTVY-EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CTTCCCC-CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccc-cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 2211100 011122334568899999999999999999999999999999964
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=397.29 Aligned_cols=274 Identities=43% Similarity=0.827 Sum_probs=228.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++.... ......+.+|+.++++|+|+||+++++++.+ .+.+
T Consensus 16 G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~ 78 (317)
T 2pmi_A 16 GTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT----------------ENKL 78 (317)
T ss_dssp ---CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC----------------TTEE
T ss_pred CCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE----------------CCeE
Confidence 8999999999999999999999986643 2345678899999999999999999999987 6689
Q ss_pred EEEEecCCCChhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 83 YMVFEYMDHDLTGLADRP-----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~-----~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
||||||++++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+
T Consensus 79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 999999999888776542 235899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
... .......++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+++..+.+....|+...
T Consensus 159 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIP-VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSC-CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCC-cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 432 2234456789999999999875678999999999999999999999999999999999999999999999998877
Q ss_pred CCCccccCCCchhhhhhHHH-----HHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVRE-----VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.++.+........ ...+.. ....++.++++||.+||..||++|||++|+|+||||..
T Consensus 238 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 238 KLPKYNPNIQQRP-PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp GCTTCCTTCCCCC-CCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhhccccccccc-chhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 6655432211110 111111 12357889999999999999999999999999999964
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=400.91 Aligned_cols=276 Identities=43% Similarity=0.790 Sum_probs=225.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...........+.+|+.++++|+|+||+++++++.+ ...+
T Consensus 45 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 108 (329)
T 3gbz_A 45 GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH----------------NHRL 108 (329)
T ss_dssp CSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE----------------TTEE
T ss_pred cCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec----------------CCEE
Confidence 899999999999999999999998776555555677899999999999999999999987 6789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-----CCCCeEEecccccccc
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-----NEGNLKLADFGLARSF 157 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~-----~~~~vkL~DFG~a~~~ 157 (481)
||||||++++|.+++.... .+++.+++.|+.||+.||+|||+++|+||||||+||||+ .++.+||+|||+++.+
T Consensus 109 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 9999999999888877654 599999999999999999999999999999999999995 4445999999999876
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
... .......++|+.|+|||++.+...++.++||||||||+|+|++|+.||...+..+.+.++++..+.+....|+...
T Consensus 188 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 188 GIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred CCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 432 2334455779999999999875668999999999999999999999999999999999999999999988888777
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
..+.+....+..........+...++.++++||.+||..||++|||++|+|+||||...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 66554433332222222333445689999999999999999999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=397.65 Aligned_cols=281 Identities=42% Similarity=0.756 Sum_probs=237.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC---CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK---EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..+++.||||+++..... ......+.+|+.++++|+|+||+++++++.+ .
T Consensus 21 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~ 84 (346)
T 1ua2_A 21 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----------------K 84 (346)
T ss_dssp ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----------------T
T ss_pred cCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee----------------C
Confidence 89999999999999999999999764322 2234577899999999999999999999976 5
Q ss_pred CeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 80 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
..+||||||++++|...+......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 85 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 85 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 67899999999999888887777799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......++|+.|+|||++.+...++.++||||||||+|+|++|.+||.+.+..+.+.++++..+.+....|+.....
T Consensus 165 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 165 P-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp C-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred C-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 2 233445678999999999976566899999999999999999999999999999999999999999999999888776
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 302 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~~~~ 302 (481)
+.+..+.... ......++..++.++++||.+||..||++|||++|+|+|+||...+.+...
T Consensus 244 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~ 304 (346)
T 1ua2_A 244 PDYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 304 (346)
T ss_dssp TTCCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred cccccccccC--CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCc
Confidence 6654433221 122445667789999999999999999999999999999999876655443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=401.11 Aligned_cols=276 Identities=41% Similarity=0.762 Sum_probs=227.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...... ....+.+|+.++++++|+||+++++++.+ ...+
T Consensus 13 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 75 (324)
T 3mtl_A 13 GTYATVYKGKSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHT----------------EKSL 75 (324)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC----------------SSCE
T ss_pred CCCEEEEEEEECCCCcEEEEEEEecccccc-cchhHHHHHHHHHhcCCCCCCeeeeEEee----------------CCEE
Confidence 899999999999999999999997654322 22244579999999999999999999987 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||++++|.+++......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... .
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~ 154 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-T 154 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-c
Confidence 999999999999988877777999999999999999999999999999999999999999999999999999765422 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
......++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+....+.+....|+.......+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 33444577999999999987667899999999999999999999999999999999999999999998888876544332
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...................++.++++||.+||+.||++|||++|+|+||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 222222222333445566789999999999999999999999999999999653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=388.17 Aligned_cols=278 Identities=41% Similarity=0.716 Sum_probs=230.5
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCC---cCCCcchhHHHHHHHHHhcC---CCCccceeeEEeCCCCCCCCCCCCCC
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPDG 75 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~~~~~~~~~ 75 (481)
-|+||+||+|++..+++.||||+++... ........+.+|+.++++|+ |+||+++++++.....
T Consensus 19 ~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~---------- 88 (308)
T 3g33_A 19 VGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT---------- 88 (308)
T ss_dssp CSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS----------
T ss_pred cCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC----------
Confidence 3899999999999999999999997653 22233456778888888775 9999999999987321
Q ss_pred CCcCCeEEEEEecCCCChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 76 NKYRGSTYMVFEYMDHDLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 76 ~~~~~~~~iV~Ey~~g~L~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
.....++|||||++++|.+++..... .+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++
T Consensus 89 -~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 89 -DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp -SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred -CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 11336899999999999888876543 4999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 155 RSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 155 ~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
+.+.. .......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+.++++..+.+....|+
T Consensus 168 ~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSY--QMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTT--CCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCC--CcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 86642 233455678999999999987 578999999999999999999999999999999999999999999888888
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
....++..... ....+........++.++++||.+||..||++|||+.|+|+|+||...
T Consensus 245 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFP---PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSC---CCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccC---CCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 76554432111 112234455667899999999999999999999999999999999653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=392.56 Aligned_cols=245 Identities=28% Similarity=0.473 Sum_probs=211.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 26 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----------------~~~~ 89 (328)
T 3fe3_A 26 GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET----------------EKTL 89 (328)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----------------CCEE
Confidence 899999999999999999999998765444445678899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.+ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++++||+|||++..+..
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 166 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-- 166 (328)
T ss_dssp EEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred EEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence 999999975 666666543 4699999999999999999999999999999999999999999999999999986643
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++|+.|+|||++.+....+.++||||||||+|+|++|+.||.+.+..+...++.......+
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p------------ 234 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP------------ 234 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence 23455678899999999998754456899999999999999999999999998888888765321111
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
..++.++.+||++||..||++|||++|||+|+||...
T Consensus 235 ------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 235 ------------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp ------------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred ------------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 1367789999999999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=416.12 Aligned_cols=282 Identities=36% Similarity=0.594 Sum_probs=213.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||++............+.+|+.+|++|+|+|||++++++..... .....+
T Consensus 64 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----------~~~~~~ 132 (458)
T 3rp9_A 64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV-----------EKFDEL 132 (458)
T ss_dssp ----CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT-----------TTCCCE
T ss_pred cCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc-----------ccCceE
Confidence 899999999999999999999997654444445678899999999999999999999976321 124579
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||++++|..++... ..+++..++.|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 133 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 211 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211 (458)
T ss_dssp EEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred EEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence 999999999988887654 4699999999999999999999999999999999999999999999999999987643211
Q ss_pred --------------------------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-----------C
Q 011627 163 --------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-----------G 205 (481)
Q Consensus 163 --------------------------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-----------G 205 (481)
...+..++|+.|+|||++.....++.++||||||||||||++ +
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~ 291 (458)
T 3rp9_A 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291 (458)
T ss_dssp CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGC
T ss_pred cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccc
Confidence 234556889999999988665679999999999999999998 7
Q ss_pred CCCCCCCC--------------------hHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCCCchhhhhhHHHHHhhhc
Q 011627 206 KPILPGKN--------------------EAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFKPSRTMKRRVREVFRHFD 263 (481)
Q Consensus 206 ~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 263 (481)
+++|.+.+ ..+++..|++.++.+....+........ +....+ ......+...+..++
T Consensus 292 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP-KREGTDLAERFPASS 370 (458)
T ss_dssp CCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSC-CCCCCCGGGGSTTSC
T ss_pred cccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcC-CCCCCCHHHHCCCCC
Confidence 88887765 3577888888888776544433221000 000000 001112333455679
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 264 RHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 264 ~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
.++++||++||..||++|+|++|+|+||||....
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 9999999999999999999999999999997643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=400.93 Aligned_cols=243 Identities=22% Similarity=0.363 Sum_probs=197.4
Q ss_pred cceeEEEEEEEccCC-----cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCC-CCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG-----EIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~h-pnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++..++ +.||||+++..... .....+++|+++|++|+| ||||+++++|.+.
T Consensus 75 G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~-~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~------------- 140 (353)
T 4ase_A 75 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP------------- 140 (353)
T ss_dssp CSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-------------
T ss_pred CCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh-HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-------------
Confidence 899999999986544 68999999755332 234568899999999976 8999999998652
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 140 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl 140 (481)
.+.+|||||||++ +|.+++... ...+++.++..|+.||+.||+|||+++||||||||+||||
T Consensus 141 --~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 141 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 218 (353)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence 3468999999985 777776532 2348999999999999999999999999999999999999
Q ss_pred cCCCCeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 011627 141 DNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQL 218 (481)
Q Consensus 141 ~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~ 218 (481)
++++++||+|||+|+.+...... .....++|+.|||||++.+ ..|+.++||||||||||||+| |+.||.+.+..+.+
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999876543322 3345678999999999987 679999999999999999998 99999987755555
Q ss_pred HHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 219 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+++.....+. ....+++++.+||.+||+.||++|||++||++|
T Consensus 298 ~~~i~~g~~~~----------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKEGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44443221111 012467789999999999999999999999976
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=413.37 Aligned_cols=277 Identities=30% Similarity=0.497 Sum_probs=217.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.+|+.++|+|||+++++|...... .....+
T Consensus 73 G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~----------~~~~~~ 142 (464)
T 3ttj_A 73 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----------EEFQDV 142 (464)
T ss_dssp CSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST----------TTCCEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc----------ccCCeE
Confidence 8999999999999999999999986644444556788999999999999999999999764211 124578
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|||||||++++...+.. .+++..++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.... .
T Consensus 143 ~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~ 217 (464)
T 3ttj_A 143 YLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 217 (464)
T ss_dssp EEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-------C
T ss_pred EEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC--C
Confidence 99999999998887754 489999999999999999999999999999999999999999999999999987642 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC----
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK---- 238 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---- 238 (481)
...+..++|+.|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+..+++.+|++.++.+....|.....
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 34456788999999999987 5789999999999999999999999999999999999999888776544432211
Q ss_pred ----CCccccCCCchh----hhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 ----MPAYNHFKPSRT----MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ----~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+.+........ .........+..+.++++||++||..||++|+|++|+|+||||..
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 000000000000 000001122334778999999999999999999999999999964
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=404.86 Aligned_cols=277 Identities=35% Similarity=0.577 Sum_probs=214.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++............+.+|+.+++++. |+||+++++++.... ...
T Consensus 20 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--------------~~~ 85 (388)
T 3oz6_A 20 GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN--------------DRD 85 (388)
T ss_dssp ----CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT--------------SSC
T ss_pred CCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC--------------CCE
Confidence 89999999999999999999999765444444567789999999997 999999999998632 447
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC-
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD- 160 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~- 160 (481)
+|||||||+++|..++... .+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 86 ~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEEECCSEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEecccCcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 9999999999988887653 6899999999999999999999999999999999999999999999999999865321
Q ss_pred -------------------CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 011627 161 -------------------HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 221 (481)
Q Consensus 161 -------------------~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 221 (481)
.....+..++|+.|+|||++.+...++.++||||||||+|||++|++||.+.+..+++.+|
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1223445688999999999987667899999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCccCCCCCc--------------cccCCCchhhhhh-HHH--HHhhhcHHHHHHHHHhcccCCCCCCCH
Q 011627 222 FELCGSPDETIWPGVSKMPA--------------YNHFKPSRTMKRR-VRE--VFRHFDRHALELLEKMLMLDPSQRISA 284 (481)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~-~~~--~~~~~~~~~~~ll~~~L~~dP~~R~sa 284 (481)
+...+.+....+.....-.. ...+......... ... ....++.++++||++||..||++|+|+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 98887766543332211000 0000000000000 000 012578899999999999999999999
Q ss_pred HHHhcCCCCCC
Q 011627 285 KDALDSEYFWT 295 (481)
Q Consensus 285 ~eiL~h~~f~~ 295 (481)
+|+|+||||..
T Consensus 324 ~e~l~Hp~~~~ 334 (388)
T 3oz6_A 324 NDALKHPFVSI 334 (388)
T ss_dssp HHHTTSTTTTT
T ss_pred HHHhCCHHHHH
Confidence 99999999954
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=391.48 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=212.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC----cchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG----FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~----~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|+++.+++.||||+++....... ....+.+|+.+|++|+||||+++++++.+
T Consensus 23 G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---------------- 86 (361)
T 2yab_A 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN---------------- 86 (361)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------
T ss_pred CcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----------------
Confidence 8999999999999999999999987643321 34567899999999999999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC----CeEEecccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKLADFGL 153 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~----~vkL~DFG~ 153 (481)
...+|||||||.+ +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 6689999999975 66666654 45799999999999999999999999999999999999998877 799999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
++.+.. .......++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..+........
T Consensus 166 a~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 238 (361)
T 2yab_A 166 AHEIED--GVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD---- 238 (361)
T ss_dssp CEECCT--TCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC----
T ss_pred ceEcCC--CCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence 987643 233455688999999999976 6789999999999999999999999999999888888865322111
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...+..++.++++||.+||..||++|||+.|+|+||||..
T Consensus 239 ----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 239 ----------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp ----------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ----------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 2345578889999999999999999999999999999963
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=406.09 Aligned_cols=282 Identities=33% Similarity=0.560 Sum_probs=221.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++...........+.+|+.+|++|+|+||+++++++..... .....+
T Consensus 37 G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----------~~~~~~ 105 (432)
T 3n9x_A 37 GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL-----------LKFDEL 105 (432)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT-----------TTCCCE
T ss_pred cCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC-----------CcCCeE
Confidence 899999999999999999999998654444445678899999999999999999999976321 113579
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||++++|..++... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 106 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 184 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184 (432)
T ss_dssp EEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred EEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence 999999999998887654 4699999999999999999999999999999999999999999999999999987653321
Q ss_pred ---------------------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-----------CCCCCC
Q 011627 163 ---------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-----------GKPILP 210 (481)
Q Consensus 163 ---------------------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-----------G~~pf~ 210 (481)
...+..++|+.|+|||++.....++.++||||||||+|||++ ++++|.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~ 264 (432)
T 3n9x_A 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264 (432)
T ss_dssp --------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCC
T ss_pred ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCC
Confidence 234667889999999997665779999999999999999998 566676
Q ss_pred CCC-----------------hHHHHHHHHHhcCCCCCCCCccCCCCCccccCC-CchhhhhhHHHHHhhhcHHHHHHHHH
Q 011627 211 GKN-----------------EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PSRTMKRRVREVFRHFDRHALELLEK 272 (481)
Q Consensus 211 ~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~ 272 (481)
+.+ ..+++..|++.++.+....+............. ............+..+++++++||++
T Consensus 265 g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 344 (432)
T 3n9x_A 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344 (432)
T ss_dssp CSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred CccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence 654 467888899888887765444332210000000 00011122344556789999999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q 011627 273 MLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 273 ~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
||..||++|+|++|+|+||||..-
T Consensus 345 mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 345 MLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HhcCCcccCCCHHHHhcChhhhhc
Confidence 999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=398.66 Aligned_cols=281 Identities=37% Similarity=0.683 Sum_probs=214.3
Q ss_pred cceeEEEEEEEc--cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREI--KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++ .+++.||||++.... ....+.+|+.+|++|+|+||+++++++.... ..
T Consensus 32 G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--------------~~ 93 (405)
T 3rgf_A 32 GTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA--------------DR 93 (405)
T ss_dssp ----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT--------------TT
T ss_pred cCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC--------------CC
Confidence 899999999966 578999999997443 2347889999999999999999999996522 56
Q ss_pred eEEEEEecCCCChhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----cCCCCeEE
Q 011627 81 STYMVFEYMDHDLTGLADR--------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKL 148 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~--------~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl----~~~~~vkL 148 (481)
.+||||||++++|+.++.. ....+++..++.|+.||+.||+|||+++|+||||||+|||| +.++.+||
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 94 KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred eEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 8999999999998877652 22249999999999999999999999999999999999999 67789999
Q ss_pred ecccccccccCCC--CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh---------HHH
Q 011627 149 ADFGLARSFSYDH--NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQ 217 (481)
Q Consensus 149 ~DFG~a~~~~~~~--~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---------~~~ 217 (481)
+|||+|+.+.... .......++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+. .+.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 9999998765321 13344567899999999998756689999999999999999999999987665 488
Q ss_pred HHHHHHhcCCCCCCCCccCCCCCccccC----CCchhhh----hhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 218 LSKIFELCGSPDETIWPGVSKMPAYNHF----KPSRTMK----RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~----~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+..+++.++.+....|.....++..... ....... ..........+.++++||++||..||++|+|++|||+
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 9999999999999999877665543211 0000000 0011111223778999999999999999999999999
Q ss_pred CCCCCCCCCCCC
Q 011627 290 SEYFWTDPLPCD 301 (481)
Q Consensus 290 h~~f~~~~~~~~ 301 (481)
||||...+++..
T Consensus 334 hp~f~~~~~~~~ 345 (405)
T 3rgf_A 334 DPYFLEDPLPTS 345 (405)
T ss_dssp SGGGTSSSCCCS
T ss_pred ChhhccCCCCcc
Confidence 999988766543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=396.08 Aligned_cols=277 Identities=35% Similarity=0.578 Sum_probs=221.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.+|+.|+|+||+++++++...... .....+
T Consensus 36 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~----------~~~~~~ 105 (367)
T 1cm8_A 36 GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL----------DDFTDF 105 (367)
T ss_dssp ----CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST----------TTCCCC
T ss_pred cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc----------ccCceE
Confidence 8999999999999999999999976544444456778999999999999999999999863211 113467
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||++++|..++.. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~--- 180 (367)
T 1cm8_A 106 YLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--- 180 (367)
T ss_dssp EEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---
T ss_pred EEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc---
Confidence 99999998888887765 3589999999999999999999999999999999999999999999999999987542
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc-
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA- 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 241 (481)
..+..++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+++..|++..+.+....+........
T Consensus 181 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 181 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred -ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 244567899999999998756789999999999999999999999999999999999999888776544433221000
Q ss_pred -cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 -YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+....+ .........++..+++++++||.+||..||++|+|++|+|+||||..-
T Consensus 260 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 260 NYMKGLP-ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHSC-CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHhCC-CCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000000 000112233445678999999999999999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=384.33 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=209.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++.... .......+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 16 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----------------~~~ 79 (337)
T 1o6l_A 16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----------------HDR 79 (337)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe----------------CCE
Confidence 8999999999999999999999986531 23345678899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|...+.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+++.....
T Consensus 80 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999986 56555543 346999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||...+..+.+..+.......
T Consensus 159 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 224 (337)
T 1o6l_A 159 -GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------------ 224 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred -CCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 233455688999999999976 678999999999999999999999999998888888776421110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
...++.++++||.+||..||++|+ +++||++|+||..
T Consensus 225 ------------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 225 ------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ------------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 124678999999999999999999 9999999999954
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=387.64 Aligned_cols=247 Identities=27% Similarity=0.381 Sum_probs=211.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++...........+.+|+.++++|+||||+++++++.+ .+.+
T Consensus 40 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----------------~~~~ 103 (362)
T 2bdw_A 40 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----------------ESFH 103 (362)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----------------CCEE
Confidence 899999999999999999999998765443345677899999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~ 158 (481)
|||||||.+ +|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+++...
T Consensus 104 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999986 666666543 4699999999999999999999999999999999999998654 59999999998765
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+...........
T Consensus 183 ~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 253 (362)
T 2bdw_A 183 D--SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE------ 253 (362)
T ss_dssp T--CCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG------
T ss_pred C--CcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc------
Confidence 2 223445688999999999976 5789999999999999999999999999998888888766433222211
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+..++.++++||.+||..||++|||+.|+|+|+||..
T Consensus 254 --------------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 254 --------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp --------------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred --------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 2357889999999999999999999999999999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=396.79 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=211.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||+|++............+.+|+.++++|+||||+++++++.+ .+.+
T Consensus 22 G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----------------~~~~ 85 (444)
T 3soa_A 22 GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE----------------EGHH 85 (444)
T ss_dssp C--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC----------------SSEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE----------------CCEE
Confidence 899999999999999999999998765444345577899999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~ 158 (481)
|||||||.+ +|.+.+... ..+++.++..++.||+.||+|||+++|+||||||+||||+. ++.+||+|||+|+.+.
T Consensus 86 ~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999986 666666554 46999999999999999999999999999999999999984 5789999999997765
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. .......++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..+...........|
T Consensus 165 ~~-~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----- 237 (444)
T 3soa_A 165 GE-QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW----- 237 (444)
T ss_dssp TT-CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT-----
T ss_pred CC-CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc-----
Confidence 32 233445688999999999976 57899999999999999999999999999999988888765444333322
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..+++++++||.+||..||++|||+.|+|+||||..
T Consensus 238 ---------------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 238 ---------------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ---------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ---------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 246789999999999999999999999999999953
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=380.78 Aligned_cols=276 Identities=35% Similarity=0.586 Sum_probs=215.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 14 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 77 (311)
T 4agu_A 14 GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR----------------KRRL 77 (311)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEE
T ss_pred cCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec----------------CCeE
Confidence 899999999999999999999997665444445667799999999999999999999987 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
+|||||++++++..+......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... .
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 156 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-S 156 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-c
Confidence 999999998776666655567999999999999999999999999999999999999999999999999999876432 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
......++|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+.+.........+........+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 23345578999999999987667899999999999999999999999999999888888776554322111111000000
Q ss_pred ccCC-CchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 243 NHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.... +...........+..++.++.+||++||..||++|||++|||+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 0000 0001112233344678999999999999999999999999999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=386.05 Aligned_cols=246 Identities=21% Similarity=0.369 Sum_probs=213.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||+|++..... ....+.+|+.+++.++||||+++++++.+ ...+
T Consensus 16 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----------------~~~~ 76 (321)
T 1tki_A 16 GEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFES----------------MEEL 76 (321)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecCcc---cHHHHHHHHHHHHhCCCCCCCeEeEEEec----------------CCEE
Confidence 8999999999999999999999975432 23467799999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC--CCCeEEecccccccccC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~ 159 (481)
|||||||++ +|.+.+......+++.+++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+++.+..
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999986 788877766667999999999999999999999999999999999999987 78899999999987643
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.......++|+.|+|||++.+ ..++.++||||||||+|+|++|..||...+..+.+..+........
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------- 223 (321)
T 1tki_A 157 --GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD---------- 223 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----------
T ss_pred --CCccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC----------
Confidence 233445678999999999986 5678999999999999999999999999999888888875432211
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...+..++.++++||.+||..||++|||+.|+|+||||+..
T Consensus 224 ----------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 224 ----------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 22345688899999999999999999999999999999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=393.38 Aligned_cols=278 Identities=36% Similarity=0.576 Sum_probs=211.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.+++.|+|+||+++++++..... ......+
T Consensus 40 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----------~~~~~~~ 109 (367)
T 2fst_X 40 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS----------LEEFNDV 109 (367)
T ss_dssp ---CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS----------GGGCCCC
T ss_pred cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc----------cccCCeE
Confidence 899999999999999999999997654433345677899999999999999999999976321 1113568
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||++++|..++.. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 110 ~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~--- 184 (367)
T 2fst_X 110 YLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--- 184 (367)
T ss_dssp EEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------------
T ss_pred EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc---
Confidence 99999998888877765 4699999999999999999999999999999999999999999999999999986542
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc-
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA- 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 241 (481)
.....++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..|++..+.+....+..+.....
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 185 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred -cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 234567899999999998756789999999999999999999999999999999999999888876555443322100
Q ss_pred -cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 242 -YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
+..... ..........+..+++++++||.+||..||++|+|+.|+|+||||....
T Consensus 264 ~~~~~~~-~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 264 NYIQSLT-QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHHTSC-CCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHhccC-CCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 000000 0011233455667889999999999999999999999999999997643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=389.84 Aligned_cols=244 Identities=25% Similarity=0.414 Sum_probs=204.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++.+++.||||+++... ........+.+|+.+++.+ +|+||+++++++.+ .+
T Consensus 34 G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----------------~~ 97 (353)
T 3txo_A 34 GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT----------------PD 97 (353)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SS
T ss_pred CCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe----------------CC
Confidence 899999999999999999999998652 1223455678999999998 79999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|||||||.+ +|..++.+. ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 89999999986 666655543 4699999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........+||+.|+|||++.+ ..++.++||||||||+|||++|+.||...+..+++.+|.......+
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p---------- 244 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP---------- 244 (353)
T ss_dssp ----------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred -CCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 2233445688999999999986 5789999999999999999999999999999999988876321111
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa------~eiL~h~~f~~ 295 (481)
..++.++++||++||..||++|+++ +||++||||..
T Consensus 245 --------------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 245 --------------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp --------------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred --------------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 1367789999999999999999999 89999999954
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=373.23 Aligned_cols=244 Identities=25% Similarity=0.436 Sum_probs=208.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++...... ....+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 31 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~ 92 (297)
T 3fxz_A 31 GASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV----------------GDEL 92 (297)
T ss_dssp ETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEE----------------CCEE
Confidence 89999999999999999999999865433 24567899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||.+ +|.+++... .+++.+++.++.||+.||+|||+++|+||||||+||||+.++++||+|||++.......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999975 666666543 58999999999999999999999999999999999999999999999999998765332
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
......++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+.........
T Consensus 171 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 237 (297)
T 3fxz_A 171 -SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ----------- 237 (297)
T ss_dssp -CCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-----------
T ss_pred -cccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-----------
Confidence 23445678999999999987 67899999999999999999999999998888777766543211100
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....++..+++||.+||..||++|||++|+|+|+||+.
T Consensus 238 ----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 238 ----------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp ----------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred ----------------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 01247788999999999999999999999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=376.18 Aligned_cols=247 Identities=28% Similarity=0.409 Sum_probs=210.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC----CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|+++.+++.||||+++...... .....+.+|+.+|++|+|+||+++++++.+
T Consensus 22 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---------------- 85 (326)
T 2y0a_A 22 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---------------- 85 (326)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe----------------
Confidence 899999999999999999999998664322 134567899999999999999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC----CeEEecccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKLADFGL 153 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~----~vkL~DFG~ 153 (481)
...+|||||||.+ +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 6689999999975 66666654 45699999999999999999999999999999999999999887 799999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
++.+... ......++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..+.......
T Consensus 165 a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 236 (326)
T 2y0a_A 165 AHKIDFG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF----- 236 (326)
T ss_dssp CEECCTT--SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC-----
T ss_pred CeECCCC--CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc-----
Confidence 9876432 23445678999999999976 578999999999999999999999999998888888776532111
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....+..++.++++||++||..||++|||+.|+|+|+||+.
T Consensus 237 ---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 237 ---------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred ---------------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 12334567889999999999999999999999999999964
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=377.13 Aligned_cols=241 Identities=24% Similarity=0.394 Sum_probs=208.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++.... .......+.+|+.+++.++||||+++++++.+ ...
T Consensus 17 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----------------~~~ 80 (318)
T 1fot_A 17 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----------------AQQ 80 (318)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----------------SSE
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe----------------CCE
Confidence 8999999999999999999999986532 22345567899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 9999999986 676666543 4699999999999999999999999999999999999999999999999999986542
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.....++|+.|+|||++.+ ..++.++||||||||+|||++|+.||...+..+.+.++.......
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------------ 222 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF------------ 222 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC------------
T ss_pred ---ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------
Confidence 2334678999999999986 678999999999999999999999999999888888887532110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
...++.++++||.+||..||++|+ +++||++||||..
T Consensus 223 ------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 223 ------------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred ------------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 023678899999999999999999 9999999999964
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=394.01 Aligned_cols=273 Identities=32% Similarity=0.551 Sum_probs=215.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++..... ...+|+++|++|+|+|||+++++|...... .....+
T Consensus 65 G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~----------~~~~~~ 128 (420)
T 1j1b_A 65 GSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK----------KDEVYL 128 (420)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETT----------TTEEEE
T ss_pred CCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCC----------CcceeE
Confidence 8999999999999999999999975422 223799999999999999999998652210 113457
Q ss_pred EEEEecCCCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCeEEeccccccccc
Q 011627 83 YMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~ 158 (481)
+|||||+.+++...+. .....+++..++.|+.||+.||+|||+++|+||||||+||||+.+ +.+||+|||+|+.+.
T Consensus 129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 8999999998766554 345579999999999999999999999999999999999999965 568999999998764
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. ......++|+.|+|||++.+...++.++||||||||||||++|+.||.+.+..+.+.++++..+.+....|.....
T Consensus 209 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 209 RG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp TT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 32 2334567899999999998756789999999999999999999999999999999999998877665433322211
Q ss_pred CCccccCCCchhhhhhHHH-HHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVRE-VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+..+.........+.. +...++.++++||.+||..||++|+|+.|+|+|+||..
T Consensus 287 --~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 287 --NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp --CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred --hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 11111111111111122 22457889999999999999999999999999999954
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=374.65 Aligned_cols=249 Identities=31% Similarity=0.453 Sum_probs=202.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++....... ....+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----------------~~~~ 80 (323)
T 3tki_A 18 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRRE----------------GNIQ 80 (323)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEE
T ss_pred CCCEEEEEEEECCCCcEEEEEEEEcccccc-hHHHHHHHHHHHHhCCCCCCCeEEEEEec----------------CCeE
Confidence 899999999999999999999997654322 33567899999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||.+ +|.+.+. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+....
T Consensus 81 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999987 5666554 44569999999999999999999999999999999999999999999999999998654322
Q ss_pred -CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 -NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 -~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......++|+.|+|||++.+...++.++||||||||+|+|++|+.||...+...............
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------ 227 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------ 227 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT------------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc------------
Confidence 2233456789999999999875445788999999999999999999998766543322222111000
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...+..++.++++||.+||..||++|||++|||+|+||...
T Consensus 228 ---------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 228 ---------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp ---------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ---------------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 01124578899999999999999999999999999999653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=383.43 Aligned_cols=276 Identities=32% Similarity=0.611 Sum_probs=217.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.++++++|+||+++++++.+ ...+
T Consensus 36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 99 (331)
T 4aaa_A 36 GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK----------------KKRW 99 (331)
T ss_dssp GTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEE
T ss_pred cCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec----------------CCEE
Confidence 899999999999999999999997665444445567799999999999999999999987 6789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||++++++..+......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+... .
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 178 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-G 178 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC-c
Confidence 999999998877766655567999999999999999999999999999999999999999999999999999765432 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
......++|..|+|||++.+...++.++||||||||+|+|++|+.||...+..+.+..+....+......+......+.+
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 23344578999999999987557899999999999999999999999999999988888776654332211111111110
Q ss_pred ccCC-CchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 243 NHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.... +...........+..++.++.+||.+||..||++|||++|||+|+||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0000 0011112233445678999999999999999999999999999999954
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=385.06 Aligned_cols=244 Identities=24% Similarity=0.386 Sum_probs=200.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++.+++.||||++++... .......+.+|+.+|+++ +||||++++++|.+ ..
T Consensus 63 G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----------------~~ 126 (396)
T 4dc2_A 63 GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----------------ES 126 (396)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC----------------SS
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE----------------CC
Confidence 8999999999999999999999986632 233445678999999887 89999999999987 67
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|||||||.+ +|...+.+ ...+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 89999999986 56555554 34699999999999999999999999999999999999999999999999999975332
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhcCCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---------EAEQLSKIFELCGSPDE 230 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~---------~~~~~~~i~~~~~~~~~ 230 (481)
........+||+.|+|||++.+ ..++.++||||||||+|||++|+.||.... .......+......
T Consensus 206 -~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--- 280 (396)
T 4dc2_A 206 -PGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--- 280 (396)
T ss_dssp -TTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC---
T ss_pred -CCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC---
Confidence 2334456789999999999987 678999999999999999999999996432 22233333321100
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDSEYFWT 295 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa------~eiL~h~~f~~ 295 (481)
+...++.++++||++||+.||++|+++ +||++||||..
T Consensus 281 ---------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 281 ---------------------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp ---------------------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred ---------------------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 112477899999999999999999985 89999999954
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=370.62 Aligned_cols=248 Identities=28% Similarity=0.391 Sum_probs=199.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC------------------------CcchhHHHHHHHHHhcCCCCccceee
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE------------------------GFPITAIREIKILKKLQHENVIKLKE 58 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~------------------------~~~~~~~~Ei~il~~L~hpnIv~l~~ 58 (481)
|+||+||+|++..+++.||||+++...... .....+.+|+.++++|+|+||+++++
T Consensus 24 G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 103 (298)
T 2zv2_A 24 GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVE 103 (298)
T ss_dssp --CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 899999999999999999999997653211 12356789999999999999999999
Q ss_pred EEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 59 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
++.+.. ...+||||||++++.+..+.. ...+++.+++.++.||+.||+|||+++|+||||||+||
T Consensus 104 ~~~~~~--------------~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 104 VLDDPN--------------EDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp EEECSS--------------SSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred EEEcCC--------------CCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 998632 568999999998644333332 24699999999999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCCCccccccccccCCCchhhcCCCC--CCCCCchhhHHHHHHHHHhCCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~--~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 216 (481)
||+.++.+||+|||+++.+... .......++|+.|+|||++.+... ++.++||||||||+|+|++|+.||...+...
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGS-DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSS-SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EECCCCCEEEecCCCccccccc-cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 9999999999999999876532 223345678999999999876332 4678999999999999999999999888777
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
....+......... ...++.++.+||.+||..||++|||+.|||+||||+
T Consensus 248 ~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 248 LHSKIKSQALEFPD----------------------------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHCCCCCCS----------------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHhcccCCCCC----------------------------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 66666542211100 023677899999999999999999999999999984
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=389.98 Aligned_cols=250 Identities=25% Similarity=0.299 Sum_probs=210.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++... ........+.+|+.+++.++|+||++++++|.+ ...
T Consensus 80 G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----------------~~~ 143 (410)
T 3v8s_A 80 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD----------------DRY 143 (410)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE----------------CCE
Confidence 899999999999999999999997642 122234567899999999999999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+...
T Consensus 144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999975 77776654 35899999999999999999999999999999999999999999999999999876544
Q ss_pred CCCccccccccccCCCchhhcCCC---CCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGAT---KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~---~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
........+||+.|+|||++.+.. .++.++||||||||+|||++|+.||.+.+..+.+.+|...........
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~----- 296 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD----- 296 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT-----
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC-----
Confidence 333445678999999999998632 178899999999999999999999999999998888875321110000
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTD 296 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~sa~eiL~h~~f~~~ 296 (481)
...++.++++||++||..+|.+ |++++||++|+||+..
T Consensus 297 ---------------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 297 ---------------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp ---------------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred ---------------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 1137789999999999999988 9999999999999653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=383.69 Aligned_cols=247 Identities=24% Similarity=0.394 Sum_probs=211.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||+|++...... ....+.+|+.+|++|+|+||+++++++.+ ...+
T Consensus 62 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~----------------~~~~ 123 (387)
T 1kob_A 62 GAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFED----------------KYEM 123 (387)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEEC----------------SSEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEecccchh--hHHHHHHHHHHHHhCCCcCCCeEEEEEEe----------------CCEE
Confidence 89999999999999999999999865322 23467899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC--CCCeEEecccccccccC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~ 159 (481)
|||||||.+ +|.+.+......+++.+++.++.||+.||+|||+++|+||||||+||||+. ++.+||+|||+++.+..
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999985 777777766667999999999999999999999999999999999999974 46799999999987643
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. ......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+...........
T Consensus 204 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------- 273 (387)
T 1kob_A 204 D--EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA------- 273 (387)
T ss_dssp T--SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST-------
T ss_pred C--cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc-------
Confidence 2 23344578999999999986 6789999999999999999999999999998888888765433222211
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+..++.++++||++||..||++|||+.|+|+|+||+..
T Consensus 274 -------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 274 -------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp -------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 12477899999999999999999999999999999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=381.24 Aligned_cols=244 Identities=26% Similarity=0.439 Sum_probs=208.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++.+++.||||+++.... .......+.+|+.+++++ +||||+++++++.+ ..
T Consensus 28 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----------------~~ 91 (345)
T 1xjd_A 28 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----------------KE 91 (345)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----------------SS
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----------------CC
Confidence 8999999999999999999999986531 223455678899999987 99999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|||||||.+ +|..++.+. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+|+....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 89999999986 666666543 4699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......+||+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+++.+|.......
T Consensus 171 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 237 (345)
T 1xjd_A 171 G-DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----------- 237 (345)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------
T ss_pred C-CCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence 2 223455688999999999987 578999999999999999999999999999988888876431110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK-DALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~-eiL~h~~f~~ 295 (481)
...++.++++||.+||..||++|+++. ||++|+||..
T Consensus 238 -------------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 238 -------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp -------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred -------------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 013678899999999999999999998 9999999964
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=383.40 Aligned_cols=280 Identities=36% Similarity=0.599 Sum_probs=224.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++..... ......+.+|++++++|+|+||+++++++..... .....+
T Consensus 38 G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----------~~~~~~ 105 (364)
T 3qyz_A 38 GAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTI-----------EQMKDV 105 (364)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST-----------TTCCCE
T ss_pred CCCeEEEEEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc-----------cccceE
Confidence 8999999999999999999999975432 2234577899999999999999999999976321 124578
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||++++|.+++... .+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.......
T Consensus 106 ~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 999999999998887653 589999999999999999999999999999999999999999999999999987653222
Q ss_pred --CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 163 --NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 163 --~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
......++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+....+.+....+.......
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 223456889999999998765668999999999999999999999999999999999999887776554433221110
Q ss_pred cccc-CCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 241 AYNH-FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.... ..............+..++.++++||.+||+.||++|||++|+|+||||...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0000 0000001112344556788999999999999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=387.28 Aligned_cols=245 Identities=30% Similarity=0.468 Sum_probs=203.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++... ........+.+|+.+++.++||||+++++++.+ ...
T Consensus 20 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----------------~~~ 83 (336)
T 3h4j_B 20 GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT----------------PTD 83 (336)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----------------CCE
Confidence 899999999999999999999997652 223345578899999999999999999999987 668
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+||||||++++|++.+... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++++||+|||++.....
T Consensus 84 ~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~-- 160 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-- 160 (336)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT--
T ss_pred EEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC--
Confidence 9999999998988877654 3699999999999999999999999999999999999999999999999999986543
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++|+.|+|||++.+....+.++||||||||+|+|++|+.||...+..+...++. ....
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-----------~~~~---- 225 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN-----------SCVY---- 225 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC-----------SSCC----
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH-----------cCCC----
Confidence 2334556889999999999874445789999999999999999999997654322111110 0000
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.....+++++.+||++||..||++|||++||++||||...
T Consensus 226 ---------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 226 ---------------VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ---------------CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ---------------CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 0112478899999999999999999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=391.54 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=213.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++... ........+.+|+.+++.++|+||++++++|.+ .+.
T Consensus 85 G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~----------------~~~ 148 (437)
T 4aw2_A 85 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD----------------DNN 148 (437)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC----------------SSE
T ss_pred CCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----------------CCE
Confidence 899999999999999999999997642 122234457899999999999999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|.+++.+....+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999974 788887775667999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCccccccccccCCCchhhc----CCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 161 HNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~----~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
........+||+.|+|||++. +...++.++||||||||+|||++|+.||.+.+..+.+.+|+........ +
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---p-- 303 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF---P-- 303 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC---C--
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC---C--
Confidence 444445568999999999987 2356899999999999999999999999999999988888653211100 0
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWT 295 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~sa~eiL~h~~f~~ 295 (481)
. ....+++++++||++||..+|++ |++++||++||||..
T Consensus 304 ----~----------------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 304 ----T----------------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp ----S----------------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred ----c----------------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 0 01237889999999999998888 999999999999965
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=390.80 Aligned_cols=277 Identities=30% Similarity=0.496 Sum_probs=209.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.+++.++|+||+++++++..... ......+
T Consensus 36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----------~~~~~~~ 105 (371)
T 2xrw_A 36 GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS----------LEEFQDV 105 (371)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS----------TTTCCEE
T ss_pred cCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc----------cccccce
Confidence 899999999999999999999998654444445677899999999999999999999986321 1124578
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|||||||+++|.+.+.. .+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.... .
T Consensus 106 ~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~--~ 180 (371)
T 2xrw_A 106 YIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 180 (371)
T ss_dssp EEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred EEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc--c
Confidence 99999999998887753 489999999999999999999999999999999999999999999999999986542 2
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC----
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK---- 238 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---- 238 (481)
......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+.++++..+.+....+.....
T Consensus 181 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 181 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ---------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 23445678999999999987 5789999999999999999999999999999999999987766554333222110
Q ss_pred ----CCccccCCCch----hhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 ----MPAYNHFKPSR----TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ----~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+.+....... .............+.++++||++||..||++|||++|+|+||||..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00000000000 0000001122345778999999999999999999999999999964
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=384.73 Aligned_cols=276 Identities=36% Similarity=0.589 Sum_probs=219.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++......+.....+.+|+.++++++|+||+++++++...... .....+
T Consensus 53 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----------~~~~~~ 122 (371)
T 4exu_A 53 GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL----------RNFYDF 122 (371)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS----------TTCCCC
T ss_pred CCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc----------ccceeE
Confidence 8999999999999999999999987655444556788999999999999999999999873211 112245
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++|...+.. .+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 123 ~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--- 196 (371)
T 4exu_A 123 YLVMPFMQTDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--- 196 (371)
T ss_dssp EEEEECCCEEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--------
T ss_pred EEEEccccccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc---
Confidence 99999999988877643 489999999999999999999999999999999999999999999999999986542
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc-
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA- 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 241 (481)
.....++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..++...+.+....+........
T Consensus 197 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 197 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred -CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 234457799999999998756789999999999999999999999999999999999988877665433322211000
Q ss_pred -cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 -YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+... ............+..++.++++||++||+.||++|||++|+|+||||..-
T Consensus 276 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 276 SYIQS-LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHH-SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhc-cCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0000 00000122334456789999999999999999999999999999999643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=384.99 Aligned_cols=282 Identities=30% Similarity=0.523 Sum_probs=215.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCC------------
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ------------ 70 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~------------ 70 (481)
|+||+||+|++..+++.||||++..+... ..+|+.+++.|+|+||++++++|..........
T Consensus 18 G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (383)
T 3eb0_A 18 GSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGG 91 (383)
T ss_dssp C-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------
T ss_pred ccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccc
Confidence 89999999999999999999999754322 237999999999999999999997643210000
Q ss_pred ----------CCCCCCCcCCeEEEEEecCCCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 011627 71 ----------GRPDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 137 (481)
Q Consensus 71 ----------~~~~~~~~~~~~~iV~Ey~~g~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~N 137 (481)
...........++|||||+.++|.+.+. .....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~N 171 (383)
T 3eb0_A 92 KNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171 (383)
T ss_dssp ------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGG
T ss_pred cccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHH
Confidence 0000012355689999999998666554 355679999999999999999999999999999999999
Q ss_pred EEEc-CCCCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH
Q 011627 138 LLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 216 (481)
Q Consensus 138 ILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 216 (481)
|||+ .++.+||+|||+|+.+.. .......++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+
T Consensus 172 il~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 249 (383)
T 3eb0_A 172 LLVNSKDNTLKLCDFGSAKKLIP--SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID 249 (383)
T ss_dssp EEEETTTTEEEECCCTTCEECCT--TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEcCCCCcEEEEECCCCcccCC--CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH
Confidence 9998 578899999999987643 2334456789999999999876678999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhH-HHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV-REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
.+..++...+.+....+..... .+............. ..+...++.++++||.+||..||++|+|+.|+|+||||.
T Consensus 250 ~~~~i~~~~g~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 250 QLVRIIQIMGTPTKEQMIRMNP--HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326 (383)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCT--TC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGH
T ss_pred HHHHHHHHhCCCCHHHHHHhCc--ccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHH
Confidence 9999998887765433222111 111111111111112 222345888999999999999999999999999999994
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=382.22 Aligned_cols=248 Identities=30% Similarity=0.458 Sum_probs=204.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC---cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|+++.+++.||||+++... ........+.+|+.++++|+|+||+++++++.+ .
T Consensus 35 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----------------~ 98 (351)
T 3c0i_A 35 GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----------------D 98 (351)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------T
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----------------C
Confidence 899999999999999999999997542 112234578899999999999999999999987 6
Q ss_pred CeEEEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---eEEeccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFG 152 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG 152 (481)
+.+|||||||++ +|.+.+.. ....+++..++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 789999999985 66655543 3345899999999999999999999999999999999999987655 9999999
Q ss_pred ccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 011627 153 LARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 232 (481)
Q Consensus 153 ~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (481)
+++.+... .......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+ .+.+..+.......
T Consensus 179 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~---- 251 (351)
T 3c0i_A 179 VAIQLGES-GLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM---- 251 (351)
T ss_dssp TCEECCTT-SCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC----
T ss_pred ceeEecCC-CeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC----
Confidence 99876532 223345678999999999986 578999999999999999999999998753 44555554321110
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....+..++.++++||.+||..||++|||+.|+|+|+||+.
T Consensus 252 ----------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 252 ----------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp ----------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ----------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 11234568889999999999999999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=376.68 Aligned_cols=244 Identities=24% Similarity=0.389 Sum_probs=201.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++.+++.||||+++..... ......+.+|+.+++++ +||||++++++|.+ ..
T Consensus 20 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----------------~~ 83 (345)
T 3a8x_A 20 GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----------------ES 83 (345)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SS
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe----------------CC
Confidence 89999999999999999999999866432 22345677899999998 89999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|..++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+|+....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 89999999986 666665543 4699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHHhcCCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK---------NEAEQLSKIFELCGSPDE 230 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~---------~~~~~~~~i~~~~~~~~~ 230 (481)
. .......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||... +.......+......
T Consensus 163 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--- 237 (345)
T 3a8x_A 163 P-GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--- 237 (345)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC---
T ss_pred C-CCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC---
Confidence 2 233455688999999999987 67899999999999999999999999752 223333344321100
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDSEYFWT 295 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa------~eiL~h~~f~~ 295 (481)
+...++.++++||++||..||++|+++ +||++||||..
T Consensus 238 ---------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 238 ---------------------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp ---------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred ---------------------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 112467899999999999999999995 89999999954
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=378.82 Aligned_cols=241 Identities=25% Similarity=0.394 Sum_probs=209.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++... ........+.+|+.+|+.++|+||+++++++.+ ...
T Consensus 52 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~ 115 (350)
T 1rdq_E 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----------------NSN 115 (350)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSE
T ss_pred CcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc----------------CCE
Confidence 899999999999999999999997653 222345678899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 9999999975 676666543 4699999999999999999999999999999999999999999999999999987642
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.....++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+.++.......
T Consensus 194 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 257 (350)
T 1rdq_E 194 ---RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF------------ 257 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred ---CcccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 2334688999999999986 678999999999999999999999999999988888886532110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
...++.++.+||.+||..||++|++ ++||++|+||..
T Consensus 258 ------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 258 ------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp ------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred ------------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 1246788999999999999999998 999999999954
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=375.60 Aligned_cols=246 Identities=22% Similarity=0.263 Sum_probs=179.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++ +|+.||||+++..... ......|+.++.+|+|||||++++++.+... ....+
T Consensus 14 G~fG~Vy~~~~--~g~~VAvK~l~~~~~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~------------~~~~~ 76 (303)
T 3hmm_A 14 GRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNG------------TWTQL 76 (303)
T ss_dssp CSSSEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS------------SSEEE
T ss_pred CCCeEEEEEEE--CCEEEEEEEECccchh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCC------------CceEE
Confidence 89999999987 6899999999754322 1122346666678999999999999986321 12368
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEcCCCCeEEecccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--------QVLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~--------giiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
|||||||++ +|.+++.+. .++++.+..++.||+.||+|||++ +||||||||+||||+.++++||+|||+
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999985 777777553 589999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCC---ccccccccccCCCchhhcCCC-----CCCCCCchhhHHHHHHHHHhCCCCCCCCCh-----------
Q 011627 154 ARSFSYDHNN---TLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNE----------- 214 (481)
Q Consensus 154 a~~~~~~~~~---~~~~~~gt~~Y~aPEvl~~~~-----~~~~~~DiwSlGvil~elltG~~pf~~~~~----------- 214 (481)
|+........ .....+||+.|||||++.+.. .++.++||||||||||||+||.+||...+.
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 9876543221 233458999999999997632 356789999999999999999887653321
Q ss_pred ---HHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 215 ---AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 215 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.+.+.+...... .++..+.. .........+.+||.+||..||++|||+.||++
T Consensus 235 ~~~~~~~~~~~~~~~------------------~rp~~p~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQK------------------LRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHHTTSC------------------CCCCCCGG----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhccc------------------CCCCCCcc----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 111111111000 00000000 000124457889999999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=388.52 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=210.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||++++.. ........+.+|+.+++.++|+||++++++|.+ .+.
T Consensus 72 G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~----------------~~~ 135 (412)
T 2vd5_A 72 GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD----------------ENY 135 (412)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee----------------CCE
Confidence 899999999999999999999997542 122234567899999999999999999999987 678
Q ss_pred EEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||. ++|.+++.+....+++..++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+...
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999996 5787777665557999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCccccccccccCCCchhhcC------CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 161 HNNTLTNRVITLWYRPPELLLG------ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
........+||+.|+|||++.. ...++.++||||||||+|||++|+.||...+..+++.+|........
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~----- 290 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS----- 290 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-----
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC-----
Confidence 3333345689999999999873 24689999999999999999999999999999888888864211000
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR---ISAKDALDSEYFWTD 296 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R---~sa~eiL~h~~f~~~ 296 (481)
.......++.++++||++||. ||++| ++++||++|+||+.-
T Consensus 291 --------------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 291 --------------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp --------------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred --------------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 001123578899999999999 99998 499999999999653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=389.49 Aligned_cols=269 Identities=31% Similarity=0.539 Sum_probs=215.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc------CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL------QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L------~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++..+++.||||+++... .....+.+|+.+++.| +|+||+++++++..
T Consensus 108 G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-------------- 170 (429)
T 3kvw_A 108 GSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-------------- 170 (429)
T ss_dssp SSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--------------
T ss_pred CccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--------------
Confidence 899999999999999999999997532 2334667899999888 56799999999987
Q ss_pred CcCCeEEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC--eEEecccc
Q 011627 77 KYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN--LKLADFGL 153 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~--vkL~DFG~ 153 (481)
...+||||||+.++|.+++.... ..+++..++.|+.||+.||+|||+++|+||||||+||||+.++. +||+|||+
T Consensus 171 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 171 --RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp --TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred --CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 67899999999999988887654 35999999999999999999999999999999999999999887 99999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
|+... ......++|+.|+|||++.+ ..++.++||||||||+|||++|++||.+.+..+.+..+++..+.+....+
T Consensus 249 a~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 249 SCYEH----QRVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp CEETT----CCCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecC----CcccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 97643 23344678999999999987 57899999999999999999999999999999999999988777654432
Q ss_pred ccCCCCC---------cccc--------------------CCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH
Q 011627 234 PGVSKMP---------AYNH--------------------FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 284 (481)
Q Consensus 234 ~~~~~~~---------~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa 284 (481)
....... .+.. .............+....++++++||++||+.||++|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 2111100 0000 0000000111112223457889999999999999999999
Q ss_pred HHHhcCCCCCC
Q 011627 285 KDALDSEYFWT 295 (481)
Q Consensus 285 ~eiL~h~~f~~ 295 (481)
+|||+||||+.
T Consensus 404 ~e~L~Hpw~~~ 414 (429)
T 3kvw_A 404 GQALRHPWLRR 414 (429)
T ss_dssp HHHHTSTTTC-
T ss_pred HHHhCChhhcc
Confidence 99999999965
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=378.51 Aligned_cols=244 Identities=24% Similarity=0.421 Sum_probs=208.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++.+++.||||+++.... .......+.+|+.+++.+ +|+||+++++++.+ .+
T Consensus 31 G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----------------~~ 94 (353)
T 2i0e_A 31 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----------------MD 94 (353)
T ss_dssp ETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC----------------SS
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc----------------CC
Confidence 8999999999999999999999986532 223456778999999988 79999999999987 66
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|||||||.+ +|..++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 89999999986 666666543 4699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......+||+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+++.+|.......
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----------- 240 (353)
T 2i0e_A 174 D-GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY----------- 240 (353)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------
T ss_pred C-CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence 2 233445688999999999986 678999999999999999999999999999988888887532111
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
...++.++++||++||..||++|++ ++||++|+||..
T Consensus 241 -------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 241 -------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp -------------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred -------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 1246789999999999999999994 699999999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=378.72 Aligned_cols=281 Identities=30% Similarity=0.474 Sum_probs=213.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++..... ......+|+..++.++|+||++++++|...... ......+
T Consensus 34 G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~---------~~~~~~~ 101 (360)
T 3e3p_A 34 GTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER---------DRRDIYL 101 (360)
T ss_dssp -----CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS---------CTTCEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc---------cccceeE
Confidence 8999999999999999999999865432 334677889999999999999999999763211 1123458
Q ss_pred EEEEecCCCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEEcC-CCCeEEeccccccc
Q 011627 83 YMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCH--VNQVLHRDIKGSNLLIDN-EGNLKLADFGLARS 156 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH--~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~ 156 (481)
||||||+.++|...+. .....+++..++.++.||+.||.||| +++|+||||||+||||+. ++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 9999999998766544 35557899999999999999999999 999999999999999997 88999999999987
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
+... ......++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+.+..+.+....|...
T Consensus 182 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 182 LSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp CCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 6532 23345578999999999977566899999999999999999999999999999999999887776654433322
Q ss_pred CCCCc-cccCCCc-hhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 237 SKMPA-YNHFKPS-RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 237 ~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
..... ....... ..............+.++++||.+||+.||++|||+.|+|+||||....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 11000 0000000 0000111111123678899999999999999999999999999997543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=383.08 Aligned_cols=276 Identities=21% Similarity=0.265 Sum_probs=204.2
Q ss_pred ceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEE
Q 011627 4 CISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 83 (481)
Q Consensus 4 ~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (481)
+||+||+|+++.+++.||||+++...........+.+|+.++++|+|+|||++++++.+ .+.+|
T Consensus 39 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~ 102 (389)
T 3gni_B 39 DLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----------------DNELW 102 (389)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEE
T ss_pred CceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----------------CCEEE
Confidence 89999999999999999999998775555455677889999999999999999999987 67899
Q ss_pred EEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 84 MVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 84 iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||.+ +|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 99999985 666666543 3469999999999999999999999999999999999999999999999999986543211
Q ss_pred ------CCccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC------
Q 011627 162 ------NNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP------ 228 (481)
Q Consensus 162 ------~~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~------ 228 (481)
.......++|+.|+|||++.+. ..++.++||||||||+|+|++|+.||.+.+..+.+..+.......
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 1122334779999999999763 468999999999999999999999999877666555443211100
Q ss_pred --CCCCCccCCCCCcc----ccC----CCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 229 --DETIWPGVSKMPAY----NHF----KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 229 --~~~~~~~~~~~~~~----~~~----~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.............. ... ................++.++++||++||+.||++|||++|||+||||..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 00000000000000 000 00000011112345678999999999999999999999999999999964
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=371.13 Aligned_cols=244 Identities=29% Similarity=0.400 Sum_probs=189.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++.... ...+.+|+.++++|+|+||+++++++.+ ...+
T Consensus 64 G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~ 123 (349)
T 2w4o_A 64 GATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFET----------------PTEI 123 (349)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC----------------SSEE
T ss_pred CCCEEEEEEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEec----------------CCeE
Confidence 8999999999999999999999986532 2356789999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~ 158 (481)
||||||+.+ +|.+.+.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+. ++.+||+|||+++...
T Consensus 124 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999985 66666654 346999999999999999999999999999999999999975 7889999999998654
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCCCCCccCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 237 (481)
. .......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+ .+..+..........
T Consensus 203 ~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~------ 273 (349)
T 2w4o_A 203 H--QVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP------ 273 (349)
T ss_dssp ------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT------
T ss_pred c--ccccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc------
Confidence 2 223344678999999999986 578999999999999999999999998766554 555554432211111
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.+..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 274 --------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 274 --------------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp --------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred --------------------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 123477899999999999999999999999999999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=384.15 Aligned_cols=246 Identities=30% Similarity=0.399 Sum_probs=207.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++..... ....+.+|+.++++|+|+||+++++++.+ .+.+
T Consensus 100 G~~g~Vy~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----------------~~~~ 161 (373)
T 2x4f_A 100 GRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFES----------------KNDI 161 (373)
T ss_dssp ----CEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEE
T ss_pred CcCEEEEEEEEcCCCcEEEEEEEcccccc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEE----------------CCEE
Confidence 79999999999999999999999865322 24567899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE--cCCCCeEEecccccccccC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI--DNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl--~~~~~vkL~DFG~a~~~~~ 159 (481)
|||||||++ +|.+.+......+++..++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++.+..
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999985 7777776665679999999999999999999999999999999999999 5567899999999987643
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. ......++|+.|+|||++.. ..++.++||||||||+|+|++|+.||.+.+..+.+..+..........
T Consensus 242 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-------- 310 (373)
T 2x4f_A 242 R--EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE-------- 310 (373)
T ss_dssp T--CBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG--------
T ss_pred c--cccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh--------
Confidence 2 23344578999999999876 578899999999999999999999999999999888887653322211
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+..++.++++||.+||..||++|||+.|+|+||||..
T Consensus 311 ------------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 311 ------------------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp ------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred ------------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 12357889999999999999999999999999999953
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=367.85 Aligned_cols=276 Identities=39% Similarity=0.716 Sum_probs=225.6
Q ss_pred cceeEEEEEEEc-cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc---CCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREI-KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~-~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++. .+++.||||+++...........+.+|+.+++.| +|+||+++++++.... ...
T Consensus 22 G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~-----------~~~ 90 (326)
T 1blx_A 22 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR-----------TDR 90 (326)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE-----------CSS
T ss_pred cccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc-----------cCC
Confidence 799999999995 7789999999987655444455777888888877 8999999999987311 011
Q ss_pred CCeEEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...++|||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 91 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170 (326)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence 56899999999999888776543 35999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+.++.+..+.+....|+...
T Consensus 171 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (326)
T 1blx_A 171 SFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247 (326)
T ss_dssp CGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred cCC--CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence 422 23345677999999999986 578999999999999999999999999999999999999888887777776544
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..+....... .......+...++.++++||.+||..||++|||+.|+|+|+||+.
T Consensus 248 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 248 ALPRQAFHSK---SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp SSCGGGSCCC---CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccchhhhccc---CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 3332111110 011223344568899999999999999999999999999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=389.05 Aligned_cols=245 Identities=30% Similarity=0.459 Sum_probs=210.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... .......+.+|+.+++.++|+||+++++++.+ ...
T Consensus 27 G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----------------~~~ 90 (476)
T 2y94_A 27 GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST----------------PSD 90 (476)
T ss_dssp CSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCE
Confidence 8999999999999999999999976532 22345678899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|.+++.+ ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++++||+|||++.....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~- 168 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 168 (476)
T ss_dssp EEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT-
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc-
Confidence 9999999975 66666654 45699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......++|+.|+|||++.+....+.++||||||||+|+|++|+.||...+....+.++.......
T Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 235 (476)
T 2y94_A 169 -GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT------------ 235 (476)
T ss_dssp -TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC------------
T ss_pred -cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC------------
Confidence 2334556889999999999875445789999999999999999999999988888888776432111
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...+++++++||++||..||++|||++||++|+||+..
T Consensus 236 ------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 236 ------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 01367789999999999999999999999999999764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=371.07 Aligned_cols=242 Identities=23% Similarity=0.286 Sum_probs=198.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++.............++|+..+.++ +|+||+++++++.+ .+.
T Consensus 68 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~----------------~~~ 131 (311)
T 3p1a_A 68 GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE----------------GGI 131 (311)
T ss_dssp ETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTE
T ss_pred CCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe----------------CCE
Confidence 8999999999999999999999876544433344556677666666 89999999999987 678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+||||||++++|.+.+......+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+++.....
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence 9999999999999888876667999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......+|+.|+|||++.+ .++.++||||||||+|||++|..+|...+.. ..+...
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~----------------- 267 (311)
T 3p1a_A 211 -GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQG----------------- 267 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTT-----------------
T ss_pred -CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhcc-----------------
Confidence 23344568999999999875 6899999999999999999998776553322 222110
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.........++.++.+||.+||..||++|||++|||+||||+.
T Consensus 268 -----------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 268 -----------YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -----------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 0011234568899999999999999999999999999999953
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=377.79 Aligned_cols=280 Identities=30% Similarity=0.466 Sum_probs=215.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCc---------chhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGF---------PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 73 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~---------~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~ 73 (481)
|+||+||+|++.. ++.||||++......... ...+.+|+.++++|+|+||+++++++....
T Consensus 33 G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------- 102 (362)
T 3pg1_A 33 GSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE--------- 102 (362)
T ss_dssp ETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC---------
T ss_pred CCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc---------
Confidence 8999999999865 999999999765433221 256789999999999999999999987532
Q ss_pred CCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccc
Q 011627 74 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 74 ~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
......+||||||++++|.+.+......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 103 --~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 103 --EPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp --TTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred --CCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCc
Confidence 112557999999999999999888777899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
++.... ........+|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+.+..+.+....+
T Consensus 181 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (362)
T 3pg1_A 181 AREDTA--DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258 (362)
T ss_dssp -----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccc--ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence 975432 223344577999999999987567899999999999999999999999999999999999887766543221
Q ss_pred ccCCCC--CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 234 PGVSKM--PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 234 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...... ..+...................+++.+.+||.+||..||++|||+.|+|+||||...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 111000 000000000011122344556778999999999999999999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=366.26 Aligned_cols=245 Identities=25% Similarity=0.447 Sum_probs=207.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++..... ....+.+|+.++++++|+||+++++++.. .+.+
T Consensus 56 G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~ 117 (321)
T 2c30_A 56 GSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLV----------------GEEL 117 (321)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEE----------------CCEE
Confidence 89999999999999999999999865432 34567899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.+ +|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+....
T Consensus 118 ~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp EEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence 999999986 55555543 369999999999999999999999999999999999999999999999999998765322
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+........
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 261 (321)
T 2c30_A 196 -PKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL------------ 261 (321)
T ss_dssp -CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC------------
T ss_pred -cccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc------------
Confidence 22345678999999999976 6789999999999999999999999999888877777654211100
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.....++.++.+||.+||..||++|||+.|+|+|+||...
T Consensus 262 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 262 ---------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp ---------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ---------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0012467889999999999999999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=383.31 Aligned_cols=272 Identities=32% Similarity=0.539 Sum_probs=213.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++ ||+|++...... ..+|+.+++.|+|+||++++++|...... .....+
T Consensus 51 G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~----------~~~~~~ 113 (394)
T 4e7w_A 51 GSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDK----------KDEVFL 113 (394)
T ss_dssp ETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSS----------SSCEEE
T ss_pred CCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCC----------CCceEE
Confidence 8999999999988776 888877643221 23799999999999999999999763211 114458
Q ss_pred EEEEecCCCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-CCCCeEEeccccccccc
Q 011627 83 YMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~ 158 (481)
|||||||.++++..+. .....+++..++.|+.||+.||+|||+++|+||||||+||||+ .++.+||+|||+|+.+.
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 8999999998766543 2345799999999999999999999999999999999999999 78899999999998764
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .......++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+++..+.+....+.....
T Consensus 194 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 194 A--GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp T--TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred C--CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 3 22334567899999999998766789999999999999999999999999999999999998877765433222111
Q ss_pred CCccccCCCchhhhhhHHH-HHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVRE-VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+............... +...+++++++||.+||+.||++|+|+.|+|+||||..
T Consensus 272 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 272 --NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp --GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred --hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 11111100001111222 22358899999999999999999999999999999965
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=376.69 Aligned_cols=268 Identities=24% Similarity=0.358 Sum_probs=212.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-----CCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-----HENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-----hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|++..+++.||||+++... .....+.+|+.+++++. |+||+++++++..
T Consensus 46 G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--------------- 107 (360)
T 3llt_A 46 GTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--------------- 107 (360)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE---------------
T ss_pred cCCeEEEEEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE---------------
Confidence 899999999999999999999997432 22346678999999997 9999999999987
Q ss_pred cCCeEEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC--------------
Q 011627 78 YRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-------------- 142 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-------------- 142 (481)
.+.+||||||+.++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||||+.
T Consensus 108 -~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 -YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp -TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred -CCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 66899999999889988887644 35999999999999999999999999999999999999975
Q ss_pred -----------CCCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCC
Q 011627 143 -----------EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG 211 (481)
Q Consensus 143 -----------~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 211 (481)
++.+||+|||+|+.... .....++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||..
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 77899999999986432 2334678999999999987 5789999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCCCCCCccCCCCCc--------c-ccCCCchhhh-------hhHHHHHhhhcHHHHHHHHHhcc
Q 011627 212 KNEAEQLSKIFELCGSPDETIWPGVSKMPA--------Y-NHFKPSRTMK-------RRVREVFRHFDRHALELLEKMLM 275 (481)
Q Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--------~-~~~~~~~~~~-------~~~~~~~~~~~~~~~~ll~~~L~ 275 (481)
.+..+.+..+.......+...+........ . ..+....... ..........++.+++||.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 999999988887766544322111110000 0 0000000000 01111222345789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCC
Q 011627 276 LDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 276 ~dP~~R~sa~eiL~h~~f~ 294 (481)
.||++|||++|||+|+||+
T Consensus 342 ~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 342 IDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGC
T ss_pred CChhhCCCHHHHhcCcccC
Confidence 9999999999999999994
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=364.93 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=210.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC----cchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG----FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~----~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++.||||+++....... ....+.+|+.++++|+|+||+++++++.+
T Consensus 23 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------------- 86 (321)
T 2a2a_A 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN---------------- 86 (321)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------
T ss_pred cCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----------------
Confidence 8999999999999999999999987643321 24568899999999999999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC----CeEEecccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKLADFGL 153 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~----~vkL~DFG~ 153 (481)
...+||||||+.+ +|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 6689999999975 67666654 44699999999999999999999999999999999999999887 799999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
+..... ........+|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+.......
T Consensus 166 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----- 237 (321)
T 2a2a_A 166 AHEIED--GVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF----- 237 (321)
T ss_dssp CEECCT--TCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC-----
T ss_pred ceecCc--cccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc-----
Confidence 987653 223345678999999999976 678999999999999999999999999999888888776432111
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....+..++..+.+||++||..||++|||+.|+|+|+||+.
T Consensus 238 ---------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 238 ---------------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp ---------------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ---------------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 11234567889999999999999999999999999999953
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=379.23 Aligned_cols=244 Identities=26% Similarity=0.391 Sum_probs=199.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHH-HHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKI-LKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~i-l~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++.+++.||||++++.... ......+++|..+ ++.++|+||++++++|.+ .+
T Consensus 49 G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----------------~~ 112 (373)
T 2r5t_A 49 GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----------------AD 112 (373)
T ss_dssp CTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC----------------SS
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe----------------CC
Confidence 89999999999999999999999866422 2234456677776 577899999999999987 67
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|||||||.+ +|..++.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+++....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 89999999986 66665554 34689999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........+||+.|+|||++.+ ..++.++||||||||+|||++|..||...+..+++.+|.......
T Consensus 192 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----------- 258 (373)
T 2r5t_A 192 -HNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----------- 258 (373)
T ss_dssp -CCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC-----------
T ss_pred -CCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC-----------
Confidence 2234455688999999999986 678999999999999999999999999999988888887532110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa----~eiL~h~~f~~ 295 (481)
...++.++++||++||..||++|+++ .+|++|+||..
T Consensus 259 -------------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 259 -------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp -------------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred -------------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 12467789999999999999999987 69999999954
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=374.49 Aligned_cols=245 Identities=26% Similarity=0.414 Sum_probs=209.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++...... ......+.+|+.++++|+|+||+++++++.+ ...
T Consensus 65 G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~ 128 (348)
T 1u5q_A 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----------------EHT 128 (348)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTE
T ss_pred CCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----------------CCe
Confidence 89999999999999999999999865322 2233567899999999999999999999987 668
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+||||||+.+++.+++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 129 ~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 999999999998888876566799999999999999999999999999999999999999999999999999976532
Q ss_pred CCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
....++|+.|+|||++.+ ...++.++||||||||+|||++|+.||...+..+.+..+.........
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 274 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--------- 274 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC---------
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---------
Confidence 234578999999999853 356889999999999999999999999998888777766542211000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...++..+.+||.+||..||++|||++++|+|+||...
T Consensus 275 -------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 275 -------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 01367789999999999999999999999999999653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=369.62 Aligned_cols=244 Identities=25% Similarity=0.426 Sum_probs=197.3
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCc--CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNE--KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|++. .+++.||||+++.... .......+.+|+.+|++|+|+||+++++++.+
T Consensus 28 G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--------------- 92 (327)
T 3a62_A 28 GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--------------- 92 (327)
T ss_dssp ETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---------------
T ss_pred CCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---------------
Confidence 899999999985 7899999999986532 12234456789999999999999999999987
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.+.+|||||||.+ +|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 -GGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp -SSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 6689999999985 666666543 4689999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.... .......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+.++.......+
T Consensus 171 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p------- 241 (327)
T 3a62_A 171 SIHD-GTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP------- 241 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-------
T ss_pred cccC-CccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 4322 223344678999999999976 5789999999999999999999999999998888888875321111
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
..++.++++||.+||..||++|+ ++.|+++||||..
T Consensus 242 -----------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 242 -----------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp -----------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred -----------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 13677899999999999999999 8999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=376.52 Aligned_cols=244 Identities=23% Similarity=0.376 Sum_probs=202.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++... ........+.+|+.+|+.++|||||+++++|.+ ...
T Consensus 26 G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----------------~~~ 89 (384)
T 4fr4_A 26 GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD----------------EED 89 (384)
T ss_dssp CTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----------------CCE
Confidence 899999999999999999999997653 223345678899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|..++.. ...+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR- 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC-
Confidence 9999999986 55555544 45799999999999999999999999999999999999999999999999999987642
Q ss_pred CCCccccccccccCCCchhhcCC--CCCCCCCchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCCCCCcc
Q 011627 161 HNNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.......++|+.|+|||++... ..++.++||||||||+|+|++|+.||...+. .+.+..+......
T Consensus 168 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 238 (384)
T 4fr4_A 168 -ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT-------- 238 (384)
T ss_dssp -TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC--------
T ss_pred -CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC--------
Confidence 3345567899999999998742 3588999999999999999999999975433 3333333221100
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-AKDALDSEYFWT 295 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-a~eiL~h~~f~~ 295 (481)
....++.++.+||.+||..||++|++ +++|++|+||..
T Consensus 239 ----------------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 239 ----------------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred ----------------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 01246789999999999999999998 899999999954
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=372.21 Aligned_cols=244 Identities=27% Similarity=0.431 Sum_probs=183.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||++... ....+.+|+.+++++. |+||+++++++.+ ...
T Consensus 22 G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~----------------~~~ 80 (325)
T 3kn6_A 22 GSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD----------------QLH 80 (325)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc----------------CCE
Confidence 89999999999999999999999753 2346779999999997 9999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~ 157 (481)
+|||||||++ +|.+.+... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999986 676666554 4699999999999999999999999999999999999998766 7999999999865
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-------AEQLSKIFELCGSPDE 230 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~~~~~ 230 (481)
... .......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+. .+.+.++.......
T Consensus 160 ~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~-- 235 (325)
T 3kn6_A 160 PPD-NQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF-- 235 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--
T ss_pred CCC-CCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--
Confidence 432 233445678999999999876 6789999999999999999999999987543 33444442211100
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
....+..++.++++||.+||..||++|||++|+|+|+||...
T Consensus 236 ------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 236 ------------------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp ------------------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ------------------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 112345688999999999999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.97 Aligned_cols=247 Identities=27% Similarity=0.382 Sum_probs=210.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.++++++|+||+++++++.+ ....
T Consensus 17 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 80 (284)
T 3kk8_A 17 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----------------ESFH 80 (284)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEE
T ss_pred cCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc----------------CCEE
Confidence 899999999999999999999998765444445677899999999999999999999987 6688
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---eEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG~a~~~~ 158 (481)
|+||||+.+ +|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||++....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999986 665655543 46899999999999999999999999999999999999987665 9999999997664
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. ........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...........
T Consensus 160 ~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 230 (284)
T 3kk8_A 160 D--SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE------ 230 (284)
T ss_dssp S--SCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT------
T ss_pred c--CccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchh------
Confidence 3 223344678999999999986 5789999999999999999999999999998888888765433322211
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+..+++++.+||.+||+.||++|||++|+|+|+||+.
T Consensus 231 --------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 231 --------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp --------------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred --------------------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 1246778999999999999999999999999999965
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=372.39 Aligned_cols=242 Identities=28% Similarity=0.390 Sum_probs=200.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++.... ...+|++++.++ +||||+++++++.+ ...
T Consensus 33 G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~----------------~~~ 90 (342)
T 2qr7_A 33 GSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDD----------------GKY 90 (342)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEEC----------------SSE
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEc----------------CCE
Confidence 8999999999999999999999976532 235799999888 79999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-C---CeEEeccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-G---NLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~-~---~vkL~DFG~a~~ 156 (481)
+|||||||.+ +|.+.+.+. ..+++.+++.++.||+.||+|||+++|+||||||+||||.++ + .+||+|||+++.
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999986 677666554 469999999999999999999999999999999999998543 2 499999999987
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCC---CChHHHHHHHHHhcCCCCCCCC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG---KNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~---~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
+... .......++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.. .+..+.+..+...........
T Consensus 170 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 246 (342)
T 2qr7_A 170 LRAE-NGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY- 246 (342)
T ss_dssp CBCT-TCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT-
T ss_pred CcCC-CCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc-
Confidence 6533 233445688999999999976 4578899999999999999999999986 345556666654322222111
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+..++.++++||++||..||++|+|+.|+|+|+||..
T Consensus 247 -------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 247 -------------------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp -------------------------TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred -------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 2357889999999999999999999999999999954
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=370.81 Aligned_cols=282 Identities=34% Similarity=0.562 Sum_probs=219.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++.... ......+.+|+.++++|+|+||+++++++.... ......+
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----------~~~~~~~ 89 (353)
T 2b9h_A 22 GAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDS-----------FENFNEV 89 (353)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC-----------STTCCCE
T ss_pred CCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeecccc-----------cCccceE
Confidence 8999999999999999999999964322 223456779999999999999999999987532 1224679
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++|.+.+.. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 90 ~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 90 YIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 99999999998887765 3589999999999999999999999999999999999999999999999999987643211
Q ss_pred C---------ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 163 N---------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 163 ~---------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
. .....++|+.|+|||++.....++.++||||||||+|+|++|+.||.+.+..+.+..++...+.+.....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 1 1233577999999999876567899999999999999999999999999999999888887776543221
Q ss_pred ccCCCCCccccC--CCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 011627 234 PGVSKMPAYNHF--KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298 (481)
Q Consensus 234 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~ 298 (481)
...........+ .............+..++.++++||.+||..||++|||++|||+|+||.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 111000000000 00000011233445678999999999999999999999999999999976433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=365.49 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=209.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++...........+.+|+.+++++. |+||+++++++.+ ...
T Consensus 40 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~----------------~~~ 103 (327)
T 3lm5_A 40 GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN----------------TSE 103 (327)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe----------------CCe
Confidence 89999999999999999999999876555555667889999999995 6999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCeEEeccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~ 156 (481)
+|||||||.+ +|.+++... ...+++.+++.++.||+.||+|||+++|+||||||+||||+. ++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 9999999986 676666543 356999999999999999999999999999999999999988 78999999999987
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.... ......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+...........
T Consensus 184 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---- 256 (327)
T 3lm5_A 184 IGHA--CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET---- 256 (327)
T ss_dssp C-----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT----
T ss_pred cCCc--cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh----
Confidence 6432 22344578999999999976 6789999999999999999999999999999888888776543332221
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+..++..+++||.+||..||++|||++|||+|+||+..
T Consensus 257 ----------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 257 ----------------------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp ----------------------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred ----------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 12467789999999999999999999999999999654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=388.30 Aligned_cols=246 Identities=33% Similarity=0.533 Sum_probs=211.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||++...... ......+.+|+.++++|+||||+++++++.+ .+.
T Consensus 37 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~ 100 (484)
T 3nyv_A 37 GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED----------------KGY 100 (484)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----------------CCE
Confidence 89999999999999999999999766432 3345678899999999999999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~ 157 (481)
+|||||||.+ +|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+|+.+
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999986 666666543 469999999999999999999999999999999999999 45678999999999876
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
.. .......++|+.|+|||++.+ .++.++||||||||+|+|++|+.||.+.+..+.+.++..........
T Consensus 180 ~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------ 249 (484)
T 3nyv_A 180 EA--SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP------ 249 (484)
T ss_dssp CC--CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG------
T ss_pred cc--ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc------
Confidence 43 233455678999999999976 58999999999999999999999999999999888887643222211
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+..++.++++||++||..||++|||+.|+|+||||+.
T Consensus 250 --------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 250 --------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp --------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred --------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 23457889999999999999999999999999999964
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=375.64 Aligned_cols=276 Identities=36% Similarity=0.600 Sum_probs=215.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.++++++|+||+++++++...... .....+
T Consensus 35 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~~~~ 104 (353)
T 3coi_A 35 GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL----------RNFYDF 104 (353)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG----------GGCCCC
T ss_pred CCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc----------ccceeE
Confidence 8999999999999999999999986554444456778999999999999999999999863211 112356
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||||||+.++|...+.. .+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 105 ~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--- 178 (353)
T 3coi_A 105 YLVMPFMQTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--- 178 (353)
T ss_dssp EEEEECCSEEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred EEEeccccCCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC---
Confidence 99999999988776643 489999999999999999999999999999999999999999999999999976532
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc-
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA- 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 241 (481)
.....++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+....+.+....+........
T Consensus 179 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred -CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 233457799999999998756789999999999999999999999999999999999888776654433222111000
Q ss_pred -cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 -YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+....+ ..........+..++.++++||.+||..||++|||++|+|+|+||...
T Consensus 258 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 258 SYIQSLP-QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHTSC-BCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHhCc-CCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000000 000011122334678899999999999999999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=389.32 Aligned_cols=246 Identities=29% Similarity=0.489 Sum_probs=206.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++...........+.+|+.++++|+||||+++++++.+ ...+
T Consensus 48 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~~ 111 (494)
T 3lij_A 48 GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED----------------KRNY 111 (494)
T ss_dssp C---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEE
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----------------CCEE
Confidence 899999999999999999999998765444456678899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC---CCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE---GNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~---~~vkL~DFG~a~~~~ 158 (481)
|||||||.+ +|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+||||+.. +.+||+|||+|+.+.
T Consensus 112 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999986 666655543 469999999999999999999999999999999999999764 459999999998765
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .......++|+.|+|||++.+ .++.++||||||||+|+|++|..||.+.+..+.+..+...........
T Consensus 191 ~--~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 260 (494)
T 3lij_A 191 N--QKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE------ 260 (494)
T ss_dssp T--TBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG------
T ss_pred C--CccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh------
Confidence 3 233455688999999999864 689999999999999999999999999999998888876543332222
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+..++.++++||++||..||++|||+.|+|+||||+.
T Consensus 261 --------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 --------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp --------------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred --------------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 2357889999999999999999999999999999954
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=387.52 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=198.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++... ........+.+|+.++++++|+||+++++++.+ .+.
T Consensus 159 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----------------~~~ 222 (446)
T 4ejn_A 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----------------HDR 222 (446)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE----------------TTE
T ss_pred CcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee----------------CCE
Confidence 899999999999999999999998652 222334567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+|||||||.+ +|...+.. ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999987 55555543 3469999999999999999999998 9999999999999999999999999999976432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
........++|+.|+|||++.+ ..++.++||||||||+|||++|+.||...+..+.+..+.......
T Consensus 302 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 368 (446)
T 4ejn_A 302 -DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF----------- 368 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------
T ss_pred -CCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence 2233455788999999999986 678999999999999999999999999999888888776532111
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
...+++++.+||.+||..||++|+ |++|||+|+||..
T Consensus 369 -------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 369 -------------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp -------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred -------------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 123678899999999999999999 9999999999954
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=389.45 Aligned_cols=247 Identities=32% Similarity=0.511 Sum_probs=209.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.++++|+||||+++++++.+ ...+
T Consensus 33 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~~ 96 (486)
T 3mwu_A 33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----------------SSSF 96 (486)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEE
T ss_pred cCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc----------------CCEE
Confidence 899999999999999999999998665444456678899999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~ 158 (481)
|||||||.+ +|.+.+... ..+++.+++.++.||+.||.|||+++|+||||||+||||+. ++.+||+|||+|+.+.
T Consensus 97 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999986 666665543 46999999999999999999999999999999999999954 4579999999998664
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .......++|+.|+|||++.+ .++.++||||||||+|+|++|+.||.+.+..+.+..+..........
T Consensus 176 ~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------- 244 (486)
T 3mwu_A 176 Q--NTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP------- 244 (486)
T ss_dssp C--C----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG-------
T ss_pred C--CCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc-------
Confidence 3 233455678999999999976 58999999999999999999999999999999888886643222211
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.+..+++++++||++||..||++|||+.++|+||||+..
T Consensus 245 -------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 245 -------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp -------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred -------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 234578899999999999999999999999999999653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=374.67 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=189.3
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
-|+||+||+|++..+++.||||++..... ....+.+|+.++++|+|+||+++++++.+ ...
T Consensus 30 ~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~ 90 (361)
T 3uc3_A 30 SGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILT----------------PTH 90 (361)
T ss_dssp SSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSE
T ss_pred cCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEee----------------CCE
Confidence 38999999999999999999999975432 23567899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC--eEEeccccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN--LKLADFGLARSFS 158 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~--vkL~DFG~a~~~~ 158 (481)
+|||||||.+ +|...+... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||+|+...
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999975 666666443 46999999999999999999999999999999999999987765 9999999997533
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH----HHHHHHHHhcCCCCCCCCc
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA----EQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~ 234 (481)
. .......++|+.|+|||++.+....+.++||||||||+|+|++|+.||...+.. ..+..+.......+.
T Consensus 170 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 243 (361)
T 3uc3_A 170 L--HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD---- 243 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT----
T ss_pred c--cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC----
Confidence 2 223344578999999999987443445589999999999999999999876543 333333221111100
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...++.++++||.+||..||++|||+.|||+|+||...
T Consensus 244 ------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 244 ------------------------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ------------------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ------------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 01367889999999999999999999999999999653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=357.50 Aligned_cols=245 Identities=29% Similarity=0.392 Sum_probs=200.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++...... .....+.+|++++++|+|+||+++++++.+ ...+
T Consensus 33 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~ 95 (285)
T 3is5_A 33 GAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFED----------------YHNM 95 (285)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEE
T ss_pred CCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheec----------------CCeE
Confidence 89999999999999999999999876433 235678899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc---CCCCeEEecccccc
Q 011627 83 YMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID---NEGNLKLADFGLAR 155 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~---~~~~vkL~DFG~a~ 155 (481)
||||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+++|+||||||+||||+ .++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999986 77766643 235699999999999999999999999999999999999994 45789999999997
Q ss_pred cccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.+... .......+|+.|+|||++.+ .++.++||||||||+|+|++|+.||.+.+..+....+.........
T Consensus 176 ~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 246 (285)
T 3is5_A 176 LFKSD--EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV----- 246 (285)
T ss_dssp C------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-----
T ss_pred ecCCc--ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc-----
Confidence 65432 23344578999999999864 6789999999999999999999999998887776666442211110
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....+++++.+||++||..||++|||+.|||+|+||+.
T Consensus 247 ----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 247 ----------------------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ------------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----------------------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 01125778999999999999999999999999999963
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=355.43 Aligned_cols=243 Identities=31% Similarity=0.428 Sum_probs=207.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||+|++...... ....+.+|+.++++|+|+||+++++++.+ ...+
T Consensus 20 G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 81 (277)
T 3f3z_A 20 GSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED----------------NTDI 81 (277)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEE
T ss_pred cCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec----------------CCeE
Confidence 89999999999999999999999865432 35578899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~ 158 (481)
||||||+.+ +|.+.+... ..+++.+++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||++..+.
T Consensus 82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999986 666655543 458999999999999999999999999999999999999 778899999999998764
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. ........+|+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+.+..+.+......
T Consensus 161 ~--~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 227 (277)
T 3f3z_A 161 P--GKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP--------- 227 (277)
T ss_dssp T--TSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred C--ccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence 3 233445578999999999875 489999999999999999999999999998888887765322111
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
...+..+++++.+||.+||..||++|||+.++|+|+||.
T Consensus 228 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 228 -----------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp -----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred -----------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 122345788999999999999999999999999999994
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=368.86 Aligned_cols=290 Identities=34% Similarity=0.574 Sum_probs=213.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++..... .....+.+|+.++++|+|+||+++++++......... ..........+
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~--~~~~~~~~~~~ 97 (320)
T 2i6l_A 22 GGNGLVFSAVDNDCDKRVAIKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD--DVGSLTELNSV 97 (320)
T ss_dssp ----CEEEEEETTTTEEEEEEEEECCSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC------CCSCSEE
T ss_pred CCCeEEEEEEECCCCeEEEEEEEecCCh--HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc--ccccccccCce
Confidence 7899999999999999999999975532 2345778999999999999999999998764321100 00111235689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-CCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||++++|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+||||+ .++.+||+|||+++......
T Consensus 98 ~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 175 (320)
T 2i6l_A 98 YIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175 (320)
T ss_dssp EEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC----
T ss_pred eEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCc
Confidence 99999999988887754 4689999999999999999999999999999999999997 45689999999998654321
Q ss_pred --CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC-
Q 011627 162 --NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK- 238 (481)
Q Consensus 162 --~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 238 (481)
........+|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+...........+.....
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (320)
T 2i6l_A 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSV 255 (320)
T ss_dssp ----CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTT
T ss_pred ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhc
Confidence 12233456699999999987656789999999999999999999999999999888888876544332211111100
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~ 299 (481)
++.+.... ..............++.++++||++||..||++|||++|+|+|+||+....+
T Consensus 256 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 256 IPVYIRND-MTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp SCHHHHHH-TTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred Cccccccc-ccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 00000000 0000112234445789999999999999999999999999999999765443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=363.86 Aligned_cols=248 Identities=24% Similarity=0.356 Sum_probs=195.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... .....+.+|+.+++++ +|+||+++++++.+ .+.
T Consensus 24 G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----------------~~~ 85 (316)
T 2ac3_A 24 GAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEE----------------EDR 85 (316)
T ss_dssp CSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTE
T ss_pred CceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEee----------------CCE
Confidence 8999999999999999999999976532 3456788999999995 79999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---eEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG~a~~~ 157 (481)
+||||||+.+ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||++..+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999985 777666543 46899999999999999999999999999999999999998776 999999999765
Q ss_pred cCCC------CCccccccccccCCCchhhcCC----CCCCCCCchhhHHHHHHHHHhCCCCCCCCCh-------------
Q 011627 158 SYDH------NNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNE------------- 214 (481)
Q Consensus 158 ~~~~------~~~~~~~~gt~~Y~aPEvl~~~----~~~~~~~DiwSlGvil~elltG~~pf~~~~~------------- 214 (481)
.... .......++|+.|+|||++... ..++.++||||||||+|+|++|+.||...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 4221 1122345689999999998641 3478899999999999999999999987642
Q ss_pred --HHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 011627 215 --AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292 (481)
Q Consensus 215 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~ 292 (481)
...+..+...... .....+..++.++++||++||..||++|||++|+|+|+|
T Consensus 245 ~~~~~~~~i~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 245 CQNMLFESIQEGKYE--------------------------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHHHHHCCCC--------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHHHHhccCcc--------------------------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 1222333221100 001223467889999999999999999999999999999
Q ss_pred CCC
Q 011627 293 FWT 295 (481)
Q Consensus 293 f~~ 295 (481)
|..
T Consensus 299 ~~~ 301 (316)
T 2ac3_A 299 VQG 301 (316)
T ss_dssp CC-
T ss_pred hcC
Confidence 964
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=376.99 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=192.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHh-cCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKK-LQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~-L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++. ...+.+|+.++.+ ++|+||++++++|..... ...+
T Consensus 73 G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~------------~~~~ 133 (400)
T 1nxk_A 73 GINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA------------GRKC 133 (400)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET------------TEEE
T ss_pred ccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeeccc------------CCcE
Confidence 8999999999999999999999963 2356789998854 589999999999864110 1457
Q ss_pred EEEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCeEEeccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~ 156 (481)
+|||||||.+ +|.+++.... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+. ++.+||+|||+++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 8999999986 7877776543 46999999999999999999999999999999999999998 78899999999986
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCCCCC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE----QLSKIFELCGSPDETI 232 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~----~~~~i~~~~~~~~~~~ 232 (481)
... .......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+... ....+..........
T Consensus 214 ~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~- 289 (400)
T 1nxk_A 214 TTS--HNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP- 289 (400)
T ss_dssp CC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT-
T ss_pred cCC--CCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc-
Confidence 542 233455688999999999876 678999999999999999999999998765432 233333221111111
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.+..++.++++||++||..||++|||+.|||+|+||+..
T Consensus 290 -------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 290 -------------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp -------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 123578899999999999999999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=366.86 Aligned_cols=251 Identities=27% Similarity=0.398 Sum_probs=204.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC---cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..+++.||||++.... ........+.+|+.++++|+|+||+++++++.+ .
T Consensus 37 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~ 100 (345)
T 3hko_A 37 GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED----------------E 100 (345)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------S
T ss_pred cCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc----------------C
Confidence 899999999999999999999997542 123345678899999999999999999999987 6
Q ss_pred CeEEEEEecCCC-ChhhhhcC---------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 011627 80 GSTYMVFEYMDH-DLTGLADR---------------------------------------PGLRFTVPQIKCYMKQLLTG 119 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~---------------------------------------~~~~l~~~~i~~i~~Qil~g 119 (481)
+.+|||||||.+ +|.+++.. ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 689999999975 66665531 01124678899999999999
Q ss_pred HHHHHhCCcccCCCCCCcEEEcCCC--CeEEecccccccccCCCC---CccccccccccCCCchhhcCC-CCCCCCCchh
Q 011627 120 LHYCHVNQVLHRDIKGSNLLIDNEG--NLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGA-TKYGPAVDMW 193 (481)
Q Consensus 120 L~~LH~~giiHrDLKp~NILl~~~~--~vkL~DFG~a~~~~~~~~---~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~Diw 193 (481)
|+|||+++|+||||||+||||+.++ .+||+|||+++.+..... .......+|+.|+|||++.+. ..++.++|||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999999999999999999998776 899999999986543221 123456789999999998642 5688999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHh
Q 011627 194 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKM 273 (481)
Q Consensus 194 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 273 (481)
|||||+|+|++|+.||...+..+.+.++......... ..+..++.++.+||.+|
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN--------------------------PNYNVLSPLARDLLSNL 314 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS--------------------------GGGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC--------------------------cccccCCHHHHHHHHHH
Confidence 9999999999999999999998888888753322111 11234788999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 011627 274 LMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 274 L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
|..||++|||+.|+|+||||..
T Consensus 315 l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 315 LNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp SCSCTTTSCCHHHHHHSHHHHT
T ss_pred cCCChhHCCCHHHHhcChhhcc
Confidence 9999999999999999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=356.71 Aligned_cols=242 Identities=30% Similarity=0.476 Sum_probs=203.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++.... ........+.+|+.++++++|+||+++++++.+ ...
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~ 83 (279)
T 3fdn_A 20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----------------ATR 83 (279)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec----------------CCE
Confidence 899999999999999999999997543 222334567899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+++ +|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 9999999986 666655443 4689999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.......+
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 227 (279)
T 3fdn_A 162 --SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----------- 227 (279)
T ss_dssp --------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----------
T ss_pred --ccccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC-----------
Confidence 22344578999999999976 6788999999999999999999999999988888877765322111
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..++.++.+||.+||..||++|||++|||+|+||..
T Consensus 228 -------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 228 -------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp -------------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred -------------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 136678999999999999999999999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=386.02 Aligned_cols=247 Identities=32% Similarity=0.485 Sum_probs=208.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-----------CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-----------EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 71 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-----------~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~ 71 (481)
|+||+||+|+++.+++.||||++...... +.....+.+|+.++++|+||||+++++++.+
T Consensus 47 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------- 117 (504)
T 3q5i_A 47 GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED--------- 117 (504)
T ss_dssp --CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC---------
T ss_pred cCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc---------
Confidence 89999999999999999999999865322 1345678899999999999999999999987
Q ss_pred CCCCCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CeE
Q 011627 72 RPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLK 147 (481)
Q Consensus 72 ~~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~---~vk 147 (481)
...+|||||||.+ +|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++ .+|
T Consensus 118 -------~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 118 -------KKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp -------SSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred -------CCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 6789999999986 666666543 4699999999999999999999999999999999999999876 699
Q ss_pred EecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 011627 148 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 227 (481)
Q Consensus 148 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 227 (481)
|+|||+|+.+.. .......++|+.|+|||++.+ .++.++||||||||+|+|++|..||.+.+..+.+..+......
T Consensus 190 l~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 190 IVDFGLSSFFSK--DYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp ECCCTTCEECCT--TSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EEECCCCEEcCC--CCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999987643 233455678999999999864 5899999999999999999999999999999888888653211
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 228 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.. ...+..++.++++||++||..||++|||++|+|+|+||+..
T Consensus 266 ~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 266 FD--------------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CC--------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CC--------------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 11 12345688999999999999999999999999999999653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=351.78 Aligned_cols=247 Identities=31% Similarity=0.448 Sum_probs=203.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++..... .....+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 80 (276)
T 2yex_A 18 GAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE----------------GNIQ 80 (276)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc----------------CCEE
Confidence 89999999999999999999999865432 245677899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+++ +|.+.+.. ...+++.+++.++.||+.||+|||+++|+|+||||+||||+.++.+||+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999986 66666543 4569999999999999999999999999999999999999999999999999998654322
Q ss_pred -CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 -NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 -~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.......++|..|+|||++.+...++.++|||||||++|+|++|+.||...+... .+..+......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------ 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT------------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc------------
Confidence 1223445789999999999864445778999999999999999999998766542 22222211000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...+..++.++++||.+||..||++|||++||++|+||+.
T Consensus 228 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 228 ----------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp ----------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ----------------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 0012357889999999999999999999999999999965
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=355.25 Aligned_cols=245 Identities=28% Similarity=0.456 Sum_probs=182.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++..... .......+.+|+.++++++|+||+++++++.+ .+.
T Consensus 22 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~ 85 (278)
T 3cok_A 22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED----------------SNY 85 (278)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC----------------SSE
T ss_pred CCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc----------------CCe
Confidence 7999999999999999999999975532 22345678899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+++ +|.+++......+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999975 777777766667999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+.++.... ..
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~~-- 230 (278)
T 3cok_A 166 H-EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-----------YE-- 230 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC-----------CC--
T ss_pred C-CcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc-----------cC--
Confidence 2 22234577999999999876 578899999999999999999999998766544333221000 00
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....++.++.+||.+||..||++|||++++|+|+||..
T Consensus 231 -----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 231 -----------------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp -----------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred -----------------CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 01236778999999999999999999999999999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=367.56 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=207.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC------CcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE------GFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDG 75 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~------~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~ 75 (481)
|+||+||+|++..+|+.||||+++...... .....+.+|+.+++++ +|+||+++++++..
T Consensus 105 G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~------------- 171 (365)
T 2y7j_A 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES------------- 171 (365)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-------------
T ss_pred CCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-------------
Confidence 789999999999999999999998654221 1234567899999999 79999999999987
Q ss_pred CCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 76 NKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 76 ~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
...+||||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 172 ---~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 172 ---SSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp ---SSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ---CCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 6689999999987 66666553 346999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccCCCchhhcCC-----CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 011627 155 RSFSYDHNNTLTNRVITLWYRPPELLLGA-----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 229 (481)
Q Consensus 155 ~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~ 229 (481)
..+.. .......++|+.|+|||++.+. ..++.++||||||||+|+|++|+.||...+....+..+........
T Consensus 248 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 248 CHLEP--GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp EECCT--TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred cccCC--CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 87653 2334456789999999998632 3578899999999999999999999999888887777755321111
Q ss_pred CCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 230 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
...+..++.++.+||.+||..||++|||+.|+|+||||.
T Consensus 326 --------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 326 --------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp --------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred --------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 122345788899999999999999999999999999995
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=363.63 Aligned_cols=247 Identities=29% Similarity=0.426 Sum_probs=208.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||+|++..... .......+.+|+.++++|+|+||+++++++.+ .+.
T Consensus 52 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~ 115 (335)
T 2owb_A 52 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----------------NDF 115 (335)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----------------CCe
Confidence 8999999999999999999999986532 22234567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+++ +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 116 ~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999996 56655543 346999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
. .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+.......
T Consensus 195 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 260 (335)
T 2owb_A 195 G-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI------------ 260 (335)
T ss_dssp T-CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC------------
T ss_pred c-ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC------------
Confidence 2 23344578999999999986 578899999999999999999999999988877776665421110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~ 298 (481)
...++.++.+||.+||..||++|||++|+|+|+||+....
T Consensus 261 ------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 261 ------------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 1236778999999999999999999999999999976543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=373.58 Aligned_cols=271 Identities=26% Similarity=0.422 Sum_probs=210.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC--------CCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ--------HENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~--------hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||+||+|++..+++.||||+++... .....+.+|+.++++|+ |+||+++++++.....
T Consensus 48 G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~--------- 115 (397)
T 1wak_A 48 GHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV--------- 115 (397)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET---------
T ss_pred cCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC---------
Confidence 899999999999999999999997432 23456789999999996 7889999999974211
Q ss_pred CCCcCCeEEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCC--------
Q 011627 75 GNKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEG-------- 144 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~-------- 144 (481)
....+||||||++++++..+.... ..+++.+++.|+.||+.||+|||++ +|+||||||+||||+.++
T Consensus 116 ---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 ---NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp ---TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred ---CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 155899999999999888776543 5699999999999999999999998 999999999999998775
Q ss_pred -----------------------------------------CeEEecccccccccCCCCCccccccccccCCCchhhcCC
Q 011627 145 -----------------------------------------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183 (481)
Q Consensus 145 -----------------------------------------~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~ 183 (481)
.+||+|||+|+.... .....++|+.|+|||++.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----~~~~~~gt~~y~aPE~~~~- 267 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIG- 267 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----CSCSCCSCGGGCCHHHHHT-
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----cCccCCCCCcccCChhhcC-
Confidence 799999999987642 2344578999999999987
Q ss_pred CCCCCCCchhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCCCCCC----------ccCCCCCccccCCC
Q 011627 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKN------EAEQLSKIFELCGSPDETIW----------PGVSKMPAYNHFKP 247 (481)
Q Consensus 184 ~~~~~~~DiwSlGvil~elltG~~pf~~~~------~~~~~~~i~~~~~~~~~~~~----------~~~~~~~~~~~~~~ 247 (481)
..++.++||||||||+|+|++|+.||...+ ..+.+..+.+..+.++...+ .............+
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 568999999999999999999999998755 55667777776665433221 11111111111111
Q ss_pred chhhhhhHH---HHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 248 SRTMKRRVR---EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 248 ~~~~~~~~~---~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
... ...+. .....++.++++||.+||..||++|||++|||+||||+
T Consensus 348 ~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 348 WGL-FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCH-HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cch-hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 100 00011 11235677899999999999999999999999999995
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=397.23 Aligned_cols=244 Identities=24% Similarity=0.421 Sum_probs=210.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++.+++.||||+++... ........+++|+.+|..+ +|++|++++++|.+ .+
T Consensus 352 G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----------------~~ 415 (674)
T 3pfq_A 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----------------MD 415 (674)
T ss_dssp TTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC----------------SS
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe----------------CC
Confidence 899999999999999999999998652 2233456778999999988 79999999999987 67
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|..++... ..+++..++.|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+....
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 89999999986 666665543 4699999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......+||+.|+|||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.+|.+.....
T Consensus 495 ~-~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----------- 561 (674)
T 3pfq_A 495 D-GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY----------- 561 (674)
T ss_dssp T-TCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC-----------
T ss_pred C-CcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence 2 233455789999999999976 678999999999999999999999999999999998887532111
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa-----~eiL~h~~f~~ 295 (481)
...++.++++||++||..||++|+++ +||++|+||..
T Consensus 562 -------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 562 -------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp -------------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred -------------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 12478899999999999999999997 99999999964
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=354.74 Aligned_cols=243 Identities=30% Similarity=0.480 Sum_probs=207.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++.... ........+.+|+.++++++|+||+++++++.+ .+.
T Consensus 25 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~ 88 (284)
T 2vgo_A 25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD----------------RKR 88 (284)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc----------------CCE
Confidence 889999999999999999999997553 223344578899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 9999999986 777766543 3689999999999999999999999999999999999999999999999999976542
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......+|..|+|||++.+ ..++.++||||||||+|+|++|..||...+..+....+.......
T Consensus 167 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 231 (284)
T 2vgo_A 167 --LRRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF------------ 231 (284)
T ss_dssp --SCBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC------------
T ss_pred --cccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC------------
Confidence 22334578999999999986 578999999999999999999999999988888777775421110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...++.++++||.+||..||++|||++|+|+|+||+..
T Consensus 232 ------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 232 ------------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ------------------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 02367789999999999999999999999999999643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=360.64 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=195.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCC---------------
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER--------------- 67 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~--------------- 67 (481)
|+||+||+|+++.+++.||||+++... .+.....+.+|+.+|++|+||||++++++|.+.....
T Consensus 17 G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (332)
T 3qd2_B 17 GGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDEST 95 (332)
T ss_dssp C-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccc
Confidence 899999999999999999999998654 2334567889999999999999999999987643210
Q ss_pred --------------------------CCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCCC--CCCHHHHHHHHHHHHH
Q 011627 68 --------------------------DEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGL--RFTVPQIKCYMKQLLT 118 (481)
Q Consensus 68 --------------------------~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~--~l~~~~i~~i~~Qil~ 118 (481)
..-+.......+..+|||||||++ +|.+++.+... ..++..++.++.||+.
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~ 175 (332)
T 3qd2_B 96 DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE 175 (332)
T ss_dssp ------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHH
T ss_pred cccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHH
Confidence 000000001224468999999986 77776665332 3566779999999999
Q ss_pred HHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC-----------CccccccccccCCCchhhcCCCCCC
Q 011627 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-----------NTLTNRVITLWYRPPELLLGATKYG 187 (481)
Q Consensus 119 gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-----------~~~~~~~gt~~Y~aPEvl~~~~~~~ 187 (481)
||+|||+++|+||||||+||||+.++.+||+|||+++....... ......++|+.|+|||++.+ ..++
T Consensus 176 aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 254 (332)
T 3qd2_B 176 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYS 254 (332)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC-CCCC
T ss_pred HHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC-CCCc
Confidence 99999999999999999999999999999999999987654321 22344578999999999987 5789
Q ss_pred CCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHH
Q 011627 188 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHAL 267 (481)
Q Consensus 188 ~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (481)
.++||||||||+|+|++|..++.. ....+..+... .....+...+++++
T Consensus 255 ~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 255 HKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL-----------------------------KFPLLFTQKYPQEH 303 (332)
T ss_dssp THHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT-----------------------------CCCHHHHHHCHHHH
T ss_pred chhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc-----------------------------CCCcccccCChhHH
Confidence 999999999999999998655321 11111111110 11123345677889
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 268 ELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 268 ~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
+||.+||+.||++|||++|+|+|+||.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIENAIFE 330 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHSTTCC
T ss_pred HHHHHHccCCCCcCCCHHHHhhchhhh
Confidence 999999999999999999999999995
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=373.98 Aligned_cols=248 Identities=29% Similarity=0.443 Sum_probs=192.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc------CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE------KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++..+++.||||++..... .......+.+|+.+|++|+|+||+++++++..
T Consensus 146 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------------- 211 (419)
T 3i6u_A 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-------------- 211 (419)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--------------
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--------------
Confidence 8999999999999999999999976531 11223457899999999999999999999863
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CeEEeccc
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFG 152 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG 152 (481)
..+|||||||.+ +|.+.+.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||
T Consensus 212 ---~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 ---EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ---SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ---CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 357999999986 56565554 45799999999999999999999999999999999999997654 49999999
Q ss_pred ccccccCCCCCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 011627 153 LARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 230 (481)
Q Consensus 153 ~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 230 (481)
+|+.+.. .......++|+.|+|||++.+ ...++.++||||||||+|+|++|+.||........+...+....
T Consensus 288 ~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~---- 361 (419)
T 3i6u_A 288 HSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK---- 361 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC----
T ss_pred cceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC----
Confidence 9987642 233445678999999999853 34678899999999999999999999987554333322221100
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.......+..++.++++||.+||..||++|||++|+|+||||+.
T Consensus 362 ---------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 362 ---------------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ---------------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------------------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 00122345568899999999999999999999999999999953
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=355.23 Aligned_cols=248 Identities=22% Similarity=0.294 Sum_probs=202.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..++..||+|++............+.+|+.++++|+|+||+++++++..... ....+
T Consensus 37 G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------------~~~~~ 104 (290)
T 1t4h_A 37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK------------GKKCI 104 (290)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS------------SCEEE
T ss_pred CCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC------------CCceE
Confidence 899999999999999999999998765444445678899999999999999999999875321 14578
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEc-CCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLID-NEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g--iiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~ 158 (481)
||||||+++ +|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999986 66666654 346899999999999999999999999 99999999999998 78899999999997543
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||........+.........+
T Consensus 184 ~---~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 248 (290)
T 1t4h_A 184 A---SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 248 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred c---cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc----------
Confidence 2 23344578999999998874 58999999999999999999999998866555444433211000
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
......+++++.+||.+||..||++|||++|||+|+||..
T Consensus 249 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 249 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 0112245678999999999999999999999999999965
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=357.26 Aligned_cols=247 Identities=19% Similarity=0.271 Sum_probs=189.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...........+.++..+++.++|+||+++++++.+ .+.+
T Consensus 18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----------------~~~~ 81 (290)
T 3fme_A 18 GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR----------------EGDV 81 (290)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSSE
T ss_pred CCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec----------------cCCE
Confidence 899999999999999999999997654333333334455556888899999999999987 6679
Q ss_pred EEEEecCCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
||||||++++|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 82 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 82 WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999987665543 456799999999999999999999998 99999999999999999999999999997664
Q ss_pred CCCCCccccccccccCCCchhhc---CCCCCCCCCchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCc
Q 011627 159 YDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~---~~~~~~~~~DiwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
.. .......+|+.|+|||++. ....++.++||||||||+|+|++|+.||.. ......+..+.........
T Consensus 162 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 235 (290)
T 3fme_A 162 DD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP---- 235 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC----
T ss_pred cc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc----
Confidence 32 2233346899999999972 335688899999999999999999999986 4444455544432111000
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...++.++.+||.+||..||++|||+.|+|+||||+.
T Consensus 236 ------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 236 ------------------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ------------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ------------------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 1246778999999999999999999999999999953
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=367.82 Aligned_cols=238 Identities=25% Similarity=0.377 Sum_probs=197.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC------cchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|+++.+++.||||+++....... ....+.+|+.++++|+|+||+++++++.+
T Consensus 35 G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-------------- 100 (335)
T 3dls_A 35 GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-------------- 100 (335)
T ss_dssp SSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--------------
T ss_pred cCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--------------
Confidence 8999999999999999999999987643221 33456789999999999999999999987
Q ss_pred CcCCeEEEEEecCCC--ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 77 KYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g--~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
.+.++|||||+.. +|..++.. ...+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++
T Consensus 101 --~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 101 --QGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp --SSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred --CCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 6789999999864 56666554 346999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 155 RSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 155 ~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
+.+.. .......++|+.|+|||++.+...++.++||||||||+|+|++|+.||...... .. .
T Consensus 178 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~---~------- 239 (335)
T 3dls_A 178 AYLER--GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE---A------- 239 (335)
T ss_dssp EECCT--TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT---T-------
T ss_pred eECCC--CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh---h-------
Confidence 87643 233445678999999999987444588999999999999999999999653210 00 0
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
... ....++.++.+||.+||..||++|||++|||+|+||+.
T Consensus 240 -~~~-------------------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 240 -AIH-------------------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp -CCC-------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred -ccC-------------------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 000 01136788999999999999999999999999999964
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=354.90 Aligned_cols=248 Identities=29% Similarity=0.427 Sum_probs=208.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||+|++...... ......+.+|+.++++++|+||+++++++.+ .+.
T Consensus 26 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~ 89 (294)
T 2rku_A 26 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----------------NDF 89 (294)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSE
T ss_pred cCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc----------------CCE
Confidence 89999999999999999999999865322 2234567789999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+++ +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999996 55555543 346999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
. .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 234 (294)
T 2rku_A 169 G-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI------------ 234 (294)
T ss_dssp T-CCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC------------
T ss_pred c-cccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCC------------
Confidence 2 22344578999999999876 568899999999999999999999999988877766664321100
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~ 299 (481)
...++.++.+||.+||..||++|||++|+|+|+||.....+
T Consensus 235 ------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 235 ------------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ------------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 12367789999999999999999999999999999765443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=356.63 Aligned_cols=245 Identities=28% Similarity=0.425 Sum_probs=205.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++..... ....+.+|+.++++|+|+||+++++++.+ ...+
T Consensus 20 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 81 (304)
T 2jam_A 20 GAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYES----------------TTHY 81 (304)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEE
T ss_pred CCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhccc----------------CCEE
Confidence 89999999999999999999999865332 23467899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~ 158 (481)
||||||+.+ +|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999985 676666543 368999999999999999999999999999999999999 678889999999997543
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. ......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+.+.........
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 230 (304)
T 2jam_A 161 N---GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF------ 230 (304)
T ss_dssp C---BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT------
T ss_pred C---CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc------
Confidence 2 22344568999999999876 5789999999999999999999999999998888888765432222111
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+..++.++.+||.+||..||++|||++|+|+|+||...
T Consensus 231 --------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 231 --------------------WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp --------------------TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred --------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 12467889999999999999999999999999999653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=357.07 Aligned_cols=268 Identities=32% Similarity=0.526 Sum_probs=202.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++... ...+.+|+.++++|+ |+||+++++++.+.. ...
T Consensus 47 G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~--------------~~~ 107 (330)
T 3nsz_A 47 GKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPV--------------SRT 107 (330)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--------------TCC
T ss_pred cCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC--------------CCc
Confidence 899999999999999999999987432 357889999999997 999999999998632 457
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~ 159 (481)
++|||||+.+ +|..++. .+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 108 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 8999999986 5555543 389999999999999999999999999999999999999777 799999999986643
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP-GKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .......+|..|+|||++.+...++.++||||||||+|+|++|+.||. ..+..+.+..+....+......+-....
T Consensus 184 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 G--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp T--CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred C--CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 2 234455789999999999875678999999999999999999998884 4555566655554333211000000000
Q ss_pred ---CCcc----ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 ---MPAY----NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ---~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+.+ ...................++.++++||.+||..||++|||++|||+||||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 0000 00000000000001112347899999999999999999999999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=370.94 Aligned_cols=248 Identities=28% Similarity=0.411 Sum_probs=197.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC--CCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ--HENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~--hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++.. ++.||||+++...........+.+|+.+|++|+ |+||+++++++.. ..
T Consensus 67 G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~----------------~~ 129 (390)
T 2zmd_A 67 GGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----------------DQ 129 (390)
T ss_dssp CSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SS
T ss_pred CCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec----------------CC
Confidence 8999999999865 999999999876554445567889999999997 5999999999987 66
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
.+|||||+..++|.+++.... .+++.+++.|+.||+.||+|||+++|+||||||+||||+ ++.+||+|||+++.+...
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 799999977778888777643 689999999999999999999999999999999999996 578999999999876533
Q ss_pred CC-CccccccccccCCCchhhcCC----------CCCCCCCchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCC
Q 011627 161 HN-NTLTNRVITLWYRPPELLLGA----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGSP 228 (481)
Q Consensus 161 ~~-~~~~~~~gt~~Y~aPEvl~~~----------~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~~ 228 (481)
.. ......++|+.|+|||++.+. ..++.++||||||||||+|++|+.||..... ...+..+......
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~- 286 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE- 286 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC-
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc-
Confidence 22 123456789999999998651 3578899999999999999999999987543 3444444321111
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
..++ ...+.++++||.+||..||++|||+.|||+|+||....
T Consensus 287 --~~~~-------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 287 --IEFP-------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp --CCCC-------------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred --CCCC-------------------------ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 0000 12356799999999999999999999999999997543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=370.72 Aligned_cols=267 Identities=29% Similarity=0.499 Sum_probs=210.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CC-----CccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HE-----NVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hp-----nIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++..+++.||||+++... .....+.+|+.+++.++ |+ +|+++++++..
T Consensus 65 G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-------------- 127 (382)
T 2vx3_A 65 GSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-------------- 127 (382)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--------------
T ss_pred cCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--------------
Confidence 899999999999999999999997432 23456678999999885 55 49999999987
Q ss_pred CcCCeEEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEEc--CCCCeEEecc
Q 011627 77 KYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCH--VNQVLHRDIKGSNLLID--NEGNLKLADF 151 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH--~~giiHrDLKp~NILl~--~~~~vkL~DF 151 (481)
.+.+||||||++++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+||||+ .++.+||+||
T Consensus 128 --~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 128 --RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp --TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred --CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 67899999999999988887654 45999999999999999999999 57999999999999995 4678999999
Q ss_pred cccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 011627 152 GLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 231 (481)
Q Consensus 152 G~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (481)
|+|+.... .....++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+.+.++.+..+.+...
T Consensus 206 G~a~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 206 GSSCQLGQ----RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp TTCEETTC----CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cCceeccc----ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99987642 2345678999999999987 578999999999999999999999999999999999999877765543
Q ss_pred CCccCCC-------CCc-----------cccCCCchhhhhhHHHHHh------------------hhcHHHHHHHHHhcc
Q 011627 232 IWPGVSK-------MPA-----------YNHFKPSRTMKRRVREVFR------------------HFDRHALELLEKMLM 275 (481)
Q Consensus 232 ~~~~~~~-------~~~-----------~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~ll~~~L~ 275 (481)
.+..... ++. ...+.. ...+.+...+. ..+.++++||++||+
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKP--PGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCC--TTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCC--cchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 3221110 000 000000 00011111110 122578999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCC
Q 011627 276 LDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 276 ~dP~~R~sa~eiL~h~~f~~ 295 (481)
.||++|||++|+|+||||+.
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~ 378 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKK 378 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC
T ss_pred CChhhCCCHHHHhcCccccc
Confidence 99999999999999999965
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=382.26 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=204.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++.... .......+.+|+.+|++++|+||++++++|.+ ...
T Consensus 196 G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----------------~~~ 259 (543)
T 3c4z_A 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET----------------KTD 259 (543)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee----------------CCE
Confidence 8999999999999999999999976532 22345577899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~---~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
+|||||||.+ +|...+... ...+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+++.+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999985 666665543 346999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCCCCCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN----EAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~----~~~~~~~i~~~~~~~~~~~~ 233 (481)
.... ......+||+.|+|||++.+ ..++.++||||||||+|||++|+.||...+ ..++...+......
T Consensus 340 ~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~------ 411 (543)
T 3c4z_A 340 KAGQ-TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT------ 411 (543)
T ss_dssp CTTC-CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC------
T ss_pred cCCC-cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC------
Confidence 4322 22344588999999999987 678999999999999999999999998764 34445555432110
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
+...++.++++||++||..||++|++ +++|++||||..
T Consensus 412 ------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 412 ------------------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp ------------------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred ------------------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 01247889999999999999999995 589999999964
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=388.51 Aligned_cols=244 Identities=25% Similarity=0.405 Sum_probs=203.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++.... .......+.+|+.+|++++|+||+++++++.+ ...
T Consensus 195 G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----------------~~~ 258 (576)
T 2acx_A 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----------------KDA 258 (576)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee----------------CCE
Confidence 8999999999999999999999976532 22334567899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+|||||||.+ +|..++.... ..+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+..
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999975 6766665533 3499999999999999999999999999999999999999999999999999987642
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCCCCCcc
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE----AEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.......+||+.|+|||++.+ ..++.++||||||||+|||++|+.||...+. .++...+......
T Consensus 339 --~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~-------- 407 (576)
T 2acx_A 339 --GQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE-------- 407 (576)
T ss_dssp --TCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC--------
T ss_pred --CccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc--------
Confidence 223445689999999999986 5789999999999999999999999987643 3333333321100
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
+...++.++++||++||..||++|+ +++||++|+||..
T Consensus 408 ----------------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 408 ----------------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred ----------------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 0124788999999999999999999 8999999999965
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=352.25 Aligned_cols=248 Identities=26% Similarity=0.416 Sum_probs=207.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-------CCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-------EGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-------~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||+||+|+++.+++.||||+++..... ......+.+|+.+++++. |+||+++++++.+
T Consensus 28 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~------------ 95 (298)
T 1phk_A 28 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET------------ 95 (298)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC------------
T ss_pred CCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc------------
Confidence 78999999999999999999999865421 112345678999999995 9999999999987
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccc
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
...+||||||+.+ +|.+++.. ...+++..++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||+
T Consensus 96 ----~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 ----NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ----CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 6789999999985 67666654 34699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCCchhhc-----CCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLL-----GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 228 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~-----~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 228 (481)
+..+.. ........+|..|+|||++. ....++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 171 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 171 SCQLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp CEECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hhhcCC--CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 987643 22334457899999999985 23457889999999999999999999999988888777776543221
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
... .+..++.++.+||.+||..||++|||+.|+|+|+||..
T Consensus 249 ~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 249 GSP--------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp CTT--------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred Ccc--------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence 111 12357789999999999999999999999999999964
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=350.04 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=204.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC----CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++.||||+++...... .....+.+|+.++++|+|+||+++++++.+
T Consensus 16 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---------------- 79 (283)
T 3bhy_A 16 GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN---------------- 79 (283)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------
T ss_pred cCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----------------
Confidence 899999999999999999999998664322 134577899999999999999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC----CeEEecccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKLADFGL 153 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~----~vkL~DFG~ 153 (481)
...+||||||+.+ +|.+++.. ...+++.+++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 6689999999975 67666654 34689999999999999999999999999999999999998877 799999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
+...... .......+|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+.......
T Consensus 159 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 230 (283)
T 3bhy_A 159 AHKIEAG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF----- 230 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-----
T ss_pred ceeccCC--CcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC-----
Confidence 9876432 22344568999999999876 578999999999999999999999999998888777765422110
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
....+..++..+.+||.+||..||++|||+.|+|+|+||+
T Consensus 231 ---------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 270 (283)
T 3bhy_A 231 ---------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270 (283)
T ss_dssp ---------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred ---------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence 1223456788999999999999999999999999999994
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=362.73 Aligned_cols=248 Identities=29% Similarity=0.427 Sum_probs=196.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCC--CCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--ENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~h--pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++ .+++.||||+++...........+.+|+.+|++|+| +||+++++++.+ ..
T Consensus 20 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----------------~~ 82 (343)
T 3dbq_A 20 GGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----------------DQ 82 (343)
T ss_dssp CSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SS
T ss_pred CCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee----------------CC
Confidence 89999999998 568999999998765544445677899999999987 999999999987 66
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
.+|||||++.++|.+++... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+ ++.+||+|||+++.+...
T Consensus 83 ~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 89999998888888887764 4699999999999999999999999999999999999997 578999999999876533
Q ss_pred CCC-ccccccccccCCCchhhcC----------CCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCC
Q 011627 161 HNN-TLTNRVITLWYRPPELLLG----------ATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGSP 228 (481)
Q Consensus 161 ~~~-~~~~~~gt~~Y~aPEvl~~----------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~~ 228 (481)
... .....++|+.|+|||++.+ ...++.++||||||||+|+|++|+.||..... ...+..+....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--- 237 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN--- 237 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT---
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC---
Confidence 222 2335678999999999863 24678899999999999999999999987543 23333333211
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
....++ ...+.++.+||.+||..||++|||+.|+|+|+||+...
T Consensus 238 ~~~~~~-------------------------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 238 HEIEFP-------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp SCCCCC-------------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cccCCc-------------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 111111 12456799999999999999999999999999997543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=355.21 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=203.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++.... ....+.+|+.++++++|+||+++++++.. .+.+
T Consensus 40 G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 99 (314)
T 3com_A 40 GSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK----------------NTDL 99 (314)
T ss_dssp ---CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEe----------------CCEE
Confidence 789999999999999999999998643 24578899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+++ +|.+++......+++..++.++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT- 178 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT-
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh-
Confidence 999999987 777776645567999999999999999999999999999999999999999999999999999776432
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
........+|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+....+..+....... +
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~-------- 245 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT----F-------- 245 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----C--------
T ss_pred ccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc----c--------
Confidence 222344578999999999976 578999999999999999999999999887766655443321100 0
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.....++.++.+||.+||..||++|||+.++|+|+||+..
T Consensus 246 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 246 ---------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp ---------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred ---------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0012467889999999999999999999999999999653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=350.19 Aligned_cols=245 Identities=30% Similarity=0.432 Sum_probs=198.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++... ........+.+|+.++++++|+||+++++++.+ .+.
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~ 85 (276)
T 2h6d_A 22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST----------------PTD 85 (276)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec----------------CCe
Confidence 899999999999999999999997653 223345678899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+.+ +|.+++... ..+++.+++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999985 776666543 36899999999999999999999999999999999999999999999999999776432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......+|+.|+|||++.+....+.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 230 (276)
T 2h6d_A 165 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI------------ 230 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred --cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC------------
Confidence 223345679999999999874444689999999999999999999999888877777665421110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...++.++.+||.+||..||++|||+.||++|+||+..
T Consensus 231 ------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 231 ------------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 01356789999999999999999999999999999653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=353.67 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=197.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++..... .......+.+|+.++++++|+||+++++++.+ .+.
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----------------~~~ 85 (294)
T 4eqm_A 22 GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE----------------DDC 85 (294)
T ss_dssp ETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC----------------SSE
T ss_pred CCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee----------------CCe
Confidence 8999999999999999999999976533 22334577899999999999999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+++ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+++.+...
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999986 666666543 46999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...+......
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-------------- 229 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-------------- 229 (294)
T ss_dssp ----------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC--------------
T ss_pred cccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC--------------
Confidence 3344445678999999999987 6789999999999999999999999999888776655542110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
..........++..+.+||.+||..||++|++..+.+.+.|.
T Consensus 230 -----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 230 -----------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp -----------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred -----------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 001122234578899999999999999999965555555554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=351.56 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=200.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||+|++..... .....+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 30 G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 91 (302)
T 2j7t_A 30 GAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYH----------------DGKL 91 (302)
T ss_dssp STTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------C-CE
T ss_pred CCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeee----------------CCeE
Confidence 8999999999999999999999976532 235678899999999999999999999987 5688
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.+ +|..++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999986 565555554557999999999999999999999999999999999999999999999999997643211
Q ss_pred CCccccccccccCCCchhhc----CCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 162 NNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~----~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
........+|..|+|||++. ....++.++||||||||+|+|++|+.||...+..+.+..+........
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 242 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-------- 242 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--------
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc--------
Confidence 11123346799999999984 235688999999999999999999999999888877776654321100
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....++.++.+||.+||..||++|||+.+|++|+||..
T Consensus 243 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 243 -------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp -------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred -------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 001246778999999999999999999999999999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=351.66 Aligned_cols=240 Identities=21% Similarity=0.230 Sum_probs=196.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++...........+.+|+.++.++ +|+||+++++++.+ .+.
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~----------------~~~ 85 (289)
T 1x8b_A 22 GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE----------------DDH 85 (289)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE----------------TTE
T ss_pred CCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec----------------CCe
Confidence 7999999999999999999999987655554566788999999999 99999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC--------------
Q 011627 82 TYMVFEYMDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-------------- 143 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~---~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~-------------- 143 (481)
+||||||+++ +|.+++... ...+++.+++.++.||+.||+|||+++|+||||||+||||+.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999976 777776543 2458999999999999999999999999999999999999844
Q ss_pred -----CCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 011627 144 -----GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 218 (481)
Q Consensus 144 -----~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 218 (481)
..+||+|||++...... ....+|..|+|||++.+...++.++||||||||+|+|++|.+++..... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred ccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence 47999999999876432 2245799999999998754667899999999999999999987754432 2
Q ss_pred HHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 219 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..+..... + .+...++.++.+||.+||..||++|||+.|+|+|+||..
T Consensus 238 ~~~~~~~~-------~----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 238 HEIRQGRL-------P----------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHHHTTCC-------C----------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHHHcCCC-------C----------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 22322100 0 011246788999999999999999999999999999964
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=358.38 Aligned_cols=269 Identities=24% Similarity=0.413 Sum_probs=210.6
Q ss_pred cceeEEEEEEE-ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCC------ccceeeEEeCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE-IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN------VIKLKEIVTSPGPERDEQGRPDG 75 (481)
Q Consensus 3 G~fg~Vy~a~~-~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpn------Iv~l~~~~~~~~~~~~~~~~~~~ 75 (481)
|+||+||+|++ ..+++.||||+++... .....+.+|+.+++.++|++ |+++++++.+
T Consensus 25 G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~------------- 88 (339)
T 1z57_A 25 GAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH------------- 88 (339)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-------------
T ss_pred CCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-------------
Confidence 79999999999 5689999999997432 23456788999999997654 9999999987
Q ss_pred CCcCCeEEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC------------
Q 011627 76 NKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN------------ 142 (481)
Q Consensus 76 ~~~~~~~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~------------ 142 (481)
.+.+||||||++++|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.
T Consensus 89 ---~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 89 ---HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp ---TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ---CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 66899999999889988877644 36899999999999999999999999999999999999987
Q ss_pred -------CCCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH
Q 011627 143 -------EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 215 (481)
Q Consensus 143 -------~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 215 (481)
++.+||+|||+++.... .....++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 56799999999976432 2334578999999999986 57899999999999999999999999999998
Q ss_pred HHHHHHHHhcCCCCCCCCccCCCCCcc----ccCCCchhhhhhHHHH----------HhhhcHHHHHHHHHhcccCCCCC
Q 011627 216 EQLSKIFELCGSPDETIWPGVSKMPAY----NHFKPSRTMKRRVREV----------FRHFDRHALELLEKMLMLDPSQR 281 (481)
Q Consensus 216 ~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~----------~~~~~~~~~~ll~~~L~~dP~~R 281 (481)
+.+..+....+..+...+........+ ..+............. ....+.++.+||.+||..||++|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 888888777665443322211110000 0011100001101000 12346789999999999999999
Q ss_pred CCHHHHhcCCCCCC
Q 011627 282 ISAKDALDSEYFWT 295 (481)
Q Consensus 282 ~sa~eiL~h~~f~~ 295 (481)
||++|+|+|+||+.
T Consensus 321 pt~~ell~hp~f~~ 334 (339)
T 1z57_A 321 ITLREALKHPFFDL 334 (339)
T ss_dssp CCHHHHTTSGGGGG
T ss_pred cCHHHHhcCHHHHH
Confidence 99999999999954
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=366.54 Aligned_cols=246 Identities=26% Similarity=0.437 Sum_probs=198.5
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCc--CCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNE--KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++. .+++.||||+++.... .......+.+|+.+|+++ +|+||+++++++..
T Consensus 65 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-------------- 130 (355)
T 1vzo_A 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-------------- 130 (355)
T ss_dssp TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--------------
T ss_pred CCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--------------
Confidence 899999999995 5899999999975431 222344566899999999 69999999999987
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
...+|||||||.+ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+++
T Consensus 131 --~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 --ETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred --CceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 6689999999986 666666543 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCC
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNE----AEQLSKIFELCGSPDE 230 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~~~~~~~ 230 (481)
.+...........++|+.|+|||++.+. ..++.++||||||||||+|++|+.||...+. ......+......
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 284 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--- 284 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC---
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC---
Confidence 7654434444556789999999999752 3478999999999999999999999975432 2333333221100
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
....++..+++||.+||..||++|+ |++|+++|+||..
T Consensus 285 ---------------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 285 ---------------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp ---------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ---------------------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 0124677899999999999999999 9999999999954
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=349.12 Aligned_cols=246 Identities=32% Similarity=0.514 Sum_probs=207.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.++++|+|+||+++++++.+ ...+
T Consensus 33 G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 96 (287)
T 2wei_A 33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----------------SSSF 96 (287)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEE
T ss_pred CCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC----------------CCeE
Confidence 789999999999999999999998766555556788899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~ 158 (481)
||||||+.+ +|.+.+... ..+++.+++.++.||+.||.|||+++|+||||||+||||+.++ .+||+|||++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999975 666665543 3689999999999999999999999999999999999997643 69999999998654
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. .......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+.+..+.........
T Consensus 176 ~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 243 (287)
T 2wei_A 176 QN--TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-------- 243 (287)
T ss_dssp CC--SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--------
T ss_pred CC--CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--------
Confidence 32 22334567999999999875 4889999999999999999999999999888887777653221111
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..+..++.++.+||++||..||++|||+.|+|+|+||..
T Consensus 244 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 244 ------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp ------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred ------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 012346789999999999999999999999999999953
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=351.87 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=206.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc--CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE--KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++..+++.||||+++.... .......+.+|+.++++|+|+||+++++++.... ..
T Consensus 16 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------------~~ 81 (305)
T 2wtk_C 16 GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE--------------KQ 81 (305)
T ss_dssp CSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----------------
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--------------CC
Confidence 8999999999999999999999976532 1234567889999999999999999999986422 55
Q ss_pred eEEEEEecCCCChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+++++.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.....
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 7899999999887776654 345699999999999999999999999999999999999999999999999999987643
Q ss_pred C-CCCccccccccccCCCchhhcCCC-CCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 160 D-HNNTLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 160 ~-~~~~~~~~~gt~~Y~aPEvl~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
. .........+|..|+|||++.+.. .++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--------- 232 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI--------- 232 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---------
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC---------
Confidence 2 222334456899999999987532 24678999999999999999999999988887777765421110
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...++.++.+||.+||..||++|||+.|+++|+||...
T Consensus 233 ---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 233 ---------------------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ---------------------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ---------------------CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 01366789999999999999999999999999999654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=354.14 Aligned_cols=247 Identities=30% Similarity=0.451 Sum_probs=196.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc------CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE------KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++..+++.||||++..... .......+.+|+.++++|+|+||+++++++..
T Consensus 21 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------------- 86 (322)
T 2ycf_A 21 GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-------------- 86 (322)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--------------
T ss_pred CCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--------------
Confidence 8999999999999999999999975431 11223467899999999999999999999875
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---eEEeccc
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFG 152 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG 152 (481)
. .+||||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||
T Consensus 87 --~-~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 87 --E-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp --S-SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred --C-ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 2 37999999986 67666654 457999999999999999999999999999999999999987665 9999999
Q ss_pred ccccccCCCCCccccccccccCCCchhhc--CCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCC
Q 011627 153 LARSFSYDHNNTLTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSKIFELCGSPD 229 (481)
Q Consensus 153 ~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~--~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~~~ 229 (481)
+++.... ........+|+.|+|||++. +...++.++||||||||+|+|++|..||....... ....+.....
T Consensus 163 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 237 (322)
T 2ycf_A 163 HSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY--- 237 (322)
T ss_dssp TCEECCC--CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC---
T ss_pred cceeccc--ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc---
Confidence 9987542 22233456799999999974 23568899999999999999999999998655432 2222322110
Q ss_pred CCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 230 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
......+..++.++.+||.+||..||++|||+.|+|+|+||+.
T Consensus 238 -----------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 238 -----------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -----------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -----------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 0112344568889999999999999999999999999999953
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=363.21 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=200.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++..... ......+.+|+.++++|+|+||+++++++..... ....
T Consensus 23 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~------------~~~~ 90 (311)
T 3ork_A 23 GGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP------------AGPL 90 (311)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET------------TEEE
T ss_pred CCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC------------CCcc
Confidence 89999999999999999999999865432 2334567899999999999999999999876321 1235
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+++ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 6999999985 666666543 46999999999999999999999999999999999999999999999999999866432
Q ss_pred CC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 161 HN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 161 ~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.. ......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+....+......+
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------- 238 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---------- 238 (311)
T ss_dssp ------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC----------
T ss_pred ccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC----------
Confidence 22 22334568999999999987 578999999999999999999999999998887777665422111
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
.......++.++.+||.+||..||++|+++.++|.|+|+.
T Consensus 239 ----------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 239 ----------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp ----------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 1122345788999999999999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=359.76 Aligned_cols=269 Identities=26% Similarity=0.404 Sum_probs=210.2
Q ss_pred cceeEEEEEEEccCC-cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCC------ccceeeEEeCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG-EIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN------VIKLKEIVTSPGPERDEQGRPDG 75 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpn------Iv~l~~~~~~~~~~~~~~~~~~~ 75 (481)
|+||+||+|++..++ +.||||+++... .....+.+|+.++++|+|++ |+.+++++..
T Consensus 30 G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~------------- 93 (355)
T 2eu9_A 30 GTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF------------- 93 (355)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-------------
T ss_pred cCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-------------
Confidence 899999999998887 689999997432 23456778999999998765 8999998887
Q ss_pred CCcCCeEEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE--------------
Q 011627 76 NKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI-------------- 140 (481)
Q Consensus 76 ~~~~~~~~iV~Ey~~g~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl-------------- 140 (481)
.+.+||||||+++++++.+.... ..+++.+++.++.||+.||+|||+++|+||||||+||||
T Consensus 94 ---~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 ---HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp ---TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred ---CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 66899999999999888776644 469999999999999999999999999999999999999
Q ss_pred -----cCCCCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH
Q 011627 141 -----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 215 (481)
Q Consensus 141 -----~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 215 (481)
+.++.+||+|||+++.... .....++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5678899999999976432 2344578999999999986 57899999999999999999999999999998
Q ss_pred HHHHHHHHhcCCCCCCCCccCCCCCcc----ccCCCchhhhhhHHHH----------HhhhcHHHHHHHHHhcccCCCCC
Q 011627 216 EQLSKIFELCGSPDETIWPGVSKMPAY----NHFKPSRTMKRRVREV----------FRHFDRHALELLEKMLMLDPSQR 281 (481)
Q Consensus 216 ~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~----------~~~~~~~~~~ll~~~L~~dP~~R 281 (481)
+.+..+....+..+...+........+ ..+.......+..... ....+.++.+||++||..||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 888888877765543322211110000 0000000000000000 11245689999999999999999
Q ss_pred CCHHHHhcCCCCCC
Q 011627 282 ISAKDALDSEYFWT 295 (481)
Q Consensus 282 ~sa~eiL~h~~f~~ 295 (481)
||+.|+|+|+||..
T Consensus 326 pt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 326 ITLAEALLHPFFAG 339 (355)
T ss_dssp CCHHHHTTSGGGGG
T ss_pred cCHHHHhcChhhcC
Confidence 99999999999964
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=353.74 Aligned_cols=240 Identities=20% Similarity=0.255 Sum_probs=197.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++...... ..+.+|+.++++| +|+||+++++++.+ ...
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~----------------~~~ 79 (330)
T 2izr_A 20 GNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC----------------GKY 79 (330)
T ss_dssp -CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE----------------TTE
T ss_pred cCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec----------------CCc
Confidence 89999999999999999999999765432 3678999999999 99999999999987 668
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC-----eEEeccccccc
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-----LKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~-----vkL~DFG~a~~ 156 (481)
+||||||+.++|.+++......+++..++.|+.||+.||+|||+++|+||||||+||||+.++. +||+|||+++.
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 80 NAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred cEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999987898888766667999999999999999999999999999999999999998887 99999999987
Q ss_pred ccCCCCC------ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCC
Q 011627 157 FSYDHNN------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---EQLSKIFELCGS 227 (481)
Q Consensus 157 ~~~~~~~------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~ 227 (481)
+...... .....++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+.. +.+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~- 237 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR- 237 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-
Confidence 6433221 1245678999999999987 67899999999999999999999999875433 33333322100
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 228 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
..........++ ++.+||.+||..||.+||++.+|++
T Consensus 238 ------------------------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ------------------------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------------------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000111122345 8999999999999999999998874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=353.34 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=202.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...... ....+.+|++++++|+|+||+++++++.... ...+
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------------~~~~ 84 (319)
T 4euu_A 20 GATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETT--------------TRHK 84 (319)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--------------TCCE
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCC--------------CceE
Confidence 899999999999999999999998654332 3456789999999999999999999998632 4478
Q ss_pred EEEEecCCC-ChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----cCCCCeEEecccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLAR 155 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl----~~~~~vkL~DFG~a~ 155 (481)
||||||+.+ +|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999985 7777766533 238999999999999999999999999999999999999 777789999999998
Q ss_pred cccCCCCCccccccccccCCCchhhcC-------CCCCCCCCchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHh
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLG-------ATKYGPAVDMWSVGCIFAELLNGKPILPGKN----EAEQLSKIFEL 224 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~-------~~~~~~~~DiwSlGvil~elltG~~pf~~~~----~~~~~~~i~~~ 224 (481)
.+... ......++|..|+|||++.. ...++.++||||||||+|||++|+.||.... ..+.+.++...
T Consensus 165 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 76432 33345678999999999862 2568899999999999999999999997533 23445555443
Q ss_pred cCCCCCCCCccCCCCCc-cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 011627 225 CGSPDETIWPGVSKMPA-YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291 (481)
Q Consensus 225 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~ 291 (481)
. +...|........ ...+..... ....+...++..+.+||++||+.||++|+|++|+|+|+
T Consensus 243 ~---p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 243 K---PSGAISGVQKAENGPIDWSGDMP---VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp C---CTTCCEEEECSTTCCEEEESSCC---TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred C---CcccchhhhcccCCccccCccCC---cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 2 2222222211110 000000000 00112245777899999999999999999999999885
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=376.43 Aligned_cols=253 Identities=15% Similarity=0.196 Sum_probs=188.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHH---HHHHhcCCCCcccee-------eEEeCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREI---KILKKLQHENVIKLK-------EIVTSPGPERDEQG 71 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei---~il~~L~hpnIv~l~-------~~~~~~~~~~~~~~ 71 (481)
|+||+||+|++..+++.||||+++... ........+.+|+ +++++++|||||+++ +++.+.........
T Consensus 84 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~ 163 (377)
T 3byv_A 84 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163 (377)
T ss_dssp ETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCcccccc
Confidence 899999999999999999999998653 2333456778999 455555899999998 66665321000000
Q ss_pred CC-CCCCcCCeEEEEEecCCCChhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC
Q 011627 72 RP-DGNKYRGSTYMVFEYMDHDLTGLADRPG------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 144 (481)
Q Consensus 72 ~~-~~~~~~~~~~iV~Ey~~g~L~~~~~~~~------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~ 144 (481)
.. ....+-...||||||++++|.+++.... ..+++..++.|+.||+.||+|||+++|+||||||+||||+.++
T Consensus 164 ~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 243 (377)
T 3byv_A 164 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 243 (377)
T ss_dssp ------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred ccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 00 0000001379999999989888776532 1233478888999999999999999999999999999999999
Q ss_pred CeEEecccccccccCCCCCccccccccccCCCchhhcCC----------CCCCCCCchhhHHHHHHHHHhCCCCCCCCCh
Q 011627 145 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNE 214 (481)
Q Consensus 145 ~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~----------~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 214 (481)
.+||+|||+|+... ......++ +.|+|||++.+. ..++.++||||||||+|||++|+.||...+.
T Consensus 244 ~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~ 318 (377)
T 3byv_A 244 GVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318 (377)
T ss_dssp CEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred CEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccc
Confidence 99999999998643 23344567 999999999863 2689999999999999999999999976543
Q ss_pred HHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 215 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
...+..+.. ....++.++++||.+||..||++|||+.|+|+|+||.
T Consensus 319 ~~~~~~~~~----------------------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 319 LGGSEWIFR----------------------------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp -CCSGGGGS----------------------------------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred ccchhhhhh----------------------------------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 322211110 0135778999999999999999999999999999993
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=363.44 Aligned_cols=271 Identities=23% Similarity=0.316 Sum_probs=201.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||+|+++.... ......+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 44 G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 106 (360)
T 3eqc_A 44 GNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS----------------DGEI 106 (360)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE----------------CCEE
Confidence 8999999999999999999999986532 2234577899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
||||||+++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++++||+|||++..+...
T Consensus 107 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999986 676666543 3689999999999999999999996 9999999999999999999999999999765322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG-SPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~ 239 (481)
......+|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+....+..... ......+......
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 2334578999999999986 5789999999999999999999999998876655433321111 0000000000000
Q ss_pred CccccCC----CchhhhhhHHHH---------HhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 240 PAYNHFK----PSRTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~----~~~~~~~~~~~~---------~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....+. ...........+ ...++.++.+||++||..||++|||++|+|+|+||..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 0000000 000000111111 1236889999999999999999999999999999953
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=353.50 Aligned_cols=256 Identities=21% Similarity=0.334 Sum_probs=185.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++...... .....+.+|+.++++++|+||+++++++.. .+.+
T Consensus 26 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 88 (303)
T 2vwi_A 26 GATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVV----------------KDEL 88 (303)
T ss_dssp --CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES----------------SSCE
T ss_pred ccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEee----------------cCCc
Confidence 78999999999999999999998765432 234567899999999999999999999987 5679
Q ss_pred EEEEecCCC-ChhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 83 YMVFEYMDH-DLTGLADR-------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~-------~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
||||||+.+ +|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999975 67666643 3446999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC----CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 011627 155 RSFSYDH----NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 230 (481)
Q Consensus 155 ~~~~~~~----~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 230 (481)
..+.... ........+|+.|+|||++.+...++.++||||||||+|+|++|+.||...+....+............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 7654321 112234567999999999875446889999999999999999999999988776665554432111000
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.. .........++.++.+||.+||..||++|||+.|+|+|+||..
T Consensus 249 ~~--------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 249 TG--------------------VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp C-------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred cc--------------------cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 00 0001112357788999999999999999999999999999954
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=347.63 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=205.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++............+.+|+.++++++|+||+++++++.+.. ...+
T Consensus 17 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~ 82 (279)
T 2w5a_A 17 GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--------------NTTL 82 (279)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG--------------GTEE
T ss_pred CCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC--------------CceE
Confidence 79999999999999999999999876544444567889999999999999999999886421 5689
Q ss_pred EEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEEcCCCCeEEecccc
Q 011627 83 YMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQ-----VLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~g-----iiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
||||||+++ +|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999986 77776654 2345999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
++...... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+....+.......
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----- 235 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR----- 235 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-----
T ss_pred heeecccc-ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc-----
Confidence 97654221 12233467999999999986 578899999999999999999999999988877777775432110
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+...++.++.+||.+||..||++|||+.|||+|+|+..
T Consensus 236 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 236 ------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ------------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 01246778999999999999999999999999999965
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=349.36 Aligned_cols=239 Identities=23% Similarity=0.312 Sum_probs=191.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++ +++.||||++............+.+|+.++++|+|+||+++++++.+ ...+
T Consensus 48 G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~ 109 (309)
T 3p86_A 48 GSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ----------------PPNL 109 (309)
T ss_dssp CSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------TTCC
T ss_pred CCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----------------CCce
Confidence 89999999987 68899999998665444445678899999999999999999999987 5578
Q ss_pred EEEEecCCC-ChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGL--RFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~--~l~~~~i~~i~~Qil~gL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
||||||+.+ +|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999986 77777765432 3899999999999999999999999 999999999999999999999999999754
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
... ........+|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+........
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-------- 259 (309)
T 3p86_A 190 AST-FLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE-------- 259 (309)
T ss_dssp -------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--------
T ss_pred ccc-ccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Confidence 322 222344678999999999986 5789999999999999999999999999888877766643221111
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+...++.++.+||++||..||++|||+++|++
T Consensus 260 --------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 260 --------------------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11246788999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=345.66 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=207.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++..... .....+.+|+.++++++|+||+++++++.+ ...+
T Consensus 33 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 95 (303)
T 3a7i_A 33 GSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK----------------DTKL 95 (303)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEE
T ss_pred cCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEec----------------CCeE
Confidence 89999999999999999999999866433 345678899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++..+....
T Consensus 96 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999986 66666643 468999999999999999999999999999999999999999999999999998765322
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+.......
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 238 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT------------- 238 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------------
T ss_pred -cccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC-------------
Confidence 22344578999999999976 578899999999999999999999999888777666654321100
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
....++..+.+||.+||..||++|||+.|||+|+||...
T Consensus 239 ----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 239 ----------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ----------------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ----------------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 012367789999999999999999999999999999653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.22 Aligned_cols=238 Identities=21% Similarity=0.333 Sum_probs=201.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++. +++.||||++...... ...+.+|+.++++++|+||+++++++.+ ...+
T Consensus 21 G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 80 (269)
T 4hcu_A 21 GQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE----------------QAPI 80 (269)
T ss_dssp CSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS----------------SSSE
T ss_pred CCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEec----------------CCce
Confidence 899999999986 5778999999865432 3468899999999999999999999987 5679
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+++ +|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999986 6777776766679999999999999999999999999999999999999999999999999998664333
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+.+..+........
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 228 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----------- 228 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-----------
T ss_pred cccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC-----------
Confidence 233344456788999999976 578999999999999999999 9999999998888877754321111
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...++.++.+||.+||..||++|||+++++++
T Consensus 229 ------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 229 ------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 01356789999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=358.89 Aligned_cols=274 Identities=27% Similarity=0.447 Sum_probs=206.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-----------CCCccceeeEEeCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-----------HENVIKLKEIVTSPGPERDEQG 71 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-----------hpnIv~l~~~~~~~~~~~~~~~ 71 (481)
|+||+||+|++..+++.||||+++.... ....+.+|+.++++++ |+||+++++++.....
T Consensus 30 G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~------ 100 (373)
T 1q8y_A 30 GHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP------ 100 (373)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET------
T ss_pred cCCeEEEEEEecCCCcEEEEEEecCCcc---chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCC------
Confidence 8999999999999999999999974321 2346778999999987 7899999999986221
Q ss_pred CCCCCCcCCeEEEEEecCCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcC------C
Q 011627 72 RPDGNKYRGSTYMVFEYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDN------E 143 (481)
Q Consensus 72 ~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~------~ 143 (481)
....++|||||+.++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||||+. .
T Consensus 101 ------~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 101 ------NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp ------TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ------CCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 13378999999988888887653 34599999999999999999999998 9999999999999953 3
Q ss_pred CCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC------hHHH
Q 011627 144 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN------EAEQ 217 (481)
Q Consensus 144 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~------~~~~ 217 (481)
+.+||+|||+++.... .....++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+ ..+.
T Consensus 175 ~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCC----CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 4799999999987642 2344578999999999987 578999999999999999999999998754 5566
Q ss_pred HHHHHHhcCCCCCCCCccCC----------CCCccccCC--CchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHH
Q 011627 218 LSKIFELCGSPDETIWPGVS----------KMPAYNHFK--PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 285 (481)
Q Consensus 218 ~~~i~~~~~~~~~~~~~~~~----------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~ 285 (481)
+..+++..+..+...+.... ......... ...........+...++.++.+||.+||+.||++|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 77777766655432211100 000000000 000000111112245778899999999999999999999
Q ss_pred HHhcCCCCCCC
Q 011627 286 DALDSEYFWTD 296 (481)
Q Consensus 286 eiL~h~~f~~~ 296 (481)
|||+||||+..
T Consensus 330 ell~hp~f~~~ 340 (373)
T 1q8y_A 330 GLVNHPWLKDT 340 (373)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhhChhhhcc
Confidence 99999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=370.15 Aligned_cols=267 Identities=16% Similarity=0.142 Sum_probs=182.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhc--CCCCcccee-------eEEeCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKL--QHENVIKLK-------EIVTSPGPERDEQGR 72 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L--~hpnIv~l~-------~~~~~~~~~~~~~~~ 72 (481)
|+||+||+|++..+++.||||+++..... ......+.+|+.+++.| +||||++++ +++.........+..
T Consensus 73 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~ 152 (371)
T 3q60_A 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLS 152 (371)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCS
T ss_pred CCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeecc
Confidence 89999999999999999999999876432 22344556775555555 699988755 455442211000000
Q ss_pred C-CCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC
Q 011627 73 P-DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQI------KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 145 (481)
Q Consensus 73 ~-~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i------~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~ 145 (481)
. ........+|||||||+++|.+++......+.+..+ ..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 153 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~ 232 (371)
T 3q60_A 153 PGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR 232 (371)
T ss_dssp CC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSC
T ss_pred CCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCC
Confidence 0 000012468999999999999888764333444444 567799999999999999999999999999999999
Q ss_pred eEEecccccccccCCCCCccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 011627 146 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 224 (481)
Q Consensus 146 vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 224 (481)
+||+|||+|+.... ......+|+.|+|||++.+. ..++.++||||||||+|+|++|+.||...+...
T Consensus 233 ~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------- 300 (371)
T 3q60_A 233 LMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-------- 300 (371)
T ss_dssp EEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC--------
T ss_pred EEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc--------
Confidence 99999999986532 12245668999999999741 468999999999999999999999998764321
Q ss_pred cCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 225 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
...|........ ... .........++.++.+||.+||..||++|||+.|+|+||||.
T Consensus 301 -----~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 301 -----KGSWKRPSLRVP-GTD-------SLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp -----TTCCCBCCTTSC-CCC-------SCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred -----ccchhhhhhhhc-ccc-------ccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 000110000000 000 000001235788999999999999999999999999999993
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=352.08 Aligned_cols=240 Identities=24% Similarity=0.333 Sum_probs=198.8
Q ss_pred cceeEEEEEEEccCCc---EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..+++ .||||+++.... ......+.+|+.++++|+|+||+++++++.+ .
T Consensus 60 G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~ 122 (325)
T 3kul_A 60 GDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVTR----------------G 122 (325)
T ss_dssp TTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECG----------------G
T ss_pred CCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----------------C
Confidence 8999999999987665 499999975432 2234567899999999999999999999976 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.+||||||+++ +|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 678999999976 7777777666689999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 159 YDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 159 ~~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
..... ......+|..|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+.+..+......+.
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 275 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA------ 275 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC------
T ss_pred cCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC------
Confidence 43222 1222344778999999976 568899999999999999999 9999999998888887765321111
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++|||+.+|++
T Consensus 276 -----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 -----------------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1146778999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=352.87 Aligned_cols=261 Identities=22% Similarity=0.375 Sum_probs=204.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcc---------------hhHHHHHHHHHhcCCCCccceeeEEeCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFP---------------ITAIREIKILKKLQHENVIKLKEIVTSPGPER 67 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~---------------~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~ 67 (481)
|+||+||+|++ +++.||||++.......... ..+.+|+.++++|+|+||+++++++.+
T Consensus 42 G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 114 (348)
T 2pml_X 42 GKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN----- 114 (348)
T ss_dssp CSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES-----
T ss_pred CCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee-----
Confidence 89999999999 99999999998654322111 678899999999999999999999987
Q ss_pred CCCCCCCCCCcCCeEEEEEecCCC-Chhhh------hcCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcE
Q 011627 68 DEQGRPDGNKYRGSTYMVFEYMDH-DLTGL------ADRP-GLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNL 138 (481)
Q Consensus 68 ~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~------~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NI 138 (481)
.+.+||||||+++ +|.++ +... ...+++..++.++.||+.||+|||+ ++|+||||||+||
T Consensus 115 -----------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 115 -----------YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp -----------SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred -----------CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 6689999999987 67665 4332 4579999999999999999999999 9999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCC-CCchhhHHHHHHHHHhCCCCCCCCCh-HH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP-AVDMWSVGCIFAELLNGKPILPGKNE-AE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~-~~DiwSlGvil~elltG~~pf~~~~~-~~ 216 (481)
||+.++.+||+|||++...... ......+|..|+|||++.+...++. ++||||||||+|+|++|+.||...+. .+
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999999999999876432 3445678999999999987435555 89999999999999999999998877 56
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+..+.......+.. +... .. .............++.++.+||.+||..||++|||+.|+|+|+||..
T Consensus 261 ~~~~i~~~~~~~~~~-~~~~-----~~-----~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 261 LFNNIRTKNIEYPLD-RNHF-----LY-----PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHTSCCCCCCCS-SSSS-----TT-----TTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHhccCcCCccc-hhhh-----hc-----cccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 555554321111100 0000 00 00011112233568899999999999999999999999999999954
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=339.78 Aligned_cols=241 Identities=19% Similarity=0.210 Sum_probs=200.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++..... ...+.+|+.+++++ +|+||+++++++.+ ...
T Consensus 21 G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~----------------~~~ 80 (298)
T 1csn_A 21 GSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQE----------------GLH 80 (298)
T ss_dssp CSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEE----------------TTE
T ss_pred cCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCC----------------Cce
Confidence 8999999999999999999999875433 23678999999999 79999999999986 678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC-----eEEeccccccc
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-----LKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~-----vkL~DFG~a~~ 156 (481)
+||||||+.++|.+++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||+++.
T Consensus 81 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 81 NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred eEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999988899888876667999999999999999999999999999999999999987776 99999999987
Q ss_pred ccCCCC------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCC
Q 011627 157 FSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---EAEQLSKIFELCGS 227 (481)
Q Consensus 157 ~~~~~~------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~ 227 (481)
...... .......+|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+ ..+.+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 237 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-- 237 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH--
T ss_pred cccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc--
Confidence 654322 12345578999999999976 578999999999999999999999998743 334444433211
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 228 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...........++.++.+||.+||..||++|||+++|++
T Consensus 238 -----------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 238 -----------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp -----------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------------------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 011123334568899999999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=348.25 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=187.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...........+.++..+++.++|+||+++++++.+ .+.+
T Consensus 36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----------------~~~~ 99 (318)
T 2dyl_A 36 GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT----------------NTDV 99 (318)
T ss_dssp ----CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SSEE
T ss_pred cCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec----------------CCcE
Confidence 789999999999999999999998664433333334455567888899999999999987 6689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||++..+..+.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 100 ~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (318)
T 2dyl_A 100 FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD- 178 (318)
T ss_dssp EEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence 99999996655555554456799999999999999999999995 9999999999999999999999999999765432
Q ss_pred CCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCccC
Q 011627 162 NNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.......+|+.|+|||++.. ...++.++||||||||+|+|++|+.||.. .+..+.+..+........ +.
T Consensus 179 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~- 252 (318)
T 2dyl_A 179 -KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL----PG- 252 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC----CS-
T ss_pred -ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC----Cc-
Confidence 22334567999999999852 34678999999999999999999999987 445555665554221100 00
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
...++.++.+||.+||..||++|||+.|||+|+||.
T Consensus 253 ----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (318)
T 2dyl_A 253 ----------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288 (318)
T ss_dssp ----------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ----------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence 013677899999999999999999999999999994
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=347.59 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=198.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++..... ....+.+|+.+++++ +|+||+++++++...... .....
T Consensus 35 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~----------~~~~~ 101 (326)
T 2x7f_A 35 GTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP----------GMDDQ 101 (326)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC------------CCCCE
T ss_pred CCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc----------cccce
Confidence 7899999999999999999999976532 245788999999999 799999999999863211 11458
Q ss_pred EEEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 82 TYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+||||||+++ +|.+++... ...+++..++.++.||+.||+|||+++|+|+||||+||||+.++.+||+|||++..+..
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 9999999986 777776653 24689999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 160 DHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
. ........+|..|+|||++.. ...++.++||||||||+|+|++|+.||...+....+..+........
T Consensus 182 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 254 (326)
T 2x7f_A 182 T-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL------ 254 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC------
T ss_pred C-ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC------
Confidence 2 122334578999999999863 24688999999999999999999999998887776666543211000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....++.++.+||.+||..||++|||+.++|+|+||+.
T Consensus 255 ----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 255 ----------------------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp ----------------------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred ----------------------CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 01236778999999999999999999999999999965
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=341.86 Aligned_cols=246 Identities=29% Similarity=0.455 Sum_probs=196.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++..... .....+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 33 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 94 (295)
T 2clq_A 33 GTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSE----------------NGFI 94 (295)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTEE
T ss_pred cCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEe----------------CCcE
Confidence 8999999999999999999999976532 235678899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~ 158 (481)
+|||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+++|+|+||||+||||+. ++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999999975 7777665432 34679999999999999999999999999999999999987 8899999999998764
Q ss_pred CCCCCccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCccC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 236 (481)
.. ........+|..|+|||++.+. ..++.++|||||||++|+|++|+.||........ +...... ....
T Consensus 175 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~------- 245 (295)
T 2clq_A 175 GI-NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-KVHP------- 245 (295)
T ss_dssp C------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-CCCC-------
T ss_pred CC-CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-cccc-------
Confidence 32 1223345779999999998753 2378899999999999999999999976543322 2221111 1000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+...++.++.+||.+||..||++|||++|+|+|+||+.
T Consensus 246 --------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 246 --------------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp --------------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred --------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 011246788999999999999999999999999999964
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=344.37 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=194.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++... .....+.+|+.++++++|+||+++++++.+...... ..........+
T Consensus 17 G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~---~~~~~~~~~~~ 90 (303)
T 1zy4_A 17 GAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK---PMTAVKKKSTL 90 (303)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---------CEEEE
T ss_pred CCcEEEEEEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh---hhcccccCCce
Confidence 899999999999999999999997532 234567899999999999999999999876321000 00111225688
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+++ +|.+++......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 170 (303)
T 1zy4_A 91 FIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170 (303)
T ss_dssp EEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC--
T ss_pred EEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhccccc
Confidence 999999985 8888887666678999999999999999999999999999999999999999999999999997654221
Q ss_pred -------------CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCC
Q 011627 162 -------------NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFELCGS 227 (481)
Q Consensus 162 -------------~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~ 227 (481)
........+|..|+|||++.+...++.++|||||||++|+|++ ||... +..+.+..+......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 1zy4_A 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIE 247 (303)
T ss_dssp -----------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCC
T ss_pred chhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccc
Confidence 1223445789999999999865578999999999999999998 45433 333344444322111
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 228 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+.. .....+..+++||++||..||++|||+.++|+|+||..
T Consensus 248 ~~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 248 FPPD--------------------------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp CCTT--------------------------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred cCcc--------------------------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 1100 01235667899999999999999999999999999954
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=355.48 Aligned_cols=241 Identities=26% Similarity=0.403 Sum_probs=197.9
Q ss_pred cceeEEEEEEEc-------cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-------KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~-------~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||+||+|++. .++..||||+++.... ......+.+|+.++++| +|+||+++++++.+
T Consensus 92 G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~------------ 158 (370)
T 2psq_A 92 GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ------------ 158 (370)
T ss_dssp CSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS------------
T ss_pred CCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc------------
Confidence 899999999975 3556899999976532 22345788999999999 89999999999987
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
.+.+||||||+.+ +|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+||
T Consensus 159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 159 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred ----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 5678999999986 7777765432 3589999999999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 216 (481)
||+.++.+||+|||+++.+..... .......+|+.|+|||++.+ ..++.++||||||||+|||++ |..||...+..+
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999986643222 22233456889999999987 678999999999999999999 999999988777
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+..+....... ....++.++.+||.+||..||++|||+.|++++
T Consensus 314 ~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGHRMD-----------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTCCCC-----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 776664321110 012467789999999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=340.58 Aligned_cols=238 Identities=22% Similarity=0.320 Sum_probs=198.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++. ++..||||+++..... ...+.+|++++++|+|+||+++++++.+ ...+
T Consensus 35 G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 94 (283)
T 3gen_A 35 GQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK----------------QRPI 94 (283)
T ss_dssp --CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS----------------SSSE
T ss_pred CCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEec----------------CCCe
Confidence 899999999885 6778999999855332 3568899999999999999999999976 6679
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.+ +|.+++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999975 7777777655679999999999999999999999999999999999999999999999999998664332
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.........
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 243 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---------- 243 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC----------
T ss_pred cccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC----------
Confidence 223333455788999999986 568999999999999999998 99999999988888777653221111
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
..++..+.+||.+||..||++|||++++++|
T Consensus 244 -------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 244 -------------------HLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1356789999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=345.17 Aligned_cols=241 Identities=23% Similarity=0.358 Sum_probs=193.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++.... ......+.+|+.++++|+|+||+++++++.+ .+.+
T Consensus 21 G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~ 82 (310)
T 3s95_A 21 GCFGQAIKVTHRETGEVMVMKELIRFD--EETQRTFLKEVKVMRCLEHPNVLKFIGVLYK----------------DKRL 82 (310)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEESCCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCEEEEEEEECCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCcCcccEEEEEec----------------CCee
Confidence 899999999999999999999985432 2235577899999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+.+ +|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999986 7777777766779999999999999999999999999999999999999999999999999998764322
Q ss_pred CC-------------ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 011627 162 NN-------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 228 (481)
Q Consensus 162 ~~-------------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 228 (481)
.. .....++|+.|+|||++.+ ..++.++||||||||+|+|++|..||........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~----------- 230 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM----------- 230 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT-----------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH-----------
Confidence 21 1124578999999999986 6789999999999999999999988864321100
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.... .............++.++.+||.+||..||++|||++++++
T Consensus 231 ---------------~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 231 ---------------DFGL-NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ---------------TSSB-CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------HHhh-hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000 00000001112456778999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=337.77 Aligned_cols=238 Identities=20% Similarity=0.259 Sum_probs=199.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++. ++..||||+++..... ...+.+|+.++++|+|+||+++++++.+ ...+
T Consensus 19 G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 78 (268)
T 3sxs_A 19 GQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSK----------------EYPI 78 (268)
T ss_dssp ETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSE
T ss_pred CCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEcc----------------CCce
Confidence 899999999875 5778999999755432 3467899999999999999999999976 6678
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
||||||+++ +|.+++......+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999975 6777776655569999999999999999999999999999999999999999999999999998765443
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.........
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 227 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---------- 227 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC----------
T ss_pred hhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC----------
Confidence 333334455778999999976 568899999999999999999 99999998888877776543211110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
..+++++.+||.+||..||++|||+.|++++
T Consensus 228 -------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 228 -------------------HLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -------------------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------CcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1256789999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=355.32 Aligned_cols=244 Identities=18% Similarity=0.291 Sum_probs=198.4
Q ss_pred cceeEEEEEE-----EccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAR-----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~-----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|+ +..+++.||||+++..... .....+.+|+.++++|+|+||+++++++.+
T Consensus 82 G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------------- 145 (367)
T 3l9p_A 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIVRCIGVSLQ--------------- 145 (367)
T ss_dssp CSSSCEEEEEECC-----CCEEEEEEECCSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS---------------
T ss_pred CCCEEEEEEEEccCCCCCcceeEEEEecccccCh-hhHHHHHHHHHHHHhCCCCCCCeEEEEEec---------------
Confidence 8999999999 5667889999999754322 234467899999999999999999999987
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CeE
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPG------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLK 147 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~---~vk 147 (481)
...+|||||||.+ +|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+|
T Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 5567999999975 7877776432 3589999999999999999999999999999999999999555 499
Q ss_pred EecccccccccCCC-CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 011627 148 LADFGLARSFSYDH-NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 225 (481)
Q Consensus 148 L~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 225 (481)
|+|||+|+.+.... ........+|+.|+|||++.+ ..++.++||||||||+|||++ |..||...+..+.+..+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999997653221 222334566899999999976 578999999999999999998 999999999888887776432
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.... ...++.++.+||.+||+.||++|||+.+|+++-++
T Consensus 304 ~~~~-----------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 304 RMDP-----------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp CCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC-----------------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1110 12367789999999999999999999999987655
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=348.02 Aligned_cols=253 Identities=19% Similarity=0.256 Sum_probs=185.2
Q ss_pred cceeEEEEEEEccCCc---EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..+++ .||||+++...........+.+|+.++++|+|+||+++++++...... ...
T Consensus 34 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~ 103 (323)
T 3qup_A 34 GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK----------GRL 103 (323)
T ss_dssp ETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----------------
T ss_pred cCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc----------cCC
Confidence 8999999999988876 899999987654444566788999999999999999999999873211 001
Q ss_pred CeEEEEEecCCC-ChhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~-----~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
...|+||||+.+ +|.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~ 183 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccc
Confidence 235999999986 66665543 222589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 011627 154 ARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDET 231 (481)
Q Consensus 154 a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (481)
++....... .......+|+.|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+....+........
T Consensus 184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 260 (323)
T 3qup_A 184 SRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ-- 260 (323)
T ss_dssp -----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC--
T ss_pred cccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCC--
Confidence 986543221 12223345778999999986 578999999999999999999 9999999888887777754321110
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-------HHHHhcCCCCCC
Q 011627 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-------AKDALDSEYFWT 295 (481)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-------a~eiL~h~~f~~ 295 (481)
...++.++.+||.+||..||++||| ++++++|+|+..
T Consensus 261 ---------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 261 ---------------------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp ---------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred ---------------------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 1236778999999999999999999 788889999964
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=340.34 Aligned_cols=240 Identities=20% Similarity=0.321 Sum_probs=187.3
Q ss_pred cceeEEEEEEEccC---CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKT---GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..+ +..||||+++.... ......+.+|+.++++++|+||+++++++.+
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------- 87 (281)
T 1mp8_A 26 GQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVITE----------------- 87 (281)
T ss_dssp CSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----------------
T ss_pred cCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----------------
Confidence 89999999999764 45799999875432 2234567899999999999999999999843
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.+||||||+.+ +|.+++......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 357999999986 7887777666679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
...........+|+.|+|||++.. ..++.++|||||||++|+|++ |..||...+..+.+..+.......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~--------- 237 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--------- 237 (281)
T ss_dssp -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---------
T ss_pred cccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---------
Confidence 433323333455788999999976 578899999999999999996 999999988887777765421110
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....++.++.+||.+||..||++|||+.|++++
T Consensus 238 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 238 --------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012467889999999999999999999999863
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.09 Aligned_cols=243 Identities=23% Similarity=0.368 Sum_probs=196.2
Q ss_pred cceeEEEEEE-----EccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAR-----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~-----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|+ +..+++.||||+++..... .....+.+|+.++++| +|+||+++++++.+.
T Consensus 33 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~------------- 98 (359)
T 3vhe_A 33 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP------------- 98 (359)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-------------
T ss_pred CCCceEEEEEeccccccccceEEEEEEecCcCCH-HHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-------------
Confidence 8999999999 5677799999999754322 2245678999999999 789999999999762
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCC-----------------------------------------------------
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGL----------------------------------------------------- 102 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~----------------------------------------------------- 102 (481)
...++||||||.+ +|.+++.....
T Consensus 99 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 99 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred --CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 3358999999986 77777655321
Q ss_pred ------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC-Ccccccc
Q 011627 103 ------------RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRV 169 (481)
Q Consensus 103 ------------~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~ 169 (481)
.+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..... .......
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 289999999999999999999999999999999999999999999999999986543222 2333456
Q ss_pred ccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 011627 170 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 248 (481)
Q Consensus 170 gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (481)
+|+.|+|||++.+ ..++.++||||||||+|+|++ |+.||.+.+..+.+............
T Consensus 257 ~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------ 317 (359)
T 3vhe_A 257 LPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA------------------ 317 (359)
T ss_dssp ECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC------------------
T ss_pred CCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC------------------
Confidence 7889999999986 678999999999999999998 99999987765555554433211110
Q ss_pred hhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 249 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...+++++.+||.+||..||++|||++||++|
T Consensus 318 ----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 318 ----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 12367789999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=350.56 Aligned_cols=241 Identities=24% Similarity=0.379 Sum_probs=199.4
Q ss_pred cceeEEEEEEEccCC-------cEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG-------EIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||+||+|++..++ ..||||+++..... .....+.+|+++++++ +|+||+++++++.+
T Consensus 80 G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~------------ 146 (382)
T 3tt0_A 80 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGACTQ------------ 146 (382)
T ss_dssp CSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS------------
T ss_pred CCCeEEEEEEEccccccccccceEEEEEeeccccCH-HHHHHHHHHHHHHHHhcCCchhhhheeeecc------------
Confidence 899999999986443 57999999765322 2345778999999999 99999999999987
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
.+.+||||||+.+ +|.+++.... ..+++.+++.|+.||+.||+|||+++|+||||||+||
T Consensus 147 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 147 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred ----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 5678999999986 7777765432 3599999999999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 216 (481)
||+.++.+||+|||+|+.+..... .......+|+.|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999986643222 22333456889999999987 678999999999999999999 999999988888
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+..+........ ...++.++.+||++||..||++|||++||+++
T Consensus 302 ~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDK-----------------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCC-----------------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCC-----------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7776654321110 01367789999999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.03 Aligned_cols=244 Identities=25% Similarity=0.339 Sum_probs=188.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+|+ .+...+++.||||++.... ...+.+|+.+|+++ +|||||++++++.+ ...
T Consensus 35 G~~G~V~-~~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~----------------~~~ 92 (432)
T 3p23_A 35 GAEGTIV-YRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKD----------------RQF 92 (432)
T ss_dssp CGGGCEE-EEEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEE----------------TTE
T ss_pred CcCEEEE-EEEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec----------------CCE
Confidence 8999976 3556789999999996532 23456899999999 79999999999987 668
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-----CCeEEeccccccc
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-----GNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~-----~~vkL~DFG~a~~ 156 (481)
+|||||||.++|.+++......+.+..++.++.||+.||+|||+++|+||||||+||||+.+ ..+||+|||+|+.
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999999999999988777667777788999999999999999999999999999999532 3588999999987
Q ss_pred ccCCCC--CccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 011627 157 FSYDHN--NTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDET 231 (481)
Q Consensus 157 ~~~~~~--~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (481)
+..... ......++|+.|+|||++.+ ...++.++||||||||+|||++ |..||......... .+.. .....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~---~~~~~ 248 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLG---ACSLD 248 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTT---CCCCT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhc---cCCcc
Confidence 643221 23345678999999999874 2456789999999999999999 89999665443322 2211 10000
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+ . .....+..+++||.+||+.||++|||++|||+||||+.
T Consensus 249 ~~------------~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 249 CL------------H-----------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp TS------------C-----------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cc------------C-----------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 00 0 00134567899999999999999999999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=337.50 Aligned_cols=242 Identities=20% Similarity=0.242 Sum_probs=195.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++...... ..+.+|+.++++++|++++..+..+... ....
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~---------------~~~~ 80 (296)
T 4hgt_A 20 GSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE---------------GDYN 80 (296)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE---------------TTEE
T ss_pred CCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC---------------CCce
Confidence 89999999999999999999997765433 3578999999999998888877766441 5688
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCeEEecccccccccC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~ 159 (481)
+|||||+.++|.+++......+++.+++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++.+..
T Consensus 81 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 81 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9999999889988887666679999999999999999999999999999999999999 7888999999999987654
Q ss_pred CCC------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCC
Q 011627 160 DHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---EQLSKIFELCGSPDE 230 (481)
Q Consensus 160 ~~~------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~~~~ 230 (481)
... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+.. ..+.++....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 234 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 234 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-----
T ss_pred cccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-----
Confidence 322 12334578999999999987 57899999999999999999999999764432 2222221100
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...........+++++.+||.+||..||++|||+++|++
T Consensus 235 --------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 --------------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------------------ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 011122233567889999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=332.96 Aligned_cols=238 Identities=21% Similarity=0.321 Sum_probs=199.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++. +++.||||++...... ...+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 19 G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 78 (267)
T 3t9t_A 19 GQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE----------------QAPI 78 (267)
T ss_dssp ETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS----------------SSSC
T ss_pred CCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc----------------CCCe
Confidence 899999999986 6789999999865432 3578899999999999999999999986 5578
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|+||||+++ +|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999985 7877777666679999999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+........
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~----------- 226 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----------- 226 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-----------
T ss_pred ccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC-----------
Confidence 222333456788999999976 568899999999999999999 8999999888887777754211100
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...++.++.+||.+||..||++|||+++++++
T Consensus 227 ------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 227 ------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01356789999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=333.90 Aligned_cols=242 Identities=19% Similarity=0.239 Sum_probs=196.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++...... ..+.+|+.++++++|++++..+..+... ...+
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~---------------~~~~ 80 (296)
T 3uzp_A 20 GSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE---------------GDYN 80 (296)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE---------------TTEE
T ss_pred CCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC---------------CCce
Confidence 78999999999999999999998765432 3688999999999999888777666441 5688
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCeEEecccccccccC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~ 159 (481)
||||||+.++|.+++......+++.+++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 81 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9999999888988887666679999999999999999999999999999999999999 4788999999999987654
Q ss_pred CCCC------ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCC
Q 011627 160 DHNN------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSKIFELCGSPDE 230 (481)
Q Consensus 160 ~~~~------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~ 230 (481)
.... ......+|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+. .+.+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 234 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 234 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-----
T ss_pred cccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc-----
Confidence 3221 2244578999999999987 5689999999999999999999999986432 22222222110
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...........++.++.+||.+||+.||++|||+++|++
T Consensus 235 --------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 235 --------------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------------------cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 001112233567889999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=334.17 Aligned_cols=237 Identities=20% Similarity=0.277 Sum_probs=193.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCc-----chhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGF-----PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~-----~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|++..+++.||||++......... ...+.+|+.++++++|+||+++++++.+
T Consensus 30 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------------- 94 (287)
T 4f0f_A 30 GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--------------- 94 (287)
T ss_dssp CSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---------------
T ss_pred CCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---------------
Confidence 89999999999999999999999765433221 2577899999999999999999999865
Q ss_pred cCCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCC-----eEEe
Q 011627 78 YRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGN-----LKLA 149 (481)
Q Consensus 78 ~~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g--iiHrDLKp~NILl~~~~~-----vkL~ 149 (481)
. .+|||||+. ++|.+.+......+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+
T Consensus 95 -~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 95 -P--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -T--TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -C--CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 2 279999998 5787888777778999999999999999999999999 999999999999988776 9999
Q ss_pred cccccccccCCCCCccccccccccCCCchhhcC-CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcC
Q 011627 150 DFGLARSFSYDHNNTLTNRVITLWYRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ--LSKIFELCG 226 (481)
Q Consensus 150 DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~ 226 (481)
|||+++... .......+|+.|+|||++.. ...++.++|||||||++|+|++|+.||...+.... ...+.....
T Consensus 172 Dfg~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 172 DFGLSQQSV----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CCTTCBCCS----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCCcccccc----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 999997543 23444678999999999843 24578899999999999999999999987654433 333322111
Q ss_pred CCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 227 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.+ . +...+++++.+||.+||..||++|||++|+++
T Consensus 248 ~~-~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 RP-T---------------------------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CC-C---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-C---------------------------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0 11246788999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=336.92 Aligned_cols=238 Identities=20% Similarity=0.303 Sum_probs=201.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++.... .....+.+|+.++++|+|+||+++++++.+ ...+
T Consensus 24 G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 84 (288)
T 3kfa_A 24 GQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----------------EPPF 84 (288)
T ss_dssp GTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSE
T ss_pred CCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----------------CCCE
Confidence 899999999999999999999997543 234578899999999999999999999976 5678
Q ss_pred EEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
||||||+.+ +|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999984 78777765 3345999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........+|..|+|||++.+ ..++.++||||||||+|+|++ |..||...+.......+........
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 233 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---------- 233 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC----------
T ss_pred ccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC----------
Confidence 4344444556888999999976 578999999999999999999 9999998887776666643211100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||++||..||++|||++++++
T Consensus 234 -------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 234 -------------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1246778999999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=345.19 Aligned_cols=240 Identities=19% Similarity=0.238 Sum_probs=194.7
Q ss_pred cceeEEEEEEEccCCcE----EEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEI----VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++. ||+|++..... ......+.+|+.++++++|+||+++++++.
T Consensus 24 G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----------------- 85 (325)
T 3kex_A 24 GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP----------------- 85 (325)
T ss_dssp CSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----------------
T ss_pred cCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----------------
Confidence 89999999999988886 67777654432 223456779999999999999999999885
Q ss_pred CCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...+++||||+. ++|.+++......+++..+..++.||+.||+|||+++|+||||||+||||+.++++||+|||+++.+
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 346899999998 5788887776667999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
...... ......+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+....+.........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 239 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP----- 239 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC-----
T ss_pred CcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC-----
Confidence 543322 2334456789999999986 578999999999999999999 99999988877776666432111110
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
..++.++.+||.+||..||++|||+.+++++
T Consensus 240 ------------------------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 240 ------------------------QICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ------------------------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ------------------------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1245568899999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=346.05 Aligned_cols=241 Identities=21% Similarity=0.330 Sum_probs=198.1
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|++. .+++.||||+++.... ......+.+|+.++++|+|+||+++++++.+
T Consensus 58 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--------------- 121 (343)
T 1luf_A 58 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAV--------------- 121 (343)
T ss_dssp CSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---------------
T ss_pred cCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc---------------
Confidence 899999999997 4568999999975532 2234567899999999999999999999976
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPG-----------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 133 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~-----------------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDL 133 (481)
.+.+||||||+.+ +|.+++.... ..+++.+++.++.||+.||+|||+++|+||||
T Consensus 122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 122 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred -CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 5678999999986 7777665431 46899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCC
Q 011627 134 KGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 211 (481)
Q Consensus 134 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~ 211 (481)
||+||||+.++.+||+|||+++.+..... .......+|+.|+|||++.+ ..++.++||||||||+|+|++ |..||..
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999986543221 22334466889999999886 568999999999999999999 9999999
Q ss_pred CChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 212 KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+..+.+..+....... ....++.++.+||.+||..||++|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILA-----------------------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCC-----------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88888777765421100 012467789999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=354.78 Aligned_cols=240 Identities=23% Similarity=0.350 Sum_probs=197.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++.... ......+.+|+.++++|+|+||+++++++.+ .+.+
T Consensus 125 G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~~ 187 (377)
T 3cbl_A 125 GNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----------------KQPI 187 (377)
T ss_dssp ETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECS----------------SSSC
T ss_pred CCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEec----------------CCCc
Confidence 8999999999999999999999875422 2233467799999999999999999999976 5578
Q ss_pred EEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||. ++|.+++......+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++......
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999997 57887777655569999999999999999999999999999999999999999999999999997643221
Q ss_pred CCc-cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~-~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
... .....++..|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+......+.
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 336 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC---------- 336 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC----------
T ss_pred eeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 111 112234778999999976 568899999999999999998 9999999888777666543211100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++|||+++|++
T Consensus 337 -------------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 337 -------------------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1136678999999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=340.37 Aligned_cols=248 Identities=28% Similarity=0.392 Sum_probs=194.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC--CCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ--HENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~--hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++. +++.||||+++...........+.+|+.++++|+ |+||+++++++.+ ..
T Consensus 39 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----------------~~ 101 (313)
T 3cek_A 39 GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----------------DQ 101 (313)
T ss_dssp CSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC----------------SS
T ss_pred CCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec----------------CC
Confidence 899999999985 5899999999876544444567789999999997 5999999999987 66
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
.+|||||+..++|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||++ +.+||+|||+++.+...
T Consensus 102 ~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 89999998778888887754 36899999999999999999999999999999999999965 78999999999876432
Q ss_pred CC-CccccccccccCCCchhhcCC----------CCCCCCCchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCC
Q 011627 161 HN-NTLTNRVITLWYRPPELLLGA----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGSP 228 (481)
Q Consensus 161 ~~-~~~~~~~gt~~Y~aPEvl~~~----------~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~~ 228 (481)
.. .......+|+.|+|||++.+. ..++.++||||||||+|+|++|+.||..... ...+..+......
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~- 258 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE- 258 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC-
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc-
Confidence 22 122345679999999998641 3578899999999999999999999987543 3333333221100
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~ 297 (481)
..+ ....+.++.+||.+||..||++|||+.|+|+|+||....
T Consensus 259 --~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 259 --IEF-------------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp --CCC-------------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred --cCC-------------------------cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 000 012466899999999999999999999999999997643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=348.85 Aligned_cols=237 Identities=24% Similarity=0.343 Sum_probs=196.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC----CcchhHHHHHHHHHhcC--CCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQ--HENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~L~--hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++..+++.||||+++...... .....+.+|+.++++++ |+||+++++++.+
T Consensus 54 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-------------- 119 (320)
T 3a99_A 54 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-------------- 119 (320)
T ss_dssp SSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--------------
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--------------
Confidence 899999999999999999999998664322 12345668999999996 5999999999987
Q ss_pred CcCCeEEEEEecCC--CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-CCCCeEEecccc
Q 011627 77 KYRGSTYMVFEYMD--HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGL 153 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~--g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~-~~~~vkL~DFG~ 153 (481)
.+.+++|||++. ++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+||||+ +++.+||+|||+
T Consensus 120 --~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 --PDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred --CCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 668999999997 4777766543 4689999999999999999999999999999999999999 778999999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
++.... .......+|+.|+|||++.+...++.++||||||||+|+|++|+.||...+. +..... .
T Consensus 197 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~-----~- 261 (320)
T 3a99_A 197 GALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQV-----F- 261 (320)
T ss_dssp CEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCC-----C-
T ss_pred cccccc---ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcccc-----c-
Confidence 987653 2334457899999999997644457889999999999999999999975321 111000 0
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....++.++.+||++||..||++|||++||++|+||..
T Consensus 262 ------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 262 ------------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp ------------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred ------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 00236778999999999999999999999999999965
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=343.56 Aligned_cols=240 Identities=19% Similarity=0.275 Sum_probs=189.5
Q ss_pred cceeEEEEEEEccCCcEE----EEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIV----ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~v----AvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++.+ |+|+++... .......+.+|+.++++++|+||+++++++.+
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------------- 88 (327)
T 3poz_A 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---------------- 88 (327)
T ss_dssp ETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES----------------
T ss_pred CCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec----------------
Confidence 899999999999888765 677665433 22345678899999999999999999999985
Q ss_pred CCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
. ..++|+||+. ++|.+++......+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+
T Consensus 89 ~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 2 3678899887 5788887776677999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
...... ......+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+....+........
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------ 240 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------ 240 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC------
T ss_pred cCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC------
Confidence 533222 2223345789999999986 678999999999999999999 9999998887776655543211110
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...++.++.+||.+||..||++|||+.+++++
T Consensus 241 -----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 241 -----------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -----------------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 12356789999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=347.23 Aligned_cols=248 Identities=21% Similarity=0.332 Sum_probs=177.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHH-HHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++...... ....+.+|+. +++.++|+||+++++++.+ .+.
T Consensus 33 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~----------------~~~ 95 (327)
T 3aln_A 33 GAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFR----------------EGD 95 (327)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEe----------------CCc
Confidence 899999999999999999999998653322 2334556666 6777899999999999987 668
Q ss_pred EEEEEecCCCChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 82 TYMVFEYMDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~----~~~~l~~~~i~~i~~Qil~gL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
+||||||+.++|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999999999987776652 345689999999999999999999999 999999999999999999999999999976
Q ss_pred ccCCCCCccccccccccCCCchhhc---CCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCCC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA-EQLSKIFELCGSPDETI 232 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~---~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 232 (481)
+... .......+|..|+|||++. ....++.++||||||||+|+|++|+.||...+.. +.+..+. ....
T Consensus 176 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~--- 247 (327)
T 3aln_A 176 LVDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV---KGDP--- 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC---CSCC---
T ss_pred cccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh---cCCC---
Confidence 6432 2233346899999999984 2246889999999999999999999999865432 1111110 0000
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
+ .++. .....++.++.+||.+||..||++|||+.|||+|+||.
T Consensus 248 -~---~~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 248 -P---QLSN---------------SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp -C---CCCC---------------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred -C---CCCC---------------cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 0 0000 00124678899999999999999999999999999994
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=340.32 Aligned_cols=242 Identities=22% Similarity=0.312 Sum_probs=187.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++..... ......+.+|+.++++|+|+||+++++++.+ .+.
T Consensus 45 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----------------~~~ 108 (309)
T 2h34_A 45 GGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI----------------DGQ 108 (309)
T ss_dssp CSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTE
T ss_pred CCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee----------------CCe
Confidence 79999999999999999999999765332 2234567899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+++ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999986 777666543 46999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.........+|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+.......+... ...
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~------------ 253 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA-IPR------------ 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSC-CCC------------
T ss_pred ccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccC-CCC------------
Confidence 3344445678999999999876 67899999999999999999999999887665433333211 000
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-CHHHHhc
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-SAKDALD 289 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-sa~eiL~ 289 (481)
.......++.++.+||.+||..||++|| |++++++
T Consensus 254 --------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 --------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 0011234677899999999999999999 8888775
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=347.64 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=171.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHH-HHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREI-KILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei-~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||++.... ...+|+ ..++.+.|+||+++++++..... ....
T Consensus 40 G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~------------~~~~ 100 (336)
T 3fhr_A 40 GVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHH------------GKRC 100 (336)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET------------TEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccC------------CCce
Confidence 899999999999999999999986431 233344 34677799999999999975211 1446
Q ss_pred EEEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC---CCeEEeccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE---GNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~---~~vkL~DFG~a~~ 156 (481)
+|||||||++ +|.+++.+.. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.+ +.+||+|||+++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 8999999986 7887776643 469999999999999999999999999999999999999864 4599999999976
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
... ......++|+.|+|||++.. ..++.++||||||||+|+|++|+.||...+.......+.........
T Consensus 181 ~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 250 (336)
T 3fhr_A 181 TTQ---NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY------ 250 (336)
T ss_dssp C--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred ccc---cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc------
Confidence 542 23344577999999999865 56788999999999999999999999876654432221111000000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.. ....+..++.++++||.+||..||++|||++|+|+|+||...
T Consensus 251 -~~---------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 251 -GF---------------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -CC---------------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -cc---------------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00 001123578899999999999999999999999999999653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=349.87 Aligned_cols=240 Identities=23% Similarity=0.344 Sum_probs=188.1
Q ss_pred cceeEEEEEEEc---cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREI---KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~---~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|+++ .++..||||+++.... ......+.+|+.++++|+|+||+++++++.+ .
T Consensus 56 G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~ 118 (373)
T 2qol_A 56 GEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----------------S 118 (373)
T ss_dssp CSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----------------S
T ss_pred CCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----------------C
Confidence 899999999987 5677899999976532 2234578899999999999999999999976 5
Q ss_pred CeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
..+||||||+. ++|.+++.+....+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 57899999997 57888887766679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCccc--cccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 159 YDHNNTLT--NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 159 ~~~~~~~~--~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
........ ...+|..|+|||++.+ ..++.++||||||||+|||++ |+.||...+..+.+..+......+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~------ 271 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------ 271 (373)
T ss_dssp ---------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC------
T ss_pred cCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 33222211 2234678999999986 578999999999999999998 9999999888877776654321111
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++|||+.+|++
T Consensus 272 -----------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 272 -----------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -----------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0136778999999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=342.29 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=195.6
Q ss_pred cceeEEEEEEE-----ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE-----IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++ ..+++.||||+++.... ......+.+|+.++++| +|+||+++++++..
T Consensus 56 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-------------- 120 (344)
T 1rjb_A 56 GAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTL-------------- 120 (344)
T ss_dssp CSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--------------
T ss_pred CCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--------------
Confidence 89999999997 34677899999985432 23456788999999999 89999999999987
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGL----------------------RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 133 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~----------------------~l~~~~i~~i~~Qil~gL~~LH~~giiHrDL 133 (481)
.+.+||||||+.+ +|.+++..... .+++..++.++.||+.||+|||+++|+||||
T Consensus 121 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 121 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred --CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 5578999999975 88877765432 3789999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCC
Q 011627 134 KGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 211 (481)
Q Consensus 134 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~ 211 (481)
||+||||+.++.+||+|||+++.+...... ......+|+.|+|||++.+ ..++.++||||||||+|+|++ |..||..
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999876533222 2233456888999999876 578999999999999999998 9999998
Q ss_pred CChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 212 KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
......+..+......... ...++.++.+||.+||..||++|||+.||+++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQ----------------------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCCC----------------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 8766665555442211100 01357789999999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=356.64 Aligned_cols=246 Identities=27% Similarity=0.395 Sum_probs=185.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||.+ ...+++.||||++.... ...+.+|+.+|+++ +|||||++++++.+ ...
T Consensus 26 G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----------------~~~ 83 (434)
T 2rio_A 26 GSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETT----------------DRF 83 (434)
T ss_dssp CSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec----------------CCe
Confidence 899999875 55789999999987542 34567999999987 89999999999987 678
Q ss_pred EEEEEecCCCChhhhhcCCCCC------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC------------
Q 011627 82 TYMVFEYMDHDLTGLADRPGLR------FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE------------ 143 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~------l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~------------ 143 (481)
+|||||||+++|.+++...... .++..++.++.||+.||+|||+++|+||||||+||||+.+
T Consensus 84 ~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 84 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 9999999999988888754321 1333467899999999999999999999999999999754
Q ss_pred -CCeEEecccccccccCCCCC---ccccccccccCCCchhhcC------CCCCCCCCchhhHHHHHHHHHh-CCCCCCCC
Q 011627 144 -GNLKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLG------ATKYGPAVDMWSVGCIFAELLN-GKPILPGK 212 (481)
Q Consensus 144 -~~vkL~DFG~a~~~~~~~~~---~~~~~~gt~~Y~aPEvl~~------~~~~~~~~DiwSlGvil~ellt-G~~pf~~~ 212 (481)
..+||+|||+++.+...... .....++|+.|+|||++.+ ...++.++||||||||+|||++ |+.||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 37999999999876543221 2334578999999999965 2468899999999999999999 99999766
Q ss_pred ChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 011627 213 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292 (481)
Q Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~ 292 (481)
...+ ..+......... ... . ....++.++++||.+||..||++|||+.|||+|||
T Consensus 244 ~~~~--~~i~~~~~~~~~-----~~~------~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 244 YSRE--SNIIRGIFSLDE-----MKC------L------------HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp TTHH--HHHHHTCCCCCC-----CTT------C------------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhH--HHHhcCCCCccc-----ccc------c------------ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 5443 233322111110 000 0 01246778999999999999999999999999999
Q ss_pred CCC
Q 011627 293 FWT 295 (481)
Q Consensus 293 f~~ 295 (481)
||.
T Consensus 299 f~~ 301 (434)
T 2rio_A 299 FWP 301 (434)
T ss_dssp GSC
T ss_pred cCC
Confidence 974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=339.10 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=188.4
Q ss_pred cceeEEEEEE----EccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAR----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|+ +..+++.||||++..... .....+.+|+.++++|+|+||+++++++....
T Consensus 21 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------------- 84 (295)
T 3ugc_A 21 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-------------- 84 (295)
T ss_dssp CSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH--------------
T ss_pred cCCEEEEEEEEecccCCCCcEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--------------
Confidence 8999999999 678999999999975432 23456789999999999999999999986521
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...+||||||+.+ +|.+++......+++..+..++.||+.||+|||+++|+||||||+||||+.++++||+|||+++.+
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 3468999999975 888887776666999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
..... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... ...... .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~---~~~~~~~~~ 238 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIG---NDKQGQMIV 238 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHHHC---TTCCTHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHhhhc---CccccchhH
Confidence 43221 12223345778999999986 57899999999999999999999988653221 111100 000000000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
. . .. ..............++.++.+||.+||..||++|||++|+++
T Consensus 239 ~-~--~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 239 F-H--LI-----ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp H-H--HH-----HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred H-H--HH-----HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 0 00 000000000011247789999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=335.93 Aligned_cols=243 Identities=19% Similarity=0.290 Sum_probs=185.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++. ..||||+++...........+.+|+.++++++|+||++++++.. ...+
T Consensus 35 G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----------------~~~~ 94 (289)
T 3og7_A 35 GSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----------------APQL 94 (289)
T ss_dssp CSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----------------SSSC
T ss_pred CCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-----------------CCcc
Confidence 899999999864 35999999876555445567889999999999999999999654 3457
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC-
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD- 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~- 160 (481)
+|||||+.+ +|.+.+......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999985 777777666677999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccccCCCchhhcC--CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.........+|..|+|||++.. ...++.++||||||||+|+|++|+.||...+..+.+..+......... .
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~-- 247 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD-----L-- 247 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-----T--
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-----h--
Confidence 2223344578999999999862 246788999999999999999999999987766665555443211110 0
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
......++.++.+||.+||..||++|||+.++++
T Consensus 248 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 248 -----------------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -----------------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0011246788999999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=336.45 Aligned_cols=234 Identities=18% Similarity=0.251 Sum_probs=190.3
Q ss_pred cceeEEEEEEEccCC-------cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTG-------EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 75 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~ 75 (481)
|+||+||+|++..++ ..||+|++..... .....+.+|+.++++++|+||+++++++.+
T Consensus 19 G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------------- 83 (289)
T 4fvq_A 19 GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCVC------------- 83 (289)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEECC-------------
T ss_pred CCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-------------
Confidence 899999999999888 4799999875432 245678899999999999999999999987
Q ss_pred CCcCCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC--------e
Q 011627 76 NKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN--------L 146 (481)
Q Consensus 76 ~~~~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~--------v 146 (481)
.+..||||||+. ++|.+++......+++..++.++.||+.||+|||+++|+||||||+||||+.++. +
T Consensus 84 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 84 ---GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ---TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred ---CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 556799999998 4788877766556999999999999999999999999999999999999998887 9
Q ss_pred EEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhc
Q 011627 147 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELC 225 (481)
Q Consensus 147 kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~ 225 (481)
||+|||++..... .....+|..|+|||++.+...++.++|||||||++|+|++| .+||...+........ ...
T Consensus 161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~ 234 (289)
T 4fvq_A 161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDR 234 (289)
T ss_dssp EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTT
T ss_pred eeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hcc
Confidence 9999999865431 22345788999999998656789999999999999999995 4555555544433333 211
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.... ..++.++.+||.+||..||++|||+.|++++
T Consensus 235 ~~~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQLP------------------------------APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCC------------------------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCC------------------------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1100 1234468899999999999999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=334.57 Aligned_cols=240 Identities=21% Similarity=0.269 Sum_probs=193.4
Q ss_pred cceeEEEEEEEcc---CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIK---TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++.. ++..||||+++..... .....+.+|+.++++|+|+||+++++++.+
T Consensus 23 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------- 84 (281)
T 3cc6_A 23 GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-DNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----------------- 84 (281)
T ss_dssp CSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-HHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----------------
T ss_pred cCCeeEEEeEEcCCCCCcceEEEEecccccCc-hHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----------------
Confidence 8999999999754 3456999999765322 234577899999999999999999999864
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+..|+||||+.+ +|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 245899999985 7777776666679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
...........+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+....+......+.
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 235 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-------- 235 (281)
T ss_dssp --------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC--------
T ss_pred cccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC--------
Confidence 433333334456888999999976 578899999999999999998 9999988777776666644321110
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...++..+.+||.+||..||++|||+.|++++
T Consensus 236 ---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 236 ---------------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 01367789999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.95 Aligned_cols=236 Identities=25% Similarity=0.348 Sum_probs=183.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC--CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK--EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++ +++.||||+++..... ......+.+|+.++++++|+||+++++++.+ .+
T Consensus 18 G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~ 79 (271)
T 3dtc_A 18 GGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK----------------EP 79 (271)
T ss_dssp ETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC----------------C-
T ss_pred CCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec----------------CC
Confidence 89999999998 4899999999765322 2344677899999999999999999999987 55
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCcEEEcC--------CCCeEE
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ---VLHRDIKGSNLLIDN--------EGNLKL 148 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g---iiHrDLKp~NILl~~--------~~~vkL 148 (481)
.+||||||+++ +|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+||||+. ++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 78999999986 55555532 46999999999999999999999999 899999999999986 677999
Q ss_pred ecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 011627 149 ADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 228 (481)
Q Consensus 149 ~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 228 (481)
+|||+++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.......
T Consensus 158 ~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3dtc_A 158 TDFGLAREWHRT---TKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233 (271)
T ss_dssp CCCCC----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC
T ss_pred ccCCcccccccc---cccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC
Confidence 999999765432 2234578999999999986 578999999999999999999999999988877766654321111
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
. ....++.++.+||.+||..||++|||+.|++++
T Consensus 234 ~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 234 P----------------------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp C----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C----------------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0 012467789999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=339.29 Aligned_cols=240 Identities=20% Similarity=0.336 Sum_probs=191.6
Q ss_pred cceeEEEEEEEccCC----cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTG----EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..++ ..||||+++..... .....+.+|+.++++|+|+||+++++++.+
T Consensus 55 G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------------- 117 (333)
T 1mqb_A 55 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISK---------------- 117 (333)
T ss_dssp CSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECS----------------
T ss_pred CCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEec----------------
Confidence 899999999987664 35999999754322 234467899999999999999999999976
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
.+.+||||||+.+ +|.+++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 5679999999986 787777766667999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCc--cccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 158 SYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 158 ~~~~~~~--~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
....... .....+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+.+..+......+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~----- 271 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT----- 271 (333)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-----
T ss_pred ccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC-----
Confidence 5332211 122344778999999986 578999999999999999998 9999998888877777654211110
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++||++.++++
T Consensus 272 ------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 272 ------------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp ------------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0136778999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=340.68 Aligned_cols=237 Identities=25% Similarity=0.360 Sum_probs=189.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC----CcchhHHHHHHHHHhc----CCCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKL----QHENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~L----~hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||+||+|++..+++.||||+++...... .....+.+|+.+++++ +|+||+++++++.+
T Consensus 42 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~------------ 109 (312)
T 2iwi_A 42 GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET------------ 109 (312)
T ss_dssp ETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--------------
T ss_pred CCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec------------
Confidence 889999999999999999999997653221 1223456799999999 89999999999976
Q ss_pred CCCcCCeEEEEEec-CC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-CCCCeEEecc
Q 011627 75 GNKYRGSTYMVFEY-MD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADF 151 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey-~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~-~~~~vkL~DF 151 (481)
.+.+++|||+ +. ++|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+ .++.+||+||
T Consensus 110 ----~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 110 ----QEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ----CCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 5578999998 55 4777766553 3699999999999999999999999999999999999999 7889999999
Q ss_pred cccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 011627 152 GLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 231 (481)
Q Consensus 152 G~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (481)
|+++.... .......+|..|+|||++.+....+.++||||||||+|+|++|+.||..... +......
T Consensus 185 g~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~---- 251 (312)
T 2iwi_A 185 GSGALLHD---EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELH---- 251 (312)
T ss_dssp SSCEECCS---SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCCC----
T ss_pred chhhhccc---CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------HhhhccC----
Confidence 99987653 2334567899999999987644445689999999999999999999975321 1111000
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+...++.++.+||.+||..||++|||++|+|+|+||..
T Consensus 252 --------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 252 --------------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp --------------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred --------------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 01246778999999999999999999999999999964
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=332.04 Aligned_cols=240 Identities=19% Similarity=0.235 Sum_probs=198.2
Q ss_pred cceeEEEEEEEc--cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREI--KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++. .+++.||||+++.... ......+.+|+.++++|+|+||+++++++. .+
T Consensus 21 G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----------------~~ 82 (287)
T 1u59_A 21 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----------------AE 82 (287)
T ss_dssp CTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----------------SS
T ss_pred cCceeEEEeEeccCCCcceEEEEecCCccc-hhHHHHHHHHHHHHHhCCCCCEeEEEEEec-----------------CC
Confidence 899999999864 5788899999986532 223556789999999999999999999995 34
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|.+++......+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 58999999986 77777766666799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 160 DHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 160 ~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
... .......+|+.|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+....+.......
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~-------- 233 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME-------- 233 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC--------
T ss_pred CcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC--------
Confidence 222 11223345888999999976 568899999999999999998 999999988877776665421100
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....++.++.+||.+||..||++|||+.+++++
T Consensus 234 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 234 ---------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp ---------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012467889999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=339.42 Aligned_cols=241 Identities=20% Similarity=0.319 Sum_probs=196.8
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|++. .+++.||||+++.... ......+.+|+.++++|+|+||+++++++.+
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--------------- 97 (314)
T 2ivs_A 34 GEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--------------- 97 (314)
T ss_dssp CSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---------------
T ss_pred cCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEec---------------
Confidence 899999999984 4568999999975432 2234567899999999999999999999976
Q ss_pred cCCeEEEEEecCC-CChhhhhcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 011627 78 YRGSTYMVFEYMD-HDLTGLADRPG-----------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 133 (481)
Q Consensus 78 ~~~~~~iV~Ey~~-g~L~~~~~~~~-----------------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDL 133 (481)
.+.+||||||+. ++|.+++.... ..+++.+++.++.||+.||+|||+++|+||||
T Consensus 98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 98 -DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred -CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 557899999998 47777665432 23899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCC
Q 011627 134 KGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 211 (481)
Q Consensus 134 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~ 211 (481)
||+||||+.++.+||+|||+++....... .......+|+.|+|||++.+ ..++.++||||||||+|+|++ |..||..
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986643222 12233355788999999986 568899999999999999999 9999998
Q ss_pred CChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 212 KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+..+....+....... ....++.++.+||.+||..||++|||+.||+++
T Consensus 256 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 256 IPPERLFNLLKTGHRME-----------------------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCGGGHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHhhcCCcCC-----------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88777666654321100 012467889999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=360.68 Aligned_cols=238 Identities=20% Similarity=0.297 Sum_probs=200.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++.... ....+.+|+.+|++|+|+||+++++++.+ ...+
T Consensus 231 G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~----------------~~~~ 291 (495)
T 1opk_A 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR----------------EPPF 291 (495)
T ss_dssp GTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSC
T ss_pred CCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEec----------------CCcE
Confidence 8999999999999999999999975432 35678899999999999999999999986 5578
Q ss_pred EEEEecCC-CChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMD-HDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~-g~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||||||. ++|.+++... ...+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999998 5788777653 346899999999999999999999999999999999999999999999999999876533
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........+|..|+|||++.. ..++.++||||||||||||++ |..||.+.+..+++..+.......
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------- 439 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME----------- 439 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-----------
T ss_pred ceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 3233333455788999999976 568999999999999999999 999999888777666654321110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.+|++
T Consensus 440 ------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 440 ------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 01246778999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=336.44 Aligned_cols=242 Identities=23% Similarity=0.329 Sum_probs=197.8
Q ss_pred cceeEEEEEEE-----ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE-----IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++ ..+++.||||+++..... .....+.+|+.++++| +|+||+++++++.+
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-------------- 98 (313)
T 1t46_A 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTI-------------- 98 (313)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--------------
T ss_pred cCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEEec--------------
Confidence 89999999995 567889999999755322 2345778999999999 99999999999987
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGL-----------------RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~-----------------~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
.+.+||||||+.+ +|.+++..... .+++.+++.++.||+.||+|||+++|+||||||+||
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 5578999999986 78777765432 489999999999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 216 (481)
||+.++.+||+|||+++........ ......+|+.|+|||++.+ ..++.++||||||||+|+|++ |+.||...+...
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999876543322 2233456788999999876 578999999999999999998 999999877666
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+..+......... ...++.++.+||.+||..||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRMLS----------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCCC----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCCC----------------------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55555443211100 12367789999999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=341.88 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=176.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++..... .....+.+|+.+++++. |+||+++++++...... .......
T Consensus 39 G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~--------~~~~~~~ 108 (337)
T 3ll6_A 39 GGFAFVYEAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE--------SDTGQAE 108 (337)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT--------STTSSEE
T ss_pred CCceEEEEEEECCCCcEEEEEEecCCch--HHHHHHHHHHHHHHHhccCCChhhccccccccccc--------cccCCce
Confidence 8999999999999999999999865432 23456789999999996 99999999999653211 1122567
Q ss_pred EEEEEecCCCChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDHDLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~--~~~~l~~~~i~~i~~Qil~gL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
++|||||+.++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 109 ~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 188 (337)
T 3ll6_A 109 FLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188 (337)
T ss_dssp EEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCC
T ss_pred EEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceec
Confidence 899999999998887754 4456999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCC-----------ccccccccccCCCchhhc--CCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 011627 158 SYDHNN-----------TLTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 224 (481)
Q Consensus 158 ~~~~~~-----------~~~~~~gt~~Y~aPEvl~--~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 224 (481)
...... ......+|+.|+|||++. ....++.++||||||||+|+|++|+.||........+......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 268 (337)
T 3ll6_A 189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSI 268 (337)
T ss_dssp SSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------CCC
T ss_pred cccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCcccC
Confidence 532221 112446799999999984 2356788999999999999999999999765544332221100
Q ss_pred cCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 225 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
+. ....+..+.+||++||+.||++|||+.|++++
T Consensus 269 ---~~-----------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 269 ---PP-----------------------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ---CT-----------------------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---Cc-----------------------------ccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 01234468899999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.50 Aligned_cols=242 Identities=19% Similarity=0.258 Sum_probs=196.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...... .+.+|+++++.|+|.+++..+..+... ....
T Consensus 18 G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~---------------~~~~ 78 (483)
T 3sv0_A 18 GSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVE---------------GDYN 78 (483)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEE---------------TTEE
T ss_pred CCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEee---------------CCEE
Confidence 899999999999999999999987654333 578999999999886555544444321 6688
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCeEEecccccccccC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~ 159 (481)
||||||+.++|.+++......+++.+++.|+.||+.||+|||+++||||||||+|||| +.++.+||+|||+++.+..
T Consensus 79 ~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999999889999888666789999999999999999999999999999999999999 6788999999999987654
Q ss_pred CCCC------ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCC
Q 011627 160 DHNN------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSKIFELCGSPDE 230 (481)
Q Consensus 160 ~~~~------~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~ 230 (481)
.... .....++|..|+|||++.+ ..++.++||||||||||||++|+.||..... .+.+.++...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~------ 231 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------ 231 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH------
T ss_pred CccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc------
Confidence 3221 1235678999999999987 6789999999999999999999999987544 3333333221
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 231 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
........+...++.++.+||.+||..||++||++.+|++
T Consensus 232 -------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 232 -------------------KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -------------------HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -------------------cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112233444678899999999999999999999998874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=330.39 Aligned_cols=241 Identities=22% Similarity=0.308 Sum_probs=195.2
Q ss_pred cceeEEEEEEEccCCc---EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..+++ .||||++...... .....+.+|+.++++++|+||+++++++.+. +
T Consensus 32 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---------------~ 95 (298)
T 3pls_A 32 GHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMRGLNHPNVLALIGIMLPP---------------E 95 (298)
T ss_dssp ETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---------------S
T ss_pred CCCceEEEEEEecCCCceeeeeeeeccccccH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEecC---------------C
Confidence 8999999999876665 7999998754322 2345778999999999999999999999762 3
Q ss_pred CeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
...++||||+. ++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 34489999996 58888887767779999999999999999999999999999999999999999999999999997654
Q ss_pred CCC---CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 159 YDH---NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 159 ~~~---~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
... ........+|..|+|||++.+ ..++.++|||||||++|+|++ +.++|...+..+....+........
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~----- 249 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ----- 249 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC-----
T ss_pred CCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC-----
Confidence 321 122334466889999999976 678999999999999999999 5566776666666665543321111
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++|||++++++
T Consensus 250 ------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 250 ------------------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1236678999999999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=333.64 Aligned_cols=239 Identities=18% Similarity=0.245 Sum_probs=193.3
Q ss_pred cceeEEEEEE--EccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAR--EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~--~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+ +..+++.||||+++...........+.+|+.++++++|+||+++++++. .+
T Consensus 28 G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----------------~~ 90 (291)
T 1xbb_A 28 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----------------AE 90 (291)
T ss_dssp CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----------------SS
T ss_pred ccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----------------CC
Confidence 8999999995 4677899999999876544444667889999999999999999999984 44
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+||||||+.+ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 68999999985 676666543 4699999999999999999999999999999999999999999999999999987653
Q ss_pred CCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 160 DHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 160 ~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.... ......+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+....+.......
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 240 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-------- 240 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--------
T ss_pred CCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 3221 1222344688999999976 567889999999999999999 999999988877766664321100
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.++++
T Consensus 241 ---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 241 ---------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01246788999999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=333.44 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=190.8
Q ss_pred cceeEEEEEE----EccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAR----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|+ +..+++.||||+++..... .....+.+|+.++++|+|+||+++++++.+..
T Consensus 32 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------------- 96 (302)
T 4e5w_A 32 GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGICTEDG-------------- 96 (302)
T ss_dssp CSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------
T ss_pred CCceEEEEEEEccccCccCeEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--------------
Confidence 8999999999 6789999999999865432 34567889999999999999999999998732
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...+||||||+.+ +|.+++......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 3578999999986 787777666667999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
..... .......+|..|+|||++.+ ..++.++||||||||+|+|++|..|+.... ....... .....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~---~~~~~----- 245 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM--ALFLKMI---GPTHG----- 245 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HHHHHHH---CSCCG-----
T ss_pred cCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh--hHHhhcc---CCccc-----
Confidence 54322 22334566888999999976 567889999999999999999988754221 1111110 00000
Q ss_pred CCCCCccccCCCchhhhhhH--------HHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRV--------REVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
........ ......++.++.+||.+||..||++|||+.|+++
T Consensus 246 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 246 ------------QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp ------------GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ------------ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00000000 0011357789999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=339.20 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=192.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++ .+++.||||++..... .....+.+|+.++++++|+||+++++++.+ .+.+
T Consensus 50 G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 110 (321)
T 2qkw_B 50 GVFGKVYKGVL-RDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDE----------------RNEM 110 (321)
T ss_dssp CSSSEEEEEEC-TTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCC----------------TTCC
T ss_pred CCCeeEEEEEE-CCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC----------------CCeE
Confidence 89999999996 4789999999875432 235678899999999999999999999876 5678
Q ss_pred EEEEecCCC-ChhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPG---LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~---~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
||||||+++ +|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999985 7777665433 358999999999999999999999999999999999999999999999999998654
Q ss_pred CCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHH---HHh--cCCCCCCC
Q 011627 159 YDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI---FEL--CGSPDETI 232 (481)
Q Consensus 159 ~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i---~~~--~~~~~~~~ 232 (481)
.... .......+|+.|+|||++.+ ..++.++||||||||+|+|++|+.||......+....+ ... ........
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred cccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 3222 22334567999999999876 57899999999999999999999999765432211111 000 00000000
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+. ........++.++.+||.+||..||++|||+.|++++
T Consensus 270 ~~~------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 270 DPN------------------LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSS------------------CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Chh------------------hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 0001113466789999999999999999999999965
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=338.19 Aligned_cols=239 Identities=19% Similarity=0.278 Sum_probs=190.1
Q ss_pred cceeEEEEEEEccCCcEE----EEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIV----ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~v----AvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++.| |+|.++... .......+.+|+.++++++|+||+++++++..
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---------------- 88 (327)
T 3lzb_A 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---------------- 88 (327)
T ss_dssp CSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES----------------
T ss_pred CCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec----------------
Confidence 899999999999998866 555554332 23345678899999999999999999999985
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
. ..++|+||+.+ +|.+++......+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+
T Consensus 89 ~-~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 89 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred C-CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 2 37888998875 788888776677999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
..... .......+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+....+......+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 240 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------ 240 (327)
T ss_dssp ------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC------
T ss_pred cCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 43222 22223345778999999986 678999999999999999999 9999999888776666543221111
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||++||..||++|||+.|+++
T Consensus 241 -----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 241 -----------------------PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -----------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1236778999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.89 Aligned_cols=249 Identities=17% Similarity=0.185 Sum_probs=190.6
Q ss_pred cceeEEEEEEEccC-----CcEEEEEEeecCCcCC---------CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCC
Q 011627 3 VCISQVFMAREIKT-----GEIVALKKIRMDNEKE---------GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 68 (481)
Q Consensus 3 G~fg~Vy~a~~~~t-----g~~vAvK~i~~~~~~~---------~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~ 68 (481)
|+||+||+|++..+ ++.||||++....... ......+.|+.+++.++|+||+++++++.....
T Consensus 46 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~--- 122 (364)
T 3op5_A 46 GGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKN--- 122 (364)
T ss_dssp C-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEET---
T ss_pred CCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccC---
Confidence 89999999999765 5889999987543110 011233456666777789999999999876211
Q ss_pred CCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc--CCCCe
Q 011627 69 EQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID--NEGNL 146 (481)
Q Consensus 69 ~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~--~~~~v 146 (481)
....+|||||||.++|.+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+ .++.+
T Consensus 123 ---------~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 123 ---------GKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp ---------TEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred ---------CcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 1356899999997788888877667899999999999999999999999999999999999999 88899
Q ss_pred EEecccccccccCCCC------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011627 147 KLADFGLARSFSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 220 (481)
Q Consensus 147 kL~DFG~a~~~~~~~~------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 220 (481)
||+|||+|+.+..... ......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+......+..
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999987643221 11234458999999999987 5689999999999999999999999986443332222
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHH------hhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 221 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF------RHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
..... ....+..+. ..++.++.+||.+||..||++||++.+|++
T Consensus 273 ~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIR-------------------------YRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHH-------------------------HHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHH-------------------------hhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 21110 000111111 356889999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=367.34 Aligned_cols=239 Identities=18% Similarity=0.247 Sum_probs=195.8
Q ss_pred cceeEEEEEEE--ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMARE--IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~--~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|.+ ..+++.||||+++...........+.+|+.++++|+|+|||++++++.. .
T Consensus 380 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----------------~ 442 (635)
T 4fl3_A 380 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----------------E 442 (635)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----------------S
T ss_pred CCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----------------C
Confidence 89999999954 5677899999998765554456788999999999999999999999864 3
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.++||||||.+ +|.+++.. ...+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred CEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 57999999986 66666654 44699999999999999999999999999999999999999999999999999987653
Q ss_pred CCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 160 DHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 160 ~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
... .......+|..|+|||++.. ..++.++||||||||||||++ |+.||.+.+..+....+........
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~------- 593 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC------- 593 (635)
T ss_dssp -------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-------
T ss_pred CccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 322 22233345788999999976 678999999999999999998 9999999998887777754321100
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++|||+++|++
T Consensus 594 ----------------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 594 ----------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1246788999999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.68 Aligned_cols=239 Identities=26% Similarity=0.332 Sum_probs=194.3
Q ss_pred cceeEEEEEEEccCCcEE--EEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIV--ALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~v--AvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..+++.+ |||+++..... .....+.+|+.++++| +|+||+++++++.+ .
T Consensus 36 G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----------------~ 98 (327)
T 1fvr_A 36 GNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEH----------------R 98 (327)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----------------T
T ss_pred CCCceEEEEEEccCCcccceeeeeeccccch-HHHHHHHHHHHHHHhccCCCchhhhceeeee----------------C
Confidence 899999999999999866 99998754322 2345788999999999 89999999999987 6
Q ss_pred CeEEEEEecCCC-ChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 143 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~ 143 (481)
+.+||||||+++ +|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 689999999975 7877776543 369999999999999999999999999999999999999999
Q ss_pred CCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011627 144 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 222 (481)
Q Consensus 144 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~ 222 (481)
+.+||+|||+++..... .......+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+....+.
T Consensus 179 ~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CeEEEcccCcCcccccc--ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 99999999999753321 12223355888999999976 567899999999999999998 999999988877766654
Q ss_pred HhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...... ....++.++.+||.+||..||++|||++|++++
T Consensus 256 ~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLE-----------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCC-----------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC-----------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 321000 011467789999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=326.32 Aligned_cols=237 Identities=16% Similarity=0.199 Sum_probs=196.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++ +++.||||+++...........+.+|+.++++++|+||+++++++.+.. ...+
T Consensus 21 G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------------~~~~ 84 (271)
T 3kmu_A 21 NHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP--------------APHP 84 (271)
T ss_dssp ETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT--------------SSSC
T ss_pred CCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC--------------CCCe
Confidence 89999999998 4899999999876544444567889999999999999999999997632 3578
Q ss_pred EEEEecCCC-ChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+|||||+.+ +|.+++..... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||+++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999985 88887776443 5899999999999999999999999 9999999999999999999999999875432
Q ss_pred CCCCCccccccccccCCCchhhcCCCC--CCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~--~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.....+|+.|+|||++.+... ++.++|||||||++|+|++|+.||...+..+....+......+.
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 231 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT------- 231 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC-------
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC-------
Confidence 223467999999999986322 23379999999999999999999999888887776654321111
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||++|+++
T Consensus 232 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 232 ---------------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01246788999999999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=331.15 Aligned_cols=241 Identities=23% Similarity=0.309 Sum_probs=193.2
Q ss_pred cceeEEEEEEEccCC---cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTG---EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..++ ..||||+++..... .....+.+|+.++++++|+||+++++++... +
T Consensus 36 G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---------------~ 99 (298)
T 3f66_A 36 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---------------E 99 (298)
T ss_dssp ETTEEEEEEEEC-----CEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---------------S
T ss_pred cCCceEEEEEEecCCCceeEEEEEecccCCCH-HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC---------------C
Confidence 899999999976544 35899988754322 2345678999999999999999999986542 4
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+..|+||||+.+ +|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 567999999986 8888887766779999999999999999999999999999999999999999999999999998654
Q ss_pred CCCC---CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 159 YDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 159 ~~~~---~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ +.+||...+..+....+........
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 253 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ----- 253 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC-----
T ss_pred ccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC-----
Confidence 3221 22333456788999999976 578999999999999999999 7788888777776666654321111
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++|||++|+++
T Consensus 254 ------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 254 ------------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0135678999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=334.45 Aligned_cols=247 Identities=18% Similarity=0.229 Sum_probs=189.4
Q ss_pred cceeEEEEEEEcc---CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIK---TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~---tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++.. +++.||||+++...........+.+|+.++++|+|+||+++++++.+... ...
T Consensus 45 G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----------~~~ 113 (313)
T 3brb_A 45 GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS-----------QGI 113 (313)
T ss_dssp -CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----------------
T ss_pred cCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc-----------cCC
Confidence 8999999998875 55689999998765444445678899999999999999999999987321 112
Q ss_pred CeEEEEEecCCC-Chhhhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccc
Q 011627 80 GSTYMVFEYMDH-DLTGLAD-----RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~-----~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
...|+||||+.+ +|..++. .....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 357999999986 6666653 2335699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 011627 154 ARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDET 231 (481)
Q Consensus 154 a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (481)
++.+..... .......+++.|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+....+.......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--- 269 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK--- 269 (313)
T ss_dssp C----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---
T ss_pred ceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC---
Confidence 986643221 12223355788999999986 678999999999999999999 999999888877777665421110
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....++.++.+||.+||..||++|||+.+++++
T Consensus 270 --------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 270 --------------------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp --------------------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012467789999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=347.87 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=198.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++...... ....+.+|++++++|+|+||+++++++.+.. ...+
T Consensus 20 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--------------~~~~ 84 (396)
T 4eut_A 20 GATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETT--------------TRHK 84 (396)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--------------TCCE
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCC--------------CCee
Confidence 899999999999999999999998654322 3456789999999999999999999998632 4478
Q ss_pred EEEEecCCC-ChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----cCCCCeEEecccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLAR 155 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl----~~~~~vkL~DFG~a~ 155 (481)
|||||||.+ +|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999985 7777766532 239999999999999999999999999999999999999 777789999999998
Q ss_pred cccCCCCCccccccccccCCCchhhcCC-------CCCCCCCchhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHh
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGA-------TKYGPAVDMWSVGCIFAELLNGKPILPGK----NEAEQLSKIFEL 224 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~-------~~~~~~~DiwSlGvil~elltG~~pf~~~----~~~~~~~~i~~~ 224 (481)
.... .......++|..|+|||++.+. ..++.++||||||||+|+|++|+.||... ...+.+.++...
T Consensus 165 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELED--DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCC--GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccC--CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 7643 2233456789999999998641 34678999999999999999999999742 334555555442
Q ss_pred cCCCCCCCCccCCCCCc-cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 225 CGSPDETIWPGVSKMPA-YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 225 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.+...|........ ...+..... ....+...++..+.+||++||..||++|+|+.|+++
T Consensus 243 ---~p~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 ---KPSGAISGVQKAENGPIDWSGDMP---VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp ---CCTTCCEEEECSTTCCEEEESSCC---TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred ---CCcccchhheeccCCCcccCccCC---cccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 22222222211100 000000000 000122456778999999999999999999999854
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=334.80 Aligned_cols=243 Identities=23% Similarity=0.367 Sum_probs=195.2
Q ss_pred cceeEEEEEEE-----ccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE-----IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~-----~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++ ..+++.||||+++..... .....+.+|+.+++++ +|+||+++++++...
T Consensus 38 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~------------- 103 (316)
T 2xir_A 38 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP------------- 103 (316)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-------------
T ss_pred CCceeEEEEEEecCCccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-------------
Confidence 89999999995 467799999999765322 2345678999999999 799999999998762
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGL---------------RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 140 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~---------------~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl 140 (481)
...+|+||||+.+ +|.+++..... .+++..++.++.||+.||+|||+++|+||||||+||||
T Consensus 104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 3458999999986 77777765432 28999999999999999999999999999999999999
Q ss_pred cCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 011627 141 DNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQL 218 (481)
Q Consensus 141 ~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~ 218 (481)
+.++++||+|||+++.+..... .......+|+.|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+.+
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 9999999999999986643322 22234466889999999976 578999999999999999998 99999887655444
Q ss_pred HHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 219 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...+....... ....++.++.+||.+||..||++|||+.||++|
T Consensus 261 ~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCccCC----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 44333211110 011356789999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=336.36 Aligned_cols=241 Identities=25% Similarity=0.391 Sum_probs=196.1
Q ss_pred cceeEEEEEEEc-------cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-------KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~-------~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||+||+|++. .+++.||||+++.... ......+.+|+.+++++ +|+||+++++++.+
T Consensus 46 G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~------------ 112 (334)
T 2pvf_A 46 GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ------------ 112 (334)
T ss_dssp CSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS------------
T ss_pred cCceeEEEeEeccccccccccceEEEEeeeccCCc-HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc------------
Confidence 899999999986 4678999999975532 22345678999999999 89999999999976
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
.+.+||||||+.+ +|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||
T Consensus 113 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 113 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp ----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 5678999999986 7777766533 2489999999999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 216 (481)
||+.++.+||+|||+++....... .......+|+.|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 999999999999999987653221 12223355788999999976 568899999999999999999 999999988887
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
....+........ ...++.++.+||.+||..||++|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRMDK-----------------------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCC-----------------------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7776654321100 12367789999999999999999999999863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=339.28 Aligned_cols=261 Identities=21% Similarity=0.237 Sum_probs=187.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++. ++.||||+++.... ......+|+.++++|+|+||+++++++.+... ....+
T Consensus 35 G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~------------~~~~~ 97 (322)
T 3soc_A 35 GRFGCVWKAQLL--NEYVAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRGTS------------VDVDL 97 (322)
T ss_dssp STTCEEEEEEET--TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS------------SSEEE
T ss_pred cCceEEEEEEEC--CCEEEEEEeecCch---HHHHHHHHHHHHhcCCCCCchhhcceeccCCC------------CCceE
Confidence 899999999874 89999999975432 23345679999999999999999999987321 13468
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCcEEEcCCCCeEEecc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN----------QVLHRDIKGSNLLIDNEGNLKLADF 151 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~----------giiHrDLKp~NILl~~~~~vkL~DF 151 (481)
|||||||.+ +|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999986 777777653 489999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC-CccccccccccCCCchhhcCC----CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 011627 152 GLARSFSYDHN-NTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 226 (481)
Q Consensus 152 G~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 226 (481)
|+|+.+..... ......++|+.|+|||++.+. ..++.++||||||||+|||++|+.||.+......+........
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99987654322 223345789999999999763 2345678999999999999999999976543211000000000
Q ss_pred CCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 227 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.+....+...... ....+.. .... .....+.++.+||++||+.||++|||+.||++
T Consensus 256 ~~~~~~~~~~~~~---~~~~~~~--~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 256 HPSLEDMQEVVVH---KKKRPVL--RDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SCCHHHHHHHHTT---SCCCCCC--CGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhhhhhc---ccCCCCc--cccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000000000000 0000000 0000 00124567999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=352.45 Aligned_cols=236 Identities=21% Similarity=0.356 Sum_probs=196.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++. ++..||||+++.... ....+++|+.+|++|+|+||+++++++.. ..+
T Consensus 199 G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-----------------~~~ 257 (454)
T 1qcf_A 199 GQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK-----------------EPI 257 (454)
T ss_dssp CSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS-----------------SSC
T ss_pred CCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC-----------------Ccc
Confidence 899999999985 467899999985432 35678899999999999999999999853 357
Q ss_pred EEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||||||.+ +|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999985 7877776432 35899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........+|..|+|||++.. ..++.++||||||||||||++ |+.||.+.+..+.+..+......+.
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---------- 406 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---------- 406 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC----------
T ss_pred ceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 2222233345788999999976 578999999999999999999 9999999988888877764321111
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++|||+++|++
T Consensus 407 -------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 407 -------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1236778999999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=325.46 Aligned_cols=236 Identities=21% Similarity=0.375 Sum_probs=194.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++. +++.||||+++.... ....+.+|++++++|+|+||+++++++.+ +.+
T Consensus 24 G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----------------~~~ 82 (279)
T 1qpc_A 24 GQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----------------EPI 82 (279)
T ss_dssp ETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSC
T ss_pred CCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC-----------------CCc
Confidence 899999999975 567899999975432 24578899999999999999999999863 347
Q ss_pred EEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999975 7777765432 25899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+.+..+........
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 231 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---------- 231 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----------
T ss_pred ccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC----------
Confidence 3333334456788999999975 567899999999999999999 9999999888877776653211100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++|||+.++++
T Consensus 232 -------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 232 -------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------cccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1246778999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=330.68 Aligned_cols=241 Identities=29% Similarity=0.393 Sum_probs=183.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++.... .......+.+|+.++++|+|+||+++++++.+ .+.
T Consensus 43 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~ 106 (310)
T 2wqm_A 43 GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----------------DNE 106 (310)
T ss_dssp C--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTE
T ss_pred CCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----------------CCc
Confidence 8999999999999999999999986432 22234567899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
++|||||+++ +|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999986 66665543 3456899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN--EAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
.... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.. .......+... ..+..
T Consensus 187 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~----- 258 (310)
T 2wqm_A 187 SSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPL----- 258 (310)
T ss_dssp -------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-CSCCC-----
T ss_pred cCCC-ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-cCCCC-----
Confidence 4322 22334567999999999876 578999999999999999999999997643 22333333221 11000
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.+|++
T Consensus 259 ----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 259 ----------------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ----------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01246778999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=336.27 Aligned_cols=241 Identities=18% Similarity=0.281 Sum_probs=197.4
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|++. .+++.||||+++..... .....+.+|+.++++++|+||+++++++.+
T Consensus 36 G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------------- 99 (322)
T 1p4o_A 36 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQ--------------- 99 (322)
T ss_dssp CSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEECS---------------
T ss_pred CCceEEEeeeecCccCCCCceEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---------------
Confidence 899999999987 46889999999754322 223467899999999999999999999976
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeE
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRP---------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 147 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~---------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vk 147 (481)
...+||||||+.+ +|.+++... ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+|
T Consensus 100 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 100 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred -CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 5578999999985 777766532 13579999999999999999999999999999999999999999999
Q ss_pred EecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 011627 148 LADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 225 (481)
Q Consensus 148 L~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 225 (481)
|+|||+++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 999999976543221 12233456889999999876 568999999999999999999 899999988887777665421
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
... ....++.++.+||.+||..||++|||+.|++++
T Consensus 258 ~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 LLD-----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 100 012467789999999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.49 Aligned_cols=255 Identities=18% Similarity=0.273 Sum_probs=193.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++ .+++.||||++....... ....+.+|+.++++++|+||+++++++.+ ....
T Consensus 41 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 102 (326)
T 3uim_A 41 GGFGKVYKGRL-ADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMT----------------PTER 102 (326)
T ss_dssp CSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC----------------SSCC
T ss_pred CCCcEEEEEEe-cCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEec----------------CCce
Confidence 89999999985 478999999998654332 23468899999999999999999999987 5577
Q ss_pred EEEEecCCC-ChhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPG---LRFTVPQIKCYMKQLLTGLHYCHVN---QVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~---~~l~~~~i~~i~~Qil~gL~~LH~~---giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
+|||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 999999986 7777665532 3499999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcCCCCCC
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK----NEAEQLSKIFELCGSPDET 231 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~----~~~~~~~~i~~~~~~~~~~ 231 (481)
..............+|+.|+|||++.+ ..++.++||||||||+|+|++|+.||... .....+....... ....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~ 259 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL--LKEK 259 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT--TSSC
T ss_pred ccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH--hhch
Confidence 776544444555668999999999976 56899999999999999999999999621 1111111111100 0000
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 011627 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291 (481)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~ 291 (481)
....... .. .........+..+.+||.+||..||++|||+.||++|-
T Consensus 260 ~~~~~~~------~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 260 KLEALVD------VD-------LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp CSTTSSC------TT-------CTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hhhhhcC------hh-------hccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 0000000 00 00011134567899999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=338.91 Aligned_cols=250 Identities=18% Similarity=0.154 Sum_probs=190.0
Q ss_pred cceeEEEEEEEcc---CCcEEEEEEeecCCcC---------CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCC
Q 011627 3 VCISQVFMAREIK---TGEIVALKKIRMDNEK---------EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 70 (481)
Q Consensus 3 G~fg~Vy~a~~~~---tg~~vAvK~i~~~~~~---------~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~ 70 (481)
|+||+||+|++.. ++..||||++...... ......+.+|+.+++.++|+||+++++++....
T Consensus 48 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~------ 121 (345)
T 2v62_A 48 GGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF------ 121 (345)
T ss_dssp ----CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES------
T ss_pred cCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc------
Confidence 8999999999987 8899999999765321 011234667889999999999999999987621
Q ss_pred CCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC--CeEE
Q 011627 71 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG--NLKL 148 (481)
Q Consensus 71 ~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~--~vkL 148 (481)
.....+|||||||.++|.+++.... .+++.+++.|+.||+.||+|||+++|+||||||+||||+.++ .+||
T Consensus 122 ------~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 122 ------KGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp ------SSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ------CCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 1145799999999668877776544 799999999999999999999999999999999999999877 9999
Q ss_pred ecccccccccCCCC------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCC--ChHHHHHH
Q 011627 149 ADFGLARSFSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK--NEAEQLSK 220 (481)
Q Consensus 149 ~DFG~a~~~~~~~~------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~--~~~~~~~~ 220 (481)
+|||+|+.+..... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||... +.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999987643211 12244578999999999987 57899999999999999999999999653 22222222
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHh--hhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 221 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR--HFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
........ ......... .++.++.+||.+||..||++|||+++|++
T Consensus 274 ~~~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 274 KTNLLDEL-----------------------PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHTT-----------------------THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhcccc-----------------------cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 21111000 011111111 57889999999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.69 Aligned_cols=244 Identities=18% Similarity=0.285 Sum_probs=194.7
Q ss_pred cceeEEEEEE-----EccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAR-----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~-----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|+ +..+++.||||++..... ......+.+|+.++++|+|+||+++++++.+
T Consensus 41 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------------- 104 (327)
T 2yfx_A 41 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQ--------------- 104 (327)
T ss_dssp -CSSCEEEEEC--------CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---------------
T ss_pred CCCeeEEEEEEcCCCCCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC---------------
Confidence 8999999999 667889999999974432 2234567899999999999999999999987
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC---CCeE
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPG------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE---GNLK 147 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~---~~vk 147 (481)
...+||||||+.+ +|.+++.... ..+++.+++.++.||+.||.|||+++|+||||||+||||+.+ ..+|
T Consensus 105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 5567999999964 7877776543 348999999999999999999999999999999999999844 4599
Q ss_pred EecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 011627 148 LADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 225 (481)
Q Consensus 148 L~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~ 225 (481)
|+|||+++....... .......+|+.|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+.+..+....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999976543221 22233466889999999976 578999999999999999998 999999988887777665422
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
.... ...++..+.+||.+||..||++|||+.+|+++.|+
T Consensus 263 ~~~~-----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 263 RMDP-----------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp CCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC-----------------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1100 12467789999999999999999999999998776
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=340.42 Aligned_cols=243 Identities=14% Similarity=0.139 Sum_probs=189.0
Q ss_pred cceeEEEEEEEccC--------CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccce---------------eeE
Q 011627 3 VCISQVFMAREIKT--------GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKL---------------KEI 59 (481)
Q Consensus 3 G~fg~Vy~a~~~~t--------g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l---------------~~~ 59 (481)
|+||+||+|++..| ++.||||+++.. ..+.+|+.++++++|+||+++ +++
T Consensus 53 G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~ 125 (352)
T 2jii_A 53 DNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGF 125 (352)
T ss_dssp ETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEE
T ss_pred CCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhc
Confidence 89999999999884 889999999754 267899999999999999984 444
Q ss_pred EeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
+.. ....+||||||+.++|.+++... ...+++.+++.++.||+.||+|||+++|+||||||+||
T Consensus 126 ~~~---------------~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 126 GVH---------------QDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp EEE---------------TTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccc---------------CCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 432 15689999999977888887754 35699999999999999999999999999999999999
Q ss_pred EEcCCC--CeEEecccccccccCCCC------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCC
Q 011627 139 LIDNEG--NLKLADFGLARSFSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP 210 (481)
Q Consensus 139 Ll~~~~--~vkL~DFG~a~~~~~~~~------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~ 210 (481)
||+.++ .+||+|||+++.+..... .......+|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999988 899999999986643221 12234578999999999986 578999999999999999999999998
Q ss_pred CCC--hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHh
Q 011627 211 GKN--EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288 (481)
Q Consensus 211 ~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL 288 (481)
... .......+........... .. . ..+..++.++.+||.+||..||++|||+++|+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~-~~---~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 328 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFV-GP---C-----------------GHWIRPSETLQKYLKVVMALTYEEKPPYAMLR 328 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEE-CT---T-----------------SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhh-hh---c-----------------cccCCCcHHHHHHHHHHHhCChhhCCCHHHHH
Confidence 764 3333333322211111100 00 0 00124678999999999999999999999997
Q ss_pred c
Q 011627 289 D 289 (481)
Q Consensus 289 ~ 289 (481)
+
T Consensus 329 ~ 329 (352)
T 2jii_A 329 N 329 (352)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=336.38 Aligned_cols=241 Identities=23% Similarity=0.358 Sum_probs=196.1
Q ss_pred cceeEEEEEEEccCCc-----EEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGE-----IVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++..+++ .||||+++..... .....+.+|+.++++| +|+||+++++++.+
T Consensus 57 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-------------- 121 (333)
T 2i1m_A 57 GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQHENIVNLLGACTH-------------- 121 (333)
T ss_dssp CSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--------------
T ss_pred CCCcceEEEEecCCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--------------
Confidence 8999999999987765 7999999755322 2345678999999999 89999999999986
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRP-------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 142 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~-------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~ 142 (481)
.+.+||||||+.+ +|.+++... ...+++..+..++.||+.||+|||+++|+||||||+||||+.
T Consensus 122 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 122 --GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred --CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 5578999999986 777766532 335899999999999999999999999999999999999999
Q ss_pred CCCeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011627 143 EGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSK 220 (481)
Q Consensus 143 ~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~ 220 (481)
++.+||+|||+++........ ......+|..|+|||++.+ ..++.++||||||||+|+|++ |..||........+..
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 999999999999866433222 2233455788999999886 578999999999999999998 9999998776666655
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 221 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+......... ...++.++.+||.+||..||++|||+.||++
T Consensus 279 ~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 279 LVKDGYQMAQ----------------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCC----------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5543211110 0125678999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=359.97 Aligned_cols=239 Identities=18% Similarity=0.232 Sum_probs=194.9
Q ss_pred cceeEEEEEEEc--cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREI--KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|.+. .++..||||+++.... ......+++|+.+|++|+|+|||++++++.. +
T Consensus 347 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----------------~ 408 (613)
T 2ozo_A 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----------------E 408 (613)
T ss_dssp CSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----------------S
T ss_pred CCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----------------C
Confidence 899999999876 4566799999986533 2345678899999999999999999999874 3
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|||||||.+ +|.+++......+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 58999999986 67777766666799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 160 DHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 160 ~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.... ......+|..|+|||++.. ..++.++||||||||||||++ |+.||...+..+++..+.......
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 559 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME-------- 559 (613)
T ss_dssp -------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC--------
T ss_pred CCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 2221 1122234688999999976 578999999999999999998 999999998888877775422110
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.+|++
T Consensus 560 ---------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 560 ---------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ---------------------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ---------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01246788999999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=337.53 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=193.7
Q ss_pred cceeEEEEEE----EccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAR----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|+ +..+++.||||++..... .....+.+|+.++++|+|+||+++++++....
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------------- 97 (327)
T 3lxl_A 34 GNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--DQQRDFQREIQILKALHSDFIVKYRGVSYGPG-------------- 97 (327)
T ss_dssp ETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--------------
T ss_pred CCCeEEEEEEeccCCCCcceEEEEEEeccCCH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCC--------------
Confidence 8999999999 678999999999975532 23456789999999999999999999987532
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...+||||||+++ +|.+++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 5679999999965 777777664556999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHH-----------HHHHHh
Q 011627 158 SYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL-----------SKIFEL 224 (481)
Q Consensus 158 ~~~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-----------~~i~~~ 224 (481)
..... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||......... ..+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 43322 12233456888999999976 56789999999999999999999998754332111 000000
Q ss_pred cCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 225 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
..... .......++.++.+||.+||..||++|||+.|++++
T Consensus 257 ~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 LEEGQ-------------------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccc-------------------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000 000113577899999999999999999999999753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=326.69 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=194.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++... ..+.+|++++++|+|+||+++++++.....................+
T Consensus 22 G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (284)
T 2a19_B 22 GGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCL 95 (284)
T ss_dssp SSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceE
Confidence 899999999999999999999997543 25679999999999999999999986421100000000111224568
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
||||||+++ +|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 96 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175 (284)
T ss_dssp EEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCC
T ss_pred EEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheecccc
Confidence 999999996 777776543 346899999999999999999999999999999999999999999999999999876532
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..+|... ......+... .
T Consensus 176 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~------------- 235 (284)
T 2a19_B 176 --GKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--I------------- 235 (284)
T ss_dssp --SCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--C-------------
T ss_pred --ccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--c-------------
Confidence 22344578999999999986 57899999999999999999998876421 1112222110 0
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+...++.++.+||.+||..||++|||+.|++++.+.+.
T Consensus 236 -----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 -----------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -----------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 01236778999999999999999999999999877654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=342.60 Aligned_cols=241 Identities=23% Similarity=0.304 Sum_probs=186.8
Q ss_pred cceeEEEEEEEccCC---cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTG---EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..++ ..||||+++.... ......+.+|+.++++|+|+||+++++++... +
T Consensus 100 G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---------------~ 163 (373)
T 3c1x_A 100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---------------E 163 (373)
T ss_dssp CSSSEEEEEEEEETTTEEEEEEEEECCSCSC-SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC---------------S
T ss_pred CCCeEEEEEEEECCCCcEEEEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC---------------C
Confidence 899999999986543 4689999875332 23456788999999999999999999987542 4
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+..||||||+.+ +|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 467999999986 8888887766679999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCC---ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 159 YDHNN---TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 159 ~~~~~---~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
..... ......+|..|+|||++.+ ..++.++||||||||+|||++ |.+||...+..+....+........
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~----- 317 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ----- 317 (373)
T ss_dssp --------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC-----
T ss_pred ccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 32211 1233455788999999986 678999999999999999999 7888988777666655543211100
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++|||++|+++
T Consensus 318 ------------------------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 318 ------------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp ------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1236778999999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=327.88 Aligned_cols=244 Identities=22% Similarity=0.281 Sum_probs=185.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHh--cCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKK--LQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++ +++.||||++.... .....+|.+++.. ++|+||+++++++.... ....
T Consensus 19 G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~------------~~~~ 79 (301)
T 3q4u_A 19 GRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSR------------HSST 79 (301)
T ss_dssp CSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE------------TTEE
T ss_pred CCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeecccc------------CCCc
Confidence 89999999987 79999999987542 3355677887777 79999999999976521 1145
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEEcCCCCeEEecc
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH--------VNQVLHRDIKGSNLLIDNEGNLKLADF 151 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH--------~~giiHrDLKp~NILl~~~~~vkL~DF 151 (481)
.+||||||+.+ +|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+||||+.++++||+||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 68999999986 77777743 36999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCC---ccccccccccCCCchhhcCCC-----CCCCCCchhhHHHHHHHHHhC----------CCCCCCCC
Q 011627 152 GLARSFSYDHNN---TLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNG----------KPILPGKN 213 (481)
Q Consensus 152 G~a~~~~~~~~~---~~~~~~gt~~Y~aPEvl~~~~-----~~~~~~DiwSlGvil~elltG----------~~pf~~~~ 213 (481)
|+|+........ .....++|+.|+|||++.+.. .++.++||||||||+|||++| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999765433221 123347899999999997632 234689999999999999999 78885432
Q ss_pred ----hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 214 ----EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 214 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....+..+......... .+ .......++.++.+||.+||+.||++|||++||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~--------~~--------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPN--------IP--------------NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCC--------CC--------------GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCC--------CC--------------hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22333333221111000 00 00011246678999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.74 Aligned_cols=232 Identities=20% Similarity=0.343 Sum_probs=192.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++ +++.||||+++... ....+.+|+.++++|+|+||+++++++.+. ...+
T Consensus 204 G~fg~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---------------~~~~ 262 (450)
T 1k9a_A 204 GEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---------------KGGL 262 (450)
T ss_dssp CSSEEEEEEEE--TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT---------------TSCE
T ss_pred cCCeeEEEEEe--cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC---------------CCce
Confidence 89999999987 47899999997543 345788999999999999999999998762 3478
Q ss_pred EEEEecCCC-ChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||||||.+ +|.+++..... .+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999985 78777765433 3799999999999999999999999999999999999999999999999999854322
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||...+..+.+..+.......
T Consensus 343 ----~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------- 406 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD----------- 406 (450)
T ss_dssp --------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC-----------
T ss_pred ----ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 122356889999999986 678999999999999999998 999999888777776664321110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.+|++
T Consensus 407 ------------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 407 ------------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01246788999999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=330.99 Aligned_cols=239 Identities=18% Similarity=0.238 Sum_probs=193.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++.. .||||+++...........+.+|+.++++++|+||+++++++.+ ...+
T Consensus 44 G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~ 104 (319)
T 2y4i_B 44 GRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS----------------PPHL 104 (319)
T ss_dssp SSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC----------------SSCE
T ss_pred CCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec----------------CCce
Confidence 8999999999854 49999998765555555677799999999999999999999987 5679
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC-
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD- 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~- 160 (481)
+|||||+.+ +|.+++......+++..++.++.||+.||+|||+++|+||||||+||||+ ++.+||+|||+++.....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999985 77777776666799999999999999999999999999999999999998 578999999998764321
Q ss_pred ---CCCccccccccccCCCchhhcC--------CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 011627 161 ---HNNTLTNRVITLWYRPPELLLG--------ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 229 (481)
Q Consensus 161 ---~~~~~~~~~gt~~Y~aPEvl~~--------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~ 229 (481)
.........+|..|+|||++.. ...++.++||||||||+|+|++|+.||...+....+..+........
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 1223334467999999999874 23578899999999999999999999999888877776654221110
Q ss_pred CCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 230 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
. ...++.++.+||.+||..||++|||+.++++
T Consensus 264 ~----------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 264 S----------------------------QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp C----------------------------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred C----------------------------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 0125567999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.46 Aligned_cols=240 Identities=25% Similarity=0.417 Sum_probs=192.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++.. +..||||+++.... ....+.+|+.++++|+|+||+++++++.+ +.+
T Consensus 195 G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----------------~~~ 253 (452)
T 1fmk_A 195 GCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----------------EPI 253 (452)
T ss_dssp CSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSC
T ss_pred CCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----------------Cce
Confidence 8999999999865 46799999986432 24578899999999999999999999853 357
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||||||.+ +|.+++... ...+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999985 777777642 245899999999999999999999999999999999999999999999999999876533
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........+|..|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+.+..+......+.
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---------- 402 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---------- 402 (452)
T ss_dssp ---------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----------
T ss_pred ceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 3233333455788999999986 578999999999999999999 9999999988888777754221110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc--CCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD--SEYF 293 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~--h~~f 293 (481)
...++.++.+||.+||..||++|||+++|++ ..++
T Consensus 403 -------------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 403 -------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp -------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1246778999999999999999999999986 3444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=330.52 Aligned_cols=253 Identities=24% Similarity=0.304 Sum_probs=193.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC--cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN--EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++ +++.||||++.... ..+.....+.+|+.++++|+|+||+++++++.+ .+
T Consensus 42 G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~ 103 (307)
T 2nru_A 42 GGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD----------------GD 103 (307)
T ss_dssp CSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SS
T ss_pred CCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec----------------CC
Confidence 89999999986 68899999997543 233345678899999999999999999999976 55
Q ss_pred eEEEEEecCCC-ChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 81 STYMVFEYMDH-DLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~--~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
.+||||||+.+ +|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 104 DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183 (307)
T ss_dssp SCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 78999999975 77776653 2345899999999999999999999999999999999999999999999999999866
Q ss_pred cCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 158 SYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 158 ~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
...... ......+|+.|+|||++.+ .++.++||||||||+|+|++|..||...+....+..+.+......... ...
T Consensus 184 ~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 260 (307)
T 2nru_A 184 EKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTI-EDY 260 (307)
T ss_dssp CSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCH-HHH
T ss_pred ccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhh-hhh
Confidence 432222 2233567999999999875 478999999999999999999999987655433333322111100000 000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
. ...........+..+.+||.+||..||++|||+.+++++
T Consensus 261 ~--------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 261 I--------------DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp S--------------CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred c--------------cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 000001112456789999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=332.65 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=188.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||++..... .....+.+|+.++++|+|+||+++++++.... .....+
T Consensus 40 G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------------~~~~~~ 105 (317)
T 2buj_A 40 GGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRER------------GAKHEA 105 (317)
T ss_dssp --CEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE------------TTEEEE
T ss_pred CCCeEEEEEEecCCCcEEEEEEEecCCH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc------------CCCcee
Confidence 8999999999999999999999876432 23457789999999999999999999987421 014578
Q ss_pred EEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
|+||||+.+ +|.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999986 77666654 45579999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCC--------ccccccccccCCCchhhcCCC--CCCCCCchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcC
Q 011627 159 YDHNN--------TLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNE--AEQLSKIFELCG 226 (481)
Q Consensus 159 ~~~~~--------~~~~~~gt~~Y~aPEvl~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~~ 226 (481)
..... ......+|..|+|||++.+.. .++.++||||||||+|+|++|+.||..... ......+....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~- 264 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL- 264 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC-
Confidence 21111 112335689999999987532 268899999999999999999999953211 01111111100
Q ss_pred CCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 227 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.. + ....++.++.+||.+||..||++|||+.+++++
T Consensus 265 ~~-----~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 SI-----P-----------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -C-----C-----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-----C-----------------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00 0 012467789999999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=354.99 Aligned_cols=240 Identities=25% Similarity=0.413 Sum_probs=197.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++.. +..||||+++.... ....+++|+.+|++|+|+||+++++++.+ +.+
T Consensus 278 G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----------------~~~ 336 (535)
T 2h8h_A 278 GCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----------------EPI 336 (535)
T ss_dssp CSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSC
T ss_pred CCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-----------------ccc
Confidence 8999999999865 46799999986532 24578899999999999999999999853 357
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||||||.+ +|.+++... ...+++.++..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999986 787777642 245899999999999999999999999999999999999999999999999999866432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........++..|+|||++.. ..++.++||||||||||||++ |+.||.+.+..+++..+......+.
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---------- 485 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---------- 485 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC----------
T ss_pred ceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence 2122233445788999999986 578999999999999999999 9999999988888777754211100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC--CCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS--EYF 293 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h--~~f 293 (481)
...++.++.+||.+||..||++|||+++|++. .+|
T Consensus 486 -------------------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 486 -------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 12467789999999999999999999999863 444
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.81 Aligned_cols=252 Identities=15% Similarity=0.158 Sum_probs=186.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCC-CCc---------cceeeEEeCCCCCCCCC-
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQH-ENV---------IKLKEIVTSPGPERDEQ- 70 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~h-pnI---------v~l~~~~~~~~~~~~~~- 70 (481)
|+||+||+|++..+++.||||+++... ........+.+|+.+++.|.| .|+ +...++...........
T Consensus 89 G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (413)
T 3dzo_A 89 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 168 (413)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-------
T ss_pred CCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccc
Confidence 899999999999999999999998443 223345678899999999987 322 22222222211100000
Q ss_pred CCCCCCCcCCeEEEEEecCCCChhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC
Q 011627 71 GRPDGNKYRGSTYMVFEYMDHDLTGLAD------RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 144 (481)
Q Consensus 71 ~~~~~~~~~~~~~iV~Ey~~g~L~~~~~------~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~ 144 (481)
...........++++|+++.++|.+++. .....+++..+..++.||+.||+|||+++|+||||||+||||+.++
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~ 248 (413)
T 3dzo_A 169 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 248 (413)
T ss_dssp --------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred cCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCC
Confidence 0000011133578999999999888773 3344578889999999999999999999999999999999999999
Q ss_pred CeEEecccccccccCCCCCccccccccccCCCchhhc---------CCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH
Q 011627 145 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---------GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 215 (481)
Q Consensus 145 ~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~---------~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 215 (481)
.+||+|||+++..... ....++ +.|+|||++. ....++.++||||||||+|+|++|+.||...+..
T Consensus 249 ~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~ 323 (413)
T 3dzo_A 249 GVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323 (413)
T ss_dssp CEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGG
T ss_pred eEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9999999999865422 444567 9999999983 2345788999999999999999999999876543
Q ss_pred HHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 216 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 216 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+....++. ....++.++.+||.+||..||++|||+.++|+|+||
T Consensus 324 ~~~~~~~~----------------------------------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~ 367 (413)
T 3dzo_A 324 GGSEWIFR----------------------------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 367 (413)
T ss_dssp SCSGGGGS----------------------------------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred hhHHHHHh----------------------------------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 22211110 011467889999999999999999999999999999
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=327.41 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=188.6
Q ss_pred cceeEEEEEEEcc-CCc--EEEEEEeecCCc-CCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIK-TGE--IVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~-tg~--~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++.. +++ .||||+++.... .......+.+|+.++++|+|+||+++++++.+
T Consensus 29 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------------- 92 (291)
T 1u46_A 29 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---------------- 92 (291)
T ss_dssp ---CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------
T ss_pred CCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----------------
Confidence 7899999999654 333 689999876532 23345677899999999999999999999975
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
. .+++||||+.+ +|.+.+......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 93 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 P-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred C-CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 2 37899999984 787777765556999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 158 SYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 158 ~~~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
...... ......+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+.+..+.........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 246 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR---- 246 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC----
T ss_pred cccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC----
Confidence 433221 1223455778999999976 567899999999999999999 99999999888877777542211110
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++|||+.++++
T Consensus 247 ------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 247 ------------------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1246778999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=329.88 Aligned_cols=244 Identities=25% Similarity=0.359 Sum_probs=188.5
Q ss_pred cceeEEEEEE----EccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAR----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||++. +..+++.||||+++.... ......+.+|+.++++|+|+||+++++++.+..
T Consensus 42 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------------- 106 (318)
T 3lxp_A 42 GHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG-------------- 106 (318)
T ss_dssp CSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--------------
T ss_pred CCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC--------------
Confidence 8999997775 456899999999986532 223456789999999999999999999998732
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...+||||||+.+ +|.+++.+. .+++.+++.++.||+.+|+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 4578999999986 777776654 4899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHH-----------HHHHHHHh
Q 011627 158 SYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-----------QLSKIFEL 224 (481)
Q Consensus 158 ~~~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-----------~~~~i~~~ 224 (481)
..... .......+|..|+|||++.+ ..++.++||||||||+|+|++|..||....... ....+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 53321 12233456888999999986 567889999999999999999999987543211 01111110
Q ss_pred cCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 225 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...... ......++.++.+||++||..||++|||+.|+++
T Consensus 264 ~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 264 LERGER-------------------------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHTTCC-------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcccC-------------------------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000000 0011247789999999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=325.01 Aligned_cols=229 Identities=24% Similarity=0.361 Sum_probs=179.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++ +++.||||++.... ....+.+|+.++++++|+||+++++++.+ .+
T Consensus 19 G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------------------~~ 74 (307)
T 2eva_A 19 GAFGVVCKAKW--RAKDVAIKQIESES----ERKAFIVELRQLSRVNHPNIVKLYGACLN------------------PV 74 (307)
T ss_dssp CSSSEEEEEEE--TTEEEEEEECSSTT----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT------------------TT
T ss_pred CCCceEEEEEE--CCeeEEEEEecChh----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC------------------Cc
Confidence 89999999997 47899999986432 34578899999999999999999998753 36
Q ss_pred EEEEecCCC-ChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCcEEEcCCCC-eEEecccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGL--RFTVPQIKCYMKQLLTGLHYCHV---NQVLHRDIKGSNLLIDNEGN-LKLADFGLAR 155 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~--~l~~~~i~~i~~Qil~gL~~LH~---~giiHrDLKp~NILl~~~~~-vkL~DFG~a~ 155 (481)
||||||+++ +|.+++..... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 899999985 77777665432 47899999999999999999999 89999999999999998887 7999999997
Q ss_pred cccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCCCCC
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA--EQLSKIFELCGSPDETIW 233 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~~~~~~~ 233 (481)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+... ....
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~--- 224 (307)
T 2eva_A 155 DIQT----HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG--TRPP--- 224 (307)
T ss_dssp --------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT--CCCC---
T ss_pred cccc----ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC--CCCC---
Confidence 6532 2234468999999999986 67899999999999999999999999864332 222222211 0000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++..+.+||.+||..||++|||++++++
T Consensus 225 ------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 225 ------------------------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ------------------------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------cccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11246778999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=323.17 Aligned_cols=232 Identities=21% Similarity=0.344 Sum_probs=184.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||++++ +++.||||+++... ....+.+|+.++++|+|+||+++++++.+. .+.+
T Consensus 32 G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---------------~~~~ 90 (278)
T 1byg_A 32 GEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---------------KGGL 90 (278)
T ss_dssp CSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC-----------------CC
T ss_pred CCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---------------CCce
Confidence 89999999987 58899999997543 345788999999999999999999997652 3468
Q ss_pred EEEEecCCC-ChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|+||||+.+ +|.+++..... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999986 78777764322 2789999999999999999999999999999999999999999999999999765422
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.......
T Consensus 171 ----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------- 234 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD----------- 234 (278)
T ss_dssp ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC-----------
T ss_pred ----ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-----------
Confidence 223356889999999976 578999999999999999998 999999887776666553211000
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....+++++.+||++||..||++|||+.|+++
T Consensus 235 ------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 235 ------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 01246778999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=328.31 Aligned_cols=229 Identities=24% Similarity=0.351 Sum_probs=179.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHH-HhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKIL-KKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il-~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++. ...+.+|+.++ +.++|+||+++++++..... ....
T Consensus 29 G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~------------~~~~ 89 (299)
T 3m2w_A 29 GINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA------------GRKC 89 (299)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET------------TEEE
T ss_pred CCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC------------CCce
Confidence 7999999999999999999999963 23567899998 56689999999999875110 1457
Q ss_pred EEEEEecCCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCeEEeccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~ 156 (481)
+||||||+.+ +|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||+. ++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 8999999986 7877776543 46999999999999999999999999999999999999998 78899999999864
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.. ...++.++||||||||+|+|++|+.||...+.......+.. ..
T Consensus 170 ~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-------~~---- 214 (299)
T 3m2w_A 170 TT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------RI---- 214 (299)
T ss_dssp CT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-------SS----
T ss_pred cc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-------HH----
Confidence 32 13467889999999999999999999977654332111100 00
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.... .......+..++.++.+||.+||..||++|||+.|+|+|+||...
T Consensus 215 ----~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 215 ----RMGQ-------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp ----CTTC-------CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ----hhcc-------ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 0000 011122345688999999999999999999999999999999654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=327.80 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=190.6
Q ss_pred cceeEEEEEE----EccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAR----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~----~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|+ +..+++.||||++.... ......+.+|+.++++|+|+||+++++++....
T Consensus 52 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------------- 115 (326)
T 2w1i_A 52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-------------- 115 (326)
T ss_dssp CSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----------------
T ss_pred CCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--------------
Confidence 8999999999 56789999999997542 223457889999999999999999999987632
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...++|||||+.+ +|.+++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 3468999999985 888888776667999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH------------HHHHHHHH
Q 011627 158 SYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA------------EQLSKIFE 223 (481)
Q Consensus 158 ~~~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~------------~~~~~i~~ 223 (481)
...... ......++..|+|||++.+ ..++.++||||||||+|+|++|..||...... .....+.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 533221 1223355778999999976 56789999999999999999999887643111 00001111
Q ss_pred hcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 224 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....... ......++.++.+||++||..||++|||+.||++
T Consensus 275 ~~~~~~~-------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 275 LLKNNGR-------------------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHTTCC-------------------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhcCCC-------------------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000000 0011246789999999999999999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=328.12 Aligned_cols=252 Identities=17% Similarity=0.137 Sum_probs=184.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc------CCCcchhHHHHHHHHHhcC---------CCCccceeeEEeCCCCC-
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE------KEGFPITAIREIKILKKLQ---------HENVIKLKEIVTSPGPE- 66 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~L~---------hpnIv~l~~~~~~~~~~- 66 (481)
|+||+||+|++ +++.||||+++.... .......+.+|+.++++|+ |+|||++++++...+..
T Consensus 31 G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~h 108 (336)
T 2vuw_A 31 GVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYP 108 (336)
T ss_dssp ETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCC
T ss_pred cCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCc
Confidence 89999999998 789999999987642 2223367889999999996 77777666654321000
Q ss_pred -------------CCCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccC
Q 011627 67 -------------RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHR 131 (481)
Q Consensus 67 -------------~~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH-~~giiHr 131 (481)
...............+|||||||.+ ++++.+.+ ..+++.+++.|+.||+.||+||| +++|+||
T Consensus 109 p~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHr 186 (336)
T 2vuw_A 109 PLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHR 186 (336)
T ss_dssp HHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeEC
Confidence 0000000000115689999999976 46666654 45899999999999999999999 9999999
Q ss_pred CCCCCcEEEcCCC--------------------CeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCc
Q 011627 132 DIKGSNLLIDNEG--------------------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 191 (481)
Q Consensus 132 DLKp~NILl~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~D 191 (481)
||||+||||+.++ .+||+|||+|+.... ...++|+.|+|||++.+. . +.++|
T Consensus 187 DlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~~~g~-~-~~~~D 258 (336)
T 2vuw_A 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDLFTGD-G-DYQFD 258 (336)
T ss_dssp CCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGGGCCC-S-SHHHH
T ss_pred CCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhhhcCC-C-cccee
Confidence 9999999999887 899999999987642 234789999999999873 3 88999
Q ss_pred hhhHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHH
Q 011627 192 MWSVGCI-FAELLNGKPILPGKNE-AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALEL 269 (481)
Q Consensus 192 iwSlGvi-l~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (481)
||||+++ .+++++|..||..... ......+........ ......+..+++++++|
T Consensus 259 iwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 259 IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT-----------------------KCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp HHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS-----------------------CCCSHHHHHHHHHHHHH
T ss_pred hhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc-----------------------ccchhhhhhcCHHHHHH
Confidence 9998777 7788889998854221 112223322111000 01123456789999999
Q ss_pred HHHhcccCCCCCCCHHHHh-cCCCCC
Q 011627 270 LEKMLMLDPSQRISAKDAL-DSEYFW 294 (481)
Q Consensus 270 l~~~L~~dP~~R~sa~eiL-~h~~f~ 294 (481)
|++||+.| |++|+| +||||+
T Consensus 316 i~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHHhccC-----CHHHHHhcCCCcC
Confidence 99999987 999999 999994
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=334.67 Aligned_cols=231 Identities=17% Similarity=0.217 Sum_probs=182.4
Q ss_pred cceeEEEEE-----EEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC---CCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMA-----REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a-----~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||+||+| .+..+++.||||+++... ...+.+|+.+++.|+ |+||+++++++..
T Consensus 76 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~------------ 138 (365)
T 3e7e_A 76 GAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF------------ 138 (365)
T ss_dssp CSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC------------
T ss_pred cCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec------------
Confidence 899999999 578899999999987542 346778999999887 9999999999987
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-------
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN------- 142 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~----~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~------- 142 (481)
.+..|||||||++ +|.+++.. ....+++.+++.|+.||+.||+|||+++|+||||||+||||+.
T Consensus 139 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 139 ----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp ----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred ----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 6688999999985 77777653 3456999999999999999999999999999999999999998
Q ss_pred ----CCCeEEecccccccccC-CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHH
Q 011627 143 ----EGNLKLADFGLARSFSY-DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 217 (481)
Q Consensus 143 ----~~~vkL~DFG~a~~~~~-~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 217 (481)
++.+||+|||+|+.+.. .........++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 88999999999976542 22334456688999999999987 568999999999999999999999986432210
Q ss_pred HHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 218 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
|.....+..+ ..++.+.+|+.+||+.+|.+|++..+.|.
T Consensus 293 ---------------~~~~~~~~~~------------------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 293 ---------------CKPEGLFRRL------------------PHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp ---------------EEECSCCTTC------------------SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred ---------------eeechhcccc------------------CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 0000000000 13456889999999999999976555444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=321.53 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=181.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc--CCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL--QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L--~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++. ++.||||++.... .....+|.+++..+ +|+||+++++++..... ...
T Consensus 48 G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~------------~~~ 108 (337)
T 3mdy_A 48 GRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTG------------SWT 108 (337)
T ss_dssp ETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG------------GGC
T ss_pred CCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC------------CCC
Confidence 899999999984 8999999986442 23445666666655 89999999999986321 126
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEcCCCCeEEecc
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--------QVLHRDIKGSNLLIDNEGNLKLADF 151 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~--------giiHrDLKp~NILl~~~~~vkL~DF 151 (481)
.+||||||+.+ +|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 89999999986 787777553 599999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCC---ccccccccccCCCchhhcCCCCCCCC------CchhhHHHHHHHHHhC----------CCCCCCC
Q 011627 152 GLARSFSYDHNN---TLTNRVITLWYRPPELLLGATKYGPA------VDMWSVGCIFAELLNG----------KPILPGK 212 (481)
Q Consensus 152 G~a~~~~~~~~~---~~~~~~gt~~Y~aPEvl~~~~~~~~~------~DiwSlGvil~elltG----------~~pf~~~ 212 (481)
|+++.+...... .....++|+.|+|||++.+ ..+... +||||||||+|||++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999766433221 1234578999999999976 344444 8999999999999999 5566442
Q ss_pred C----hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHh
Q 011627 213 N----EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288 (481)
Q Consensus 213 ~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL 288 (481)
. ....+..+......... + + .......++.++.+||.+||..||++|||+.||+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~--~------~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPS--F------P--------------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCC--C------C--------------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCCCchhhhHHHHhhhccCcc--c------c--------------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 1 12222222211110000 0 0 0001124677899999999999999999999998
Q ss_pred cC
Q 011627 289 DS 290 (481)
Q Consensus 289 ~h 290 (481)
++
T Consensus 324 ~~ 325 (337)
T 3mdy_A 324 KT 325 (337)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=355.91 Aligned_cols=272 Identities=23% Similarity=0.284 Sum_probs=199.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++.... ......+.+|+.++++|+|+||+++++++..... ....+..
T Consensus 25 G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~----------~~~~~~~ 93 (676)
T 3qa8_A 25 GGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK----------LAPNDLP 93 (676)
T ss_dssp CSSSBCCCCCCTTTTCCEEECCCCSCCC-HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC----------CCTTSSC
T ss_pred CCCeEEEEEEECCCCcEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc----------ccCCCeE
Confidence 8999999999999999999999875432 2234567899999999999999999998765211 1115577
Q ss_pred EEEEecCCC-ChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---eEEeccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARS 156 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG~a~~ 156 (481)
|||||||.+ +|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||++..
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 999999975 7777776533 25899999999999999999999999999999999999997765 99999999987
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||........+...+..........+...
T Consensus 174 ~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 174 LDQG--ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp TTSC--CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred cccc--cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 6432 23345678999999999876 67899999999999999999999999876554322111111000000111111
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
.....+....+ ....+...++..+.+||.+||..||++|||++|+|+|+||.
T Consensus 251 ~g~~~~~~~lp------~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 251 TGAVKFSSVLP------TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp SSSCCCCSSSC------CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred ccccccccccC------CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence 00000000000 00112234778899999999999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.40 Aligned_cols=239 Identities=20% Similarity=0.319 Sum_probs=194.8
Q ss_pred cceeEEEEEEEccC---CcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKT---GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~t---g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..+ +..||||+++.... ......+.+|+.++++++|+||+++++++.+
T Consensus 401 G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----------------- 462 (656)
T 2j0j_A 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVITE----------------- 462 (656)
T ss_dssp CSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------
T ss_pred CCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----------------
Confidence 89999999998654 45799999875432 2234578899999999999999999999853
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.+||||||+.+ +|.+++......+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 357999999984 7877777666679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
...........+|+.|+|||++.+ ..++.++||||||||+|||++ |..||.+.+..+.+..+........
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~-------- 613 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-------- 613 (656)
T ss_dssp C----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC--------
T ss_pred CCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 433333333455789999999976 578999999999999999997 9999999998888877765321110
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||..||++|||+.+|++
T Consensus 614 ---------------------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 614 ---------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1246778999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=319.45 Aligned_cols=245 Identities=22% Similarity=0.270 Sum_probs=186.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHh--cCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKK--LQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++ +++.||||+++... ...+.+|+++++. ++|+||+++++++..... ...
T Consensus 53 G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~------------~~~ 113 (342)
T 1b6c_B 53 GRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNG------------TWT 113 (342)
T ss_dssp ETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS------------SCC
T ss_pred CCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC------------ccc
Confidence 79999999998 68999999996432 3467789999988 789999999999987321 123
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEEcCCCCeEEecc
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH--------VNQVLHRDIKGSNLLIDNEGNLKLADF 151 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH--------~~giiHrDLKp~NILl~~~~~vkL~DF 151 (481)
.+||||||+.+ +|.+++.+. .+++.+++.++.||+.||+||| +++|+||||||+||||+.++++||+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 78999999986 787777653 5899999999999999999999 899999999999999999999999999
Q ss_pred cccccccCCCCC---ccccccccccCCCchhhcCCCC-----CCCCCchhhHHHHHHHHHhC----------CCCCCCCC
Q 011627 152 GLARSFSYDHNN---TLTNRVITLWYRPPELLLGATK-----YGPAVDMWSVGCIFAELLNG----------KPILPGKN 213 (481)
Q Consensus 152 G~a~~~~~~~~~---~~~~~~gt~~Y~aPEvl~~~~~-----~~~~~DiwSlGvil~elltG----------~~pf~~~~ 213 (481)
|+++........ ......+|+.|+|||++.+... ++.++||||||||+|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999876543221 2344578999999999976322 22679999999999999999 67776542
Q ss_pred h----HHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 214 E----AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 214 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
. .+.+...+........ ++ ... ....++..+.+||.+||..||++|||+.||++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~--------~~------------~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPN--------IP------------NRW--QSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCC--------CC------------GGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCC--------Cc------------ccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 2222222211000000 00 000 01235567999999999999999999999986
Q ss_pred C
Q 011627 290 S 290 (481)
Q Consensus 290 h 290 (481)
+
T Consensus 330 ~ 330 (342)
T 1b6c_B 330 T 330 (342)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=322.75 Aligned_cols=246 Identities=24% Similarity=0.297 Sum_probs=176.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHH--HHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKI--LKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~i--l~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++ +++.||||+++.... ..+..|.++ ++.++|+||+++++.+..... ....
T Consensus 24 G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-----------~~~~ 85 (336)
T 3g2f_A 24 GRYGAVYKGSL--DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTA-----------DGRM 85 (336)
T ss_dssp CSSEEEEEEEE--TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT-----------TSCE
T ss_pred CCCeEEEEEEE--CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheeccccccc-----------CCCc
Confidence 89999999976 789999999975432 233444444 456899999999986654211 1144
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCcEEEcCCCCeEEec
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN---------QVLHRDIKGSNLLIDNEGNLKLAD 150 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~---------giiHrDLKp~NILl~~~~~vkL~D 150 (481)
.+|||||||++ +|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred eEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 68999999975 777777554 358899999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC-------CCccccccccccCCCchhhcCC------CCCCCCCchhhHHHHHHHHHhCCCCCC-CCChH-
Q 011627 151 FGLARSFSYDH-------NNTLTNRVITLWYRPPELLLGA------TKYGPAVDMWSVGCIFAELLNGKPILP-GKNEA- 215 (481)
Q Consensus 151 FG~a~~~~~~~-------~~~~~~~~gt~~Y~aPEvl~~~------~~~~~~~DiwSlGvil~elltG~~pf~-~~~~~- 215 (481)
||+++.+.... .......++|+.|+|||++.+. ..++.++||||||||+|||++|..||. .....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 99998764321 1223345789999999999752 235578999999999999999966543 32211
Q ss_pred ---------------HHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCC
Q 011627 216 ---------------EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 280 (481)
Q Consensus 216 ---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 280 (481)
+.+..+........ .++. .+. ....++.++.+||.+||..||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~-----------~~~~~~~~l~~li~~cl~~dP~~ 302 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRP--------KFPE--AWK-----------ENSLAVRSLKETIEDCWDQDAEA 302 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCC--------CCCT--TCC-----------CCSHHHHHHHHHHHHHSCSSGGG
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCC--------CCCc--ccc-----------cccchHHHHHHHHHHHhcCChhh
Confidence 11111111000000 0000 000 01135668999999999999999
Q ss_pred CCCHHHHhc
Q 011627 281 RISAKDALD 289 (481)
Q Consensus 281 R~sa~eiL~ 289 (481)
|||++|+++
T Consensus 303 Rps~~e~l~ 311 (336)
T 3g2f_A 303 RLTAQXAEE 311 (336)
T ss_dssp SCCHHHHHH
T ss_pred CcchHHHHH
Confidence 999999954
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=304.06 Aligned_cols=215 Identities=18% Similarity=0.152 Sum_probs=172.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||+++..... ......+.+|+.++++++|+||+++++++.+ .+.
T Consensus 42 G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----------------~~~ 105 (286)
T 3uqc_A 42 VPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT----------------RAG 105 (286)
T ss_dssp STTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTE
T ss_pred cCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE----------------CCc
Confidence 89999999999999999999999866433 2334678899999999999999999999987 668
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+++ +|.+++.+ .....++..|+.||+.||+|||++||+||||||+||||+.++.+||++++.
T Consensus 106 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~------- 175 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT------- 175 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-------
T ss_pred EEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-------
Confidence 9999999986 67666643 246668899999999999999999999999999999999999999986542
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
++ .++.++||||||||+|+|++|+.||.+.+..+.+...
T Consensus 176 --------------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------------- 214 (286)
T 3uqc_A 176 --------------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------------- 214 (286)
T ss_dssp --------------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------------------
T ss_pred --------------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------------------
Confidence 22 3678899999999999999999999876542111000
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.... .............++.++.+||.+||..||++| |+.|+++
T Consensus 215 -~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 215 -ERDT---AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp -CBCT---TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred -HHHh---ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 0000 000112234445788999999999999999999 9999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.53 Aligned_cols=232 Identities=21% Similarity=0.321 Sum_probs=183.3
Q ss_pred cceeEEEEEEEcc-CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIK-TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~-tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++.. +++.||||++..... ......+.+|+.++++|+|+||+++++++.+.... ....
T Consensus 91 G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-----------~~~~ 158 (681)
T 2pzi_A 91 GGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH-----------GDPV 158 (681)
T ss_dssp ETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT-----------SCEE
T ss_pred CCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC-----------CCce
Confidence 8999999999986 799999999875432 22345678999999999999999999999873210 0123
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+||||||+++ +|.+.+.. .+++.+++.|+.||+.+|.|||+++||||||||+||||+.+ .+||+|||+++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 7999999987 45444332 69999999999999999999999999999999999999985 8999999999876432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
...++|+.|+|||++.+ .++.++||||||||+|+|++|..+|...... .++
T Consensus 235 -----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------------~~~ 285 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------------GLP 285 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------------------SCC
T ss_pred -----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc----------------------ccc
Confidence 44578999999999875 3488999999999999999998887642110 000
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
. . .....+++.+.+||.+||..||++|+++.++|.|+|+
T Consensus 286 ------~----~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 ------E----D----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ------T----T----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ------c----c----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 0 0112356789999999999999999999999888765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.64 Aligned_cols=181 Identities=18% Similarity=0.073 Sum_probs=129.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC--------CCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK--------EGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRP 73 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~--------~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~ 73 (481)
|+++.+..++..-+|+.||||++.++... +.....+.+|+++|+++ .|+||+++++++++
T Consensus 245 ~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed----------- 313 (569)
T 4azs_A 245 GAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN----------- 313 (569)
T ss_dssp -------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-----------
T ss_pred CCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-----------
Confidence 56777888888889999999999865321 12234578899999999 79999999999998
Q ss_pred CCCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccc
Q 011627 74 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 152 (481)
Q Consensus 74 ~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG 152 (481)
++.+|||||||+| +|.+++. ....+++. .|+.||+.||+|||++|||||||||+||||+.+++|||+|||
T Consensus 314 -----~~~~yLVMEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFG 384 (569)
T 4azs_A 314 -----AQSGWLVMEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFG 384 (569)
T ss_dssp -----SSEEEEEEECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCT
T ss_pred -----CCEEEEEEecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecc
Confidence 7799999999998 5555554 44567764 478999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCC
Q 011627 153 LARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 206 (481)
Q Consensus 153 ~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~ 206 (481)
+|+.+... .....+.+||+.|||||++.+ .+..++|+||+|+++++|+++.
T Consensus 385 lAr~~~~~-~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 385 SIVTTPQD-CSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp TEESCC----CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred cCeeCCCC-CccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence 99876533 234556789999999999976 4577899999999998876653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=246.68 Aligned_cols=178 Identities=14% Similarity=0.131 Sum_probs=137.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC------cchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+++ ..++.+++|++........ ....+.+|++++++|+|+||+++..++..
T Consensus 347 G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-------------- 410 (540)
T 3en9_A 347 GAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-------------- 410 (540)
T ss_dssp -CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--------------
T ss_pred CCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--------------
Confidence 8999999994 4678999998754322111 12346899999999999999954444443
Q ss_pred CcCCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 77 KYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
....|||||||+ ++|.+++.. +..++.||+.+|+|||+++|+||||||+||||+. ++||+|||+|+
T Consensus 411 --~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~ 477 (540)
T 3en9_A 411 --LDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGK 477 (540)
T ss_dssp --TTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred --CCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCE
Confidence 335599999998 477776654 5689999999999999999999999999999999 89999999998
Q ss_pred cccCCCCC------ccccccccccCCCchhhcCC-CCCCCCCchhhHHHHHHHHHhCCCCC
Q 011627 156 SFSYDHNN------TLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPIL 209 (481)
Q Consensus 156 ~~~~~~~~------~~~~~~gt~~Y~aPEvl~~~-~~~~~~~DiwSlGvil~elltG~~pf 209 (481)
........ .....++|+.|||||++... ..|+..+|+|+..+-..+.+..+..|
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 76532211 12356789999999998741 24677889999998888887766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=204.91 Aligned_cols=136 Identities=17% Similarity=0.130 Sum_probs=107.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC----------------cchhHHHHHHHHHhcCCCCccceeeEEeCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG----------------FPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~----------------~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~ 66 (481)
|+||.||+|++ .+++.||||+++....... ....+.+|+.++++|+ | +++.+++..
T Consensus 101 G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~---- 172 (282)
T 1zar_A 101 GKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW---- 172 (282)
T ss_dssp CSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE----
T ss_pred CCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec----
Confidence 89999999999 8999999999975422110 2345779999999999 5 677776543
Q ss_pred CCCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC
Q 011627 67 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 145 (481)
Q Consensus 67 ~~~~~~~~~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~ 145 (481)
+..|||||||++ +|.. +.. ..+..++.||+.||.|||++||+||||||+||||+ ++.
T Consensus 173 -------------~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 173 -------------EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp -------------ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE
T ss_pred -------------cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc
Confidence 245999999987 6665 321 24567999999999999999999999999999999 899
Q ss_pred eEEecccccccccCCCCCccccccccccCCCchhhcC
Q 011627 146 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182 (481)
Q Consensus 146 vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~ 182 (481)
+||+|||+|+. +..++|||++.+
T Consensus 231 vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 231 IWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99999999864 345789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.9e-20 Score=179.93 Aligned_cols=129 Identities=16% Similarity=0.253 Sum_probs=98.2
Q ss_pred cceeEEEEEEEccCCcE--EEEEEeecCCcCCC----------------------cchhHHHHHHHHHhcCCCCc--cce
Q 011627 3 VCISQVFMAREIKTGEI--VALKKIRMDNEKEG----------------------FPITAIREIKILKKLQHENV--IKL 56 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~--vAvK~i~~~~~~~~----------------------~~~~~~~Ei~il~~L~hpnI--v~l 56 (481)
|+||+||+|++..+|+. ||||+++....... ....+.+|+.+|++|.|++| ..+
T Consensus 58 G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 137 (258)
T 1zth_A 58 GKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQP 137 (258)
T ss_dssp CSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCE
T ss_pred cceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeE
Confidence 89999999999889999 99999865421100 01256789999999998865 333
Q ss_pred eeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC------ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcc
Q 011627 57 KEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH------DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVL 129 (481)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g------~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH-~~gii 129 (481)
+.. . ..||||||+++ .|.+.... +++..+..++.||+.+|.||| ++||+
T Consensus 138 ~~~--~------------------~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~giv 193 (258)
T 1zth_A 138 YTY--M------------------KNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELV 193 (258)
T ss_dssp EEE--E------------------TTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEE
T ss_pred EEc--C------------------CCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 322 1 34899999952 33333221 235578899999999999999 99999
Q ss_pred cCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 130 HRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 130 HrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
||||||+||||+. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-16 Score=160.71 Aligned_cols=131 Identities=19% Similarity=0.231 Sum_probs=90.0
Q ss_pred CcceeEEEEEEEccCCcEEEEEEeecCCcC-------CC-----cc--------hhHHHHHHHHHhcCCCCccceeeEEe
Q 011627 2 LVCISQVFMAREIKTGEIVALKKIRMDNEK-------EG-----FP--------ITAIREIKILKKLQHENVIKLKEIVT 61 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-------~~-----~~--------~~~~~Ei~il~~L~hpnIv~l~~~~~ 61 (481)
.|+||.||+|++ .+|+.||||+++..... .+ .. ..+.+|...|.+|.+.+|....-+..
T Consensus 105 ~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~ 183 (397)
T 4gyi_A 105 VGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQ 183 (397)
T ss_dssp ECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEE
T ss_pred eCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeec
Confidence 389999999998 47999999998643211 00 00 11235666677764444322111111
Q ss_pred CCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc
Q 011627 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 141 (481)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~ 141 (481)
. ..+|||||+++..+..+.. ...+..++.||+.+|.+||++|||||||||+||||+
T Consensus 184 -----------------~-~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 184 -----------------S-RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp -----------------E-TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred -----------------c-CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 1 1279999999744333222 124567899999999999999999999999999998
Q ss_pred CCCC----------eEEecccccccc
Q 011627 142 NEGN----------LKLADFGLARSF 157 (481)
Q Consensus 142 ~~~~----------vkL~DFG~a~~~ 157 (481)
+++. +.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 8763 899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.6e-11 Score=117.23 Aligned_cols=128 Identities=15% Similarity=0.120 Sum_probs=96.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+++.||++.. .++.++||+....... ....+.+|+.+++.|. +..+.++++++.+ .+.
T Consensus 25 ~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----------------~~~ 84 (263)
T 3tm0_A 25 MSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH----------------DGW 84 (263)
T ss_dssp CSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE----------------TTE
T ss_pred CCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEec----------------CCc
Confidence 45678999975 3689999998753211 1236789999999995 6677888888875 567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV------------------------------------ 125 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~------------------------------------ 125 (481)
.|+||||++|..+..... +......++.++..+|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 899999999843332211 122345788899999999998
Q ss_pred -----------------------CCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 126 -----------------------NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 126 -----------------------~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
..++|+|+++.|||+++...+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=4.6e-11 Score=113.38 Aligned_cols=123 Identities=14% Similarity=0.101 Sum_probs=90.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCC--ccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|..+.||++.. .+++.++||+.... ....+.+|+.+++.|.+.+ |.+++.+... .+
T Consensus 31 g~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~----------------~~ 88 (264)
T 1nd4_A 31 CSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE----------------AG 88 (264)
T ss_dssp TSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC----------------SS
T ss_pred CCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC----------------CC
Confidence 34589999964 56788999997643 1236779999999996544 4568877765 45
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 011627 81 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--------------------------------- 127 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g--------------------------------- 127 (481)
..|+||||++|..+. ... .+ ...++.++...|..||+..
T Consensus 89 ~~~~v~e~i~G~~l~-~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL-SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEETT-TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCcccC-cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 689999999985444 211 12 2356777888888888753
Q ss_pred -------------------------cccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 128 -------------------------VLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 128 -------------------------iiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
++|+||+|.|||++++..++|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876656799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.8e-10 Score=113.88 Aligned_cols=135 Identities=13% Similarity=0.179 Sum_probs=97.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEee--cCCcCCCcchhHHHHHHHHHhcCC--CCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIR--MDNEKEGFPITAIREIKILKKLQH--ENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~--~~~~~~~~~~~~~~Ei~il~~L~h--pnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|.++.||++.. .+..++||+.. ..... .....+.+|+.+++.|.. ..+.+++.++.+.. .
T Consensus 49 G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~-------------~ 112 (359)
T 3dxp_A 49 GQSNPTFKLVT--PGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDES-------------V 112 (359)
T ss_dssp -CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT-------------T
T ss_pred cccceEEEEEE--CCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC-------------c
Confidence 66788999876 34688899876 33211 123467799999999974 45788888776521 1
Q ss_pred CCeEEEEEecCCCChh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q 011627 79 RGSTYMVFEYMDHDLT-GLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-------------------------------- 125 (481)
Q Consensus 79 ~~~~~iV~Ey~~g~L~-~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-------------------------------- 125 (481)
.+..|+||||++|..+ +... ..++..+...++.+++..|..||+
T Consensus 113 ~g~~~~vme~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 113 IGRAFYIMEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp TSSCEEEEECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 2457999999998433 2111 237888889999999999999997
Q ss_pred --------------------------CCcccCCCCCCcEEEcCCCC--eEEeccccccc
Q 011627 126 --------------------------NQVLHRDIKGSNLLIDNEGN--LKLADFGLARS 156 (481)
Q Consensus 126 --------------------------~giiHrDLKp~NILl~~~~~--vkL~DFG~a~~ 156 (481)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997753 69999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.4e-09 Score=106.35 Aligned_cols=179 Identities=16% Similarity=0.080 Sum_probs=109.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCc--cceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENV--IKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnI--v~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|....||++. +.++||+.... .....+.+|+.+|+.|. +..| .+++...... ...
T Consensus 31 G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~-------------~~~ 88 (304)
T 3sg8_A 31 GNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS-------------ETY 88 (304)
T ss_dssp CSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC-------------SSC
T ss_pred CCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC-------------CCC
Confidence 5667788763 46888986532 12446789999999984 3332 3333322110 012
Q ss_pred CeEEEEEecCCCChhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------
Q 011627 80 GSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHV--------------------------------- 125 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~-~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~--------------------------------- 125 (481)
...|+|||+++|..+. ... ..++..+...++.++...|..||+
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp SCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred CcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 2348999999984332 222 246788888888999988888886
Q ss_pred -------------------------CCcccCCCCCCcEEEcC--CCCeEEecccccccccCCCCCc-cccc---cc----
Q 011627 126 -------------------------NQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSYDHNNT-LTNR---VI---- 170 (481)
Q Consensus 126 -------------------------~giiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~-~~~~---~g---- 170 (481)
..++|+||++.|||++. ...+.|+||+.+........-. .... .+
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFV 245 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHH
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHH
Confidence 13699999999999998 4568999999986532110000 0000 00
Q ss_pred -----cccCCC-chhhcCCCCCCCCCchhhHHHHHHHHHhCCCCC
Q 011627 171 -----TLWYRP-PELLLGATKYGPAVDMWSVGCIFAELLNGKPIL 209 (481)
Q Consensus 171 -----t~~Y~a-PEvl~~~~~~~~~~DiwSlGvil~elltG~~pf 209 (481)
...... |+.... ...-.++|+++.++|.+.+|..+|
T Consensus 246 ~~~l~~Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001111 222211 112258999999999999997554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=8.2e-07 Score=86.67 Aligned_cols=127 Identities=13% Similarity=0.095 Sum_probs=84.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCC---CccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE---NVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hp---nIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|....||++ ++.++||+.... .....+.+|+.+|+.|.+. .|.+++.+.... .
T Consensus 30 G~~n~v~~v-----g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~---------------~ 85 (306)
T 3tdw_A 30 GFRNYAILV-----NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS---------------D 85 (306)
T ss_dssp CSSEEEEEE-----TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT---------------T
T ss_pred CcceeEEEE-----CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC---------------C
Confidence 445678877 567888885321 1245678999999999753 244555554321 3
Q ss_pred CeEEEEEecCCCChhhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------
Q 011627 80 GSTYMVFEYMDHDLTGL-ADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-------------------------------- 126 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~~-~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-------------------------------- 126 (481)
+..|+|||+++|..+.. ... .++..+...++.++...|..||+.
T Consensus 86 g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~ 162 (306)
T 3tdw_A 86 GNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFP 162 (306)
T ss_dssp SCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGG
T ss_pred CceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccc
Confidence 45689999999843322 111 245556666666666666666642
Q ss_pred ----------------------------CcccCCCCCCcEEEcC---CCC-eEEeccccccc
Q 011627 127 ----------------------------QVLHRDIKGSNLLIDN---EGN-LKLADFGLARS 156 (481)
Q Consensus 127 ----------------------------giiHrDLKp~NILl~~---~~~-vkL~DFG~a~~ 156 (481)
.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 163 ~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 163 LLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 455 48999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.1e-06 Score=83.75 Aligned_cols=125 Identities=14% Similarity=0.101 Sum_probs=87.6
Q ss_pred eEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEE
Q 011627 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYM 84 (481)
Q Consensus 6 g~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 84 (481)
+.||+......+..++||+-... ....+.+|..+|+.|. +--|-+++.++.+ .+..||
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~----------------~~~~~l 97 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRT----------------PDDAWL 97 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE----------------TTEEEE
T ss_pred CeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEE----------------CCeEEE
Confidence 36999888778888999987533 2345678999999985 3235667777765 557899
Q ss_pred EEecCCCC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 011627 85 VFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN------------------------------------- 126 (481)
Q Consensus 85 V~Ey~~g~-L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~------------------------------------- 126 (481)
|||++.|. +.+.... .......+..++...|..||..
T Consensus 98 vme~l~G~~~~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEECCCSEEHHHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEeeCCccccccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 99999984 3332221 1123344556666666666641
Q ss_pred ---------------------CcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 127 ---------------------QVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 127 ---------------------giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.++|+|+.+.|||+++.+.+-|+||+.+..
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999999877677999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=3.7e-06 Score=83.59 Aligned_cols=76 Identities=8% Similarity=0.127 Sum_probs=48.0
Q ss_pred cceeEEEEEEEc--c----CCcEEEEEEeecCCc-CCCcchhHHHHHHHHHhcCC---CCccceeeEEeCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI--K----TGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQH---ENVIKLKEIVTSPGPERDEQGR 72 (481)
Q Consensus 3 G~fg~Vy~a~~~--~----tg~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~L~h---pnIv~l~~~~~~~~~~~~~~~~ 72 (481)
|....||++... . +++.++||+...... .......+.+|+.+++.|.. -.+.+++.+..+..
T Consensus 32 G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~-------- 103 (357)
T 3ats_A 32 GMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD-------- 103 (357)
T ss_dssp SSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST--------
T ss_pred CccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC--------
Confidence 556779988753 1 267889998654321 00012467789999999853 34667777665421
Q ss_pred CCCCCcCCeEEEEEecCCC
Q 011627 73 PDGNKYRGSTYMVFEYMDH 91 (481)
Q Consensus 73 ~~~~~~~~~~~iV~Ey~~g 91 (481)
..+..|+|||+++|
T Consensus 104 -----~~g~~~~v~e~l~G 117 (357)
T 3ats_A 104 -----VLGTPFFLMDYVEG 117 (357)
T ss_dssp -----TTSSCEEEEECCCC
T ss_pred -----ccCCceEEEEecCC
Confidence 02345899999987
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.2e-05 Score=81.22 Aligned_cols=71 Identities=14% Similarity=-0.012 Sum_probs=43.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-----CCCcchhHHHHHHHHHhcCC--CC-ccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-----KEGFPITAIREIKILKKLQH--EN-VIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-----~~~~~~~~~~Ei~il~~L~h--pn-Iv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|.++.||++++..+++.|+||....... .......+..|+++|+.+.. +. +.+++.+.
T Consensus 41 G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------------- 106 (397)
T 2olc_A 41 GNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------------- 106 (397)
T ss_dssp SSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--------------
T ss_pred CceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--------------
Confidence 6689999998766778999998653211 11233456789999998843 33 33555432
Q ss_pred CCCcCCeEEEEEecCCC
Q 011627 75 GNKYRGSTYMVFEYMDH 91 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g 91 (481)
....+||||++++
T Consensus 107 ----~~~~~lvmE~l~g 119 (397)
T 2olc_A 107 ----TEMAVTVMEDLSH 119 (397)
T ss_dssp ----TTTTEEEECCCTT
T ss_pred ----CCccEEEEEeCCC
Confidence 1234799999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=2.1e-05 Score=77.26 Aligned_cols=30 Identities=17% Similarity=0.297 Sum_probs=27.1
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 126 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999877889999999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00012 Score=70.79 Aligned_cols=29 Identities=21% Similarity=0.260 Sum_probs=24.6
Q ss_pred CcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 127 QVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 127 giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
.++|+|+.+.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5566799999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00036 Score=67.89 Aligned_cols=30 Identities=27% Similarity=0.310 Sum_probs=25.8
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 126 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.+++|+|+++.|||++.+..+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 369999999999999887556899999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00066 Score=66.14 Aligned_cols=67 Identities=16% Similarity=0.212 Sum_probs=49.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC---CCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|.+..||++.. ++..++||+.... ....+.+|..+|+.|. ...|.+++.+... .
T Consensus 47 G~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~----------------~ 103 (312)
T 3jr1_A 47 GEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS----------------Q 103 (312)
T ss_dssp SSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC----------------S
T ss_pred ccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec----------------C
Confidence 66788999875 5678899987643 2446778999999884 2557777777654 4
Q ss_pred CeEEEEEecCCCC
Q 011627 80 GSTYMVFEYMDHD 92 (481)
Q Consensus 80 ~~~~iV~Ey~~g~ 92 (481)
+..|+|||++++.
T Consensus 104 g~~~lvme~l~G~ 116 (312)
T 3jr1_A 104 GHSFLLLEALNKS 116 (312)
T ss_dssp SEEEEEEECCCCC
T ss_pred CceEEEEEeccCC
Confidence 5789999999873
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00044 Score=63.04 Aligned_cols=97 Identities=15% Similarity=0.020 Sum_probs=65.2
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCCCccccccc
Q 011627 92 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 170 (481)
Q Consensus 92 ~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH-~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 170 (481)
+|.+++...+..++++++|.++.|.+..|.-+- ...-..+=+.+..|+|..+|+|.+.+ ..+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence 577777777778999999999999999988762 22222344557899999999988774 2110 11
Q ss_pred cccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh
Q 011627 171 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 204 (481)
Q Consensus 171 t~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt 204 (481)
...+.+||.+. ...+.+.=|+|||++||..+-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 33466888663 244577889999999999985
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00046 Score=70.09 Aligned_cols=32 Identities=9% Similarity=0.313 Sum_probs=28.1
Q ss_pred HhCCcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 124 H~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
+...++|+||++.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 356799999999999999876 99999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00061 Score=67.84 Aligned_cols=28 Identities=29% Similarity=0.513 Sum_probs=24.2
Q ss_pred CcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 127 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 127 giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.++|+|+++.|||++++. +.|+||..|.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999998654 9999999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00082 Score=68.53 Aligned_cols=64 Identities=19% Similarity=0.152 Sum_probs=42.4
Q ss_pred ceeEEEEEEEcc-------CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCc-cceeeEEeCCCCCCCCCCCCCC
Q 011627 4 CISQVFMAREIK-------TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENV-IKLKEIVTSPGPERDEQGRPDG 75 (481)
Q Consensus 4 ~fg~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnI-v~l~~~~~~~~~~~~~~~~~~~ 75 (481)
....||++.... +++.|+||+.... .....+.+|+.+++.|...+| .+++..+.+
T Consensus 85 ~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~------------- 147 (429)
T 1nw1_A 85 MSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG------------- 147 (429)
T ss_dssp TTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-------------
T ss_pred cccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC-------------
Confidence 346799988642 3578999988421 111356689999999854444 566665532
Q ss_pred CCcCCeEEEEEecCCC
Q 011627 76 NKYRGSTYMVFEYMDH 91 (481)
Q Consensus 76 ~~~~~~~~iV~Ey~~g 91 (481)
.+|+||++|
T Consensus 148 -------g~v~e~l~G 156 (429)
T 1nw1_A 148 -------GRLEEYIPS 156 (429)
T ss_dssp -------EEEECCCCE
T ss_pred -------CEEEEEeCC
Confidence 389999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0009 Score=66.99 Aligned_cols=127 Identities=17% Similarity=0.118 Sum_probs=77.2
Q ss_pred eEEEEEEEcc-------CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCC-ccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 6 SQVFMAREIK-------TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN-VIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 6 g~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpn-Iv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
..+|++.... +++.|+||+.... ........+|..+++.|..-. ..+++.++.+
T Consensus 64 N~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--------------- 125 (379)
T 3feg_A 64 NLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--------------- 125 (379)
T ss_dssp CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---------------
T ss_pred ccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---------------
Confidence 4588887632 3578999986321 112445668999999985333 3556655532
Q ss_pred cCCeEEEEEecCCCChhh---hh---------------cCCC----CCCC--HHHHHHHHHHHHH---------------
Q 011627 78 YRGSTYMVFEYMDHDLTG---LA---------------DRPG----LRFT--VPQIKCYMKQLLT--------------- 118 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g~L~~---~~---------------~~~~----~~l~--~~~i~~i~~Qil~--------------- 118 (481)
.+||||++|..+. +. .... .... ..++..++.++..
T Consensus 126 -----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 126 -----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp -----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred -----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 2899999872111 00 0111 1111 3456666655422
Q ss_pred ----HHHHHH----h----CCcccCCCCCCcEEEcCC----CCeEEecccccc
Q 011627 119 ----GLHYCH----V----NQVLHRDIKGSNLLIDNE----GNLKLADFGLAR 155 (481)
Q Consensus 119 ----gL~~LH----~----~giiHrDLKp~NILl~~~----~~vkL~DFG~a~ 155 (481)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 223332 2 259999999999999876 689999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0035 Score=64.36 Aligned_cols=64 Identities=19% Similarity=0.171 Sum_probs=42.5
Q ss_pred eeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCc-cceeeEEeCCCCCCCCCCCCCCCCcCCeEE
Q 011627 5 ISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENV-IKLKEIVTSPGPERDEQGRPDGNKYRGSTY 83 (481)
Q Consensus 5 fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnI-v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (481)
-..||++....+++.|+||+..... . ......+|+.+++.|...+| .+++.++.. .
T Consensus 121 tN~~y~v~~~~~~~~~vLRi~g~~~--~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~--------------------G 177 (458)
T 2qg7_A 121 TNILIKVKDMSKQAKYLIRLYGPKT--D-EIINREREKKISCILYNKNIAKKIYVFFTN--------------------G 177 (458)
T ss_dssp CEEEEEEEETTTTEEEEEEEECC-C--C-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT--------------------E
T ss_pred EeEEEEEEECCCCceEEEEECCCCh--h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC--------------------e
Confidence 3669998875445789999875321 1 12233689999999975555 456666521 3
Q ss_pred EEEecCCC
Q 011627 84 MVFEYMDH 91 (481)
Q Consensus 84 iV~Ey~~g 91 (481)
+||||++|
T Consensus 178 ~v~e~I~G 185 (458)
T 2qg7_A 178 RIEEFMDG 185 (458)
T ss_dssp EEEECCCS
T ss_pred EEEEeeCC
Confidence 59999987
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0032 Score=61.25 Aligned_cols=136 Identities=13% Similarity=0.106 Sum_probs=75.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCC--ccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|....||++.. .+|+.++||+.+.... ....+..|+.+++.|.... +.+++.. +... -....+
T Consensus 36 g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~---------~~~~~g 100 (328)
T 1zyl_A 36 SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQT---------LLNHQG 100 (328)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBS---------CEEETT
T ss_pred CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcE---------EEEECC
Confidence 34457887754 3566799999863321 2345677999998885322 3444432 1100 001245
Q ss_pred eEEEEEecCCCChhh-------------------hhcCC----CCCCCHHHH----------------------HHHHHH
Q 011627 81 STYMVFEYMDHDLTG-------------------LADRP----GLRFTVPQI----------------------KCYMKQ 115 (481)
Q Consensus 81 ~~~iV~Ey~~g~L~~-------------------~~~~~----~~~l~~~~i----------------------~~i~~Q 115 (481)
..++|||+++|.... ..... ...++.... ..++..
T Consensus 101 ~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 180 (328)
T 1zyl_A 101 FYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDE 180 (328)
T ss_dssp EEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHH
T ss_pred EEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHH
Confidence 678999999872110 00000 001121110 111222
Q ss_pred HHHHHHHH----HhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 116 LLTGLHYC----HVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 116 il~gL~~L----H~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
++..|+-+ ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 181 ~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 181 LIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 22223222 234689999999999999 4 89999999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0033 Score=60.06 Aligned_cols=66 Identities=14% Similarity=0.060 Sum_probs=44.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCC---CccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE---NVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hp---nIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|..+.||+++. .+|+.|+||+....... ....+.+|+..|+.|... -+.+++.+-.
T Consensus 26 G~~~~vyrv~l-~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~------------------ 84 (288)
T 3f7w_A 26 SHRWHLYRVEL-ADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWDD------------------ 84 (288)
T ss_dssp ETTEEEEEEEE-TTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEET------------------
T ss_pred CCCeEEEEEEE-CCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEeccC------------------
Confidence 56788999875 67899999986543221 233567899999999532 2344443321
Q ss_pred CeEEEEEecCCC
Q 011627 80 GSTYMVFEYMDH 91 (481)
Q Consensus 80 ~~~~iV~Ey~~g 91 (481)
-++||||+++
T Consensus 85 --~~lv~e~l~~ 94 (288)
T 3f7w_A 85 --RTLAMEWVDE 94 (288)
T ss_dssp --TEEEEECCCC
T ss_pred --ceEEEEeecc
Confidence 2789999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0033 Score=61.38 Aligned_cols=31 Identities=32% Similarity=0.397 Sum_probs=27.1
Q ss_pred CCcccCCCCCCcEEEcCC----CCeEEeccccccc
Q 011627 126 NQVLHRDIKGSNLLIDNE----GNLKLADFGLARS 156 (481)
Q Consensus 126 ~giiHrDLKp~NILl~~~----~~vkL~DFG~a~~ 156 (481)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6799999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.005 Score=60.50 Aligned_cols=31 Identities=26% Similarity=0.415 Sum_probs=27.5
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEeccccccc
Q 011627 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156 (481)
Q Consensus 126 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 156 (481)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999878899999988754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.011 Score=60.03 Aligned_cols=28 Identities=25% Similarity=0.583 Sum_probs=25.2
Q ss_pred CcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 127 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 127 giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.++|+|+.+.||| +.++.+.|+||..|.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 5899999999999 777889999999885
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.038 Score=55.49 Aligned_cols=28 Identities=29% Similarity=0.513 Sum_probs=24.2
Q ss_pred cccCCCCCCcEEE------cCCCCeEEecccccc
Q 011627 128 VLHRDIKGSNLLI------DNEGNLKLADFGLAR 155 (481)
Q Consensus 128 iiHrDLKp~NILl------~~~~~vkL~DFG~a~ 155 (481)
++|+|+.+.|||+ +++..|+|+||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 345679999999885
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.92 E-value=0.062 Score=55.09 Aligned_cols=60 Identities=12% Similarity=0.009 Sum_probs=16.5
Q ss_pred CcceeEEEEEEEccCCcEEEE------EEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeC
Q 011627 2 LVCISQVFMAREIKTGEIVAL------KKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTS 62 (481)
Q Consensus 2 ~G~fg~Vy~a~~~~tg~~vAv------K~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~ 62 (481)
+| ||.||++....+...||+ |..+.....++....+.+|..+++.++|+|+++.+.+...
T Consensus 150 lG-fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 150 VG-YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp SS-BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred CC-chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 57 999999998766668888 7665433333344567789999999999999999887654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.23 E-value=3.5 Score=37.19 Aligned_cols=91 Identities=14% Similarity=0.113 Sum_probs=61.5
Q ss_pred HHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC-hhhhhcCCCCCCCHHHHHHHHHHHHH
Q 011627 40 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLT 118 (481)
Q Consensus 40 ~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~Ey~~g~-L~~~~~~~~~~l~~~~i~~i~~Qil~ 118 (481)
.|+.+|. ..|++++.. .+-.+ .+.+.|.++.-+.. -+..+. .++..+.++++..|+.
T Consensus 35 ~el~LL~-~~~~~Fl~~-~I~e~----------------eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~ 92 (215)
T 4ann_A 35 HLMYLLE-QHSPYFIDA-ELTEL----------------RDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKN 92 (215)
T ss_dssp GGGGGGG-SCCTTBCCE-EEEEC----------------SSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGG
T ss_pred HHHHHHh-ccCCcccce-EEEEc----------------ccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHH
Confidence 3444333 257888876 44444 44566666655432 222222 3788899999999988
Q ss_pred HHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 119 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 119 gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
...+++ .-+|--|.|+||+++.++.++|+--|+-
T Consensus 93 l~~~~~--~r~tf~L~P~NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 93 LEEVNR--TRYTFVLAPDELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp GGGGGG--SSEECCCSGGGEEECTTSCEEESCCEET
T ss_pred HHHHhc--CceEEEEecceEEEcCCCCEEEEEccCc
Confidence 774443 3577789999999999999999988864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.11 E-value=3.5 Score=37.29 Aligned_cols=70 Identities=11% Similarity=0.012 Sum_probs=50.4
Q ss_pred CCeEEEEEecCCCCh-hhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 011627 79 RGSTYMVFEYMDHDL-TGLADRPGLRFTVPQIKCYMKQLLTGLH-YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 154 (481)
Q Consensus 79 ~~~~~iV~Ey~~g~L-~~~~~~~~~~l~~~~i~~i~~Qil~gL~-~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 154 (481)
.+.+.|.++.-.... +..+. .++..+.++++..|+.... ++ ..-+|--|.|+||+++.++.++|.-.|+-
T Consensus 60 eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 60 EDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp SSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTCCEEESCCEET
T ss_pred CCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCCcEEEEEcCCc
Confidence 456666666654322 22332 4788889998888877555 33 45677889999999999999999988864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 481 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-92 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-81 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-74 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-73 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-71 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-71 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-70 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-68 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-67 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-67 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-66 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-65 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-63 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-62 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-60 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-59 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-58 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-58 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-54 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-52 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-46 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-46 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-43 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 281 bits (719), Expect = 3e-92
Identities = 147/303 (48%), Positives = 203/303 (66%), Gaps = 13/303 (4%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+VF AR KTG+ VALKK+ M+NEKEGFPITA+REIKIL+ L+HENV+ L EI +
Sbjct: 24 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+ +GS Y+VF++ +HDL GL ++FT+ +IK M+ LL GL+Y H
Sbjct: 84 PYNR--------CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS---YDHNNTLTNRVITLWYRPPELLLG 182
N++LHRD+K +N+LI +G LKLADFGLAR+FS N TNRV+TLWYRPPELLLG
Sbjct: 136 NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 195
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
YGP +D+W GCI AE+ PI+ G E QL+ I +LCGS +WP V Y
Sbjct: 196 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY 255
Query: 243 NHFKPSRTMKRRVREVFRHF--DRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPC 300
+ + KR+V++ + + D +AL+L++K+L+LDP+QRI + DAL+ ++FW+DP+P
Sbjct: 256 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315
Query: 301 DPK 303
D K
Sbjct: 316 DLK 318
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 6e-81
Identities = 120/305 (39%), Positives = 171/305 (56%), Gaps = 22/305 (7%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTS 62
+ V+ AR+ T +IVA+KKI++ + K+G TA+REIK+L++L H N+I L +
Sbjct: 12 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
+ +VF++M+ DL + L T IK YM L GL Y
Sbjct: 72 KS----------------NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
H + +LHRD+K +NLL+D G LKLADFGLA+SF + T++V+T WYR PELL G
Sbjct: 116 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFG 174
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
A YG VDMW+VGCI AELL P LPG ++ +QL++IFE G+P E WP + +P Y
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 302
FK + +F L+L++ + + +P RI+A AL +YF P P
Sbjct: 235 VTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 303 KSLPK 307
LP+
Sbjct: 293 CQLPR 297
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 2e-74
Identities = 133/297 (44%), Positives = 180/297 (60%), Gaps = 21/297 (7%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V+ AR TGE+VALKKIR+D E EG P TAIREI +LK+L H N++KL +++ +
Sbjct: 16 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN- 74
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCH 124
Y+VFE++ DL D +P IK Y+ QLL GL +CH
Sbjct: 75 ---------------KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
++VLHRD+K NLLI+ EG +KLADFGLAR+F T+ V+TLWYR PE+LLG
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCK 178
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
Y AVD+WS+GCIFAE++ + + PG +E +QL +IF G+PDE +WPGV+ MP Y
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW--TDPLP 299
P + ++ +V D LL +ML DP++RISAK AL +F T P+P
Sbjct: 239 SFP-KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 4e-73
Identities = 112/336 (33%), Positives = 170/336 (50%), Gaps = 19/336 (5%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V A + VA+KKI E + + +REIKIL + +HEN+I + +I+ +P
Sbjct: 22 GMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
E+ + Y+V M DL L + I ++ Q+L GL Y H
Sbjct: 81 EQMKDV-----------YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS 127
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGA 183
VLHRD+K SNLL++ +LK+ DFGLAR DH++ LT V T WYR PE++L +
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
Y ++D+WSVGCI AE+L+ +PI PGK+ +QL+ I + GSP + + + A N
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 244 H-FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD- 301
+ K +F + D AL+LL+KML +P +RI + AL Y P D
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 307
Query: 302 PKSLPKYESSHEYQT-KKRRQQQRQHEEATKRQKLH 336
P + ++ E K + ++ EE + Q +
Sbjct: 308 PIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 343
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 227 bits (578), Expect = 1e-71
Identities = 122/288 (42%), Positives = 174/288 (60%), Gaps = 19/288 (6%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V+ A+ GE ALKKIR++ E EG P T IREI ILK+L+H N++KL +++ +
Sbjct: 16 GVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK- 73
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+VFE++D DL L D K ++ QLL G+ YCH
Sbjct: 74 ---------------RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
+VLHRD+K NLLI+ EG LK+ADFGLAR+F T+ ++TLWYR P++L+G+ K
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y +D+WSVGCIFAE++NG P+ PG +EA+QL +IF + G+P+ WP V+++P Y+
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD-P 236
Query: 246 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ + D ++LL KML LDP+QRI+AK AL+ YF
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 3e-71
Identities = 102/320 (31%), Positives = 165/320 (51%), Gaps = 17/320 (5%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V A + +TG VA+KK+ + E F A RE+++LK ++HENVI L ++ T
Sbjct: 32 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
D Y+V +M DL L + +I+ + Q+L GL Y H
Sbjct: 92 LDD----------FTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA 139
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
++HRD+K NL ++ + LK+ DFGLAR ++ +T V+T WYR PE++L +
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILNWMR 195
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y VD+WSVGCI AE++ GK + G + +QL +I ++ G+P + A N+
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 246 KPSRTMKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 304
K ++++ + + A+ LLEKML+LD QR++A +AL YF + D
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 315
Query: 305 LPKYESSHEYQTKKRRQQQR 324
+ KY+ S + + + +R
Sbjct: 316 VQKYDDSFDDVDRTLDEWKR 335
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (573), Expect = 5e-70
Identities = 100/344 (29%), Positives = 160/344 (46%), Gaps = 32/344 (9%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V+ A+ +GE+VA+KK+ D + RE++I++KL H N+++L+ S G
Sbjct: 34 GVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHY 122
++DE +V +Y+ + +A R V +K YM QL L Y
Sbjct: 88 KKDEV----------YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
H + HRDIK NLL+D + + KL DFG A+ + + + +YR PEL+
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIF 195
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
GAT Y ++D+WS GC+ AELL G+PI PG + +QL +I ++ G+P ++ P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PN 253
Query: 242 YNHFKPSRTMKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPC 300
Y FK + +VFR A+ L ++L P+ R++ +A +F D L
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELRD 311
Query: 301 DPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRL 344
LP + ++ AT PH R+
Sbjct: 312 PNVKLPNGRDTPALFNFTTQELSSNPPLATILI-----PPHARI 350
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (557), Expect = 2e-68
Identities = 118/295 (40%), Positives = 171/295 (57%), Gaps = 21/295 (7%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
VF A+ +T EIVALK++R+D++ EG P +A+REI +LK+L+H+N+++L +++ S
Sbjct: 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+VFE+ D DL D +K ++ QLL GL +CH
Sbjct: 76 ----------------LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
VLHRD+K NLLI+ G LKLA+FGLAR+F + V+TLWYRPP++L GA
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 186 YGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
Y ++DMWS GCIFAEL N P+ PG + +QL +IF L G+P E WP ++K+P Y
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 297
+ P + V + +LL+ +L +P QRISA++AL YF + P
Sbjct: 239 Y-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-68
Identities = 63/303 (20%), Positives = 116/303 (38%), Gaps = 36/303 (11%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
VF +G ++A K I ++ K IRE+++L + ++ S G
Sbjct: 20 GVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG- 77
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH- 124
+ E+MD + R + ++ GL Y
Sbjct: 78 ---------------EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
++++HRD+K SN+L+++ G +KL DFG++ ++ + V T Y PE L G T
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG-T 178
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSKIFELCGSPDET----IWPGVSKM 239
Y D+WS+G E+ G+ +P + E +L ++ G ET PG
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 240 PAYNHFKPSRTMKRRVREVFRH---------FDRHALELLEKMLMLDPSQRISAKDALDS 290
+P + + + F + + K L+ +P++R K +
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
Query: 291 EYF 293
+
Sbjct: 299 AFI 301
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-67
Identities = 107/336 (31%), Positives = 159/336 (47%), Gaps = 20/336 (5%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V A + KTG VA+KK+ + RE+++LK ++HENVI L ++ T
Sbjct: 32 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+ Y+V M DL + + T ++ + Q+L GL Y H
Sbjct: 92 LEEFN----------DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS 139
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
++HRD+K SNL ++ + LK+ DFGLAR + T V T WYR PE++L
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMH 195
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 245
Y VD+WSVGCI AELL G+ + PG + +QL I L G+P + +S A N+
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 246 K-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 304
+ ++ K VF + A++LLEKML+LD +RI+A AL YF P D
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 315
Query: 305 LPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQP 340
Y+ S E + + + + P P
Sbjct: 316 ADPYDQSFESRDLLIDEWKSLTYDEVIS---FVPPP 348
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 217 bits (554), Expect = 2e-67
Identities = 69/355 (19%), Positives = 131/355 (36%), Gaps = 51/355 (14%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V E TG A K + +E + T +EI+ + L+H ++ L +
Sbjct: 40 GVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDN- 96
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
M++E+M +L + + + YM+Q+ GL + H
Sbjct: 97 ---------------EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 125 VNQVLHRDIKGSNLLIDNE--GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
N +H D+K N++ + LKL DFGL D ++ T + PE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEG 199
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
G DMWSVG + LL+G G+N+ E L + + D++ + G+S+
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE---- 254
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 302
+ + K+L+ DP+ R++ AL+ + P
Sbjct: 255 ----------------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292
Query: 303 KSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWS 357
+P + + + + E ++ + + P +++ + W
Sbjct: 293 SQIPS-SRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWD 346
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 2e-66
Identities = 111/293 (37%), Positives = 164/293 (55%), Gaps = 22/293 (7%)
Query: 6 SQVFMAREIKT-GEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVT 61
+VF AR++K G VALK++R+ +EG P++ IRE+ +L+ L +H NV++L ++ T
Sbjct: 21 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGL 120
+R+ +VFE++D D T L P IK M QLL GL
Sbjct: 81 VSRTDRE-----------TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 180
+ H ++V+HRD+K N+L+ + G +KLADFGLAR +S+ T + V+TLWYR PE+L
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--SVVVTLWYRAPEVL 187
Query: 181 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
L + Y VD+WSVGCIFAE+ KP+ G ++ +QL KI ++ G P E WP +P
Sbjct: 188 LQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
S + + + D +LL K L +P++RISA AL YF
Sbjct: 247 RQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-65
Identities = 79/295 (26%), Positives = 118/295 (40%), Gaps = 46/295 (15%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V +A T E VA+K + M + P +EI I K L HENV+K
Sbjct: 19 GEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGN- 76
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
Y+ EY P + P + + QL+ G+ Y H
Sbjct: 77 ---------------IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGAT 184
+ HRDIK NLL+D NLK++DFGLA F Y++ L N++ TL Y PELL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
+ VD+WS G + +L G+ +++ Q +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---------------------- 219
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299
K+ ++ D L LL K+L+ +PS RI+ D ++ PL
Sbjct: 220 -----KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPLK 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 7e-63
Identities = 57/319 (17%), Positives = 112/319 (35%), Gaps = 51/319 (15%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V E + + K +++ + + +EI IL +H N++ L E S
Sbjct: 19 GIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRNILHLHESFESMEE 75
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
M+FE++ D+ + +I Y+ Q+ L + H
Sbjct: 76 ----------------LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 125 VNQVLHRDIKGSNLLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
+ + H DI+ N++ + +K+ +FG AR N L Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQH 177
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
A DMWS+G + LL+G + + + I + DE + +S
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI---- 232
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 302
A++ ++++L+ + R++A +AL +
Sbjct: 233 ----------------------EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVST 270
Query: 303 KSLPKYESSHEYQTKKRRQ 321
K + + Y T ++
Sbjct: 271 KVIRTLKHRRYYHTLIKKD 289
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 205 bits (522), Expect = 1e-62
Identities = 62/333 (18%), Positives = 124/333 (37%), Gaps = 55/333 (16%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V E TG + K I + + T EI I+ +L H +I L +
Sbjct: 43 GVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHPKLINLHDAFEDKY- 99
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
++ E++ +L + + ++ YM+Q GL + H
Sbjct: 100 ---------------EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 125 VNQVLHRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
+ ++H DIK N++ + ++K+ DFGLA + + + T + PE++
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR 202
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
G DMW++G + LL+G G+++ E L + DE + VS
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP---- 257
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 302
A + ++ +L +P +R++ DAL+ + D
Sbjct: 258 ----------------------EAKDFIKNLLQKEPRKRLTVHDALEHPWL-----KGDH 290
Query: 303 KSLPKYESSHEYQTKKRRQQQRQHEEATKRQKL 335
+L S Y +++ +++ + + +
Sbjct: 291 SNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAI 323
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 4e-62
Identities = 67/324 (20%), Positives = 119/324 (36%), Gaps = 54/324 (16%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
V+ AR+++ E+VA+KK+ + I+E++ L+KL+H N I+ +
Sbjct: 29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+ ++V EY + L + +I L GL Y H
Sbjct: 89 ----------------TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
+ ++HRD+K N+L+ G +KL DFG A + V T ++ PE++L
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAMD 187
Query: 185 --KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
+Y VD+WS+G EL KP L N L I + S+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPALQSGHWSEY--- 242
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 302
++ L P R +++ L + + P
Sbjct: 243 -----------------------FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 279
Query: 303 KSLPKY--ESSHEYQTKKRRQQQR 324
L + ++ E + R+ ++
Sbjct: 280 MDLIQRTKDAVRELDNLQYRKMKK 303
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (518), Expect = 5e-62
Identities = 88/330 (26%), Positives = 151/330 (45%), Gaps = 28/330 (8%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V A + VA+KK+ + + A RE+ ++K + H+N+I L + T
Sbjct: 31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+ Q Y+V E MD L + ++ + Q+L G+ + H
Sbjct: 91 LEEFQ----------DVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 185
++HRD+K SN+++ ++ LK+ DFGLAR + + +T V+T +YR PE++LG
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG-MG 194
Query: 186 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG--------VS 237
Y VD+WSVGCI E++ K + PG++ +Q +K+ E G+P V
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 238 KMPAYNHFKPSRTMKRRV----REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
P Y + + E + A +LL KML++DP++RIS DAL Y
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 294 WTDPLPCDPKSLPKYESSHEYQTKKRRQQQ 323
P + ++ P + ++ ++
Sbjct: 315 NVWYDPAEVEAPPPQIYDKQLDEREHTIEE 344
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-61
Identities = 62/293 (21%), Positives = 111/293 (37%), Gaps = 51/293 (17%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V+ A+ +T + A K I +E+E + EI IL H N++KL +
Sbjct: 26 GKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDAFYYEN- 82
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+ +++ E+ + + T QI+ KQ L L+Y H
Sbjct: 83 ---------------NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
N+++HRD+K N+L +G++KLADFG++ + + + T ++ PE+++ T
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 185 ----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
Y D+WS+G E+ +P N L KI + P S
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSRWSS-- 243
Query: 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ + L+K L + R + L +
Sbjct: 244 ------------------------NFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-61
Identities = 73/289 (25%), Positives = 117/289 (40%), Gaps = 51/289 (17%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
V++ARE ++ I+ALK + EK G RE++I L+H N+++L
Sbjct: 20 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
Y++ EY + +F + Y+ +L L YCH
Sbjct: 80 ----------------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
+V+HRDIK NLL+ + G LK+ADFG + TL TL Y PPE++ G
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEG-R 179
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
+ VD+WS+G + E L GKP E +I + + +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-------------- 225
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
A +L+ ++L +PSQR ++ L+ +
Sbjct: 226 ----------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-60
Identities = 66/289 (22%), Positives = 123/289 (42%), Gaps = 50/289 (17%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V+ A ++ TG+ VA++++ + + + I I EI ++++ ++ N++ +
Sbjct: 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYLDSYLVGD- 90
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCH 124
++V EY+ L D QI ++ L L + H
Sbjct: 91 ---------------ELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
NQV+HRDIK N+L+ +G++KL DFG + + + + V T ++ PE++
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTR-K 191
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
YGP VD+WS+G + E++ G+P +N L I G+P+ +S
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSA------ 244
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
+ L + L +D +R SAK+ L ++
Sbjct: 245 --------------------IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 8e-60
Identities = 62/296 (20%), Positives = 112/296 (37%), Gaps = 54/296 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+ R G+I+ K++ + E + E+ +L++L+H N+++ + +
Sbjct: 18 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
+ Y+V EY + + + + M QL L
Sbjct: 78 --------------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 122 YCH-----VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
CH + VLHRD+K +N+ +D + N+KL DFGLAR + + V T +Y
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
PE + Y D+WS+GC+ EL P ++ E KI
Sbjct: 183 PEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--------------- 226
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 292
+ + R + + E++ +ML L R S ++ L++
Sbjct: 227 --------------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 196 bits (498), Expect = 2e-59
Identities = 86/300 (28%), Positives = 144/300 (48%), Gaps = 34/300 (11%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPG 64
S+VF A I E V +K ++ +K+ REIKIL+ L+ N+I L +IV P
Sbjct: 49 SEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGPNIITLADIVKDPV 103
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+ +VFE++++ + T I+ YM ++L L YCH
Sbjct: 104 --------------SRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCH 146
Query: 125 VNQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
++HRD+K N++ID+E L+L D+GLA + RV + +++ PELL+
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDY 204
Query: 184 TKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
Y ++DMWS+GC+ A ++ K P G + +QL +I ++ G+ D + +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 243 NHFKPSRTMKRRVR-------EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295
F R R E AL+ L+K+L D R++A++A++ YF+T
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 7e-59
Identities = 75/331 (22%), Positives = 129/331 (38%), Gaps = 51/331 (15%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
S+V +A + +T ++VA+K I EG + EI +L K++H N++ L +I S G
Sbjct: 23 SEVILAEDKRTQKLVAIKCIAKKA-LEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG- 80
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
Y++ + + +L G +T + Q+L + Y H
Sbjct: 81 ---------------HLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 125 VNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
++HRD+K NLL D + + ++DFGL++ D + L+ T Y PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLA 182
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
Y AVD WS+G I LL G P +N+A+ +I + D W +S
Sbjct: 183 Q-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD--- 238
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 301
A + + ++ DP +R + + AL + D
Sbjct: 239 -----------------------SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275
Query: 302 PKSLPKYESSHEYQTKKRRQQQRQHEEATKR 332
E + K + +Q +
Sbjct: 276 NIHQSVSEQIKKNFAKSKWKQAFNATAVVRH 306
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-58
Identities = 66/294 (22%), Positives = 112/294 (38%), Gaps = 49/294 (16%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
S V +ARE+ T A+K + + KE RE ++ +L H +KL
Sbjct: 22 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
Y Y + R F + Y ++++ L Y H
Sbjct: 82 ----------------KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGA 183
++HRD+K N+L++ + ++++ DFG A+ S + N + T Y PELL
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE- 184
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
+ D+W++GCI +L+ G P NE KI +L E +P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP--------- 235
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 297
A +L+EK+L+LD ++R+ ++ P
Sbjct: 236 ---------------------KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 191 bits (485), Expect = 5e-58
Identities = 68/302 (22%), Positives = 114/302 (37%), Gaps = 59/302 (19%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-------EKEGFPITAIREIKILKKLQ-HENVIKLK 57
S V T + A+K I + E + ++E+ IL+K+ H N+I+LK
Sbjct: 17 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76
Query: 58 EIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQL 116
+ + ++VF+ M +L + + + M+ L
Sbjct: 77 DTYETNT----------------FFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRAL 119
Query: 117 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
L + H ++HRD+K N+L+D++ N+KL DFG + D L T Y
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLA 177
Query: 177 PELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 231
PE++ + YG VDMWS G I LL G P + + L I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 232 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 291
W S +L+ + L++ P +R +A++AL
Sbjct: 238 EWDDYSD--------------------------TVKDLVSRFLVVQPQKRYTAEEALAHP 271
Query: 292 YF 293
+F
Sbjct: 272 FF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-55
Identities = 72/316 (22%), Positives = 124/316 (39%), Gaps = 58/316 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIR---MDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVT 61
+ V RE TG A K I+ + + G I RE+ ILK++QH NVI L E+
Sbjct: 24 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
+ ++ E + T + ++KQ+L G++
Sbjct: 84 NKT----------------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 122 YCHVNQVLHRDIKGSNLLIDNEG----NLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 177
Y H Q+ H D+K N+++ + +K+ DFGLA D N N T + P
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAP 185
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237
E++ G DMWS+G I LL+G G + E L+ + + ++ + S
Sbjct: 186 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF---- 293
+ A + + ++L+ DP +R++ +D+L +
Sbjct: 245 AL--------------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278
Query: 294 WTDPLPCDPKSLPKYE 309
L S P++E
Sbjct: 279 TQQALS-SAWSHPQFE 293
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-54
Identities = 52/291 (17%), Positives = 102/291 (35%), Gaps = 47/291 (16%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V+ + +T VA +++ + E ++LK LQH N+++ + S
Sbjct: 23 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+ +V E M + + ++ + +Q+L GL + H
Sbjct: 83 GKK------------CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 126 N--QVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
++HRD+K N+ I G++K+ D GLA + + T + PE+
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYEE 187
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
KY +VD+++ G E+ + A Q+ + G +
Sbjct: 188 --KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-TSGVKPASFDKVAIP---- 240
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293
E++E + + +R S KD L+ +F
Sbjct: 241 ----------------------EVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-52
Identities = 72/350 (20%), Positives = 130/350 (37%), Gaps = 56/350 (16%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPG 64
+V +T E ALK ++ + A RE+++ + Q +++++ ++ +
Sbjct: 26 GKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLY 78
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDH-DL-TGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
R +V E +D +L + + DR FT + MK + + Y
Sbjct: 79 AGRK------------CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 123 CHVNQVLHRDIKGSNLLID---NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 179
H + HRD+K NLL LKL DFG A+ +N+LT T +Y PE+
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPYYVAPEV 184
Query: 180 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
L KY + DMWS+G I LL G P + + I G +
Sbjct: 185 LGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-------IRMGQYEF 236
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD-PL 298
P + L+ +L +P+QR++ + ++ + +
Sbjct: 237 P---------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281
Query: 299 PCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQ 348
P P +S + K R + + E + + ++ I+
Sbjct: 282 PQTP-----LHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIE 326
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-52
Identities = 52/306 (16%), Positives = 111/306 (36%), Gaps = 55/306 (17%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V+ + VA+K + + E+ +L+K +H N++ T+P
Sbjct: 22 GTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL 78
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+V ++ + L +F + ++ +Q G+ Y H
Sbjct: 79 -----------------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG- 182
++HRD+K +N+ + + +K+ DFGLA S + ++ ++ + PE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 183 -ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
Y D+++ G + EL+ G+ N +Q+ + + P +SK+ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----RGYLSPDLSKVRS 236
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 301
+ + L+ + L +R L S +
Sbjct: 237 -------------------NCPKAMKRLMAECLKKKRDERPLFPQILAS-------IELL 270
Query: 302 PKSLPK 307
+SLPK
Sbjct: 271 ARSLPK 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (433), Expect = 2e-50
Identities = 58/286 (20%), Positives = 104/286 (36%), Gaps = 42/286 (14%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
S+V +AR+++ VA+K +R D F + RE + L H ++ + + +
Sbjct: 21 SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
P Y+V EY+D T + + L++ H
Sbjct: 81 PAGPLP------------YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLG 182
N ++HRD+K +N++I +K+ DFG+AR+ + N+ + T Y PE G
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
D++S+GC+ E+L G+P G + + P G+S
Sbjct: 189 D-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA---- 243
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
++ K L +P R +
Sbjct: 244 ----------------------DLDAVVLKALAKNPENRYQTAAEM 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 173 bits (439), Expect = 2e-50
Identities = 53/298 (17%), Positives = 110/298 (36%), Gaps = 55/298 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRM----DNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+V+ R+ TG++ A+K + + E + + ++ ++ +
Sbjct: 18 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 77
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
+P + + M+ F+ ++ Y +++ GL
Sbjct: 78 TPD----------------KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
+ H V++RD+K +N+L+D G+++++D GLA FS V T Y PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVLQ 178
Query: 182 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
Y + D +S+GC+ +LL G ++ +I + + + S
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSP--- 234
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFW 294
LLE +L D ++R+ A++ +S +F
Sbjct: 235 -----------------------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 6e-47
Identities = 60/285 (21%), Positives = 117/285 (41%), Gaps = 50/285 (17%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN--EKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
+VF+A KT + A+K ++ D + T + + + +H + + +
Sbjct: 16 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+ + V EY++ + +F + + Y +++ GL +
Sbjct: 76 E----------------NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
H +++RD+K N+L+D +G++K+ADFG+ + + T Y PE+LLG
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM-LGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 184 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
KY +VD WS G + E+L G+ G++E E I D +P
Sbjct: 179 -KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPFYP--------- 223
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
R ++ A +LL K+ + +P +R+ + +
Sbjct: 224 ----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (411), Expect = 1e-46
Identities = 56/294 (19%), Positives = 104/294 (35%), Gaps = 57/294 (19%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
+V + R G A+K ++ + + E +L + H +I++
Sbjct: 18 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+M+ +Y++ R RF P K Y ++ L Y H
Sbjct: 78 ----------------QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
+++RD+K N+L+D G++K+ DFG A+ + T Y PE++
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVST-K 176
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
Y ++D WS G + E+L G N + KI + P ++
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----AELRFPPFFNE------ 226
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYF 293
+LL +++ D SQR+ +D + +F
Sbjct: 227 --------------------DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-46
Identities = 52/287 (18%), Positives = 100/287 (34%), Gaps = 58/287 (20%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V + G VA+K I+ D + F + E ++ +L+H N+++L ++
Sbjct: 21 GDVMLGD--YRGNKVAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVEE-- 72
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+G Y+V EYM + L R + + + + Y
Sbjct: 73 -------------KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
N +HRD+ N+L+ + K++DFGL + S +T + + + PE L
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALRE- 174
Query: 184 TKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
K+ D+WS G + E+ G+ P + + ++
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--------------------- 213
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
K + E+++ LD + R S +
Sbjct: 214 --------EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (410), Expect = 4e-46
Identities = 72/329 (21%), Positives = 132/329 (40%), Gaps = 34/329 (10%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
S V++A+++ VA+K +R D + + A EIK+L+++ + K + +
Sbjct: 27 STVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+ + G + ++ L + + +K KQLL GL Y H
Sbjct: 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR 143
Query: 126 NQ-VLHRDIKGSNLLIDNEG------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 178
++H DIK N+L++ +K+AD G A + + N++ R YR PE
Sbjct: 144 RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR----EYRSPE 199
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK------NEAEQLSKIFELCGSPDETI 232
+LLGA +G D+WS C+ EL+ G + + + +++I EL G +
Sbjct: 200 VLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258
Query: 233 WPGVSKMPAYNH------------FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 280
+ + F P + + + + + L ML LDP +
Sbjct: 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318
Query: 281 RISAKDALDSEYFWTDPLPCDPKSLPKYE 309
R A ++ + D L + +P E
Sbjct: 319 RADAGGLVNHPWL-KDTLGMEEIRVPDRE 346
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-46
Identities = 62/309 (20%), Positives = 103/309 (33%), Gaps = 65/309 (21%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPIT----AIREIKILKKLQ--HENVIKLKEI 59
V+ + VA+K + D + + E+ +LKK+ VI+L +
Sbjct: 18 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMD--HDLTGLADRPGLRFTVPQIKCYMKQLL 117
P S ++ E + DL G + + Q+L
Sbjct: 78 FERPD----------------SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVL 120
Query: 118 TGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 176
+ +CH VLHRDIK N+LID N G LKL DFG + T+ T Y P
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVYSP 177
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
PE + +G + +WS+G + +++ G E + F
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------------- 224
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296
+ L+ L L PS R + ++ + +
Sbjct: 225 -----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 297 PLPCDPKSL 305
LP + +
Sbjct: 262 LLPQETAEI 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-45
Identities = 64/294 (21%), Positives = 110/294 (37%), Gaps = 54/294 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
+V + RE TG A+K +R + + + E ++L+ +H + LK +
Sbjct: 19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
V EY + FT + + Y ++++ L Y H
Sbjct: 79 ----------------RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
V++RDIK NL++D +G++K+ DFGL + T+ T Y PE+L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLED-N 180
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 244
YG AVD W +G + E++ G+ ++ I + +S
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----MEEIRFPRTLSP------ 230
Query: 245 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYF 293
A LL +L DP QR+ AK+ ++ +F
Sbjct: 231 --------------------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 7e-45
Identities = 52/293 (17%), Positives = 108/293 (36%), Gaps = 56/293 (19%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V+M VA+K ++ + + E ++K+LQH+ +++L +VT
Sbjct: 27 GEVWMGY-YNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAVVTQEPI 82
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLRFTVPQIKCYMKQLLTGLHYC 123
Y++ EYM++ L G++ T+ ++ Q+ G+ +
Sbjct: 83 -----------------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 183
+HRD++ +N+L+ + + K+ADFGLAR + + + PE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 184 TKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
+ D+WS G + E++ +G+ PG E + + Y
Sbjct: 186 -TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----------------GY 227
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD--SEYF 293
+P + +L+ P R + ++F
Sbjct: 228 RMVRPD------------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-44
Identities = 61/303 (20%), Positives = 110/303 (36%), Gaps = 58/303 (19%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
+V+M T VA+K ++ E F ++E +++KKL+HE +++L +V+
Sbjct: 31 GEVWMGTWNGTTR-VAIKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSEEP 85
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLA--DRPGLRFTVPQIKCYMKQLLTGLHY 122
Y+V EYM G +PQ+ Q+ +G+ Y
Sbjct: 86 I-----------------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
+HRD++ +N+L+ K+ADFGLAR + + + PE L
Sbjct: 129 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 183 ATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241
++ D+WS G + EL G+ PG E L ++ P +
Sbjct: 189 -GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPE--- 241
Query: 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD--SEYFWTDPLP 299
+L+ + +P +R + + +YF +
Sbjct: 242 -----------------------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
Query: 300 CDP 302
P
Sbjct: 279 YQP 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 6e-44
Identities = 55/286 (19%), Positives = 100/286 (34%), Gaps = 52/286 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V + + VA+K I+ + E I E K++ L HE +++L + T P
Sbjct: 18 GVVKYGK-WRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVCTKQRP 73
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+++ EYM + L RF Q+ K + + Y
Sbjct: 74 ----------------IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
Q LHRD+ N L++++G +K++DFGL+R D + + + PPE+L+ +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-S 176
Query: 185 KYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
K+ D+W+ G + E+ GK +E I + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS--------- 227
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
++ +R + K L
Sbjct: 228 --------------------EKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 7e-44
Identities = 43/296 (14%), Positives = 95/296 (32%), Gaps = 55/296 (18%)
Query: 6 SQVFMA--REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
V + K + VA+K ++ + + E ++++L + ++++ I +
Sbjct: 21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 80
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 123
+V E + + I + Q+ G+ Y
Sbjct: 81 SW-----------------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 123
Query: 124 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELLL 181
+ +HRD+ N+L+ + K++DFGL+++ ++ T+ + + PE +
Sbjct: 124 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 182 GATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
K+ D+WS G + E + G+ G +E + +
Sbjct: 184 Y-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML------------------- 223
Query: 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD---ALDSEYF 293
K R +L+ D R L + Y+
Sbjct: 224 ----------EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-43
Identities = 55/285 (19%), Positives = 99/285 (34%), Gaps = 52/285 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
V + + VA+K IR E I E +++ KL H +++L + P
Sbjct: 19 GLVHLGYW-LNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+VFE+M+H L+ F + + G+ Y
Sbjct: 75 ----------------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
V+HRD+ N L+ +K++DFG+ R D + T + + PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-S 177
Query: 185 KYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 243
+Y D+WS G + E+ + GK ++ +E + I +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-----------------STGFR 220
Query: 244 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
+KP R H +++ P R + L
Sbjct: 221 LYKP------------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 8e-43
Identities = 57/300 (19%), Positives = 120/300 (40%), Gaps = 54/300 (18%)
Query: 6 SQVFMAREI---KTGEIVALKKIRMDN--EKEGFPITAIREIKILKKLQHE-NVIKLKEI 59
+VF+ R+I TG++ A+K ++ +K E ++L+ ++ ++ L
Sbjct: 38 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTG 119
+ +++ +Y++ RFT +++ Y+ +++
Sbjct: 98 FQTET----------------KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 120 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPE 178
L + H +++RDIK N+L+D+ G++ L DFGL++ F + + + P
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238
+ G + + AVD WS+G + ELL G E ++I + +S
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261
Query: 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYF 293
A +L++++LM DP +R+ A + + +F
Sbjct: 262 --------------------------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-42
Identities = 54/292 (18%), Positives = 93/292 (31%), Gaps = 54/292 (18%)
Query: 6 SQVFMAREIKT---GEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
V VA+K ++ D + IRE+ + L H N+I+L +V
Sbjct: 22 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGL 120
+P MV E L + F + + Y Q+ G+
Sbjct: 82 TPPM-----------------KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPE 178
Y + +HRD+ NLL+ +K+ DFGL R+ + ++ + +R + + PE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 179 LLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237
L + A D W G E+ G+ G N ++ L KI
Sbjct: 185 SLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI--DKEGERLPRPEDCP 241
Query: 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+ ++ + P R + D
Sbjct: 242 Q--------------------------DIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 2e-42
Identities = 48/293 (16%), Positives = 87/293 (29%), Gaps = 51/293 (17%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+++ +I GE VA+K + + E KI K +Q I + G
Sbjct: 21 GDIYLGTDIAAGEEVAIKLECVKTKHPQL----HIESKIYKMMQGGVGIPTIRWCGAEG- 75
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
MV E + L L + +F++ + Q+++ + Y H
Sbjct: 76 --------------DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 126 NQVLHRDIKGSNLLI---DNEGNLKLADFGLARSF------SYDHNNTLTNRVITLWYRP 176
+HRD+K N L+ + + DFGLA+ + + N T Y
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 177 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
LG + D+ S+G + G G A + K +
Sbjct: 182 INTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---------- 230
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+ M + + + + L L +
Sbjct: 231 ------------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-41
Identities = 59/301 (19%), Positives = 105/301 (34%), Gaps = 44/301 (14%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+V+ + GE VA+K E+ F EI L+HEN++
Sbjct: 17 GEVWRGKW--RGEEVAVKIFSSREERSWF---REAEIYQTVMLRHENILGFIAADNKDNG 71
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+ ++V +Y +H L +R + TV + +GL + H
Sbjct: 72 TWTQ------------LWLVSDYHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLH 117
Query: 125 V--------NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLW 173
+ + HRD+K N+L+ G +AD GLA + +RV T
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 174 YRPPELLLGA-----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 228
Y PE+L + + D++++G +F E+ I G +E QL + P
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSDP 236
Query: 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
V P+R V +++ + + + R++A
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA-------KIMRECWYANGAARLTALRIK 289
Query: 289 D 289
Sbjct: 290 K 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (373), Expect = 2e-41
Identities = 53/287 (18%), Positives = 101/287 (35%), Gaps = 52/287 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
+V+ K VA+K ++ D E E F ++E ++K+++H N+++L + T
Sbjct: 31 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREP 86
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
P Y++ E+M + L L + + + Q+ + + Y
Sbjct: 87 P----------------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 182
+HRD+ N L+ +K+ADFGL+R + D + + PE L
Sbjct: 131 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 183 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242
K+ D+W+ G + E+ + Q+ ++ L G +
Sbjct: 191 -NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL--LEKDYRMERPEGCPE---- 243
Query: 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
EL+ +PS R S +
Sbjct: 244 ----------------------KVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-41
Identities = 47/289 (16%), Positives = 93/289 (32%), Gaps = 53/289 (18%)
Query: 6 SQVFMAREIKT---GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTS 62
V + VA+K + + + ++E +++ H +++KL ++T
Sbjct: 21 GDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
+++ E +L + + Y QL T L
Sbjct: 79 ----------------ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 181
Y + +HRDI N+L+ + +KL DFGL+R + + + + PE +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 182 GATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240
++ A D+W G E+L +G G + + +I
Sbjct: 183 F-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI------------------- 222
Query: 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+ + L+ K DPS+R +
Sbjct: 223 ----------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (371), Expect = 3e-41
Identities = 47/287 (16%), Positives = 82/287 (28%), Gaps = 53/287 (18%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 65
+F + + VA+K ++ E + K L I
Sbjct: 19 GVIFEGTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLAGCTGIPNVYYFGQ--- 71
Query: 66 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 125
+G +V + + L L D G +F+V + KQ+L + H
Sbjct: 72 --------EGLHN----VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 126 NQVLHRDIKGSNLLIDN-----EGNLKLADFGLARSFSYD------HNNTLTNRVITLWY 174
+++RDIK N LI + + DFG+ + + N T Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 175 RPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234
LG + D+ ++G +F L G G A K +
Sbjct: 180 MSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG--------- 229
Query: 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 281
+ +RE+ F + + L
Sbjct: 230 -------------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (370), Expect = 4e-41
Identities = 55/309 (17%), Positives = 112/309 (36%), Gaps = 60/309 (19%)
Query: 6 SQVFMAREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTS 62
+V G+ VA+K ++ ++ + E I+ + H NVI L+ +VT
Sbjct: 40 GEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHPNVIHLEGVVTK 98
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
P ++ E+M++ L + +FTV Q+ ++ + G+
Sbjct: 99 STP----------------VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV----ITLWYRPP 177
Y +HRD+ N+L+++ K++DFGL+R D ++ I + + P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 178 ELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236
E + K+ A D+WS G + E+++ G+ + ++ I
Sbjct: 203 EAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI--------------- 246
Query: 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296
+ +L+ D + R +++ D
Sbjct: 247 --------------EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT----LD 288
Query: 297 PLPCDPKSL 305
+ +P SL
Sbjct: 289 KMIRNPNSL 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 8e-41
Identities = 48/290 (16%), Positives = 89/290 (30%), Gaps = 54/290 (18%)
Query: 6 SQVFMA--REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 63
V R K VA+K ++ EK +RE +I+ +L + +++L + +
Sbjct: 23 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLIGVCQAE 81
Query: 64 GPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 122
+V E L V + + Q+ G+ Y
Sbjct: 82 AL-----------------MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124
Query: 123 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD--HNNTLTNRVITLWYRPPELL 180
+HRD+ N+L+ N K++DFGL+++ D + + L + PE +
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 181 LGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
K+ D+WS G E L+ G+ E ++ I
Sbjct: 185 NF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------------ 225
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+ + E L+ + R
Sbjct: 226 -----------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 264
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (365), Expect = 8e-40
Identities = 57/316 (18%), Positives = 108/316 (34%), Gaps = 31/316 (9%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 64
+V + + ++G A+K + K + E +IL+ + ++KL+
Sbjct: 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF------ 108
Query: 65 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 124
+ M + + L RF+ P + Y Q++ Y H
Sbjct: 109 --------SFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH 158
Query: 125 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 184
+++RD+K NLLID +G +++ DFG A+ T PE++L
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEIILS-K 213
Query: 185 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG----VSKMP 240
Y AVD W++G + E+ G P + KI + +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273
Query: 241 AYNHFKPSRTMKRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 298
+ K +K V ++ H F + + ++ K D+ F D
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR-KVEAPFIPKFKGPGDTSNF--DDY 330
Query: 299 PCDPKSLPKYESSHEY 314
+ + E +
Sbjct: 331 EEEEIRVSINEKCGKE 346
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 54/315 (17%), Positives = 112/315 (35%), Gaps = 28/315 (8%)
Query: 6 SQVFMAREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
V+ I GE VA+K++R + + E ++ + + +V +L I
Sbjct: 23 GTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICL 81
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
+ + + L + + Q+ G++
Sbjct: 82 TSTVQ----------------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELL 180
Y +++HRD+ N+L+ ++K+ DFGLA+ + + + + + E +
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 181 LGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
L Y D+WS G EL+ G G +E S + + P I M
Sbjct: 186 LH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 299
+ + + RE+ F + A + ++ L++ +R+ DS ++
Sbjct: 245 IMVKCWMIDADSRPKFRELIIEFSKMARD-PQRYLVIQGDERMHLPSPTDSNFY---RAL 300
Query: 300 CDPKSLPKYESSHEY 314
D + + + EY
Sbjct: 301 MDEEDMDDVVDADEY 315
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (355), Expect = 7e-39
Identities = 54/314 (17%), Positives = 100/314 (31%), Gaps = 78/314 (24%)
Query: 6 SQVFMAR-----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIV 60
+VF AR + +VA+K ++ + RE ++ + + N++KL +
Sbjct: 27 GRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLR---------------- 103
P ++FEYM + DL
Sbjct: 86 AVGKP----------------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 104 -------FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156
+ + C +Q+ G+ Y + +HRD+ N L+ +K+ADFGL+R+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 157 F-SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNE 214
S D+ N I + + PPE + +Y D+W+ G + E+ + G G
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 215 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKML 274
E + + + + L+
Sbjct: 249 EEVIYYV-----------------------------RDGNILACPENCPLELYNLMRLCW 279
Query: 275 MLDPSQRISAKDAL 288
P+ R S
Sbjct: 280 SKLPADRPSFCSIH 293
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-38
Identities = 57/292 (19%), Positives = 95/292 (32%), Gaps = 54/292 (18%)
Query: 6 SQVFMAREIK---TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTS 62
V+ + A+K + + G + E I+K H NV+ L I
Sbjct: 41 GCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 99
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
GS +V YM H DL TV + + Q+ G+
Sbjct: 100 S---------------EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF---SYDHNNTLTNRVITLWYRPPE 178
+ + +HRD+ N ++D + +K+ADFGLAR +D + T + + + E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 179 LLLGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237
L K+ D+WS G + EL+ G P P N + + + P
Sbjct: 205 SLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP--- 260
Query: 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
E++ K R S + +
Sbjct: 261 --------------------------DPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-38
Identities = 57/315 (18%), Positives = 103/315 (32%), Gaps = 77/315 (24%)
Query: 6 SQVFMAREIKTGEI-----VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEI 59
+V A + VA+K ++ + + E+K++ +L HEN++ L
Sbjct: 51 GKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHENIVNLLGA 109
Query: 60 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-----------------------DLTGL 96
T GP Y++FEY +
Sbjct: 110 CTLSGP----------------IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 97 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 156
+ T + C+ Q+ G+ + +HRD+ N+L+ + +K+ DFGLAR
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 157 FSYDHNNTL-TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNE 214
D N + N + + + PE L Y D+WS G + E+ + G PG
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 215 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKML 274
K+ + N FK + + +++
Sbjct: 273 DANFYKLIQ-------------------NGFKMDQP---------FYATEEIYIIMQSCW 304
Query: 275 MLDPSQRISAKDALD 289
D +R S +
Sbjct: 305 AFDSRKRPSFPNLTS 319
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 9e-36
Identities = 62/305 (20%), Positives = 102/305 (33%), Gaps = 69/305 (22%)
Query: 6 SQVFMAREIKTGEI--VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTS 62
QV AR K G A+K+++ K+ E+++L KL H N+I L
Sbjct: 24 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLGHHPNIINLLGACE- 81
Query: 63 PGPERDEQGRPDGNKYRGSTYMVFEYMDH----------------DLTGLADRPGLRFTV 106
+RG Y+ EY H +A+ +
Sbjct: 82 ---------------HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 107 PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 166
Q+ + + G+ Y Q +HRD+ N+L+ K+ADFGL+R + T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKT 184
Query: 167 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELC 225
+ + + E L + Y D+WS G + E++ G G AE K+
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 239
Query: 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 285
+ E + D +L+ + P +R S
Sbjct: 240 -------------------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 274
Query: 286 DALDS 290
L S
Sbjct: 275 QILVS 279
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-35
Identities = 48/292 (16%), Positives = 103/292 (35%), Gaps = 55/292 (18%)
Query: 6 SQVFMAREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVT 61
+V+ + VA+K ++ E + + E I+ + H N+I+L+ +++
Sbjct: 21 GEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGL 120
P ++ EYM++ F+V Q+ ++ + G+
Sbjct: 80 KYKP----------------MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 121 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF--SYDHNNTLTNRVITLWYRPPE 178
Y +HRD+ N+L+++ K++DFGL+R + T + I + + PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 179 LLLGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237
+ K+ A D+WS G + E++ G+ + E + I
Sbjct: 184 AISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---------------- 226
Query: 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+L+ + + ++R D +
Sbjct: 227 -------------NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-34
Identities = 55/308 (17%), Positives = 101/308 (32%), Gaps = 69/308 (22%)
Query: 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVT 61
V + + + VA+K ++ + E+K+L L H N++ L T
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97
Query: 62 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH------------------DLTGLADRPGLR 103
GP T ++ EY + + + L
Sbjct: 98 IGGP----------------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 104 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 163
+ + + Q+ G+ + +HRD+ N+L+ + K+ DFGLAR D N
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 164 TL-TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 221
+ N + + + PE + Y D+WS G EL + G PG + K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 222 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQ 280
+K R + H ++++ DP +
Sbjct: 261 -----------------------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 281 RISAKDAL 288
R + K +
Sbjct: 292 RPTFKQIV 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-33
Identities = 48/290 (16%), Positives = 88/290 (30%), Gaps = 32/290 (11%)
Query: 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTS 62
V + F + T VA+K ++ ++ H NV+ L T
Sbjct: 29 VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88
Query: 63 PGPERDEQGRP-DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 121
PG D T+ + CY Q+ G+
Sbjct: 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 148
Query: 122 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELL 180
+ + +HRD+ N+L+ + +K+ DFGLAR D + L + PE +
Sbjct: 149 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 208
Query: 181 LGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239
Y D+WS G + E+ + PG E+ + +
Sbjct: 209 FD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK---------------- 251
Query: 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289
+ + + + +PSQR + + ++
Sbjct: 252 ------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-32
Identities = 58/310 (18%), Positives = 105/310 (33%), Gaps = 73/310 (23%)
Query: 6 SQVFMAREIKTGE-------IVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLK 57
QV +A I + VA+K ++ D ++ I E++++K + +H+N+I L
Sbjct: 27 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIINLL 85
Query: 58 EIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH----------------DLTGLADRPG 101
T GP Y++ EY + P
Sbjct: 86 GACTQDGP----------------LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 102 LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161
+ + + Q+ G+ Y + +HRD+ N+L+ + +K+ADFGLAR +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 162 NNTLT-NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLS 219
T N + + + PE L Y D+WS G + E+ G PG E
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 220 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPS 279
+ + + + ++ PS
Sbjct: 249 LL-----------------------------KEGHRMDKPSNCTNELYMMMRDCWHAVPS 279
Query: 280 QRISAKDALD 289
QR + K ++
Sbjct: 280 QRPTFKQLVE 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-30
Identities = 45/314 (14%), Positives = 103/314 (32%), Gaps = 64/314 (20%)
Query: 6 SQVFMAR-----EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIV 60
V+ + + VA+K + + I + E ++K+ +V++L +V
Sbjct: 34 GMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92
Query: 61 TSPGPERDEQGRPDGNKYRGSTYMVFEYMD----------HDLTGLADRPGLRFTVPQIK 110
+ P T ++ E M + ++ ++
Sbjct: 93 SQGQP----------------TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 111 CYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRV 169
++ G+ Y + N+ +HRD+ N ++ + +K+ DFG+ R D+ +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 170 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSP 228
+ + + PE L + D+WS G + E+ + G + + L +
Sbjct: 197 LPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------- 248
Query: 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288
M+ + + + EL+ +P R S + +
Sbjct: 249 ----------------------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286
Query: 289 DSEYFWTDPLPCDP 302
S +P +
Sbjct: 287 SSIKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.1 bits (220), Expect = 3e-21
Identities = 30/210 (14%), Positives = 59/210 (28%), Gaps = 56/210 (26%)
Query: 6 SQVFMAREIKTGEIVALKKIRMDNE----------------KEGFPITAIREIKILKKLQ 49
S VF + +K ++ + +A E + L+KLQ
Sbjct: 14 SAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72
Query: 50 HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQI 109
V K+ ++ E +D R V
Sbjct: 73 GLAVPKVYAW--------------------EGNAVLMELIDAKELY-------RVRVENP 105
Query: 110 KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR- 168
+ +L + + ++H D+ N+L+ EG + + DF + + + R
Sbjct: 106 DEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERD 164
Query: 169 --VITLWYRPPELLLGATKYGPAVDMWSVG 196
I ++ Y D+ S
Sbjct: 165 VRNIITYFS--------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 481 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.18 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.61 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-59 Score=458.07 Aligned_cols=286 Identities=42% Similarity=0.756 Sum_probs=243.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC---CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK---EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|+++.+++.||||+++..... +.....+++|+.+|++++|||||+++++|.+ +
T Consensus 9 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~----------------~ 72 (299)
T d1ua2a_ 9 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----------------K 72 (299)
T ss_dssp ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----------------T
T ss_pred CcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc----------------C
Confidence 89999999999999999999999765322 2335678899999999999999999999987 6
Q ss_pred CeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 80 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 80 ~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
+++|||||||.++++..+......+++.+++.+++||+.||+|||+++|+||||||+|||++.++++||+|||+|+.+..
T Consensus 73 ~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred CceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC
Confidence 67899999999988887777777899999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......++|+.|+|||++.....|+.++||||||||+|||++|.+||.+.++.+++.+|++..+.+....|+.....
T Consensus 153 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 153 P-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp C-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred C-cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 3 233445688999999999987667899999999999999999999999999999999999999999999888887776
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 307 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~~~~~~~~~ 307 (481)
.....+.... .......+..+++++++||++||+.||++|+|++|+|+||||+..+.++....+|+
T Consensus 232 ~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 232 PDYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp TTCCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred chhhhhccCC--CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence 5544443221 22345566788999999999999999999999999999999998887776665553
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-57 Score=437.54 Aligned_cols=248 Identities=30% Similarity=0.444 Sum_probs=205.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.|++.||||+++.....+ ....+.+|+++|++|+|||||++++++.+ .+.+
T Consensus 16 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~----------------~~~~ 78 (271)
T d1nvra_ 16 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRRE----------------GNIQ 78 (271)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHhCCCCCEeeEeeeecc----------------Ccee
Confidence 899999999999999999999998764332 34578899999999999999999999988 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||++ +|.+++.. ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+....
T Consensus 79 ~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999986 77776654 4579999999999999999999999999999999999999999999999999998765332
Q ss_pred -CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 -NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 -~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......+||+.|||||++.+...++.++||||||||+|||++|+.||...++..............
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------------ 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------ 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT------------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------
Confidence 2334567899999999999875445788999999999999999999998766544433333211110
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...+..+++++++||.+||+.||++|||++|||+||||+.
T Consensus 226 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 ---------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ---------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0112457889999999999999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-57 Score=433.48 Aligned_cols=242 Identities=30% Similarity=0.467 Sum_probs=210.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.|++.||||++.... ........+.+|+.++++|+|||||++++++.+ ++.
T Consensus 17 G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----------------~~~ 80 (263)
T d2j4za1 17 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----------------ATR 80 (263)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSE
T ss_pred CCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE----------------CCE
Confidence 899999999999999999999997653 233445678899999999999999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||++ +|.+++.+ ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+....
T Consensus 81 ~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred EEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 9999999986 66666554 34699999999999999999999999999999999999999999999999999976542
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
......+||+.|||||++.+ ..++.++||||||||||+|++|+.||.+.+..+.+.++.+.....
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------------ 223 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF------------ 223 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC------------
T ss_pred --CcccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 33445688999999999987 678999999999999999999999999999988888876432111
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.+.+++++++||.+||+.||++|||++|||+||||+.
T Consensus 224 ------------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 224 ------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 1236789999999999999999999999999999953
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-56 Score=434.75 Aligned_cols=276 Identities=47% Similarity=0.843 Sum_probs=234.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+++.||||+++.....+.....+.+|+++|++|+|||||+++++|.+ .+++
T Consensus 13 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~----------------~~~~ 76 (298)
T d1gz8a_ 13 GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----------------ENKL 76 (298)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc----------------ccce
Confidence 899999999999999999999998776555566788999999999999999999999998 6789
Q ss_pred EEEEecCCCChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~-~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||.++++.++. .....+++.+++.|+.||+.||+|||+++||||||||+|||++.++++||+|||+|+.... .
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~-~ 155 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-P 155 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-C
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC-C
Confidence 9999999988776654 4455699999999999999999999999999999999999999999999999999987653 2
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++|+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+.+++...+.+.+..|......+.
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 33455568899999999988766678999999999999999999999999999999999999999999888887766554
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
+....+. ............++.+++|||++||+.||++|+|++|||+|+||+.-
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 236 YKPSFPK-WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCTTSCC-CCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccc-ccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 4332221 22233455666889999999999999999999999999999999643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=434.13 Aligned_cols=244 Identities=25% Similarity=0.432 Sum_probs=211.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.||+.||||+++..... ....+.+|+.+|++|+|||||+++++|.+ .+.+
T Consensus 31 G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~~ 92 (293)
T d1yhwa1 31 GASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV----------------GDEL 92 (293)
T ss_dssp SSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE----------------CCEE
Confidence 89999999999999999999999866433 34578899999999999999999999988 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||.+ +|..++.+ ..+++.+++.|++||+.||+|||++||+||||||+||||+.++++||+|||+|+.+...
T Consensus 93 ~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~- 169 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169 (293)
T ss_dssp EEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred EEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc-
Confidence 999999986 56555543 35999999999999999999999999999999999999999999999999999876533
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......+||+.|+|||++.+ ..|+.++||||||||+|+|++|+.||.+.+..+.+..+........
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~------------ 236 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL------------ 236 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC------------
T ss_pred cccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence 234455689999999999987 6789999999999999999999999999998888877765321110
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....++.++++||.+||..||++|||++|||+||||+.
T Consensus 237 ---------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 ---------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ---------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ---------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 012357889999999999999999999999999999964
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=433.67 Aligned_cols=291 Identities=51% Similarity=0.907 Sum_probs=234.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++.....+....++.+|+++|++|+|+||+++++++...... ....+.++
T Consensus 21 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~--------~~~~~~~~ 92 (318)
T d3blha1 21 GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP--------YNRCKGSI 92 (318)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------------------CE
T ss_pred CcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc--------ccccCceE
Confidence 8999999999999999999999988776666778899999999999999999999999764321 12225679
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC-
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH- 161 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 161 (481)
|||||||.++++.........+++.+++.|++||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus 93 ~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~ 172 (318)
T d3blha1 93 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 172 (318)
T ss_dssp EEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC---
T ss_pred EEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccc
Confidence 9999999998888887777789999999999999999999999999999999999999999999999999998765322
Q ss_pred --CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 --NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 --~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.......++|+.|+|||++.+...|+.++||||||||+|||++|+.||.+.++.+.+..+.+..+.+....+......
T Consensus 173 ~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 252 (318)
T d3blha1 173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252 (318)
T ss_dssp --CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC
T ss_pred cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchh
Confidence 223344578999999999987667999999999999999999999999999999999999999998888777766554
Q ss_pred CccccCCCchhhhhhHHHHH--hhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 301 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~~~ 301 (481)
..+................+ ...+++++|||.+||+.||++|+|++|||+||||+.++.|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~ 316 (318)
T d3blha1 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316 (318)
T ss_dssp -------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred hhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence 44333332222222222222 235788999999999999999999999999999998877654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-56 Score=432.98 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=210.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.|++.||||+++.... .....+.+|+++|++|+|||||++++++.+ .+.+
T Consensus 23 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----------------~~~~ 84 (288)
T d2jfla1 23 GAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYY----------------ENNL 84 (288)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEee----------------CCeE
Confidence 8999999999999999999999986533 235678899999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||.+ +|..++.+....+++.+++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.....
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~- 163 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 163 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC-
Confidence 999999986 666665655567999999999999999999999999999999999999999999999999999765321
Q ss_pred CCccccccccccCCCchhhcC----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 162 NNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
.......+||+.|+|||++.. ...|+.++||||||||+|||++|+.||.+.+..+.+.++........
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-------- 235 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-------- 235 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC--------
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 122345688999999999853 24588999999999999999999999999999888888765321100
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
.....+++++++||.+||+.||++|||++|||+||||+.
T Consensus 236 -------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 236 -------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp -------------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred -------------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011357889999999999999999999999999999964
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-55 Score=439.87 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=218.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.||+.||||++...... ....+.+|+.+|++|+|||||+++++|.+ .+.+
T Consensus 37 G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~~ 98 (350)
T d1koaa2 37 GAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFED----------------DNEM 98 (350)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEECCCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEE----------------TTEE
T ss_pred CcCeEEEEEEECCCCCEEEEEEEcccchh--hHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEE
Confidence 89999999999999999999999765432 24567899999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC--CCCeEEecccccccccC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~ 159 (481)
|||||||++ +|.+++.+....+++.+++.|+.||+.||+|||+++||||||||+||||+. ++.+||+|||+|+.+..
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999985 777877766667999999999999999999999999999999999999964 57899999999987653
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.......+||+.|||||++.+ ..++.++||||||||+|+|++|+.||.+.+..+++.+|..........
T Consensus 179 --~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------- 247 (350)
T d1koaa2 179 --KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-------- 247 (350)
T ss_dssp --TSCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG--------
T ss_pred --ccccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--------
Confidence 334455688999999999987 678999999999999999999999999999999999887654332221
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 303 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~~~~~~~~ 303 (481)
.+..+++++++||++||..||++|||++|||+||||+....+....
T Consensus 248 ------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~ 293 (350)
T d1koaa2 248 ------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293 (350)
T ss_dssp ------------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCC
T ss_pred ------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchh
Confidence 2235788999999999999999999999999999998765544333
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=425.51 Aligned_cols=247 Identities=22% Similarity=0.299 Sum_probs=202.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.|++.||||++............+.+|+++|++|+|||||+++++|.+... .+..+
T Consensus 20 G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~------------~~~~~ 87 (270)
T d1t4ha_ 20 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK------------GKKCI 87 (270)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS------------SCEEE
T ss_pred CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc------------cCCEE
Confidence 899999999999999999999998765444445678899999999999999999999875221 14578
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcC-CCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDN-EGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g--iiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~ 158 (481)
|||||||++ +|.+++.+ ...+++.+++.|+.||+.||+|||+++ |+||||||+||||++ ++.+||+|||+|+...
T Consensus 88 ~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999986 56565544 346999999999999999999999998 999999999999974 7899999999997643
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
.......+||+.|||||++.+ .++.++||||||||+|||++|+.||...+....+.+.+.....+
T Consensus 167 ---~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~---------- 231 (270)
T d1t4ha_ 167 ---ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 231 (270)
T ss_dssp ---TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred ---CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC----------
Confidence 233445689999999999875 58999999999999999999999998766554444333211000
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
..+...+++++++||.+||+.||++|||++|||+||||+
T Consensus 232 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 011234678899999999999999999999999999994
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-55 Score=430.53 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=196.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.|++.||||++....... ....+.+|+.+|++|+|||||+++++|.+ .+.+
T Consensus 20 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----------------~~~~ 82 (307)
T d1a06a_ 20 GAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES----------------GGHL 82 (307)
T ss_dssp GGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC----------------SSEE
T ss_pred ccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEE
Confidence 899999999999999999999998664332 23467799999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc---CCCCeEEeccccccccc
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID---NEGNLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~---~~~~vkL~DFG~a~~~~ 158 (481)
|||||||++ +|.+++.+. ..+++.+++.|+.||+.||+|||+++|+||||||+|||+. .++.+||+|||+|+...
T Consensus 83 ~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999985 777777653 4699999999999999999999999999999999999995 46789999999998654
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .....+.+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+....+..........
T Consensus 162 ~--~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------- 231 (307)
T d1a06a_ 162 P--GSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP------- 231 (307)
T ss_dssp -------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT-------
T ss_pred C--CCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc-------
Confidence 2 233455789999999999987 678999999999999999999999999999988888887643222221
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.+..+++++++||.+||+.||++|||++|+|+||||+..
T Consensus 232 -------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 232 -------------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -------------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 123578899999999999999999999999999999653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-55 Score=438.95 Aligned_cols=247 Identities=23% Similarity=0.386 Sum_probs=215.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.|++.||||+++..... ....+.+|+.+|++|+|||||+++++|.+ ++.+
T Consensus 40 G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----------------~~~~ 101 (352)
T d1koba_ 40 GAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFED----------------KYEM 101 (352)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEEC----------------SSEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEECCcchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEE
Confidence 89999999999999999999999865432 23467799999999999999999999987 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc--CCCCeEEecccccccccC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID--NEGNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~--~~~~vkL~DFG~a~~~~~ 159 (481)
|||||||++ +|.+.+......+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.|||+|||+|+.+..
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999985 67777777767799999999999999999999999999999999999998 567899999999987653
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.......++|+.|+|||++.+ ..|+.++||||||||+|+|++|+.||.+.+..+++.++...........|
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------ 252 (352)
T d1koba_ 182 --DEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------ 252 (352)
T ss_dssp --TSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT------
T ss_pred --CCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc------
Confidence 334455688999999999986 67899999999999999999999999999999999988765443332222
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
..+++++++||.+||+.||++|||++|||+||||+..
T Consensus 253 --------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 253 --------------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp --------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --------------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 2478899999999999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=426.20 Aligned_cols=246 Identities=26% Similarity=0.414 Sum_probs=199.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.||+.||||+++.....+.....+.+|+++|++|+|||||++++++.+.. .+.+
T Consensus 15 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--------------~~~~ 80 (269)
T d2java1 15 GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--------------NTTL 80 (269)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC------------------CE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC--------------CCEE
Confidence 89999999999999999999999877555445567889999999999999999999997532 4578
Q ss_pred EEEEecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEEcCCCCeEEecccc
Q 011627 83 YMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQ-----VLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~g-----iiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
|||||||++ +|.+++.+ ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999985 77776643 3456999999999999999999999876 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
|+.+... .......++|+.|||||++.+ ..|+.++||||||||+|||++|+.||.+.+..+++.++.+.....
T Consensus 161 a~~~~~~-~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~----- 233 (269)
T d2java1 161 ARILNHD-TSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR----- 233 (269)
T ss_dssp HHHC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-----
T ss_pred eeecccC-CCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence 9876532 223445688999999999976 678999999999999999999999999999988888876532110
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 293 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f 293 (481)
+...+++++++||++||+.||++|||++|||+|||+
T Consensus 234 ------------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 ------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 012477899999999999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=430.42 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=207.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.|++.||||+++... ..+.....+.+|+++|++|+|||||+++++|.+ ++.
T Consensus 19 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----------------~~~ 82 (288)
T d1uu3a_ 19 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----------------DEK 82 (288)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC----------------SSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE----------------CCE
Confidence 899999999999999999999998653 233445678899999999999999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||++ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||++++.+||+|||+|+.+...
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999986 666665543 46999999999999999999999999999999999999999999999999999877543
Q ss_pred C-CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 H-NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~-~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. .......+||+.|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+..+++.+|.......
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 229 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----------- 229 (288)
T ss_dssp --------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC-----------
T ss_pred CcccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence 2 233455689999999999987 678999999999999999999999999999999888886532111
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD------ALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~e------iL~h~~f~~ 295 (481)
...+++++++||++||+.||++|+|++| |++||||..
T Consensus 230 -------------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 230 -------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp -------------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred -------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 1246789999999999999999999987 578999954
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-55 Score=433.17 Aligned_cols=244 Identities=26% Similarity=0.411 Sum_probs=210.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.|++.||||+++..... ......+.+|+.+|++|+|||||++++++.+ .+.
T Consensus 26 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----------------~~~ 89 (309)
T d1u5ra_ 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----------------EHT 89 (309)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE----------------CCE
Confidence 89999999999999999999999866432 2334567899999999999999999999987 668
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+|||||||.++++..+......+++.+++.|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+....
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999999877766655556799999999999999999999999999999999999999999999999999976532
Q ss_pred CCccccccccccCCCchhhcCC--CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
....+||+.|||||++.+. ..|+.++||||||||+|||++|+.||.+.+..+.+.++.........
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 235 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--------- 235 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS---------
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC---------
Confidence 3346889999999998652 45889999999999999999999999999988888887653211100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...+++++++||.+||+.||++|||++|||+||||..
T Consensus 236 -------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 236 -------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 0246789999999999999999999999999999965
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.4e-55 Score=425.17 Aligned_cols=273 Identities=45% Similarity=0.813 Sum_probs=233.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++ +++.||||+++.....+.....+.+|+.+|++|+|+|||+++++|.+ .+.+
T Consensus 13 G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----------------~~~~ 75 (286)
T d1ob3a_ 13 GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----------------KKRL 75 (286)
T ss_dssp ETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----------------SSCE
T ss_pred CCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc----------------CCce
Confidence 899999999995 88999999998776666667789999999999999999999999988 6789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||+|||+.++++..+......+++.+++.|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|.......
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 9999999998888888877889999999999999999999999999999999999999999999999999998765332
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
.......+++.|+|||++.+...++.++|||||||++|||++|+.||.+.++.+++.+++...+.+....|........+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 23344567999999999987677899999999999999999999999999999999999999999988888877665543
Q ss_pred ccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 011627 243 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 294 (481)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~ 294 (481)
...... ............++++++|||++||+.||++|+|++|||+||||+
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 235 DPNFTV-YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp CTTCCC-CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccccc-ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 322211 112223344567889999999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=432.31 Aligned_cols=244 Identities=27% Similarity=0.410 Sum_probs=211.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.|++.||||++++.. ........+++|+.+|++++|||||+++++|.+ .+.
T Consensus 16 G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----------------~~~ 79 (337)
T d1o6la_ 16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----------------HDR 79 (337)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----------------SSE
T ss_pred CcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc----------------ccc
Confidence 899999999999999999999998653 223345678899999999999999999999998 778
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||.+ +|..++. ....+++..++.++.||+.||+|||+++||||||||+||||+.++++||+|||+|+....
T Consensus 80 ~~iv~ey~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~- 157 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS- 157 (337)
T ss_dssp EEEEEECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred cccceeccCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc-
Confidence 9999999996 5555544 445799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........+||+.|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+..+++.++.......
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~------------ 224 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------------ 224 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred CCcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC------------
Confidence 2334556789999999999987 678999999999999999999999999999988888876532111
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
++.+++++++||++||+.||++|++ ++||++||||..
T Consensus 225 ------------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 225 ------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ------------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 1247889999999999999999994 999999999954
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=437.58 Aligned_cols=271 Identities=23% Similarity=0.333 Sum_probs=202.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.|++.||||+++.... ......+.+|+.+|++|+|||||+++++|.+ .+++
T Consensus 17 G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----------------~~~~ 79 (322)
T d1s9ja_ 17 GNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS----------------DGEI 79 (322)
T ss_dssp CSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC----------------SSEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEE
Confidence 8999999999999999999999986543 3345678899999999999999999999997 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||||||.+ +|.+++.+. ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+|+.+..
T Consensus 80 ~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 999999996 666666543 469999999999999999999997 5999999999999999999999999999987643
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhcCCCCCCC----Ccc
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS-KIFELCGSPDETI----WPG 235 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~i~~~~~~~~~~~----~~~ 235 (481)
....+.+||+.|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+..+... .+....+...... +..
T Consensus 158 --~~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 --SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp --HTC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred --CccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 23345689999999999997 679999999999999999999999998766543221 1111111111110 000
Q ss_pred CCCCCccccCCCchhhhhhHHHHH---------hhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVF---------RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
...........+..........+. ..++.+++|||++||..||++|||++|+|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000000000011111111111111 136889999999999999999999999999999953
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-54 Score=427.12 Aligned_cols=242 Identities=23% Similarity=0.366 Sum_probs=212.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.||+.||||+++... ........+.+|+.+|++++|||||++++++.+ .+.
T Consensus 15 G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~ 78 (316)
T d1fota_ 15 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----------------AQQ 78 (316)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----------------SSE
T ss_pred CcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee----------------CCe
Confidence 899999999999999999999998653 233345678899999999999999999999987 679
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+|||||||.++.+..+......+++..++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+|+....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 999999999866665555566789999999999999999999999999999999999999999999999999987642
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
...+.+||+.|||||++.+ ..|+.++||||||||||+|++|+.||.+.+..+.+.++.......+
T Consensus 157 --~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p------------ 221 (316)
T d1fota_ 157 --VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP------------ 221 (316)
T ss_dssp --CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC------------
T ss_pred --ccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC------------
Confidence 3345689999999999986 6789999999999999999999999999999999888875321111
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
..+++++++||.+||..||++|+ |++|||+||||+.
T Consensus 222 ------------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 222 ------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp ------------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred ------------------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 24678899999999999999996 9999999999965
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=421.91 Aligned_cols=247 Identities=28% Similarity=0.410 Sum_probs=212.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC----CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|+++.||+.||||++++..... .....+.+|+.+|++|+|||||+++++|.+
T Consensus 21 G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---------------- 84 (293)
T d1jksa_ 21 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---------------- 84 (293)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------
Confidence 899999999999999999999998654222 234567899999999999999999999988
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC----CeEEecccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKLADFGL 153 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~----~vkL~DFG~ 153 (481)
.+.+|||||||++ +|.+++.+. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 6789999999986 666666543 4699999999999999999999999999999999999998776 499999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
|+.+.. ........+|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+.+..+.......
T Consensus 164 a~~~~~--~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~----- 235 (293)
T d1jksa_ 164 AHKIDF--GNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF----- 235 (293)
T ss_dssp CEECTT--SCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC-----
T ss_pred hhhcCC--CccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-----
Confidence 987643 233445678999999999986 678999999999999999999999999999999888886532111
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
....+..++.++++||++||+.||++|||++|||+||||+.
T Consensus 236 ---------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 236 ---------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred ---------------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 12344568899999999999999999999999999999964
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=423.55 Aligned_cols=276 Identities=40% Similarity=0.726 Sum_probs=228.8
Q ss_pred cceeEEEEEEEccC-CcEEEEEEeecCCcCCCcchhHHHHHHHHHhc---CCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKT-GEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~t-g~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+ ++.||||+++.....+.....+.+|+.+|+.| +|||||+++++|..... ..
T Consensus 18 G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~-----------~~ 86 (305)
T d1blxa_ 18 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT-----------DR 86 (305)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC-----------SS
T ss_pred ccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc-----------cc
Confidence 89999999999766 67799999987765555566788899988877 79999999999975221 12
Q ss_pred CCeEEEEEecCCCChhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDHDLTGLA-DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g~L~~~~-~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
...+||+||||+++++.+. ......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 5689999999998766544 445557999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
.. .......+||+.|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+..+++.++++..+.+....|+...
T Consensus 167 ~~--~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 167 SF--QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CG--GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred cc--cccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 42 334456788999999999987 679999999999999999999999999999999999999999988887777655
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..+........ ..........++++++|||.+||+.||++|||++|+|+||||+.
T Consensus 244 ~~~~~~~~~~~---~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 244 ALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp SSCGGGSCCCC---CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cchhhhhcccc---ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 54432221111 11223344578899999999999999999999999999999964
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-53 Score=427.74 Aligned_cols=241 Identities=25% Similarity=0.396 Sum_probs=209.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.||+.||||++++.. ........+++|+.+|+.|+|||||+++++|.+ ...
T Consensus 52 G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----------------~~~ 115 (350)
T d1rdqe_ 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----------------NSN 115 (350)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSE
T ss_pred CcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc----------------ccc
Confidence 899999999999999999999997653 233445678899999999999999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|+||||+.+ +|...+.+ ...+++.+++.|+.||+.||.|||+++||||||||+||||+.++++||+|||+|+.+..
T Consensus 116 ~~~v~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred cccccccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 9999999987 45555443 34699999999999999999999999999999999999999999999999999987642
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.....+||+.|||||++.+ ..++.++||||||||+|||++|+.||.+.+...++.+|.......+
T Consensus 194 ---~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----------- 258 (350)
T d1rdqe_ 194 ---RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----------- 258 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------
T ss_pred ---ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC-----------
Confidence 2345688999999999987 6789999999999999999999999999999998888875422111
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
..+++++.+||++||..||++|+ |++|||+||||..
T Consensus 259 -------------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 259 -------------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp -------------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred -------------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 24778999999999999999995 9999999999954
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-53 Score=410.64 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=212.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCC-------cchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEG-------FPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~-------~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||+||+|+++.+++.||||++++...... ....+.+|+.++++|+ |||||+++++|.+
T Consensus 14 G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~------------ 81 (277)
T d1phka_ 14 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET------------ 81 (277)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC------------
T ss_pred CcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc------------
Confidence 8999999999999999999999987643322 2235778999999997 9999999999998
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccc
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 153 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 153 (481)
++.+|||||||++ +|.+++... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 82 ----~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 ----NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ----CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 7799999999985 777777653 4699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcC-----CCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLG-----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 228 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~ 228 (481)
|+.+.. .......+||..|+|||++.+ ...++.++||||||||||+|++|+.||.+.+..+.+..+.+.....
T Consensus 157 a~~~~~--~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 157 SCQLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp CEECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred eeEccC--CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 987653 233455688999999999863 2457889999999999999999999999999999888887643222
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 229 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
... .+..+|+++++||.+||+.||++|||++|||+|+||+.
T Consensus 235 ~~~--------------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 235 GSP--------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CTT--------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCc--------------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 111 12358889999999999999999999999999999953
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=425.11 Aligned_cols=246 Identities=21% Similarity=0.376 Sum_probs=214.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.|++.||||+++..... ...+.+|+++|++++|||||+++++|.+ .+.+
T Consensus 16 G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~----------------~~~~ 76 (321)
T d1tkia_ 16 GEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFES----------------MEEL 76 (321)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEE----------------TTEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEE----------------CCEE
Confidence 89999999999999999999999865322 3457799999999999999999999988 6789
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC--CCeEEecccccccccC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE--GNLKLADFGLARSFSY 159 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~--~~vkL~DFG~a~~~~~ 159 (481)
|||||||++ +|.+++.+....+++.+++.|+.||+.||+|||+++|+||||||+||||+.+ ..+||+|||+++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999986 7888777766679999999999999999999999999999999999999854 4799999999987642
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.......++|+.|+|||++.+ ..|+.++||||||||+|+|++|+.||.+.+..+++.+|.+.....+
T Consensus 157 --~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---------- 223 (321)
T d1tkia_ 157 --GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD---------- 223 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----------
T ss_pred --CCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence 233445678999999999876 6789999999999999999999999999999999999876432221
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
...+..+++++++||.+||..||++|+|++|+|+||||+..
T Consensus 224 ----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 224 ----------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 23445688999999999999999999999999999999653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-54 Score=428.38 Aligned_cols=278 Identities=35% Similarity=0.560 Sum_probs=221.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.|++.||||+++.....+.....+++|+.+|++|+|+|||+++++|...... ....++
T Consensus 29 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~----------~~~~~~ 98 (346)
T d1cm8a_ 29 GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL----------DDFTDF 98 (346)
T ss_dssp ----CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST----------TTCCCC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc----------cccceE
Confidence 8999999999999999999999987655555566788999999999999999999999874321 124578
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|||||||+.+|..+... ..|++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 99 ~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~--- 173 (346)
T d1cm8a_ 99 YLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--- 173 (346)
T ss_dssp EEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---
T ss_pred EEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC---
Confidence 99999997777766654 3599999999999999999999999999999999999999999999999999987642
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
..+..++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+....+.+....|.........
T Consensus 174 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 174 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred -ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 3455688999999999987667899999999999999999999999999999999999888777655443322210000
Q ss_pred cc-CCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 243 NH-FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 243 ~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.. ..............+..++++++|||++||..||++|||++|||+||||+.-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00 0000000112223345678999999999999999999999999999999753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-53 Score=421.82 Aligned_cols=274 Identities=31% Similarity=0.521 Sum_probs=217.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++.+... ..+|+.+|++|+|+|||+++++|..... .....++
T Consensus 31 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~----------~~~~~~~ 94 (350)
T d1q5ka_ 31 GSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGE----------KKDEVYL 94 (350)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC------------CCSCCEE
T ss_pred CcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCc----------cCCceEE
Confidence 79999999999999999999999765322 2379999999999999999999976321 1225578
Q ss_pred EEEEecCCCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CeEEeccccccccc
Q 011627 83 YMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFS 158 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~ 158 (481)
|||||||++++...+. .....+++.+++.|++||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999999987655443 3555799999999999999999999999999999999999999775 89999999998764
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .....+.++|..|+|||++.+...++.++||||||||+|||++|+.||...+..+.+.++++..+.+....|.....
T Consensus 175 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 R--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp T--TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred C--CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 3 23345568899999999988767899999999999999999999999999999999999998887765544433221
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
......+.. .............+++++++||.+||..||++|+|+.|+|+||||..
T Consensus 253 ~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 253 NYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp ---CCCCCC-CCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred chhhccccc-cccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 100000000 00000111223457889999999999999999999999999999964
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=407.41 Aligned_cols=275 Identities=42% Similarity=0.772 Sum_probs=234.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++.....+....++.+|+.+|+.++|+|||++++++.+ ...+
T Consensus 13 G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----------------~~~~ 76 (292)
T d1unla_ 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----------------DKKL 76 (292)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEE
T ss_pred CcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc----------------ccce
Confidence 899999999999999999999998877666667788999999999999999999999988 6789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
+||+|++.++++..+......+++.+++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+|+......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 9999999987777776777789999999999999999999999999999999999999999999999999998765332
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 241 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (481)
.......++..|+|||++.....++.++||||||||+|||++|+.| |.+.+..+.+.++....+.+....|+.......
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 2333446688999999998766689999999999999999998876 677788888999999999888888877766554
Q ss_pred cccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 242 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+....... ...........++.+++|||++||+.||++|+||+|||+||||..
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 236 YKPYPMYP-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCC-TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccc-ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 43322211 122333444578899999999999999999999999999999953
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=415.34 Aligned_cols=244 Identities=26% Similarity=0.443 Sum_probs=208.1
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCC-cCCCcchhHHHHHHHHH-hcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILK-KLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~-~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|+++.|++.||||++++.. ........+++|+.++. .++|||||++++++.+ .+
T Consensus 13 G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~----------------~~ 76 (320)
T d1xjda_ 13 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----------------KE 76 (320)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----------------SS
T ss_pred CCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc----------------CC
Confidence 899999999999999999999998653 22334556677777765 6899999999999998 67
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|||||||++ +|..++. ....+++.+++.++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+....
T Consensus 77 ~~yivmEy~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred ceeEEEeecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 89999999996 5655554 445799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 160 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 160 ~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
. ....+..+||+.|+|||++.+ ..|+.++||||||||+|+|++|+.||.+.+..+++.++.......
T Consensus 156 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----------- 222 (320)
T d1xjda_ 156 G-DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----------- 222 (320)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----------
T ss_pred c-cccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2 334455688999999999987 678999999999999999999999999999999888886421110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK-DALDSEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~-eiL~h~~f~~ 295 (481)
.+.+++++++||++||..||++|+|+. |+++||||+.
T Consensus 223 -------------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 223 -------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp -------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred -------------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 124788999999999999999999996 8999999964
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-52 Score=421.88 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=199.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCc-CCCcchhHHH---HHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNE-KEGFPITAIR---EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~-~~~~~~~~~~---Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|+++.||+.||||+++.... .......+.+ |+.+++.++|||||+++++|.+
T Consensus 15 G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~---------------- 78 (364)
T d1omwa3 15 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---------------- 78 (364)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----------------
T ss_pred CCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----------------
Confidence 8999999999999999999999975421 1112223334 4667777789999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
.+.+|||||||.+ +|.+++.+ ...+++.+++.|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.+
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred CCEEEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 6789999999995 66666554 346899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 158 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 158 ~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
.. ......+||+.|+|||++.....|+.++||||||||||||++|+.||...+..+....+.... .....
T Consensus 158 ~~---~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~~~------ 227 (364)
T d1omwa3 158 SK---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAVE------ 227 (364)
T ss_dssp SS---SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-SCCCC------
T ss_pred CC---CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCC------
Confidence 53 234456899999999999765678999999999999999999999998765443332222111 11111
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 295 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s-----a~eiL~h~~f~~ 295 (481)
+...+++++++||.+||+.||++|+| ++|||+||||+.
T Consensus 228 --------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 228 --------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp --------------------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred --------------------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 11247889999999999999999999 799999999964
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=416.03 Aligned_cols=280 Identities=36% Similarity=0.592 Sum_probs=220.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.|++.||||+++.... ......+++|+.+|++|+|+||+++++++.... ......+
T Consensus 19 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~-----------~~~~~~~ 86 (345)
T d1pmea_ 19 GAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPT-----------IEQMKDV 86 (345)
T ss_dssp --CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS-----------TTTCCCE
T ss_pred ccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc-----------ccccceE
Confidence 8999999999999999999999976542 234557889999999999999999999997632 2224567
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC-
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH- 161 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 161 (481)
||+|++++++|.+++... .+++.+++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+......
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 888888888999888653 59999999999999999999999999999999999999999999999999998664322
Q ss_pred -CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 -NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 -~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
.......++|+.|+|||++.....++.++||||+|||+|+|++|+.||.+.+..+....+......+............
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 2234556789999999998766778999999999999999999999999999988888887766555432211111100
Q ss_pred ccc-cCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 241 AYN-HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 241 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
... ...............+..++.++++||.+||+.||++|||++|||+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000 00000011122344566789999999999999999999999999999999754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=414.46 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=200.6
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.|++.||||+++. ...+.+|+.++.++ +|||||+++++|.+.. ..+.+
T Consensus 23 G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~------------~~~~~ 83 (335)
T d2ozaa1 23 GINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY------------AGRKC 83 (335)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE------------TTEEE
T ss_pred ccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc------------cCCCE
Confidence 8999999999999999999999863 23677999997655 8999999999997521 11467
Q ss_pred EEEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCeEEeccccccc
Q 011627 82 TYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~ 156 (481)
+|||||||++ +|.+++.+. ...|++.+++.|+.||+.||+|||+++|+||||||+|||++. .+.+||+|||+|+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 9999999985 888887654 356999999999999999999999999999999999999986 45699999999987
Q ss_pred ccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 157 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 157 ~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
... .......+||+.|+|||++.+ ..|+.++||||||||||+|++|+.||.+.+..+....+.........
T Consensus 164 ~~~--~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~------ 234 (335)
T d2ozaa1 164 TTS--HNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------ 234 (335)
T ss_dssp CCC--CCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS------
T ss_pred ccC--CCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC------
Confidence 653 334455789999999999876 67899999999999999999999999887766655544332111000
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.+ ....+..+++++++||++||+.||++|+|+.|||+||||...
T Consensus 235 -~~---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 235 -EF---------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -SC---------------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred -CC---------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 00 011234689999999999999999999999999999999643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=402.48 Aligned_cols=237 Identities=24% Similarity=0.329 Sum_probs=196.0
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC----CcchhHHHHHHHHHhcC--CCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQ--HENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~L~--hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|+++.|++.||||+++...... .....+.+|+.+|++++ |||||+++++|.+
T Consensus 15 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-------------- 80 (273)
T d1xwsa_ 15 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-------------- 80 (273)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--------------
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--------------
Confidence 899999999999999999999998653221 12234668999999997 8999999999987
Q ss_pred CcCCeEEEEEecCCC--ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCeEEecccc
Q 011627 77 KYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGL 153 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g--~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~ 153 (481)
.+.+||||||+.+ ++.+++.+ ...+++.+++.++.||+.||+|||+++|+||||||+||||+.+ +.+||+|||+
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred --CCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 6789999999975 44444443 3469999999999999999999999999999999999999854 6899999999
Q ss_pred cccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 154 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 154 a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
|+... ....++.+||+.|+|||++.+...++.++||||||||+|||++|+.||...+ .+......
T Consensus 158 a~~~~---~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~------ 222 (273)
T d1xwsa_ 158 GALLK---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF------ 222 (273)
T ss_dssp CEECC---SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC------
T ss_pred ceecc---cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccC------
Confidence 98654 3344567899999999999875556788999999999999999999997632 12221000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
+...+++++++||++||+.||++|||++|||+||||+.
T Consensus 223 ------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 223 ------------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp ------------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred ------------------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 01247889999999999999999999999999999964
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=416.66 Aligned_cols=278 Identities=30% Similarity=0.490 Sum_probs=214.2
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+|+.||+.||||+++...........+.+|+.+|++++|||||+++++|...... +...++
T Consensus 28 G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~----------~~~~~~ 97 (355)
T d2b1pa1 28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----------EEFQDV 97 (355)
T ss_dssp C--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST----------TTCCEE
T ss_pred CcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc----------ccCcee
Confidence 8999999999999999999999987655444556788999999999999999999999864321 225789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
|||||||.++++..+.. .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 98 ~iv~Ey~~~~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~--~ 172 (355)
T d2b1pa1 98 YLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 172 (355)
T ss_dssp EEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEEeccchHHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc--c
Confidence 99999999998887753 589999999999999999999999999999999999999999999999999886643 3
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC---
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM--- 239 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--- 239 (481)
......++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+.+++.....+....|......
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp --------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 34455678999999999987 67899999999999999999999999999999999999887766554444322210
Q ss_pred -----CccccCCCc----hhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 240 -----PAYNHFKPS----RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 240 -----~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
......... .............++.+++|||++||..||++||||+|||+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 000000000 000011122334578899999999999999999999999999999753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=411.99 Aligned_cols=278 Identities=36% Similarity=0.577 Sum_probs=217.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++...........+.+|+.+|++|+|+|||+++++|...... +....+
T Consensus 29 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~----------~~~~~~ 98 (348)
T d2gfsa1 29 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL----------EEFNDV 98 (348)
T ss_dssp GTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST----------TTCCCC
T ss_pred CCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc----------ccCceE
Confidence 8999999999999999999999987654444456788999999999999999999999764221 113456
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCCC
Q 011627 83 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 162 (481)
Q Consensus 83 ~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 162 (481)
||++++++++|.+++.. .++++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 99 ~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~---- 172 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 172 (348)
T ss_dssp EEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT----
T ss_pred EEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC----
Confidence 66666666788877754 369999999999999999999999999999999999999999999999999997653
Q ss_pred CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 011627 163 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 242 (481)
Q Consensus 163 ~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (481)
....+..+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+....+.+....+.........
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 33445678999999999887667899999999999999999999999999999999999887766544332221110000
Q ss_pred cc-CCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 011627 243 NH-FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 296 (481)
Q Consensus 243 ~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~~ 296 (481)
.. ..............+..++++++|||++||..||++|+|++|||+||||+.-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00 0000011122344556789999999999999999999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=396.14 Aligned_cols=244 Identities=18% Similarity=0.261 Sum_probs=197.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+. +..||||+++...........+.+|+.+|++|+|||||++++++.+ ..+
T Consensus 19 G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-----------------~~~ 78 (276)
T d1uwha_ 19 GSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-----------------PQL 78 (276)
T ss_dssp CSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----------------SSC
T ss_pred CCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-----------------cEE
Confidence 89999999975 3469999998776556566788899999999999999999998753 357
Q ss_pred EEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||+ ++|.+++......+++..+..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999 48888887776789999999999999999999999999999999999999999999999999998765332
Q ss_pred -CCccccccccccCCCchhhcCC--CCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 162 -NNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 162 -~~~~~~~~gt~~Y~aPEvl~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
........+|+.|||||++... ..|+.++||||||||||||+||+.||.+.+....+..+.......+.
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-------- 230 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-------- 230 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC--------
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc--------
Confidence 2344556789999999998642 35789999999999999999999999988776666555543221110
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...+...+++++.+||.+||..||++|||++||+++
T Consensus 231 ----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 ----------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ----------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011223578899999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.4e-51 Score=404.04 Aligned_cols=269 Identities=31% Similarity=0.492 Sum_probs=205.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++... ...+.+|+.+|++|+ |+||++++++|.... ...
T Consensus 46 G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~--------------~~~ 106 (328)
T d3bqca1 46 GKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPV--------------SRT 106 (328)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--------------TCS
T ss_pred CcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecC--------------CCc
Confidence 899999999999999999999987432 457789999999995 999999999998632 557
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CeEEecccccccccCC
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~ 160 (481)
+|+|||||.++.+..+. ..+++.+++.+++||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999975544433 3599999999999999999999999999999999999998765 5999999999876432
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-EAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
......++|+.|+|||++.+...++.++|||||||++|+|++|+.||.... ..+....+...++.+....|......
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred --CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 334556789999999999876678999999999999999999999987654 44555555554432211111000000
Q ss_pred ---CccccCC----CchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 011627 240 ---PAYNHFK----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 295 (481)
Q Consensus 240 ---~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h~~f~~ 295 (481)
..+.... ...............++++++|||++||..||++|+|++|||+||||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0000000 0000011111223457899999999999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=389.39 Aligned_cols=238 Identities=21% Similarity=0.330 Sum_probs=190.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++ +++.||||+++.... ....+.+|++++++|+|||||++++++.+ .+.+
T Consensus 16 G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----------------~~~~ 75 (263)
T d1sm2a_ 16 GQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLE----------------QAPI 75 (263)
T ss_dssp CSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSC
T ss_pred CCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceecc----------------CCce
Confidence 899999999985 567899999975432 24578899999999999999999999987 5578
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
|||||||.+ +|.+++......+++..+..|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+....
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999985 6777777776779999999999999999999999999999999999999999999999999998776544
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........+|..|+|||++.+ ..|+.++|||||||++|||+| |.+||...+..+.+..+........
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~----------- 223 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----------- 223 (263)
T ss_dssp ---------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC-----------
T ss_pred ceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC-----------
Confidence 444455678999999999986 678999999999999999999 6778888888777777755321111
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...+++++.+||.+||+.||++|||++|||+|
T Consensus 224 ------------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 224 ------------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01356789999999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-50 Score=394.83 Aligned_cols=238 Identities=20% Similarity=0.284 Sum_probs=197.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++.+++.||||+++.+.. ....+.+|+.+|++|+|||||++++++.+ .+.+
T Consensus 28 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~~ 88 (287)
T d1opja_ 28 GQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR----------------EPPF 88 (287)
T ss_dssp TTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSC
T ss_pred CCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEee----------------CCee
Confidence 8999999999999999999999975432 34578899999999999999999999987 5678
Q ss_pred EEEEecCCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||||||.+ +|..++.+ ....+++..+..|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999985 66666653 4456999999999999999999999999999999999999999999999999999877654
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........+|+.|+|||++.+ ..|+.++|||||||++|||+++..| |...+..+....+... ..+.
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~~---------- 236 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME---------- 236 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCC----------
T ss_pred CceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCCC----------
Confidence 4444455567999999999986 6789999999999999999996655 5555554444443221 1100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....+++++++||.+||+.||++|||++||++
T Consensus 237 ------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 237 ------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11247789999999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.9e-51 Score=396.46 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=196.8
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++..... ......+.+|+.++++++|||||++++++..... ....
T Consensus 18 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~------------~~~~ 85 (277)
T d1o6ya_ 18 GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP------------AGPL 85 (277)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS------------SSEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC------------CCce
Confidence 89999999999999999999999876433 2334567899999999999999999999986321 1346
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 82 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 82 ~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
+|||||||++ +|...+. ....+++.+++.|+.||+.||+|||++||+||||||+||||+.++.++|+|||++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 8999999997 4554444 3457999999999999999999999999999999999999999999999999998765432
Q ss_pred C--CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 011627 161 H--NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 238 (481)
Q Consensus 161 ~--~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (481)
. .......+||+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+.++......+...
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------- 236 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA------- 236 (277)
T ss_dssp --------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG-------
T ss_pred cccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch-------
Confidence 2 234455688999999999986 678999999999999999999999999999988888887543222111
Q ss_pred CCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-CHHHHhcCCCC
Q 011627 239 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-SAKDALDSEYF 293 (481)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-sa~eiL~h~~f 293 (481)
....+++++.+||.+||+.||++|| |++++ .|+|.
T Consensus 237 -------------------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 237 -------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp -------------------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred -------------------hccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence 1135788999999999999999999 55554 44443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=383.02 Aligned_cols=238 Identities=22% Similarity=0.324 Sum_probs=205.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++ .+++.||||+++.... ....+++|+.++++++|||||++++++.+ ++.+
T Consensus 15 G~fg~Vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~----------------~~~~ 74 (258)
T d1k2pa_ 15 GQFGVVKYGKW-RGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTK----------------QRPI 74 (258)
T ss_dssp ETTEEEEEEEE-TTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECC----------------SSSE
T ss_pred CCCeEEEEEEE-CCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEee----------------CCce
Confidence 89999999998 4788999999986543 24578999999999999999999999987 6689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCCC
Q 011627 83 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 161 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 161 (481)
+|||||+++ +|..++......+++..+..|+.||+.||+|||+++|+||||||+||||++++.+||+|||+|+.+....
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999985 6677766666679999999999999999999999999999999999999999999999999998776555
Q ss_pred CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 011627 162 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 240 (481)
Q Consensus 162 ~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (481)
........+|..|+|||++.+ ..++.++|||||||++|||+| |+.||...+..++..++.+.......
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---------- 223 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---------- 223 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC----------
T ss_pred ceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----------
Confidence 555556678999999999986 678999999999999999998 89999999999888888653211111
Q ss_pred ccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 241 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
..++.++.+||.+||+.||++|||+++||+|
T Consensus 224 -------------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 224 -------------------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------ccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1356789999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-51 Score=393.51 Aligned_cols=238 Identities=18% Similarity=0.255 Sum_probs=193.5
Q ss_pred cceeEEEEEEEc--cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREI--KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~--~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|.+. .+++.||||+++...........+++|+++|++|+|||||++++++.+ +
T Consensus 18 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----------------~ 80 (277)
T d1xbba_ 18 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----------------E 80 (277)
T ss_dssp CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----------------S
T ss_pred CCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----------------C
Confidence 899999999864 456889999997665544455678899999999999999999999864 3
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|||||||++ +|.+++.+ ...+++.++..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 81 ~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 81 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CEEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 57899999986 66665554 44699999999999999999999999999999999999999999999999999987653
Q ss_pred CCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 160 DHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 160 ~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
.... ......+|+.|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..++...+.+.....
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~-------- 230 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-------- 230 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--------
T ss_pred cccccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 3222 2233467999999999986 578999999999999999998 899999998887777665321100
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHh
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL 288 (481)
....+++++.+||.+||+.||++|||+++|+
T Consensus 231 ---------------------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 231 ---------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVE 261 (277)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ---------------------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 0124678899999999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-50 Score=391.50 Aligned_cols=241 Identities=21% Similarity=0.331 Sum_probs=189.5
Q ss_pred cceeEEEEEEEccCCc---EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|+++.+++ .||||++...... .....+++|+.+|++|+|||||++++++.+ .
T Consensus 37 G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----------------~ 99 (299)
T d1jpaa_ 37 GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTK----------------S 99 (299)
T ss_dssp CSSSEEEEEEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS----------------S
T ss_pred CCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCCCCCCccEEEEEee----------------C
Confidence 8999999999987775 5888888654332 234578899999999999999999999977 5
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.+|||||||++ +|.+++......+++.++..|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 678999999986 6666677666679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC----ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 011627 159 YDHNN----TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIW 233 (481)
Q Consensus 159 ~~~~~----~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (481)
..... ......+|+.|||||++.. ..++.++||||||||+|||+| |+.||.+.+..+++..+......+.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 254 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP---- 254 (299)
T ss_dssp ----------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----
T ss_pred CCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 33221 1222456899999999986 678999999999999999998 8999999998888877754321111
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 234 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...++.++.+||.+||+.||++|||+.||+++
T Consensus 255 -------------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 -------------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12367789999999999999999999999853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=395.16 Aligned_cols=242 Identities=23% Similarity=0.362 Sum_probs=198.5
Q ss_pred cceeEEEEEEEccCCc-----EEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGE-----IVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++..+++ .||||++...... .....+.+|+.+|+++ +|||||++++++.+
T Consensus 48 G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-------------- 112 (325)
T d1rjba_ 48 GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVNLLGACTL-------------- 112 (325)
T ss_dssp CSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--------------
T ss_pred CCCeEEEEEEEcCCCcccceeEEEEEEeccccCH-HHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--------------
Confidence 8999999999977654 6999998755332 2455788999999998 89999999999987
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPG----------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 133 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~----------------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDL 133 (481)
.+.+|||||||++ +|.+++.... ..+++.+++.|+.||+.||+|||+++||||||
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred --CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 5678999999985 7777775543 24889999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEecccccccccCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCC
Q 011627 134 KGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 211 (481)
Q Consensus 134 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~ 211 (481)
||+|||++.++++||+|||+|+........ ......+|+.|||||++.+ ..++.++||||||||||||++ |+.||.+
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876543332 2344567999999999986 678999999999999999997 8999998
Q ss_pred CChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 212 KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+..+.+.+++.....++. ...+++++++||.+||+.||++|||++||++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~----------------------------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMDQ----------------------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCCSHHHHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCC----------------------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8877777776653221110 12467889999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=386.46 Aligned_cols=238 Identities=19% Similarity=0.235 Sum_probs=198.3
Q ss_pred cceeEEEEEEEcc--CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIK--TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~--tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++.. ++..||||+++..... .....+++|+++|++|+|||||++++++.+ +
T Consensus 20 G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----------------~ 81 (285)
T d1u59a_ 20 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----------------E 81 (285)
T ss_dssp CTTEEEEEEEEC---CCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----------------S
T ss_pred ccCeEEEEEEEecCCCcEEEEEEEEChhcCH-HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----------------C
Confidence 8999999998764 4457999999765432 235678899999999999999999999864 3
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccC
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 159 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 159 (481)
.+|||||||++ +|.+++......+++.++..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 57999999996 77777776667899999999999999999999999999999999999999999999999999987654
Q ss_pred CCC--CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 011627 160 DHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 236 (481)
Q Consensus 160 ~~~--~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (481)
... .......+|+.|+|||++.. ..++.++|||||||++|||+| |+.||...+..+++..+.+.....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 232 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME-------- 232 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC--------
T ss_pred cccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 322 22334467899999999976 578999999999999999998 999999988888777775421110
Q ss_pred CCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHh
Q 011627 237 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288 (481)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL 288 (481)
..+.+++++.+||.+||+.||++|||+.+|+
T Consensus 233 ---------------------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~ 263 (285)
T d1u59a_ 233 ---------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVE 263 (285)
T ss_dssp ---------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred ---------------------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 1124778999999999999999999999885
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=387.05 Aligned_cols=241 Identities=22% Similarity=0.392 Sum_probs=198.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|+++ +++.||||+++.... ....+.+|+.++++|+|||||++++++.+ +.+
T Consensus 24 G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----------------~~~ 82 (272)
T d1qpca_ 24 GQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----------------EPI 82 (272)
T ss_dssp ETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSC
T ss_pred CCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-----------------CCe
Confidence 899999999975 678899999975432 24578999999999999999999998753 356
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||||||.+ +|.+++... ...+++.++..|+.||+.||+|||+++|+||||||+||||++++.+||+|||+|+.+...
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 999999986 555544432 235899999999999999999999999999999999999999999999999999887644
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........+|+.|+|||++.. ..++.++||||||||+|||+| |.++|...+..+.+..+........
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---------- 231 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---------- 231 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----------
T ss_pred ccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC----------
Confidence 4444455678999999999986 578999999999999999999 5667777777777777654211110
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD--SEYFW 294 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~--h~~f~ 294 (481)
...+++++.+||.+||+.||++|||++||++ ++||+
T Consensus 232 -------------------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 -------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------------cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1246778999999999999999999999988 77774
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=392.96 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=204.6
Q ss_pred cceeEEEEEEE---ccCCcEEEEEEeecCC--cCCCcchhHHHHHHHHHhcCC-CCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMARE---IKTGEIVALKKIRMDN--EKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~---~~tg~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~L~h-pnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++ +.+|+.||||++++.. ........+.+|+++|++|+| +||+++++++.+
T Consensus 35 G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-------------- 100 (322)
T d1vzoa_ 35 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-------------- 100 (322)
T ss_dssp TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--------------
T ss_pred CCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--------------
Confidence 89999999997 4579999999997553 222345567899999999977 799999999988
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
...+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+
T Consensus 101 --~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 101 --ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred --CCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence 6789999999996 56555544 3468899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccccCCCchhhcCCC-CCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 156 SFSYDHNNTLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 156 ~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
.+............+|+.|+|||++.... .++.++||||||||||+|++|+.||.+.+..+....+.+........
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~--- 254 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--- 254 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC---
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC---
Confidence 77655555566678899999999997633 47889999999999999999999998877665555554322111100
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 295 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----sa~eiL~h~~f~~ 295 (481)
+...+++++++||++||+.||++|+ |++|||+||||+.
T Consensus 255 -----------------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 255 -----------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred -----------------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 1135788999999999999999999 5899999999954
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=381.85 Aligned_cols=240 Identities=20% Similarity=0.319 Sum_probs=188.7
Q ss_pred cceeEEEEEEEccCC---cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTG---EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..++ ..||||+++.... ......+.+|+.+|++|+|||||++++++.+
T Consensus 18 G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----------------- 79 (273)
T d1mp8a_ 18 GQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVITE----------------- 79 (273)
T ss_dssp CSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----------------
T ss_pred CCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----------------
Confidence 899999999987654 4688888864432 2234568899999999999999999999853
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.+|||||||.+ ++..++......+++..++.++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+.+.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 367999999986 6666666666679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 011627 159 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 237 (481)
Q Consensus 159 ~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (481)
...........+|+.|+|||++.. ..++.++||||||||+|||++ |.+||...+..+++.++.+....+
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~--------- 229 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--------- 229 (273)
T ss_dssp -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---------
T ss_pred CCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 444444455567999999999986 678999999999999999998 899999999988888876432111
Q ss_pred CCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 238 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
+...+++++.+||.+||..||++|||++||+++
T Consensus 230 --------------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 230 --------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 112477899999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=375.05 Aligned_cols=240 Identities=20% Similarity=0.325 Sum_probs=187.8
Q ss_pred cceeEEEEEEEccCC----cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTG----EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..++ ..||||+++...... ....+++|+.+|++|+|||||++++++.+
T Consensus 18 G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~~~g~~~~---------------- 80 (283)
T d1mqba_ 18 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIRLEGVISK---------------- 80 (283)
T ss_dssp CSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEECS----------------
T ss_pred CCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-HHHHHHHHHHHHHhcCCCCEeeeeEEEec----------------
Confidence 899999999987665 479999997554322 34467899999999999999999999987
Q ss_pred CCeEEEEEecCCCC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g~-L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
.+.+++|||||.++ +...+......+++.++..++.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 56789999999874 55556556667999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 158 SYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 158 ~~~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
...... ......+|+.|+|||++.+ ..++.++||||||||+|||+++ .++|...+..+++..+......+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~----- 234 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT----- 234 (283)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-----
T ss_pred cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC-----
Confidence 433221 2233467899999999986 6789999999999999999995 556666666666666543211110
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
...++.++.+||.+||+.||++|||+.||++
T Consensus 235 ------------------------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 235 ------------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1236778999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=376.61 Aligned_cols=242 Identities=25% Similarity=0.410 Sum_probs=192.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++..+ +.||||+++.... ....+.+|+.++++++|+|||++++++.+ +.+
T Consensus 28 G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-----------------~~~ 86 (285)
T d1fmka3 28 GCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----------------EPI 86 (285)
T ss_dssp CSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSC
T ss_pred CCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-----------------CCe
Confidence 89999999999765 5799999975533 24578899999999999999999999853 346
Q ss_pred EEEEecCCCC-hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDHD-LTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g~-L~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
|||||||.++ |..++.. ....+++.++..|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+...
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 8999999964 5555443 2346999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
.........+|+.|+|||++.. ..++.++||||||||||||++| .++|...+..+.+..+......+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~----------- 234 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----------- 234 (285)
T ss_dssp ---------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred CceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 4444555678999999999986 6789999999999999999995 56667777777777765432111
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD--SEYFWT 295 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~--h~~f~~ 295 (481)
....++.++++||.+||+.||++|||+++|++ ++||..
T Consensus 235 ------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 ------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11246788999999999999999999999988 889965
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=380.15 Aligned_cols=240 Identities=19% Similarity=0.274 Sum_probs=193.4
Q ss_pred cceeEEEEEEEccCCc----EEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+++ .||||+++.... ......+++|++++++|+|||||++++++.+
T Consensus 20 G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---------------- 82 (317)
T d1xkka_ 20 GAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLT---------------- 82 (317)
T ss_dssp CSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES----------------
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec----------------
Confidence 8999999999998887 578887764432 2345678999999999999999999999985
Q ss_pred CCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~-g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
. ..+++|||+. ++|.+.+......+++..+..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+.+
T Consensus 83 ~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 83 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred C-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 2 4567777776 5788888777778999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC-ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 011627 158 SYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 235 (481)
Q Consensus 158 ~~~~~~-~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (481)
...... ......+|+.|+|||++.+ ..++.++|||||||+||||+| |.+||.+.+..++...+......+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~------ 234 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------ 234 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC------
T ss_pred ccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 543322 2233467999999999987 578999999999999999998 8999998887777666654221110
Q ss_pred CCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 236 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
...++.++.+||.+||..||++|||+.||++|
T Consensus 235 -----------------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 235 -----------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp -----------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 12467789999999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=370.02 Aligned_cols=241 Identities=22% Similarity=0.293 Sum_probs=190.3
Q ss_pred cceeEEEEEEEccC-C--cEEEEEEeecCCcC-CCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCc
Q 011627 3 VCISQVFMAREIKT-G--EIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 78 (481)
Q Consensus 3 G~fg~Vy~a~~~~t-g--~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 78 (481)
|+||+||+|++..+ + ..||||+++..... ....+.+.+|+.+|++|+|||||++++++.+
T Consensus 19 G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---------------- 82 (273)
T d1u46a_ 19 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---------------- 82 (273)
T ss_dssp ---CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------
T ss_pred CCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----------------
Confidence 89999999986533 3 36899999766433 3334678899999999999999999999964
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccc
Q 011627 79 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 157 (481)
Q Consensus 79 ~~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 157 (481)
..++||||||++ ++.+.+......+++..+..++.||+.||+|||+++|+||||||+||||+.++++||+|||+++.+
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 246899999985 666666665567999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC--ccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 011627 158 SYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 158 ~~~~~~--~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
...... ......+|..|+|||++.+ ..++.++||||||||+|||+| |+.||.+.+..+.+.++.+....++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~----- 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP----- 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-----
T ss_pred ccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC-----
Confidence 543222 2223456889999999987 678999999999999999998 8999999999999888865322211
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
....++.++.+||.+||..||++|||+.||++
T Consensus 236 -----------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 -----------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01246778999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=368.85 Aligned_cols=240 Identities=21% Similarity=0.320 Sum_probs=197.5
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|+++ .+++.||||+++..... .....+.+|+.+|++|+|+||+++++++.+
T Consensus 24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~--------------- 87 (301)
T d1lufa_ 24 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDNPNIVKLLGVCAV--------------- 87 (301)
T ss_dssp CSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECS---------------
T ss_pred CCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-HHHHHHHHHHHHHHhcCCCCcccceeeecc---------------
Confidence 899999999975 46689999999765432 235678899999999999999999999987
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADRPG-----------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 133 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~~~-----------------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDL 133 (481)
.+.+++||||+.+ +|.+++.... ..+++.++..|+.||+.||+|||+++||||||
T Consensus 88 -~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 88 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred -CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 5678999999985 6776664321 24889999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEecccccccccCCC-CCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCC-CCCCC
Q 011627 134 KGSNLLIDNEGNLKLADFGLARSFSYDH-NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPG 211 (481)
Q Consensus 134 Kp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~-~pf~~ 211 (481)
||+||||+.++++||+|||+|+.+.... ....++..+|+.|+|||++.+ ..|+.++||||||||+|||+++. +||..
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 9999999999999999999998664332 223344577899999999986 67899999999999999999985 78999
Q ss_pred CChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 212 KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.+..+.+..+.+..... ....+++++.+||.+||+.||++|||+.||++
T Consensus 246 ~~~~e~~~~v~~~~~~~-----------------------------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNILA-----------------------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp SCHHHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCCC-----------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99988888775432110 11246778999999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=368.72 Aligned_cols=243 Identities=22% Similarity=0.351 Sum_probs=186.2
Q ss_pred cceeEEEEEEEcc-----CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIK-----TGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~~-----tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++.. +++.||||+++...... ....+++|+.++.++ +|+|||.+++++.+.
T Consensus 24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~------------- 89 (299)
T d1ywna1 24 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKP------------- 89 (299)
T ss_dssp CSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECST-------------
T ss_pred cCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-HHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-------------
Confidence 8999999999754 45789999997553322 244667888888877 688999999988652
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 140 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl 140 (481)
...++||||||++ +|.+++... ...+++.++..|+.||+.||+|||+++||||||||+||||
T Consensus 90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 4468999999985 676666432 2348999999999999999999999999999999999999
Q ss_pred cCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhC-CCCCCCCChHHHH
Q 011627 141 DNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQL 218 (481)
Q Consensus 141 ~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~ 218 (481)
+.++++||+|||+|+....... .......||+.|+|||++.+ ..++.++||||||||+|||+++ .+||...+..+.+
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987654332 23345678999999999987 6789999999999999999986 5688887766655
Q ss_pred HHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 219 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
.+++.....+. ....+++++++||.+||+.||++|||++||++|
T Consensus 247 ~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCC----------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55544321111 012467789999999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-46 Score=363.12 Aligned_cols=248 Identities=19% Similarity=0.237 Sum_probs=195.3
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEE-eCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIV-TSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~-~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|++..+++.||||++...... ..+.+|++++++++|+|+|.++..+ .+ ...
T Consensus 18 G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~----------------~~~ 77 (299)
T d1ckia_ 18 GSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE----------------GDY 77 (299)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE----------------TTE
T ss_pred CCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec----------------CCE
Confidence 89999999999999999999998865433 3578999999999887766655444 44 668
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCeEEeccccccccc
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFS 158 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~ 158 (481)
.+||||||++++...+......+++..+..++.||+.||+|||+++||||||||+|||++. +..+||+|||+|+.+.
T Consensus 78 ~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 78 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 8999999999998888877778999999999999999999999999999999999999864 4469999999998775
Q ss_pred CCCC------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 011627 159 YDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 232 (481)
Q Consensus 159 ~~~~------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (481)
.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~------ 230 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE------ 230 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH------
T ss_pred ccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc------
Confidence 4322 22345678999999999987 6789999999999999999999999987766554443322100
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHH---hcCCCC
Q 011627 233 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA---LDSEYF 293 (481)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~ei---L~h~~f 293 (481)
.............+++++.+||.+||..||++||++++| |+|.|.
T Consensus 231 ----------------~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 231 ----------------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----------------HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----------------ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 000111233445788999999999999999999998755 555544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=362.32 Aligned_cols=233 Identities=21% Similarity=0.336 Sum_probs=186.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeE
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 82 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (481)
|+||+||+|++ +++.||||+++.+. ..+.+.+|++++++|+|||||++++++.+. ++.+
T Consensus 18 G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---------------~~~~ 76 (262)
T d1byga_ 18 GEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---------------KGGL 76 (262)
T ss_dssp CSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC-----------------CC
T ss_pred CCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec---------------CCcE
Confidence 89999999998 57899999997543 345788999999999999999999998652 4467
Q ss_pred EEEEecCCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEecccccccccCC
Q 011627 83 YMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 160 (481)
Q Consensus 83 ~iV~Ey~~g-~L~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 160 (481)
||||||+.+ +|.+++... ...+++..+..|+.||+.||+|||+++|+||||||+|||++.++++||+|||+++....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence 999999985 677766543 23489999999999999999999999999999999999999999999999999986542
Q ss_pred CCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 011627 161 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 239 (481)
Q Consensus 161 ~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (481)
......+|..|+|||++.+ ..++.++||||||||+|||+| |++||...+..+.+..+.+.....
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~----------- 220 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD----------- 220 (262)
T ss_dssp ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC-----------
T ss_pred ---CCccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2233466899999999986 578999999999999999998 789999888887777764311100
Q ss_pred CccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 240 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
+...+++++++||++||..||++|||+.||+++
T Consensus 221 ------------------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 221 ------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 112467789999999999999999999999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=364.17 Aligned_cols=240 Identities=25% Similarity=0.388 Sum_probs=193.9
Q ss_pred cceeEEEEEEEccCCc-------EEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGE-------IVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~-------~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|+||+||+|++..+++ .||||+++.+.... ....+.+|+.+++++ +|||||++++++.+
T Consensus 24 G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~------------ 90 (299)
T d1fgka_ 24 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGACTQ------------ 90 (299)
T ss_dssp ----CEEEEEEECC----CCCEEEEEEECCCTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS------------
T ss_pred cCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH-HHHHHHHHHHHHHHhcCCCeEEeccccccc------------
Confidence 8999999999876653 79999998654332 345778899999888 79999999999987
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 75 GNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g-~L~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
++.+|+|||||++ +|.+++.... ..+++.++..+++||+.||+|||+++||||||||+||
T Consensus 91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 5678999999985 6666664332 3589999999999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 216 (481)
|++.++.+||+|||+++....... .......+|+.|+|||++.+ ..|+.++||||||||+|||++ |.+||.+.+..+
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 999999999999999987754332 23344567999999999986 689999999999999999998 799999888877
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
++..+..... +. ....+++++++||.+||+.||++|||+.|||+
T Consensus 246 ~~~~i~~~~~-~~----------------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 246 LFKLLKEGHR-MD----------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHTTCC-CC----------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCC-CC----------------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 7666543211 10 01246778999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=363.29 Aligned_cols=242 Identities=21% Similarity=0.259 Sum_probs=191.0
Q ss_pred cceeEEEEEEEccCC---cEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTG---EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|++..++ ..||||+++.... ......+.+|+++|++|+|||||++++++.+. +
T Consensus 38 G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---------------~ 101 (311)
T d1r0pa_ 38 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---------------E 101 (311)
T ss_dssp ETTEEEEEEEECC----CEEEEEEEECCCCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET---------------T
T ss_pred cCCeEEEEEEEECCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec---------------C
Confidence 899999999987654 3689999975432 23456788999999999999999999997652 4
Q ss_pred CeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeEEeccccccccc
Q 011627 80 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 158 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 158 (481)
+.++||||||++ +|.+++......+++..+..++.||+.||.|||+++|+||||||+||||++++.+||+|||+++...
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 578999999996 5666666666678899999999999999999999999999999999999999999999999998765
Q ss_pred CCCC---CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCc
Q 011627 159 YDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFELCGSPDETIWP 234 (481)
Q Consensus 159 ~~~~---~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 234 (481)
.... .......+|..|+|||++.. ..++.++||||||||+|||+++..||... +..+....+.......
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~------ 254 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL------ 254 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC------
T ss_pred ccccccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 3322 22233467999999999886 67899999999999999999977666544 3334444443221110
Q ss_pred cCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 235 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
..+.+++++.+||.+||..||++|||+.||++|
T Consensus 255 -----------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 255 -----------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 012467789999999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=364.99 Aligned_cols=239 Identities=25% Similarity=0.317 Sum_probs=194.0
Q ss_pred cceeEEEEEEEccCCcE--EEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCCCcC
Q 011627 3 VCISQVFMAREIKTGEI--VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYR 79 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~--vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 79 (481)
|+||+||+|+++.++.. ||||+++..... +....+.+|+++|+++ +|||||++++++.+ .
T Consensus 21 G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----------------~ 83 (309)
T d1fvra_ 21 GNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEH----------------R 83 (309)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----------------T
T ss_pred CCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEec----------------C
Confidence 89999999999999875 667776544333 2345789999999999 79999999999987 6
Q ss_pred CeEEEEEecCCC-ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC
Q 011627 80 GSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 143 (481)
Q Consensus 80 ~~~~iV~Ey~~g-~L~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~ 143 (481)
+.+|||||||++ +|.+++.+. ...+++.++..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 789999999995 777766543 3569999999999999999999999999999999999999999
Q ss_pred CCeEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHH
Q 011627 144 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIF 222 (481)
Q Consensus 144 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~-~pf~~~~~~~~~~~i~ 222 (481)
+.+||+|||+|+...... ......+|..|+|||++.. ..++.++||||||||+|||++|. +||.+.+..+++..+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp GCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CceEEccccccccccccc--cccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999997654322 2233467999999999986 67899999999999999999965 6798888888777764
Q ss_pred HhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 011627 223 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 290 (481)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~h 290 (481)
+..... ....+++++++||.+||+.||++|||++||+++
T Consensus 241 ~~~~~~-----------------------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLE-----------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCC-----------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCC-----------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 321100 112467899999999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.5e-45 Score=355.83 Aligned_cols=240 Identities=19% Similarity=0.210 Sum_probs=198.5
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCC-CCccceeeEEeCCCCCCCCCCCCCCCCcCCe
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 81 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~h-pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (481)
|+||+||+|+++.+++.||||+++..... ..+.+|+++++.|.| +||+.+++++.+ ...
T Consensus 16 G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~----------------~~~ 75 (293)
T d1csna_ 16 GSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE----------------GLH 75 (293)
T ss_dssp CSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE----------------TTE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec----------------CCc
Confidence 89999999999999999999998765433 357789999999975 899999999987 678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-----CCCeEEeccccccc
Q 011627 82 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-----EGNLKLADFGLARS 156 (481)
Q Consensus 82 ~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~-----~~~vkL~DFG~a~~ 156 (481)
.|+|||||+++|.+++......+++..+..++.||+.||+|||++||+||||||+||||+. ++.+||+|||+|+.
T Consensus 76 ~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 76 NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred cEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999999999988877778999999999999999999999999999999999999974 56799999999987
Q ss_pred ccCCCC------CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCC
Q 011627 157 FSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---EQLSKIFELCGS 227 (481)
Q Consensus 157 ~~~~~~------~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~ 227 (481)
+..... ......+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+.. +.+.++....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-- 232 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-- 232 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH--
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc--
Confidence 653322 22345678999999999987 67899999999999999999999999865433 3333332210
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHh
Q 011627 228 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 288 (481)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL 288 (481)
......++.+.+++++.+||..|+..+|++||+.+.+.
T Consensus 233 -----------------------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 233 -----------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp -----------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred -----------------------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 01112344467889999999999999999999877664
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=361.42 Aligned_cols=241 Identities=23% Similarity=0.346 Sum_probs=198.3
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhc-CCCCccceeeEEeCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGN 76 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 76 (481)
|+||+||+|++. .+++.||||+++...... ....+++|+.++++| +|||||++++++.+
T Consensus 34 G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-------------- 98 (311)
T d1t46a_ 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-EREALMSELKVLSYLGNHMNIVNLLGACTI-------------- 98 (311)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS--------------
T ss_pred cCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH-HHHHHHHHHHHHHhccCCCCEEEEEEEEee--------------
Confidence 899999999863 567899999998654322 345678999999999 69999999999987
Q ss_pred CcCCeEEEEEecCCC-ChhhhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 011627 77 KYRGSTYMVFEYMDH-DLTGLADRP-----------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 138 (481)
Q Consensus 77 ~~~~~~~iV~Ey~~g-~L~~~~~~~-----------------~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NI 138 (481)
...+|||||||.+ +|..++.+. ...+++..+..|+.||+.||+|||+++|+||||||+||
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 5578999999986 666655432 22589999999999999999999999999999999999
Q ss_pred EEcCCCCeEEecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHh-CCCCCCCCChHH
Q 011627 139 LIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 216 (481)
Q Consensus 139 Ll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 216 (481)
||+.++.+||+|||+++....... ......++|+.|+|||++.. ..++.++|||||||++|||+| |.++|...+..+
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987654332 23344577999999999986 678999999999999999998 777788888777
Q ss_pred HHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 217 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
.+.++++....+.. ...++.++.+||.+||+.||++|||+++||+
T Consensus 256 ~~~~~i~~~~~~~~----------------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 256 KFYKMIKEGFRMLS----------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHTCCCCC----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCCC----------------------------cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77777653222111 1236778999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=361.35 Aligned_cols=240 Identities=18% Similarity=0.273 Sum_probs=197.6
Q ss_pred cceeEEEEEEEc-----cCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREI-----KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 3 G~fg~Vy~a~~~-----~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
|+||+||+|+++ .+++.||||+++..... .....+++|+.++++++|+|||++++++..
T Consensus 31 G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--------------- 94 (308)
T d1p4oa_ 31 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQ--------------- 94 (308)
T ss_dssp CSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEECS---------------
T ss_pred CCCeEEEEEEECCcccCCCCcEEEEEEECcccCh-HHHHHHHHHHHHHHHcCCCCEeeeeeEEec---------------
Confidence 899999999985 34678999999754322 234567899999999999999999999976
Q ss_pred cCCeEEEEEecCCC-ChhhhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCeE
Q 011627 78 YRGSTYMVFEYMDH-DLTGLADR---------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 147 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g-~L~~~~~~---------~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~vk 147 (481)
...++||||||.+ +|.+++.. ....+++..+..++.||+.||.|||+++|+||||||+||||+.++++|
T Consensus 95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 5678999999985 66655442 123478999999999999999999999999999999999999999999
Q ss_pred EecccccccccCCCC-CccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhc
Q 011627 148 LADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELC 225 (481)
Q Consensus 148 L~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~ 225 (481)
|+|||+|+.+..... .......+|+.|+|||++.+ ..++.++||||||||+|||+|+ .+||.+.+..+.+..+.+..
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 999999987653322 22333467999999999986 6788999999999999999998 58899999888888776422
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 226 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
... ....++.++.+||.+||+.||++|||+++|++
T Consensus 253 ~~~-----------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 253 LLD-----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 110 01246778999999999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-44 Score=360.15 Aligned_cols=271 Identities=26% Similarity=0.422 Sum_probs=198.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-----------CCCccceeeEEeCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-----------HENVIKLKEIVTSPGPERDEQG 71 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-----------hpnIv~l~~~~~~~~~~~~~~~ 71 (481)
|+||+||+|+++.+++.||||+++.+.. ....+.+|+.+++.++ |+||+++++++....
T Consensus 24 G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~------- 93 (362)
T d1q8ya_ 24 GHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG------- 93 (362)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE-------
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc-------
Confidence 8999999999999999999999985432 2346678999998886 478999999987522
Q ss_pred CCCCCCcCCeEEEEEecCCC--Ch-hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCC--
Q 011627 72 RPDGNKYRGSTYMVFEYMDH--DL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGN-- 145 (481)
Q Consensus 72 ~~~~~~~~~~~~iV~Ey~~g--~L-~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~giiHrDLKp~NILl~~~~~-- 145 (481)
....+++|+++.. +. ..........+++..++.+++||+.||+|||+ .||+||||||+||||+.++.
T Consensus 94 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 94 -------PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp -------TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred -------ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 3456677766653 22 22333455579999999999999999999998 89999999999999987654
Q ss_pred ----eEEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHHHHHHhCCCCCCCCC------hH
Q 011627 146 ----LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN------EA 215 (481)
Q Consensus 146 ----vkL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~------~~ 215 (481)
+||+|||.|..... .....++|+.|+|||++.. ..++.++|||||||++++|++|+.||...+ ..
T Consensus 167 ~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred ccceeeEeeccccccccc----ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 99999999986542 2344678999999999986 678999999999999999999999997543 34
Q ss_pred HHHHHHHHhcCCCCCCCCccCCC---------C-Ccccc--CCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCC
Q 011627 216 EQLSKIFELCGSPDETIWPGVSK---------M-PAYNH--FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 283 (481)
Q Consensus 216 ~~~~~i~~~~~~~~~~~~~~~~~---------~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~s 283 (481)
+.+.+++..++..+...+..... . ..... .................++++++|||.+||..||++|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 55666666666543322211100 0 00000 001111111111223467889999999999999999999
Q ss_pred HHHHhcCCCCCC
Q 011627 284 AKDALDSEYFWT 295 (481)
Q Consensus 284 a~eiL~h~~f~~ 295 (481)
++|||+||||+.
T Consensus 322 a~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 322 AGGLVNHPWLKD 333 (362)
T ss_dssp HHHHHTCGGGTT
T ss_pred HHHHhcCcccCC
Confidence 999999999974
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=344.81 Aligned_cols=244 Identities=22% Similarity=0.262 Sum_probs=178.7
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCCCcchhHH--HHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKEGFPITAI--REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 80 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~--~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 80 (481)
|+||+||+|++ +|+.||||+++.... .... +|+..+++++|||||++++++.+... ...
T Consensus 14 G~fg~Vy~~~~--~g~~vAvK~~~~~~~-----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~------------~~~ 74 (303)
T d1vjya_ 14 GRFGEVWRGKW--RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDNG------------TWT 74 (303)
T ss_dssp CSSSEEEEEEE--TTEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS------------SSE
T ss_pred CCCeEEEEEEE--CCEEEEEEEECccch-----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC------------cce
Confidence 89999999986 789999999975432 2333 45555567899999999999986321 134
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCcEEEcCCCCeEEecc
Q 011627 81 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV--------NQVLHRDIKGSNLLIDNEGNLKLADF 151 (481)
Q Consensus 81 ~~~iV~Ey~~g-~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~--------~giiHrDLKp~NILl~~~~~vkL~DF 151 (481)
.+|||||||.+ +|.+++.+. .+++..+..++.|++.||+|||+ ++|+||||||+||||+.++++||+||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 68999999985 777777653 58999999999999999999996 59999999999999999999999999
Q ss_pred cccccccCCCC---CccccccccccCCCchhhcCCC-----CCCCCCchhhHHHHHHHHHhCCCCCCCCChH--------
Q 011627 152 GLARSFSYDHN---NTLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEA-------- 215 (481)
Q Consensus 152 G~a~~~~~~~~---~~~~~~~gt~~Y~aPEvl~~~~-----~~~~~~DiwSlGvil~elltG~~pf~~~~~~-------- 215 (481)
|+++....... ......+||+.|+|||++.+.. .++.++||||||||||||+||..||......
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 99987654322 2334567899999999987532 1466899999999999999998877532211
Q ss_pred ------HHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHHhhhcHHHHHHHHHhcccCCCCCCCHHHHhc
Q 011627 216 ------EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 289 (481)
Q Consensus 216 ------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~sa~eiL~ 289 (481)
+.+.+...... .++... . .........++.+||.+||+.||++|||+.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~------------------~~p~~~--~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQK------------------LRPNIP--N--RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CSSCCHHHHHHHHTTSC------------------CCCCCC--G--GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHhccc------------------cCCCCC--c--ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11111110000 000000 0 0001123456889999999999999999999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1e-24 Score=197.90 Aligned_cols=163 Identities=17% Similarity=0.091 Sum_probs=114.4
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecCCcCC----------------CcchhHHHHHHHHHhcCCCCccceeeEEeCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMDNEKE----------------GFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 66 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~~~~~----------------~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~ 66 (481)
|+||+||+|++. +|+.||||+++...... .....+.+|+.++.++.|.+++..+++...
T Consensus 11 G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~~---- 85 (191)
T d1zara2 11 GKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN---- 85 (191)
T ss_dssp CSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEETT----
T ss_pred CcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecCC----
Confidence 899999999984 78999999986432110 001233468899999999999998876432
Q ss_pred CCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCe
Q 011627 67 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 146 (481)
Q Consensus 67 ~~~~~~~~~~~~~~~~~iV~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~giiHrDLKp~NILl~~~~~v 146 (481)
+|+|||+++..... +++..+..++.||+.+|+|||++||+||||||+|||+++++ +
T Consensus 86 ----------------~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~ 141 (191)
T d1zara2 86 ----------------AVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-I 141 (191)
T ss_dssp ----------------EEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-E
T ss_pred ----------------EEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-E
Confidence 79999999854432 34445678999999999999999999999999999999754 9
Q ss_pred EEecccccccccCCCCCccccccccccCCCchhhcCCCCCCCCCchhhHHHHH
Q 011627 147 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 199 (481)
Q Consensus 147 kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPEvl~~~~~~~~~~DiwSlGvil 199 (481)
+|+|||+|+............+-.+. --|.+. +.|+.++|+||+.--+
T Consensus 142 ~liDFG~a~~~~~~~~~~~l~rd~~~---~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWREILERDVRN---IITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHHHHHHHHHHH---HHHHHH--HHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcHHHHHHHHHH---HHHHHc--CCCCCcccHHHHHHHH
Confidence 99999999765422111110000000 012222 4578899999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.29 E-value=3.7e-06 Score=77.32 Aligned_cols=125 Identities=15% Similarity=0.119 Sum_probs=80.9
Q ss_pred eEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcC-CCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEE
Q 011627 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYM 84 (481)
Q Consensus 6 g~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 84 (481)
+.||++. .+++.++||+....... ....+.+|..+++.|. +--+.+++.+..+ .+..||
T Consensus 28 ~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~----------------~~~~~l 87 (263)
T d1j7la_ 28 AKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH----------------DGWSNL 87 (263)
T ss_dssp SEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE----------------TTEEEE
T ss_pred CcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEec----------------CCceEE
Confidence 5799875 46777888887654322 2335678999998884 3335666766655 567899
Q ss_pred EEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 011627 85 VFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV--------------------------------------- 125 (481)
Q Consensus 85 V~Ey~~g~L~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~--------------------------------------- 125 (481)
||++++|.......... . ....++.++...|..||+
T Consensus 88 v~~~l~G~~~~~~~~~~--~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE--Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTTTC--S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEeccccccccccccc--c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999984332221111 1 122233444444444442
Q ss_pred --------------------CCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 126 --------------------NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 126 --------------------~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
..++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 126899999999999987656799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=1.3e-05 Score=73.13 Aligned_cols=64 Identities=14% Similarity=0.137 Sum_probs=45.0
Q ss_pred eEEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCC--ccceeeEEeCCCCCCCCCCCCCCCCcCCeEE
Q 011627 6 SQVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 83 (481)
Q Consensus 6 g~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (481)
+.||++.. .++..++||...... ...+.+|+.+|+.|.... +.+++.+..+ .+..+
T Consensus 25 ~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~----------------~~~~~ 82 (255)
T d1nd4a_ 25 AAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE----------------AGRDW 82 (255)
T ss_dssp CEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC----------------SSCEE
T ss_pred CeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeeccc----------------ccceE
Confidence 57898875 456778889765432 235678999998885433 4556666655 45679
Q ss_pred EEEecCCC
Q 011627 84 MVFEYMDH 91 (481)
Q Consensus 84 iV~Ey~~g 91 (481)
+|||+++|
T Consensus 83 ~v~~~i~G 90 (255)
T d1nd4a_ 83 LLLGEVPG 90 (255)
T ss_dssp EEEECCSS
T ss_pred EEEEeeec
Confidence 99999987
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=4e-05 Score=74.95 Aligned_cols=71 Identities=17% Similarity=0.013 Sum_probs=42.9
Q ss_pred cceeEEEEEEEccCCcEEEEEEeecC-----CcCCCcchhHHHHHHHHHhcC-C--CCccceeeEEeCCCCCCCCCCCCC
Q 011627 3 VCISQVFMAREIKTGEIVALKKIRMD-----NEKEGFPITAIREIKILKKLQ-H--ENVIKLKEIVTSPGPERDEQGRPD 74 (481)
Q Consensus 3 G~fg~Vy~a~~~~tg~~vAvK~i~~~-----~~~~~~~~~~~~Ei~il~~L~-h--pnIv~l~~~~~~~~~~~~~~~~~~ 74 (481)
|....||++.+..+++.|+||.-... ........+...|.++|+.+. + ..+.+++.+..
T Consensus 37 G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~------------- 103 (392)
T d2pula1 37 GNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------------- 103 (392)
T ss_dssp SSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------------
T ss_pred CceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------------
Confidence 44578999998888899999975421 111223345667999998873 2 34555554432
Q ss_pred CCCcCCeEEEEEecCCC
Q 011627 75 GNKYRGSTYMVFEYMDH 91 (481)
Q Consensus 75 ~~~~~~~~~iV~Ey~~g 91 (481)
...+||||++++
T Consensus 104 -----~~~~lvmE~L~~ 115 (392)
T d2pula1 104 -----EMAVTVMEDLSH 115 (392)
T ss_dssp -----TTTEEEECCCTT
T ss_pred -----CCCEEEEeccCC
Confidence 234789999975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.63 E-value=7.2e-05 Score=71.05 Aligned_cols=134 Identities=13% Similarity=0.109 Sum_probs=76.0
Q ss_pred EEEEEEEccCCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCccceeeEEeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 011627 7 QVFMAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 86 (481)
Q Consensus 7 ~Vy~a~~~~tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV~ 86 (481)
.||+++. ++|+.|++|+.+.... ...++..|+..+..|....|.-..-+..... ......+..+.|+
T Consensus 37 ~vy~v~~-~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~---------~~~~~~~~~~~l~ 103 (325)
T d1zyla1 37 RVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQ---------TLLNHQGFYFAVF 103 (325)
T ss_dssp EEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTB---------SCEEETTEEEEEE
T ss_pred eeEEEEc-CCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCC---------eeeeeeeEEEEEE
Confidence 6999876 5788899999875432 2446778999999886433321111111110 1112366789999
Q ss_pred ecCCCChhh-------------------hhcCC----CCCCCH----------------------HHHHHHHHHHHHHHH
Q 011627 87 EYMDHDLTG-------------------LADRP----GLRFTV----------------------PQIKCYMKQLLTGLH 121 (481)
Q Consensus 87 Ey~~g~L~~-------------------~~~~~----~~~l~~----------------------~~i~~i~~Qil~gL~ 121 (481)
+++.|.... ..... ...++. ......+..++..+.
T Consensus 104 ~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 183 (325)
T d1zyla1 104 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 183 (325)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred eecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999862110 00000 001111 112223333443333
Q ss_pred HHH----hCCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 122 YCH----VNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 122 ~LH----~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
-+- ..++||+|+.+.|||++++ ..|+||+.++
T Consensus 184 ~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 184 AHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred HhccccCCceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 321 1368999999999999753 5689999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.18 E-value=0.00081 Score=65.30 Aligned_cols=62 Identities=21% Similarity=0.195 Sum_probs=41.5
Q ss_pred eEEEEEEEcc-------CCcEEEEEEeecCCcCCCcchhHHHHHHHHHhcCCCCc-cceeeEEeCCCCCCCCCCCCCCCC
Q 011627 6 SQVFMAREIK-------TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENV-IKLKEIVTSPGPERDEQGRPDGNK 77 (481)
Q Consensus 6 g~Vy~a~~~~-------tg~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~L~hpnI-v~l~~~~~~~~~~~~~~~~~~~~~ 77 (481)
-.+|++.... ..+.|.|++.-.. . ......+|..+++.+.--+| .+++.++.+
T Consensus 56 N~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--------------- 116 (395)
T d1nw1a_ 56 NMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E-TESHLVAESVIFTLLSERHLGPKLYGIFSG--------------- 116 (395)
T ss_dssp EEEEEEEECTTSCCSSSCCSEEEEEEECSC---C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT---------------
T ss_pred cceEEEEeCCCCccccCCCCcEEEEecCCc---c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---------------
Confidence 3588887643 3466777776521 1 23456689999999964344 477777643
Q ss_pred cCCeEEEEEecCCC
Q 011627 78 YRGSTYMVFEYMDH 91 (481)
Q Consensus 78 ~~~~~~iV~Ey~~g 91 (481)
.+|+||+++
T Consensus 117 -----g~I~efi~g 125 (395)
T d1nw1a_ 117 -----GRLEEYIPS 125 (395)
T ss_dssp -----EEEECCCCE
T ss_pred -----ceEEEEecc
Confidence 689999987
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.61 E-value=0.0012 Score=61.69 Aligned_cols=30 Identities=27% Similarity=0.310 Sum_probs=26.8
Q ss_pred CCcccCCCCCCcEEEcCCCCeEEecccccc
Q 011627 126 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 155 (481)
Q Consensus 126 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 155 (481)
.|+||+|+.++||+++.+..+-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988777899999874
|